Psyllid ID: psy3663
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 259 | 2.2.26 [Sep-21-2011] | |||||||
| Q9NRH2 | 765 | SNF-related serine/threon | yes | N/A | 0.861 | 0.291 | 0.834 | 1e-111 | |
| Q8VDU5 | 748 | SNF-related serine/threon | yes | N/A | 0.861 | 0.298 | 0.834 | 1e-111 | |
| Q63553 | 746 | SNF-related serine/threon | yes | N/A | 0.861 | 0.298 | 0.834 | 1e-111 | |
| Q9P0L2 | 795 | Serine/threonine-protein | no | N/A | 0.787 | 0.256 | 0.533 | 7e-63 | |
| Q8VHF0 | 797 | MAP/microtubule affinity- | no | N/A | 0.799 | 0.259 | 0.531 | 9e-63 | |
| Q8VHJ5 | 795 | Serine/threonine-protein | no | N/A | 0.787 | 0.256 | 0.533 | 1e-62 | |
| O08678 | 793 | Serine/threonine-protein | no | N/A | 0.787 | 0.257 | 0.533 | 2e-62 | |
| P27448 | 753 | MAP/microtubule affinity- | no | N/A | 0.853 | 0.293 | 0.504 | 3e-62 | |
| Q03141 | 753 | MAP/microtubule affinity- | no | N/A | 0.799 | 0.274 | 0.526 | 4e-62 | |
| O08679 | 722 | Serine/threonine-protein | no | N/A | 0.849 | 0.304 | 0.504 | 3e-61 |
| >sp|Q9NRH2|SNRK_HUMAN SNF-related serine/threonine-protein kinase OS=Homo sapiens GN=SNRK PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 401 bits (1031), Expect = e-111, Method: Compositional matrix adjust.
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD ++ HL+QEVRC
Sbjct: 7 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRC 66
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 67 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHA 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CHKLHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 127 ISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 186
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 187 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 229
|
May play a role in hematopoietic cell proliferation or differentiation. Potential mediator of neuronal apoptosis. Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8VDU5|SNRK_MOUSE SNF-related serine/threonine-protein kinase OS=Mus musculus GN=Snrk PE=1 SV=1 | Back alignment and function description |
|---|
Score = 400 bits (1027), Expect = e-111, Method: Compositional matrix adjust.
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD ++ HL+QEVRC
Sbjct: 7 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRC 66
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 67 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHA 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CHKLHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 127 ISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 186
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 187 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 229
|
May play a role in hematopoietic cell proliferation or differentiation. Potential mediator of neuronal apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q63553|SNRK_RAT SNF-related serine/threonine-protein kinase OS=Rattus norvegicus GN=Snrk PE=1 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1026), Expect = e-111, Method: Compositional matrix adjust.
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD ++ HL+QEVRC
Sbjct: 7 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRC 66
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 67 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHA 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CHKLHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 127 ISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 186
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 187 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 229
|
May play a role in hematopoietic cell proliferation or differentiation. Potential mediator of neuronal apoptosis. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9P0L2|MARK1_HUMAN Serine/threonine-protein kinase MARK1 OS=Homo sapiens GN=MARK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 240 bits (613), Expect = 7e-63, Method: Compositional matrix adjust.
Identities = 110/206 (53%), Positives = 149/206 (72%), Gaps = 2/206 (0%)
Query: 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
G Y L++T+G+G+FA VKLARHV TG +VAVK+IDKT+L+P S L++EVR MK++ HP
Sbjct: 58 GNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 117
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
N+V+L+EVI+T LYL++E GG+++DY++ H + E AR F QIV A+ +CH+
Sbjct: 118 NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAVQYCHQK 176
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDA 197
++VHRDLK EN++ + +K+ DFGFSN F G KL+T CGS Y+APE+ G YD
Sbjct: 177 YIVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDG 235
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEAN 223
P VDVWSLGVILY LV+G PF N
Sbjct: 236 PEVDVWSLGVILYTLVSGSLPFDGQN 261
|
Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates DCX, MAP2, MAP4 and MAPT/TAU. Involved in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q8VHF0|MARK3_RAT MAP/microtubule affinity-regulating kinase 3 OS=Rattus norvegicus GN=Mark3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (612), Expect = 9e-63, Method: Compositional matrix adjust.
Identities = 111/209 (53%), Positives = 149/209 (71%), Gaps = 2/209 (0%)
Query: 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
G Y L +T+G+G+FA VKLARH+ TG +VA+K+IDKT+L+P S L++EVR MK++ HP
Sbjct: 54 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 113
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
N+V+L+EVI+T LYLI+E GG+++DY++ H + E AR F QIV A+ +CH+
Sbjct: 114 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAVQYCHQK 172
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDA 197
+VHRDLK EN++ + +K+TDFGFSN F G KL+T CGS Y+APE+ G YD
Sbjct: 173 RIVHRDLKAENLLLDADMN-IKITDFGFSNEFTVGSKLDTFCGSPPYAAPELFQGKKYDG 231
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSE 226
P VDVWSLGVILY LV+G PF N E
Sbjct: 232 PEVDVWSLGVILYTLVSGSLPFDGQNLKE 260
|
Involved in the specific phosphorylation of microtubule-associated proteins for tau, MAP2 and MAP4. Phosphorylates CDC25C. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8VHJ5|MARK1_MOUSE Serine/threonine-protein kinase MARK1 OS=Mus musculus GN=Mark1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 110/206 (53%), Positives = 148/206 (71%), Gaps = 2/206 (0%)
Query: 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
G Y L++T+G+G+FA VKLARHV TG +VAVK+IDKT+L+P S L++EVR MK++ HP
Sbjct: 58 GNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 117
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
N+V+L+EVI+T LYL++E GG+++DY++ H + E AR F QIV A+ +CH+
Sbjct: 118 NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAVQYCHQK 176
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDA 197
+VHRDLK EN++ + +K+ DFGFSN F G KL+T CGS Y+APE+ G YD
Sbjct: 177 CIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDG 235
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEAN 223
P VDVWSLGVILY LV+G PF N
Sbjct: 236 PEVDVWSLGVILYTLVSGSLPFDGQN 261
|
Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates DCX, MAP2, MAP4 and MAPT/TAU. Involved in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|O08678|MARK1_RAT Serine/threonine-protein kinase MARK1 OS=Rattus norvegicus GN=Mark1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (610), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 110/206 (53%), Positives = 148/206 (71%), Gaps = 2/206 (0%)
Query: 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
G Y L++T+G+G+FA VKLARHV TG +VAVK+IDKT+L+P S L++EVR MK++ HP
Sbjct: 58 GNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 117
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
N+V+L+EVI+T LYL++E GG+++DY++ H + E AR F QIV A+ +CH+
Sbjct: 118 NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAVQYCHQK 176
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDA 197
+VHRDLK EN++ + +K+ DFGFSN F G KL+T CGS Y+APE+ G YD
Sbjct: 177 CIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDG 235
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEAN 223
P VDVWSLGVILY LV+G PF N
Sbjct: 236 PEVDVWSLGVILYTLVSGSLPFDGQN 261
|
Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates DCX, MAP2, MAP4 and MAPT/TAU. Involved in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P27448|MARK3_HUMAN MAP/microtubule affinity-regulating kinase 3 OS=Homo sapiens GN=MARK3 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 238 bits (607), Expect = 3e-62, Method: Compositional matrix adjust.
Identities = 117/232 (50%), Positives = 157/232 (67%), Gaps = 11/232 (4%)
Query: 2 SRSGSRS-------SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKT 54
SRSG+R +D P G Y L +T+G+G+FA VKLARH+ TG +VA+K+IDKT
Sbjct: 33 SRSGARCRNSIASCADEQPH--IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKT 90
Query: 55 KLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG 114
+L+P S L++EVR MK++ HPN+V+L+EVI+T LYLI+E GG+++DY++ H
Sbjct: 91 QLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GR 149
Query: 115 LSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174
+ E AR F QIV A+ +CH+ +VHRDLK EN++ + +K+ DFGFSN F G K
Sbjct: 150 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGK 208
Query: 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226
L+T CGS Y+APE+ G YD P VDVWSLGVILY LV+G PF N E
Sbjct: 209 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 260
|
Involved in the specific phosphorylation of microtubule-associated proteins for tau, MAP2 and MAP4. Phosphorylates CDC25C on 'Ser-216'. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q03141|MARK3_MOUSE MAP/microtubule affinity-regulating kinase 3 OS=Mus musculus GN=Mark3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 238 bits (606), Expect = 4e-62, Method: Compositional matrix adjust.
Identities = 110/209 (52%), Positives = 148/209 (70%), Gaps = 2/209 (0%)
Query: 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
G Y L +T+G+G+FA VKLARH+ TG +VA+K+IDKT+L+P S L++EVR MK++ HP
Sbjct: 54 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 113
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
N+V+L+EVI+T LYLI+E GG+++DY++ H + E AR F QIV A+ +CH+
Sbjct: 114 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARAKFRQIVSAVQYCHQK 172
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDA 197
+VHRDLK EN++ + +K+ DFGFSN F G KL+T CGS Y+APE+ G YD
Sbjct: 173 RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGSKLDTFCGSPPYAAPELFQGKKYDG 231
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSE 226
P VDVWSLGVILY LV+G PF N E
Sbjct: 232 PEVDVWSLGVILYTLVSGSLPFDGQNLKE 260
|
Involved in the specific phosphorylation of microtubule-associated proteins for tau, MAP2 and MAP4. Phosphorylates CDC25C. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O08679|MARK2_RAT Serine/threonine-protein kinase MARK2 OS=Rattus norvegicus GN=Mark2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 234 bits (598), Expect = 3e-61, Method: Compositional matrix adjust.
Identities = 113/224 (50%), Positives = 155/224 (69%), Gaps = 4/224 (1%)
Query: 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD 62
R+ + S+D P G Y L +T+G+G+FA VKLARH+ TG++VAVK+IDKT+L+ S
Sbjct: 38 RNSATSADEQPH--IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ 95
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE 122
L++EVR MK++ HPN+V+L+EVI+T LYL++E GG+++DY++ H + E AR
Sbjct: 96 KLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARA 154
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
F QIV A+ +CH+ +VHRDLK EN++ + +K+ DFGFSN F G KL+T CGS
Sbjct: 155 KFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSP 213
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226
Y+APE+ G YD P VDVWSLGVILY LV+G PF N E
Sbjct: 214 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 257
|
Serine/threonine-protein kinase involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4, MAPT/TAU and RAB11FIP2. Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 259 | ||||||
| 332031576 | 1102 | SNF-related serine/threonine-protein kin | 0.849 | 0.199 | 0.909 | 1e-116 | |
| 307171702 | 1102 | SNF-related serine/threonine-protein kin | 0.880 | 0.206 | 0.878 | 1e-116 | |
| 350408791 | 1093 | PREDICTED: hypothetical protein LOC10074 | 0.884 | 0.209 | 0.879 | 1e-116 | |
| 307213114 | 1122 | SNF-related serine/threonine-protein kin | 0.884 | 0.204 | 0.875 | 1e-116 | |
| 340720315 | 1096 | PREDICTED: hypothetical protein LOC10064 | 0.884 | 0.208 | 0.879 | 1e-116 | |
| 383848127 | 1096 | PREDICTED: uncharacterized protein LOC10 | 0.849 | 0.200 | 0.909 | 1e-116 | |
| 66518314 | 1092 | PREDICTED: hypothetical protein LOC41351 | 0.884 | 0.209 | 0.879 | 1e-116 | |
| 380027655 | 1100 | PREDICTED: uncharacterized protein LOC10 | 0.884 | 0.208 | 0.879 | 1e-116 | |
| 157138605 | 1121 | serine/threonine protein kinase [Aedes a | 0.845 | 0.195 | 0.894 | 1e-115 | |
| 242008953 | 317 | RAC protein kinase DRAC-PK85, putative [ | 0.876 | 0.716 | 0.886 | 1e-115 |
| >gi|332031576|gb|EGI71048.1| SNF-related serine/threonine-protein kinase [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1090), Expect = e-116, Method: Compositional matrix adjust.
Identities = 200/220 (90%), Positives = 209/220 (95%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDK+KLD VS+ HL+QEVRCMKLV
Sbjct: 13 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKSKLDEVSRAHLFQEVRCMKLV 72
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
QHPNVVRLYEVIDT +KLYLILELGDGGDLYDYIM+HD+GLSE AR YF QIVRAIS+C
Sbjct: 73 QHPNVVRLYEVIDTQTKLYLILELGDGGDLYDYIMRHDSGLSEEVARTYFRQIVRAISYC 132
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDS 194
H+LHVVHRDLKPENVVFFE+LG VKLTDFGFSNRF PGQKLETSCGSLAYSAPEILLGDS
Sbjct: 133 HRLHVVHRDLKPENVVFFEKLGTVKLTDFGFSNRFCPGQKLETSCGSLAYSAPEILLGDS 192
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
YDAPAVDVWSLGVILYMLV GQAPFQEANDSETLTMIMD
Sbjct: 193 YDAPAVDVWSLGVILYMLVCGQAPFQEANDSETLTMIMDC 232
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307171702|gb|EFN63437.1| SNF-related serine/threonine-protein kinase [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 424 bits (1089), Expect = e-116, Method: Compositional matrix adjust.
Identities = 203/231 (87%), Positives = 213/231 (92%), Gaps = 3/231 (1%)
Query: 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD 62
R G + DG KIAGLYDLEETLGRGHFA+VKLARHVFTGEKVAVKVIDK KLD VS+
Sbjct: 4 RVGYSNYDG---KIAGLYDLEETLGRGHFAIVKLARHVFTGEKVAVKVIDKNKLDEVSRA 60
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE 122
HL+QEVRCMKLVQHPNVVRLYEVIDT +KLYLILELGDGGDLYDYIM+HD+GLSE AR
Sbjct: 61 HLFQEVRCMKLVQHPNVVRLYEVIDTQTKLYLILELGDGGDLYDYIMRHDSGLSEEVART 120
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
YF QIVRAIS+CH+LHVVHRDLKPENVVFFE+LG VKLTDFGFSNRF PGQKLETSCGSL
Sbjct: 121 YFRQIVRAISYCHRLHVVHRDLKPENVVFFEKLGTVKLTDFGFSNRFYPGQKLETSCGSL 180
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
AYSAPEILLGDSYDAPAVDVWSLGVILYMLV GQAPFQEANDSETLTMIMD
Sbjct: 181 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVCGQAPFQEANDSETLTMIMD 231
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350408791|ref|XP_003488516.1| PREDICTED: hypothetical protein LOC100742095 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1088), Expect = e-116, Method: Compositional matrix adjust.
Identities = 204/232 (87%), Positives = 214/232 (92%), Gaps = 3/232 (1%)
Query: 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD 62
R G + DG KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDK+KLD VS+
Sbjct: 4 RVGYSNYDG---KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKSKLDEVSRA 60
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE 122
HL+QEVRCMKLVQHPNVVRLYEVIDT +KLYLILELGDGGDLYDYIM+HD+GLSE AR
Sbjct: 61 HLFQEVRCMKLVQHPNVVRLYEVIDTQTKLYLILELGDGGDLYDYIMRHDSGLSEEVART 120
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
YF QIVRAIS+CH+LHVVHRDLKPENVVFFE+LG VKLTDFGFSNRF PGQKLETSCGSL
Sbjct: 121 YFRQIVRAISYCHRLHVVHRDLKPENVVFFEKLGTVKLTDFGFSNRFCPGQKLETSCGSL 180
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
AYSAPEILLGDSYDAPAVDVWSLGVILYMLV GQAPFQEANDSETLTMIMD
Sbjct: 181 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVCGQAPFQEANDSETLTMIMDC 232
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307213114|gb|EFN88636.1| SNF-related serine/threonine-protein kinase [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1088), Expect = e-116, Method: Compositional matrix adjust.
Identities = 203/232 (87%), Positives = 215/232 (92%), Gaps = 3/232 (1%)
Query: 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD 62
R G ++ DG KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVI+K+KLD VS+
Sbjct: 4 RVGYKNYDG---KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIEKSKLDEVSRA 60
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE 122
HL+QEVRCMKLVQHPNVVRLYEVIDT +KLYLILELGDGGDLYDYIM+HD+GLSE AR
Sbjct: 61 HLFQEVRCMKLVQHPNVVRLYEVIDTQTKLYLILELGDGGDLYDYIMRHDSGLSEEVART 120
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
YF QIVRAIS+CH+LHVVHRDLKPENVVFFE+LG VKLTDFGFSNRF PGQKLETSCGSL
Sbjct: 121 YFRQIVRAISYCHRLHVVHRDLKPENVVFFEKLGTVKLTDFGFSNRFCPGQKLETSCGSL 180
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
AYSAPEILLGDSYDAPAVDVWSLGVILYMLV GQAPFQEANDSETLTMIMD
Sbjct: 181 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVCGQAPFQEANDSETLTMIMDC 232
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340720315|ref|XP_003398586.1| PREDICTED: hypothetical protein LOC100643582 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1088), Expect = e-116, Method: Compositional matrix adjust.
Identities = 204/232 (87%), Positives = 213/232 (91%), Gaps = 3/232 (1%)
Query: 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD 62
R G + DG KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDK KLD VS+
Sbjct: 4 RVGYSNYDG---KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKNKLDEVSRA 60
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE 122
HL+QEVRCMKLVQHPNVVRLYEVIDT +KLYLILELGDGGDLYDYIM+HD+GLSE AR
Sbjct: 61 HLFQEVRCMKLVQHPNVVRLYEVIDTQTKLYLILELGDGGDLYDYIMRHDSGLSEEVART 120
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
YF QIVRAIS+CH+LHVVHRDLKPENVVFFE+LG VKLTDFGFSNRF PGQKLETSCGSL
Sbjct: 121 YFRQIVRAISYCHRLHVVHRDLKPENVVFFEKLGTVKLTDFGFSNRFCPGQKLETSCGSL 180
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
AYSAPEILLGDSYDAPAVDVWSLGVILYMLV GQAPFQEANDSETLTMIMD
Sbjct: 181 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVCGQAPFQEANDSETLTMIMDC 232
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383848127|ref|XP_003699703.1| PREDICTED: uncharacterized protein LOC100877868 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1087), Expect = e-116, Method: Compositional matrix adjust.
Identities = 200/220 (90%), Positives = 209/220 (95%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDK+KLD VS+ HL+QEVRCMKLV
Sbjct: 13 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKSKLDEVSRAHLFQEVRCMKLV 72
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
QHPNVVRLYEVIDT +KLYLILELGDGGDLYDYIM+HD+GLSE AR YF QIVRAIS+C
Sbjct: 73 QHPNVVRLYEVIDTQTKLYLILELGDGGDLYDYIMRHDSGLSEEVARTYFRQIVRAISYC 132
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDS 194
H+LHVVHRDLKPENVVFFE+LG VKLTDFGFSNRF PGQKLETSCGSLAYSAPEILLGDS
Sbjct: 133 HRLHVVHRDLKPENVVFFEKLGTVKLTDFGFSNRFCPGQKLETSCGSLAYSAPEILLGDS 192
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
YDAPAVDVWSLGVILYMLV GQAPFQEANDSETLTMIMD
Sbjct: 193 YDAPAVDVWSLGVILYMLVCGQAPFQEANDSETLTMIMDC 232
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|66518314|ref|XP_396953.2| PREDICTED: hypothetical protein LOC413510 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1087), Expect = e-116, Method: Compositional matrix adjust.
Identities = 204/232 (87%), Positives = 214/232 (92%), Gaps = 3/232 (1%)
Query: 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD 62
R G + DG KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDK+KLD VS+
Sbjct: 4 RVGYSNYDG---KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKSKLDEVSRA 60
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE 122
HL+QEVRCMKLVQHPNVVRLYEVIDT +KLYLILELGDGGDLYDYIM+HD+GLSE AR
Sbjct: 61 HLFQEVRCMKLVQHPNVVRLYEVIDTQTKLYLILELGDGGDLYDYIMRHDSGLSEEVART 120
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
YF QIVRAIS+CH+LHVVHRDLKPENVVFFE+LG VKLTDFGFSNRF PGQKLETSCGSL
Sbjct: 121 YFRQIVRAISYCHRLHVVHRDLKPENVVFFEKLGTVKLTDFGFSNRFCPGQKLETSCGSL 180
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
AYSAPEILLGDSYDAPAVDVWSLGVILYMLV GQAPFQEANDSETLTMIMD
Sbjct: 181 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVCGQAPFQEANDSETLTMIMDC 232
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380027655|ref|XP_003697536.1| PREDICTED: uncharacterized protein LOC100869602 [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 423 bits (1087), Expect = e-116, Method: Compositional matrix adjust.
Identities = 204/232 (87%), Positives = 214/232 (92%), Gaps = 3/232 (1%)
Query: 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD 62
R G + DG KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDK+KLD VS+
Sbjct: 12 RVGYSNYDG---KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKSKLDEVSRA 68
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE 122
HL+QEVRCMKLVQHPNVVRLYEVIDT +KLYLILELGDGGDLYDYIM+HD+GLSE AR
Sbjct: 69 HLFQEVRCMKLVQHPNVVRLYEVIDTQTKLYLILELGDGGDLYDYIMRHDSGLSEEVART 128
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
YF QIVRAIS+CH+LHVVHRDLKPENVVFFE+LG VKLTDFGFSNRF PGQKLETSCGSL
Sbjct: 129 YFRQIVRAISYCHRLHVVHRDLKPENVVFFEKLGTVKLTDFGFSNRFCPGQKLETSCGSL 188
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
AYSAPEILLGDSYDAPAVDVWSLGVILYMLV GQAPFQEANDSETLTMIMD
Sbjct: 189 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVCGQAPFQEANDSETLTMIMDC 240
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|157138605|ref|XP_001664275.1| serine/threonine protein kinase [Aedes aegypti] gi|108880563|gb|EAT44788.1| AAEL003896-PA [Aedes aegypti] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1080), Expect = e-115, Method: Compositional matrix adjust.
Identities = 196/219 (89%), Positives = 207/219 (94%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
KIAGLYDLEETLG GHFAVVKLARHVFTGEKVAVKVIDKTKLD +S+ HL+QEVRCMKLV
Sbjct: 19 KIAGLYDLEETLGSGHFAVVKLARHVFTGEKVAVKVIDKTKLDEISRAHLFQEVRCMKLV 78
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
QHPNVVRLYEVIDT +KLYLILELGDGGDLYDYIM+HD GL+E AREYF QIVRAIS+C
Sbjct: 79 QHPNVVRLYEVIDTQTKLYLILELGDGGDLYDYIMRHDKGLTENVAREYFRQIVRAISYC 138
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDS 194
H+LHVVHRDLKPENVVFFE+LGVVKLTDFGFSN+F PGQKLETSCGSLAYSAPEILLGDS
Sbjct: 139 HQLHVVHRDLKPENVVFFEKLGVVKLTDFGFSNKFCPGQKLETSCGSLAYSAPEILLGDS 198
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
YDAPAVDVWSLGVIL+MLV G PFQEANDSETLTMIMD
Sbjct: 199 YDAPAVDVWSLGVILFMLVCGHPPFQEANDSETLTMIMD 237
|
Source: Aedes aegypti Species: Aedes aegypti Genus: Aedes Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242008953|ref|XP_002425258.1| RAC protein kinase DRAC-PK85, putative [Pediculus humanus corporis] gi|212509014|gb|EEB12520.1| RAC protein kinase DRAC-PK85, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 420 bits (1079), Expect = e-115, Method: Compositional matrix adjust.
Identities = 204/230 (88%), Positives = 215/230 (93%), Gaps = 3/230 (1%)
Query: 4 SGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH 63
+ +S DG KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD VS+ H
Sbjct: 9 TAKKSYDG---KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDEVSKAH 65
Query: 64 LYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREY 123
L+QEVRCMKLVQHPNVVRLYEVIDT +KLYLILELGDGGDLYDYIMKH+ GL E A+EY
Sbjct: 66 LFQEVRCMKLVQHPNVVRLYEVIDTQTKLYLILELGDGGDLYDYIMKHETGLGEDMAKEY 125
Query: 124 FAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA 183
F QIVRAIS+CH+LHVVHRDLKPENVVFFERLGVVKLTDFGFSN+F PGQKL+TSCGSLA
Sbjct: 126 FRQIVRAISYCHQLHVVHRDLKPENVVFFERLGVVKLTDFGFSNKFCPGQKLDTSCGSLA 185
Query: 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD
Sbjct: 186 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 235
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 259 | ||||||
| FB|FBgn0033915 | 860 | CG8485 [Drosophila melanogaste | 0.857 | 0.258 | 0.862 | 1.6e-102 | |
| UNIPROTKB|F1NZ22 | 772 | SNRK "Uncharacterized protein" | 0.861 | 0.288 | 0.834 | 2.1e-100 | |
| UNIPROTKB|E1BHE7 | 694 | SNRK "Uncharacterized protein" | 0.861 | 0.321 | 0.834 | 2.1e-100 | |
| UNIPROTKB|F1PNI5 | 755 | SNRK "Uncharacterized protein" | 0.861 | 0.295 | 0.834 | 2.1e-100 | |
| UNIPROTKB|J9NSM5 | 719 | SNRK "Uncharacterized protein" | 0.861 | 0.310 | 0.834 | 2.1e-100 | |
| UNIPROTKB|Q9NRH2 | 765 | SNRK "SNF-related serine/threo | 0.861 | 0.291 | 0.834 | 2.1e-100 | |
| UNIPROTKB|F1SRD3 | 767 | SNRK "Uncharacterized protein" | 0.861 | 0.290 | 0.834 | 2.1e-100 | |
| MGI|MGI:108104 | 748 | Snrk "SNF related kinase" [Mus | 0.861 | 0.298 | 0.834 | 2.1e-100 | |
| RGD|69653 | 746 | Snrk "SNF related kinase" [Rat | 0.861 | 0.298 | 0.834 | 2.1e-100 | |
| ZFIN|ZDB-GENE-040718-84 | 804 | snrka "SNF related kinase a" [ | 0.861 | 0.277 | 0.834 | 2.1e-100 |
| FB|FBgn0033915 CG8485 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1016 (362.7 bits), Expect = 1.6e-102, P = 1.6e-102
Identities = 194/225 (86%), Positives = 211/225 (93%)
Query: 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEV 68
SDG KIAGLYDLEETLG GHFAVVKLARHVFTG KVAVKV+DKTKLD VS+ HL+QEV
Sbjct: 12 SDG---KIAGLYDLEETLGSGHFAVVKLARHVFTGAKVAVKVVDKTKLDDVSKAHLFQEV 68
Query: 69 RCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIV 128
RCMKLVQHPNVVRLYEVIDT +KLYL+LELGDGGDLYDYIMKHD+GLSE AR+YF QI+
Sbjct: 69 RCMKLVQHPNVVRLYEVIDTQTKLYLVLELGDGGDLYDYIMKHDSGLSEELARKYFRQIL 128
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPE 188
RAI++CH+LHVVHRDLKPENVVFFE+LG+VKLTDFGFSN+F PGQKLET CGSLAYSAPE
Sbjct: 129 RAITYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFLPGQKLETFCGSLAYSAPE 188
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
ILLGDSYDAPAVD+WSLGVILYMLV GQAPF++ANDSETLTMIMD
Sbjct: 189 ILLGDSYDAPAVDIWSLGVILYMLVCGQAPFEKANDSETLTMIMD 233
|
|
| UNIPROTKB|F1NZ22 SNRK "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD ++ HL+QEVRC
Sbjct: 14 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRC 73
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 74 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHA 133
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CHKLHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 134 ISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 193
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 194 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 236
|
|
| UNIPROTKB|E1BHE7 SNRK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD ++ HL+QEVRC
Sbjct: 7 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRC 66
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 67 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHA 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CHKLHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 127 ISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 186
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 187 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 229
|
|
| UNIPROTKB|F1PNI5 SNRK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD ++ HL+QEVRC
Sbjct: 7 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRC 66
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 67 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHA 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CHKLHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 127 ISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 186
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 187 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 229
|
|
| UNIPROTKB|J9NSM5 SNRK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD ++ HL+QEVRC
Sbjct: 7 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRC 66
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 67 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHA 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CHKLHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 127 ISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 186
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 187 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 229
|
|
| UNIPROTKB|Q9NRH2 SNRK "SNF-related serine/threonine-protein kinase" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD ++ HL+QEVRC
Sbjct: 7 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRC 66
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 67 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHA 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CHKLHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 127 ISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 186
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 187 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 229
|
|
| UNIPROTKB|F1SRD3 SNRK "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD ++ HL+QEVRC
Sbjct: 7 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRC 66
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 67 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHA 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CHKLHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 127 ISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 186
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 187 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 229
|
|
| MGI|MGI:108104 Snrk "SNF related kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD ++ HL+QEVRC
Sbjct: 7 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRC 66
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 67 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHA 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CHKLHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 127 ISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 186
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 187 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 229
|
|
| RGD|69653 Snrk "SNF related kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD ++ HL+QEVRC
Sbjct: 7 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLATGHLFQEVRC 66
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 67 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEDLAKKYFAQIVHA 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CHKLHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 127 ISYCHKLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 186
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 187 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 229
|
|
| ZFIN|ZDB-GENE-040718-84 snrka "SNF related kinase a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 2.1e-100, P = 2.1e-100
Identities = 186/223 (83%), Positives = 207/223 (92%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G+ KIAGLYDL++TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD V+ HL+QEVRC
Sbjct: 7 GYDGKIAGLYDLDKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTVATGHLFQEVRC 66
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
MKLVQHPN+VRLYEVIDT +KLYLILELGDGGD++DYIMKH+ GL+E A++YFAQIV A
Sbjct: 67 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDMFDYIMKHEEGLNEELAKKYFAQIVHA 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
IS+CH+LHVVHRDLKPENVVFFE+ G+VKLTDFGFSN+F PG+KL TSCGSLAYSAPEIL
Sbjct: 127 ISYCHRLHVVHRDLKPENVVFFEKQGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEIL 186
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
LGD YDAPAVD+WSLGVIL+MLV GQ PFQEANDSETLTMIMD
Sbjct: 187 LGDEYDAPAVDIWSLGVILFMLVCGQPPFQEANDSETLTMIMD 229
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q63553 | SNRK_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.8340 | 0.8610 | 0.2989 | yes | N/A |
| Q8VDU5 | SNRK_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.8340 | 0.8610 | 0.2981 | yes | N/A |
| Q9NRH2 | SNRK_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.8340 | 0.8610 | 0.2915 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 259 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-90 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-76 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-72 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-63 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-59 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-51 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-51 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-50 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-50 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-46 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-46 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-44 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-43 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-43 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-43 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-40 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-40 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-39 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-39 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-38 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-38 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-38 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-38 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-37 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-37 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-36 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-36 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-36 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-36 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-35 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-35 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-35 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-35 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-35 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-34 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-34 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-34 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-34 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-34 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-34 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-34 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-34 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-34 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-33 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-33 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-33 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-33 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-33 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-33 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-33 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-32 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-32 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-32 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-32 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-32 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-32 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-31 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-31 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-31 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-31 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-31 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-30 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-30 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-30 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-30 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-30 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-30 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-29 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-29 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-29 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-29 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-29 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-29 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-28 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-28 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-28 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-28 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-28 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-28 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-28 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-28 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-28 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-28 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-27 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-27 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-27 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-27 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-27 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-27 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-27 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-27 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-27 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-27 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-27 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-26 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-26 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-26 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-26 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-26 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-26 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-26 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-25 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-25 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-25 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-25 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-25 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-25 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-25 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-25 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-25 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-24 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-24 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-24 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-24 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-24 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-23 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-23 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-23 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-22 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-22 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-22 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-22 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-21 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-21 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-20 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-20 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-20 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-17 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-17 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-17 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-15 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-15 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-11 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-05 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.003 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 266 bits (683), Expect = 3e-90
Identities = 97/213 (45%), Positives = 136/213 (63%), Gaps = 4/213 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y++ E LG G F V LAR TG+ VA+KVI K K+ ++ + +E++ +K ++HPN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK-KDRERILREIKILKKLKHPNI 59
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
VRLY+V + KLYL++E +GGDL+D + K LSE AR Y QI+ A+ + H +
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSKGI 118
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
VHRDLKPEN++ E G VKL DFG + + +PG+KL T G+ Y APE+LLG Y A
Sbjct: 119 VHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYG-KA 176
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
VD+WSLGVILY L+ G+ PF + L +
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKI 209
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 230 bits (590), Expect = 5e-76
Identities = 86/213 (40%), Positives = 124/213 (58%), Gaps = 3/213 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y+L LG G F V A+H TG+ VAVK++ K +E+R ++ + HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
VRL + + LYL++E +GGDL+DY+ + LSE A++ QI+R + + H +
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGDSYDAP 198
+HRDLKPEN + + GVVK+ DFG + + L T G+ Y APE+LLG + P
Sbjct: 120 IHRDLKPEN-ILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
VDVWSLGVILY L+ G+ PF N + L +I
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 220 bits (564), Expect = 1e-72
Identities = 77/188 (40%), Positives = 111/188 (59%), Gaps = 2/188 (1%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG G F V LAR TG+KVA+K+I K + ++ L +E+ +K + HPN+V+LY V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE-LLREIEILKKLNHPNIVKLYGV 59
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
+ + LYL++E +GG L D + +++ LSE QI+ + + H ++HRDLK
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 146 PENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-CGSLAYSAPEILLGDSYDAPAVDVWS 204
PEN++ G VKL DFG S + L + G+ AY APE+LLG Y + D+WS
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179
Query: 205 LGVILYML 212
LGVILY L
Sbjct: 180 LGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 198 bits (506), Expect = 3e-63
Identities = 68/217 (31%), Positives = 112/217 (51%), Gaps = 6/217 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y++ + +G+G F V L R G+ +K ID + + ++ EV+ +K + HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG---LSETYAREYFAQIVRAISFCHK 136
++ YE + KL +++E DGGDL I K E ++F Q+ A+ + H
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLETSCGSLAYSAPEILLGDSY 195
++HRD+KP+N +F G+VKL DFG S + +T G+ Y +PE+ Y
Sbjct: 122 RKILHRDIKPQN-IFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY 180
Query: 196 DAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ + D+WSLG +LY L + PF+ N E I+
Sbjct: 181 NYKS-DIWSLGCVLYELCTLKHPFEGENLLELALKIL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 2e-59
Identities = 83/210 (39%), Positives = 119/210 (56%), Gaps = 5/210 (2%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYE 84
LG+G F V L R TG+ A+KV+ K K + +H E + + HP +V+L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDL 144
T KLYL+LE GG+L+ ++ K SE AR Y A+IV A+ + H L +++RDL
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119
Query: 145 KPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVW 203
KPEN++ G +KLTDFG + + G + T CG+ Y APE+LLG Y AVD W
Sbjct: 120 KPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYG-KAVDWW 177
Query: 204 SLGVILYMLVAGQAPFQEANDSETLTMIMD 233
SLGV+LY ++ G+ PF + E I+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 3e-51
Identities = 77/216 (35%), Positives = 114/216 (52%), Gaps = 16/216 (7%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDK-----TKLDPVSQDHLYQEVRCMKLVQHPNVV 80
LG G F V+L + A+K + K T Q+H++ E ++ HP +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ----QEHIFSEKEILEECNHPFIV 56
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKLHV 139
+LY +Y+++E GG+L+ + D G E AR Y A +V A + H +
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTIL--RDRGLFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
++RDLKPEN++ G VKL DFGF+ + GQK T CG+ Y APEI+L YD +
Sbjct: 115 IYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDF-S 172
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDS--ETLTMIMD 233
VD WSLG++LY L+ G+ PF E ++ E I+
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK 208
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 4e-51
Identities = 65/214 (30%), Positives = 115/214 (53%), Gaps = 4/214 (1%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
L+++ E +G+G F V ARH TG++VA+KVI + ++ + E++ +K +HPN
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE--KKEKIINEIQILKKCKHPN 58
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V+ Y +L++++E GG L D + + L+E+ ++++ + + H
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
++HRD+K N++ G VKL DFG S + + + T G+ + APE++ G YD
Sbjct: 119 IIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
A D+WSLG+ L G+ P+ E + L I
Sbjct: 178 A-DIWSLGITAIELAEGKPPYSELPPMKALFKIA 210
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 6e-51
Identities = 79/201 (39%), Positives = 122/201 (60%), Gaps = 6/201 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPN 78
++ +TLG G F V L RH +G+ A+K++ K K+ + Q +H+ E R ++ ++HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V LY +S LYL++E GG+L+ ++ K E AR Y AQ+V A+ + H L
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQVVLALEYLHSLD 121
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
+V+RDLKPEN++ + G +K+TDFGF+ R T CG+ Y APEI+L Y
Sbjct: 122 IVYRDLKPENLL-LDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGYGK- 177
Query: 199 AVDVWSLGVILYMLVAGQAPF 219
AVD W+LG+++Y ++AG PF
Sbjct: 178 AVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-50
Identities = 74/212 (34%), Positives = 111/212 (52%), Gaps = 13/212 (6%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRLYE 84
+ +G + V LA+ TG+ A+KVI K + +Q D + E + Q P VV+LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDL 144
LYL++E GGDL ++++ L E AR Y A+IV A+ + H ++HRDL
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119
Query: 145 KPENVVFFERLGVVKLTDFGFS---------NRFNPGQKLETSCGSLAYSAPEILLGDSY 195
KP+N++ + G +KLTDFG S N + ++ + G+ Y APE++LG +
Sbjct: 120 KPDNIL-IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 196 DAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227
+ VD WSLG ILY + G PF E
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHGETPEEI 209
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 1e-50
Identities = 68/237 (28%), Positives = 118/237 (49%), Gaps = 26/237 (10%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-QDHLYQEVRCM-KLVQHP 77
+ + +G G F+ V LA+ T ++ A+K++DK +L ++ E + +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
+++LY LY +LE G+L YI K+ L E R Y A+I+ A+ + H
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSK 121
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS------------------- 178
++HRDLKPEN++ + +K+TDFG + +P E++
Sbjct: 122 GIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 179 --CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
G+ Y +PE LL + + D+W+LG I+Y ++ G+ PF+ +N+ T I+
Sbjct: 181 SFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK 236
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-50
Identities = 83/214 (38%), Positives = 119/214 (55%), Gaps = 17/214 (7%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKL 73
Y+ E LG G + VV AR TGE VA+K I +LD P + +E+ +K
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---RLDNEEEGIPST---ALREISLLKE 54
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
++HPN+V+L +VI T KLYL+ E D DL Y+ K LS + Q++R +++
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLG 192
CH ++HRDLKP+N + R GV+KL DFG + F P + +L Y APEILLG
Sbjct: 114 CHSHRILHRDLKPQN-ILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG 172
Query: 193 DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226
+ + AVD+WS+G I ++ G+ F DSE
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFP--GDSE 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 6e-48
Identities = 77/227 (33%), Positives = 118/227 (51%), Gaps = 16/227 (7%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDK-TKLDPVSQDHLYQEVRCMKLVQHP- 77
Y + LG G F V LAR + VA+KV+ K + + +E++ + + HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG--LSETYAREYFAQIVRAISFCH 135
N+V+LY+ LYL++E DGG L D + K LSE+ A AQI+ A+ + H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFS-------NRFNPGQKLETSCGSLAYSAPE 188
++HRD+KPEN++ VVKL DFG + + + TS G+ Y APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 189 ILLG--DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
+LLG +Y + + D+WSLG+ LY L+ G PF+ +S + +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 1e-46
Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 8/206 (3%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
E LGRG F V LA TGE +AVK ++ + + L +E+R + +QHPN+VR Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 84 --EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
E + + L + LE GG L ++K L E R+Y QI+ +++ H +VH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSS-LLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVH 124
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE---TSCGSLAYSAPEILLGDSYDAP 198
RD+K N++ GVVKL DFG + R + E + G+ + APE++ G+ Y
Sbjct: 125 RDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183
Query: 199 AVDVWSLGVILYMLVAGQAPFQEAND 224
A D+WSLG + + G+ P+ E +
Sbjct: 184 A-DIWSLGCTVIEMATGKPPWSELGN 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-46
Identities = 72/210 (34%), Positives = 110/210 (52%), Gaps = 3/210 (1%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G + VV AR TGE VA+K I +E++ +K + HPN+++L +V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
LYL+ E D DLY I GL E+ + Y Q+++ ++FCH ++HRDLK
Sbjct: 67 FRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLK 125
Query: 146 PENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-CGSLAYSAPEILLGDSYDAPAVDVWS 204
PEN++ GV+KL DFG + F + T + Y APE+LLGD + VD+WS
Sbjct: 126 PENLLINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWS 184
Query: 205 LGVILYMLVAGQAPFQEANDSETLTMIMDV 234
+G I L++ + F ++ + L I
Sbjct: 185 VGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-44
Identities = 65/218 (29%), Positives = 110/218 (50%), Gaps = 6/218 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + +G G +V A+ TGE VA+K + +L+ + +E++ ++ QHP V
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V+L +V S L++E DL + + + L E + Y +++ +++ H +
Sbjct: 62 VKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILLGD-SYD 196
+HRDLKP N++ GV+K+ DFG + F+ + S + Y APE+L G YD
Sbjct: 121 MHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
P VD+W++G I L+ G F ND E L ++
Sbjct: 180 -PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRT 216
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 6e-43
Identities = 71/223 (31%), Positives = 108/223 (48%), Gaps = 13/223 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y++ ET+G+G F V+ R G+ + K ID + + L EV ++ ++HPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 80 VRLY--EVIDTNSKLYLILELGDGGDLYDYI---MKHDAGLSETYAREYFAQIVRAISFC 134
VR Y + +N LY+++E +GGDL I K + E + Q++ A+ C
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 135 HKLH-----VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC-GSLAYSAPE 188
H V+HRDLKP N +F + VKL DFG + + G+ Y +PE
Sbjct: 122 HNRSDPGNTVLHRDLKPAN-IFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
L SYD D+WSLG ++Y L A PF N + + I
Sbjct: 181 QLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 7e-43
Identities = 72/215 (33%), Positives = 119/215 (55%), Gaps = 4/215 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y++ +G G + VV R+ TGE VA+K +++ D + +EV+ ++ ++H N+
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V L E +LYL+ E + L + + GL R Y Q+++AI++CH ++
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSN--RFNPGQKLETSCGSLAYSAPEILLGDSYDA 197
+HRD+KPEN++ E GV+KL DFGF+ R P L + Y APE+L+GD+
Sbjct: 122 IHRDIKPENILVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
VDVW++G I+ L+ G+ F +D + L +I
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 8e-43
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 6/200 (3%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG+G VV RH TG+ A+K I D + L +E++ ++ + P VV+ Y
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KLHVVHRDL 144
++ ++LE DGG L D ++K + E QI++ + + H K H++HRD+
Sbjct: 68 FYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDI 126
Query: 145 KPENVVFFERLGVVKLTDFGFSNRFNPGQKLE-TSCGSLAYSAPEILLGDSYDAPAVDVW 203
KP N++ + G VK+ DFG S T G++ Y +PE + G+SY A D+W
Sbjct: 127 KPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAA-DIW 184
Query: 204 SLGVILYMLVAGQAPFQEAN 223
SLG+ L G+ PF
Sbjct: 185 SLGLTLLECALGKFPFLPPG 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-40
Identities = 78/214 (36%), Positives = 116/214 (54%), Gaps = 12/214 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH----LYQEVRCMKLV-QHPNVV 80
LG+G F V LA T E AVKV+ K D + QD E R + L +HP +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKK---DVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
+L+ T +L+ ++E +GGDL + ++ E AR Y A+IV + F H+ ++
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLM-FHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+RDLK +NV+ + G +K+ DFG G T CG+ Y APEIL Y PA
Sbjct: 119 YRDLKLDNVLL-DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYG-PA 176
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
VD W+LGV+LY ++AGQ+PF+ ++ E I++
Sbjct: 177 VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 6e-40
Identities = 74/226 (32%), Positives = 119/226 (52%), Gaps = 9/226 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR-CMKLVQHPN 78
+D++ +GRGHF V++ R TG+ A+KV+ K+ L ++E R + + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+ +L LYL++E GGDL + +++ E A+ Y A++V AI H++
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL--ETSCGSLAYSAPEILLGDSYD 196
VHRD+KPENV+ +R G +KL DFG + R + + + G+ Y APE+L + D
Sbjct: 123 YVHRDIKPENVL-IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181
Query: 197 A-----PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237
D WSLGVI Y ++ G++PF E ++T IM+
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF 227
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-39
Identities = 76/216 (35%), Positives = 120/216 (55%), Gaps = 10/216 (4%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVI--DKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
E LG G +A V R+ TGE VA+K I D + P + +E+ MK ++H N+VR
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IREISLMKELKHENIVR 62
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKH--DAGLSETYAREYFAQIVRAISFCHKLHV 139
L++VI T +KL L+ E D DL Y+ H L + + Q+++ I+FCH+ V
Sbjct: 63 LHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGDSYDAP 198
+HRDLKP+N++ +R G +KL DFG + F P +L Y AP++LLG +
Sbjct: 122 LHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYST 180
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
++D+WS+G I+ ++ G+ F N+ + L I +
Sbjct: 181 SIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI 216
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-39
Identities = 66/220 (30%), Positives = 105/220 (47%), Gaps = 12/220 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH------LYQEVRCMKL 73
Y+ + LG G +AVV AR TG VA+K K KL + +E++ ++
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIK---KIKLGERKEAKDGINFTALREIKLLQE 58
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
++HPN++ L +V S + L+ E + DL I L+ + Y +R + +
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLG 192
H ++HRDLKP N + GV+KL DFG + F +P +K+ + Y APE+L G
Sbjct: 118 LHSNWILHRDLKPNN-LLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176
Query: 193 DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ VD+WS+G I L+ +D + L I
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 8e-39
Identities = 79/245 (32%), Positives = 111/245 (45%), Gaps = 36/245 (14%)
Query: 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD-HLYQEVRCMKLVQHPNVVRLY 83
+GRG F V L R TG+ A+KV+ K+ + +Q H+ E + P +V+LY
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
LYL++E GGDL + +++ D E AR Y A++V A+ HKL +HRD
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELVLALDSVHKLGFIHRD 126
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFN-------------------PGQKLETSC----- 179
+KP+N++ + G +KL DFG + N
Sbjct: 127 IKPDNIL-IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRV 185
Query: 180 ------GSLAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIM 232
G+ Y APE+L G Y D WSLGVILY ML G PF ET I+
Sbjct: 186 RANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLY-GFPPFYSDTLQETYNKII 243
Query: 233 DVSES 237
+ ES
Sbjct: 244 NWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-38
Identities = 65/201 (32%), Positives = 110/201 (54%), Gaps = 4/201 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y L + +GRG F VV ++ TG+ VA+K I K+ + + QE+ +K ++HPN+
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V+ I+T+ LY+ILE + G L I+K E+ Y Q+++ +++ H+ V
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSLRQ-IIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLETSCGSLAYSAPEILLGDSYDAP 198
+HRD+K N++ + GVVKL DFG + + N + + G+ + APE++
Sbjct: 121 IHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST- 178
Query: 199 AVDVWSLGVILYMLVAGQAPF 219
A D+WSLG + L+ G P+
Sbjct: 179 ASDIWSLGCTVIELLTGNPPY 199
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-38
Identities = 65/224 (29%), Positives = 116/224 (51%), Gaps = 9/224 (4%)
Query: 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEV 68
S+G P + LY E +G G V A TG++VA+K + K +++ + E+
Sbjct: 13 SEGDPRE---LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK---QNKELIINEI 66
Query: 69 RCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIV 128
MK +HPN+V Y+ +L++++E DGG L D I ++ ++E +++
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL 126
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-CGSLAYSAP 187
+ + + H +V+HRD+K +N++ + G VKL DFGF+ + + S G+ + AP
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
E++ Y P VD+WSLG++ + G+ P+ L +I
Sbjct: 186 EVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-38
Identities = 73/213 (34%), Positives = 120/213 (56%), Gaps = 3/213 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y+ +G G + VV R+ TG+ VA+K +++ DPV + +E+R +K ++HPN+
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V L EV KL+L+ E D L + + K+ G+ E ++ Q ++A++FCHK +
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC-GSLAYSAPEILLGDSYDAP 198
+HRD+KPEN + + G +KL DFGF+ T + Y APE+L+GD+ P
Sbjct: 122 IHRDVKPEN-ILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP 180
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
VDVW++G + L+ GQ + +D + L +I
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-38
Identities = 74/205 (36%), Positives = 117/205 (57%), Gaps = 10/205 (4%)
Query: 19 LYDLE--ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQ 75
L D E ETLG G F V++A+H TGE A+K + K ++ + Q H+ QE + +
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFC 134
HP +V + +++Y +LE GG+L+ ++ K AG A+ Y A++V A +
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYL 134
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDS 194
H +++RDLKPEN++ + G VK+TDFGF+ + + T CG+ Y APE++
Sbjct: 135 HSKDIIYRDLKPENLL-LDNKGHVKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQSKG 191
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPF 219
+ AVD W++GV+LY +AG PF
Sbjct: 192 HGK-AVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 7e-38
Identities = 79/232 (34%), Positives = 113/232 (48%), Gaps = 35/232 (15%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC-MKLVQHPN 78
Y + + LG G F V LAR+ TGE VA+K + K K + +EV+ KL +HPN
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKL 137
+V+L EV N +LY + E +G +LY + SE+ R QI++ ++ HK
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGF--------------SNRFNPGQKLETSCGSLA 183
HRDLKPEN++ VVK+ DFG S R+
Sbjct: 119 GFFHRDLKPENLL-VSGPEVVKIADFGLAREIRSRPPYTDYVSTRW-------------- 163
Query: 184 YSAPEILLGD-SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
Y APEILL SY +P VD+W+LG I+ L + F +++ + L I V
Sbjct: 164 YRAPEILLRSTSYSSP-VDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV 214
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-37
Identities = 68/214 (31%), Positives = 119/214 (55%), Gaps = 6/214 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPN 78
+ +T+G G F V L R + A+KV+ ++ + Q H++ E R +K V HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++RL+ LY+++E GG+L+ Y +++ S + Y ++IV A+ + H
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSY-LRNSGRFSNSTGLFYASEIVCALEYLHSKE 121
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
+V+RDLKPEN++ ++ G +KLTDFGF+ + + T CG+ Y APE++ ++
Sbjct: 122 IVYRDLKPENIL-LDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQSKGHNK- 177
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
AVD W+LG+++Y ++ G PF + N I+
Sbjct: 178 AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL 211
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-37
Identities = 70/204 (34%), Positives = 115/204 (56%), Gaps = 11/204 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G F V A ++ TGE +AVK I DP + + E++ ++L++HPN+V+ Y V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
K+Y+ +E GG L + +++H L E R Y Q++ +++ H +VHRD+K
Sbjct: 68 EVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 146 PENVVFFERLGVVKLTDFGFSNRFNP-----GQKLETSCGSLAYSAPEILLGDSYDAP-- 198
P N +F + GV+KL DFG + + G+++++ G+ AY APE++ G
Sbjct: 127 PAN-IFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGR 185
Query: 199 AVDVWSLG-VILYMLVAGQAPFQE 221
A D+WSLG V+L M G+ P+ E
Sbjct: 186 AADIWSLGCVVLEM-ATGKRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-37
Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 4/201 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV-SQDHLYQEVRCMKLVQHPN 78
++L +G+G F V + + T + A+K ++K K S ++ E R ++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V L+ +YL+++L GGDL Y + SE + + +IV A+ + H
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
++HRD+KP+N++ E+ G V +TDF + + P ++ G+ Y APE+L Y
Sbjct: 121 IIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSV- 178
Query: 199 AVDVWSLGVILYMLVAGQAPF 219
AVD WSLGV Y + G+ P+
Sbjct: 179 AVDWWSLGVTAYECLRGKRPY 199
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-36
Identities = 79/208 (37%), Positives = 117/208 (56%), Gaps = 12/208 (5%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ---DHLYQEVRCMKLVQHPNVV 80
E +G G + VV AR+ TGE VA+K K +LD ++ +E+ +K + HPN+V
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKELNHPNIV 62
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYI-MKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
+L +VI T +KLYL+ E DL ++ +G+ + Y Q+++ ++FCH V
Sbjct: 63 KLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGDSYDAP 198
+HRDLKP+N++ G +KL DFG + F P + +L Y APEILLG Y +
Sbjct: 122 LHRDLKPQNLLI-NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSE 226
AVD+WSLG I +V +A F DSE
Sbjct: 181 AVDIWSLGCIFAEMVTRRALF--PGDSE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-36
Identities = 75/214 (35%), Positives = 124/214 (57%), Gaps = 3/214 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y+ +G G + +V +H TG+ VA+K +++ D + + +E+R +K ++H N+
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V L EV +LYL+ E D L D + K+ GL E+ R+Y QI+R I FCH ++
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNI 121
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGDSYDAP 198
+HRD+KPEN++ + GVVKL DFGF+ PG+ + Y APE+L+GD+
Sbjct: 122 IHRDIKPENIL-VSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
AVD+W++G ++ ++ G+ F +D + L I+
Sbjct: 181 AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-36
Identities = 78/210 (37%), Positives = 116/210 (55%), Gaps = 16/210 (7%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH-----LYQEVRCMKLVQHPN 78
E +G G + VV AR TGE VA+K K +L+ ++D +E+ +K + HPN
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALK---KIRLE--TEDEGVPSTAIREISLLKELNHPN 59
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKL 137
+VRL +V+ + +KLYL+ E D DL Y+ GL + Y Q+++ I++CH
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGDSYD 196
V+HRDLKP+N++ +R G +KL DFG + F P + +L Y APEILLG
Sbjct: 119 RVLHRDLKPQNLL-IDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQY 177
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSE 226
+ VD+WS+G I +V + F DSE
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLF--PGDSE 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 4e-36
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 10/219 (4%)
Query: 22 LEETLGRGHFAVVKLAR----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
L + LG G F V + +VAVK + + + ++ +E R M+ + HP
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHP 61
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
NVV+L V LY+++E +GGDL Y+ K+ LS + + QI R + +
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL--AYSAPEILLGDSY 195
+ +HRDL N + E L VVK++DFG S G L + APE L +
Sbjct: 122 NFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 196 DAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
DVWS GV+L+ + G+ P+ ++ E L + +
Sbjct: 181 T-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN 218
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-36
Identities = 75/213 (35%), Positives = 108/213 (50%), Gaps = 10/213 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKT---KLDPVSQDHLYQEVRCMKLVQH 76
+ + +G+G + V LA+ TGE VA+K + K+ KL+ V H+ E + +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVR--HVLTERDILTTTKS 60
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
+V+L + LYL +E GGD + LSE +AR Y A++ A+ H+
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALHE 119
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYD 196
L +HRDLKPEN + + G +KLTDFG S + GS Y APE+L G YD
Sbjct: 120 LGYIHRDLKPENFL-IDASGHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYD 176
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229
VD WSLG +LY + G PF + +ET
Sbjct: 177 F-TVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-36
Identities = 68/220 (30%), Positives = 102/220 (46%), Gaps = 11/220 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
L + LG G F V GE KVAVK + + + ++ +E MK + HP
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHP 61
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
N+VRL V LY++ E GGDL D++ KH L+ + QI + + +
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL---AYSAPEILLGDS 194
+ VHRDL N + E L VVK++DFG S G + APE L
Sbjct: 122 NFVHRDLAARNCLVTENL-VVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 195 YDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ + DVWS GV+L+ + G+ P+ ++ E L ++ D
Sbjct: 181 FTS-KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-35
Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 4/210 (1%)
Query: 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYE 84
LG+G F L R V K ++ T+L + E+ + L+QHPN++ Y
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKHDAGL-SETYAREYFAQIVRAISFCHKLHVVHRD 143
++ L + +E +GG LYD I++ L E Y QIV A+S+ HK ++HRD
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRD 126
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC-GSLAYSAPEILLGDSYDAPAVDV 202
+K N +F + G++KL DFG S + + G+ Y +PE+ G Y+ + D+
Sbjct: 127 IKTLN-IFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKS-DI 184
Query: 203 WSLGVILYMLVAGQAPFQEANDSETLTMIM 232
W+LG +LY L+ + F N + I+
Sbjct: 185 WALGCVLYELLTLKRTFDATNPLNLVVKIV 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-35
Identities = 67/198 (33%), Positives = 108/198 (54%), Gaps = 4/198 (2%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL-YQEVRCMKLVQHPNVVRLYE 84
LG+G F V + TG+ A K +DK +L + + E + ++ V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
+T L L++ L +GGDL +I G E A Y AQI+ + H+ +V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVW 203
LKPENV+ + G V+++D G + G+K++ G+ Y APE+L G+ YD VD +
Sbjct: 121 LKPENVL-LDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-VDWF 178
Query: 204 SLGVILYMLVAGQAPFQE 221
+LG LY ++AG++PF++
Sbjct: 179 ALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 4e-35
Identities = 67/195 (34%), Positives = 106/195 (54%), Gaps = 8/195 (4%)
Query: 28 RGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ--HPNVVRLYEV 85
+G F V LA+ TG+ A+KV+ K+ + +Q + R + ++Q P V +LY
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
+ LYL++E +GGD I K GL E +A++Y A++V + H+ ++HRD+K
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK 124
Query: 146 PENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSL 205
PEN++ + G +KLTDFG S G + + G+ Y APE +LG D D WSL
Sbjct: 125 PENLLIDQT-GHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGDDK-MSDWWSL 179
Query: 206 GVILYMLVAGQAPFQ 220
G +++ + G PF
Sbjct: 180 GCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 76/207 (36%), Positives = 115/207 (55%), Gaps = 12/207 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-----QHPNVV 80
+GRG +A V L T A+KVI K + V+ D V+ K V HP +V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKK---ELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
L+ T S+L+ ++E GGDL + M+ L E +AR Y A+I A++F H+ ++
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLM-FHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+RDLK +NV+ + G +KLTD+G PG T CG+ Y APEIL G+ Y +
Sbjct: 119 YRDLKLDNVL-LDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGF-S 176
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSE 226
VD W+LGV+++ ++AG++PF S+
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-35
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 11/220 (5%)
Query: 22 LEETLGRGHFAVVKLAR----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
L + LG G F V +VAVK + + + ++ +E R M+ + HP
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHP 61
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHK 136
N+V+L V L +++E GGDL DY+ K+ LS + + QI R + +
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL--AYSAPEILLGDS 194
+ +HRDL N + E L VVK++DFG S + G L + APE L
Sbjct: 122 KNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 195 YDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ DVWS GV+L+ + G+ P+ +++E L +
Sbjct: 181 FT-SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK 219
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 9e-35
Identities = 67/214 (31%), Positives = 110/214 (51%), Gaps = 2/214 (0%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y+ +GRG F +V L R + V +K I ++ + E + +KL+ HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLH 138
+ YE + L +++E GG L +YI K ++ L E +F QI+ A+ H
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL 121
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
++HRDLK +N++ + VVK+ DFG S + K T G+ Y +PE+ G Y+
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQK 181
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ D+W+LG +LY L + + F+ AN + IM
Sbjct: 182 S-DIWALGCVLYELASLKRAFEAANLPALVLKIM 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 67/226 (29%), Positives = 119/226 (52%), Gaps = 20/226 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKL 73
Y+ +G G + V AR+ TGE VA+K K +++ P++ +E++ ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPITA---IREIKLLQK 54
Query: 74 VQHPNVVRLYEVIDTNSK--LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
++HPN+VRL E++ + K +Y++ E D DL + + +E+ + Y Q++ +
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGL 113
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCG--SLAYSAPEI 189
+ H ++HRD+K N++ GV+KL DFG + + + + +L Y PE+
Sbjct: 114 QYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172
Query: 190 LLGD-SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
LLG Y P VD+WS+G IL L G+ FQ + + E L I ++
Sbjct: 173 LLGATRYG-PEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 77/213 (36%), Positives = 116/213 (54%), Gaps = 9/213 (4%)
Query: 26 LGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDPVSQD--HLYQEVRCMKLVQHPNVV 80
LG+G + V R V TG+ A+KV+ K + +D H E ++ V+HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
L T KLYLILE GG+L+ ++ + + +T A Y ++I A+ H+ ++
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT-ACFYLSEISLALEHLHQQGII 122
Query: 141 HRDLKPENVVFFERLGVVKLTDFGF-SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+RDLKPEN++ + G VKLTDFG + G T CG++ Y APEIL+ S A
Sbjct: 123 YRDLKPENIL-LDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM-RSGHGKA 180
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
VD WSLG ++Y ++ G PF N +T+ I+
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-34
Identities = 75/211 (35%), Positives = 116/211 (54%), Gaps = 7/211 (3%)
Query: 26 LGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRL 82
LG+G F V L R + G+ A+KV+ K L + E + V HP +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
+ T KLYLIL+ GGDL+ + K + +E + Y A++ A+ H L +++R
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYR 122
Query: 143 DLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVD 201
DLKPEN++ E G +KLTDFG S + +K + CG++ Y APE++ + A D
Sbjct: 123 DLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA-D 180
Query: 202 VWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
WS GV+++ ++ G PFQ + ET+TMI+
Sbjct: 181 WWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 2e-34
Identities = 77/213 (36%), Positives = 114/213 (53%), Gaps = 6/213 (2%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCM-KLVQHPNVVR 81
+ +G+G F V LARH + AVKV+ K L + H+ E + K V+HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
L+ T KLY +L+ +GG+L+ Y ++ + E AR Y A+I A+ + H L++V+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELF-YHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 142 RDLKPENVVFFERLGVVKLTDFGF-SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAV 200
RDLKPEN++ + G + LTDFG T CG+ Y APE+L YD V
Sbjct: 120 RDLKPENIL-LDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR-TV 177
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
D W LG +LY ++ G PF N +E I++
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-34
Identities = 74/228 (32%), Positives = 116/228 (50%), Gaps = 20/228 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ----EVRCMKLVQ 75
Y+ +G G + V AR + TG VA+K + P+S++ + E+ +K ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLE 56
Query: 76 ---HPNVVRLYEVIDTNS-----KLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQ 126
HPN+VRL +V KL L+ E D DL Y+ K GL ++ Q
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSA 186
++R + F H +VHRDLKP+N++ G VK+ DFG + ++ L + +L Y A
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNIL-VTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRA 174
Query: 187 PEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
PE+LL SY A VD+WS+G I L + F+ ++++ L I DV
Sbjct: 175 PEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDV 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-34
Identities = 69/208 (33%), Positives = 111/208 (53%), Gaps = 9/208 (4%)
Query: 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQH 76
G + +E+ +G+G F+VV A + G VA+K + ++ D ++ +E+ +K + H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYI---MKHDAGLSETYAREYFAQIVRAISF 133
PNV++ N++L ++LEL D GDL I K + E +YF Q+ A+
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE--TSCGSLAYSAPEILL 191
H ++HRD+KP N VF GVVKL D G RF + + G+ Y +PE +
Sbjct: 122 MHSKRIMHRDIKPAN-VFITATGVVKLGDLGLG-RFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPF 219
+ Y+ + D+WSLG +LY + A Q+PF
Sbjct: 180 ENGYNFKS-DIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 3e-34
Identities = 64/227 (28%), Positives = 119/227 (52%), Gaps = 18/227 (7%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y+L + +G G + VV A TG KVA+K I D + + +E++ ++ ++H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 80 VRLYEVI-----DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
+ L +++ + + +Y++ EL + DL+ ++K L++ + + + QI+R + +
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELME-TDLH-KVIKSPQPLTDDHIQYFLYQILRGLKYL 119
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA-------YSAP 187
H +V+HRDLKP N++ +K+ DFG + +P E G L Y AP
Sbjct: 120 HSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDP---DEDEKGFLTEYVVTRWYRAP 175
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
E+LL S A+D+WS+G I L+ + F + + L +I++V
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 4e-34
Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 33/231 (14%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQHPN 78
Y + +G G F+ V A+ TG+ A+K + K + Q + +E++ ++ L HPN
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 79 VVRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
++RL EV+ +L L+ EL D +LY+ I L E + Y Q+++++ H+
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA------------- 183
+ HRD+KPEN++ + ++KL DFG SC +
Sbjct: 119 NGIFHRDIKPENILI--KDDILKLADFG-------------SCRGIYSKPPYTEYISTRW 163
Query: 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
Y APE LL D Y P +D+W++G + + +++ F N+ + + I DV
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 5e-34
Identities = 75/205 (36%), Positives = 112/205 (54%), Gaps = 6/205 (2%)
Query: 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCM-KLVQHPNVVRL 82
+G+G F V LA+H G+ AVKV+ K L Q H+ E + K V+HP +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
+ T KLY +L+ +GG+L+ + ++ + E AR Y A+I A+ + H L++++R
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELF-FHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 143 DLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVD 201
DLKPEN++ + G V LTDFG + T CG+ Y APE+L YD VD
Sbjct: 121 DLKPENIL-LDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDR-TVD 178
Query: 202 VWSLGVILYMLVAGQAPFQEANDSE 226
W LG +LY ++ G PF + +E
Sbjct: 179 WWCLGAVLYEMLYGLPPFYSRDTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-34
Identities = 74/197 (37%), Positives = 111/197 (56%), Gaps = 6/197 (3%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDK-TKLDPVSQDHLYQEVRCM-KLVQHPNVVRLY 83
+G+G F V LA+ G AVKV+ K T L Q+H+ E + K ++HP +V L+
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
T KLY +L+ +GG+L+ + ++ + E AR Y A++ AI + H L++++RD
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELF-FHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 144 LKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDV 202
LKPEN++ + G V LTDFG P + T CG+ Y APE+L + YD VD
Sbjct: 122 LKPENIL-LDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR-TVDW 179
Query: 203 WSLGVILYMLVAGQAPF 219
W LG +LY ++ G PF
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-33
Identities = 76/213 (35%), Positives = 111/213 (52%), Gaps = 13/213 (6%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y+ E +G G + VV AR T E +A+K I + D +E+ +K +QH N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-----DAGLSETYAREYFAQIVRAISFC 134
VRL +V+ + +LYL+ E D DL KH D + + Y QI+R I++C
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDL-DL----KKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGD 193
H V+HRDLKP+N++ R +KL DFG + F P + +L Y APEILLG
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226
+ + VD+WS+G I +V + F DSE
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQKPLF--PGDSE 209
|
Length = 294 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 79/214 (36%), Positives = 113/214 (52%), Gaps = 12/214 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH----LYQEVRCMKLV-QHPNVV 80
LG+G F V LAR +G AVKV+ K D + QD E R + L HP +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKK---DVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
+LY T +L+ ++E +GGDL +I K E AR Y A+I A+ F H ++
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDKGII 118
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+RDLK +NV+ + G KL DFG G+ T CG+ Y APEIL Y P+
Sbjct: 119 YRDLKLDNVLL-DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPS 176
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
VD W++GV+LY ++ G APF+ N+ + I++
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 72/206 (34%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
E +G G + VV R+ TG+ VA+K I + +E+ +K +QHPN+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 84 EVIDTNSKLYLILELGDGGDLYDYI--MKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
+V+ S+LYLI E DL Y+ + + + Y QI++ I FCH V+H
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGDSYDAPAV 200
RDLKP+N++ + GV+KL DFG + F P + +L Y APE+LLG + V
Sbjct: 125 RDLKPQNLL-IDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPV 183
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSE 226
D+WS+G I + + F DSE
Sbjct: 184 DIWSIGTIFAEMATKKPLFH--GDSE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 73/222 (32%), Positives = 109/222 (49%), Gaps = 13/222 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y+L E +G G AVV A + EKVA+K ID K S D L +EV+ M HPNV
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNV 61
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHK 136
V+ Y +L+L++ GG L D IMK GL E ++++ + + H
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFS-NRFNPGQ----KLETSCGSLAYSAPEILL 191
+HRD+K N++ E G VK+ DFG S + + G +T G+ + APE++
Sbjct: 121 NGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 192 GDS-YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
YD A D+WS G+ L G AP+ + + L + +
Sbjct: 180 QVHGYDFKA-DIWSFGITAIELATGAAPYSKYPPMKVLMLTL 220
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 78/253 (30%), Positives = 115/253 (45%), Gaps = 43/253 (16%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRL 82
+ +GRG F V+L + TG A+K + K+++ Q H+ E + +P VV+L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
Y + LYLI+E GGD+ +MK D +E R Y A+ + AI HKL +HR
Sbjct: 67 YYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-FTEEETRFYIAETILAIDSIHKLGYIHR 125
Query: 143 DLKPENVVFFERLGVVKLTDFGFSNRFN---------------PGQKLETSCG------- 180
D+KP+N++ + G +KL+DFG P L+
Sbjct: 126 DIKPDNLL-LDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRK 184
Query: 181 ---------SLAYS--------APEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223
+LAYS APE+ L Y+ D WSLGVI+Y ++ G PF N
Sbjct: 185 AETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPFCSDN 243
Query: 224 DSETLTMIMDVSE 236
ET I++ E
Sbjct: 244 PQETYRKIINWKE 256
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-33
Identities = 71/202 (35%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-------QHPN 78
LGRGHF V LA + TGE A+K + K D +++D + + + C K + +HP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKG--DIIARDEV-ESLMCEKRIFETANSERHPF 63
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V L+ T + ++E GGDL +I H SE A Y A +V + + H+
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDA 197
+V+RDLK +N++ + G VK+ DFG G + T CG+ + APE+L SY
Sbjct: 122 IVYRDLKLDNLL-LDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180
Query: 198 PAVDVWSLGVILYMLVAGQAPF 219
AVD W LGV++Y ++ G++PF
Sbjct: 181 -AVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-33
Identities = 71/240 (29%), Positives = 118/240 (49%), Gaps = 34/240 (14%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-QDHLYQEVRCMKLVQHPNVVRLYE 84
LG+G V L R TG+ A+KV+DK ++ + + E + + HP + LY
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKLHVVHRD 143
T + L L+++ GG+L+ + + LSE AR Y A+++ A+ + H L +V+RD
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRD 128
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET-------------------------- 177
LKPEN++ E G + L+DF S + + +
Sbjct: 129 LKPENILLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187
Query: 178 ---SC-GSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
S G+ Y APE++ GD + + AVD W+LG++LY ++ G PF+ +N ET + I+
Sbjct: 188 RSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILK 246
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 76/208 (36%), Positives = 117/208 (56%), Gaps = 10/208 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLV 74
++L + LG G + V L R V TG+ A+KV+ K L + +H E ++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 75 -QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
Q P +V L+ T +KL+LIL+ GG+++ ++ + D SE R Y +I+ A+
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEH 120
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILL 191
HKL +V+RD+K EN++ + G V LTDFG S F +K T CG++ Y APEI+
Sbjct: 121 LHKLGIVYRDIKLENILL-DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPF 219
G AVD WSLG++++ L+ G +PF
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-32
Identities = 63/203 (31%), Positives = 107/203 (52%), Gaps = 10/203 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH---LYQEVRCMKLVQHPNVVRL 82
LG+G F V L V TG ++AVK + P ++ L E++ +K +QH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
Y + + L + +E GG + D + + A L+ET R+Y QI+ + + H +VHR
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 143 DLKPENVVFFERLGVVKLTDFGFSNRFNP----GQKLETSCGSLAYSAPEILLGDSYDAP 198
D+K N++ + G VKL DFG S R G +++ G+ + +PE++ G+ Y
Sbjct: 129 DIKGANIL-RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187
Query: 199 AVDVWSLGVILYMLVAGQAPFQE 221
A DVWS+G + ++ + P+ E
Sbjct: 188 A-DVWSVGCTVVEMLTEKPPWAE 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 75/213 (35%), Positives = 111/213 (52%), Gaps = 12/213 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH----LYQEVRCMKLV-QHPNVV 80
LG+G F V LA T E A+KV+ K D + QD E R + L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKK---DVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
L+ T +L+ ++E +GGDL I + E +R Y A++ A+ F H+ V+
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+RDLK +N++ + G KL DFG G T CG+ Y APEIL Y P+
Sbjct: 119 YRDLKLDNILL-DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYG-PS 176
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
VD W+LGV++Y ++AGQ PF+ N+ + I+
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-32
Identities = 71/210 (33%), Positives = 117/210 (55%), Gaps = 13/210 (6%)
Query: 20 YDLEETLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLV 74
++L LG G + V L R V G+ A+KV+ K + + +H E + ++ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 75 QH-PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ P +V L+ T++KL+LIL+ +GG+L+ ++ +E+ R Y A+IV A+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVLALDH 120
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILL 191
H+L +++RD+K EN++ G V LTDFG S F ++ CG++ Y APE++
Sbjct: 121 LHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 192 G--DSYDAPAVDVWSLGVILYMLVAGQAPF 219
G +D AVD WSLGV+ + L+ G +PF
Sbjct: 180 GGSGGHDK-AVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-32
Identities = 74/232 (31%), Positives = 117/232 (50%), Gaps = 19/232 (8%)
Query: 20 YDLEETLGRGHFA-VVKLARHVFTGEKVAVKVID-------KTKLD-PVSQDHLYQEVRC 70
Y + E LG G F V K+ + +A+K I+ K K + S + EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 71 MK-LVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYI--MKHDAG-LSETYAREYFAQ 126
+K ++HPN+VR Y+ N +LY++++L +G L ++ +K +E F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 127 IVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYS 185
+V A+ + HK +VHRDL P N++ E V +TDFG + + P KL + G++ YS
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVT-ITDFGLAKQKQPESKLTSVVGTILYS 180
Query: 186 APEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237
PEI+ + Y A DVW+ G ILY + Q PF N L++ + E+
Sbjct: 181 CPEIVKNEPYGEKA-DVWAFGCILYQMCTLQPPFYSTN---MLSLATKIVEA 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 8e-32
Identities = 72/214 (33%), Positives = 110/214 (51%), Gaps = 12/214 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ----EVRCMKLVQHPN-VV 80
LG+G F V LA T E A+K++ K D + QD + E R + L P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKK---DVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
+L+ T +LY ++E +GGDL Y ++ E +A Y A+I + F H ++
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLM-YHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 141 HRDLKPENVVFFERLGVVKLTDFGF-SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+RDLK +NV+ + G +K+ DFG G+ T CG+ Y APEI+ Y +
Sbjct: 124 YRDLKLDNVML-DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK-S 181
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
VD W+ GV+LY ++AGQ PF ++ E IM+
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 9e-32
Identities = 72/220 (32%), Positives = 120/220 (54%), Gaps = 9/220 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR-CMKLVQHPN 78
Y++ + +GRG F V+L RH T + A+K++ K ++ S + E R M P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
VV+L+ + LY+++E GGDL + + +D + E +AR Y A++V A+ H +
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMG 162
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--KLETSCGSLAYSAPEILL---GD 193
+HRD+KP+N++ ++ G +KL DFG + N + +T+ G+ Y +PE+L GD
Sbjct: 163 FIHRDVKPDNML-LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
Y D WS+GV LY ++ G PF + T + IM+
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 74/212 (34%), Positives = 114/212 (53%), Gaps = 6/212 (2%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDK-TKLDPVSQDHLYQEVRCM-KLVQHPNVVR 81
+ +G+G F V LA+ G+ AVKV+ K L+ Q H+ E + K V+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
L+ T KLY +L+ +GG+L+ ++ + + E AR Y A+I A+ + H +++V+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPAV 200
RDLKPEN++ + G V LTDFG T CG+ Y APE++ YD V
Sbjct: 120 RDLKPENIL-LDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-TV 177
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
D W LG +LY ++ G PF + +E I+
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 66/213 (30%), Positives = 108/213 (50%), Gaps = 4/213 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y++ + +G G F + LA+ E +K ID TK+ ++ +EV + ++HPN+
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYI-MKHDAGLSETYAREYFAQIVRAISFCHKLH 138
V + N +L++++E DGGDL I + SE +F QI + H
Sbjct: 62 VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK 121
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC-GSLAYSAPEILLGDSYDA 197
++HRD+K +N+ + V KL DFG + + N +L +C G+ Y +PEI Y+
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSETLTM 230
D+WSLG +LY L + PF E N+ L +
Sbjct: 182 -KTDIWSLGCVLYELCTLKHPF-EGNNLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 1e-31
Identities = 70/225 (31%), Positives = 100/225 (44%), Gaps = 18/225 (8%)
Query: 24 ETLGRGHFAVVKLAR-HVFTGEK--VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
+ LG G F V + G+ VAVK + + + +D +E R MK + HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVV 59
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKH--------DAGLSETYAREYFAQIVRAIS 132
RL V LYL+LE +GGDL DY+ K + LS + QI + +
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 133 FCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCG---SLAYSAPEI 189
+ VHRDL N + E L VVK++DFG S G + + APE
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178
Query: 190 LLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
L + DVWS GV+L+ + G P+ ++ E L +
Sbjct: 179 LKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 11/218 (5%)
Query: 21 DLE--ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
DLE LG G+ VV H TG+ +AVK I ++ Q + +E+ + P
Sbjct: 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPY 60
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KL 137
+V Y N + + +E DGG L + + + E + +++ +++ H K
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYD 196
++HRD+KP N++ R G +KL DFG S + N K T G+ +Y APE + G+ Y
Sbjct: 121 KIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYS 177
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
+ D+WSLG+ L L G+ P+ ND I ++
Sbjct: 178 VKS-DIWSLGLSLIELATGRFPYPPEND--PPDGIFEL 212
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-31
Identities = 71/226 (31%), Positives = 122/226 (53%), Gaps = 9/226 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR-CMKLVQHPN 78
YD+ + +GRG F V+L RH + + A+K++ K ++ S + E R M P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
VV+L+ + LY+++E GGDL + + +D + E +A+ Y A++V A+ H +
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIHSMG 162
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--KLETSCGSLAYSAPEILL---GD 193
++HRD+KP+N++ ++ G +KL DFG + + + +T+ G+ Y +PE+L GD
Sbjct: 163 LIHRDVKPDNML-LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239
Y D WS+GV L+ ++ G PF + T + IMD S
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 9e-31
Identities = 73/208 (35%), Positives = 120/208 (57%), Gaps = 16/208 (7%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVI------DKTKLDPV-SQDHLYQEVRCMKLVQHPN 78
+GRG +A V L R + A+KV+ D +D V ++ H++++ +P
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQAS-----SNPF 57
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V L+ T S+L+L++E +GGDL + M+ L E +AR Y A+I A++F H+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLM-FHMQRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDA 197
+++RDLK +NV+ + G +KLTD+G PG T CG+ Y APEIL G+ Y
Sbjct: 117 IIYRDLKLDNVL-LDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-G 174
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDS 225
+VD W+LGV+++ ++AG++PF D+
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 9e-31
Identities = 75/207 (36%), Positives = 110/207 (53%), Gaps = 12/207 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH----LYQEVRCMKLV-QHPNVV 80
LG+G F V LA T E A+K + K D V +D E R + L +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK---DVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
L+ T L+ ++E +GGDL +I + E AR Y A+I+ + F HK ++
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHI-QSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSN-RFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+RDLK +NV+ ++ G +K+ DFG N K T CG+ Y APEIL G Y+ +
Sbjct: 119 YRDLKLDNVLL-DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE-S 176
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSE 226
VD WS GV+LY ++ GQ+PF ++ E
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-30
Identities = 70/202 (34%), Positives = 109/202 (53%), Gaps = 7/202 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTG-EKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHP 77
++ TLG G F V LA + VA+K +K+K+ Q DH++ E + + + HP
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
V LY S LYL+LE GG+ + + ++ + Y AQIV + L
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTF-LRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDA 197
++V+RDLKPEN++ ++ G +K+TDFGF+ + + T CG+ Y APEILL +
Sbjct: 151 NIVYRDLKPENLL-LDKDGFIKMTDFGFAKVVD--TRTYTLCGTPEYIAPEILLNVGH-G 206
Query: 198 PAVDVWSLGVILYMLVAGQAPF 219
A D W+LG+ +Y ++ G PF
Sbjct: 207 KAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-30
Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG+G + V + + + A+K +D + ++ E+R + V HPN++ E
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 86 -IDTNSKLYLILELGDGGDLYDYIMKHDAG---LSETYAREYFAQIVRAISFCHKLHVVH 141
+D N KL +++E GDL I K + E F Q++R + H+ ++H
Sbjct: 68 FLDGN-KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILH 126
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVD 201
RDLK N++ +VK+ D G S + +T G+ Y APE+ G Y + D
Sbjct: 127 RDLKSANILLVAN-DLVKIGDLGIS-KVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKS-D 183
Query: 202 VWSLGVILYMLVAGQAPFQEANDSETL 228
+WSLG +LY + PF EA + L
Sbjct: 184 IWSLGCLLYEMATFAPPF-EARSMQDL 209
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 71/211 (33%), Positives = 119/211 (56%), Gaps = 9/211 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD---HLYQEVRCMKLVQHPNVVRL 82
LG+G F V L R TG+ A+K++ K + +++D H E R ++ +HP + L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVI--IAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
T+ +L ++E +GG+L+ + + + SE AR Y A+IV A+ + H VV+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELF-FHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 143 DLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVD 201
DLK EN++ ++ G +K+TDFG + G ++T CG+ Y APE+L + Y AVD
Sbjct: 120 DLKLENLM-LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 202 VWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
W LGV++Y ++ G+ PF + + +I+
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 2e-30
Identities = 73/209 (34%), Positives = 119/209 (56%), Gaps = 16/209 (7%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVI------DKTKLDPV-SQDHLYQEVRCMKLVQHPN 78
+GRG +A V L R T A+KV+ D +D V ++ H++++ HP
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPF 57
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V L+ T S+L+ ++E +GGDL + M+ L E +AR Y A+I A+++ H+
Sbjct: 58 LVGLHSCFQTESRLFFVIEYVNGGDLM-FHMQRQRKLPEEHARFYSAEISLALNYLHERG 116
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDA 197
+++RDLK +NV+ + G +KLTD+G PG T CG+ Y APEIL G+ Y
Sbjct: 117 IIYRDLKLDNVL-LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-G 174
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSE 226
+VD W+LGV+++ ++AG++PF S+
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-30
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 4/215 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+++ +G+G F VV A+K ID +K++ ++ E R + + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYI-MKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+R YE KL +++E + GDL+ + M+ L E +F QI+ ++ H
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL-ETSCGSLAYSAPEILLGDSYDA 197
++HRD+K N +F + VK+ D G + + T G+ Y +PE+ Y+
Sbjct: 122 ILHRDIKSLN-LFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ DVW+LGV+LY G+ PF N + I+
Sbjct: 181 KS-DVWALGVVLYECCTGKHPFDANNQGALILKII 214
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-30
Identities = 70/220 (31%), Positives = 120/220 (54%), Gaps = 9/220 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR-CMKLVQHPN 78
+D+ + +GRG F V+L RH + + A+K++ K ++ S + E R M
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V+L+ + LY+++E GGDL + + +D + E +AR Y A++V A+ H +
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIHSMG 162
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQ-KLETSCGSLAYSAPEILL---GD 193
+HRD+KP+N++ ++ G +KL DFG + + G + +T+ G+ Y +PE+L GD
Sbjct: 163 FIHRDVKPDNML-LDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
Y D WS+GV LY ++ G PF + T + IMD
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-30
Identities = 72/209 (34%), Positives = 109/209 (52%), Gaps = 5/209 (2%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRLYE 84
+G+G F V R T A+K I K + S+ H E + V P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDL 144
+ KLYL+L +GG+L+ ++ + + + AR Y A+++ A+ HK +V++RDL
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119
Query: 145 KPENVVFFERLGVVKLTDFGFSN-RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVW 203
KPEN++ + G + L DFG K T CG+ Y APE+LLG Y AVD W
Sbjct: 120 KPENIL-LDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY-TKAVDWW 177
Query: 204 SLGVILYMLVAGQAPFQEANDSETLTMIM 232
+LGV+LY ++ G PF + N +E I+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKIL 206
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 8e-30
Identities = 69/211 (32%), Positives = 117/211 (55%), Gaps = 9/211 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD---HLYQEVRCMKLVQHPNVVRL 82
LG+G F V L R TG A+K++ K + +++D H E R ++ +HP + L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVI--IAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
T+ +L ++E +GG+L+ ++ + +E AR Y A+IV A+ + H VV+R
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 143 DLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVD 201
D+K EN++ ++ G +K+TDFG + G ++T CG+ Y APE+L + Y AVD
Sbjct: 120 DIKLENLM-LDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 202 VWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
W LGV++Y ++ G+ PF + +I+
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 4/200 (2%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G F L + G++ +K I+ +K+ P ++ +EV + ++HPN+V+ E
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGL-SETYAREYFAQIVRAISFCHKLHVVHRDL 144
+ N LY++++ +GGDLY I L E ++F QI A+ H ++HRD+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDI 127
Query: 145 KPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC-GSLAYSAPEILLGDSYDAPAVDVW 203
K +N +F + G +KL DFG + N +L +C G+ Y +PEI Y+ + D+W
Sbjct: 128 KSQN-IFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKS-DIW 185
Query: 204 SLGVILYMLVAGQAPFQEAN 223
+LG +LY + + F+ N
Sbjct: 186 ALGCVLYEMCTLKHAFEAGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 70/203 (34%), Positives = 109/203 (53%), Gaps = 8/203 (3%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG G F V A+H TG A K+I + + D + E+ + +HPN+V LYE
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMV-EIDILSECKHPNIVGLYEA 70
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
+KL++++E DGG L +++ + GL+E R Q++ A++F H V+HRDLK
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130
Query: 146 PENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSY-DAP---AV 200
N++ G VKL DFG S + + QK +T G+ + APE++ +++ D P
Sbjct: 131 AGNIL-LTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA 189
Query: 201 DVWSLGVILYMLVAGQAPFQEAN 223
D+WSLG+ L L + P E N
Sbjct: 190 DIWSLGITLIELAQMEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-29
Identities = 68/211 (32%), Positives = 112/211 (53%), Gaps = 5/211 (2%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G + VV RH T E VA+K ++ + ++ +E++ ++ ++ N+V L E
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
KLYL+ E + ++ + + + G+ R Y Q+++AI +CHK +VHRD+K
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127
Query: 146 PENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILLGDSYDAPAVDVW 203
PEN++ V+KL DFGF+ + G + + Y +PE+LLG Y AVD+W
Sbjct: 128 PENLLISHN-DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY-GKAVDMW 185
Query: 204 SLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
S+G IL L GQ F ++ + L I V
Sbjct: 186 SVGCILGELSDGQPLFPGESEIDQLFTIQKV 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-29
Identities = 70/209 (33%), Positives = 121/209 (57%), Gaps = 11/209 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLV 74
++L + LG G + V L R V +G+ A+KV+ K + + +H E + ++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 75 -QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
Q P +V L+ T++KL+LIL+ +GG+L+ ++ + + E + Y +IV A+
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER-FKEQEVQIYSGEIVLALEH 120
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF--NPGQKLETSCGSLAYSAPEILL 191
HKL +++RD+K EN++ + G V LTDFG S F + ++ + CG++ Y AP+I+
Sbjct: 121 LHKLGIIYRDIKLENILL-DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 192 G-DSYDAPAVDVWSLGVILYMLVAGQAPF 219
G D AVD WS+GV++Y L+ G +PF
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 3e-29
Identities = 71/212 (33%), Positives = 119/212 (56%), Gaps = 10/212 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD---HLYQEVRCMKLVQHPNVVRL 82
LG+G F V L + TG A+K++ K + V++D H E R ++ +HP + L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVI--VAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KLHVVH 141
T+ +L ++E +GG+L+ + + + SE AR Y A+IV A+ + H + +VV+
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELF-FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPAV 200
RDLK EN++ ++ G +K+TDFG G ++T CG+ Y APE+L + Y AV
Sbjct: 120 RDLKLENLML-DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
D W LGV++Y ++ G+ PF + + +I+
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-29
Identities = 70/205 (34%), Positives = 108/205 (52%), Gaps = 7/205 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPN 78
+ +E+ +GRG F+ V A + G VA+K + L D ++ +E+ +K + HPN
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYI---MKHDAGLSETYAREYFAQIVRAISFCH 135
V++ Y +++L ++LEL D GDL I K + E +YF Q+ A+ H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-CGSLAYSAPEILLGDS 194
V+HRD+KP N VF GVVKL D G F+ S G+ Y +PE + +
Sbjct: 124 SRRVMHRDIKPAN-VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPF 219
Y+ + D+WSLG +LY + A Q+PF
Sbjct: 183 YNFKS-DIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-29
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 3/208 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y+ E +G G + V A++ T E VA+K + D +E+ +K ++H N+
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
VRLY+V+ ++ KL L+ E D DL Y + + + + Q+++ ++FCH +V
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGDSYDAP 198
+HRDLKP+N++ + G +KL DFG + F P + +L Y P++L G +
Sbjct: 121 LHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 179
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSE 226
++D+WS G I L P ND +
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFPGNDVD 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-29
Identities = 69/208 (33%), Positives = 109/208 (52%), Gaps = 20/208 (9%)
Query: 29 GHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRLYEVID 87
G + V L RH T ++ A+K I+K L +Q ++ E + ++P VV ++ +
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71
Query: 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPE 147
T L +++E +GGD ++K+ L AR YFA+ V A+ + H +VHRDLKP+
Sbjct: 72 TKRHLCMVMEYVEGGDCAT-LLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPD 130
Query: 148 NVVFFERLGVVKLTDFGFS---------NRFNPGQKLETS-------CGSLAYSAPEILL 191
N++ +G +KLTDFG S N + + +T CG+ Y APE++L
Sbjct: 131 NLL-ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL 189
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPF 219
Y P VD W++G+ILY + G PF
Sbjct: 190 RQGYGKP-VDWWAMGIILYEFLVGCVPF 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 68/211 (32%), Positives = 115/211 (54%), Gaps = 9/211 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD---HLYQEVRCMKLVQHPNVVRL 82
LG+G F V L R +G+ A+K++ K + +++D H E R +K +HP + L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVI--IAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
T +L ++E +GG+L+ ++ + SE R Y A+IV A+ + H +V+R
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERV-FSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 143 DLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVD 201
DLK EN++ ++ G +K+TDFG ++T CG+ Y APE+L + Y AVD
Sbjct: 120 DLKLENLM-LDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 202 VWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
W LGV++Y ++ G+ PF + + +I+
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 65/201 (32%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEV------RCMKLVQHPNV 79
+G+G F V R T A+KV+ K ++ V++ + + L + P +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEI--VAKKEVAHTIGERNILVRTLLDESPFI 58
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V L T+S LYL+ + GG+L+ + ++ + SE A+ Y A++V A+ HK +
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSEDRAKFYIAELVLALEHLHKYDI 117
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSN-RFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
V+RDLKPEN++ + G + L DFG S + T CG+ Y APE+LL +
Sbjct: 118 VYRDLKPENILL-DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176
Query: 199 AVDVWSLGVILYMLVAGQAPF 219
VD WSLGV+++ + G +PF
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 67/205 (32%), Positives = 109/205 (53%), Gaps = 7/205 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPN 78
+ +E+ +GRG F+ V A + + VA+K + ++ D ++ +E+ +K + HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIM---KHDAGLSETYAREYFAQIVRAISFCH 135
V++ + +++L ++LEL D GDL I K + E +YF Q+ A+ H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-CGSLAYSAPEILLGDS 194
V+HRD+KP N VF GVVKL D G F+ S G+ Y +PE + +
Sbjct: 124 SRRVMHRDIKPAN-VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPF 219
Y+ + D+WSLG +LY + A Q+PF
Sbjct: 183 YNFKS-DIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-28
Identities = 78/216 (36%), Positives = 111/216 (51%), Gaps = 15/216 (6%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ----EVRCMKLV-QHPNVV 80
LG+G F V LA T + A+K + K D V D + E R + L +HP +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKK---DVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMK-HDAGLSETYAREYFAQIVRAISFCHKLHV 139
LY T L+ ++E +GGDL +I H L A Y A+I+ + F H +
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPR--ATFYAAEIICGLQFLHSKGI 117
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAPEILLGDSYDAP 198
V+RDLK +N++ + G +K+ DFG G K T CG+ Y APEILLG Y+
Sbjct: 118 VYRDLKLDNILL-DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNT- 175
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMI-MD 233
+VD WS GV+LY ++ GQ+PF ++ E I MD
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 66/219 (30%), Positives = 111/219 (50%), Gaps = 21/219 (9%)
Query: 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM-KLVQ 75
G+++L E +G G + V ARH TG+ VA+K++D + ++ + +E + K
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKEEYNILRKYSN 61
Query: 76 HPNVVRLYEVIDTNS------KLYLILELGDGG---DLYDYIMKHDAGLSETYAREYFAQ 126
HPN+ Y + +L+L++EL GG DL + K L E + +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYS 185
+R +++ H+ V+HRD+K +N++ + VKL DFG S + + + T G+ +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWM 180
Query: 186 APEILLGD-----SYDAPAVDVWSLGVILYMLVAGQAPF 219
APE++ D SYDA + DVWSLG+ L G+ P
Sbjct: 181 APEVIACDEQPDASYDARS-DVWSLGITAIELADGKPPL 218
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 74/233 (31%), Positives = 120/233 (51%), Gaps = 15/233 (6%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-----PVSQDHLYQEVRCMKLV 74
Y + LG G +A V R TG+ VA+K I +L+ P + +E +K +
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAPFTA---IREASLLKDL 60
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
+H N+V L+++I T L L+ E D DL Y+ GLS R + Q++R +++C
Sbjct: 61 KHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN-RFNPGQKLETSCGSLAYSAPEILLGD 193
H+ V+HRDLKP+N++ ER G +KL DFG + + P + +L Y P++LLG
Sbjct: 120 HQRRVLHRDLKPQNLLISER-GELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGS 178
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDS-ETLTMIMDVSESSCTCWWRG 245
+ + ++D+W +G I Y + G+ F + D + L I V + W G
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 76/227 (33%), Positives = 119/227 (52%), Gaps = 18/227 (7%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEET--LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV 59
S S S +S P+ L +LE +G G V H TG A+KVI D V
Sbjct: 56 SSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV 115
Query: 60 SQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETY 119
+ + +E+ ++ V HPNVV+ +++ D N ++ ++LE DGG L + + L++
Sbjct: 116 -RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV- 173
Query: 120 AREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE--- 176
AR QI+ I++ H+ H+VHRD+KP N++ VK+ DFG S Q ++
Sbjct: 174 AR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKN-VKIADFGVSRILA--QTMDPCN 226
Query: 177 TSCGSLAYSAPEILLGD----SYDAPAVDVWSLGVILYMLVAGQAPF 219
+S G++AY +PE + D +YD A D+WSLGV + G+ PF
Sbjct: 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 73/242 (30%), Positives = 116/242 (47%), Gaps = 26/242 (10%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKL 73
+D+ +G G + V AR TGE VA+K K +LD P++ +E++ ++
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITA---IREIKILRQ 62
Query: 74 VQHPNVVRLYE-VIDTNSKL---------YLILELGDGGDLYDYIMKHDAGLSETYAREY 123
+ H N+V L E V D L YL+ E D DL + SE + + +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSF 121
Query: 124 FAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK--LETSCGS 181
Q++ +++CHK + +HRD+K N++ + G +KL DFG + +N + +
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 182 LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTC 241
L Y PE+LLG+ PA+DVWS G IL L + FQ + L +I + S C
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240
Query: 242 WW 243
W
Sbjct: 241 VW 242
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-28
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 9/214 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+D+ E LG G + V A H TG+ VA+KV+ ++ Q+ + +E+ +K P +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQE-IIKEISILKQCDSPYI 60
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMK-HDAGLSETYAREYFAQIVRAISFCHKLH 138
V+ Y N+ L++++E G + D IMK + L+E Q ++ + + H
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSD-IMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAPEILLGDSYDA 197
+HRD+K N++ E G KL DFG S + K T G+ + APE++ Y+
Sbjct: 120 KIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
A D+WSLG+ + G+ P+ + + + MI
Sbjct: 179 KA-DIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-28
Identities = 67/223 (30%), Positives = 113/223 (50%), Gaps = 24/223 (10%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH-----LYQEVRCMKLV 74
Y+ E +G G + V AR TG+ VA+K KT+L+ + +E+ ++++
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTRLE--MDEEGIPPTALREISLLQML 57
Query: 75 QH-PNVVRLYEVIDTNSK-----LYLILELGDGGDLYDYIMKHDAG----LSETYAREYF 124
+VRL +V K LYL+ E D DL ++ + G L + +
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 125 AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLA 183
Q+++ ++ CHK V+HRDLKP+N++ ++ G++K+ D G F+ P + +L
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW 176
Query: 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226
Y APE+LLG ++ + VD+WS+G I + Q F DSE
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF--PGDSE 217
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-28
Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 18/210 (8%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVID-KTKLDPVSQDHLYQEVRCMKLVQHP 77
L+ L E +G+G F V A T + VA+KVID + D + + + QE++ + + P
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI--EDIQQEIQFLSQCRSP 59
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
+ + Y SKL++I+E GG D ++K L ETY +++ + + H+
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKP-GKLDETYIAFILREVLLGLEYLHEE 117
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ------KLETSCGSLAYSAPEILL 191
+HRD+K N++ E G VKL DFG S GQ K T G+ + APE++
Sbjct: 118 GKIHRDIKAANILLSEE-GDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221
YD A D+WSLG+ L G+ P +
Sbjct: 172 QSGYDEKA-DIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-28
Identities = 73/224 (32%), Positives = 117/224 (52%), Gaps = 10/224 (4%)
Query: 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEV 68
S G P K Y E +G+G V A V TG++VA+K I+ K P ++ + E+
Sbjct: 13 SIGDPKK---KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QP-KKELIINEI 67
Query: 69 RCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIV 128
MK +++PN+V + +L++++E GG L D + + + E + +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECL 125
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAP 187
+A+ F H V+HRD+K +NV+ G VKLTDFGF + P Q K T G+ + AP
Sbjct: 126 QALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
E++ +Y P VD+WSLG++ +V G+ P+ N L +I
Sbjct: 185 EVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-28
Identities = 63/217 (29%), Positives = 114/217 (52%), Gaps = 17/217 (7%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKLVQHPNV 79
+G G + +V AR +GE VA+K K ++D P+S +E+ + ++HPN+
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALK---KVRMDNERDGIPISS---LREITLLLNLRHPNI 68
Query: 80 VRLYEVIDTNS--KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
V L EV+ ++L++E + DL + SE+ + Q++R + + H+
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCG-SLAYSAPEILLGDSYD 196
++HRDLK N++ ++ G +K+ DFG + + K T +L Y APE+LLG +
Sbjct: 128 FIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTY 186
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
A+D+W++G IL L+A + ++ E L +I+
Sbjct: 187 TTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-27
Identities = 66/211 (31%), Positives = 114/211 (54%), Gaps = 11/211 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G +V +A TG +VAVK +D K ++ L+ EV M+ QHPN+V +Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
+L++++E +GG L D I+ H ++E +++A+SF H V+HRD+K
Sbjct: 85 YLVGDELWVVMEFLEGGALTD-IVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 146 PENVVFFERLGVVKLTDFGFSNRFN---PGQKLETSCGSLAYSAPEILLGDSYDAPAVDV 202
++++ G VKL+DFGF + + P +K + G+ + APE++ Y VD+
Sbjct: 143 SDSIL-LTSDGRVKLSDFGFCAQVSKEVPRRK--SLVGTPYWMAPEVISRLPYG-TEVDI 198
Query: 203 WSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
WSLG+++ +V G+ P+ + + I D
Sbjct: 199 WSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD 229
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-27
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 7/202 (3%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH---LYQEVRCMKLVQHPNVV 80
E LG G F V ++ G+ AVK + Q+ L QE+ + +QHPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
+ LY+ LEL GG L + K+ + E R Y QI+ + + H + V
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS-FPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLG-DSYDAPA 199
HRD+K N++ + GVVKL DFG + + ++ GS + APE++ Y A
Sbjct: 125 HRDIKGANIL-VDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 200 VDVWSLGVILYMLVAGQAPFQE 221
D+WSLG + + G+ P+ +
Sbjct: 184 -DIWSLGCTVLEMATGKPPWSQ 204
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 72/222 (32%), Positives = 117/222 (52%), Gaps = 14/222 (6%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVID-KTKLDPVSQDHLYQEVRCM---KLV 74
LY E +GRG + V +HV TG VA+K+I+ T D VS + +EV + +
Sbjct: 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSD--IQREVALLSQLRQS 59
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISF 133
Q PN+ + Y +L++I+E +GG + +MK AG ++E Y +++ A+ +
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMK--AGPIAEKYISVIIREVLVALKY 116
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAPEILL- 191
HK+ V+HRD+K N++ G VKL DFG + N K T G+ + APE++
Sbjct: 117 IHKVGVIHRDIKAANILV-TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE 175
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
G YD A D+WSLG+ +Y + G P+ + + + +I
Sbjct: 176 GKYYDTKA-DIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK 216
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 73/226 (32%), Positives = 117/226 (51%), Gaps = 14/226 (6%)
Query: 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEV 68
S G P K Y E +G+G V A V TG++VA+K ++ + P ++ + E+
Sbjct: 13 SVGDPKK---KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QP-KKELIINEI 67
Query: 69 RCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMK--HDAGLSETYAREYFAQ 126
M+ +HPN+V + +L++++E GG L D + + D G RE
Sbjct: 68 LVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE---- 123
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYS 185
++A+ F H V+HRD+K +N++ G VKLTDFGF + P Q K T G+ +
Sbjct: 124 CLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 186 APEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
APE++ +Y P VD+WSLG++ +V G+ P+ N L +I
Sbjct: 183 APEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 69/213 (32%), Positives = 111/213 (52%), Gaps = 5/213 (2%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
E LG G +A V G+ VA+KVI + V + +E +K ++H N+V L+
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAI-REASLLKGLKHANIVLLH 69
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
++I T L + E DL Y+++H GL R + Q++R +++ H H++HRD
Sbjct: 70 DIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRD 128
Query: 144 LKPENVVFFERLGVVKLTDFGFSN-RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDV 202
LKP+N++ LG +KL DFG + + P Q + +L Y P++LLG + + A+D+
Sbjct: 129 LKPQNLL-ISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 203 WSLGVILYMLVAGQAPFQEANDS-ETLTMIMDV 234
W G I ++ GQ F +D E L I V
Sbjct: 188 WGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 75/215 (34%), Positives = 116/215 (53%), Gaps = 14/215 (6%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ----EVRCMKLV-QHPNVV 80
LG+G F V LA T E A+K++ K D V QD + E R + L + P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKK---DVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
+L+ T +LY ++E +GGDL Y ++ E +A Y A+I + F H ++
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLM-YQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 141 HRDLKPENVVFFERLGVVKLTDFGF--SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
+RDLK +NV+ + G +K+ DFG N ++ G +T CG+ Y APEI+ Y
Sbjct: 124 YRDLKLDNVML-DSEGHIKIADFGMCKENMWD-GVTTKTFCGTPDYIAPEIIAYQPY-GK 180
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
+VD W+ GV+LY ++AGQAPF+ ++ E IM+
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-27
Identities = 71/204 (34%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y++ +G G F L +HV + +K A+K I K +D + V K+ +HPN+
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNI 60
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGL-SETYAREYFAQIVRAISFCHKLH 138
V E + + LY+++E DGGDL I L E ++F Q+ + H+
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRF--NPGQKLETSCGSLAYSAPEILLGDSYD 196
V+HRD+K +N +F + G VKL DFG S R +PG T G+ Y PEI Y+
Sbjct: 121 VLHRDIKSKN-IFLTQNGKVKLGDFG-SARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 197 APAVDVWSLGVILYMLVAGQAPFQ 220
+ D+WSLG ILY L + PFQ
Sbjct: 179 NKS-DIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-27
Identities = 70/222 (31%), Positives = 119/222 (53%), Gaps = 10/222 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN- 78
+++ + +GRG F V + + TG+ A+K+++K ++ ++ ++E R + LV
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDV-LVNGDRR 61
Query: 79 -VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
+ L+ + LYL+++ GGDL + K + L E AR Y A++V AI H+L
Sbjct: 62 WITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILL---- 191
VHRD+KP+NV+ ++ G ++L DFG R ++++ G+ Y +PEIL
Sbjct: 122 GYVHRDIKPDNVL-LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
G P D WSLGV +Y ++ G+ PF + ET IM+
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-27
Identities = 68/221 (30%), Positives = 115/221 (52%), Gaps = 4/221 (1%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG G +A V R T VA+K I + + + + +EV +K ++H N+V L+++
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
I T L L+ E D DL Y+ +S + + Q++R +S+CHK ++HRDLK
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLK 130
Query: 146 PENVVFFERLGVVKLTDFGFSN-RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWS 204
P+N++ E+ G +KL DFG + + P + +L Y P++LLG + + +D+W
Sbjct: 131 PQNLLINEK-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWG 189
Query: 205 LGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245
+G ILY + G+ F + E L +I + + W G
Sbjct: 190 VGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-27
Identities = 78/215 (36%), Positives = 111/215 (51%), Gaps = 14/215 (6%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ----EVRCMKLV-QHPN 78
+ LG+G F V LA GE AVK + K D V D + E R + L ++P
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKK---DVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETY-AREYFAQIVRAISFCHKL 137
+ LY T L+ ++E +GGDL +I D G + Y A Y A+IV + F H
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHI--QDKGRFDLYRATFYAAEIVCGLQFLHSK 115
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAPEILLGDSYD 196
+++RDLK +NV+ +R G +K+ DFG G + T CG+ Y APEIL G Y
Sbjct: 116 GIIYRDLKLDNVML-DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYT 174
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
+VD WS GV+LY ++ GQ+PF ++ E I
Sbjct: 175 F-SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 6e-27
Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 39/231 (16%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMK 72
L +EE G + VV AR TGE VA+K K K++ P++ +E+ +
Sbjct: 10 LNRIEE----GTYGVVYRARDKKTGEIVALK---KLKMEKEKEGFPITS---LREINILL 59
Query: 73 LVQHPNVVRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFA---- 125
+QHPN+V + EV+ K+Y+++E ++HD L ET + +
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIYMVMEY----------VEHDLKSLMETMKQPFLQSEVK 109
Query: 126 ----QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCG 180
Q++ ++ H ++HRDLK N++ R G++K+ DFG + + +P +
Sbjct: 110 CLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLKPYTQLVV 168
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
+L Y APE+LLG + A+D+WS+G I L+ + F ++ + L I
Sbjct: 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-27
Identities = 67/223 (30%), Positives = 117/223 (52%), Gaps = 4/223 (1%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
E LG G +A V R T VA+K I + + + + +EV +K ++H N+V L+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
+++ T+ L L+ E D DL Y+ +S + + QI+R +++CH+ V+HRD
Sbjct: 71 DIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRD 129
Query: 144 LKPENVVFFERLGVVKLTDFGFSN-RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDV 202
LKP+N++ ER G +KL DFG + + P + +L Y P++LLG S + +D+
Sbjct: 130 LKPQNLLINER-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188
Query: 203 WSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245
W +G I + + +G+ F + + L +I + + W G
Sbjct: 189 WGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-26
Identities = 65/198 (32%), Positives = 104/198 (52%), Gaps = 4/198 (2%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL-YQEVRCMKLVQHPNVVRLYE 84
LG+G F V + TG+ A K +DK +L S + + E ++ V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMK-HDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
++ + L L++ L +GGDL +I + GL Y AQI I H + +V+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVW 203
+KPENV+ + G +L+D G + G+ + G+ Y APEIL + Y P VD +
Sbjct: 121 MKPENVL-LDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP-VDWF 178
Query: 204 SLGVILYMLVAGQAPFQE 221
++G +Y +VAG+ PF++
Sbjct: 179 AMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 4/209 (1%)
Query: 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
A Y+ E LG G +A V + G+ VA+KVI + + + + +E +K ++H
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKH 62
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
N+V L+++I T L L+ E DL Y+ KH GL + + Q++R +S+ H+
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSN-RFNPGQKLETSCGSLAYSAPEILLGDSY 195
+++HRDLKP+N++ + G +KL DFG + + P +L Y P++LLG +
Sbjct: 122 RYILHRDLKPQNLLISDT-GELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 196 DAPAVDVWSLGVILYMLVAGQAPFQEAND 224
+ +D+W +G I ++ G A F D
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 61/225 (27%), Positives = 109/225 (48%), Gaps = 19/225 (8%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ----EVRCMKLVQHPNV 79
+ LG G F+ AR V TG +AVK + + Q+ + + E+R M + HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
+R+ +S L +E GG + + K+ A E Y Q++R +S+ H+ +
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA-FKEAVIINYTEQLLRGLSYLHENQI 124
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNP---------GQKLETSCGSLAYSAPEIL 190
+HRD+K N++ +++ DFG + R GQ L G++A+ APE+L
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL----GTIAFMAPEVL 180
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235
G+ Y + DVWS+G ++ + + P+ S L +I ++
Sbjct: 181 RGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA 224
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 69/223 (30%), Positives = 111/223 (49%), Gaps = 24/223 (10%)
Query: 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR 69
D H I Y++ + LG+G + +V A T E VA+K I + ++E+
Sbjct: 2 DKH---ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIM 58
Query: 70 CMK-LVQHPNVVRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREY-FA 125
++ L HPN+V+L VI + + +YL+ E + DL+ I A + E + Y
Sbjct: 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI---RANILEDVHKRYIMY 114
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA-- 183
Q+++A+ + H +V+HRDLKP N+ VKL DFG + + +LE + +
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNI-LLNSDCRVKLADFGLARSLS---ELEENPENPVLT 170
Query: 184 -------YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPF 219
Y APEILLG + VD+WS+G IL ++ G+ F
Sbjct: 171 DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 81/261 (31%), Positives = 114/261 (43%), Gaps = 52/261 (19%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRLYE 84
+G+G F V+L + TG+ A+K + K+++ Q H+ E + P VV LY
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDL 144
LYLI+E GGDL ++K+D SE R Y A+ V AI HKL +HRD+
Sbjct: 69 SFQDAQYLYLIMEFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 145 KPENVVFFERLGVVKLTDFGFSNRF------NPGQKLETSCGS----------------- 181
KP+N++ +R G +KL+DFG S F QKL +
Sbjct: 128 KPDNIL-IDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 182 -----------------LAYS--------APEILLGDSYDAPAVDVWSLGVILYMLVAGQ 216
+AYS APEI L Y D WSLG I++ + G
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 217 APFQEANDSETLTMIMDVSES 237
PF N ET I++ E+
Sbjct: 246 PPFCSENSHETYRKIINWRET 266
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 70/225 (31%), Positives = 119/225 (52%), Gaps = 10/225 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN- 78
+++ + +GRG F V + + + A+K+++K ++ ++ ++E R + LV N
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV-LVNGDNQ 61
Query: 79 -VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
+ L+ + LYL+++ GGDL + K + L E AR Y A++V AI H+L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILL---- 191
H VHRD+KP+N++ + G ++L DFG + +++S G+ Y +PEIL
Sbjct: 122 HYVHRDIKPDNIL-MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236
G P D WSLGV +Y ++ G+ PF + ET IM+ E
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 73/214 (34%), Positives = 109/214 (50%), Gaps = 12/214 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ----EVRCMKLVQHPN-VV 80
LG+G F V LA T E A+K++ K D V QD + E R + L P +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKK---DVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
+L+ T +LY ++E +GGDL Y ++ E A Y A+I + F H+ ++
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLM-YHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGII 123
Query: 141 HRDLKPENVVFFERLGVVKLTDFGF-SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+RDLK +NV+ + G +K+ DFG G T CG+ Y APEI+ Y +
Sbjct: 124 YRDLKLDNVML-DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKS 181
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
VD W+ GV+LY ++AGQ PF ++ E IM+
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-26
Identities = 75/219 (34%), Positives = 118/219 (53%), Gaps = 14/219 (6%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM-KLVQH---PNVVR 81
+GRG F V R TG+ A+K +DK ++ + L R M LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
+ T KL IL+L +GGDL+ ++ +H SE R Y A+I+ + H VV+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL-GDSYDAPAV 200
RDLKP N++ E G V+++D G + F+ +K S G+ Y APE+L G +YD+ A
Sbjct: 121 RDLKPANILLDEH-GHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSSA- 177
Query: 201 DVWSLGVILYMLVAGQAPFQE-----ANDSETLTMIMDV 234
D +SLG +L+ L+ G +PF++ ++ + +T+ M V
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-26
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL---YQEVRCMKLVQ 75
Y+L + +G G + V AR + TGE VA+KVI KL+P D QE+ +K +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEP--GDDFEIIQQEISMLKECR 58
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
HPN+V + KL++++E GG L D LSE + ++ +++ H
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEIL---L 191
+ +HRD+K N++ E G VKL DFG S + K ++ G+ + APE+
Sbjct: 119 ETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAP 218
YD D+W+LG+ L Q P
Sbjct: 178 KGGYDG-KCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-26
Identities = 71/226 (31%), Positives = 117/226 (51%), Gaps = 14/226 (6%)
Query: 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEV 68
S G P K Y E +G+G V A + TG++VA+K ++ + P ++ + E+
Sbjct: 13 SVGDPKK---KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QP-KKELIINEI 67
Query: 69 RCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMK--HDAGLSETYAREYFAQ 126
M+ ++PN+V + +L++++E GG L D + + D G RE
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE---- 123
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYS 185
++A+ F H V+HRD+K +N++ G VKLTDFGF + P Q K T G+ +
Sbjct: 124 CLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182
Query: 186 APEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
APE++ +Y P VD+WSLG++ +V G+ P+ N L +I
Sbjct: 183 APEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 76/224 (33%), Positives = 119/224 (53%), Gaps = 16/224 (7%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM-KLVQH---PNVVR 81
+GRG F V R TG+ A+K +DK ++ + L R M LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
+ T KL IL+L +GGDL+ ++ +H SE R Y +I+ + H VV+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL-GDSYDAPAV 200
RDLKP N++ E G V+++D G + F+ +K S G+ Y APE+L G +YD+ A
Sbjct: 121 RDLKPANILLDEH-GHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGTAYDSSA- 177
Query: 201 DVWSLGVILYMLVAGQAPFQEAN-------DSETLTMIMDVSES 237
D +SLG +L+ L+ G +PF++ D TLT+ +++ +S
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 66/226 (29%), Positives = 115/226 (50%), Gaps = 23/226 (10%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG G +V A ++VAVK I T DP S H +E++ ++ + H N+V++YEV
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 86 I-DTNSKL-------------YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
+ + S L Y++ E + DL + +++ LSE +AR + Q++R +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLAN-VLEQGP-LSEEHARLFMYQLLRGL 127
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK----LETSCGSLAYSAP 187
+ H +V+HRDLKP NV V+K+ DFG + +P L + Y +P
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
+LL + A+D+W+ G I ++ G+ F A++ E + +I++
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 67/223 (30%), Positives = 114/223 (51%), Gaps = 4/223 (1%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
+ LG G +A V R T VA+K I + + + + +EV +K ++H N+V L+
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
++I T L L+ E D DL Y+ ++ + + Q++R +++CH+ V+HRD
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRD 129
Query: 144 LKPENVVFFERLGVVKLTDFGFSN-RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDV 202
LKP+N++ ER G +KL DFG + + P + +L Y P+ILLG + + +D+
Sbjct: 130 LKPQNLLINER-GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188
Query: 203 WSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245
W +G I Y + G+ F + E L I + + W G
Sbjct: 189 WGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 72/230 (31%), Positives = 107/230 (46%), Gaps = 11/230 (4%)
Query: 19 LYDLEETLGRGHFAVVKLA-RHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
+Y L +GR +A R EKV K + D + E+ C+ H
Sbjct: 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHF 125
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYI---MKHDAGLSETYAREYFAQIVRAISFC 134
+V+ ++ ++ KL LI+E G GGDL I +K E F QIV A+
Sbjct: 126 GIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS---CGSLAYSAPEILL 191
H ++HRDLK N +F G++KL DFGFS +++ L+ + CG+ Y APE+
Sbjct: 186 HSRKMMHRDLKSAN-IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE 244
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTC 241
Y A D+WSLGVILY L+ PF+ + E + ++ C
Sbjct: 245 RKRYSKKA-DMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPC 293
|
Length = 478 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-25
Identities = 72/225 (32%), Positives = 119/225 (52%), Gaps = 10/225 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN- 78
+++ + +GRG F V + + T A+K+++K ++ ++ ++E R + LV
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV-LVNGDCQ 61
Query: 79 -VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
+ L+ + LYL+++ GGDL + K + L E AR Y A++V AI H+L
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILL---- 191
H VHRD+KP+NV+ + G ++L DFG + N +++S G+ Y +PEIL
Sbjct: 122 HYVHRDIKPDNVL-LDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236
G P D WSLGV +Y ++ G+ PF + ET IM+ E
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE 225
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-25
Identities = 65/217 (29%), Positives = 96/217 (44%), Gaps = 13/217 (5%)
Query: 24 ETLGRGHFAVVKLARHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
+ LG G F VV+ +G K VAVK + KL + D L +E M + H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLI 59
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKLHV 139
RLY V+ T L ++ EL G L D + K G + +Y QI + +
Sbjct: 60 RLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL----AYSAPEILLGDSY 195
+HRDL N++ VK+ DFG + L A+ APE L ++
Sbjct: 119 IHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 196 DAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMI 231
+ A DVW GV L+ M G+ P+ + S+ L I
Sbjct: 178 -SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 61/237 (25%), Positives = 110/237 (46%), Gaps = 39/237 (16%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVI---DKTKLDPVSQDHLYQEVRCMKLVQH 76
Y+ +G+G F V ARH T + VA+K + ++ + P++ +E++ ++L++H
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA---LREIKILQLLKH 70
Query: 77 PNVVRLYEVIDTNSK--------LYLILELGDGGDLYDYIMKHD-AGL--------SETY 119
NVV L E+ T + YL+ E + HD AGL + +
Sbjct: 71 ENVVNLIEICRTKATPYNRYKGSFYLVFEFCE----------HDLAGLLSNKNVKFTLSE 120
Query: 120 AREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG----FSNRFNP-GQK 174
++ ++ + + H+ ++HRD+K N++ + G++KL DFG FS N +
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILI-TKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
+L Y PE+LLG+ P +D+W G I+ + Q + LT+I
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 67/203 (33%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ----EVRCMKLVQHPNVVR 81
LG+G F V + TG+ A K ++K +L + Y+ E R + V +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL---KKRKGYEGAMVEKRILAKVHSRFIVS 57
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHD---AGLSETYAREYFAQIVRAISFCHKLH 138
L T + L L++ + +GGDL +I D G E A Y AQI+ + H+
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAPEILLGDSYDA 197
+++RDLKPENV+ + G V+++D G + GQ K + G+ + APE+L G+ YD
Sbjct: 118 IIYRDLKPENVL-LDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 198 PAVDVWSLGVILYMLVAGQAPFQ 220
+VD ++LGV LY ++A + PF+
Sbjct: 177 -SVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 6e-25
Identities = 70/226 (30%), Positives = 117/226 (51%), Gaps = 14/226 (6%)
Query: 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEV 68
S G P K Y E +G+G V A V TG++VA++ ++ + P ++ + E+
Sbjct: 14 SVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QP-KKELIINEI 68
Query: 69 RCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMK--HDAGLSETYAREYFAQ 126
M+ ++PN+V + +L++++E GG L D + + D G RE
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRE---- 124
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYS 185
++A+ F H V+HRD+K +N++ G VKLTDFGF + P Q K T G+ +
Sbjct: 125 CLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183
Query: 186 APEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
APE++ +Y P VD+WSLG++ ++ G+ P+ N L +I
Sbjct: 184 APEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 7e-25
Identities = 73/225 (32%), Positives = 116/225 (51%), Gaps = 13/225 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVA----VKVIDKTKLDPVSQDHLYQEVRCMKLVQ 75
Y+ +G G + V AR + G + V+V + P+S +R ++ +
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 76 HPNVVRLYEV-----IDTNSKLYLILELGDGGDLYDYIMK-HDAGLSETYAREYFAQIVR 129
HPNVVRL++V D +KL L+ E D DL Y+ K + G+ ++ Q++R
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 130 AISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEI 189
+ F H VVHRDLKP+N++ G +KL DFG + ++ L + +L Y APE+
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180
Query: 190 LLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
LL SY P VD+WS+G I + + F+ ++D + L I+DV
Sbjct: 181 LLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 76/252 (30%), Positives = 115/252 (45%), Gaps = 42/252 (16%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRL 82
+ +GRG F V+L + TG A+K++ K + Q H+ E + VV++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
+ LYLI+E GGD+ +MK D L+E + Y A+ V AI H+L +HR
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLAIDSIHQLGFIHR 125
Query: 143 DLKPENVVFFERLGVVKLTDFG--------------------------FSNRFNPGQKLE 176
D+KP+N++ + G VKL+DFG F N N +K E
Sbjct: 126 DIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN-MNSKRKAE 183
Query: 177 T-----------SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225
T + G+ Y APE+ + Y+ D WSLGVI+Y ++ G PF
Sbjct: 184 TWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK-LCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 226 ETLTMIMDVSES 237
ET +M+ E+
Sbjct: 243 ETYKKVMNWKET 254
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 77/252 (30%), Positives = 115/252 (45%), Gaps = 42/252 (16%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRL 82
+ +GRG F V+L + TG A+K++ K + Q H+ E + VV++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
+ LYLI+E GGD+ +MK D LSE + Y A+ V AI H+L +HR
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIHQLGFIHR 125
Query: 143 DLKPENVVFFERLGVVKLTDFG--------------------------FSNRFNPGQKLE 176
D+KP+N++ + G VKL+DFG F N N +K E
Sbjct: 126 DIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN-MNSKRKAE 183
Query: 177 T-----------SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225
T + G+ Y APE+ + Y+ D WSLGVI+Y ++ G PF
Sbjct: 184 TWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK-LCDWWSLGVIMYEMLIGYPPFCSETPQ 242
Query: 226 ETLTMIMDVSES 237
ET +M+ E+
Sbjct: 243 ETYRKVMNWKET 254
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 8e-25
Identities = 65/199 (32%), Positives = 109/199 (54%), Gaps = 6/199 (3%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL-YQEVRCMKLVQHPNVVRLYE 84
LG+G F V + TG+ A K ++K ++ + + E + ++ V VV L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
+T L L+L L +GGDL +I +AG E A Y A+I + H+ +V+RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYD-APAVDV 202
LKPEN++ + G ++++D G + GQ ++ G++ Y APE++ + Y +P D
Sbjct: 128 LKPENILLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP--DW 184
Query: 203 WSLGVILYMLVAGQAPFQE 221
W+LG +LY ++AGQ+PFQ+
Sbjct: 185 WALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-24
Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 20 YDLEET-----LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
Y+ +E LG+G + +V AR + T ++A+K I + V L++E+ +
Sbjct: 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQP--LHEEIALHSYL 62
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLS--ETYAREYFAQIVRAIS 132
+H N+V+ N + +E GG L + L E Y QI+ +
Sbjct: 63 KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122
Query: 133 FCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF---NPGQKLETSCGSLAYSAPEI 189
+ H +VHRD+K +NV+ GVVK++DFG S R NP ET G+L Y APE+
Sbjct: 123 YLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEV 180
Query: 190 LLGD----SYDAPAVDVWSLGVILYMLVAGQAPFQE 221
+ D Y APA D+WSLG + + G+ PF E
Sbjct: 181 I--DKGPRGYGAPA-DIWSLGCTIVEMATGKPPFIE 213
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 1e-24
Identities = 59/225 (26%), Positives = 109/225 (48%), Gaps = 14/225 (6%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y E +G G + VV A +G+KVA+K I P +E++ ++ +H N+
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 80 VRLYEVIDTNSKL----YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
+ + +++ Y++++L DL+ +I+ D L+E + R + Q++R + + H
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLM-ESDLH-HIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-----CGSLAYSAPEIL 190
+V+HRDLKP N++ E +++ DFG + + + Y APE+L
Sbjct: 125 SANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 191 LG-DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
L Y A+D+WS+G I ++ + F N L +I+ V
Sbjct: 184 LSLPEYTT-AIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV 227
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 73/239 (30%), Positives = 114/239 (47%), Gaps = 31/239 (12%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y++ + +G G F V L +H T E K I L + L EV M+ ++H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 80 VRLYE--VIDTNSKLYLILELGDGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFC 134
VR + + N KLY+++E D GDL I K + E + Q++ A+++C
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 135 HKL-------HVVHRDLKPENVVF---FERLG-------------VVKLTDFGFSNRFNP 171
H L V+HRDLKP+N+ +G + K+ DFG S
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 172 GQKLETSCGSLAYSAPEILLGD--SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
+ G+ Y +PE+LL + SYD + D+W+LG I+Y L +G+ PF +AN+ L
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKS-DMWALGCIIYELCSGKTPFHKANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 7e-24
Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH---------------LYQEVRC 70
LG G + V+ A TG+ VA+K K K+ +S D +E++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIK---KVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
M ++H N++ L +V + L++++ DL ++ L+E+ + QI+
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKK-VVDRKIRLTESQVKCILLQILNG 131
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF------NPGQKLETSCG---- 180
++ HK + +HRDL P N+ F G+ K+ DFG + R+ + K ET
Sbjct: 132 LNVLHKWYFMHRDLSPANI-FINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 181 -----SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
+L Y APE+L+G AVD+WS+G I L+ G+ F N+ + L I
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246
|
Length = 335 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 9e-24
Identities = 72/248 (29%), Positives = 106/248 (42%), Gaps = 48/248 (19%)
Query: 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRLY 83
T+G G F V L R V T A+K + K + +Q H+ E + + VV+LY
Sbjct: 8 TIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
LY +++ GGD+ +++ E AR Y A++ AI HK+ +HRD
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHKMGFIHRD 126
Query: 144 LKPENVVFFERLGVVKLTDFGF---------SNRFNPGQ--------------------- 173
+KP+N++ +R G +KLTDFG S + G
Sbjct: 127 IKPDNIL-IDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL 185
Query: 174 --------KLETSC------GSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPF 219
+ C G+ Y APE+LL Y D WS+GVILY ++ GQ PF
Sbjct: 186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ-LCDWWSVGVILYEMLVGQPPF 244
Query: 220 QEANDSET 227
+ET
Sbjct: 245 LADTPAET 252
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-23
Identities = 73/228 (32%), Positives = 113/228 (49%), Gaps = 20/228 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL----YQEVRCMKLVQ 75
Y+ +G G + V AR +G VA+K + ++D L +EV +K ++
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----QTNEDGLPLSTVREVALLKRLE 57
Query: 76 ---HPNVVRLYEV-----IDTNSKLYLILELGDGGDLYDYIMKHDA-GLSETYAREYFAQ 126
HPN+VRL +V D +K+ L+ E D DL Y+ K GL ++ Q
Sbjct: 58 AFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSA 186
+R + F H +VHRDLKPEN++ G VKL DFG + ++ L +L Y A
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 187 PEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
PE+LL +Y P VD+WS+G I + + F ++++ L I D+
Sbjct: 176 PEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 222
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-23
Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 4/198 (2%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL-YQEVRCMKLVQHPNVVRLYE 84
LG+G F V + TG+ A K ++K ++ + + E + ++ V VV L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMK-HDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
+T L L+L L +GGDL +I + G E A Y A+I + H+ +V+RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVW 203
LKPEN++ + G ++++D G + G+ + G++ Y APE++ + Y + D W
Sbjct: 128 LKPENILLDDY-GHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF-SPDWW 185
Query: 204 SLGVILYMLVAGQAPFQE 221
LG ++Y ++ G++PF++
Sbjct: 186 GLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-23
Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 26 LGRGHFAVVKLARHVFTGE-KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYE 84
LG G F VVK + + G+ VA+K+I K +S+D +E + M + H +V+LY
Sbjct: 12 LGTGQFGVVKYGK--WRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDL 144
V +Y++ E G L +Y+ +H + E + +++ +HRDL
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDL 126
Query: 145 KPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSYDAPAVD 201
N + + G VK++DFG S R+ + +S GS + +S PE+LL + + + D
Sbjct: 127 AARNCL-VDDQGCVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS-D 183
Query: 202 VWSLGVILYMLVA-GQAPFQEANDSET 227
VW+ GV+++ + + G+ P++ N+SET
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSET 210
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-23
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 11/212 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G F +V AR TG+ VA+K I K PV Y+E++ +K ++H N++ L ++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 86 -IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLHVVHRD 143
I +Y + EL G DL+ + + E +YF QI+R + + H VVHRD
Sbjct: 78 FISPLEDIYFVTEL-LGTDLHRLL---TSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLG-DSYDAPAVDV 202
LKP N++ E +K+ DFG + +P ++ + Y APEI+L YD VD+
Sbjct: 134 LKPSNILINENCD-LKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDV-EVDI 189
Query: 203 WSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
WS G I ++ G+ F + ++I D+
Sbjct: 190 WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDL 221
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-23
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
LE LG G F V + + G KVAVK + + P + L QE + MK ++H +V
Sbjct: 10 LERKLGAGQFGEVWMG--TWNGTTKVAVKTLKPGTMSP--EAFL-QEAQIMKKLRHDKLV 64
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG--LSETYAREYFAQIVRAISFCHKLH 138
+LY V +Y++ E G L D+ +K G L + AQI +++ +
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDF-LKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN 123
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSY 195
+HRDL N++ E L V K+ DFG + R + G+ + ++APE +
Sbjct: 124 YIHRDLAARNILVGENL-VCKIADFGLA-RLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181
Query: 196 DAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIM 232
+ DVWS G++L +V G+ P+ + E L +
Sbjct: 182 TIKS-DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-23
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 6/214 (2%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
L+ E +G+G F V T E VA+K+ID + + +D + QE+ + P
Sbjct: 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPY 63
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+ R Y +KL++I+E GG D + L ETY +I++ + + H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSER 121
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAPEILLGDSYDA 197
+HRD+K NV+ E+ G VKL DFG + + Q K T G+ + APE++ +YD
Sbjct: 122 KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
A D+WSLG+ L G+ P + + L +I
Sbjct: 181 KA-DIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-23
Identities = 65/220 (29%), Positives = 111/220 (50%), Gaps = 21/220 (9%)
Query: 19 LYDLEETLGRGHFAVVKLAR--HVFTGEKVAVKVI--DKTKLDPVSQDHLYQEVRCMKLV 74
Y++E +GRG + V A+ + G++ A+K DK + +SQ +E+ ++ +
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA-CREIALLREL 59
Query: 75 QHPNVVRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHDAG----LSETYAREYFAQIV 128
+H NVV L EV + +YL+ + + DL+ I H + + + QI+
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 129 RAISFCHKLHVVHRDLKPENVV----FFERLGVVKLTDFGFSNRFN-PGQKLETSCG--- 180
+ + H V+HRDLKP N++ ER GVVK+ D G + FN P + L
Sbjct: 119 NGVHYLHSNWVLHRDLKPANILVMGEGPER-GVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220
++ Y APE+LLG + A+D+W++G I L+ + F+
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-23
Identities = 58/198 (29%), Positives = 105/198 (53%), Gaps = 4/198 (2%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL-YQEVRCMKLVQHPNVVRLYE 84
LG+G F V + TG+ A K ++K ++ + + E R ++ V VV L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
+T L L+L + +GGDL +I + G E A Y A++ + + +V+RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVW 203
LKPEN++ +R G ++++D G + + G+ + G++ Y APE++ + Y + D W
Sbjct: 128 LKPENILLDDR-GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY-TFSPDWW 185
Query: 204 SLGVILYMLVAGQAPFQE 221
LG ++Y ++ GQ+PF++
Sbjct: 186 GLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-23
Identities = 64/209 (30%), Positives = 113/209 (54%), Gaps = 7/209 (3%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G +V +A +G+ VAVK +D K ++ L+ EV M+ QH NVV +Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
+L++++E +GG L D I+ H ++E +++A+S H V+HRD+K
Sbjct: 86 YLVGDELWVVMEFLEGGALTD-IVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 146 PENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCGSLAYSAPEILLGDSYDAPAVDVWS 204
++++ G VKL+DFGF + + + ++ G+ + APE++ Y P VD+WS
Sbjct: 144 SDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 205 LGVILYMLVAGQAPFQEANDSETLTMIMD 233
LG+++ +V G+ P+ + + MI D
Sbjct: 202 LGIMVIEMVDGEPPYFNEPPLKAMKMIRD 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 3e-23
Identities = 64/241 (26%), Positives = 113/241 (46%), Gaps = 36/241 (14%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVK-VIDKTKLD--PVSQDHLYQEVRCMKLVQH 76
Y++ LG G F V AR + TG VA+K ++ + D P++ +E++ +K ++H
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA---LREIKILKKLKH 66
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLY---DYIMKHD-AGL--------SETYAREYF 124
PNVV L ++ G +Y Y M HD +GL +E+ + Y
Sbjct: 67 PNVVPLIDMAVERPDK----SKRKRGSVYMVTPY-MDHDLSGLLENPSVKLTESQIKCYM 121
Query: 125 AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLA 183
Q++ I++ H+ H++HRD+K N++ + G++K+ DFG + + P + G
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILI-DNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180
Query: 184 -----------YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
Y PE+LLG+ AVD+W +G + + + Q +D + L +I
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240
Query: 233 D 233
Sbjct: 241 K 241
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 4e-23
Identities = 60/195 (30%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G +V +AR +G +VAVK++D K ++ L+ EV M+ QH NVV +Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
+L++++E GG L D + + L+E +++A+ + H V+HRD+K
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 146 PENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCGSLAYSAPEILLGDSYDAPAVDVWS 204
++++ G VKL+DFGF + + K ++ G+ + APE++ Y VD+WS
Sbjct: 145 SDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWS 202
Query: 205 LGVILYMLVAGQAPF 219
LG+++ +V G+ P+
Sbjct: 203 LGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 5e-23
Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 22/226 (9%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y +G G + V A TG KVA+K + + + Y+E+R +K + H NV
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76
Query: 80 VRLYEVIDTNSKL------YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ L +V S L YL+ L G DL + I+K LS+ + + QI+R + +
Sbjct: 77 IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNN-IVKCQK-LSDDHIQFLVYQILRGLKY 133
Query: 134 CHKLHVVHRDLKPENVVFFERLGV-----VKLTDFGFSNRFNPGQKLETSCGSLAYSAPE 188
H ++HRDLKP N + V +K+ DFG + + ++ + Y APE
Sbjct: 134 IHSAGIIHRDLKPSN------IAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPE 185
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
I+L + VD+WS+G I+ L+ G+ F ++ + L IM++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL 231
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 6e-23
Identities = 64/211 (30%), Positives = 110/211 (52%), Gaps = 8/211 (3%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG G F V A++ TG A KVI+ TK + +D++ E+ + HP +V+L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIE-TKSEEELEDYMV-EIEILATCNHPYIVKLLGA 77
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
+ KL++++E GG + +++ D GL+E + Q++ A+ + H + ++HRDLK
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK 137
Query: 146 PENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSY-DAP---AV 200
NV+ G +KL DFG S + Q+ ++ G+ + APE+++ ++ D P
Sbjct: 138 AGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 196
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
D+WSLG+ L + + P E N L I
Sbjct: 197 DIWSLGITLIEMAQIEPPHHELNPMRVLLKI 227
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-22
Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 18/214 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD------HLYQEVRCMKL 73
+ L + LGRG F V L TG ++AVK + DP SQ+ L E++ +K
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVK---QVPFDPDSQETSKEVNALECEIQLLKN 60
Query: 74 VQHPNVVRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
++H +V+ Y + KL + +E GG + D + + A L+E R Y QI++ +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGV 119
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN----PGQKLETSCGSLAYSAP 187
S+ H +VHRD+K N++ + G VKL DFG S R G +++ G+ + +P
Sbjct: 120 SYLHSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221
E++ G+ Y A DVWS+ + ++ + P+ E
Sbjct: 179 EVISGEGYGRKA-DVWSVACTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-22
Identities = 59/237 (24%), Positives = 116/237 (48%), Gaps = 26/237 (10%)
Query: 24 ETLGRGHFAVVKLARHVFTGE-KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRL 82
+ LG G F VV L + + G+ VA+K+I + + S+D +E + M + HPN+V+L
Sbjct: 10 KELGSGQFGVVHLGK--WRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQL 64
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
Y V ++++ E G L +Y+ + L + + + + A+ + +HR
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124
Query: 143 DLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSYDAPA 199
DL N + E VVK++DFG + R+ + +S G+ + ++ PE+ + + +
Sbjct: 125 DLAARNCLVGED-NVVKVSDFGLA-RYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 200 VDVWSLGVILYMLVA-GQAPFQEANDSETLTMI-------------MDVSESSCTCW 242
DVWS GV+++ + + G+ P++ ++SE + + +V +CW
Sbjct: 183 -DVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCW 238
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-22
Identities = 68/242 (28%), Positives = 116/242 (47%), Gaps = 27/242 (11%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG G F VV L + KVA+K I++ + S++ +E + M + HP +V+LY V
Sbjct: 12 LGSGQFGVVHLGKWR-AQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
LY++ E + G L +Y+ + LS+ + + + + +HRDL
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127
Query: 146 PENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSYDAPAVDV 202
N + GVVK++DFG + R+ + +S G+ + +S PE+ Y + + DV
Sbjct: 128 ARNCLVSS-TGVVKVSDFGMT-RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS-DV 184
Query: 203 WSLGVILY-MLVAGQAPFQEANDSETLTMI-------------MDVSESSCTCWW---RG 245
WS GV+++ + G+ PF++ ++ E + MI M V E +CW G
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEG 244
Query: 246 RP 247
RP
Sbjct: 245 RP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-22
Identities = 70/227 (30%), Positives = 123/227 (54%), Gaps = 17/227 (7%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH-LYQEVRCMKLVQHPN 78
Y ++E +G+G + VV A TGEKVA+K I+ + VS + +E++ ++L++HP+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-FEHVSDATRILREIKLLRLLRHPD 60
Query: 79 VVRLYEVIDTNSK-----LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+V + ++ S+ +Y++ EL + DL+ I +D L+ + + + Q++RA+ +
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAND-DLTPEHHQFFLYQLLRALKY 118
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN-RFN--PGQKLETS-CGSLAYSAPEI 189
H +V HRDLKP+N++ +K+ DFG + FN P T + Y APE
Sbjct: 119 IHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE- 176
Query: 190 LLGDSYD--APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
L G + PA+D+WS+G I ++ G+ F N L +I D+
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL 223
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 61/215 (28%), Positives = 109/215 (50%), Gaps = 10/215 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G F VV G++VA+K + + VS +++E++ + +H NV+ ++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 86 -----IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
ID ++Y++ EL DL+ I+ LS + + + QI+R + + H ++
Sbjct: 68 LQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQP-LSSDHVKVFLYQILRGLKYLHSAGIL 125
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA--YSAPEILLGDSYDAP 198
HRD+KP N++ V+K+ DFG + P + + + Y APEIL+G +
Sbjct: 126 HRDIKPGNLLVNSNC-VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS 184
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
AVD+WS+G I L+ + FQ + + L +I D
Sbjct: 185 AVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-22
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 8/213 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y +G+G + V L RH G++ +K ++ + QE + + ++HPN+
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 80 VRLYEVID-TNSKLYLILELGDGGDLYDYIMKHDAG--LSETYAREYFAQIVRAISFCHK 136
V E + + LY+++ +GGDLY + +K G L E E+F QI A+ + H+
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLY-HKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSY 195
H++HRDLK +N VF R ++K+ D G + N T G+ Y +PE+ Y
Sbjct: 121 KHILHRDLKTQN-VFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 196 DAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
+ + DVW+LG +Y + + F A D +L
Sbjct: 180 NYKS-DVWALGCCVYEMATLKHAFN-AKDMNSL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-22
Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 13/209 (6%)
Query: 21 DLE--ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR-CMKLVQHP 77
DLE E LGRG + VV RHV TG +AVK I + ++ Q L ++ M+ V P
Sbjct: 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 78 NVVRLYEVIDTNSKLYLILELGDGG--DLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
V Y + +++ +E+ D Y + + E + IV+A+ + H
Sbjct: 61 YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 136 -KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD- 193
KL V+HRD+KP NV+ R G VKL DFG S G Y APE + +
Sbjct: 121 SKLSVIHRDVKPSNVL-INRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179
Query: 194 ---SYDAPAVDVWSLGVILYMLVAGQAPF 219
YD + DVWSLG+ + L G+ P+
Sbjct: 180 NQKGYDVKS-DVWSLGITMIELATGRFPY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-22
Identities = 76/237 (32%), Positives = 107/237 (45%), Gaps = 35/237 (14%)
Query: 17 AGLYDLE--ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-----------LDPVSQDH 63
A L DLE +G G V R TG +AVK + +T LD V + H
Sbjct: 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH 71
Query: 64 LYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYARE 122
C P +V+ Y T+S +++ +EL D ++K G + E +
Sbjct: 72 -----DC------PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGK 118
Query: 123 YFAQIVRAISFCHKLH-VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS 181
IV+A+ + + H V+HRD+KP N++ G VKL DFG S R + S G
Sbjct: 119 MTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSKAKTRSAGC 177
Query: 182 LAYSAPEIL----LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN-DSETLTMIMD 233
AY APE + YD A DVWSLG+ L L GQ P++ + E LT I+
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRA-DVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ 233
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 7e-22
Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 6/214 (2%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
L+ E +G+G F V T + VA+K+ID + + +D + QE+ + P
Sbjct: 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPY 63
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
V + Y ++KL++I+E GG D + L ET +I++ + + H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEK 121
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAPEILLGDSYDA 197
+HRD+K NV+ E G VKL DFG + + Q K T G+ + APE++ +YD+
Sbjct: 122 KIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
A D+WSLG+ L G+ P E + + L +I
Sbjct: 181 KA-DIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 9e-22
Identities = 65/208 (31%), Positives = 109/208 (52%), Gaps = 18/208 (8%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD------HLYQEVRCMKLVQHPNV 79
LG+G F V L V TG ++A K + + DP S + L E++ +K +QH +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAK---QVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 80 VRLYEVIDTNSK--LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
V+ Y + ++ L + +E GG + D + + A L+E+ R+Y QI+ +S+ H
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLHSN 125
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN----PGQKLETSCGSLAYSAPEILLGD 193
+VHRD+K N++ + G VKL DFG S R G + + G+ + +PE++ G+
Sbjct: 126 MIVHRDIKGANIL-RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQE 221
Y A DVWSLG + ++ + P+ E
Sbjct: 185 GYGRKA-DVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 77/253 (30%), Positives = 109/253 (43%), Gaps = 52/253 (20%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRL 82
+TLG G F V LAR V T A+K + K + +Q H+ E + + VVRL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
Y LY +++ GGD+ +++ E AR Y A++ A+ HK+ +HR
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 143 DLKPENVVFFERLGVVKLTDFG--------------------------FSN--------- 167
D+KP+N++ +R G +KLTDFG FSN
Sbjct: 126 DIKPDNIL-IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184
Query: 168 ---RFNP----GQKLETSC------GSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA 214
R P + C G+ Y APE+LL Y D WS+GVILY ++
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV 243
Query: 215 GQAPFQEANDSET 227
GQ PF ET
Sbjct: 244 GQPPFLAQTPLET 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-21
Identities = 59/215 (27%), Positives = 112/215 (52%), Gaps = 9/215 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+GRG + +V A++ T EKVA+K I + + +E++ ++ + H NV+ + ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 86 IDTNSK-----LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
+ + +Y++ EL D DL+ I++ LS+ + + + Q++R + + H +V+
Sbjct: 73 MPPPHREAFNDVYIVYELMDT-DLHQ-IIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVL 130
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGDSYDAPA 199
HRDLKP N++ +K+ DFG + + G + + Y APE+LL S A
Sbjct: 131 HRDLKPSNLLLNANCD-LKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTA 189
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
+DVWS+G I L+ + F + L +I ++
Sbjct: 190 IDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL 224
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-21
Identities = 70/231 (30%), Positives = 117/231 (50%), Gaps = 23/231 (9%)
Query: 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM-KLVQ 75
AG+++L E +G G + V RHV TG+ A+KV+D T + ++ + QE+ + K
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSH 61
Query: 76 HPNVVRLYEVI------DTNSKLYLILELGDGGDLYDYIMKHDAG--LSETYAREYFAQI 127
H N+ Y + +L+L++E G + D I K+ G L E + +I
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREI 120
Query: 128 VRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP--GQKLETSCGSLAYS 185
+R +S H+ V+HRD+K +NV+ E VKL DFG S + + G++ T G+ +
Sbjct: 121 LRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRR-NTFIGTPYWM 178
Query: 186 APEILLGD-----SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
APE++ D +YD + D+WSLG+ + G P + + L +I
Sbjct: 179 APEVIACDENPDATYDFKS-DLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-21
Identities = 59/197 (29%), Positives = 104/197 (52%), Gaps = 4/197 (2%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL-YQEVRCMKLVQHPNVVRLYE 84
LG+G F V + TG+ A K ++K ++ + + E + ++ V VV L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
+T L L+L + +GGDL +I + G E A Y A+I+ + H+ + V+RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVW 203
LKPEN++ + G ++++D G + + G+ + G++ Y APE+L Y + D W
Sbjct: 128 LKPENIL-LDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL-SPDYW 185
Query: 204 SLGVILYMLVAGQAPFQ 220
LG ++Y ++ GQ+PF+
Sbjct: 186 GLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 74/246 (30%), Positives = 117/246 (47%), Gaps = 31/246 (12%)
Query: 1 MSRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS 60
++RS ++S Y L +G G F VV A + T EKVA+K K DP
Sbjct: 60 INRSPNKS-----------YKLGNIIGNGSFGVVYEAICIDTSEKVAIK---KVLQDPQY 105
Query: 61 QDHLYQEVRCMKLVQHPNVVRL-----YEVIDTNSK---LYLILELGDGGDLYDYIMKHD 112
++ +E+ MK + H N++ L E N K L +++E ++ Y MKH
Sbjct: 106 KN---RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKY-MKHY 160
Query: 113 A----GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168
A L + Y Q+ RA+++ H + HRDLKP+N++ +KL DFG +
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220
Query: 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
GQ+ + S Y APE++LG + +D+WSLG I+ ++ G F + + L
Sbjct: 221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL 280
Query: 229 TMIMDV 234
I+ V
Sbjct: 281 VRIIQV 286
|
Length = 440 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-21
Identities = 60/195 (30%), Positives = 108/195 (55%), Gaps = 7/195 (3%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G +V +A TG++VAVK +D K ++ L+ EV M+ H NVV +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ--RRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
+L++++E +GG L D I+ H ++E ++RA+S+ H V+HRD+K
Sbjct: 88 YLVGDELWVVMEFLEGGALTD-IVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 146 PENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCGSLAYSAPEILLGDSYDAPAVDVWS 204
++++ G +KL+DFGF + + K ++ G+ + APE++ Y VD+WS
Sbjct: 146 SDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203
Query: 205 LGVILYMLVAGQAPF 219
LG+++ ++ G+ P+
Sbjct: 204 LGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-21
Identities = 66/212 (31%), Positives = 112/212 (52%), Gaps = 10/212 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG G F V A++ TG A KVID TK + +D++ E+ + HPN+V+L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID-TKSEEELEDYMV-EIDILASCDHPNIVKLLDA 70
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145
+ L++++E GG + +++ + L+E R Q + A+++ H+ ++HRDLK
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLK 130
Query: 146 PENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCGSLAYSAPEILLGDS-----YDAPA 199
N++F G +KL DFG S + Q+ ++ G+ + APE+++ ++ YD A
Sbjct: 131 AGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 189
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
DVWSLG+ L + + P E N L I
Sbjct: 190 -DVWSLGITLIEMAQIEPPHHELNPMRVLLKI 220
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 2e-21
Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 24/248 (9%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ LE LG G+F V +VA+K++ D + Q +EV+ +K ++H ++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWK-NRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHL 64
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLH 138
+ L+ V +Y+I EL + G L ++ + + + A Q+ +++ + +
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAY--SAPEILLGDSYD 196
+HRDL N++ E L V K+ DFG + R +S + Y +APE ++
Sbjct: 125 SIHRDLAARNILVGEDL-VCKVADFGLA-RLIKEDVYLSSDKKIPYKWTAPEAASHGTFS 182
Query: 197 APAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD----VSESSC---------TCW 242
+ DVWS G++LY M GQ P+ N+ E I + C C
Sbjct: 183 TKS-DVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLEC- 240
Query: 243 WRGRPRSR 250
W P R
Sbjct: 241 WAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-21
Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 10/211 (4%)
Query: 20 YDLEETLGRGHFAVVKLA--RHVFTGEKVAV-KVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
Y L++ LG+G F V L + E++ V K I +L+P QE + + + H
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYI--MKHDAG-LSETYAREYFAQIVRAISF 133
P +V+ + +I E +G DL + +KH LSE E+F Q++ + +
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-CGSLAYSAPEILLG 192
H+ ++HRDLK +N+ F + ++K+ DFG S L T+ G+ Y +PE L
Sbjct: 122 MHQRRILHRDLKAKNI--FLKNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179
Query: 193 DSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223
YD+ + D+WSLG ILY + F+ N
Sbjct: 180 QGYDSKS-DIWSLGCILYEMCCLAHAFEGQN 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-21
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 16/223 (7%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
LG G V R TG A+K I T +P Q + +E+ K + P +V+ Y
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 84 E--VIDTNSKLYLILELGDGGDL---YDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+ +++S + + +E +GG L Y + K + E + +++ +S+ H
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDA 197
++HRD+KP N++ R G VKL DFG S N T G+ Y APE + G Y
Sbjct: 126 IIHRDIKPSNIL-LTRKGQVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQGKPYSI 182
Query: 198 PAVDVWSLGVILYMLVAGQAPF-----QEANDSETLTMIMDVS 235
+ DVWSLG+ L + + PF E L+ I+++
Sbjct: 183 TS-DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-21
Identities = 67/237 (28%), Positives = 104/237 (43%), Gaps = 35/237 (14%)
Query: 22 LEETLGRGHFAVV--KLARHVFTGE---KVAVKVIDKTKLDPVSQD--HLYQEVRCMKLV 74
L LG+G F +V LA+ V GE +VA+K +++ + ++ E MK
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNE---NASMRERIEFLNEASVMKEF 66
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-------DAGLSETYAR--EYFA 125
+VVRL V+ T +++EL GDL Y+ T + + A
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF------SNRFNPGQKLETSC 179
+I +++ VHRDL N + E L VK+ DFG ++ + G K
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGGK----- 180
Query: 180 GSLA--YSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
G L + APE L D DVWS GV+L+ M + P+Q ++ E L ++D
Sbjct: 181 GLLPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 68/234 (29%), Positives = 113/234 (48%), Gaps = 29/234 (12%)
Query: 20 YDLEETLGRGHFAVVKLARHVFT--GEKVAVK----VIDKTKLDPVSQDHLYQEVRCMKL 73
Y+L + LG+G + +V AR+ T E VA+K V K L + +R +KL
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL-------AKRALRELKL 54
Query: 74 VQ----HPNVVRLYEV-IDTNSK---LYLILELGDGGDLYDYIMKHDAGLSETYAREYFA 125
++ H N+ LY++ I LYL EL + DL+ I++ L++ + + +
Sbjct: 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQ-IIRSGQPLTDAHFQSFIY 112
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-----CG 180
QI+ + + H +V+HRDLKP N++ +K+ DFG + F+
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
+ Y APEI+L A+DVWS+G IL L+ + F+ + + L I+ V
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV 225
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-21
Identities = 71/230 (30%), Positives = 105/230 (45%), Gaps = 30/230 (13%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + LG G V A+ V GE AVKV+D + ++ EV C+ ++
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 80 VRLYEVI---DTN-----SKLYLILELGDGGDLYDYI----------MKHDAGLSETYAR 121
V+ +E D + L+L+ + GDL I +H+AGL
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL------ 147
Query: 122 EYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN---PGQKLETS 178
F Q++ A+ H H++HRD+K N++ G+VKL DFGFS + T
Sbjct: 148 -LFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 179 CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
CG+ Y APEI Y A D++SLGV+LY L+ + PF N E +
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKA-DMFSLGVLLYELLTLKRPFDGENMEEVM 254
|
Length = 496 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 4e-21
Identities = 61/229 (26%), Positives = 111/229 (48%), Gaps = 24/229 (10%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLY-----QEVRCMKLV 74
Y +G G + +V A H TG KVA+K K+ P + +E++ ++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISPFEH-QTFCQRTLREIKILRRF 60
Query: 75 QHPNVVRLYEVI-----DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVR 129
+H N++ + ++I ++ + +Y++ EL + DLY I LS + + + QI+R
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH--LSNDHIQYFLYQILR 117
Query: 130 AISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS----NRFNPGQKLETSCGSLAYS 185
+ + H +V+HRDLKP N++ +K+ DFG + + L + Y
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCD-LKICDFGLARIADPEHDHTGFLTEYVATRWYR 176
Query: 186 APEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
APEI+L A+D+WS+G IL +++ + F + L +I+ V
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGV 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 7e-21
Identities = 66/230 (28%), Positives = 113/230 (49%), Gaps = 21/230 (9%)
Query: 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM-KLVQ 75
AG+++L E +G G + V RHV TG+ A+KV+D T+ + ++ + E+ + K
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE---EEEIKLEINMLKKYSH 71
Query: 76 HPNVVRLYEVIDTNS------KLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIV 128
H N+ Y S +L+L++E G + D + L E + +I+
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP--GQKLETSCGSLAYSA 186
R ++ H V+HRD+K +NV+ E VKL DFG S + + G++ T G+ + A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRR-NTFIGTPYWMA 189
Query: 187 PEILLGD-----SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
PE++ D +YD + D+WSLG+ + G P + + L +I
Sbjct: 190 PEVIACDENPDATYDYRS-DIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-21
Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 18/214 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD------HLYQEVRCMKL 73
+ L + LG+G F V L TG ++AVK + + DP S + L E++ +K
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVK---QVQFDPESPETSKEVNALECEIQLLKN 60
Query: 74 VQHPNVVRLYEVI-DTNSK-LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
+ H +V+ Y + D + L + +E GG + D + + A L+E R+Y QI+ +
Sbjct: 61 LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYTRQILEGV 119
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN----PGQKLETSCGSLAYSAP 187
S+ H +VHRD+K N++ + +G VKL DFG S R G +++ G+ + +P
Sbjct: 120 SYLHSNMIVHRDIKGANIL-RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221
E++ G+ Y A D+WS+G + ++ + P+ E
Sbjct: 179 EVISGEGYGRKA-DIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-20
Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
L + LG G F V + + KVAVK + K +S +E MK +QH +VR
Sbjct: 10 LVKKLGAGQFGEVWMGYY-NNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVR 65
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAR--EYFAQIVRAISFCHKLHV 139
LY V+ +Y+I E G L D+ +K D G + ++ AQI +++ + +
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDF-LKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--KLETSCGSLAYSAPEILLGDSYDA 197
+HRDL+ NV+ E L + K+ DFG + + E + + ++APE + S+
Sbjct: 125 IHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 198 PAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
+ DVWS G++LY +V G+ P+ ++S+ ++ +
Sbjct: 184 KS-DVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 1e-20
Identities = 53/156 (33%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
+PN ++LY + T LI++ GDL+D + K LSE ++ Q+V A++ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC--GSLAYSAPEILLGD 193
K +++H D+K ENV++ + L D+G G SC G+L Y +PE + G
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII--GTP---SCYDGTLDYFSPEKIKGH 181
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229
+YD + D W++GV+ Y L+ G+ PF+E D E L
Sbjct: 182 NYD-VSFDWWAVGVLTYELLTGKHPFKEDED-EELD 215
|
Length = 267 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-20
Identities = 74/253 (29%), Positives = 110/253 (43%), Gaps = 52/253 (20%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRL 82
+TLG G F V LA V T A+K + K + +Q H+ E + + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
Y LY +++ GGD+ +++ + E AR Y A++ AI HK+ +HR
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 143 DLKPENVVFFERLGVVKLTDFGFSNRF--------------------NP----------- 171
D+KP+N++ + G +KLTDFG F P
Sbjct: 126 DIKPDNIL-IDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184
Query: 172 -GQKLET----------SC------GSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA 214
G +L+T C G+ Y APE+LL Y D WS+GVIL+ ++
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILFEMLV 243
Query: 215 GQAPFQEANDSET 227
GQ PF +ET
Sbjct: 244 GQPPFLAPTPTET 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-20
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVID--KTKLDPVSQ------DHLYQEVRCMKLVQ 75
E +G+G + V LA +V TGE +AVK ++ T L E+ +K +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
H N+V+ T L + LE GG + + + E R + Q++ +++ H
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLH 125
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR----FNPGQKLETSCGSLAYSAPEI-- 189
++HRDLK +N++ + G+ K++DFG S + ++ Q + GS+ + APE+
Sbjct: 126 SKGILHRDLKADNLL-VDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIH 183
Query: 190 LLGDSYDAPAVDVWSLGVILYMLVAGQAPF 219
Y A VD+WSLG ++ + AG+ P+
Sbjct: 184 SYSQGYSA-KVDIWSLGCVVLEMFAGRRPW 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-20
Identities = 62/224 (27%), Positives = 114/224 (50%), Gaps = 15/224 (6%)
Query: 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM 71
HP+++ L + +G G F +V L + KVA+K I + + S++ +E + M
Sbjct: 2 HPSELT----LVQEIGSGQFGLVWLG-YWLEKRKVAIKTIREGAM---SEEDFIEEAQVM 53
Query: 72 KLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
+ HP +V+LY V S + L+ E + G L DY+ S+ + +
Sbjct: 54 MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPE 188
++ +V+HRDL N + E VVK++DFG + RF + +S G+ + +S+PE
Sbjct: 114 AYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMT-RFVLDDQYTSSTGTKFPVKWSSPE 171
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
+ Y + + DVWS GV+++ + + G+ P++ ++SE + I
Sbjct: 172 VFSFSKYSSKS-DVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-20
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
E +GRG+F V R VAVK +T L P + QE R +K HPN+VRL
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
V +Y+++EL GGD ++ L + + + H +HRD
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL-----AYSAPEILLGDSYDAP 198
L N + E+ V+K++DFG S G + S G + ++APE L Y +
Sbjct: 120 LAARNCLVTEK-NVLKISDFGMSREEEDG--VYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 199 AVDVWSLGVILYMLVA-GQAPFQEANDSET 227
+ DVWS G++L+ + G P+ ++ +T
Sbjct: 177 S-DVWSFGILLWEAFSLGAVPYANLSNQQT 205
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-20
Identities = 63/200 (31%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRL 82
+E LG G+ V A H+ T +AVKVI + Q + E+ + P ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGF 64
Query: 83 YEVIDTNSKLYLILELGDGG--DLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
Y +++ + E DGG D+Y I +H G +V+ +++ L ++
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-------RIAVAVVKGLTYLWSLKIL 117
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
HRD+KP N++ R G VKL DFG S + N K T G+ AY APE + G+ Y +
Sbjct: 118 HRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNSIAK--TYVGTNAYMAPERISGEQYGIHS 174
Query: 200 VDVWSLGVILYMLVAGQAPF 219
DVWSLG+ L G+ P+
Sbjct: 175 -DVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-20
Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 15/207 (7%)
Query: 26 LGRGHFAVVKLARHVF----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
LG GHF V+L R+ TGE+VAVK ++ + + D +E+ ++ + H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHENIVK 70
Query: 82 LYEVIDTNSK--LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V + L LI+E G L DY+ +H ++ + +QI + + +
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRY 130
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYS-----APEILLGDS 194
+HRDL N++ E +VK++DFG + + P K S APE L
Sbjct: 131 IHRDLAARNIL-VESEDLVKISDFGLA-KVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQE 221
+ + A DVWS GV LY L P Q
Sbjct: 189 FSS-ASDVWSFGVTLYELFTYGDPSQS 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-20
Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS--QDHLYQEVRCMK-LVQH 76
+++ ET+G+G + V + G K AVK+ LDP+ + + E +K L H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKI-----LDPIHDIDEEIEAEYNILKALSDH 74
Query: 77 PNVVRLYEV-----IDTNSKLYLILELGDGGDLYDYI---MKHDAGLSETYAREYFAQIV 128
PNVV+ Y + + +L+L+LEL +GG + D + +K + E + +
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAP 187
+ H +HRD+K N++ G VKL DFG S + + + TS G+ + AP
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
Query: 188 EIL-----LGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221
E++ L +YDA DVWSLG+ L G P +
Sbjct: 194 EVIACEQQLDSTYDA-RCDVWSLGITAIELGDGDPPLAD 231
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-20
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 8/215 (3%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
L+ E +G+G F V T + VA+K+ID + + +D + QE+ + P
Sbjct: 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPY 63
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKL 137
V + Y +KL++I+E GG D + AG E +I++ + + H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAPEILLGDSYD 196
+HRD+K NV+ E+ G VKL DFG + + Q K T G+ + APE++ +YD
Sbjct: 121 KKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 179
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
+ A D+WSLG+ L G+ P + + L +I
Sbjct: 180 SKA-DIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 4e-20
Identities = 67/218 (30%), Positives = 112/218 (51%), Gaps = 18/218 (8%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G + V A +KVAVK + + + Y+E+R +K ++H NV+ L +V
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 86 ------IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
I+ +++YL+ L G DL + I+K LS+ + + Q++R + + H +
Sbjct: 83 FTPATSIENFNEVYLVTNLM-GADLNN-IVKCQK-LSDEHVQFLIYQLLRGLKYIHSAGI 139
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA---YSAPEILLGDSYD 196
+HRDLKP NV E + ++ DFG + Q + G +A Y APEI+L +
Sbjct: 140 IHRDLKPSNVAVNEDCEL-RILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNWMHY 193
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
VD+WS+G I+ L+ G+A F + + L IM+V
Sbjct: 194 NQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV 231
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-20
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 29/218 (13%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH-------LYQEVRCMKLVQHPN 78
+G G F V L + +GE +AVK ++ + S+D L +E+ +K +QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V+ L + LE GG + + + A ET R + QI++ +++ H
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-FEETLVRNFVRQILKGLNYLHNRG 126
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC-------------GSLAYS 185
++HRD+K N++ + G +K++DFG S +KLE + GS+ +
Sbjct: 127 IIHRDIKGANIL-VDNKGGIKISDFGIS------KKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 186 APEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223
APE++ SY D+WSLG ++ ++ G+ PF +
Sbjct: 180 APEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCT 216
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 5e-20
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
L T+G+G F V L + G+KVAVK + K D + E M ++HPN+V
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCL---KDDSTAAQAFLAEASVMTTLRHPNLV 63
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLHV 139
+L V+ + LY++ E G L DY+ + + FA + + + + +
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
VHRDL NV+ E L V K++DFG + + Q ++ + ++APE L + +
Sbjct: 124 VHRDLAARNVLVSEDL-VAKVSDFGLAKEAS--QGQDSGKLPVKWTAPEALREKKFSTKS 180
Query: 200 VDVWSLGVILYMLVA-GQAPF 219
DVWS G++L+ + + G+ P+
Sbjct: 181 -DVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-19
Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 12/216 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G + V A TG KVA+K + + + Y+E+R +K ++H NV+ L +V
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 86 ------IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
+D YL++ G DL +MKH+ LSE + Q+++ + + H +
Sbjct: 83 FTPDLSLDRFHDFYLVMPFM-GTDL-GKLMKHEK-LSEDRIQFLVYQMLKGLKYIHAAGI 139
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+HRDLKP N+ E + K+ DFG + + + ++ + Y APE++L +
Sbjct: 140 IHRDLKPGNLAVNEDCEL-KILDFGLARQTD--SEMTGYVVTRWYRAPEVILNWMHYTQT 196
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235
VD+WS+G I+ ++ G+ F+ + + L IM V+
Sbjct: 197 VDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-19
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 10/213 (4%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
E +G+G+F V + +VAVK T + + L QE +K HPN+V+L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFL-QEAEILKQYDHPNIVKLI 58
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
V +Y+++EL GG L ++ K L+ + + + + +HRD
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCG----SLAYSAPEILLGDSYDAPA 199
L N + E V+K++DFG S R G S G + ++APE L Y +
Sbjct: 119 LAARNCLVGEN-NVLKISDFGMS-REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS-E 175
Query: 200 VDVWSLGVILY-MLVAGQAPFQEANDSETLTMI 231
DVWS G++L+ G P+ ++ +T I
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-19
Identities = 69/219 (31%), Positives = 105/219 (47%), Gaps = 24/219 (10%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC-MKLVQHP 77
L DL E +GRG F V H +G +AVK I T +D Q L ++ M+ P
Sbjct: 6 LKDLGE-IGRGAFGTVNKMLHKPSGTIMAVKRIRST-VDEKEQKRLLMDLDVVMRSSDCP 63
Query: 78 NVVRLYEVIDTNSKLYLILELGDGG--DLYDYI-MKHDAGLSETYAREYFAQIVRAISFC 134
+V+ Y + ++ +EL D Y Y+ + + E + V+A+++
Sbjct: 64 YIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL 123
Query: 135 HK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS------CGSLAYSAP 187
+ L ++HRD+KP N++ +R G +KL DFG S GQ L S G Y AP
Sbjct: 124 KEELKIIHRDVKPSNILL-DRNGNIKLCDFGIS-----GQ-LVDSIAKTRDAGCRPYMAP 176
Query: 188 EILL---GDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223
E + D YD + DVWSLG+ LY + G+ P+ + N
Sbjct: 177 ERIDPSARDGYDVRS-DVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-19
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS--QDHLYQ 66
S P K+ DL E +G G F V AR V T E VA+K + + QD + +
Sbjct: 9 SKDDPEKL--FTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIK 64
Query: 67 EVRCMKLVQHPNVVRLYEVIDTNSKLYLILE--LGDGGDLYDYIMKHDAGLSETYAREYF 124
EVR ++ ++HPN + +L++E LG D+ + H L E
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEV---HKKPLQEVEIAAIC 121
Query: 125 AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAY 184
++ +++ H +HRD+K N++ E G VKL DFG ++ +P + G+ +
Sbjct: 122 HGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSPAN---SFVGTPYW 177
Query: 185 SAPEILLG---DSYDAPAVDVWSLGV 207
APE++L YD VDVWSLG+
Sbjct: 178 MAPEVILAMDEGQYDG-KVDVWSLGI 202
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 6e-19
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD-------HLYQEVRCMKLVQH 76
E LG+G + V G+ +AVK + +LD + L +EV +K ++H
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVK---QVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
N+V+ ++ + + +E GG + I+ L E +Y QI+ +++ H
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISS-ILNRFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-------NPGQKLETSCGSLAYSAPEI 189
VVHRD+K NV+ G++KL DFG + R L++ G+ + APE+
Sbjct: 121 NCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 190 LLGDSYDAPAVDVWSLGVILYMLVAGQAPF 219
+ Y + D+WS+G ++ + G+ P
Sbjct: 180 INESGYGRKS-DIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-19
Identities = 70/238 (29%), Positives = 111/238 (46%), Gaps = 27/238 (11%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ--DHLYQEV 68
G PT +++ ET+G+G + V + G AVK+ LDP+S + + E
Sbjct: 18 GDPT---DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKI-----LDPISDVDEEIEAEY 69
Query: 69 RCMK-LVQHPNVVRLYEVIDTNSK-----LYLILELGDGGDLYDYI---MKHDAGLSETY 119
++ L HPNVV+ Y + K L+L+LEL +GG + + + + L E
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 120 AREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETS 178
+ + H ++HRD+K N++ G VKL DFG S + + + TS
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 179 CGSLAYSAPEILLGD-----SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
G+ + APE++ + SYDA DVWSLG+ L G P + + +TL I
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSYDA-RCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 9e-19
Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
L E +G G F V +TG+KVAVK I K D +Q L +E M + H N+VR
Sbjct: 10 LGEIIGEGEFGAVLQGE--YTGQKVAVKNI---KCDVTAQAFL-EETAVMTKLHHKNLVR 63
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLHVV 140
L VI N LY+++EL G+L +++ L F+ + + + +V
Sbjct: 64 LLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV 122
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAV 200
HRDL N++ E GV K++DFG + R ++ S + ++APE L + + +
Sbjct: 123 HRDLAARNILVSED-GVAKVSDFGLA-RVGS-MGVDNSKLPVKWTAPEALKHKKFSSKS- 178
Query: 201 DVWSLGVILYMLVA-GQAPF 219
DVWS GV+L+ + + G+AP+
Sbjct: 179 DVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-18
Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 26 LGRG--HFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH---LYQEVRCMKLVQHPNVV 80
+G+ +V LA+H T VAVK K LD S++ L QE+ + +QHPN++
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVK---KINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHV 139
+S+LY++ L G D + H GL E ++ A+ + H
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLET-------SCGSLAYSAPEILL 191
+HR +K +++ G V L+ +S G++ S +L + +PE+L
Sbjct: 123 IHRSVKASHIL-LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 192 GD--SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229
+ Y+ + D++S+G+ L G PF++ ++ L
Sbjct: 182 QNLQGYNEKS-DIYSVGITACELANGHVPFKDMPATQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 12/214 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
LG G F V + GEK VA+KV+ + + P + + E M V HP+VVR
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVL-REETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
L + + S++ LI +L G L DY+ H + Y + QI + +S+ + +VH
Sbjct: 74 LLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVH 132
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSYDAP 198
RDL NV+ VK+TDFG + + +K + G + + A E +L Y
Sbjct: 133 RDLAARNVLVKTP-QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHK 191
Query: 199 AVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
+ DVWS GV ++ L+ G P++ E ++
Sbjct: 192 S-DVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 2e-18
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
L + LG G F V + + KVA+K + + + P + E MK +QHP +VR
Sbjct: 10 LVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVR 65
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAR--EYFAQIVRAISFCHKLHV 139
LY V+ T +Y+I E + G L D+ +K G+ T + + AQI ++F + +
Sbjct: 66 LYAVV-TQEPIYIITEYMENGSLVDF-LKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL--ETSCGSLAYSAPEILLGDSYDA 197
+HRDL+ N++ E L K+ DFG + + E + + ++APE + ++
Sbjct: 124 IHRDLRAANILVSETL-CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 198 PAVDVWSLGVILYMLVA-GQAPF 219
+ DVWS G++L +V G+ P+
Sbjct: 183 KS-DVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-18
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 21/196 (10%)
Query: 46 VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLY 105
VAVK + +DP +D L E + MK ++HP +++LY V +Y++ EL G L
Sbjct: 33 VAVKTLKPGTMDP--KDFL-AEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89
Query: 106 DYIMKHDAG--LSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDF 163
+Y ++ AG L + AQ+ +++ + +HRDL NV+ E + K+ DF
Sbjct: 90 EY-LQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADF 147
Query: 164 GFSNRF-------NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-G 215
G + G K + ++APE L + + + DVWS G++L +V G
Sbjct: 148 GLARVIKEDIYEAREGAKF-----PIKWTAPEAALYNRFSIKS-DVWSFGILLTEIVTYG 201
Query: 216 QAPFQEANDSETLTMI 231
+ P+ ++E L +
Sbjct: 202 RMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-18
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G + V A TG +VAVK + + + Y+E+R +K ++H NV+ L +V
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 86 IDTNSKL------YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
L YL+ L G DL + + L++ + + QI+R + + H +
Sbjct: 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSADI 141
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+HRDLKP N+ E + K+ DFG + + ++ + Y APEI+L +
Sbjct: 142 IHRDLKPSNLAVNEDCEL-KILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQT 198
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
VD+WS+G I+ L+ G+ F + + L +I+
Sbjct: 199 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-18
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 26 LGRGHFAVVKLARHV----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
LG GHF V L + TGE VAVK + K + + +E+ +K + H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTL-KRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 82 LYEVIDTNSK--LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQ-IVRAISFCHKLH 138
L LI+E G L DY+ KH L++ FAQ I +++ H H
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL---LFAQQICEGMAYLHSQH 127
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL----ETSCGSLAYSAPEILLGDS 194
+HRDL NV+ + +VK+ DFG + G + E + + A E L +
Sbjct: 128 YIHRDLAARNVL-LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQ 220
+ + A DVWS GV LY L+ Q
Sbjct: 187 F-SYASDVWSFGVTLYELLTHCDSKQ 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-18
Identities = 64/215 (29%), Positives = 109/215 (50%), Gaps = 19/215 (8%)
Query: 22 LEETLGRGHFAVVKLA---RHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
LE+ LG G F V +A +H KVAVK + K +S + E MK +QH
Sbjct: 10 LEKKLGAGQFGEVWMATYNKHT----KVAVKTM---KPGSMSVEAFLAEANVMKTLQHDK 62
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAR--EYFAQIVRAISFCHK 136
+V+L+ V+ T +Y+I E G L D+ +K D G + + ++ AQI ++F +
Sbjct: 63 LVKLHAVV-TKEPIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL--ETSCGSLAYSAPEILLGDS 194
+ +HRDL+ N++ L V K+ DFG + + E + + ++APE + S
Sbjct: 121 RNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 195 YDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETL 228
+ + DVWS G++L +V G+ P+ ++ E +
Sbjct: 180 FTIKS-DVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 8e-18
Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 14/221 (6%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
+E+ +G G F V R G+K VA+K + D D L E M HPN
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPN 66
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++RL V+ + + +I E + G L ++ ++D + I + + +++
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCG--SLAYSAPEILLGDSY 195
VHRDL N++ L V K++DFG S R + T G + ++APE + +Y
Sbjct: 127 YVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI---AY 182
Query: 196 DA--PAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
A DVWS G++++ +++ G+ P+ + ++ + + + D
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-18
Identities = 58/209 (27%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G +V A TG+ VA+K + + + Y+E+ MKLV H N++ L V
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83
Query: 86 ------IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE-------YFA-QIVRAI 131
++ +YL++EL M DA L + + Y Q++ I
Sbjct: 84 FTPQKSLEEFQDVYLVMEL----------M--DANLCQVIQMDLDHERMSYLLYQMLCGI 131
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL 191
H ++HRDLKP N+V +K+ DFG + + + Y APE++L
Sbjct: 132 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 190
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220
G Y VD+WS+G I+ ++ G F
Sbjct: 191 GMGYKE-NVDIWSVGCIMGEMIRGTVLFP 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-17
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 13/214 (6%)
Query: 26 LGRGHFAVVKLARHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRL 82
LG G+F V ++ K VAVK + + + + +E M + HP +VRL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI-AAGKKEFLREASVMAQLDHPCIVRL 61
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
V L L++EL G L Y+ K + + +E Q+ +++ H VHR
Sbjct: 62 IGVCKGEP-LMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 143 DLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL--ETSCGS--LAYSAPEILLGDSYDAP 198
DL NV+ R K++DFG S G T+ G L + APE + + +
Sbjct: 120 DLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSS- 177
Query: 199 AVDVWSLGVILY-MLVAGQAPFQEANDSETLTMI 231
DVWS GV L+ G P+ E +E + M+
Sbjct: 178 KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-17
Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 14/206 (6%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG G+ VV +H +G +A K+I ++ P ++ + +E++ + P +V Y
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH-VVHRDL 144
++ ++ + +E DGG L D ++K + E + ++R +++ + H ++HRD+
Sbjct: 72 FYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130
Query: 145 KPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC----GSLAYSAPEILLGDSYDAPAV 200
KP N++ R G +KL DFG S GQ +++ G+ +Y +PE L G Y +
Sbjct: 131 KPSNILVNSR-GEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQS- 183
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSE 226
D+WS+G+ L L G+ P + E
Sbjct: 184 DIWSMGLSLVELAIGRYPIPPPDAKE 209
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-17
Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 26 LGRGHFA-VVKLARHVFTGEK-VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
+GRG + V K R EK A+K I+ T + + +E+ ++ ++HPNV+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIALQ 64
Query: 84 EVIDTNS--KLYLILELGDGGDLYDYIMKHDAG--------LSETYAREYFAQIVRAISF 133
+V ++S K++L+ + + DL+ I H A L + + QI+ I +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 134 CHKLHVVHRDLKPENVVFF----ERLGVVKLTDFGFSNRFN----PGQKLETSCGSLAYS 185
H V+HRDLKP N++ ER G VK+ D GF+ FN P L+ + Y
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPER-GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 186 APEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220
APE+LLG + A+D+W++G I L+ + F
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-17
Identities = 67/252 (26%), Positives = 115/252 (45%), Gaps = 37/252 (14%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
LE LG+G F ++ + G +VA+K + + P + QE + MK ++H +V
Sbjct: 10 LEVKLGQGCFG--EVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLV 64
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAR-----EYFAQIVRAISFCH 135
+LY V+ + +Y++ E G L D++ G Y R + AQI +++
Sbjct: 65 QLYAVV-SEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLG 192
+++ VHRDL+ N++ E L V K+ DFG + R + G+ + ++APE L
Sbjct: 120 RMNYVHRDLRAANILVGENL-VCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 193 DSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI-------------MDVSESS 238
+ + DVWS G++L L G+ P+ + E L + + +
Sbjct: 178 GRFTIKS-DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 236
Query: 239 CTCWWRGRPRSR 250
C C WR P R
Sbjct: 237 CQC-WRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-17
Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 32/206 (15%)
Query: 26 LGRGHFAVVKLARHV----FTGEKVAVKVIDKTKLDPVSQDHLY---QEVRCMKLVQHPN 78
LG+G+F V+L R+ TGE VAVK KL + +HL +E+ +K +QH N
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVK-----KLQHSTAEHLRDFEREIEILKSLQHDN 66
Query: 79 VVRLYEVIDTNSK--LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
+V+ V + + L L++E G L DY+ KH L Y +QI + + +
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF----------NPGQKLETSCGSLAYSA 186
VHRDL N++ E VK+ DFG + PG+ + + A
Sbjct: 127 KRYVHRDLATRNIL-VESENRVKIGDFGLTKVLPQDKEYYKVREPGES------PIFWYA 179
Query: 187 PEILLGDSYDAPAVDVWSLGVILYML 212
PE L +S + A DVWS GV+LY L
Sbjct: 180 PES-LTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-17
Identities = 59/199 (29%), Positives = 93/199 (46%), Gaps = 11/199 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG G + V VAVK + K D + + +E MK ++HPN+V+L V
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLHVVHRDL 144
Y+I E G+L DY+ + + Y A QI A+ + K + +HRDL
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130
Query: 145 KPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSYDAPAVD 201
N + E +VK+ DFG S R G G+ + ++APE L + + + D
Sbjct: 131 AARNCLVGEN-HLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS-D 187
Query: 202 VWSLGVILYMLVA-GQAPF 219
VW+ GV+L+ + G +P+
Sbjct: 188 VWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-17
Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 26 LGRGHFAVV-----KLARHVFTGE-KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
LG G F V +G +VAVK + K D + +E M HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-EKKEFLKEAHLMSNFNHPNI 61
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMK------HDAGLSETYAREYFAQIVRAISF 133
V+L V N Y+I+EL +GGDL Y+ L+ + + + +
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 134 CHKLHVVHRDLKPENVVFFERLG----VVKLTDFG-----FSNRF--NPGQKLETSCGSL 182
++H +HRDL N + E+ VVK+ DFG + + + G+ L +
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL----PV 177
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETL 228
+ APE LL + + DVWS GV+++ +L GQ P+ N+ E L
Sbjct: 178 RWMAPESLLDGKFTTQS-DVWSFGVLMWEILTLGQQPYPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-17
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 21 DLE--ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
DLE LG G+ V +H+ TG +A KV+ + + +E++ M + P
Sbjct: 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVV-HIGAKSSVRKQILRELQIMHECRSPY 64
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KL 137
+V Y + + + +E D G L D I K + + +V +++ +
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDA 197
++HRD+KP N++ R G +KL DFG S +T G+ Y +PE + G Y
Sbjct: 124 RIMHRDIKPSNILVNSR-GQIKLCDFGVSGEL-INSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEAND 224
+ DVWSLG+ + L G+ PF +N
Sbjct: 182 KS-DVWSLGISIIELALGKFPFAFSNI 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-17
Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 15/216 (6%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
L + LG G F V + + G KVAVK + + P S +E + MK ++H +V
Sbjct: 10 LIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKKLRHDKLV 64
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDA-GLSETYAREYFAQIVRAISFCHKLHV 139
+LY V+ + +Y++ E G L D++ + L + AQ+ +++ +++
Sbjct: 65 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSYD 196
+HRDL+ N++ + L V K+ DFG + R + G+ + ++APE L +
Sbjct: 124 IHRDLRSANILVGDGL-VCKIADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 197 APAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
+ DVWS G++L LV G+ P+ N+ E L +
Sbjct: 182 IKS-DVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-17
Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
L +T+G+G F V L + G KVAVK I K D +Q L E M ++H N+V+
Sbjct: 10 LLQTIGKGEFGDVMLGDY--RGNKVAVKCI---KNDATAQAFL-AEASVMTQLRHSNLVQ 63
Query: 82 LYEVI-DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLHV 139
L VI + LY++ E G L DY+ + F+ + A+ + +
Sbjct: 64 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
VHRDL NV+ E V K++DFG + + Q +T + ++APE L + +
Sbjct: 124 VHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKS 180
Query: 200 VDVWSLGVILYMLVA-GQAPF 219
DVWS G++L+ + + G+ P+
Sbjct: 181 -DVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-17
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPN 78
++L + +G G + V AR+V TGE A+KVI KL+P + QE+ MK +H N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKL 137
+V + KL++ +E GG L D + H G LSE+ + ++ + + H
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQD--IYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCGSLAYSAPEILLGDSYD 196
+HRD+K N++ + G VKL DFG S + K ++ G+ + APE+ +
Sbjct: 126 GKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
Query: 197 A--PAVDVWSLGVILYMLVAGQAP 218
D+W++G+ L Q P
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-17
Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 15/217 (6%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKT-KLDPVSQDHLYQEVRCMKLVQHPNV 79
DL E +G G F V AR V T E VA+K + + K + +EV+ ++ ++HPN
Sbjct: 29 DLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNS 87
Query: 80 VRLYEVIDTNSKLYLILE--LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
+ +L++E LG DL + H L E ++ +++ H
Sbjct: 88 IEYKGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLG---DS 194
+++HRD+K N++ E G VKL DFG ++ +P G+ + APE++L
Sbjct: 145 NMIHRDIKAGNILLTEP-GQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQ 200
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
YD VDVWSLG+ L + P N L I
Sbjct: 201 YDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-17
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 15/199 (7%)
Query: 26 LGRGHFAVVKLARHV----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
LG GHF V+L R+ TGE+VAVK + D L +E+ ++ + H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIVK 70
Query: 82 LYEVI---DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
Y+ I D + + LI+E G L +Y+ ++ ++ +Y QI + + +
Sbjct: 71 -YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA----YSAPEILLGDS 194
VHRDL NV+ E VK+ DFG + ++ T L + APE L+
Sbjct: 130 YVHRDLAARNVL-VESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188
Query: 195 YDAPAVDVWSLGVILYMLV 213
+ A DVWS GV LY L+
Sbjct: 189 F-YIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 8e-17
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 10/216 (4%)
Query: 22 LEETLGRGHFA-VVKLARHVFTGEK--VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
L +G G F V + EK VAVK K P ++ QE M+ HP+
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V+L VI T + +++++EL G+L Y+ + L Y Q+ A+++
Sbjct: 69 IVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR 127
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL--AYSAPEILLGDSYD 196
VHRD+ NV+ VKL DFG S + S G L + APE + +
Sbjct: 128 FVHRDIAARNVLVSSP-DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186
Query: 197 APAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMI 231
+ A DVW GV ++ +L+ G PFQ +++ + I
Sbjct: 187 S-ASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-17
Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 20/173 (11%)
Query: 66 QEVRCMKLVQHPNVVRLYEVIDTNS--KLYLILELGDGGDLYDYIMKHDAG--------L 115
+E+ ++ ++HPNV+ L +V +++ K++L+ + + DL+ I H A L
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 105
Query: 116 SETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF----ERLGVVKLTDFGFSNRFN- 170
+ QI+ I + H V+HRDLKP N++ ER G VK+ D GF+ FN
Sbjct: 106 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER-GRVKIADMGFARLFNS 164
Query: 171 ---PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220
P L+ + Y APE+LLG + A+D+W++G I L+ + F
Sbjct: 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-16
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 13/216 (6%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G + V A TGEKVA+K + + + Y+E+ +K +QH NV+ L +V
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 86 IDTNSKL------YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
+ YL++ DL IM H LSE + Q++ + + H +
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQT-DL-QKIMGHP--LSEDKVQYLVYQMLCGLKYIHSAGI 138
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+HRDLKP N+ E + K+ DFG + + ++ + Y APE++L +
Sbjct: 139 IHRDLKPGNLAVNEDCEL-KILDFGLARHAD--AEMTGYVVTRWYRAPEVILNWMHYNQT 195
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235
VD+WS+G I+ ++ G+ F+ + + LT I+ V+
Sbjct: 196 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 231
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 65/245 (26%), Positives = 121/245 (49%), Gaps = 23/245 (9%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
LG G+ VV H +G +A K+I ++ P ++ + +E++ + P +V Y
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH-VVHRDL 144
++ ++ + +E DGG L D ++K + E + +++ +++ + H ++HRD+
Sbjct: 72 FYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 145 KPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC----GSLAYSAPEILLGDSYDAPAV 200
KP N++ R G +KL DFG S GQ +++ G+ +Y +PE L G Y +
Sbjct: 131 KPSNILVNSR-GEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQS- 183
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSETLTMIM------DVSESSCTCWWR--GRPRSRRR 252
D+WS+G+ L + G+ P D++ L ++ D +ES + R GRP S
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPP-DAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYG 242
Query: 253 TTRKP 257
+P
Sbjct: 243 PDSRP 247
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-16
Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 19/148 (12%)
Query: 28 RGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ---EVRCMKLVQHPNVVRLYE 84
RG F V L R + AVKV+ K D ++++ ++Q E + L + P +V LY
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKA--DMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 85 VIDTNSKLYLILELGDGGDL------YDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+ + + +YL++E GGD+ Y Y E A +Y +++ A+ + H+
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGY-------FDEEMAVKYISEVALALDYLHRHG 124
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFS 166
++HRDLKP+N++ G +KLTDFG S
Sbjct: 125 IIHRDLKPDNMLISNE-GHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-16
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 17/218 (7%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKT--KLDPVSQDHLYQEVRCMKLVQHPN 78
DL E +G G F V AR V E VA+K + + + + QD + +EVR ++ ++HPN
Sbjct: 19 DLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHPN 76
Query: 79 VVRLYEVIDTNSKLYLILE--LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
++ +L++E LG DL + H L E ++ +++ H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLG---D 193
+++HRD+K N++ E G+VKL DFG ++ P G+ + APE++L
Sbjct: 134 HNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEG 189
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
YD VDVWSLG+ L + P N L I
Sbjct: 190 QYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-16
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
L+ LG+G F V + T KVA+K + + P + QE + MK ++H +V
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMP---EAFLQEAQIMKKLRHDKLVP 65
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKLHVV 140
LY V+ + +Y++ E G L D++ + D L + AQI +++ +++ +
Sbjct: 66 LYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSYDA 197
HRDL+ N++ + L V K+ DFG + R + G+ + ++APE L +
Sbjct: 125 HRDLRAANILVGDNL-VCKIADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 198 PAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
+ DVWS G++L LV G+ P+ + E L +
Sbjct: 183 KS-DVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-16
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 12/207 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + +G G +V A G VAVK + + + Y+E+ +K V H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 80 VRLYEV------IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ L V ++ +YL++EL D +L I L Q++ I
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHME---LDHERMSYLLYQMLCGIKH 138
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD 193
H ++HRDLKP N+V + +K+ DFG + + + Y APE++LG
Sbjct: 139 LHSAGIIHRDLKPSNIV-VKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM 197
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQ 220
Y VD+WS+G I+ LV G FQ
Sbjct: 198 GYKE-NVDIWSVGCIMGELVKGSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-16
Identities = 61/244 (25%), Positives = 112/244 (45%), Gaps = 16/244 (6%)
Query: 21 DLEE--TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
D E+ LG G+ VV H +G +A K+I ++ P ++ + +E++ + P
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI-HLEIKPAIRNQIIRELKVLHECNSPY 60
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V Y ++ ++ + +E DGG L D ++K + E + ++R +++ + H
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 139 -VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE----TSCGSLAYSAPEILLGD 193
++HRD+KP N++ R G +KL DFG S GQ ++ + G+ +Y +PE L G
Sbjct: 120 KIMHRDVKPSNILVNSR-GEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT 173
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSRRRT 253
Y + D+WSLG+ L + G+ P + E M
Sbjct: 174 HYTVQS-DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232
Query: 254 TRKP 257
+ +P
Sbjct: 233 SPRP 236
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-16
Identities = 66/254 (25%), Positives = 106/254 (41%), Gaps = 33/254 (12%)
Query: 20 YDLEETLGRGHFAVVK---LARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
+ L LG+G F V+ L + +KVAVK++ + +E CMK H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 77 PNVVRLYEV-IDTNSKLYL-----ILELGDGGDLYDYIMKHDAG-----LSETYAREYFA 125
PNV++L V + + +K L IL GDL+ +++ G L +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---L 182
I + + + +HRDL N + E + V + DFG S + G C S +
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVC-VADFGLSKKIYSGDYYRQGCASKLPV 179
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIM--------- 232
+ A E L + Y + DVW+ GV ++ ++ GQ P+ +SE ++
Sbjct: 180 KWLALESLADNVYTTHS-DVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238
Query: 233 ----DVSESSCTCW 242
DV E C CW
Sbjct: 239 DCLEDVYELMCQCW 252
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 8e-16
Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 22/197 (11%)
Query: 24 ETLGRGHFAVVKLARHVFTG---EKVAVKVIDKTKLDPVSQD---HLYQEVRCMKLVQHP 77
E LG+G+F VF G +K V V KT + + Q+ E R +K HP
Sbjct: 1 ELLGKGNFG------EVFKGTLKDKTPVAV--KTCKEDLPQELKIKFLSEARILKQYDHP 52
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
N+V+L V +Y+++EL GGD ++ K L ++ +++
Sbjct: 53 NIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCG----SLAYSAPEILLGD 193
+ +HRDL N + E V+K++DFG S + + G + +S G + ++APE L
Sbjct: 113 NCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDG--IYSSSGLKQIPIKWTAPEALNYG 169
Query: 194 SYDAPAVDVWSLGVILY 210
Y + + DVWS G++L+
Sbjct: 170 RYSSES-DVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-16
Identities = 69/251 (27%), Positives = 110/251 (43%), Gaps = 28/251 (11%)
Query: 24 ETLGRGHFAVVKLARHVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ LG G F V + GEK VA+K + + P + + E M V +P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHV 71
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
RL + T S + LI +L G L DY+ +H + Y + QI + +++ + +
Sbjct: 72 CRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSYD 196
VHRDL NV+ + VK+TDFG + +K + G + + A E +L Y
Sbjct: 131 VHRDLAARNVL-VKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189
Query: 197 APAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI-------------MDVSESSCTCW 242
+ DVWS GV ++ L+ G P+ SE +++ +DV CW
Sbjct: 190 HQS-DVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCW 248
Query: 243 W---RGRPRSR 250
RP+ R
Sbjct: 249 MIDADSRPKFR 259
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-15
Identities = 56/213 (26%), Positives = 104/213 (48%), Gaps = 11/213 (5%)
Query: 26 LGRGHFAVVK--LARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
LG G+F VK + + + + VAVK++ DP +D L +E M+ + +P +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
+ + S L++EL + G L ++ K + ++E E Q+ + + + + VHRD
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS----LAYSAPEILLGDSYDAPA 199
L NV+ + K++DFG S + + + + APE + + + +
Sbjct: 121 LAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179
Query: 200 VDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
DVWS GV+++ + GQ P++ +E MI
Sbjct: 180 -DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-15
Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 28/188 (14%)
Query: 48 VKVIDKTKL--DPVSQD----------HLYQEVRCMKLVQH--PNVVRLYEVIDTNSKLY 93
+ VIDK L D +Q Y R + ++ H PN+V L++ I + ++
Sbjct: 3 LGVIDKVLLVMDTRTQQTFILKGLRKSSEYSRER-LTIIPHCVPNMVCLHKYIVSEDSVF 61
Query: 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE 153
L+L+ +GG L+ +I K + E + + A++V A+ H+ +V RDL P N++ +
Sbjct: 62 LVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD 120
Query: 154 RLGVVKLTDFGFSNRFNPGQKLETSCGSLA----YSAPEILLGDSYDAPAVDVWSLGVIL 209
R G ++LT F ++E SC A Y APE+ G S + A D WSLG IL
Sbjct: 121 R-GHIQLTYFS------RWSEVEDSCDGEAVENMYCAPEV-GGISEETEACDWWSLGAIL 172
Query: 210 YMLVAGQA 217
+ L+ G+
Sbjct: 173 FELLTGKT 180
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-15
Identities = 67/261 (25%), Positives = 109/261 (41%), Gaps = 28/261 (10%)
Query: 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEV 68
HP+ I ++ +G G F V G K VA+K + + QD L E
Sbjct: 3 HPSHITK----QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFL-SEA 57
Query: 69 RCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIV 128
M H N++RL V+ +I E + G L Y+ HD S I
Sbjct: 58 SIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIA 117
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF--NPGQKLETSCGSLA--Y 184
+ + ++ VHRDL N++ L K++DFG S +P TS G + +
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176
Query: 185 SAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD---------- 233
+APE + + A DVWS G++++ +++ G+ P+ + ++ E + I D
Sbjct: 177 TAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDC 235
Query: 234 ---VSESSCTCWWRGRPRSRR 251
V + CW + R R R
Sbjct: 236 PSAVYQLMLQCWQQDRARRPR 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 17/218 (7%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKT--KLDPVSQDHLYQEVRCMKLVQHPN 78
L E +G G F V A + T E VAVK + + + + QD + +EV+ ++ ++HPN
Sbjct: 25 GLHE-IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLKHPN 82
Query: 79 VVRLYEVIDTNSKLYLILE--LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
+ +L++E LG DL + H L E ++ +++ H
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLG---D 193
+++HRD+K N++ E G VKL DFG +++ +P G+ + APE++L
Sbjct: 140 HNMIHRDIKAGNILLTEP-GQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEG 195
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
YD VDVWSLG+ L + P N L I
Sbjct: 196 QYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-15
Identities = 61/228 (26%), Positives = 108/228 (47%), Gaps = 29/228 (12%)
Query: 21 DLEETLGRG--HFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL---YQEVRCMKLVQ 75
+L+ +GRG + V LARH TG V V++ T L+ +++HL EV +
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRI---TDLENCTEEHLKALQNEVVLSHFFR 57
Query: 76 HPNVVRLYEVIDTNSKLYLI---LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAIS 132
HPN++ + V T S L++I + G L G+SE +R ++
Sbjct: 58 HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPE--GMSEALIGNILFGALRGLN 115
Query: 133 FCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF---NPGQKLET-------SCGSL 182
+ H+ +HR++K +++ G+V L+ G S+ + GQK + S L
Sbjct: 116 YLHQNGYIHRNIKASHILISGD-GLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVL 172
Query: 183 AYSAPEILLGD--SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
+ +PE+L D Y+ + D++S+G+ L G+ PFQ+ ++ L
Sbjct: 173 PWLSPELLRQDLYGYNVKS-DIYSVGITACELATGRVPFQDMLRTQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-15
Identities = 55/218 (25%), Positives = 102/218 (46%), Gaps = 11/218 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
+E+ +G G F V R G++ VA+K + + +D L E M HPN
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL-SEASIMGQFDHPN 66
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++ L V+ + + ++ E + G L ++ KHD + I + + +
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRF--NPGQKLETSCGSLA--YSAPEILLGDS 194
VHRDL N++ L V K++DFG S +P T G + ++APE +
Sbjct: 127 YVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 195 YDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
+ + A DVWS G++++ +++ G+ P+ E ++ + + I
Sbjct: 186 FTS-ASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-15
Identities = 51/154 (33%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 67 EVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIM-KHDAGLSETYAREYFA 125
E ++ + HP++++L N LIL DLY Y+ K + + + A E
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIE--R 189
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG---FSNRFNPGQKLETSCGSL 182
++RAI + H+ ++HRD+K EN +F G V L DFG F N K G++
Sbjct: 190 SVLRAIQYLHENRIIHRDIKAEN-IFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTI 247
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQ 216
A +APE+L D Y PAVD+WS G++L+ +
Sbjct: 248 ATNAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-14
Identities = 62/247 (25%), Positives = 107/247 (43%), Gaps = 31/247 (12%)
Query: 26 LGRGHFAVVKLARHVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
LG G+F VK + V+ K VA+KV+ K + + +D + +E M + +P +VR
Sbjct: 3 LGSGNFGCVK--KGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
+ V + + L L++E+ GG L ++ ++ + E Q+ + + + VH
Sbjct: 60 MIGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET--SCGS--LAYSAPEILLGDSYDA 197
RDL NV+ + K++DFG S S G L + APE + + +
Sbjct: 119 RDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 198 PAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMDVSESSC-------------TCW- 242
+ DVWS G+ ++ GQ P+++ E ++ I C CW
Sbjct: 178 RS-DVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWI 236
Query: 243 --WRGRP 247
W RP
Sbjct: 237 YKWEDRP 243
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-14
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
+ LG+G++ V H TG +A+K I + +LD + + E+ + P +V Y
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIM---KHDAGLSETYAREYFAQIVRAISFCHKLH-V 139
+Y+ +E D G L D + G+ E R +V+ + F + H +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPE-ILLGDSYDAP 198
+HRD+KP NV+ G VKL DFG S +T+ G +Y APE I G P
Sbjct: 125 IHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLA-KTNIGCQSYMAPERIKSGGPNQNP 182
Query: 199 AV----DVWSLGVILYMLVAGQAPF 219
DVWSLG+ + + G+ P+
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-14
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLY-QEVRCMKLVQHPN 78
Y+L + +G G + V AR++ TGE AVK+I KL+P L QE+ +K +H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKL 137
+V + + KL++ +E GG L D + H G LSE + ++ +++ H
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCGSLAYSAPEILLGDS-- 194
+HRD+K N++ + G VKL DFG + + K ++ G+ + APE+ +
Sbjct: 126 GKMHRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 195 -YDAPAVDVWSLGVILYMLVAGQAP 218
Y+ D+W++G+ L Q P
Sbjct: 185 GYNQ-LCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-14
Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 21/224 (9%)
Query: 25 TLGRGHFAVVKLARHVFTGEK-----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
TLGRG F V LA+ E+ V VK + KTK + + + +E+ + + H NV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE-FRRELDMFRKLSHKNV 70
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG--------LSETYAREYFAQIVRAI 131
VRL + Y+ILE D GDL ++ + LS QI +
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 132 SFCHKLHVVHRDLKPEN-VVFFERLGVVKLTDFGFSN-RFNPG-QKLETSCGSLAYSAPE 188
VHRDL N +V +R VK++ S +N KL + L + APE
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQRE--VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
+ D + + DVWS GV+++ + G+ PF +D E L +
Sbjct: 189 AVQEDDFSTKS-DVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 58/239 (24%), Positives = 100/239 (41%), Gaps = 13/239 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G +V A VA+K + + + Y+E+ MK V H N++ L V
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 86 IDTNSKL------YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
L Y+++EL D +L I L Q++ I H +
Sbjct: 92 FTPQKSLEEFQDVYIVMELMDA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGI 147
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+HRDLKP N+V + +K+ DFG + + + Y APE++LG Y
Sbjct: 148 IHRDLKPSNIV-VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE-N 205
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG-RPRSRRRTTRKP 257
VD+WS+G I+ ++ G F + + +++ + C + + +P R +P
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP 264
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-14
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 13/220 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
+EE +G G F V R G++ VA+K + + +D L E M HPN
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFL-SEASIMGQFDHPN 66
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++ L V+ + + +I E + G L ++ ++D + I + + +++
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA------YSAPEILLG 192
VHRDL N++ L V K++DFG S T SL ++APE +
Sbjct: 127 YVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 193 DSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
+ + A DVWS G++++ +++ G+ P+ + ++ + + I
Sbjct: 186 RKFTS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-14
Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 22 LEETLGRGHFA-VVKLARHVFTG----EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
L +TLG G F VVK G VAVK++ K L E +K V H
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML-KENASSSELRDLLSEFNLLKQVNH 62
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHD----AGLSETYAREY--------- 123
P+V++LY + L LI+E G L ++ + + L R
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 124 ---------FA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS-NRFNPG 172
FA QI R + + ++ +VHRDL NV+ E +K++DFG S + +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEG-RKMKISDFGLSRDVYEED 181
Query: 173 QKLETSCGSL--AYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPF 219
++ S G + + A E L Y + DVWS GV+L+ +V G P+
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQS-DVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-13
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 27/232 (11%)
Query: 24 ETLGRGHFAVVKLARHVFTGEK-----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
E LG G F V E+ VA+K + + V Q+ QE M +QHPN
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQE-FRQEAELMSDLQHPN 69
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH----DAGLSET--------YAREYF-- 124
+V L V ++ E GDL+++++++ D G ++
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 125 -AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL- 182
QI + + H VHRDL N + E L VK++DFG S SL
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 183 --AYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
+ PE +L + D+WS GV+L+ + + G P+ ++ E + MI
Sbjct: 189 PVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 2e-13
Identities = 54/194 (27%), Positives = 84/194 (43%), Gaps = 12/194 (6%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85
+G G +V A VA+K + + + Y+E+ MK V H N++ L V
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 86 IDTNSKL------YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
L YL++EL D +L I L Q++ I H +
Sbjct: 85 FTPQKSLEEFQDVYLVMELMDA-NLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGI 140
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+HRDLKP N+V + +K+ DFG + + + Y APE++LG Y
Sbjct: 141 IHRDLKPSNIV-VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE-N 198
Query: 200 VDVWSLGVILYMLV 213
VD+WS+G I+ +V
Sbjct: 199 VDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-13
Identities = 43/158 (27%), Positives = 80/158 (50%), Gaps = 9/158 (5%)
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSET---- 118
L E+ + + H N++++ E++ + + Y+I + D DLY ++ +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLK 267
Query: 119 YAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLET 177
R Q++ A+ + H ++HRD+K EN +F G + L DFG + F + +
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 178 S-CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA 214
G++A ++PEIL GD Y D+WS G+IL +++
Sbjct: 327 GWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-13
Identities = 40/142 (28%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
V HP+V+R+ + + + + ++L DLY Y+ K L A QI+ + +
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-CGSLAYSAPEILLG 192
H ++HRD+K EN +F + V + D G + +F G++ +APE+L
Sbjct: 173 LHAQRIIHRDVKTEN-IFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLAR 230
Query: 193 DSYDAPAVDVWSLGVILYMLVA 214
D Y++ D+WS G++L+ ++A
Sbjct: 231 DKYNS-KADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-13
Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 18/223 (8%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTK--LDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
+G G F V L G A V+ + + P Q QEV+ + + HPNV++
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMK---HDAGLSETYAREYFA-QIVRAISFCHKLHV 139
+ L+LE GDL +Y+ A +++ + A ++ + + H+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS---CGSLAYSAPEILLGDSYD 196
+H DL N L VK+ D+G + P T L + APE++ D
Sbjct: 122 IHSDLALRNCQLTADLS-VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD 180
Query: 197 APAVD------VWSLGVILYMLV-AGQAPFQEANDSETLTMIM 232
D +WSLGV ++ L A P+ + +D + L ++
Sbjct: 181 LLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-13
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 25/232 (10%)
Query: 22 LEETLGRGHFAVVKLA--RHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
L+ LG G F V L H+ VAVK + +T + +D +E + QH
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAELLTNFQH 67
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-------------LSETYAREY 123
N+V+ Y V ++ E + GDL ++ H L+ + +
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 124 FAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF--NPGQKLE-TSCG 180
QI + + H VHRDL N + L VVK+ DFG S ++ +
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTML 186
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
+ + PE ++ + + DVWS GV+L+ + G+ P+ ++ E + I
Sbjct: 187 PIRWMPPESIMYRKFTTES-DVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 26/234 (11%)
Query: 42 TGEKVAVKVIDKTKLDPVSQDHLYQEVR-----CMKLVQHPNVVRLYEVIDT-NSKLYLI 95
TG +VA+K++ + D ++H R C +L HPN+V L + + L+ +
Sbjct: 2 TGHEVAIKLL---RTDAPEEEHQRARFRRETALCARL-YHPNIVALLDSGEAPPGLLFAV 57
Query: 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL 155
E G L + ++ D L Q++ A++ H +VHRDLKP+N++ +
Sbjct: 58 FEYVPGRTLRE-VLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116
Query: 156 GV--VKLTDFGFSNRFNPG--QKLETSC-------GSLAYSAPEILLGDSYDAPAVDVWS 204
K+ DFG PG + G+ Y APE L G+ P D+++
Sbjct: 117 VRPHAKVLDFGIGT-LLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-TPNSDLYA 174
Query: 205 LGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSR--RRTTRK 256
G+I + GQ Q A+ +E L + + S W G P + R+ K
Sbjct: 175 WGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNK 228
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-12
Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 23/224 (10%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
L +TLG G F V + + KVAVK + + E CMK HP
Sbjct: 3 LGKTLGEGEFGSVMEGQ--LNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 78 NVVRLYEVIDTNSKL------YLILELGDGGDLYDYIMKHDAGLSETYAR-----EYFAQ 126
NV+RL V + +IL GDL+ +++ G Y ++
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG---QKLETSCGSLA 183
I + + +HRDL N + E + V + DFG S + G ++ + +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVC-VADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSE 226
+ A E L Y + DVWS GV ++ + GQ P+ +SE
Sbjct: 180 WIAIESLADRVYTTKS-DVWSFGVTMWEIATRGQTPYPGVENSE 222
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-12
Identities = 68/264 (25%), Positives = 111/264 (42%), Gaps = 39/264 (14%)
Query: 22 LEETLGRGHFAVVKLAR-HVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
L+ LG G F V LA + E+ VAVK + K D +D ++E + +QH
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKD-FHREAELLTNLQH 66
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH--DA----------GLSETYAREYF 124
++V+ Y V L ++ E GDL ++ H DA L+++
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 125 AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL-- 182
QI + + H VHRDL N + E L +VK+ DFG S ++
Sbjct: 127 QQIAAGMVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 183 -AYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMI--------- 231
+ PE ++ + + DVWSLGV+L+ + G+ P+ + +++E + I
Sbjct: 186 IRWMPPESIMYRKFTTES-DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP 244
Query: 232 ----MDVSESSCTCWWRGRPRSRR 251
+V + CW R P R
Sbjct: 245 RTCPKEVYDLMLGCWQR-EPHMRL 267
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-12
Identities = 72/275 (26%), Positives = 108/275 (39%), Gaps = 58/275 (21%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-----KVAVKVIDKTKLDPVSQD--HLYQEVRCMKLV 74
L + LG G F V A V VAVK++ K D +D L E+ MK++
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML---KDDATEKDLSDLVSEMEMMKMI 72
Query: 75 -QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-----DAGLSETYARE------ 122
+H N++ L V LY+++E G+L D++ A + E
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 123 ---YFA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL-ET 177
FA Q+ R + F +HRDL NV+ E V+K+ DFG + + +T
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYYRKT 191
Query: 178 SCGSLAYS--APEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPF--------------- 219
+ G L APE L Y DVWS GV+L+ + G +P+
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250
Query: 220 ----QEANDSETLTMIMDVSESSCTCWWRGRPRSR 250
+ N ++ L +M C W P R
Sbjct: 251 YRMEKPQNCTQELYHLM------RDC-WHEVPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-11
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 26/226 (11%)
Query: 22 LEETLGRGHFAVV---KLARHVFTGEKVAVKVIDKTKLDPVSQDHL---YQEVRCMKLVQ 75
L + LG G F V +L++ + KVAVK + KLD + + E CMK
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM---KLDIHTYSEIEEFLSEAACMKDFD 59
Query: 76 HPNVVRLYEVIDTNSKL------YLILELGDGGDLYDYIMKHD-AGLSETYARE----YF 124
HPNV++L V S L +IL GDL+ +++ GL E + +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 125 AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS--- 181
I + + + +HRDL N + E + V + DFG S + G +
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC-VADFGLSKKIYSGDYYRQGRIAKMP 178
Query: 182 LAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSE 226
+ + A E L D DVW+ GV ++ + GQ P+ + E
Sbjct: 179 VKWIAIES-LADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE 223
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 68/255 (26%), Positives = 107/255 (41%), Gaps = 38/255 (14%)
Query: 22 LEETLGRGHFAVVKLAR-HVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
L+ LG G F V LA H E+ VAVK + K + QD +E + ++QH
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQD-FQREAELLTVLQH 66
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH--DAGLSE------------TYARE 122
++VR Y V L ++ E GDL ++ H DA +
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
+QI + + LH VHRDL N + + L VVK+ DFG S ++
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 183 ---AYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMDVSESS 238
+ PE +L + + D+WS GV+L+ + G+ P+ + +++E +
Sbjct: 186 LPIRWMPPESILYRKFTTES-DIWSFGVVLWEIFTYGKQPWYQLSNTEAI---------- 234
Query: 239 CTCWWRGRPRSRRRT 253
C +GR R RT
Sbjct: 235 -ECITQGRELERPRT 248
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
LG G F V + GE VA+KV+ + P + + E M V P V R
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
L + T S + L+ +L G L DY+ ++ + + QI + +S+ ++ +VH
Sbjct: 74 LLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSYDAP 198
RDL NV+ + VK+TDFG + + + + G + + A E +L +
Sbjct: 133 RDLAARNVL-VKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQ 191
Query: 199 AVDVWSLGVILYMLVA-GQAPFQ 220
+ DVWS GV ++ L+ G P+
Sbjct: 192 S-DVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 34/223 (15%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ-----EVRCMKLVQH 76
++ +G G+F V AR G ++ + K + S+D EV C KL H
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAI--KRMKEYASKDDHRDFAGELEVLC-KLGHH 67
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHD---------------AGLSETYAR 121
PN++ L + LYL +E G+L D++ K + LS
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 122 EYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK--LETSC 179
+ A + R + + + +HRDL N++ E V K+ DFG S GQ+ ++ +
Sbjct: 128 HFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSR----GQEVYVKKTM 182
Query: 180 GSLA--YSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPF 219
G L + A E L Y + DVWS GV+L+ +V+ G P+
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 21 DLEETLGRG--HFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD---HLYQEVRCMKLVQ 75
+L +GRG V LAR+ TGE V V+ I+ L+ + + L E+ KL
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN---LEACTNEMVTFLQGELHVSKLFN 57
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFC 134
HPN+V +++L+++ G D I H G+SE +++A+ +
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI 117
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF---NPGQKLET-------SCGSLAY 184
H + VHR +K +++ G V L+ G + N GQ+L S L +
Sbjct: 118 HHMGYVHRSVKASHIL-ISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174
Query: 185 SAPEILLGD--SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229
+PE+L + YDA + D++S+G+ L G PF++ ++ L
Sbjct: 175 LSPEVLQQNLQGYDAKS-DIYSVGITACELANGHVPFKDMPATQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-11
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 19/225 (8%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD--PVSQDHLYQEVRCMKLVQHPNVVR 81
+ +G G F V L+ ++T VA V+ + K + Q+ Q+ +++QHPN+++
Sbjct: 1 QEIGNGWFGKVLLSE-IYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHD--AGLSETYAREYFA-QIVRAISFCHKLH 138
L+ E + GDL Y+ + S+ + A +I ++ HK +
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS---CGSLAYSAPEI------ 189
+H DL N L VK+ D+G +ET C L + APE+
Sbjct: 120 FLHSDLALRNCFLTSDLT-VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 190 -LLGDSYDAPAVDVWSLGVILYMLVAGQA-PFQEANDSETLTMIM 232
L+ P+ +VW+LGV L+ L A P+ +D E L ++
Sbjct: 179 GLITAEQTKPS-NVWALGVTLWELFENAAQPYSHLSDREVLNHVI 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 34/227 (14%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-------KVAVKVIDKTKLDPVSQD--HLYQEVRCMK 72
L + LG G F V +A + + KVAVK++ K D +D L E+ MK
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMK 78
Query: 73 LV-QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYI-MKHDAGLSETYAREYFA----- 125
++ +H N++ L + LY+I+E G+L +Y+ + G+ Y
Sbjct: 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138
Query: 126 ---------QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL- 175
Q+ R + + +HRDL NV+ E V+K+ DFG + +
Sbjct: 139 FKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYK 197
Query: 176 ETSCGSL--AYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPF 219
+T+ G L + APE L Y + DVWS GV+L+ + G +P+
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-11
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 12/204 (5%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKV----AVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ LG G F V V GE V A+K++++T P + E M + HP++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHL 71
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
VRL V + + L+ +L G L DY+ +H + + QI + + + + +
Sbjct: 72 VRLLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSYD 196
VHRDL NV+ + VK+TDFG + +K + G + + A E + +
Sbjct: 131 VHRDLAARNVL-VKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 197 APAVDVWSLGVILYMLVA-GQAPF 219
+ DVWS GV ++ L+ G P+
Sbjct: 190 HQS-DVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-11
Identities = 57/239 (23%), Positives = 101/239 (42%), Gaps = 36/239 (15%)
Query: 22 LEETLGRGHFAVVKLAR----HVFTGEK------------VAVKVIDKTKLDPVSQDHLY 65
+E LG G F V L F + VAVK++ + + +++
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANKNARNDFL 67
Query: 66 QEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDA----------GL 115
+E++ M ++ PN++RL V T+ L +I E + GDL ++ +H+ +
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 116 SETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175
S + QI + + L+ VHRDL N + + +K+ DFG S G
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSGDYY 186
Query: 176 ETSCGSLA----YSAPEILLGDSYDAPAVDVWSLGVILY--MLVAGQAPFQEANDSETL 228
++ S ILLG A DVW+ GV L+ + + + P+ + +D + +
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKF--TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-11
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)
Query: 66 QEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA 125
E R ++ + HP V+ L +V L+L DLY Y+ L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYLGARLRPLGLAQVTAVAR 267
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG--------FSNRFNPGQKLET 177
Q++ AI + H ++HRD+K EN V + L DFG +S F+ G
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLGDFGAACFARGSWSTPFHYG----- 321
Query: 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILY--------MLVAGQAPFQEANDSETLT 229
G++ +APE+L GD Y P+VD+WS G++++ + A + + D++ L
Sbjct: 322 IAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILR 380
Query: 230 MIMDV----------SESSCTCWWRGRPRSRRR 252
+I + S +R R RR
Sbjct: 381 IIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRR 413
|
Length = 461 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 28/231 (12%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ---DHLYQEVRCMKLVQHP 77
E T GR + ++ G++ V V KT D S+ L QE + + H
Sbjct: 14 LQEGTFGRIFYGIL---IDEKPGKEEEVFV--KTVKDHASEIQVTLLLQESCLLYGLSHQ 68
Query: 78 NVVRLYEV-IDTNSKLYLILELGDGGDLYDYIMKHDAG-------LSETYAREYFAQIVR 129
N++ + V I+ +++ + G+L ++ + G LS QI
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 130 AISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC------GSLA 183
+S+ HK V+H+D+ N V E L VK+TD S P + C +
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQ-VKITDNALSRDLFPM---DYHCLGDNENRPVK 184
Query: 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
+ A E L+ Y + A DVWS GV+L+ L+ GQ P+ E + E + D
Sbjct: 185 WMALESLVNKEYSS-ASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD 234
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 27/229 (11%)
Query: 26 LGRGHFAVV--KLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
LG+G F +V AR + GE +VAVK ++++ + E MK +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVV 72
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYI--MKHDA----GLSETYAREYF---AQIVRAI 131
RL V+ +++EL GDL Y+ ++ +A G +E A+I +
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF------SNRFNPGQKLETSCGSLAYS 185
++ + VHRDL N + VK+ DFG ++ + G K + +
Sbjct: 133 AYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTRDIYETDYYRKGGK---GLLPVRWM 188
Query: 186 APEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
APE L D + D+WS GV+L+ + + + P+Q ++ + L +MD
Sbjct: 189 APES-LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 59/247 (23%), Positives = 99/247 (40%), Gaps = 33/247 (13%)
Query: 23 EETLGRGHFAVVKLARH--VFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
+G+G F V AR + E VAVK++ + + D +E M HP
Sbjct: 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDHP 68
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYI------MKHDAGLSETYAREYF------- 124
N+V+L V + L+ E GDL +++ + S + AR+
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 125 --------AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176
Q+ +++ + VHRDL N + E + VVK+ DFG S +
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYK 187
Query: 177 TSCGSLA---YSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIM 232
S + PE + + Y + DVW+ GV+L+ + + G P+ E + +
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTES-DVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVR 246
Query: 233 DVSESSC 239
D + SC
Sbjct: 247 DGNVLSC 253
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 34/227 (14%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK-------VAVKVIDKTKLDPVSQD--HLYQEVRCMK 72
L + LG G F V +A + + VAVK++ K D +D L E+ MK
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMK 75
Query: 73 LV-QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYI-MKHDAGLSETYAREYFA----- 125
++ +H N++ L + LY+I+E G+L +Y+ + G+ +Y
Sbjct: 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 126 ---------QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKL 175
Q+ R + + +HRDL NV+ E V+K+ DFG + N
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYK 194
Query: 176 ETSCGSL--AYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPF 219
+T+ G L + APE L Y + DVWS GV+++ + G +P+
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 55/210 (26%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 25 TLGRGHFA-VVKLARHVFTGE----KVAVKVIDKTKLDPVSQDHLYQEVRCM-KLVQHPN 78
TLG G F VV+ + + KVAVK++ K ++ L E++ M L H N
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKML-KPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKL 137
+V L + +I E GDL +++ + F+ Q+ + ++F
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK 160
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGF-------SNRFNPGQKLETSCGSLAYSAPEIL 190
+ +HRDL NV+ +VK+ DFG SN G + + APE +
Sbjct: 161 NCIHRDLAARNVLLTHG-KIVKICDFGLARDIMNDSNYVVKGNARL----PVKWMAPESI 215
Query: 191 LGDSYDAPAVDVWSLGVILYMLVA-GQAPF 219
Y + DVWS G++L+ + + G P+
Sbjct: 216 FNCVYTFES-DVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 66/266 (24%), Positives = 108/266 (40%), Gaps = 41/266 (15%)
Query: 24 ETLGRGHFAVVKLARHVF---TGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
E LG F V H+F GE+ VA+K + K K + ++ E +QHP
Sbjct: 11 EELGEDRFGKVYKG-HLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHP 68
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-----------DAGLSETYAREYF-- 124
N+V L V+ L +I DL+++++ D + T F
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 125 --AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
QI + F HVVH+DL NV+ F++L VK++D G + SL
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN-VKISDLGLFREVYAADYYKLMGNSL 187
Query: 183 ---AYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD----V 234
+ +PE ++ + + D+WS GV+L+ + + G P+ ++ + + MI +
Sbjct: 188 LPIRWMSPEAIMYGKFSIDS-DIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
Query: 235 SESSCTCW--------WRGRPRSRRR 252
C W W P R R
Sbjct: 247 CPDDCPAWVYTLMLECWNEFPSRRPR 272
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 58/235 (24%), Positives = 95/235 (40%), Gaps = 40/235 (17%)
Query: 24 ETLGRGHFAVVKLARHVFTGEK----------------VAVKVIDKTKLDPVSQDHLYQE 67
E LG G F V L + VAVKV+ D +D +E
Sbjct: 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED-FLKE 69
Query: 68 VRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH---DAGLSETYAREYF 124
V+ + + PN+ RL V + L +I+E + GDL ++ KH +GL+ F
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 125 -------AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--KL 175
QI + + L+ VHRDL N + + +K+ DFG S ++
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCL-VGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 176 ETSCGS----LAYSAPEILLGDSYDAPAVDVWSLGVILY--MLVAGQAPFQEAND 224
+ G + + A E +L + DVW+ GV L+ + + + P++ D
Sbjct: 189 Q---GRAPLPIRWMAWESVLLGKFTT-KSDVWAFGVTLWEILTLCREQPYEHLTD 239
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 30/221 (13%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKV--AVKVIDKTKLDPVSQDHLYQ-EVRCMKLVQHPN 78
E+ +G G+F V A G K+ A+K++ + + +D + EV C KL HPN
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLC-KLGHHPN 64
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSE-TYAREY-------------F 124
++ L + LY+ +E G+L D++ K ++ +A+E+ F
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 125 A-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK--LETSCGS 181
A + + + + +HRDL NV+ E L K+ DFG S G++ ++ + G
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENL-ASKIADFGLSR----GEEVYVKKTMGR 179
Query: 182 LA--YSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPF 219
L + A E L Y + DVWS GV+L+ +V+ G P+
Sbjct: 180 LPVRWMAIESLNYSVYTTKS-DVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-10
Identities = 62/238 (26%), Positives = 106/238 (44%), Gaps = 35/238 (14%)
Query: 22 LEETLGRGHFAVVKLAR----HVFTGEK----------VAVKVIDKTKLDPVSQDHLYQE 67
L+E LG G F V L F GE VAVK++ + + +++ +E
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARNDFLKE 67
Query: 68 VRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE----- 122
++ M +++PN++RL V ++ L +I E + GDL ++ + + + T+A
Sbjct: 68 IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 123 -----YFA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176
Y A QI + + L+ VHRDL N + +K+ DFG S G
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYR 186
Query: 177 TSCGS---LAYSAPE-ILLGDSYDAPAVDVWSLGVILYML--VAGQAPFQEANDSETL 228
+ + + A E ILLG A DVW+ GV L+ + + + P+ +D + +
Sbjct: 187 IQGRAVLPIRWMAWESILLGKF--TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-10
Identities = 66/268 (24%), Positives = 108/268 (40%), Gaps = 46/268 (17%)
Query: 22 LEETLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDP--VSQDHLYQEVRCMKLVQH 76
L+ LG G F V LA T +K+ V V K DP ++ +E + +QH
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAV--KALKDPTLAARKDFQREAELLTNLQH 66
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-----------------DAGLSETY 119
++V+ Y V L ++ E GDL ++ H + GLS+
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 120 AREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC 179
+QI + + H VHRDL N + L +VK+ DFG S
Sbjct: 127 --HIASQIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGG 183
Query: 180 GSL---AYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIM--- 232
++ + PE ++ + + DVWS GVIL+ + G+ P+ + +++E + I
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTES-DVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242
Query: 233 ----------DVSESSCTCWWRGRPRSR 250
+V + CW R P+ R
Sbjct: 243 VLERPRVCPKEVYDIMLGCWQR-EPQQR 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-10
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 12/202 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR----CMKLVQHPNVVR 81
LG G F V + G+ + + V KT D + +QE+ M + H +VR
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR-QTFQEITDHMLAMGSLDHAYIVR 73
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
L I + L L+ +L G L D++ +H L + QI + + + + +VH
Sbjct: 74 LLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVH 132
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAP 198
R+L N++ +V++ DFG ++ P K + + A E +L Y
Sbjct: 133 RNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQ 191
Query: 199 AVDVWSLGVILY-MLVAGQAPF 219
+ DVWS GV ++ M+ G P+
Sbjct: 192 S-DVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-10
Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK-------VAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
L + LG G F V +A + + VAVK++ D D L E+ MK++
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSD-LVSEMEMMKMI 74
Query: 75 -QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYI-MKHDAGLSETY-----AREYFA-- 125
+H N++ L + LY+++E G+L +Y+ + G+ ++ E
Sbjct: 75 GKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 126 -------QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS-NRFNPGQKLET 177
Q+ R + + +HRDL NV+ E V+K+ DFG + + N +T
Sbjct: 135 DLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKT 193
Query: 178 SCGSL--AYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPF 219
+ G L + APE L Y + DVWS GV+L+ + G +P+
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 48/239 (20%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPN 78
YD+ +G+G V LA +VA+K I + + P+ + +E + + HP
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMK-----------HDAGLSETYAREYFAQI 127
+V +Y + +Y + +G L ++K S F +I
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 128 VRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG----------------------- 164
I + H V+HRDLKP+N++ G V + D+G
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNIL-LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 165 FSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA---VDVWSLGVILYMLVAGQAPFQ 220
+S+ PG+ + G+ Y APE LLG PA D+++LGVILY ++ P++
Sbjct: 182 YSSMTIPGKIV----GTPDYMAPERLLG----VPASESTDIYALGVILYQMLTLSFPYR 232
|
Length = 932 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 36/176 (20%), Positives = 76/176 (43%), Gaps = 17/176 (9%)
Query: 67 EVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQ 126
E + H N+VRL VI + + ++ E G L ++ KH+ L
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--KLETSCGSLA- 183
+ + + ++ VH+ L V+ L K++ F Q K E +++
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLV-CKISGFR------RLQEDKSEAIYTTMSG 168
Query: 184 -----YSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
++APE + + + A DVWS G++++ +++ G+ P+ + + + + + D
Sbjct: 169 KSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 61/246 (24%), Positives = 98/246 (39%), Gaps = 42/246 (17%)
Query: 22 LEETLGRGHFAVVKLARHV-----------FTGEK-----VAVKVIDKTKLDPVSQDHLY 65
+E LG G F V L V F K VAVK++ D L
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL- 67
Query: 66 QEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHD------------- 112
+EV+ + ++ PN++RL V L +I E + GDL ++ H
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 113 ---AGLSETYAR--EYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167
+ +Y+ QI + + L+ VHRDL N + E L +K+ DFG S
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENL-TIKIADFGMSR 186
Query: 168 RFNPGQKLETSCGS---LAYSAPEILLGDSYDAPAVDVWSLGVILY--MLVAGQAPFQEA 222
G + + + A E +L + A DVW+ GV L+ +++ + P+ E
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT-ASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 223 NDSETL 228
D + +
Sbjct: 246 TDEQVI 251
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-09
Identities = 64/271 (23%), Positives = 105/271 (38%), Gaps = 41/271 (15%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH---LYQEVRCMKLVQHPNVV 80
E LG F + G A V KT D + QE M + HPN+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDY-IMK-----------HDAGLSETYAREYF---- 124
L V+ + ++ E + GDL+++ IM+ D + + F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 125 AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL-- 182
QI + + VH+DL N++ E+L VK++D G S SL
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-VKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 183 -AYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSCT 240
+ PE ++ + + + D+WS GV+L+ + + G P+ ++ E + M+ C+
Sbjct: 190 IRWMPPEAIMYGKFSSDS-DIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS 248
Query: 241 -------------CWWRG---RPRSRRRTTR 255
CW G RPR + TR
Sbjct: 249 EDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-09
Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 21/226 (9%)
Query: 26 LGRGHFAVV--KLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
LG+G F +V +A+ V E +VA+K +++ + E MK +VV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVV 72
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYI------MKHDAGLSETYAREYF---AQIVRAI 131
RL V+ +I+EL GDL Y+ M+++ + ++ +I +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL---AYSAPE 188
++ + VHRDL N + E VK+ DFG + L + +PE
Sbjct: 133 AYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
L D DVWS GV+L+ + + P+Q ++ + L +M+
Sbjct: 192 S-LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 23/194 (11%)
Query: 46 VAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYLILELGDGGDL 104
VAVK++ D D L E+ MKL+ +H N++ L V LY+I+E G+L
Sbjct: 47 VAVKMLKDNATDKDLAD-LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 105 YDYIMK---------------HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENV 149
+++ + LS Q+ R + + +HRDL NV
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165
Query: 150 VFFERLGVVKLTDFGFSNRFNPGQKL-ETSCGSL--AYSAPEILLGDSYDAPAVDVWSLG 206
+ E V+K+ DFG + + +TS G L + APE L Y + DVWS G
Sbjct: 166 LVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS-DVWSFG 223
Query: 207 VILY-MLVAGQAPF 219
++++ + G +P+
Sbjct: 224 ILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-09
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKV--AVKVIDKTKLDPVSQDHLYQ-EVRCMKLVQHPNVV 80
+ +G G+F V AR G ++ A+K + + +D + EV C KL HPN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC-KLGHHPNII 59
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSE-TYAREYFA-------QIVR--- 129
L + LYL +E G+L D++ K ++ +A Q++
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 130 ----AISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK--LETSCGSLA 183
+ + + +HRDL N++ E K+ DFG S GQ+ ++ + G L
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLSR----GQEVYVKKTMGRLP 174
Query: 184 --YSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPF 219
+ A E L Y + DVWS GV+L+ +V+ G P+
Sbjct: 175 VRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-07
Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 21/224 (9%)
Query: 26 LGRGHFAVV--KLARHVFTGEKVAVKVIDKTKLD---PVSQDHLYQEVRCMKLVQHPNVV 80
LG G F V L R G+ V ++V KT + + E M H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGR-DGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIM--KHDAGLSETYAREYFAQIVRAISF-CHKL 137
RL V +++LEL GGDL ++ + + + R ++ C L
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 138 ---HVVHRDLKPENVVFFERLG---VVKLTDFGFSN---RFNPGQKLETSCGSLAYSAPE 188
H +HRD+ N + + G V K+ DFG + R + +K + + + PE
Sbjct: 133 EENHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE 191
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
L D DVWS GV+L+ + + G P+ + E + +
Sbjct: 192 AFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 24/210 (11%)
Query: 24 ETLGRGHFAVVKLARHVFTGEK---VAVKVIDK-TKLDPVSQDHLYQEVRCMKLVQHPNV 79
+G+GHF V + + + AVK +++ T L+ V Q +E MK HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ--FLKEGIIMKDFSHPNV 58
Query: 80 VRLYEV-IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+ L + + + ++L GDL ++I + + Q+ + + +
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFG----------FSNRFNPGQKLETSCGSLAYSAPE 188
VHRDL N + E VK+ DFG +S + G KL + + A E
Sbjct: 119 FVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKL-----PVKWMALE 172
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAP 218
L + + DVWS GV+L+ L+ AP
Sbjct: 173 SLQTQKFTTKS-DVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 26/227 (11%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD--PVSQDHLYQEVRCMKLVQHPNVVRLY 83
+G G F V L V +G A V+ + ++ Q +E + + +QH N+++
Sbjct: 3 IGNGWFGKVILGE-VNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSET----YAREYFAQIVRAISFCHKLHV 139
+ L++E GDL Y+ T + +I + HK +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF 121
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNR-------FNPGQKLETSCGSLAYSAPEILLG 192
+H DL N + L VK+ D+G S+ P Q L + APE++
Sbjct: 122 IHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWV----PLRWIAPELVDE 176
Query: 193 DSYDAPAVD------VWSLGVILYMLVA-GQAPFQEANDSETLTMIM 232
+ VD VWSLGV ++ L G P++ +D + LT +
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 41/179 (22%), Positives = 79/179 (44%), Gaps = 16/179 (8%)
Query: 45 KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDL 104
KV VK + K P E+ +K + H ++ L S + +++ DL
Sbjct: 121 KVIVKAVTGGK-TPGR------EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DL 172
Query: 105 YDYI-MKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDF 163
+ Y+ L + + +++ A+++ H ++HRD+K EN +F + L DF
Sbjct: 173 FTYVDRSGPLPLEQAITIQ--RRLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLGDF 229
Query: 164 GFSNRFNP---GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPF 219
G + + + + G+L ++PE+L D Y A D+WS G++L+ +
Sbjct: 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 32/150 (21%)
Query: 104 LYDYIMKHDAGLSETYAREYFAQIV----RAISFCH-KLHVVHRDLKPENVVFFERLGVV 158
L D+IMKH ++ + AQI+ A+ + H +LH++H DLKPEN++ VV
Sbjct: 218 LLDWIMKHGP-----FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVV 272
Query: 159 KLTDFGFSNRFNPGQKLETSCGSLA-----------------YSAPEILLGDSYDAPAVD 201
+NR P L Y +PE++LG + + D
Sbjct: 273 DPV----TNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGW-MYSTD 327
Query: 202 VWSLGVILYMLVAGQAPFQEANDSETLTMI 231
+WS+G I+Y L G+ + ++ E L ++
Sbjct: 328 MWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357
|
Length = 467 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF--NPGQKLETSCG 180
Y Q+ R + F +HRDL N++ E VVK+ DFG + +P + S
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 181 -SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPF 219
L + APE + Y + DVWS GV+L+ + + G +P+
Sbjct: 238 LPLKWMAPESIFDKVYTTQS-DVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 45/207 (21%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 40 VFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLY----EVIDTNSKLYL 94
+F ++V ++ K V D E++ ++ + N++++Y +++D +L L
Sbjct: 40 IFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSL 99
Query: 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR-DLKP----ENV 149
ILE G L + + K + LS + ++ AI C L+ +++ KP +V
Sbjct: 100 ILEYCTRGYLREVLDK-EKDLS------FKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSV 152
Query: 150 VFF-ERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDAPAV--DVWSL 205
F +K+ G +P K + + Y + ++L D + + D++SL
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFK---NVNFMVYFSYKMLN-DIFSEYTIKDDIYSL 208
Query: 206 GVILYMLVAGQAPFQEANDSETLTMIM 232
GV+L+ + G+ PF+ E +I+
Sbjct: 209 GVVLWEIFTGKIPFENLTTKEIYDLII 235
|
Length = 283 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 29/98 (29%), Positives = 42/98 (42%), Gaps = 15/98 (15%)
Query: 107 YIMKHDAGLSETYARE------YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKL 160
Y++ L + RE QI+ A+ H +VHRD+KP+N++F E G K+
Sbjct: 238 YLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKI 297
Query: 161 TDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
D G + G + Y E LL Y AP
Sbjct: 298 IDLGAAADLRVG---------INYIPKEFLLDPRYAAP 326
|
Length = 566 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 24/48 (50%), Positives = 30/48 (62%), Gaps = 5/48 (10%)
Query: 180 GSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227
G+ Y APE+LLG + PAVD W+LGV L+ + G PF ND ET
Sbjct: 542 GTPDYLAPELLLGKPHG-PAVDWWALGVCLFEFLTGIPPF---ND-ET 584
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 7e-05
Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF--NPGQKLETSCG 180
Y Q+ + + F +HRDL N++ E VVK+ DFG + +P +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 181 -SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPF 219
L + APE + Y + DVWS GV+L+ + + G +P+
Sbjct: 243 LPLKWMAPETIFDRVYTIQS-DVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 54/208 (25%), Positives = 84/208 (40%), Gaps = 37/208 (17%)
Query: 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRL 82
E + RG + + G + VK I+ P S E+ M +QHPN+V+L
Sbjct: 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS------EIADMGKLQHPNIVKL 748
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH---KLHV 139
+ + YLI E +G +L + + LS R+ I +A+ F H V
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 140 VHRDLKPENVVF------FERLGVVKL--TDFGFSNRFNPGQKLETSCGSLAYSAPEILL 191
V +L PE ++ RL + L TD S AY APE
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDT-------------KCFISSAYVAPETR- 850
Query: 192 GDSYD-APAVDVWSLGVILYMLVAGQAP 218
++ D D++ G+IL L+ G++P
Sbjct: 851 -ETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 6/101 (5%)
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF--NPGQKLETSCG 180
Y Q+ R + F +HRDL N++ E VVK+ DFG + +P +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 181 -SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPF 219
L + APE + Y + DVWS GV+L+ + + G +P+
Sbjct: 237 LPLKWMAPESIFDKVYTTQS-DVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 32/104 (30%), Positives = 48/104 (46%), Gaps = 14/104 (13%)
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF-------SNRFNPGQKLETS 178
Q+ + F + VHRDL NV+ E +VK+ DFG SN + G
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEG-KLVKICDFGLARDIMRDSNYISKGSTFL-- 303
Query: 179 CGSLAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQE 221
L + APE + + Y + DVWS G++L+ + G P+ E
Sbjct: 304 --PLKWMAPESIFNNLYTTLS-DVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 9e-04
Identities = 32/111 (28%), Positives = 53/111 (47%), Gaps = 8/111 (7%)
Query: 114 GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173
GL+ + Q+ R + F + VHRDL NV+ + +VK+ DFG +
Sbjct: 233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDS 291
Query: 174 KLETSCGS----LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPF 219
S GS + + APE + + Y + DVWS G++L+ + + G P+
Sbjct: 292 NY-VSKGSTFLPVKWMAPESIFDNLYTTLS-DVWSYGILLWEIFSLGGTPY 340
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 49/194 (25%), Positives = 89/194 (45%), Gaps = 22/194 (11%)
Query: 45 KVAVKVIDKTKLDPVSQD---HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101
+V +KV LDP +D ++ M V H ++ ++ V S+ ++ E +
Sbjct: 46 RVVLKV-----LDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 102 GDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGV--- 157
G L D ++ + G + A Q+ A+S+ ++VH ++ +N++ RLG+
Sbjct: 101 GPL-DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILL-ARLGLAEG 158
Query: 158 ----VKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLG-VILYML 212
+KL+D G S F + E + + APE + G + + A D WS G +L +
Sbjct: 159 TSPFIKLSDPGVS--FTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215
Query: 213 VAGQAPFQEANDSE 226
G+ P +E SE
Sbjct: 216 FDGEVPLKERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.002
Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 13/105 (12%)
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKL-ETSCGSLAYSAPEI 189
L +HR K N++ LT G + K E S + APE+
Sbjct: 25 QCLGALRELHRQAKSGNIL---------LTWDGLLKLDGSVAFKTPEQSRPDPYFMAPEV 75
Query: 190 LLGDSYDAPAVDVWSLGVILYMLVAGQAP-FQEANDSETLTMIMD 233
+ G SY D++SLG+ LY + + P +E S L ++++
Sbjct: 76 IQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLN 119
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 24/68 (35%), Positives = 36/68 (52%), Gaps = 3/68 (4%)
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL--A 183
Q++ + H++ +VHRD+KPEN++ G VK+ DFG + G G L
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPR 375
Query: 184 YSAPEILL 191
YS PE L+
Sbjct: 376 YSPPEELV 383
|
Length = 507 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 42/137 (30%), Positives = 56/137 (40%), Gaps = 26/137 (18%)
Query: 6 SRSSDGH------PTKIAGLYD-----------LEETLGRGHFAVVKLA-----RHVFTG 43
S SSDGH P ++ YD L TLG G F V A H +
Sbjct: 10 SVSSDGHEYIYVDPMQLP--YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQST 67
Query: 44 EKVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQHPNVVRLYEVIDTNSKLYLILELGDGG 102
KVAVK++ T Q L E++ M L H N+V L +Y+I E G
Sbjct: 68 MKVAVKMLKSTARSSEKQ-ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYG 126
Query: 103 DLYDYIMKHDAGLSETY 119
DL DY+ ++ + Y
Sbjct: 127 DLVDYLHRNKHTFLQYY 143
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.004
Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 20/198 (10%)
Query: 42 TGEKVAVKVIDKTKLDPVSQD---HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98
+ +KVI K LDP +D ++ M+ V H ++V LY V + + ++ E
Sbjct: 27 YSYEKEIKVILKV-LDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEF 85
Query: 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV- 157
+ G L ++ + L+ + + Q+ A+S+ +VH ++ +N++ R G+
Sbjct: 86 VEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNIL-LAREGID 144
Query: 158 ------VKLTDFGFSNRFNPGQKL--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVIL 209
+KL+D G P L + + + APE + + A D WS G L
Sbjct: 145 GECGPFIKLSDPGI-----PITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTL 199
Query: 210 Y-MLVAGQAPFQEANDSE 226
+ + G+ P ++ +E
Sbjct: 200 WEICYNGEIPLKDKTLAE 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 259 | |||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| KOG0032|consensus | 382 | 100.0 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| KOG0614|consensus | 732 | 100.0 | ||
| KOG0986|consensus | 591 | 100.0 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| KOG0579|consensus | 1187 | 100.0 | ||
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0695|consensus | 593 | 99.98 | ||
| KOG0608|consensus | 1034 | 99.98 | ||
| KOG0984|consensus | 282 | 99.98 | ||
| KOG0196|consensus | 996 | 99.98 | ||
| KOG1035|consensus | 1351 | 99.98 | ||
| KOG0603|consensus | 612 | 99.97 | ||
| KOG1094|consensus | 807 | 99.97 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0199|consensus | 1039 | 99.97 | ||
| KOG0587|consensus | 953 | 99.97 | ||
| KOG1151|consensus | 775 | 99.97 | ||
| KOG1290|consensus | 590 | 99.97 | ||
| KOG1006|consensus | 361 | 99.97 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0200|consensus | 609 | 99.96 | ||
| KOG4278|consensus | 1157 | 99.96 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1025|consensus | 1177 | 99.96 | ||
| KOG1167|consensus | 418 | 99.96 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1345|consensus | 378 | 99.96 | ||
| KOG2052|consensus | 513 | 99.96 | ||
| KOG3653|consensus | 534 | 99.95 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1027|consensus | 903 | 99.95 | ||
| KOG1163|consensus | 341 | 99.95 | ||
| KOG1164|consensus | 322 | 99.95 | ||
| KOG1024|consensus | 563 | 99.94 | ||
| KOG1165|consensus | 449 | 99.94 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0576|consensus | 829 | 99.92 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1166|consensus | 974 | 99.86 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1240|consensus | 1431 | 99.84 | ||
| KOG0590|consensus | 601 | 99.84 | ||
| KOG0603|consensus | 612 | 99.83 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| KOG4158|consensus | 598 | 99.75 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| KOG0195|consensus | 448 | 99.7 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG0606|consensus | 1205 | 99.66 | ||
| KOG1023|consensus | 484 | 99.65 | ||
| KOG1243|consensus | 690 | 99.61 | ||
| KOG3087|consensus | 229 | 99.6 | ||
| KOG0590|consensus | 601 | 99.58 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.58 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG1033|consensus | 516 | 99.52 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.5 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.48 | |
| KOG0601|consensus | 524 | 99.38 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.34 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.34 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.32 | |
| KOG3741|consensus | 655 | 99.3 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| KOG1266|consensus | 458 | 99.22 | ||
| KOG0601|consensus | 524 | 99.18 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.17 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.15 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.1 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.04 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.99 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.94 | |
| KOG0606|consensus | 1205 | 98.93 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.93 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.74 | |
| KOG1235|consensus | 538 | 98.74 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.71 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.69 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.55 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.48 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.42 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.34 | |
| KOG2268|consensus | 465 | 98.26 | ||
| KOG2270|consensus | 520 | 98.26 | ||
| KOG2137|consensus | 700 | 98.24 | ||
| PRK10593 | 297 | hypothetical protein; Provisional | 98.23 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.21 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.15 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.11 | |
| KOG0576|consensus | 829 | 98.06 | ||
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.02 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.97 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.94 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.89 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.83 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.8 | |
| PLN02236 | 344 | choline kinase | 97.76 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.72 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.69 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.61 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.56 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.5 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.32 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.17 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.13 | |
| KOG1035|consensus | 1351 | 97.09 | ||
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.05 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.82 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.79 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.72 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.59 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.59 | |
| KOG1236|consensus | 565 | 96.48 | ||
| KOG1093|consensus | 725 | 96.01 | ||
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.02 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.86 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.6 |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=320.81 Aligned_cols=235 Identities=38% Similarity=0.693 Sum_probs=213.6
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
+-.....++|.+.+.||.|+|++||+|.+..++..|+||.+.+........+.+..|+.+|+.++||||+.++++..+.+
T Consensus 3 ~~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 3 GGSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred CCcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 34567789999999999999999999999999999999999988777778888999999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec-C----CeEEEEeccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER-L----GVVKLTDFGF 165 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~-~----~~i~l~df~~ 165 (259)
.+++|||||+|++|..++...+. +++..++.++.||+.|+++||+++|+|+||||.|||+... . -.+||.|||+
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999999999998875 9999999999999999999999999999999999999764 2 2589999999
Q ss_pred cccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc-cccccc
Q psy3663 166 SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS-CTCWWR 244 (259)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~ 244 (259)
++.+..+....+.+|++.|||||++....|+. |+|+||+|+++|++++|++||...+..+.+..+.+..... ..+-+.
T Consensus 162 AR~L~~~~~a~tlcGSplYMAPEV~~~~~YdA-KADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 162 ARFLQPGSMAETLCGSPLYMAPEVIMSQQYDA-KADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred hhhCCchhHHHHhhCCccccCHHHHHhccccc-hhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 99999999999999999999999999999987 9999999999999999999999999999988888666544 333344
Q ss_pred cCc
Q psy3663 245 GRP 247 (259)
Q Consensus 245 ~~~ 247 (259)
-+|
T Consensus 241 s~~ 243 (429)
T KOG0595|consen 241 SNP 243 (429)
T ss_pred cCc
Confidence 444
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=304.97 Aligned_cols=232 Identities=34% Similarity=0.574 Sum_probs=211.4
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc-cHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV-SQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
..-.++|++.+.||+|+||.||.+....+++-||+|++++...... .......|..+|.+++||.|++++..|++....
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 4457899999999999999999999999999999999988655433 578888999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC-CC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NP 171 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~-~~ 171 (259)
|+|+||+.|+.|.-.+++.+. ++++.+..++.+|+.||.|||++||+||||||+|||++.+ |+++|+|||++... ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~-GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQ-GHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCC-CcEEEeccccchhcccC
Confidence 999999999999999987766 9999999999999999999999999999999999999777 89999999999754 44
Q ss_pred CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCch
Q psy3663 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPR 248 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (259)
+....+.+|+..|+|||++.+..++. ++|.||||+++|+|++|.+||...+.....+.|++.....++..|+...+
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~~-~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ar 254 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYDK-AVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEAR 254 (357)
T ss_pred CCccccccCCccccChHHHhcCCCCc-ccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHH
Confidence 45666779999999999999999886 99999999999999999999999999999999999997777777766555
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=307.42 Aligned_cols=240 Identities=32% Similarity=0.595 Sum_probs=211.1
Q ss_pred CCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-----ccHHHHHHHHHHHHhCCCCCeEEE
Q psy3663 8 SSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-----VSQDHLYQEVRCMKLVQHPNVVRL 82 (259)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~ 82 (259)
++...|..+.+.|.+.+.||+|+||.|-+|+...+++.||||++++..... .....+.+|+++|++++||||+++
T Consensus 162 ~~~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~ 241 (475)
T KOG0615|consen 162 SSKVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI 241 (475)
T ss_pred hccCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE
Confidence 455566779999999999999999999999999999999999998754322 234456799999999999999999
Q ss_pred EEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC--CeEEE
Q psy3663 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL--GVVKL 160 (259)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~--~~i~l 160 (259)
.++|+..+..|+||||+.|+.|-+.+..+.. +.++.-..+++||+.|+.|||+.||+|+||||+|||+..+. -.++|
T Consensus 242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 242 KDFFEVPDSSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred eeeeecCCceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEe
Confidence 9999999999999999999999999987766 88889999999999999999999999999999999997652 36999
Q ss_pred EeccccccCCCCCccccccCCCccCCcccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCChH-HHHHhhhcccc
Q psy3663 161 TDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDS--YDAPAVDVWSLGVILYMLVAGQAPFQEANDSE-TLTMIMDVSES 237 (259)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~i~~~~~~ 237 (259)
+|||++........+.+.+|++.|.|||++.+.. .+..+.|+|||||++|-+++|.+||.+....- ..++|.++...
T Consensus 321 tDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 321 TDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred cccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 9999999988888889999999999999997543 33338899999999999999999998866555 89999999999
Q ss_pred ccccccccCch
Q psy3663 238 SCTCWWRGRPR 248 (259)
Q Consensus 238 ~~~~~~~~~~~ 248 (259)
+-++.|+....
T Consensus 401 f~p~~w~~Ise 411 (475)
T KOG0615|consen 401 FGPLQWDRISE 411 (475)
T ss_pred ccChhhhhhhH
Confidence 98888876543
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=311.69 Aligned_cols=220 Identities=34% Similarity=0.583 Sum_probs=201.5
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.+|+..+.||+|+|+.+|.+.+..+|+.||+|++.+... .+...+.+.+|++|.+.|+|||||+++++|++.+++|++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 359999999999999999999999999999999987533 4556788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Ccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~ 175 (259)
|.|..++|-+++. ...+++|.+++.+++||+.++.|||+++|+|+|||..|+|++++ .++||+|||+|+.+... ...
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~-~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN-MNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc-CcEEecccceeeeecCccccc
Confidence 9999999999988 44559999999999999999999999999999999999999777 67999999999988744 666
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
.+.+|++-|.|||++....+.- .+||||+|||||.|++|++||.....++.+..|+..-..+|.
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHsf-EvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~ 239 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHSF-EVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS 239 (592)
T ss_pred ceecCCCcccChhHhccCCCCC-chhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc
Confidence 7789999999999999888885 899999999999999999999999999999999977776654
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=293.89 Aligned_cols=222 Identities=32% Similarity=0.582 Sum_probs=202.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++.|+....+|+|+||+||+|.++.+|+-||||.+.....++......++|+++|++++|+|++.++++|......++|+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 36799999999999999999999999999999999887767777788899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CCCcc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~~~~ 175 (259)
||++. ++.+-++..+.+.+...+..++.|+++|+.|+|+++++|+||||+||+++.+ +.++|||||+|+.+. .+..-
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~-gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN-GVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC-CcEEeccchhhHhhcCCcchh
Confidence 99987 7888888888889999999999999999999999999999999999999777 899999999999887 44444
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
.-.+.+-.|+|||.+.+...+.+..||||+||++.||++|.+.|.+.++-+++..|.+.+|...+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p 223 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP 223 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence 44567889999999998666666999999999999999999999999999999999998887654
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=293.90 Aligned_cols=217 Identities=30% Similarity=0.493 Sum_probs=194.4
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS- 90 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 90 (259)
+.+....+.+..+.||+|+.|+||+|.++.+++-+|+|++.. ...+....++.+|+++++.+++|||+.+++.|..+.
T Consensus 73 ~~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 73 DNGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred ccccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 445555688899999999999999999999999999999954 456777899999999999999999999999999988
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
...++||||++++|..++...+. +++..+..++.+++++|.|||+ .+|+||||||+|||++.+ |.|||||||.+..+
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNsk-GeVKicDFGVS~~l 229 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSK-GEVKICDFGVSGIL 229 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccC-CCEEeccccccHHh
Confidence 59999999999999999987654 9999999999999999999995 999999999999999887 89999999999876
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----CChHHHHHhhh
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA-----NDSETLTMIMD 233 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~~~~~~~~i~~ 233 (259)
-.. .....+|+..|||||++.+..++. ++||||||++++|+++|+-||... ..-+.+..|+.
T Consensus 230 vnS-~a~tfvGT~~YMsPERi~g~~Ys~-~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 230 VNS-IANTFVGTSAYMSPERISGESYSV-KSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD 296 (364)
T ss_pred hhh-hcccccccccccChhhhcCCcCCc-ccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc
Confidence 544 667788999999999999999886 999999999999999999999774 45566666665
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=281.53 Aligned_cols=225 Identities=28% Similarity=0.502 Sum_probs=206.9
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
.+|...+.+|+|.||+||+|.+..+|+.||||.+..............+|++.|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 57899999999999999999999999999999999877666667778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~ 177 (259)
|++. +|...+......++...+..++.+++++++|+|.+.|.|+||||+|++++++ |.+||.|||+++..........
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~-g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD-GQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC-CcEEeecccchhccCCCCcccc
Confidence 9977 9999999998889999999999999999999999999999999999999877 8999999999988765444333
Q ss_pred -ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 178 -SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 178 -~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
.+.+-.|+|||.+.++..+....|+||.||+++||+.|.+-|.+.++-+++..|.+.+|++.+.=|-
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 3677899999999988777779999999999999999999999999999999999999999877774
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=307.58 Aligned_cols=229 Identities=30% Similarity=0.494 Sum_probs=209.7
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCC-e
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNS-K 91 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~-~ 91 (259)
..+.++|++.+.||.|.||.||+|..+..++.||||.++....+ +..-.-.+|+..|++++ ||||+++.+++.+++ .
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 35678999999999999999999999999999999999876544 23333458999999999 999999999998887 9
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.++||||++. +|.+++..++..+++..+..|+.||+++|+++|++|++|+|+||+|||+..+ ..++|+|||+|+....
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~-~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGN-DVIKIADFGLAREVRS 162 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEeccc-ceeEeccccccccccc
Confidence 9999999976 9999999999999999999999999999999999999999999999999755 5799999999999988
Q ss_pred CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
..+....+.+-.|+|||++..+.+++.+.|+|++||+++|+.+-++.|.+.+.-|++.+|.+++|++...-|.+
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE 236 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence 88888889999999999998877777799999999999999999999999999999999999999997777765
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=303.54 Aligned_cols=227 Identities=29% Similarity=0.529 Sum_probs=208.4
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CeEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--SKLY 93 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 93 (259)
..+.|+-.+.||+|.||.||+|.+..+|+-||+|.+..+...+....-..+|+.||++|+||||+++.++..+. +.+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 34578889999999999999999999999999999998876677777788999999999999999999998765 7899
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+|+|||+. +|..++....-.+++.+|..++.||+.+|+|+|++||.|+|||.+|||++.+ |.++|.|||+|+.+....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~-G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNN-GVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCC-CCEEeccccceeeccCCC
Confidence 99999987 9999998888789999999999999999999999999999999999999666 899999999999665443
Q ss_pred --ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 174 --KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 174 --~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
.....+-+..|+|||.+.+...+..+.|+||.|||+.||++|++.|.+...-+++..|.+.-+++....|.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 45566788999999999998777789999999999999999999999999999999999999999999998
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=300.39 Aligned_cols=226 Identities=34% Similarity=0.589 Sum_probs=201.0
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCe
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (259)
-.-..+|.+++.||.|+|++|++|.+..+++.||||++.+... .+.....+..|-.+|.+| .||.|++++-.|.|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4455699999999999999999999999999999999987543 333456677899999999 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.|+|++|++++.|.+++...+. +++...+.++.+|+.||+|||++||||+||||+|||++.+ ++++|+|||.+..+..
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~d-mhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKD-GHIKITDFGSAKILSP 226 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCC-CcEEEeeccccccCCh
Confidence 9999999999999999998876 9999999999999999999999999999999999999777 8999999999877643
Q ss_pred CCcc--------------ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 172 GQKL--------------ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 172 ~~~~--------------~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
.... ...+|+..|.+||++....... ++|||+|||++|+|+.|.+||...+.--.+++|+++...
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~-~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~ 305 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGP-SSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE 305 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCc-ccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence 2222 2357899999999999888875 999999999999999999999999999999999988887
Q ss_pred ccccc
Q psy3663 238 SCTCW 242 (259)
Q Consensus 238 ~~~~~ 242 (259)
+++-+
T Consensus 306 fp~~f 310 (604)
T KOG0592|consen 306 FPEGF 310 (604)
T ss_pred CCCCC
Confidence 76543
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=296.23 Aligned_cols=228 Identities=43% Similarity=0.755 Sum_probs=204.6
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC---cccHHHHHHHHHHHHhCC-CCCeEEEEEEEec
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD---PVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDT 88 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~---~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 88 (259)
.....+.|.+++.||+|+||.|+.|.+..++..|++|++...... ......+.+|+.+++.++ ||||+++++++..
T Consensus 12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 567889999999999999999999999999999999987664222 234567778999999999 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
...+++||||+.|+.|.+++.+ ...+.+.+...+++||+.|++|+|++||+|+||||+||+++.+.+.++|+|||++..
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999999998 555999999999999999999999999999999999999977757899999999998
Q ss_pred C-CCCCccccccCCCccCCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccc
Q psy3663 169 F-NPGQKLETSCGSLAYSAPEILLGDS-YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTC 241 (259)
Q Consensus 169 ~-~~~~~~~~~~~~~~~~apE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (259)
. .........+|++.|+|||++.+.. +...++|+||+|+++|-|++|+.||.+.+....+..|.++....+..
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~ 245 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY 245 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC
Confidence 7 4666778889999999999999977 88789999999999999999999999999999999977776655543
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=277.23 Aligned_cols=227 Identities=37% Similarity=0.633 Sum_probs=204.5
Q ss_pred CCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEe
Q psy3663 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVID 87 (259)
Q Consensus 9 ~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (259)
+.+.+ .-.++|++.+.||.|+||.|.++..+.+|..||+|++.+...- -...+...+|..+|+.+.||.++++++.+.
T Consensus 36 ~~~~~-~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~ 114 (355)
T KOG0616|consen 36 TPQNP-YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK 114 (355)
T ss_pred CCCCC-cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec
Confidence 33444 5678999999999999999999999999999999999875432 223456678999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
+++..++||||+.|+.|-.++.+.+. +++...+.++.||+.||+|||+++|+++||||+||+++++ |.++|+|||++.
T Consensus 115 d~~~lymvmeyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~-G~iKitDFGFAK 192 (355)
T KOG0616|consen 115 DNSNLYMVMEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN-GHIKITDFGFAK 192 (355)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC-CcEEEEeccceE
Confidence 99999999999999999999988766 9999999999999999999999999999999999999777 999999999998
Q ss_pred cCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccc
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTC 241 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (259)
..... ..+.+|++.|+|||++.+..+.. ++|.||||+++|||+.|.+||...+.-.++++|+++.-.+|.-
T Consensus 193 ~v~~r--T~TlCGTPeYLAPEii~sk~ynk-avDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~ 263 (355)
T KOG0616|consen 193 RVSGR--TWTLCGTPEYLAPEIIQSKGYNK-AVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY 263 (355)
T ss_pred EecCc--EEEecCCccccChHHhhcCCCCc-chhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc
Confidence 87654 67788999999999999999986 9999999999999999999999999999999999887776653
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=284.19 Aligned_cols=229 Identities=25% Similarity=0.431 Sum_probs=205.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCeEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT--NSKLYL 94 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 94 (259)
.+.|+.+..|++|.||.||+|.|+.+++-||+|.++.+......----.+|+++|.+++||||+.+-.+... -+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 458999999999999999999999999999999998876433333445689999999999999999999764 367999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-C
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-Q 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~ 173 (259)
||||+.. +|..++..-+.++...++..++.|++.++.|||.+.|+|+||||+|+|++.+ |.++|+|||+|+.+... .
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~-G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHK-GILKIADFGLAREYGSPLK 232 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccC-CcEEecccchhhhhcCCcc
Confidence 9999987 9999999988889999999999999999999999999999999999999766 89999999999988655 3
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRP 247 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (259)
+....+-+..|+|||.+.+...++++.|+||+||++.||+++++.|.+.+.-+++.+|.+.++++...-|-|=-
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 34556778999999999988777779999999999999999999999999999999999999999999997643
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=294.81 Aligned_cols=229 Identities=83% Similarity=1.309 Sum_probs=220.7
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
+-+.+.|-|++.+.||+|.|++|-+|.+..+|+.|+||++.+...+......+.+|++-++.+.||||+++|++..++..
T Consensus 12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 56789999999999999999999999999999999999999998888889999999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.|+|.|.-++++|.+++.+...++.++...+++.||+.|+.|+|+..+||+||||+|+.+....|-++|.|||++..+..
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999999999999888999999999999999999999999999999999999989889999999999999999
Q ss_pred CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
+....+.+|+..|.|||++.+..|+.++.||||||+++|.|.+|++||...++.+.+..|++...+-|.
T Consensus 172 G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs 240 (864)
T KOG4717|consen 172 GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS 240 (864)
T ss_pred cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch
Confidence 999999999999999999999999999999999999999999999999999999999999998887653
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=299.04 Aligned_cols=231 Identities=33% Similarity=0.490 Sum_probs=205.2
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-C-----CCeEEEEEEE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-H-----PNVVRLYEVI 86 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~ 86 (259)
-..+..+|.+.+.||+|.||.|.+|+|..+++.||||++++.. ....+...|+.+|+.++ | -|+++++++|
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 3456679999999999999999999999999999999998753 35677888999999998 3 4799999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec-CCeEEEEecc
Q psy3663 87 DTNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER-LGVVKLTDFG 164 (259)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~-~~~i~l~df~ 164 (259)
...++.++|+|.+.. +|.+++.++ -.+++...++.++.||+.||.+||++|||||||||+|||+.+- ...|||+|||
T Consensus 258 ~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 258 YFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 999999999999965 999999876 3459999999999999999999999999999999999998543 3479999999
Q ss_pred ccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 165 FSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
+++...... ....-+-.|+|||++.+.+++. +.|+||||||++||++|.+.|.+.+..+++..|++.+|.++...++
T Consensus 337 SSc~~~q~v--ytYiQSRfYRAPEVILGlpY~~-~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 337 SSCFESQRV--YTYIQSRFYRAPEVILGLPYDT-AIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred cccccCCcc--eeeeeccccccchhhccCCCCC-ccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 998765433 3666778999999999999997 9999999999999999999999999999999999999988888888
Q ss_pred cCchhh
Q psy3663 245 GRPRSR 250 (259)
Q Consensus 245 ~~~~~~ 250 (259)
.-.+..
T Consensus 414 ~~~~~~ 419 (586)
T KOG0667|consen 414 TAKKAH 419 (586)
T ss_pred hccccc
Confidence 777653
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=283.10 Aligned_cols=221 Identities=28% Similarity=0.430 Sum_probs=195.5
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS----- 90 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 90 (259)
..=.|.-.+.+|.|+||.||.|+...+++.+|||..-.+.. .-.+|+++++.++||||+++..+|..+.
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 44478899999999999999999999999999998755432 1227999999999999999999885321
Q ss_pred eEEEEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
...+||||++. +|.+++... +..++.-.+.-+..||++||.|||+.||+|+||||.|+||+.++|.+||||||+|.
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 34589999976 999998753 55689999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
.+-.+.+.....-+-.|+|||.+.+...++.+.||||.|||++||+-|++.|.+.+..+++..|++.+|+++.+-.
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9888888877777889999999999877777999999999999999999999999999999999999999976543
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=281.57 Aligned_cols=220 Identities=31% Similarity=0.540 Sum_probs=195.1
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEE-E-ecCCeEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV-I-DTNSKLYL 94 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~-~~~~~~~l 94 (259)
..+|++.+.||.|.||.||+|++..+|+.++.|.++-...+....+.+..|+.+|++|+||||++++++ + +++.-.++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 457999999999999999999999999999999998777777788899999999999999999999984 4 34444899
Q ss_pred EEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH--CC--cEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 95 ILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHK--LH--VVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~--~~--i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
+||++.+++|.+.+... ...+++..+|.++.||+.||..+|+ .. +.|+||||.||+++.+ |.++|+|||++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~-gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN-GVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC-CceeeccchhHh
Confidence 99999999999998654 4459999999999999999999998 44 9999999999999766 899999999998
Q ss_pred cCCCCCcc-ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc
Q psy3663 168 RFNPGQKL-ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 168 ~~~~~~~~-~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
.+...... ...+|++.||+||++.+..++. ++||||+||++|||+.-++||.+.+--+..++|..+-.++
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~-kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~ 247 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNF-KSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP 247 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCc-chhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC
Confidence 87665443 4568999999999999999986 9999999999999999999999998888888888875543
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=286.44 Aligned_cols=232 Identities=26% Similarity=0.470 Sum_probs=196.4
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCce-EEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-eEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEK-VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS-KLYL 94 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~-~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~l 94 (259)
.....+...||.|+||.||.+. ..|.. |++|.+.....+......+.+|+.++.+++||||+++++++.++. .+.+
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~--~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGK--WRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEE--eCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 3455666779999999999998 55666 999999887666555789999999999999999999999998877 7999
Q ss_pred EEeccCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 95 ILELGDGGDLYDYIMK-HDAGLSETYAREYFAQIVRAISFCHKLH-VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~-~~~~~~~~~i~~~~~ql~~al~~LH~~~-i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
||||+.+++|.+++.. ....++...++.++.||+.++.|||+.+ |||+||||+|||++.+.-++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999999988 3667999999999999999999999999 9999999999999777338999999999776543
Q ss_pred -CccccccCCCccCCccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh-hcccccccc-------
Q psy3663 173 -QKLETSCGSLAYSAPEILL--GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM-DVSESSCTC------- 241 (259)
Q Consensus 173 -~~~~~~~~~~~~~apE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~-~~~~~~~~~------- 241 (259)
.......|+..|+|||++. ...++. ++||||||++++||+||+.||.+.........+. ...++..+.
T Consensus 198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~-K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 198 KTSMTSVAGTYRWMAPEVLRGEKSPYTE-KSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred cccccCCCCCccccChhhhcCCCCcCCc-cchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 3334467899999999999 456665 9999999999999999999999998866666665 444444344
Q ss_pred -----ccccCchhhh
Q psy3663 242 -----WWRGRPRSRR 251 (259)
Q Consensus 242 -----~~~~~~~~~~ 251 (259)
||+.+|.+|+
T Consensus 277 ~l~~~CW~~dp~~RP 291 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRP 291 (362)
T ss_pred HHHHHhCCCCCCcCC
Confidence 8999988653
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=275.25 Aligned_cols=234 Identities=32% Similarity=0.509 Sum_probs=206.7
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC-eEEEEEEEecCC-----
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN-VVRLYEVIDTNS----- 90 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~----- 90 (259)
...|+.++.||+|.||+||+|.+..+|+.||+|.+..+...+..-....+|+.+++.++|+| |+.+++++.+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 56688888999999999999999999999999999877644445566779999999999999 999999997766
Q ss_pred -eEEEEEeccCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 91 -KLYLILELGDGGDLYDYIMKHD---AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 91 -~~~lv~e~~~~~sL~~~~~~~~---~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
..++++|+.+. +|..++...+ ..++...+..+++||+.||+|||+++|+|+||||.||+++++ |.++|+|||++
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~-G~lKlaDFGlA 167 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSS-GVLKLADFGLA 167 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCC-CcEeeeccchH
Confidence 88999999976 9999998876 458889999999999999999999999999999999999886 89999999999
Q ss_pred ccCCCCCc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 167 NRFNPGQK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 167 ~~~~~~~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
+...-... ....+.+..|+|||++.+...+....||||+||+++||+++++.|.+.++.+++..|.+.++++.+.-|-+
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 87653332 45567788899999999986666699999999999999999999999999999999999999999999988
Q ss_pred Cchhhhh
Q psy3663 246 RPRSRRR 252 (259)
Q Consensus 246 ~~~~~~~ 252 (259)
...-..+
T Consensus 248 v~~~~~~ 254 (323)
T KOG0594|consen 248 VSSLPDY 254 (323)
T ss_pred ccccccc
Confidence 7654433
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=285.04 Aligned_cols=219 Identities=36% Similarity=0.628 Sum_probs=192.9
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-.++|++.+.||+|+||.||+|..+.+|+-+|+|++++..- .......++.|-.+|...+.|+||+++-.|.+..+.|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 35799999999999999999999999999999999987642 34456778889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC--
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-- 172 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-- 172 (259)
||||++||++..++...+. ++++....++.+++.|++.||+.|++|+||||+|+|++.. |+++|+|||++..+...
T Consensus 219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~-GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAK-GHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCC-CCEeeccccccchhhhhhh
Confidence 9999999999999987765 9999999999999999999999999999999999999766 99999999988443210
Q ss_pred ----------------------C----ccc--------------------cccCCCccCCcccccCCCCCCCchhHHHHH
Q psy3663 173 ----------------------Q----KLE--------------------TSCGSLAYSAPEILLGDSYDAPAVDVWSLG 206 (259)
Q Consensus 173 ----------------------~----~~~--------------------~~~~~~~~~apE~~~~~~~~~~~~Di~slG 206 (259)
. ... ..+|++.|+|||++.+..+.- .+|.||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~-~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK-ECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc-cccHHHHH
Confidence 0 000 113789999999999999875 99999999
Q ss_pred HHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 207 VILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 207 ~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
||||||+.|.+||...+..+.+..|+.-..+
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~ 406 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRET 406 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh
Confidence 9999999999999999999999999966543
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=292.47 Aligned_cols=224 Identities=41% Similarity=0.730 Sum_probs=209.6
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccC-CCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKT-KLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.-.|-|++++.||.|+.|.|-+|.+..+|+..|||++.+. ..+......+.+|+.+++.+.||||+.++++|+++..+|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 3467899999999999999999999999999999999876 555566778899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++.||++||-|-+++...+. +++.+..+++.||+.++.|+|..+|+|+||||+|++++.++ +++|.|||+|..--.+.
T Consensus 89 lvlEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-NIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-CEeeeccceeecccCCc
Confidence 99999999999999988776 99999999999999999999999999999999999998884 59999999998877788
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
-..+.+|+++|.+||++.+.+|+.-++||||.|+++|.|++|++||.+.+-...+.++.++.+.+|.
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs 233 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS 233 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC
Confidence 8899999999999999999999999999999999999999999999999999999999999998883
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=275.86 Aligned_cols=231 Identities=28% Similarity=0.480 Sum_probs=203.9
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec----
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT---- 88 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 88 (259)
..++...|...+.||.|++|.|+.|.+..+|+.||||.+...-..........+|+++|+.++|+||+.+.+++..
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3456677887899999999999999999999999999998766667778889999999999999999999999854
Q ss_pred -CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 89 -NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 89 -~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
-...|+|+|++.. +|.+.+...+. ++++.+..++.||+.+|.|+|+.+++|+||||+|++++.+ ..++|+|||+|+
T Consensus 97 ~f~DvYiV~elMet-DL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~-c~lKI~DFGLAR 173 (359)
T KOG0660|consen 97 KFNDVYLVFELMET-DLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNAD-CDLKICDFGLAR 173 (359)
T ss_pred ccceeEEehhHHhh-HHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccC-CCEEecccccee
Confidence 3568999999954 88888876554 9999999999999999999999999999999999999888 679999999998
Q ss_pred cCCC---CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 168 RFNP---GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 168 ~~~~---~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
.... ...+...+.+..|+|||++.....++.+.||||+||+++||++|++.|.+.+.-++++.|++.++++..+.+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 8764 3444556678899999999877777779999999999999999999999999999999999999999877665
Q ss_pred cC
Q psy3663 245 GR 246 (259)
Q Consensus 245 ~~ 246 (259)
.-
T Consensus 254 ~i 255 (359)
T KOG0660|consen 254 KI 255 (359)
T ss_pred Hh
Confidence 43
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=274.92 Aligned_cols=229 Identities=30% Similarity=0.498 Sum_probs=197.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||.|++|.||+|.+..++..|++|.+..... ......+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 3579999999999999999999999999999999875432 223456778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-cc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~ 175 (259)
|++.+ +|.+++......+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++....... ..
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK-GELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEECcCcceeeccCCCccc
Confidence 99986 9999888776668999999999999999999999999999999999999766 789999999886543222 22
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCch
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPR 248 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (259)
....++..|+|||.+.+....+.++|+||+|+++|+|++|++||...+..+.+..+.+..++++..+|.+...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 3345678999999987654444599999999999999999999999999999999999999998888877554
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=290.46 Aligned_cols=216 Identities=32% Similarity=0.568 Sum_probs=198.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
+++|-+.+.||+|+||.||++..+.+.+.|++|.+.+....+.....+.+|++|++.++||||+.++++|++....++|.
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 36888999999999999999999999999999999998888888899999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
||+.| +|..++++.+. ++++.+..+..++..||.|||+++|.|+|+||.||++... +.+++||||+++.+..+...-
T Consensus 81 e~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~-~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG-GTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC-CceeechhhhhhhcccCceee
Confidence 99988 99999987665 9999999999999999999999999999999999999666 899999999999887765543
Q ss_pred -cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 177 -TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 177 -~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
...|++.|+|||...+..++. .+|+|||||++||+++|++||...+.....+.|++..-
T Consensus 158 tsikGtPlYmAPElv~e~pyd~-~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v 217 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDH-TSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV 217 (808)
T ss_pred eeccCcccccCHHHHcCCCccc-hhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC
Confidence 346899999999999999987 99999999999999999999999888888888875443
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=279.25 Aligned_cols=223 Identities=40% Similarity=0.732 Sum_probs=207.8
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.+.-+|++.+.||.|.||.|-+|++...|..|+||.+.+... ++.+.-.+++|++|+..|+||||+.++++|+..+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 345589999999999999999999999999999999988765 4445677899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+||||..++.|.+++.+++. +++.+...+++||..|+.|+|+++++|+|||.+|||++++ +.++|.|||++..+....
T Consensus 130 ivMEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N-~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN-NNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC-CCeeeeccchhhhhcccc
Confidence 99999999999999988776 9999999999999999999999999999999999999777 779999999999998888
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
...+.+|++.|.+||+..+.++..+..|.||||+++|.|.-|..||.+.+...+..+|..+....|
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP 273 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP 273 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC
Confidence 889999999999999999999999999999999999999999999999999999999998766544
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=282.00 Aligned_cols=221 Identities=31% Similarity=0.548 Sum_probs=190.4
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN 89 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (259)
+...--.++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++||||+++++.+.+.
T Consensus 11 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 11 DTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred ccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 3444456899999999999999999999999999999999875432 223356688999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
+..+++|||+.+++|.+++.... .+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++...
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK-GHVKVTDFGFAKKV 168 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCC-CCEEEeeccCceEc
Confidence 99999999999999999987654 48999999999999999999999999999999999999766 78999999998765
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
... .....++..|+|||.+.+..++. ++|+|||||++|+|++|+.||.+.+..+..+.+.+...
T Consensus 169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 232 (329)
T PTZ00263 169 PDR--TFTLCGTPEYLAPEVIQSKGHGK-AVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL 232 (329)
T ss_pred CCC--cceecCChhhcCHHHHcCCCCCC-cceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc
Confidence 432 23346788999999998877765 99999999999999999999998887777777766543
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=281.14 Aligned_cols=216 Identities=32% Similarity=0.568 Sum_probs=186.1
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|..++..++|++|+++++.+.+...++++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 479999999999999999999999999999999975432 2233466788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-- 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-- 174 (259)
||+++++|.+++.... .+++..+..++.|++.||.+||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~-~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK-GHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CCEEEeeccCccccccccccc
Confidence 9999999999987654 48999999999999999999999999999999999999766 7899999998865422110
Q ss_pred ----------------------------------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 175 ----------------------------------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 175 ----------------------------------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
.....++..|+|||.+.+..++. ++|+|||||++|+|++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~-~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK-LCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC-chhhhhhHHHHHHHHhCCCCCC
Confidence 11235788999999998887775 9999999999999999999999
Q ss_pred CCCChHHHHHhhhccc
Q psy3663 221 EANDSETLTMIMDVSE 236 (259)
Q Consensus 221 ~~~~~~~~~~i~~~~~ 236 (259)
..+..+.+..+.....
T Consensus 238 ~~~~~~~~~~i~~~~~ 253 (363)
T cd05628 238 SETPQETYKKVMNWKE 253 (363)
T ss_pred CCCHHHHHHHHHcCcC
Confidence 8888888888876443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=275.38 Aligned_cols=233 Identities=35% Similarity=0.591 Sum_probs=196.6
Q ss_pred CCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC------------CcccHHHHHHHHHHHHhC
Q psy3663 7 RSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL------------DPVSQDHLYQEVRCMKLV 74 (259)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~------------~~~~~~~~~~e~~~l~~l 74 (259)
++...+.-...++|++.+.||+|.||.|-+|++..+++.||||++.+... .....+++.+|+.++++|
T Consensus 86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 34555666778899999999999999999999999999999999986432 111235789999999999
Q ss_pred CCCCeEEEEEEEecC--CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee
Q psy3663 75 QHPNVVRLYEVIDTN--SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF 152 (259)
Q Consensus 75 ~~~~i~~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~ 152 (259)
.|||||+++++..+. +.+|+|+||+..+.+...-..... +++.+.+.++++++.+|+|||..||+|+||||+|+|+.
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~e-ls~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPE-LSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS 244 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCccc-ccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc
Confidence 999999999998764 689999999998777664332222 89999999999999999999999999999999999998
Q ss_pred ecCCeEEEEeccccccCC------CCCccccccCCCccCCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 153 ERLGVVKLTDFGFSNRFN------PGQKLETSCGSLAYSAPEILLG---DSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 153 ~~~~~i~l~df~~~~~~~------~~~~~~~~~~~~~~~apE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
++ |++||+|||.+.... .........|++.|+|||.+.+ ..+...+.||||+|+++|.|+.|++||-+..
T Consensus 245 ~~-g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 245 SD-GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred CC-CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 87 999999999988662 2233345679999999999877 4555669999999999999999999999999
Q ss_pred ChHHHHHhhhcccccccc
Q psy3663 224 DSETLTMIMDVSESSCTC 241 (259)
Q Consensus 224 ~~~~~~~i~~~~~~~~~~ 241 (259)
..+.+.+|+...-.++..
T Consensus 324 ~~~l~~KIvn~pL~fP~~ 341 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPEN 341 (576)
T ss_pred HHHHHHHHhcCcccCCCc
Confidence 999999999776665543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=272.56 Aligned_cols=214 Identities=31% Similarity=0.555 Sum_probs=185.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++||||+++++++.+....+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 479999999999999999999999999999999875432 1223556788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
||+.+++|.+++.... .+++..+..++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~-~~~kl~Dfg~~~~~~~~--~~ 156 (291)
T cd05612 81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKKLRDR--TW 156 (291)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEEecCcchhccCC--cc
Confidence 9999999999987655 48999999999999999999999999999999999999766 78999999998765432 23
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
...++..|+|||.+.+..++. ++||||||+++|+|++|+.||...+..+..+.+.....
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 215 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNK-AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL 215 (291)
T ss_pred cccCChhhcCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Confidence 345788999999998877765 99999999999999999999998887777777765543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=268.88 Aligned_cols=226 Identities=30% Similarity=0.500 Sum_probs=187.1
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||.|++|.||+|.+..+++.|++|++..... ......+.+|+.+++.++||||+++++++.+....+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 4689999999999999999999999999999999875432 223445678999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Ccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~ 175 (259)
||+.+ +|.+++......+++..+..++.||+.||.+||+.||+|+||||+||+++.+ +.++|+|||++...... ...
T Consensus 83 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 83 EYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDT-GELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred ECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECCCCcceeccCCCccC
Confidence 99965 8888887776669999999999999999999999999999999999999766 78999999988654322 122
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-ChHHHHHhhhcccccccccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN-DSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
....++..|+|||.+.+....+.++|+|||||++|+|++|..||.+.. ..+.++.+....+.+....|.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 334567889999998765544459999999999999999999998754 4566777766666655555543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=261.65 Aligned_cols=235 Identities=36% Similarity=0.610 Sum_probs=214.7
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
-..+.+.|++.+.||+|.|+.|+++.+..+|..+++|++.....+....+.+.+|+.|.+.|+||||+++.+.+...+..
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 35678899999999999999999999999999999999988887777899999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC--eEEEEeccccccCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG--VVKLTDFGFSNRFN 170 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~--~i~l~df~~~~~~~ 170 (259)
|+|+|++.|+.|..-+-.+- -.++...-..++||++||.|+|.+||+|+|++|+|+++-++.. -++|+|||.+..++
T Consensus 86 ylvFe~m~G~dl~~eIV~R~-~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEEecccchHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999999998877665543 2788999999999999999999999999999999999966533 59999999999988
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCchh
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRS 249 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (259)
.+.......++++|+|||++...++.. .+|||+-|+++|-|+.|.+||.+.+..+.+++|+++..-++.+.|++-..+
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~k-pvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCC-cchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 777777789999999999999999987 899999999999999999999999999999999999999999899886554
|
|
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=271.06 Aligned_cols=234 Identities=39% Similarity=0.672 Sum_probs=214.4
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHHHHHHHHHhCC-CCCeEEEEEEEecC
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTN 89 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 89 (259)
....+...|++.+.||.|.||.||.|.+..+|+.+++|.+.+..... .....+.+|+++++.+. ||||+.+.+.|++.
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 45677889999999999999999999999999999999998765432 24678999999999999 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC---CeEEEEecccc
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL---GVVKLTDFGFS 166 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~---~~i~l~df~~~ 166 (259)
..+++|||++.|+.|.+.+... . +++.....++.|++.++.+||+.|++|+||+|+|+++.... +.++++|||++
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999999999999999877 3 89999999999999999999999999999999999997653 37999999999
Q ss_pred ccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 167 NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
............++++.|+|||++....+.. .+|+||+|+++|.|++|.+||...+....+..+.++...+..++|+.-
T Consensus 187 ~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~-~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 187 KFIKPGERLHTIVGTPEYVAPEVLGGRPYGD-EVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred eEccCCceEeeecCCccccCchhhcCCCCCc-ccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence 9887766778889999999999999888886 999999999999999999999999999999999999999999999986
Q ss_pred ch
Q psy3663 247 PR 248 (259)
Q Consensus 247 ~~ 248 (259)
..
T Consensus 266 s~ 267 (382)
T KOG0032|consen 266 SE 267 (382)
T ss_pred CH
Confidence 44
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=274.23 Aligned_cols=212 Identities=34% Similarity=0.512 Sum_probs=185.1
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||+|.+..+++.|++|++...... ......+.+|+.++..++||||+++++.+.+.+..+++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 5799999999999999999999989999999999764322 223566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
||+.+++|.+++.... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..... ...
T Consensus 81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS-GHIKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEEEeCcCCccccc--ccC
Confidence 9999999999987654 48999999999999999999999999999999999999766 7899999998875543 233
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
...++..|+|||.+.+..++. ++|+|||||++|+|++|..||...+..+.+..+...
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~-~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 213 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDF-TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213 (333)
T ss_pred CcccCccccChhHhcCCCCCC-ccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc
Confidence 456788999999998887775 999999999999999999999988887777766643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=277.84 Aligned_cols=216 Identities=34% Similarity=0.595 Sum_probs=184.8
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||.|++|.||+|.+..+++.|+||++..... .......+.+|+.+++.++|+||+++++.+.+++.++++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 479999999999999999999999999999999975432 2233456778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-- 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-- 174 (259)
||+.+++|.+++.... .+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..+.....
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK-GHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEeecccceecccccccc
Confidence 9999999999987655 48999999999999999999999999999999999999766 7899999998865422110
Q ss_pred -------------------------------------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q psy3663 175 -------------------------------------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQA 217 (259)
Q Consensus 175 -------------------------------------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 217 (259)
.....++..|+|||++.+..++. ++|+|||||++|+|++|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNK-ECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCC-eeeeecchhHHHHhhcCCC
Confidence 01234788999999998877775 9999999999999999999
Q ss_pred CCCCCCChHHHHHhhhccc
Q psy3663 218 PFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 218 pf~~~~~~~~~~~i~~~~~ 236 (259)
||...+..+....+.+...
T Consensus 238 Pf~~~~~~~~~~~i~~~~~ 256 (364)
T cd05599 238 PFCSDNPQETYRKIINWKE 256 (364)
T ss_pred CCCCCCHHHHHHHHHcCCC
Confidence 9998887777777765443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=273.30 Aligned_cols=224 Identities=26% Similarity=0.438 Sum_probs=190.9
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
.+.++|++.+.||+|++|.||+|.+..++..|++|.+............+.+|+.+++.++||||+++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 577899999999999999999999999999999999976544444566778999999999999999999998644
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
...+++|||+.+ +|.+.+. ..+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~-~~~kl~Dfg~a~~ 172 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 172 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEecCCCccc
Confidence 357999999976 6666553 237899999999999999999999999999999999999776 7899999999876
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
...........++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+..+.+..+.+..+++...+++
T Consensus 173 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 173 ACTNFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccCccCCCCcccCCCCCchhccCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 54444444456788999999998887775 9999999999999999999999988888888888877776655443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=275.34 Aligned_cols=225 Identities=24% Similarity=0.443 Sum_probs=194.2
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
.+.++|++.+.||+|++|.||.|.+...++.|+||.+............+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 567899999999999999999999999999999999976554445566778899999999999999999987543
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
..++++|||+.+ +|.+.+.. .++...+..++.|++.||.+||++||+|+||+|+||++..+ +.++|+|||++..
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~ 175 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 175 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCC-CcEEEEeCCCccc
Confidence 357999999976 77776643 37889999999999999999999999999999999999766 7899999999976
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
...........++..|+|||.+.+..++. ++|+|||||++|+|++|+.||...+..+.+..+++..++++++++..
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cCCCCcccCCcccCCcCCHHHHhCCCCCc-hhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 65444444556788999999998877775 99999999999999999999999999999999998888877666554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=279.61 Aligned_cols=217 Identities=31% Similarity=0.520 Sum_probs=183.3
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++|+||+++++.+.+++.++++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999865422 2223566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC----
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG---- 172 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~---- 172 (259)
||+.+++|.+++...+ .+++..+..++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC-CCEEEEeCCCCcccccccccc
Confidence 9999999999987655 38899999999999999999999999999999999999766 78999999987422100
Q ss_pred ----------------------------------------CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHH
Q psy3663 173 ----------------------------------------QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYML 212 (259)
Q Consensus 173 ----------------------------------------~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l 212 (259)
.......++..|+|||++.+..++. ++|+|||||++|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvilyel 237 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ-LCDWWSVGVILYEM 237 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCc-ceeeeeccceeeeh
Confidence 0001235788999999998887775 99999999999999
Q ss_pred HhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 213 VAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 213 ~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
++|+.||...+..+....+......
T Consensus 238 l~G~~Pf~~~~~~~~~~~i~~~~~~ 262 (376)
T cd05598 238 LVGQPPFLADTPAETQLKVINWETT 262 (376)
T ss_pred hhCCCCCCCCCHHHHHHHHhccCcc
Confidence 9999999988877776666654433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=281.15 Aligned_cols=213 Identities=36% Similarity=0.596 Sum_probs=193.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 94 (259)
.++|++.+.||+|+||+|++|..+.+++.||||++++... .....+..+.|.+|+...+ ||-++.++..|.+..+.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 4689999999999999999999999999999999998754 5556788899999999887 9999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CCC
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~~ 173 (259)
||||+.|+++..+. +...+++.++..++..++.||.|||++||+++|||.+|||++.+ |.++|+|||++.... .+.
T Consensus 447 vmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~e-Gh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTE-GHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred EEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEccc-CcEEecccccccccCCCCC
Confidence 99999999844332 23449999999999999999999999999999999999999777 999999999997754 566
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
.+.+.+|++.|+|||++.+..|+. ++|.||||++|||||.|+.||.+.+.++.++.|+.
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~-aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~ 582 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTR-AVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN 582 (694)
T ss_pred ccccccCChhhcChhhhccCcccc-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 778889999999999999999987 99999999999999999999999999999999983
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=264.29 Aligned_cols=205 Identities=28% Similarity=0.511 Sum_probs=177.4
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
.|++.+.||+|++|.||+|.+..+++.|++|.+....... .....+.+|+.+++.++|++|+++.+.+.+++..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3889999999999999999999999999999987543222 223456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 98 LGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
|+.+++|...+... ...+++..+..++.|++.||.+||++||+|+||+|+||+++++ +.++|+|||++..........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR-GHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeCCCcEEcCCCCeec
Confidence 99999998887653 3458999999999999999999999999999999999999766 789999999987765444444
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
...++..|+|||.+.+..++. ++|+|||||++|+|++|+.||......
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~-~~DvwslGvil~el~~g~~pf~~~~~~ 207 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTF-SPDWWGLGCLIYEMIQGQSPFRKRKER 207 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCc-ccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence 456789999999998887775 999999999999999999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=278.86 Aligned_cols=215 Identities=34% Similarity=0.559 Sum_probs=182.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||.|++|.||+|.+..+++.|++|++..... .......+.+|+++++.++||||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 479999999999999999999999999999999865421 2233566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-- 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-- 174 (259)
||+.+++|.+++.... .+++..+..++.|++.||.+||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~-~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG-GHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEEeecccccccccccccc
Confidence 9999999999987654 48999999999999999999999999999999999999766 7899999998853211000
Q ss_pred ----------------------------------------------cccccCCCccCCcccccCCCCCCCchhHHHHHHH
Q psy3663 175 ----------------------------------------------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVI 208 (259)
Q Consensus 175 ----------------------------------------------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~ 208 (259)
.....++..|+|||.+.+..++. ++|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ-ECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC-ceeeEecchh
Confidence 00135788999999998877765 9999999999
Q ss_pred HHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 209 LYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 209 l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
+|+|++|.+||......+.+..+....
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~ 264 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWR 264 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccC
Confidence 999999999998887777777776543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=270.83 Aligned_cols=225 Identities=31% Similarity=0.533 Sum_probs=187.1
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGG 102 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (259)
+.||+|++|.||+|.+..++..|++|++..... .......+.+|+.+++.++||||+++++.+...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 468999999999999999999999999876422 2234556778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCccccccCC
Q psy3663 103 DLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLETSCGS 181 (259)
Q Consensus 103 sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~~~~~~~~ 181 (259)
+|..++.... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCC-CCEEecccHHhccccCCCCccccccCC
Confidence 9988886654 48999999999999999999999999999999999999766 7899999998765322 2222344678
Q ss_pred CccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc-----------ccccccCchhh
Q psy3663 182 LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC-----------TCWWRGRPRSR 250 (259)
Q Consensus 182 ~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------~~~~~~~~~~~ 250 (259)
..|+|||.+.+..++. ++|+|||||++|+|++|+.||...+..+....+.......+ ..+|..+|..|
T Consensus 159 ~~y~aPE~~~~~~~~~-~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCCc-hhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 8999999998877765 99999999999999999999998888777777664433322 24666777766
Q ss_pred h
Q psy3663 251 R 251 (259)
Q Consensus 251 ~ 251 (259)
.
T Consensus 238 ~ 238 (323)
T cd05595 238 L 238 (323)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=277.22 Aligned_cols=228 Identities=29% Similarity=0.473 Sum_probs=209.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe-EEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK-LYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv 95 (259)
.+.|.+++.+|.|+||.++++.++.+++.+++|.+..............+|+.++.++.||||+.+.+.|..++. .+++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 578999999999999999999999999999999999988777778888999999999999999999999998887 9999
Q ss_pred EeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-
Q psy3663 96 LELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ- 173 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~- 173 (259)
|+|++|+++.+.+.... .-++++.+..|+.||+.|+.|||+++|.|+|||+.|||++.+ +.|+|.|||++..+....
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~-~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKD-KKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcccc-CceeecchhhhhhcCCchh
Confidence 99999999999998765 669999999999999999999999999999999999999888 678999999999988776
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
......|++.|++||.+.+.++.. ++|||||||++|||++-+++|...+-.....+|......+.+.=|...
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~-KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~e 233 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNE-KSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSE 233 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCc-cCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHH
Confidence 667788999999999999999996 999999999999999999999999999999999988866655544443
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=268.12 Aligned_cols=204 Identities=30% Similarity=0.535 Sum_probs=176.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--eEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS--KLYL 94 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~l 94 (259)
...+...+.||+|+||.||++.+..+|+..++|......... .+.+.+|+.+|.+++||+||++++...... .+.+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 456889999999999999999999889999999987763222 677899999999999999999999744433 6999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC---
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP--- 171 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~--- 171 (259)
.|||+.+++|.+++...+.++++..+..+.+||+++|.|||++||+||||||+|||++...+.++|+|||++.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999999988757999999999999999999999999999999999999988447899999999877653
Q ss_pred -CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 172 -GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 172 -~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
........+++.|+|||++........++|||||||++.||+||+.||...
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 122334578999999999986333334899999999999999999999973
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=272.53 Aligned_cols=219 Identities=32% Similarity=0.545 Sum_probs=186.9
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecC-ceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTG-EKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~-~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
...-.++|++.+.||.|++|.||+|.+...+ ..|++|.+..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3344568999999999999999999876554 6899999865432 2234566788999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
..+++|||+.+++|.+++.... .+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVD 182 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEecCCCCeecC
Confidence 9999999999999999987655 48999999999999999999999999999999999999766 889999999987654
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
.. .....++..|+|||.+.+..++. ++|+|||||++|+|++|..||...+.......+.+...
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 245 (340)
T PTZ00426 183 TR--TYTLCGTPEYIAPEILLNVGHGK-AADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII 245 (340)
T ss_pred CC--cceecCChhhcCHHHHhCCCCCc-cccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 32 23446788999999998877765 99999999999999999999998888777777776554
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=265.89 Aligned_cols=223 Identities=31% Similarity=0.521 Sum_probs=189.5
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|++|.||+|.+..+++.+++|.+............+.+|+.+++.++||||+++++++...+..+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999999999999999997665444556778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--c
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK--L 175 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~--~ 175 (259)
|+.++++.. +......+++..++.++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+........ .
T Consensus 81 ~~~~~~l~~-~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 81 YVEKNMLEL-LEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN-DVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred cCCCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccCcccccccccccc
Confidence 998865554 44444568999999999999999999999999999999999999666 7899999999876543222 2
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
....++..|+|||.+.+..++. ++|+||||+++|+|++|++||...+..+.+..+.+..++.+.+++
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~-~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYGK-AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred cccccccccCCcHHHcCCCCCC-chhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 2345778899999998877765 999999999999999999999998888888777777666654443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=272.49 Aligned_cols=208 Identities=34% Similarity=0.578 Sum_probs=177.8
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGG 102 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (259)
+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++||||+++++.+..++..+++|||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999999999999999875432 2233456778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CCCccccccCC
Q psy3663 103 DLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGS 181 (259)
Q Consensus 103 sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~~~~~~~~~~ 181 (259)
+|.+++.... .+++..+..++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++.... .........++
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEeeCCCCcccccCCCcccceecC
Confidence 9999887654 48999999999999999999999999999999999999766 789999999886432 22233345688
Q ss_pred CccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 182 LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 182 ~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
..|+|||.+.+..++. ++|+|||||++|+|++|+.||...+.......+...
T Consensus 159 ~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~ 210 (323)
T cd05571 159 PEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210 (323)
T ss_pred ccccChhhhcCCCCCc-cccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999998887775 999999999999999999999887777666666543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=276.15 Aligned_cols=213 Identities=32% Similarity=0.539 Sum_probs=181.4
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
..|++.+.||+|+||.||+|.+..++..|++|++..... .......+.+|+.+++.++|+||+++++.+.+.+..+++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 369999999999999999999999999999999976432 2234566888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC---
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--- 173 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~--- 173 (259)
||+.+++|.+++..... +++..+..++.||+.||.+||+.||+|+||||+||+++.+ +.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~-~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 81 DYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD-GHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred ecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC-CCEEEeeCcCCcccccccccc
Confidence 99999999999876554 8999999999999999999999999999999999999766 789999999864321000
Q ss_pred ---------------------------------------------ccccccCCCccCCcccccCCCCCCCchhHHHHHHH
Q psy3663 174 ---------------------------------------------KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVI 208 (259)
Q Consensus 174 ---------------------------------------------~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~ 208 (259)
......++..|+|||.+.+..++. ++|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~~DiwSlG~i 237 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ-LCDWWSVGVI 237 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC-ccceeehhhH
Confidence 011235788999999998877775 9999999999
Q ss_pred HHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 209 LYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 209 l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
+|+|++|..||...+..+....++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~ 262 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKVIN 262 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHHHc
Confidence 9999999999988777666666654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=264.56 Aligned_cols=225 Identities=32% Similarity=0.523 Sum_probs=187.2
Q ss_pred cCeeEeeeecccccceEEEEEEee-cCceEEEEEcccCCCCcccHHHHHHHHHHHHhC---CCCCeEEEEEEEe-----c
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV---QHPNVVRLYEVID-----T 88 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~-~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~-----~ 88 (259)
.+|++.+.||+|++|.||+|.+.. .+..+++|.+............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 467899999876544333444556777777665 6999999999874 3
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
....+++||++.+ +|.+++... ...+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~-~~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCC-CCEEEccccceE
Confidence 4568999999975 899988764 3448999999999999999999999999999999999999766 789999999987
Q ss_pred cCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
............++..|+|||.+.+..++. ++|+||||+++|+|++|++||......+.+..+++..+.+.++.|..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCC-ccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 665444444556788999999998777765 99999999999999999999999999999999998877766655544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=275.98 Aligned_cols=213 Identities=34% Similarity=0.601 Sum_probs=187.0
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||+|.+..+++.|++|++....... .....+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999997643222 34567788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC---
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--- 173 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~--- 173 (259)
||+.+++|.+++... ..+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD-GHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEeecCCCCccCcccCccc
Confidence 999999999999876 448999999999999999999999999999999999999776 789999999987654432
Q ss_pred ---------------------------ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH
Q psy3663 174 ---------------------------KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226 (259)
Q Consensus 174 ---------------------------~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (259)
......++..|+|||.+.+..++. ++|||||||++|+|++|+.||...+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~ell~g~~Pf~~~~~~~ 237 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPFYSDTLQE 237 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCC-ceeeEecchhhhhhccCCCCCCCCCHHH
Confidence 122345788999999998887765 9999999999999999999999888887
Q ss_pred HHHHhhh
Q psy3663 227 TLTMIMD 233 (259)
Q Consensus 227 ~~~~i~~ 233 (259)
....+.+
T Consensus 238 ~~~~i~~ 244 (350)
T cd05573 238 TYNKIIN 244 (350)
T ss_pred HHHHHhc
Confidence 7777776
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=276.32 Aligned_cols=214 Identities=33% Similarity=0.523 Sum_probs=181.2
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 369999999999999999999999999999999875422 2233566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC----
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG---- 172 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~---- 172 (259)
||+.+++|.+++.... .+++..+..++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~-g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEeECCCCcccccccccc
Confidence 9999999999987654 48999999999999999999999999999999999999766 88999999986432100
Q ss_pred --------------------------------------------CccccccCCCccCCcccccCCCCCCCchhHHHHHHH
Q psy3663 173 --------------------------------------------QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVI 208 (259)
Q Consensus 173 --------------------------------------------~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~ 208 (259)
.......++..|+|||++.+..++. ++|+|||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ-LCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC-eeeEEechHH
Confidence 0001235788999999998887775 9999999999
Q ss_pred HHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 209 LYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 209 l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
+|+|++|++||...+..+....+...
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~ 263 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINW 263 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHcc
Confidence 99999999999887776666666543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=269.92 Aligned_cols=222 Identities=28% Similarity=0.501 Sum_probs=183.8
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CeEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN-----SKLY 93 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 93 (259)
+|++.+.||.|++|.||+|.+..++..|++|.+............+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999875433333456688999999999999999999987533 3589
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++|||+.+ +|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 lv~e~~~~-~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 81 VVFELMES-DLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANAD-CKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEecCCC-CHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEccCcccccccccc
Confidence 99999964 8988887654 48999999999999999999999999999999999999766 789999999986543221
Q ss_pred cc----ccccCCCccCCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 174 KL----ETSCGSLAYSAPEILLG--DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 174 ~~----~~~~~~~~~~apE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
.. ....++..|+|||.+.+ ..++ .++|+|||||++|+|++|++||...+....+..+.+..+.++..++.
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 11 23357889999999865 3444 49999999999999999999999888888887777777666555443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=264.74 Aligned_cols=227 Identities=30% Similarity=0.500 Sum_probs=194.1
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||+|.+..++..+++|.+..... ......+.+|+.++++++|+||+++++++...+..+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 3679999999999999999999999999999999875432 223445678999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-cc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~ 175 (259)
||+.+ +|.+++......++...+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||.+....... ..
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECccccceecCCCcccc
Confidence 99976 8988887766668999999999999999999999999999999999999766 789999999886543222 22
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
....++..|+|||.+.+....+.++|+||||+++|+|++|++||...+..+.+..+.+..+.+...+|...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI 232 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh
Confidence 23456788999999876544445999999999999999999999999999999999998888877777543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=274.27 Aligned_cols=219 Identities=30% Similarity=0.552 Sum_probs=185.7
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
...++|++.+.||+|++|.||+|.+..+++.+++|++.+... .......+.+|+.+++.++||||+++++.+.++...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 345789999999999999999999999999999999865322 2223456778999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+||||+.+++|.+++... .+++..+..++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~-~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKH-GHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEEecccceecccCC
Confidence 999999999999998654 37899999999999999999999999999999999999766 789999999987654322
Q ss_pred c--cccccCCCccCCcccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 174 K--LETSCGSLAYSAPEILLGDS---YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 174 ~--~~~~~~~~~~~apE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
. .....++..|+|||.+.+.. ..+.++|+|||||++|+|++|+.||...+....+..+++...
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~ 264 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN 264 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Confidence 2 23446889999999986543 233599999999999999999999998888778888776543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=274.63 Aligned_cols=214 Identities=32% Similarity=0.579 Sum_probs=184.3
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|..++..++|++|+++++.+.+.+.++++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 479999999999999999999999999999999875322 2334567788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-- 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-- 174 (259)
||+++++|.+++.+... +++..+..++.|++.||.+||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~-~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC-CCEEEeeccCCcccccccccc
Confidence 99999999999876544 8999999999999999999999999999999999999766 8899999998764421100
Q ss_pred ----------------------------------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 175 ----------------------------------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 175 ----------------------------------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
.....++..|+|||++.+..++. ++|+|||||++|+|++|+.||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~-~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK-LCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC-cceeccccceeeecccCCCCCC
Confidence 11235788999999998887775 9999999999999999999999
Q ss_pred CCCChHHHHHhhhc
Q psy3663 221 EANDSETLTMIMDV 234 (259)
Q Consensus 221 ~~~~~~~~~~i~~~ 234 (259)
..+..+.+..+...
T Consensus 238 ~~~~~~~~~~i~~~ 251 (360)
T cd05627 238 SETPQETYRKVMNW 251 (360)
T ss_pred CCCHHHHHHHHHcC
Confidence 88888877777653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=266.08 Aligned_cols=216 Identities=32% Similarity=0.522 Sum_probs=182.6
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCC-CeEEEEEEEecCCeEEEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHP-NVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~ 96 (259)
+|++.+.||+|++|.||+|.+..+++.|++|++..... .......+..|..++..++|+ +|+.+++++.+.+..+++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999876432 223456677888999998765 5888999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CCCcc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~~~~ 175 (259)
||+.+++|.+++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.+ +.++|+|||++.... .....
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKENIFGGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCC-CCEEEeecCcceecCCCCCce
Confidence 9999999999887654 38999999999999999999999999999999999999766 789999999876432 22223
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
....++..|+|||.+.+..++. ++|+|||||++|+|++|+.||...+..+.+..+.+....
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 219 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYGK-SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219 (324)
T ss_pred eeecCCccccChhhhcCCCCCc-ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 3446788999999998877765 999999999999999999999988888777777765443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=272.30 Aligned_cols=227 Identities=28% Similarity=0.481 Sum_probs=196.6
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
.+++.+.||+|.||.||.+... ....|++|.+.... .....+.+|++++++|+|++|+++++++..+..+++||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 4556789999999999999854 23389999997653 2456677999999999999999999999998899999999
Q ss_pred cCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc--
Q psy3663 99 GDGGDLYDYIMK-HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL-- 175 (259)
Q Consensus 99 ~~~~sL~~~~~~-~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~-- 175 (259)
+..++|.+++.. .+..+...+++.++.||+++++||+++++||+||...||||+.+ +.+||+|||+++........
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~-~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDED-LVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccC-ceEEEcccccccccCCCceeec
Confidence 999999999997 45669999999999999999999999999999999999999777 79999999999965544332
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccccc------------cc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSCT------------CW 242 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~------------~~ 242 (259)
........|.|||.+.-..++. ||||||||++|+||+| |+.||...+..+.++.+.++-+-+.+ .|
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~-kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSS-KSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCCCCCceecCHHHHhhCCccc-ccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 2234577899999999999987 9999999999999999 99999999999999999987766543 47
Q ss_pred cccCchhhh
Q psy3663 243 WRGRPRSRR 251 (259)
Q Consensus 243 ~~~~~~~~~ 251 (259)
|..+|.+|+
T Consensus 441 W~~~P~~RP 449 (468)
T KOG0197|consen 441 WHEDPEDRP 449 (468)
T ss_pred hhCCcccCC
Confidence 888888764
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=272.54 Aligned_cols=220 Identities=31% Similarity=0.554 Sum_probs=185.8
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.-.++|++.+.||+|++|.||+|.+..+++.+++|++..... .......+.+|..+++.++||||+++++.+.+....+
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 345799999999999999999999999999999999865321 2223455778999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++|||+.+++|.+++... .+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.......
T Consensus 120 lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~-~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCC-CCEEEEeCCceeEcCcCC
Confidence 999999999999998654 37899999999999999999999999999999999999766 789999999987654322
Q ss_pred c--cccccCCCccCCcccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 174 K--LETSCGSLAYSAPEILLGDS---YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 174 ~--~~~~~~~~~~~apE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
. .....++..|+|||.+.... ..+.++|+|||||++|+|++|..||...+....+..++.....
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 2 22446888999999986542 2335999999999999999999999988887888888765443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=274.64 Aligned_cols=218 Identities=29% Similarity=0.521 Sum_probs=196.0
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.......|+....||+|+.|.||.|....+++.|+||.+...... ..+-+.+|+.+++..+|+||+.+++.|...+..
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 345567899999999999999999999999999999999876533 466788999999999999999999999888999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
++||||++|++|.+.+.... +++.+|..+++++++||.|||.+||+|+|||.+||++..+ |.++|+|||++..+...
T Consensus 346 WVVMEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~-g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD-GSVKLTDFGFCAQISEE 422 (550)
T ss_pred EEEEeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC-CcEEEeeeeeeeccccc
Confidence 99999999999999998755 8999999999999999999999999999999999999777 78999999999887766
Q ss_pred C-ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 173 Q-KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 173 ~-~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
. .....+|++.|+|||+.....|.. +.||||||++++||..|++||=+.+.-..+..|..-+.
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtrk~YG~-KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~ 486 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTRKPYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 486 (550)
T ss_pred cCccccccCCCCccchhhhhhcccCc-cccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC
Confidence 5 667789999999999999988886 99999999999999999999998777777777764433
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=258.62 Aligned_cols=232 Identities=32% Similarity=0.506 Sum_probs=193.8
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
-.+.|++...||.|..++||+|+..-.++.|+||++..+.-.. ....+++|+..++.++||||++++-.|......++|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 3569999999999999999999999999999999998775433 378899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
|+++.++++.+++... +.++++..|..+++++++||.|||.+|-+|+|||+.|||++++ |.|+|.|||.+..+.....
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~d-G~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSD-GTVKLADFGVSASLFDSGD 181 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCC-CcEEEcCceeeeeecccCc
Confidence 9999999999998765 6669999999999999999999999999999999999999777 8999999998766543321
Q ss_pred c-----ccccCCCccCCcccc-cC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCc
Q psy3663 175 L-----ETSCGSLAYSAPEIL-LG-DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRP 247 (259)
Q Consensus 175 ~-----~~~~~~~~~~apE~~-~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (259)
. ....+++.|+|||++ .. ..|+ .|+||||||++..||.+|..||.......++-.-+ ...++..--.+.+
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL--qn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL--QNDPPTLLTSGLD 258 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh--cCCCCCcccccCC
Confidence 1 334789999999995 33 3444 59999999999999999999999888776654433 3333332244444
Q ss_pred hhhhh
Q psy3663 248 RSRRR 252 (259)
Q Consensus 248 ~~~~~ 252 (259)
+++.+
T Consensus 259 ~d~~k 263 (516)
T KOG0582|consen 259 KDEDK 263 (516)
T ss_pred hHHhh
Confidence 44443
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=276.01 Aligned_cols=220 Identities=28% Similarity=0.415 Sum_probs=183.3
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-------
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN------- 89 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------- 89 (259)
.++|++.+.||+|+||.||+|.+..+++.|+||.+.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 357999999999999999999999899999999885432 2345799999999999999998876321
Q ss_pred -CeEEEEEeccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~---~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
..++++|||+.+ +|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.+.+.++|+|||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 246789999976 77776653 3455899999999999999999999999999999999999987756799999999
Q ss_pred cccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 166 SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
+.............++..|+|||.+.+....+.++|+|||||++|+|++|.+||.+.+..+.+..+++..++++.+.+
T Consensus 218 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 218 AKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred chhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 987655444445567889999999876543345999999999999999999999999999999999888776654433
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=271.03 Aligned_cols=225 Identities=25% Similarity=0.430 Sum_probs=192.6
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
.+.++|++.+.||+|++|.||+|.+...++.+++|.+............+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 577899999999999999999999999999999999876554444566778899999999999999999988543
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
...+++||++.+ ++.+.+.. .++...+..++.|++.||.+||++||+|+||||+||++..+ +.++|+|||++..
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~-~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCC-CCEEEeeCccccc
Confidence 357999999976 67666643 37899999999999999999999999999999999999766 7899999999876
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
...........++..|+|||.+.+..++. ++|+|||||++|+|++|+.||...+..+.+..+++..+.++.+++..
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred CCCccccCCccccCCccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 65444444556788999999998877775 99999999999999999999999888888888888877776666543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=267.32 Aligned_cols=215 Identities=31% Similarity=0.520 Sum_probs=181.7
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||+|.+..+++.|++|++.+.. ........+.+|..++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999987532 22234556788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc-
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL- 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~- 175 (259)
||+.+++|.+++......+++..+..++.||+.||.+||++||+|+||+|+||++..+ +.++|+|||.+.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN-GHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC-CCEEEEECCceeecCCCCCcc
Confidence 9999999999998766669999999999999999999999999999999999999666 78999999998665433221
Q ss_pred -ccccCCCccCCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 176 -ETSCGSLAYSAPEILLG----DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 176 -~~~~~~~~~~apE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
....++..|+|||++.. ....+.++|+|||||++|+|++|+.||...+..+....+..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~ 222 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 22357889999999863 22233489999999999999999999988776666666654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=264.83 Aligned_cols=206 Identities=34% Similarity=0.565 Sum_probs=177.0
Q ss_pred ecccccceEEEEEEeecCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCCh
Q psy3663 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDL 104 (259)
Q Consensus 26 i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (259)
||+|++|.||+|.+..+++.|++|.+.... ........+.+|+.++..++||||+++++.+.+.+..+++|||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 689999999999999999999999987542 1233456677899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-CccccccCCCc
Q psy3663 105 YDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCGSLA 183 (259)
Q Consensus 105 ~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~~~~~~~~~ 183 (259)
.+++.... .+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++...... .......++..
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCC-CcEEEEECcccccCccCCCccccccCCcc
Confidence 99987654 48999999999999999999999999999999999999766 78999999988653322 22233467889
Q ss_pred cCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 184 ~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
|+|||.+.+..++. ++|+|||||++|+|++|+.||...+..+.+..+...
T Consensus 159 y~aPE~~~~~~~~~-~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~ 208 (312)
T cd05585 159 YLAPELLLGHGYTK-AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208 (312)
T ss_pred cCCHHHHcCCCCCC-ccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 99999998877775 999999999999999999999988877777776654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=270.14 Aligned_cols=217 Identities=30% Similarity=0.532 Sum_probs=184.4
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-.++|++.+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 35689999999999999999999999999999999865322 22234557789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+|||+.+++|.+++... .+++..+..++.||+.||.+||+.||+|+||+|+||+++.+ +.++|+|||.+........
T Consensus 121 v~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~-~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMDANGM 197 (370)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCC-CCEEEEeccceeeccCCCc
Confidence 99999999999988654 37899999999999999999999999999999999999766 8899999999876543221
Q ss_pred --cccccCCCccCCcccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 175 --LETSCGSLAYSAPEILLGDS---YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 --~~~~~~~~~~~apE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
.....++..|+|||.+.+.. ..+.++|+|||||++|+|++|+.||...+....+..+++..
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 263 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK 263 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC
Confidence 23346788999999986532 23359999999999999999999999888888888887654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=248.78 Aligned_cols=221 Identities=34% Similarity=0.588 Sum_probs=199.9
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-.++|++++.||.|.||.||+|....++.-|++|++.++... .....++.+|++|...|+||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 356899999999999999999999999999999999887642 2345788899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 95 ILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++||..++++...+... ...+++...+.++.|++.|+.|+|.++++|+||+|+|+|+..+ +.+++.|||-+.-.. ..
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~-~~lkiAdfGwsV~~p-~~ 177 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAP-SN 177 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCC-CCeeccCCCceeecC-CC
Confidence 99999999998888754 4459999999999999999999999999999999999999887 789999999876544 55
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
...+.+++..|.+||...+..++. ..|+|++|++.||++.|.+||...+..+.++.|.+....+|
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~-~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p 242 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDK-FVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP 242 (281)
T ss_pred CceeeecccccCCHhhcCCCCccc-hhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC
Confidence 667788999999999999999986 99999999999999999999999999999999998877666
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=257.78 Aligned_cols=223 Identities=32% Similarity=0.502 Sum_probs=184.6
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC---CCCCeEEEEEEEec-----CC
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV---QHPNVVRLYEVIDT-----NS 90 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~~ 90 (259)
+|++.+.||+|++|.||+|.+..+++.|++|.+..............+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 59999999999999999999999999999999876543333334455677766665 69999999998754 34
Q ss_pred eEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
..++++|++.+ +|.+++.... ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccCccccc
Confidence 58999999976 8888887643 348999999999999999999999999999999999999766 78999999998766
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
..........++..|+|||.+.+..++. ++|+|||||++|+|++|++||......+.+..+.+..+.+....|.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCCCC-cchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 5444444456678899999998777765 9999999999999999999999988888888888766655544444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=266.73 Aligned_cols=215 Identities=32% Similarity=0.526 Sum_probs=182.9
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||++.+..+++.|++|++.... ........+.+|..++..++|++|+.+++.+.+.+..+++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986532 12223455778899999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc-
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL- 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~- 175 (259)
||+.+++|.+++......+++..+..++.|++.||.+||++||+|+||||+||+++.+ +.++|+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC-CCEEEEeccceeeccCCCcee
Confidence 9999999999998765668999999999999999999999999999999999999766 78999999998765433221
Q ss_pred -ccccCCCccCCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 176 -ETSCGSLAYSAPEILLG-----DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 176 -~~~~~~~~~~apE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
....++..|+|||.+.+ ..++ .++|+||||+++|+|++|+.||...+..+.+..+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCC-CcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC
Confidence 22457889999998865 2344 4899999999999999999999888777777776654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=265.27 Aligned_cols=206 Identities=33% Similarity=0.570 Sum_probs=176.3
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGG 102 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (259)
+.||+|++|.||+|.+..++..|++|++..... .......+.+|+.+++.++||||+++.+.+.+.+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999999999999999976432 2334566778999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCccccccCC
Q psy3663 103 DLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLETSCGS 181 (259)
Q Consensus 103 sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~~~~~~~~ 181 (259)
+|...+.... .+++..+..++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++..... ........++
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCC-CcEEEecCcCCccCCCcccccccccCC
Confidence 9988886554 48999999999999999999999999999999999999766 7899999998865322 2222344678
Q ss_pred CccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 182 LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 182 ~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
..|+|||.+.+..++. ++|+|||||++|+|++|+.||...+..+....+.
T Consensus 159 ~~y~aPE~~~~~~~~~-~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~ 208 (328)
T cd05593 159 PEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (328)
T ss_pred cCccChhhhcCCCCCc-cCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc
Confidence 8999999998877765 9999999999999999999998877776666654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=259.60 Aligned_cols=227 Identities=30% Similarity=0.511 Sum_probs=194.2
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||.|++|.||+|.+..++..|++|.+..... ......+.+|+.+++.++|+||+++++++......++++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 4679999999999999999999998999999999875432 223445678999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-c
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-L 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~ 175 (259)
||+.+ +|.+++......+++..+..++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++........ .
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC-CcEEECcCcchhccCCCCCcc
Confidence 99975 9999888776668999999999999999999999999999999999999766 7899999998865432221 2
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
....++..|+|||.+.+....+.++|+||||+++|+|++|++||...+..+....+.+..+.+....|...
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 232 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhh
Confidence 23345778999999876554445999999999999999999999999988999888888888877777654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=268.57 Aligned_cols=215 Identities=33% Similarity=0.594 Sum_probs=184.8
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++|++|+++++.+.+....+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 479999999999999999999999999999999976532 2234566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc-
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL- 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~- 175 (259)
||+.+++|.+++......+++..+..++.||+.||.+||+++|+|+||+|+||+++.+ +.++|+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT-GHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC-CCEEeccCCCCeECCCCCcee
Confidence 9999999999998876669999999999999999999999999999999999999766 78999999998765433222
Q ss_pred -ccccCCCccCCcccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 176 -ETSCGSLAYSAPEILLG------DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 176 -~~~~~~~~~~apE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
....++..|+|||.+.. ..++ .++|+|||||++|+|++|+.||........+..+++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~ 224 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYG-VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF 224 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCC-CcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 22357889999999863 3333 4999999999999999999999888877777777654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=265.51 Aligned_cols=211 Identities=36% Similarity=0.583 Sum_probs=178.0
Q ss_pred eeecccccceEEEEEEe---ecCceEEEEEcccCCC--CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 24 ETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+.||+|+||.||+|.+. ..++.|++|++..... .......+.+|+.+++.++||||+++++.+..++..+++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999864 4678999999875432 222345567899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCcccc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~~~~ 177 (259)
+.+++|.+++..... +++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..... ......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 159 (323)
T cd05584 82 LSGGELFMHLEREGI-FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVTHT 159 (323)
T ss_pred CCCchHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEeeCcCCeecccCCCcccc
Confidence 999999998876553 8899999999999999999999999999999999999766 7899999998764322 222233
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
..++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+....+..+.+....
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 218 (323)
T cd05584 160 FCGTIEYMAPEILMRSGHGK-AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218 (323)
T ss_pred cCCCccccChhhccCCCCCC-cceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 45788999999998877765 999999999999999999999988888888877765543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=263.11 Aligned_cols=216 Identities=32% Similarity=0.516 Sum_probs=181.9
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (259)
+|++.+.||+|++|.||+|.+..++..|++|++.+... ..........|..++..+. |++|+.+.+++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999876432 2223345566777777774 788999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCcc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~~ 175 (259)
||+.+++|...+..... +++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..... ....
T Consensus 81 E~~~~g~L~~~~~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kL~DfG~~~~~~~~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENMWDGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC-CcEEEccCCCceecCCCCCcc
Confidence 99999999998876543 8999999999999999999999999999999999999776 7899999998864332 2223
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
....++..|+|||.+.+..++. ++|+|||||++|+|++|+.||...+..+.+..+.+....
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 219 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYGK-SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCCC-ccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 3446788999999998887775 999999999999999999999988888777777765443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=264.16 Aligned_cols=212 Identities=33% Similarity=0.556 Sum_probs=178.9
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHH---HhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCM---KLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|.+++ +.++||||+++++++.+....++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 7899999999999999999999999999999975432 223345666676655 456799999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~ 174 (259)
|||+.+++|...+.. ..+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++..... ...
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC-CcEEeCcccCCccCCCCCCc
Confidence 999999999887754 348999999999999999999999999999999999999776 7899999998764322 222
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
.....++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+..+.+..+....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~ 217 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSYTR-AVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE 217 (324)
T ss_pred ccccccCccccCHhHhcCCCCCc-ccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 33456788999999998877765 9999999999999999999999888777777776543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=257.64 Aligned_cols=229 Identities=32% Similarity=0.464 Sum_probs=196.4
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEec
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT 88 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (259)
..+..--...|++.+.||.|..|.||+|....++..+|+|++.+.... ......++.|.+||+.++||-++.+|..|+.
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 345555667899999999999999999999999999999999876543 3345666779999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
....+++||||.|++|..+++.++ .-++++.+..++.+++.||+|||-.|||++||||+||||.++ |+|+|+||+++.
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvred-GHIMLsDFDLS~ 227 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRED-GHIMLSDFDLSL 227 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecC-CcEEeeeccccc
Confidence 999999999999999999998774 449999999999999999999999999999999999999777 899999999764
Q ss_pred cCCC---------------------------------CCc------------------------cccccCCCccCCcccc
Q psy3663 168 RFNP---------------------------------GQK------------------------LETSCGSLAYSAPEIL 190 (259)
Q Consensus 168 ~~~~---------------------------------~~~------------------------~~~~~~~~~~~apE~~ 190 (259)
.... ... ....+|+-.|.|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 3310 000 0011367789999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 191 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
.+..+.. ++|.|+||+++|||+.|..||.+.+.++.+..|+.....++.
T Consensus 308 ~G~GHgs-AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~ 356 (459)
T KOG0610|consen 308 RGEGHGS-AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPE 356 (459)
T ss_pred ecCCCCc-hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCC
Confidence 9999997 999999999999999999999999999999999866555543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=269.52 Aligned_cols=222 Identities=27% Similarity=0.464 Sum_probs=187.3
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----eEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS-----KLY 93 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 93 (259)
+|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999999999999999998654433344567889999999999999999999997765 789
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+++||+.+ +|.+.+.... .+++..+..++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDE 157 (372)
T ss_pred EEeecccc-CHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCC-CCEEeccccceeecccCc
Confidence 99999975 7888775543 48999999999999999999999999999999999999766 789999999887543221
Q ss_pred --ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 174 --KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 174 --~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
......++..|+|||.+.+....+.++|+|||||++|+|++|+.||...+..+++..+.+..+.++.+.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~ 229 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 1223356778999999987654445999999999999999999999999999999999888776655443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=256.20 Aligned_cols=210 Identities=28% Similarity=0.484 Sum_probs=178.8
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
.|++.+.||+|++|.||++.+..++..|++|.+....... .....+.+|+.+++.++|++|+++++.+.+++..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4899999999999999999999899999999987543222 223456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 98 LGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
|+.+++|..++... ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++++ +.++|+|||++..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY-GHIRISDLGLAVEIPEGETIR 159 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC-CCEEEeeCCCceecCCCCccc
Confidence 99999999887654 3458999999999999999999999999999999999999666 789999999987654443333
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTM 230 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (259)
...++..|+|||.+.+..++. ++|+||+|+++|+|++|+.||.+.......+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~-~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTF-SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred cccCCCCccCcHHhcCCCCCc-cccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 446788999999998777765 89999999999999999999987766544333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=272.92 Aligned_cols=223 Identities=30% Similarity=0.478 Sum_probs=188.7
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS- 90 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 90 (259)
-.....++|.+.+.||+|+||.||+|.+..+++.|++|.+.....+......+.+|+.++..++|++++++...+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3345668999999999999999999999999999999999876655556677889999999999999999988764322
Q ss_pred -------eEEEEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEE
Q psy3663 91 -------KLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 91 -------~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
.++++|||+.+++|.+++... ...+++..++.++.|++.+|.|||+.+|+|+||||+||+++.+ +.++|
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~-~~vkL 184 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKL 184 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCC-CCEEE
Confidence 368999999999999988653 3458999999999999999999999999999999999999776 78999
Q ss_pred EeccccccCCCC---CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 161 TDFGFSNRFNPG---QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 161 ~df~~~~~~~~~---~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
+|||++...... .......++..|+|||.+.+..++. ++||||||+++|+|++|+.||...+..+.+..++....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~-k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSK-KADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 999998654322 1223346788999999998877775 99999999999999999999998888777777775544
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=261.77 Aligned_cols=208 Identities=35% Similarity=0.590 Sum_probs=173.7
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHh-CCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKL-VQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|.+..+++.|++|++..... .......+..|..++.. .+||||+++++.+......+++|||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999976432 12233445556666664 4799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-CccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~~~~~~ 180 (259)
++|..++.... .+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++...... .......+
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD-GHIKIADFGMCKENMNGEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC-CCEEEccCcCCeECCCCCCccccccC
Confidence 99999887654 48999999999999999999999999999999999999766 78999999998654322 22334467
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
+..|+|||.+.+..++. ++|+|||||++|+|++|+.||...+..+.+..+...
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 211 (316)
T cd05592 159 TPDYIAPEILKGQKYNE-SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND 211 (316)
T ss_pred CccccCHHHHcCCCCCC-cccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 88999999998877765 999999999999999999999988877777666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=250.49 Aligned_cols=217 Identities=25% Similarity=0.451 Sum_probs=187.7
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||+|+++.||+|.+..+++.|++|.+............+.+|+.+++.++|||++++++.+.+.+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 58899999999999999999999999999999876555555677788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-cc
Q psy3663 99 GDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LE 176 (259)
Q Consensus 99 ~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~ 176 (259)
+.+++|.+++... ...++...++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+........ ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~-~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY-DNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC-CCEEEcccccceeccCccchhh
Confidence 9999999998775 4568999999999999999999999999999999999999776 7899999998876543322 22
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
...++..|+|||.+.+..++. ++|+||||+++++|++|+.||...+..+....+.+...+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNE-KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP 219 (256)
T ss_pred ccccCccccCHHHhcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 335677899999998877765 999999999999999999999888777766666655433
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=267.68 Aligned_cols=210 Identities=35% Similarity=0.584 Sum_probs=178.8
Q ss_pred eeecccccceEEEEEEe---ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccC
Q psy3663 24 ETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGD 100 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (259)
+.||+|++|.||++.+. .+++.+++|++............+.+|++++++++||||+++++.+.+.+..+++|||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999999864 568899999997654333345567789999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Ccccccc
Q psy3663 101 GGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSC 179 (259)
Q Consensus 101 ~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~~~~~ 179 (259)
+++|.+++.... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||.+...... .......
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~ 159 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEKKAYSFC 159 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCC-CcEEEeeccCCcccCCCCCceeccc
Confidence 999999886554 48999999999999999999999999999999999999766 78999999988655433 2233446
Q ss_pred CCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 180 GSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 180 ~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+..+....+.+...
T Consensus 160 g~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~ 215 (318)
T cd05582 160 GTVEYMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL 215 (318)
T ss_pred CChhhcCHHHHcCCCCCC-ccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCC
Confidence 788999999998777765 99999999999999999999998887777777765443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=265.76 Aligned_cols=225 Identities=32% Similarity=0.533 Sum_probs=184.4
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGG 102 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (259)
+.||+|++|.||+|.+..++..|++|++..... .......+.+|+++++.++||||+++.+.+.+++..++||||+.++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 468999999999999999999999999976432 2223456678899999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CCCccccccC
Q psy3663 103 DLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCG 180 (259)
Q Consensus 103 sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~~~~~~~~~ 180 (259)
+|..++.... .+++..++.++.||+.||.|||+ .||+|+||||+||+++.+ +.++|+|||++.... .........+
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC-CCEEEecCCCCeecCCCCcccccccC
Confidence 9998886654 48999999999999999999997 799999999999999766 789999999876432 2222334468
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc-----------ccccccCchh
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC-----------TCWWRGRPRS 249 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------~~~~~~~~~~ 249 (259)
+..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+.......+.......+ ..+|..+|..
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCCC-ccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 88999999998877775 99999999999999999999988777766666654332222 2345666666
Q ss_pred hh
Q psy3663 250 RR 251 (259)
Q Consensus 250 ~~ 251 (259)
|.
T Consensus 238 R~ 239 (325)
T cd05594 238 RL 239 (325)
T ss_pred hC
Confidence 63
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=254.11 Aligned_cols=225 Identities=32% Similarity=0.545 Sum_probs=187.0
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||.|++|.||+|.+..++..|++|.+............+.+|+.+++.++||||+++++.+.++..++++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999998999999999876544444556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-c
Q psy3663 99 GDGGDLYDYIMKHD--AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-L 175 (259)
Q Consensus 99 ~~~~sL~~~~~~~~--~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~ 175 (259)
+.+ +|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++........ .
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 81 LSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK-GVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred CCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC-CcEEECcccceeecCCCcccc
Confidence 975 8888876543 558999999999999999999999999999999999999766 7899999998865432211 1
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
....++..|+|||.+.+....+.++|+||||+++++|++|++||......+....+.+..+......|.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhc
Confidence 2234567899999987655434599999999999999999999998877777666666655555555543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=263.38 Aligned_cols=216 Identities=30% Similarity=0.512 Sum_probs=182.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||++.+..+++.+++|++.+... .......+.+|..++..++|++|+++++.+.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 479999999999999999999999999999999864321 2223445778899999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-- 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-- 174 (259)
||+.+++|.+++......+++..+..++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~-~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC-CCEEEeecchheecccCCcce
Confidence 9999999999998766668999999999999999999999999999999999999766 7899999998865433222
Q ss_pred cccccCCCccCCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 175 LETSCGSLAYSAPEILLG-----DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
.....++..|+|||.+.. ..++ .++|+|||||++|+|++|+.||...+..+.+..++...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~ 224 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 224 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCC-CcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC
Confidence 123467889999999852 2344 49999999999999999999999888777777776543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=261.21 Aligned_cols=209 Identities=33% Similarity=0.522 Sum_probs=174.5
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|.+..+++.|++|.+..... .......+..|..++... +||+|+++++.+.+.+.++++|||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 468999999999999999999999999976432 122345556677777654 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~~~~~~~ 180 (259)
++|..++.... .+++..+..++.||+.||++||++||+|+||+|+||+++.+ +.++|+|||.+..... ........+
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEeCccCCCeecccCCCceeccCC
Confidence 99999887654 48999999999999999999999999999999999999766 7899999998764321 222334467
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
+..|+|||.+.+..++. ++|+||||+++|+|++|..||...+..+.++.+....
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (316)
T cd05620 159 TPDYIAPEILQGLKYTF-SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT 212 (316)
T ss_pred CcCccCHHHHcCCCCCc-ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 88999999998877775 9999999999999999999998887777777665443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=261.38 Aligned_cols=210 Identities=36% Similarity=0.585 Sum_probs=177.8
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|.+..+++.|++|++..... .......+..|..++..+ +||||+++++++.+.+.++++|||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999875422 223455667788888776 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CCCccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~~~~~~~~~ 180 (259)
++|..++.... .+++..+..++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++.... .........+
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~-~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGIFNGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeeCCCCeecCcCCCccccccc
Confidence 99998887654 48999999999999999999999999999999999999766 789999999876532 2223334467
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
+..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+..+.+..+.....
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~ 213 (320)
T cd05590 159 TPDYIAPEILQEMLYGP-SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213 (320)
T ss_pred CccccCHHHHcCCCCCC-ccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC
Confidence 88999999998877765 99999999999999999999998888888877775443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=261.00 Aligned_cols=225 Identities=34% Similarity=0.544 Sum_probs=184.5
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||.|++|.||+|.+..++..|++|++..... .......+..|..+++.+ +||||+++++++.+.+.++++|||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999998999999999976432 223355667788888887 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CCCccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~~~~~~~~~ 180 (259)
++|...+.... .+++..+..++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++.... .........+
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC-CcEEecccCCCeecCcCCCcccceec
Confidence 99998887654 48999999999999999999999999999999999999776 789999999875422 2222233457
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc-----------ccccccCchh
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC-----------TCWWRGRPRS 249 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------~~~~~~~~~~ 249 (259)
+..|+|||.+.+..++. ++|+|||||++|+|++|+.||...+.......+.......+ ..+|..+|.+
T Consensus 159 ~~~y~aPE~~~~~~~~~-~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYGP-AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCCc-chhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 88999999998888775 99999999999999999999998887777777664433322 2455666665
Q ss_pred hh
Q psy3663 250 RR 251 (259)
Q Consensus 250 ~~ 251 (259)
|.
T Consensus 238 R~ 239 (318)
T cd05570 238 RL 239 (318)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=260.34 Aligned_cols=215 Identities=32% Similarity=0.513 Sum_probs=180.9
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (259)
+|++.+.||+|++|.||+|.+..+++.|++|++..... .......+..|..++..+. |++|+++.+++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 48899999999999999999999999999999875432 2223455677888888886 567888999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Ccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~ 175 (259)
||+++++|..++..... +++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++...... ...
T Consensus 81 Ey~~~g~L~~~i~~~~~-l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~-~~ikL~Dfg~~~~~~~~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK-FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEHMVDGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeccccccccCCCCccc
Confidence 99999999998876544 8999999999999999999999999999999999999766 78999999988653322 222
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
....++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+.......+.+...
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 218 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYGK-SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218 (323)
T ss_pred cCccCCccccCHHHHcCCCCCC-ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 3345788999999998877765 99999999999999999999998887777777776443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=261.40 Aligned_cols=209 Identities=27% Similarity=0.453 Sum_probs=169.7
Q ss_pred ccCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEec-C
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDT-N 89 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~ 89 (259)
.++|++.+.||+|+||.||+|.+. ..+..|++|.+.... .......+.+|+.++..+ +||||+++++.+.. +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 368999999999999999999753 345689999986542 233456788999999999 79999999998765 4
Q ss_pred CeEEEEEeccCCCChHHHHHhcC---------------------------------------------------------
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHD--------------------------------------------------------- 112 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~--------------------------------------------------------- 112 (259)
..++++|||+++++|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 56899999999999999987531
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc---ccccCCCccC
Q psy3663 113 ----AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYS 185 (259)
Q Consensus 113 ----~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~ 185 (259)
.++++..+..++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++......... ....++..|+
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 237788899999999999999999999999999999999766 78999999998754322111 1123456799
Q ss_pred CcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHH
Q psy3663 186 APEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETL 228 (259)
Q Consensus 186 apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (259)
|||.+.+..++. ++||||||+++|+|++ |..||......+.+
T Consensus 244 aPE~~~~~~~~~-~sDiwslG~il~el~~~g~~pf~~~~~~~~~ 286 (338)
T cd05102 244 APESIFDKVYTT-QSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286 (338)
T ss_pred CcHHhhcCCCCc-ccCHHHHHHHHHHHHhCCCCCCCCCCccHHH
Confidence 999998877775 9999999999999997 99999876654443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=262.55 Aligned_cols=208 Identities=36% Similarity=0.589 Sum_probs=173.0
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHH-HHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQE-VRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e-~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|.+..++..|++|++...... ......+..| ..+++.++|+||+++++.+.+.+..+++|||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999998754321 1122333333 3457788999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~~~~~~~ 180 (259)
++|.+++.... .+++..+..++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++..... ........+
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~-~~~kl~DfG~a~~~~~~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEEccCCCCcccccCCCCcccccC
Confidence 99999887654 38899999999999999999999999999999999999766 7899999998865322 222334467
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
+..|+|||.+.+..++. ++|+|||||++|+|++|++||...+..+.+..+...
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (325)
T cd05602 159 TPEYLAPEVLHKQPYDR-TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 211 (325)
T ss_pred CccccCHHHHcCCCCCC-ccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 88999999998877775 999999999999999999999988887777777654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=268.30 Aligned_cols=216 Identities=30% Similarity=0.503 Sum_probs=183.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeec-CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFT-GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~-~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
...|.+.+.||.|++|.||+|.+..+ +..+++|.+.... ......+.+|+.++..++||||+++++.+...+..++|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 44599999999999999999998877 7789998765432 33445677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 96 LELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
|||+.+++|.+++... ..++++.++..++.||+.||.+||+++|+|+||||+||+++.+ +.++|+|||++......
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~-~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC-CcEEEEeCcCceecCCc
Confidence 9999999999887543 3458999999999999999999999999999999999999766 78999999998765433
Q ss_pred Cc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 173 QK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 173 ~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
.. .....++..|+|||.+.+..++. ++|+|||||++|+|++|+.||...+..+.+..++....
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~ 288 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSK-KADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 22 22345788999999998877765 99999999999999999999998888777777765443
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=256.91 Aligned_cols=206 Identities=25% Similarity=0.473 Sum_probs=179.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||+|.+..++..+++|.+.... .......+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 478999999999999999999999999999999987643 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL-HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~-~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
||+.+++|.+++..... +++..+..++.|++.+|.+||+. +|+|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus 83 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~-~~ 159 (331)
T cd06649 83 EHMDGGSLDQVLKEAKR-IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA 159 (331)
T ss_pred ecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCC-CcEEEccCccccccccc-cc
Confidence 99999999999876553 89999999999999999999986 69999999999999766 78999999988765332 23
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (259)
....++..|+|||.+.+..++. ++|+|||||++|+|++|+.||......+.
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~p~~~~~~~~~ 210 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVELAIGRYPIPPPDAKEL 210 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3446788999999998877765 99999999999999999999987665543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=280.14 Aligned_cols=222 Identities=32% Similarity=0.543 Sum_probs=185.0
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT- 88 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 88 (259)
-.+.....++|++.+.||.|+||.||+|.+...+..+++|.+............+..|+.+++.++||||++++++|.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3456677789999999999999999999999999999999998765555567788899999999999999999998854
Q ss_pred -CCeEEEEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CcEeccCCCCCeEeeec---
Q psy3663 89 -NSKLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKL-------HVVHRDLKPENVVFFER--- 154 (259)
Q Consensus 89 -~~~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~-------~i~H~dl~p~nIlv~~~--- 154 (259)
...+++||||+.+++|.+++... ...+++..++.++.||+.||.|||+. +|+|+||+|+|||+..+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 46789999999999999998753 24589999999999999999999985 49999999999999642
Q ss_pred -------------CCeEEEEeccccccCCCCCccccccCCCccCCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCC
Q psy3663 155 -------------LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD--SYDAPAVDVWSLGVILYMLVAGQAPF 219 (259)
Q Consensus 155 -------------~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf 219 (259)
...++|+|||++.............++..|+|||++.+. .++ .++|||||||++|+|++|..||
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s-~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCC-chhHHHHHHHHHHHHHHCCCCC
Confidence 234899999998776544444455688999999998643 344 4999999999999999999999
Q ss_pred CCCCChHHHHHhh
Q psy3663 220 QEANDSETLTMIM 232 (259)
Q Consensus 220 ~~~~~~~~~~~i~ 232 (259)
........+...+
T Consensus 244 ~~~~~~~qli~~l 256 (1021)
T PTZ00266 244 HKANNFSQLISEL 256 (1021)
T ss_pred CcCCcHHHHHHHH
Confidence 8766555444433
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=246.79 Aligned_cols=217 Identities=30% Similarity=0.508 Sum_probs=189.9
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||.|++|.+|.+.+..++..+++|.+............+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 69999999999999999999999999999999877665556677788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-ccc
Q psy3663 99 GDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLE 176 (259)
Q Consensus 99 ~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~~ 176 (259)
+.+++|.+++... ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~-~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA-GLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC-CCEEECcCcceEEccccccccc
Confidence 9999999999765 4558999999999999999999999999999999999999776 789999999887654333 223
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
...++..|.|||.+.+..++. ++|+||||+++++|++|..||......+....+.....+
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~-~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNF-KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT 219 (256)
T ss_pred ccCCCccccCHhhcCCCCCCC-cchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 445788999999998777664 899999999999999999999988888877777655443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=261.17 Aligned_cols=209 Identities=36% Similarity=0.615 Sum_probs=173.8
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHH-HHHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVR-CMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|.+..+++.|++|++..... .......+..|.. +++.++||||+++++.+.+....+++|||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 468999999999999999999999999875432 1122334444444 56789999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~~~~~~~ 180 (259)
++|..++.... .+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..... ........+
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGIEHSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC-CcEEEeccCCCcccccCCCccccccC
Confidence 99999887654 48999999999999999999999999999999999999766 7899999998865322 222333457
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
+..|+|||.+.+..++. ++|+||||+++|+|++|..||...+..+..+.+....
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 212 (323)
T cd05575 159 TPEYLAPEVLRKQPYDR-TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP 212 (323)
T ss_pred ChhhcChhhhcCCCCCc-cccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 88999999998877765 9999999999999999999999888777777776543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=260.41 Aligned_cols=210 Identities=34% Similarity=0.537 Sum_probs=177.5
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|.+..+++.|++|++..... .......+..|..++..+ +||+|+++++++.+.+.+++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 368999999999999998999999999876432 223345566788888866 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-CccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~~~~~~ 180 (259)
++|...+.... .+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++...... .......+
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEeecccceecccCCcccccccc
Confidence 99998887654 48999999999999999999999999999999999999766 78999999988653222 22233457
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
+..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+..+.++.+.....
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05591 159 TPDYIAPEILQELEYGP-SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213 (321)
T ss_pred CccccCHHHHcCCCCCC-ccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 88999999998877775 99999999999999999999998888888887775443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=263.13 Aligned_cols=215 Identities=25% Similarity=0.358 Sum_probs=180.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||.|++|.||+|.+..+++.|++|... ...+.+|+++++.++||||+++++++..+...++++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 357999999999999999999999999999999743 234678999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC--Cc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG--QK 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~--~~ 174 (259)
+++.+ +|..++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++...... ..
T Consensus 163 e~~~~-~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~-~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 163 PRYKT-DLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHP-GDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred ecCCC-CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCC-CCEEEEeCCcccccccccccc
Confidence 99964 8888876654 48999999999999999999999999999999999999766 78999999998643221 12
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------CChHHHHHhhhcccccccccc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA-------NDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~ 243 (259)
.....++..|+|||++.+..++. ++|+|||||++|+|++|..||-.. ....++..+++..++++.+++
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGP-AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred cccccCccCCCChhhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 23346889999999998877765 999999999999999999887543 245677778777776665543
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=263.67 Aligned_cols=226 Identities=27% Similarity=0.435 Sum_probs=188.8
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC---
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--- 89 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 89 (259)
..++.++|++.+.||.|++|.||+|.+..++..|++|.+............+.+|+.+++.++|+||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 34577899999999999999999999999999999999876543333456677899999999999999999887532
Q ss_pred ---CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 90 ---SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 90 ---~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
...+++++++ +.+|.+++.. ..+++..+..++.||+.||.|||++||+|+||+|+||+++.+ +.++|+|||++
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~ 165 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED-CELRILDFGLA 165 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCC-CCEEEcCCccc
Confidence 3478999998 5689887754 348999999999999999999999999999999999999766 78999999998
Q ss_pred ccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 167 NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
...... .....++..|+|||.+.+....+.++|||||||++|+|++|+.||...+..+.+..+.+..+.+....+.
T Consensus 166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 765432 2344678899999999775444459999999999999999999999988888888888777766555443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=251.86 Aligned_cols=220 Identities=28% Similarity=0.523 Sum_probs=191.0
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||.|++|.||+|.+..++..+++|.+............+.+|+.+++.++|+||+++++++.+....++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58999999999999999999998999999999987654455567788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--cc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK--LE 176 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~--~~ 176 (259)
+ +++|.+++......+++..++.++.||+.+|.+||+.|++|+||+|+||+++.+ +.++|+|||.+........ ..
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD-GVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC-CcEEEeeeeecccccCCCCCccc
Confidence 9 889999987766679999999999999999999999999999999999999776 7899999998876644321 23
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
...++..|+|||.+.+....+.++|+||+|+++++|++|.+||........+..+.+..+.+..
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE 222 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCCh
Confidence 3456778999999876655456999999999999999999999888888888888776655533
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=257.76 Aligned_cols=207 Identities=34% Similarity=0.537 Sum_probs=173.0
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHh-CCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKL-VQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|.+..+++.|++|.+..... ..........|..++.. ++||||+++++++.+.+.++++|||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999999999999999876432 12234445567777765 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~~~~~~~ 180 (259)
++|..++.... .+++..+..++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++..... ........+
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-GHIKIADFGMCKENMLGDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC-CCEEEccCCcceECCCCCCceeeecC
Confidence 99999987654 48999999999999999999999999999999999999776 7899999998764322 222334457
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
+..|+|||.+.+..++. ++|+|||||++|+|++|..||...+..+.+..+..
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~ 210 (316)
T cd05619 159 TPDYIAPEILLGQKYNT-SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210 (316)
T ss_pred CccccCHHHHcCCCCCc-hhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 88999999998877765 99999999999999999999988777776666553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=251.40 Aligned_cols=228 Identities=32% Similarity=0.526 Sum_probs=191.3
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||.|.+|.||+|.+..+++.|++|.+............+.+|+++++.++|+||+++++++.+...++++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 68999999999999999999999899999999987654444445677889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-c
Q psy3663 98 LGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-L 175 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~ 175 (259)
|+.+ +|.+.+.... ..+++..++.++.||+.||.+||+++++|+||+|+||+++.+.+.++|+|||.+........ .
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 9965 7887775543 33678889999999999999999999999999999999976657899999998865433221 1
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
....++..|+|||.+.+....+.++|+||||+++|+|++|++||......+.+..+.+..+.+...+|.+-
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 22345678999999876544445999999999999999999999988888888888888777777777653
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=260.41 Aligned_cols=208 Identities=35% Similarity=0.589 Sum_probs=172.5
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHH-HHHHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEV-RCMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|.+..+++.|++|++..... .......+..|. .+++.++||||+++++.+.+.+..+++|||+.+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999875432 112233444444 467889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~~~~~~~ 180 (259)
++|...+.... .+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ-GHVVLTDFGLCKEGVEPEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEccCCCCccCCCCCCccccccC
Confidence 99988876544 48899999999999999999999999999999999999776 7899999998865322 222233457
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
+..|+|||.+.+..++. ++|+|||||++|+|++|..||...+.......+...
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 211 (321)
T cd05603 159 TPEYLAPEVLRKEPYDR-TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK 211 (321)
T ss_pred CcccCCHHHhcCCCCCC-cCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC
Confidence 88999999998877775 999999999999999999999988777776666644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=260.17 Aligned_cols=202 Identities=36% Similarity=0.602 Sum_probs=170.5
Q ss_pred CeeEeeeecccccceEEEEEEe---ecCceEEEEEcccCCC--CcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 92 (259)
+|++.+.||+|++|.||+|.+. .++..|++|++..... .......+..|+.+++.++ |++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 4678999999875422 1223456778999999995 89999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++|||+.+++|.+++..... +++..+..++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~-~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN-FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE-GHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCC-CCEEEeeCcCCcccccc
Confidence 999999999999999876544 8999999999999999999999999999999999999776 78999999998754332
Q ss_pred C--ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 173 Q--KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 173 ~--~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
. ......++..|+|||.+.+....+.++|||||||++|+|++|+.||...
T Consensus 159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 2 2223467889999999987654445999999999999999999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=259.53 Aligned_cols=194 Identities=37% Similarity=0.613 Sum_probs=166.5
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|.+..+++.+++|++..... .......+.+|..++.++ +||||+++++++.+.+.++++|||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999976532 223345677888888776 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CCCccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~~~~~~~~~ 180 (259)
++|..++.... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.... .........+
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~-~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CCEEEeeCCccccccCCCCccccccC
Confidence 99988876554 48999999999999999999999999999999999999776 789999999886532 2222334567
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
+..|+|||.+.+..++. ++|+||||+++|+|++|+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 159 TPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCCCCCC-ccceecccHHHHHHhhCCCCCc
Confidence 88999999998877775 9999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=254.10 Aligned_cols=223 Identities=28% Similarity=0.526 Sum_probs=185.1
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||.|++|.||+|.+..+|+.+++|.+............+.+|+.+++.++|+||+++++.+.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 58999999999999999999999999999999876544334445677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-ccc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~~ 177 (259)
+.+ +|.+++......+++..++.++.||++||.+||+.|++|+||+|+||+++.+ +.++|+|||.+........ ...
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC-CcEEECccchhhccCCCCCCcCC
Confidence 976 8888877666669999999999999999999999999999999999999766 7899999998875543221 223
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCChHHHHHhhhcccccccccc
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPF-QEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
..++..|+|||.+.+....+.++|+||||+++|+|++|..|| ...+..+.+..+.+..+......|
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESW 225 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHh
Confidence 345778999999877654445999999999999999988874 656666777777666555444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=257.88 Aligned_cols=195 Identities=36% Similarity=0.603 Sum_probs=167.9
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|.+..++..+++|++..... .......+.+|+.++.++ +||+|+.+++++.+...+++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999976532 223456677899988888 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CCCccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~~~~~~~~~ 180 (259)
++|..++.... .+++..+..++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++.... .........+
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC-CCEEEeccccceeccCCCCceecccC
Confidence 99998886554 49999999999999999999999999999999999999776 789999999886432 2233344567
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
+..|+|||.+.+..++. ++|+||||+++|+|++|..||..
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 159 TPNYIAPEILRGEEYGF-SVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred CcccCCHHHHCCCCCCc-hheeehhHHHHHHHHhCCCCCCc
Confidence 88999999998877765 99999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=253.90 Aligned_cols=227 Identities=26% Similarity=0.469 Sum_probs=192.0
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CeEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--SKLY 93 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 93 (259)
-.++|++.+.||.|++|.||+|.+..+++.|++|.+............+.+|+.++++++|+|++++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 45789999999999999999999999999999999876543333344566899999999999999999998654 5689
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++||++.+ +|.+++......+++..++.++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECccceeeecCCcc
Confidence 99999976 8999888766669999999999999999999999999999999999999766 789999999987654332
Q ss_pred -ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 174 -KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 174 -~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
.......+..|+|||.+.+....+.++|+||||+++|+|++|++||...+..+.+..+.+..+.+...+|.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 22223346679999998765444459999999999999999999999999999999999988877777763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=250.66 Aligned_cols=210 Identities=38% Similarity=0.705 Sum_probs=180.0
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEecc
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELG 99 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (259)
|++++.||+|++|.||+|.+..+++.+++|.+..............+|+.+++.++||||+++++++.+....+++|+++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999877644444444566999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC-CCCCccccc
Q psy3663 100 DGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETS 178 (259)
Q Consensus 100 ~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~-~~~~~~~~~ 178 (259)
.+++|.+++.... .+++..++.++.||++||.+||++|++|+||+|+||+++.+ +.++|+|||.+... .........
T Consensus 81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~ 158 (260)
T PF00069_consen 81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSENNENFNPF 158 (260)
T ss_dssp TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTSTTSEBSSS
T ss_pred ccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccc
Confidence 9989999998444 38999999999999999999999999999999999999755 88999999998753 333444556
Q ss_pred cCCCccCCccccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 179 CGSLAYSAPEILL-GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 179 ~~~~~~~apE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
.++..|+|||... +...+ .++|+||||+++++|++|..||......+....+.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~-~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYT-RKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBS-THHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred ccccccccccccccccccc-ccccccccccccccccccccccccccchhhhhhhh
Confidence 6788999999988 55555 49999999999999999999999884444444443
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.22 Aligned_cols=224 Identities=47% Similarity=0.843 Sum_probs=205.9
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
+-..-.+.|.+.+.||+|.|+.|.+|++..++..|+||.+.+..........+.+|++++..++||||++++.+...+..
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 55567789999999999999999999999999999999999988887777889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.|+||||..++.+.+++.+.+. +.+.....++.|+..|++|+|+++|+|+|||++||+++.+ ..++|+|||++..+..
T Consensus 130 lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~-mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDEN-MNIKIADFGFSTFFDY 207 (596)
T ss_pred eEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccc-cceeeeccccceeecc
Confidence 9999999999999999998877 6668999999999999999999999999999999999887 4599999999999998
Q ss_pred CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
+......++++.|.|||++.+..+..+.+|+||+|+++|-|++|.+||.+..-.+.-...+.++..
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r 273 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR 273 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeec
Confidence 889999999999999999999999999999999999999999999999987766665555544443
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=267.10 Aligned_cols=222 Identities=23% Similarity=0.370 Sum_probs=183.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC------CCeEEEEEEEecC-
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH------PNVVRLYEVIDTN- 89 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~- 89 (259)
.++|++.+.||+|+||.||+|.+...++.|+||++.... ........|+.+++.++| .+++.+++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 478999999999999999999999999999999986432 123345567777777654 4588888888654
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCC------------
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLG------------ 156 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~------------ 156 (259)
..++++|+++ +++|.+++...+ .+++..+..++.||+.||.|||+ .||+|+||||+||++..+..
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5788999988 558888887654 48999999999999999999997 69999999999999976522
Q ss_pred ---eEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 157 ---VVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 157 ---~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
.++|+|||.+.... .......++..|+|||++.+..++. ++|||||||++|||++|++||...+..+.+..+.+
T Consensus 283 ~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~-~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMY-STDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred CCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 59999999875432 2233456788999999998888875 99999999999999999999999999999999999
Q ss_pred ccccccccccccC
Q psy3663 234 VSESSCTCWWRGR 246 (259)
Q Consensus 234 ~~~~~~~~~~~~~ 246 (259)
..+.++..|+...
T Consensus 360 ~~g~~p~~~~~~~ 372 (467)
T PTZ00284 360 TLGRLPSEWAGRC 372 (467)
T ss_pred HcCCCCHHHHhhc
Confidence 9998888776543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=247.18 Aligned_cols=212 Identities=30% Similarity=0.465 Sum_probs=181.9
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||.|+++.||+|.+..+++.+++|++..... .....+.+|+.+++.++||||+++++.+.+...++++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 3689999999999999999999988899999999976542 25678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-cc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~ 175 (259)
|++.+++|.+++.....++++..++.++.|++.++.+||+++++|+||+|+||+++.+ +.++|+|||.+....... ..
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED-GDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC-CCEEECccccchhhhhhhhcc
Confidence 9999999999988765669999999999999999999999999999999999999766 789999999887654322 22
Q ss_pred ccccCCCccCCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 176 ETSCGSLAYSAPEILLGD---SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
....++..|+|||.+... ..+ .++|+||||+++++|++|+.||...+.......+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~ 217 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLIS 217 (262)
T ss_pred ccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 233567789999998765 555 49999999999999999999998776555544443
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=249.49 Aligned_cols=211 Identities=28% Similarity=0.491 Sum_probs=179.3
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
.|+..+.||.|+||.||.|.+..+++.+++|.+....... .....+.+|+++++.++|++++++.+.+.+++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4788899999999999999999999999999987643322 223456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 98 LGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
|+.+++|..++... ...+++..+..++.|++.+|.+||+.||+|+||+|+||+++++ +.++|+|||.+..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY-GHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC-CCEEEecCCcceecCCCCccc
Confidence 99999999887654 3459999999999999999999999999999999999999766 789999999887654443334
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i 231 (259)
...++..|+|||.+.+..++. ++|+||||+++|+|++|..||.........+.+
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~ 213 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTL-SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213 (285)
T ss_pred CCCCCcCccChHHhcCCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 456788999999998777765 999999999999999999999876654443333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=259.44 Aligned_cols=208 Identities=35% Similarity=0.602 Sum_probs=173.8
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHH-HHHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVR-CMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||.|++|.||+|.+..++..+++|++..... .......+..|.. +++.++||||+++++.+...+..+++|||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 468999999999999999999999999875422 2223344444544 57778999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~~~~~~~ 180 (259)
++|...+.... .+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..... ........+
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ-GHVVLTDFGLCKEGIAQSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEEeecCCcccCCCCCCCcccccC
Confidence 99988886544 48999999999999999999999999999999999999766 7899999998865322 222334457
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
+..|+|||.+.+..++. ++|+|||||++|+|++|..||...+..+....++..
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~ 211 (325)
T cd05604 159 TPEYLAPEVIRKQPYDN-TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK 211 (325)
T ss_pred ChhhCCHHHHcCCCCCC-cCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 88999999998887775 999999999999999999999988877777776654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=244.73 Aligned_cols=217 Identities=31% Similarity=0.519 Sum_probs=190.4
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||+|++|.||+|.+..++..+++|.+............+.+|+.+++.++|||++++++.+......++++|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58999999999999999999999999999999987655555677888999999999999999999999988999999999
Q ss_pred cCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc
Q psy3663 99 GDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~ 177 (259)
+.+++|.+++... ...+++..+..++.|++.++.+||++|++|+||+|+||+++.+.+.++|+||+.+...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 9999999999765 345899999999999999999999999999999999999977756789999999887665544445
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
..++..|+|||.+.+...+. ++|+||||+++++|++|+.||...+.......+.....
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 218 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQ-KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF 218 (256)
T ss_pred cccCCcccCchhccCCCCCc-ccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC
Confidence 56778999999998776665 99999999999999999999988877777766665443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=249.99 Aligned_cols=228 Identities=31% Similarity=0.534 Sum_probs=188.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||.|++|.||+|.+..+++.|++|.+...... .....+.+|+.+++.++|+||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 47899999999999999999999989999999998764322 22344568999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc-
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL- 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~- 175 (259)
||+.+ +|.+++......+++..++.++.|++.||.+||+++++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER-GELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC-CCEEECccccccccCCCCccc
Confidence 99986 9999888766678999999999999999999999999999999999999766 78999999987654322111
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-ChHHHHHhhhccccccccccccCc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN-DSETLTMIMDVSESSCTCWWRGRP 247 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 247 (259)
....++..|+|||.+.+....+.++|+||+|+++|+|++|+.||.... ..+.+..+.+..+.+....|.+.+
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence 122356789999998764433459999999999999999999997665 566777777777776666665443
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=244.31 Aligned_cols=228 Identities=26% Similarity=0.504 Sum_probs=188.1
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|++|.||++... .+..+++|.+.... .....+.+|+.++++++||||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 46899999999999999999865 55689999876443 234678889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc-
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE- 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~- 176 (259)
|+.+++|.+++......+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST-GVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCC-CeEEECCCCCccccCCCceecc
Confidence 999999999987655568999999999999999999999999999999999999766 789999999887553322221
Q ss_pred -cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccccc------------cc
Q psy3663 177 -TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSCT------------CW 242 (259)
Q Consensus 177 -~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~------------~~ 242 (259)
...++..|+|||.+.+..++. ++|+||||+++|+|++ |+.||...+..+.+..+.+......+ .+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSS-KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhcccCccch-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 112345799999998777765 9999999999999999 99999988888888888765433222 45
Q ss_pred cccCchhhh
Q psy3663 243 WRGRPRSRR 251 (259)
Q Consensus 243 ~~~~~~~~~ 251 (259)
|..+|..|.
T Consensus 238 ~~~~p~~Rp 246 (256)
T cd05114 238 WHEKPEGRP 246 (256)
T ss_pred ccCCcccCc
Confidence 666666553
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=266.62 Aligned_cols=231 Identities=27% Similarity=0.456 Sum_probs=198.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
...|+..+.||+|+||.||+|++..+++.|++|++..+. .......+++|+.+|..++++||.++++.+......+++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 346778899999999999999999999999999998765 4556788999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc-
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL- 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~- 175 (259)
||+.|+++.+.++..+. +++.++..++++++.|+.|||..+.+|+||++.||++..+ |.++|+|||.+..+......
T Consensus 91 ey~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~-g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSES-GDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHhcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhhhcceecccccccceeEecc-CcEEEEecceeeeeechhhcc
Confidence 99999999999875543 5899999999999999999999999999999999999888 89999999999877655443
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc------------cccccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS------------ESSCTCWW 243 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~------------~~~~~~~~ 243 (259)
.+..+++.|||||++....|+. ++||||||++++||++|.+||...+....+..|-+-. ..+...|+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~-KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDT-KADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhccccccc-hhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 6678999999999999778886 9999999999999999999999988865555444322 22344566
Q ss_pred ccCchhhh
Q psy3663 244 RGRPRSRR 251 (259)
Q Consensus 244 ~~~~~~~~ 251 (259)
+.+|..|.
T Consensus 248 ~k~P~~Rp 255 (467)
T KOG0201|consen 248 DKNPEFRP 255 (467)
T ss_pred hcCcccCc
Confidence 66666543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=249.71 Aligned_cols=213 Identities=38% Similarity=0.673 Sum_probs=184.3
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||.|++|.||+|.+..+++.+++|++..... .......+.+|+++++.++||||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 479999999999999999999999999999999875432 2223566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
||+.+++|.+++.... .+++..+..++.||+.+|.+||++|++|+||+|+||++..+ +.++|+|||++...... ..
T Consensus 81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD-GYIKITDFGFAKRVKGR--TY 156 (290)
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEeeCCCccccCCC--CC
Confidence 9999999999987664 48999999999999999999999999999999999999766 78999999998765443 33
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
...++..|+|||.+.+...+. ++|+||||+++|+|++|+.||...+.....+.+....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 214 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGK-AVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214 (290)
T ss_pred CCCCCccccChhhhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 445778899999987776654 8999999999999999999998887776777666443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=257.59 Aligned_cols=194 Identities=37% Similarity=0.613 Sum_probs=167.6
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|.+..+++.|++|++...... ......+..|..+++.+ +||||+++++++.+....+++|||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999764322 23345677899999888 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC-CCCCccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~-~~~~~~~~~~~ 180 (259)
++|..++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++... ..........+
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGIRPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC-CCEEECcCccccccccCCCccccccC
Confidence 99988876554 49999999999999999999999999999999999999766 78999999988642 22233344567
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
+..|+|||.+.+..++. ++|+||||+++|+|++|+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~-~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 159 TPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred CccccCHHHHcCCCCCC-ccceechHHHHHHHHHCCCCcc
Confidence 88999999998877775 9999999999999999999996
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=248.71 Aligned_cols=216 Identities=33% Similarity=0.566 Sum_probs=181.8
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|++|.||+|.+..+++.+++|.+............+.+|+.+++.++|+|++++++.+......+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47999999999999999999999899999999987654333345667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-ccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~~ 176 (259)
|+++.+|..+... ...+++..++.++.||+.+|.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... ...
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCC-CcEEECccccceecCCCccccc
Confidence 9998777766544 3358999999999999999999999999999999999999766 789999999987664433 222
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
...++..|+|||.+.+....+.++|+||||+++++|++|+.||.+....+.+..+.+..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL 217 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 33466789999998764443459999999999999999999999888777766665443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=244.72 Aligned_cols=230 Identities=33% Similarity=0.585 Sum_probs=203.2
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC---Ccc---cHHHHHHHHHHHHhCC-CCCeEEEEEEEe
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPV---SQDHLYQEVRCMKLVQ-HPNVVRLYEVID 87 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~---~~~---~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 87 (259)
.+...|.-.+.+|.|..++|-++....+++.+++|++..... ++. -.+.-.+|+.||+++. ||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 456788999999999999999999999999999999875432 222 1233457899999997 999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.+...++|+|.++.+.|-+++...-. +++.+-..+++||++++.|||.++|+|+||||+||+++++ .+++|+|||+++
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn-~~i~isDFGFa~ 171 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDN-MNIKISDFGFAC 171 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccc-cceEEeccceee
Confidence 99999999999999999999987654 8999999999999999999999999999999999999777 679999999999
Q ss_pred cCCCCCccccccCCCccCCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccc
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILL-----GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCW 242 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (259)
.+..+......+|+++|.|||.+. +.+-+....|+|++|++||.|+.|.+||-....--++..|+++...+..+-
T Consensus 172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 999999999999999999999873 333334489999999999999999999999999999999999999998877
Q ss_pred cccC
Q psy3663 243 WRGR 246 (259)
Q Consensus 243 ~~~~ 246 (259)
|+..
T Consensus 252 Wadi 255 (411)
T KOG0599|consen 252 WADI 255 (411)
T ss_pred hhhc
Confidence 7654
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=251.89 Aligned_cols=223 Identities=29% Similarity=0.472 Sum_probs=187.5
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC---cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD---PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
+|++.+.||.|++|.||+|.+..+++.|++|.+...... ......+..|+.+++.++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 589999999999999999999989999999999765433 22345567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-c
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-K 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~ 174 (259)
|||+ +++|.+++......+++..++.++.||++||.+||++|++|+||+|+||+++.+ +.++|+|||.+....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCC-CCEEEccceeeeeccCCCcc
Confidence 9999 779999997765469999999999999999999999999999999999999776 889999999987654332 2
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
......+..|+|||.+.+....+.++|+||||+++++|++|.+||......+.++.+.+..+.+...+|
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhh
Confidence 222345678999998866544456999999999999999999999988888888887766555544444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=249.70 Aligned_cols=228 Identities=29% Similarity=0.530 Sum_probs=186.0
Q ss_pred eEeeeecccccceEEEEEEe----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 21 DLEETLGRGHFAVVKLARHV----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 21 ~~~~~i~~g~~~~vy~~~~~----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++.+.||.|.||.||+|... ..+..|+||.+... ........+.+|++.+++++||||+++++++......++++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 57889999999999999977 44668999999543 33445788999999999999999999999999888899999
Q ss_pred eccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
||+.+++|.+++... ...++...++.++.||+.||.|||+++++|++|+++||+++.+ +.++|+|||++.........
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~-~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSN-GQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETT-TEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccc
Confidence 999988999999887 5669999999999999999999999999999999999999777 79999999998776322221
Q ss_pred ---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccccc-----------
Q psy3663 176 ---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSCT----------- 240 (259)
Q Consensus 176 ---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 240 (259)
........|+|||.+.....+. ++||||||++++|+++ |+.||.+....+....+.+.......
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~-ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTK-KSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESH-HHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 2234567899999997777664 9999999999999999 78999999888888888766665433
Q ss_pred -cccccCchhhh
Q psy3663 241 -CWWRGRPRSRR 251 (259)
Q Consensus 241 -~~~~~~~~~~~ 251 (259)
.||..+|..|+
T Consensus 239 ~~C~~~~p~~RP 250 (259)
T PF07714_consen 239 QQCWSHDPEKRP 250 (259)
T ss_dssp HHHT-SSGGGS-
T ss_pred HHHcCCChhhCc
Confidence 46777777654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=244.73 Aligned_cols=214 Identities=26% Similarity=0.483 Sum_probs=180.3
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|++|.||.|... .+..+++|.+..... ....+.+|+.+++.++||||+++++++..++..+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 57999999999999999999765 345699999865432 34668899999999999999999999998889999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc-
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE- 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~- 176 (259)
|+.+++|.+++......+++..++.++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+..........
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ-GCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CCEEECCCccceecCCCceeec
Confidence 999999999998765568999999999999999999999999999999999999766 789999999886554332211
Q ss_pred -cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccc
Q psy3663 177 -TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 177 -~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
...++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+....+.+....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~-~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 220 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSS-KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL 220 (256)
T ss_pred CCCccChhhCCHHHHhcCcccc-hhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC
Confidence 122346799999998777665 9999999999999998 99999988877777777765443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=258.82 Aligned_cols=204 Identities=31% Similarity=0.492 Sum_probs=170.5
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
....++|+..+.||.|++|.||+|.+..+++.|+||++.... .......+.+|+++++.++|+||+++++++.+.+..+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 334678999999999999999999999899999999986543 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++|||+.+++|.... ..++..+..++.||+.||.|||++||+|+||+|+||+++.+ +.++|+|||++.......
T Consensus 149 lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 149 VLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA-KNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEcccccceeccccc
Confidence 999999998886532 25678889999999999999999999999999999999766 789999999987654322
Q ss_pred -ccccccCCCccCCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 174 -KLETSCGSLAYSAPEILLG----DSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 174 -~~~~~~~~~~~~apE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
......++..|+|||.+.. ..+...++|||||||++|+|++|+.||.....
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 278 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ 278 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2233467889999998743 23333489999999999999999999975443
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=257.62 Aligned_cols=224 Identities=26% Similarity=0.454 Sum_probs=191.2
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
.+.++|++.+.||+|++|.||+|.+..++..+++|.+............+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 467899999999999999999999999999999999876543444456677899999999999999999988543
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
...+++||++.+ +|.+.+... ++...+..++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~ 167 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 167 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCcccee
Confidence 357999999976 888877542 7899999999999999999999999999999999999776 7899999999977
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
...........++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+..+.+..+.+..++++..++.
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 168 AGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred CCCCCCCCCCcccccccCHHHHhCCCCCC-chhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 65444434445678899999998877775 9999999999999999999999888888888888888777665543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=252.63 Aligned_cols=213 Identities=27% Similarity=0.447 Sum_probs=174.7
Q ss_pred ccCeeEeeeecccccceEEEEEEee----------------cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVF----------------TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~----------------~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 80 (259)
.++|++.+.||+|+||.||+|.+.. .+..|++|.+.... .......+.+|+.++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 4689999999999999999997532 23479999987543 233456788999999999999999
Q ss_pred EEEEEEecCCeEEEEEeccCCCChHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Q psy3663 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHD------------------AGLSETYAREYFAQIVRAISFCHKLHVVHR 142 (259)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~------------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~ 142 (259)
++++++.+.+..+++|||+.+++|.+++.... ..++...++.++.||+.||.+||+.||+|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~ 162 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR 162 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 99999999999999999999999999886532 236778899999999999999999999999
Q ss_pred cCCCCCeEeeecCCeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh--CCC
Q psy3663 143 DLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA--GQA 217 (259)
Q Consensus 143 dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~ 217 (259)
||+|+||+++.+ +.++|+|||.+......... ....++..|+|||.+....++. ++|+||||+++|+|++ +..
T Consensus 163 dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 163 DLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT-ASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred CcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCc-hhhhHHHHHHHHHHHHccCCC
Confidence 999999999766 78999999998765433221 1223466899999988777765 9999999999999986 678
Q ss_pred CCCCCCChHHHHHhh
Q psy3663 218 PFQEANDSETLTMIM 232 (259)
Q Consensus 218 pf~~~~~~~~~~~i~ 232 (259)
||...+..+....+.
T Consensus 241 p~~~~~~~~~~~~~~ 255 (304)
T cd05096 241 PYGELTDEQVIENAG 255 (304)
T ss_pred CCCcCCHHHHHHHHH
Confidence 998877766665543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=246.47 Aligned_cols=216 Identities=19% Similarity=0.329 Sum_probs=180.6
Q ss_pred cCeeEeeeecccccceEEEEEEe---ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
.+|++.+.||+|+||.||+|... ..+..+++|.+.... .......+.+|+.++..++||||+++++++..+...++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 47999999999999999999765 345689999987643 22334667889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+|||+.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++++|||.+........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~-~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-LVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCC-CcEEECCCcccccccccch
Confidence 999999999999988766668999999999999999999999999999999999999766 7899999997654322211
Q ss_pred cc--cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 175 LE--TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 175 ~~--~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
.. ...++..|+|||.+.+..++. ++|+||||+++|++++ |..||......+.++.+.+...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~ 226 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSS-ASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR 226 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccc-hhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC
Confidence 11 122345799999998777775 9999999999999875 9999998888888887776543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=248.85 Aligned_cols=197 Identities=32% Similarity=0.549 Sum_probs=167.6
Q ss_pred ecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCCh
Q psy3663 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDL 104 (259)
Q Consensus 26 i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (259)
||+|+||.||+|.+..+++.+++|.+....... .....+..|+.+++.++|++|+++.+++......+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999999999999999987543222 2235567899999999999999999999999999999999999999
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-cccccC
Q psy3663 105 YDYIMK---HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LETSCG 180 (259)
Q Consensus 105 ~~~~~~---~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~~~~~ 180 (259)
...+.. ....+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||.+........ .....+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDND-GNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCccceecCCCCccccccCC
Confidence 887743 23458999999999999999999999999999999999999665 7899999999876543322 223457
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
+..|+|||.+.+..++. ++|+||||+++|+|++|+.||.....
T Consensus 160 ~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~g~~pf~~~~~ 202 (280)
T cd05608 160 TPGFMAPELLQGEEYDF-SVDYFALGVTLYEMIAARGPFRARGE 202 (280)
T ss_pred CcCccCHHHhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCc
Confidence 78999999998887775 99999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=244.09 Aligned_cols=212 Identities=29% Similarity=0.469 Sum_probs=179.3
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc---cHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV---SQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
+.|++.+.||.|++|.||.|.+..++..+++|.+........ ....+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 469999999999999999999998999999999875433222 24567889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
++|++++++|.+.+.... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~-~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecccccc
Confidence 999999999999887654 38999999999999999999999999999999999999765 7899999998865533221
Q ss_pred c----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 175 L----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 175 ~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
. ....++..|+|||.+.+...+. ++|+||||+++|+|++|+.||...+..+....+.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 220 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGR-KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 220 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCc-hhhhHHHHHHHHHHHhCCCCccccchHHHHHHHh
Confidence 1 1234567899999998877664 9999999999999999999998776665554444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=242.55 Aligned_cols=215 Identities=26% Similarity=0.496 Sum_probs=181.9
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCeEEEEEe
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT-NSKLYLILE 97 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 97 (259)
.|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|++++++++|+|++++.+.+.. ....++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4899999999999999999999899999999997655444556678889999999999999999998764 446899999
Q ss_pred ccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-cc
Q psy3663 98 LGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KL 175 (259)
Q Consensus 98 ~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~ 175 (259)
++++++|.+++... ...+++.+++.++.|++.++.+||++|++|+||+|+||+++.+ +.++|+||+.+....... ..
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRT-NIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecC-CcEEEecccceEEecccCCcc
Confidence 99999999988764 4458999999999999999999999999999999999999666 789999999886653322 22
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
....++..|+|||.+.+..++. ++|+||||+++++|++|+.||...+.......+....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~ 218 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPYNY-KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK 218 (257)
T ss_pred ccccCCcCccChhHhcCCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC
Confidence 3345678899999998877775 9999999999999999999998777666666665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=251.16 Aligned_cols=226 Identities=26% Similarity=0.447 Sum_probs=190.9
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CeEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--SKLYL 94 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 94 (259)
.+.|++.+.||.|++|.||+|.+..++..+++|.+............+.+|+.++.+++||||+++.+++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4689999999999999999999998899999999976554433445567899999999999999999998776 88999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-C
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-Q 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~ 173 (259)
++||+.+ +|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+...... .
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR-GILKICDFGLAREYGSPLK 161 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCC-CcEEEeecCceeeccCCcc
Confidence 9999976 9999988766669999999999999999999999999999999999999766 78999999988766543 2
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
......++..|+|||.+.+....+.++|+||||+++++|++|.+||......+.+..+.+..+.+....|.
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 22334467789999998765544459999999999999999999999988888888887766655554443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=274.45 Aligned_cols=207 Identities=26% Similarity=0.404 Sum_probs=174.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.++|++.+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+.++..++||||+++++++.+.+..+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 4799999999999999999999999999999999875432 222356688899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 96 LELGDGGDLYDYIMKH----------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~----------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
|||++|++|.+++... ....+...++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||.
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d-g~vKLiDFGL 159 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF-GEVVILDWGA 159 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC-CCEEEEecCc
Confidence 9999999999988642 1235567788999999999999999999999999999999766 7899999999
Q ss_pred cccCCCCC-------------------ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 166 SNRFNPGQ-------------------KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 166 ~~~~~~~~-------------------~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
+....... ......++..|+|||.+.+...+. ++|+|||||++|+|++|..||......
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~-kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE-STDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 87552110 011235788999999998887765 999999999999999999999775543
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=247.66 Aligned_cols=203 Identities=32% Similarity=0.524 Sum_probs=175.1
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc-cHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV-SQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
.|++.+.||+|++|.||+|.+..+++.|++|.+........ ....+.+|+.+++.++|++++++.+.+.+.+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999876543222 23456789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 98 LGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
|+.+++|.+++... ...+++..+..++.|++.||.+||+.+++|+||+|+||+++.+ +.++|+|||.+..........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC-CCEEEeeccceeecCCCcccc
Confidence 99999999988654 3358999999999999999999999999999999999999766 789999999887654443333
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
...++..|+|||.+.+..++. ++|+||+|+++|+|++|+.||....
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTF-SPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred CCCCCccccChHHHcCCCCCC-ccccHHHHHHHHHHHhCCCCCCCCC
Confidence 446788999999998877775 9999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=250.24 Aligned_cols=232 Identities=25% Similarity=0.444 Sum_probs=192.1
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC---
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--- 89 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 89 (259)
.....++|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|++++++++||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 45677899999999999999999999999999999999876544433445567899999999999999999987654
Q ss_pred -----CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecc
Q psy3663 90 -----SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG 164 (259)
Q Consensus 90 -----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~ 164 (259)
...+++|||+.+ +|.+.+......+++.+++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg 164 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKD-GILKLADFG 164 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCC-CcEEECcCC
Confidence 346999999965 8888887766568999999999999999999999999999999999999666 789999999
Q ss_pred ccccCCCCCcc-----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 165 FSNRFNPGQKL-----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 165 ~~~~~~~~~~~-----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
.+......... ....++..|+|||.+.+....+.++|+||||+++|+|++|++||...+....+..+....+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 88765432221 2234567899999887655434599999999999999999999998888888888888777777
Q ss_pred ccccccC
Q psy3663 240 TCWWRGR 246 (259)
Q Consensus 240 ~~~~~~~ 246 (259)
.++|...
T Consensus 245 ~~~~~~~ 251 (310)
T cd07865 245 PEVWPGV 251 (310)
T ss_pred hhhcccc
Confidence 6666443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=246.55 Aligned_cols=220 Identities=28% Similarity=0.494 Sum_probs=184.5
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecC--CeEEEEE
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTN--SKLYLIL 96 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~ 96 (259)
|++.+.||+|++|.||+|.+..++..+++|.+....... ......+|+.++.++. |+|++++++++.++ +..++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 788999999999999999999999999999987643222 2233456888888886 99999999999877 8899999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
||+.+ +|.+.+......+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+..........
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCCcC
Confidence 99976 888888766556899999999999999999999999999999999999966 789999999987765444434
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
...++..|+|||.+......+.++|+||||+++|+|++|.+||...+..+.+..+.+..+.++..|+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL 223 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 4456788999998765544445999999999999999999999998888888888877776666443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=247.03 Aligned_cols=214 Identities=30% Similarity=0.508 Sum_probs=183.2
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||.|++|.||+|.+..++..+++|.+.... .......+.+|+++++.++|+||+++.+.+.+....++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 47899999999999999999999999999999987543 23345667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Cccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~~ 176 (259)
++.+++|.+++... ++++..++.++.|++.++.+||+.+++|+||+|+||+++.+ +.++|+|||.+...... ....
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE-GDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEcccccceeecccccccc
Confidence 99999999998765 58999999999999999999999999999999999999776 78999999998776543 2223
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
...++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+.......+.....
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~~-~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 215 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYDE-KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP 215 (274)
T ss_pred cccCCccccChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC
Confidence 345677899999998877664 99999999999999999999987766555555554433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=246.32 Aligned_cols=196 Identities=32% Similarity=0.542 Sum_probs=167.6
Q ss_pred ecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCCh
Q psy3663 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDL 104 (259)
Q Consensus 26 i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (259)
||+|++|.||++.+..+|+.|++|.+....... .....+..|+++++.++||||+++.+.+.+....+++|||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999999999999999986543222 1234456799999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCCCc
Q psy3663 105 YDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA 183 (259)
Q Consensus 105 ~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~ 183 (259)
..++... ...+++..++.++.||+.|+.+||+.|++|+||+|+||+++.+ +.++|+|||++.............++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQ-GNCRLSDLGLAVELKDGKTITQRAGTNG 159 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCC-CCEEEeeceeeeecCCCceeeccCCCCC
Confidence 9887654 3358899999999999999999999999999999999999766 7899999999876654444344567889
Q ss_pred cCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 184 ~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
|+|||.+.+..++. ++|+|||||++|+|++|+.||....
T Consensus 160 y~aPE~~~~~~~~~-~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 160 YMAPEILKEEPYSY-PVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred ccCHHHHccCCCCC-chhHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999998877665 9999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=259.94 Aligned_cols=209 Identities=32% Similarity=0.494 Sum_probs=172.1
Q ss_pred ecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC---CCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV---QHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 26 i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
||+|++|.||+|.+..++..|++|++..... ..........|..++... +||+|+.+++.+.+...++++|||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6899999999999999999999999865322 112233444566666655 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-CccccccC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCG 180 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~~~~~~ 180 (259)
++|..++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.+ +.++|+|||++...... .......+
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKANLTDNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC-CCEEEecCCcCcCCCCCCCCccCccC
Confidence 99998887654 48999999999999999999999999999999999999766 78999999988653322 22334567
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
+..|+|||.+.+....+.++|+|||||++|+|++|+.||...+..+.++.+.....
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 214 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKV 214 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCC
Confidence 88999999987655334599999999999999999999998888777777765433
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=249.41 Aligned_cols=203 Identities=30% Similarity=0.549 Sum_probs=179.7
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
+|++.+.||.|+++.||+|.+..+++.+++|.+....... .....+.+|++++++++||||+++++.+.+....++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5899999999999999999999899999999997654322 346778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~ 177 (259)
|+.+++|.+++... .++++..+..++.||+++|.+||+++++|+||+|+||+++.+ +.++|+|||.+...........
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ-GHVHITDFNIATKVTPDTLTTS 158 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCC-CCEEEeecccccccCCCccccc
Confidence 99999999998776 458999999999999999999999999999999999999776 7899999999877655444445
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
..++..|+|||.+.+...+. ++|+||||+++|+|++|..||.....
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 159 TSGTPGYMAPEVLCRQGYSV-AVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred cCCChhhcCHHHHcccCCCC-cccchhhHHHHHHHHhCCCCCCCCCc
Confidence 56778899999998777665 99999999999999999999987764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=247.39 Aligned_cols=233 Identities=26% Similarity=0.418 Sum_probs=190.0
Q ss_pred ccCeeEeeeecccccceEEEEEEeecC-----ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTG-----EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~-----~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
.++|++.+.||+|++|.||+|.+...+ ..+++|.+.... .......+.+|+.++..++||||+++++++.+...
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 358999999999999999999876555 679999986543 23345668899999999999999999999998889
Q ss_pred EEEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~ 156 (259)
.+++|||+.+++|.+++.... ..+++..++.++.|++.||.+||++|++|+||+|+||+++++ +
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~-~ 161 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG-L 161 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC-C
Confidence 999999999999999987642 347889999999999999999999999999999999999766 7
Q ss_pred eEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhh
Q psy3663 157 VVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIM 232 (259)
Q Consensus 157 ~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~ 232 (259)
.++|+|||.+........ .....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||.+....+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTT-ESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCch-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 899999998865432221 12234467899999988777765 9999999999999998 999999888888777776
Q ss_pred hccccc------------cccccccCchhhhh
Q psy3663 233 DVSESS------------CTCWWRGRPRSRRR 252 (259)
Q Consensus 233 ~~~~~~------------~~~~~~~~~~~~~~ 252 (259)
+..... ...+|+.+|.+|..
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~ 272 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPR 272 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcC
Confidence 543322 23567777776653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=257.12 Aligned_cols=215 Identities=23% Similarity=0.378 Sum_probs=175.3
Q ss_pred ccCeeEeeeecccccceEEEEEEeec-----CceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCC
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFT-----GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNS 90 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (259)
.++|++.+.||+|+||.||+|.+... +..|++|.+..... ......+.+|+++++.+ +|+||+++++.+....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 45799999999999999999986443 35799999975432 23356788999999999 7999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcC----------------------------------------------------------
Q psy3663 91 KLYLILELGDGGDLYDYIMKHD---------------------------------------------------------- 112 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~---------------------------------------------------------- 112 (259)
..+++|||+.+++|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 9999999999999999886431
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc---cc
Q psy3663 113 -----------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE---TS 178 (259)
Q Consensus 113 -----------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~---~~ 178 (259)
.++++..++.++.||+.||.|||++|++|+||+|+||+++++ +.++|+|||++.......... ..
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEEeeceeeeeccCCcceeeccCC
Confidence 236788899999999999999999999999999999999765 789999999987654332211 11
Q ss_pred cCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 179 CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 179 ~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
.++..|+|||.+.+..++. ++|+||||+++|+|++ |+.||...........+++.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~-~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~ 330 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTV-QSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR 330 (374)
T ss_pred CCccceeCHHHhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc
Confidence 2345799999998777765 9999999999999997 99999877665555555443
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=248.38 Aligned_cols=215 Identities=23% Similarity=0.372 Sum_probs=176.1
Q ss_pred cCeeEeeeecccccceEEEEEEeecCc--eEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGE--KVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~--~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 94 (259)
++|++.+.||+|++|.||+|.+..++. .+++|.+.... .......+.+|+.++.++ +||||+++++.+...+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 579999999999999999999877665 46888775322 223356678899999999 69999999999999899999
Q ss_pred EEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEE
Q psy3663 95 ILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVK 159 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~ 159 (259)
++||+++++|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~-~~~k 159 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN-LASK 159 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC-CeEE
Confidence 999999999999986532 247889999999999999999999999999999999999766 7899
Q ss_pred EEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 160 LTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 160 l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
|+|||++..............+..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+.+..+....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999875432211111122245699999988777765 9999999999999997 999999888887777776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=247.86 Aligned_cols=215 Identities=28% Similarity=0.488 Sum_probs=180.2
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
..+.|++.+.||.|++|.||+|.+..++..+++|.+.... ......+.+|+.+++.++|+||+++++.+.....++++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 4477999999999999999999999899999999986542 33466778899999999999999999999988999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Cc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~ 174 (259)
|||+.+++|..++.+....+++..++.++.||+.++.+||+.+++|+||+|+||+++.+ +.++|+|||.+...... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC-CCEEEccCccceeccccccc
Confidence 99999999998887666668999999999999999999999999999999999999665 78999999987653222 11
Q ss_pred cccccCCCccCCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 175 LETSCGSLAYSAPEILLG-----DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
.....++..|+|||.+.+ ..++ .++|+||||+++|+|++|.+||...+.......+.+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 230 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 230 (292)
T ss_pred cceecCCccccCceeeccccccCCCCC-chhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC
Confidence 223356778999998853 2334 4899999999999999999999877666555555443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=252.36 Aligned_cols=206 Identities=25% Similarity=0.463 Sum_probs=177.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||.|++|.||+|.+..++..+++|.+.... .......+.+|+++++.++|+||+++++++.+++..+++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 578999999999999999999999899999999887643 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL-HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~-~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
||+.+++|.+++.... .+++..+..++.|++.++.|||+. +++|+||+|+||+++.+ +.++|+|||++...... ..
T Consensus 83 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~-~~~kL~Dfg~~~~~~~~-~~ 159 (333)
T cd06650 83 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MA 159 (333)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCC-CCEEEeeCCcchhhhhh-cc
Confidence 9999999999987654 389999999999999999999975 79999999999999766 78999999988654322 22
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (259)
....++..|+|||.+.+..++. ++|+|||||++|+|++|+.||......+.
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~~l~~g~~p~~~~~~~~~ 210 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 3345778999999998777665 99999999999999999999987655444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=263.94 Aligned_cols=207 Identities=31% Similarity=0.527 Sum_probs=181.4
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec------CCe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT------NSK 91 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~ 91 (259)
+.+...+.||+|+||.||++.++.+|+.||||.++... .....+..-+|++++++++|+|||+++++=++ .+.
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 67888899999999999999999999999999998765 33456677789999999999999999998543 345
Q ss_pred EEEEEeccCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC-C--eEEEEecccc
Q psy3663 92 LYLILELGDGGDLYDYIMKH--DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL-G--VVKLTDFGFS 166 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~--~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~-~--~i~l~df~~~ 166 (259)
..++||||.|++|...+++. ..++++.+++.++.++..|+.+||.+||+|+||||.||++.... | ..||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 78999999999999999864 45699999999999999999999999999999999999886543 2 5889999999
Q ss_pred ccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 167 NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
..+..+.......|+..|.+||.+....+++.-+|.|||||++|+.+||..||......
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99999998888999999999999986445555899999999999999999999655444
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=246.34 Aligned_cols=241 Identities=30% Similarity=0.500 Sum_probs=201.5
Q ss_pred CCCCCCCCCCccccCeeEe-eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEE
Q psy3663 5 GSRSSDGHPTKIAGLYDLE-ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRL 82 (259)
Q Consensus 5 ~~~~~~~~~~~~~~~y~~~-~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~ 82 (259)
+.+.++-..+.+.+.|++. +.||+|+++.|-.+.+..++..|+||++.+. .......+.+|++++..+. |+||+.+
T Consensus 64 ~gr~~ss~~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqL 141 (463)
T KOG0607|consen 64 RGRATSSLSGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQL 141 (463)
T ss_pred CCcccccccchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHH
Confidence 3455566677788888876 7899999999999999999999999999875 3446778889999999997 9999999
Q ss_pred EEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC--eEEE
Q psy3663 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG--VVKL 160 (259)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~--~i~l 160 (259)
+++|++...+|+|||.+.|++|.+.+.++.- +++.+..++.++|+.||.+||++||.|+|+||+|||..+.+. -++|
T Consensus 142 iefFEdd~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 142 IEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred HHHhcccceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceee
Confidence 9999999999999999999999999988765 999999999999999999999999999999999999866532 4899
Q ss_pred EeccccccCC--------CCCccccccCCCccCCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----
Q psy3663 161 TDFGFSNRFN--------PGQKLETSCGSLAYSAPEILL----GDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND---- 224 (259)
Q Consensus 161 ~df~~~~~~~--------~~~~~~~~~~~~~~~apE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---- 224 (259)
|||++..... ..+...+++++..|||||+.. ...++..+.|.||||+++|-|++|.+||.++=.
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 9999875432 122334557888999999762 234444699999999999999999999976422
Q ss_pred -----------hHHHHHhhhccccccccccccCch
Q psy3663 225 -----------SETLTMIMDVSESSCTCWWRGRPR 248 (259)
Q Consensus 225 -----------~~~~~~i~~~~~~~~~~~~~~~~~ 248 (259)
+..++.|-++...+|..-|-....
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~ 335 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISS 335 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhH
Confidence 345777889999999988876544
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=242.24 Aligned_cols=217 Identities=33% Similarity=0.544 Sum_probs=185.8
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCeEEEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT--NSKLYLIL 96 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~ 96 (259)
+|++.+.||.|++|.||+|.+..++..+++|.+............+.+|+.+++.++|+||+++++.+.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999987765555566778899999999999999999997753 45689999
Q ss_pred eccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 97 ELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCH-----KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 97 e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH-----~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
||+++++|.+++... ..++++..++.++.||+.+|.+|| +.+++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~-~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecC-CCEEEeccccccc
Confidence 999999999998764 456899999999999999999999 8999999999999999766 8899999999877
Q ss_pred CCCCCc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 169 FNPGQK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 169 ~~~~~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
...... .....++..|+|||.+.+...+. ++|+||||+++++|++|+.||...+..+..+.+.+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDE-KSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR 228 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCCCc-hhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC
Confidence 654433 33445788899999998777664 999999999999999999999988766666666655443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=246.03 Aligned_cols=221 Identities=32% Similarity=0.552 Sum_probs=186.3
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|+++.||+|.+..+++.|++|.+............+.+|+++++.++|+||+++++++.+.+..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999999899999999997665555556788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC--cc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--KL 175 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~--~~ 175 (259)
|+.+..+.. +......+++..++.++.||+.++.+||+.+++|+||+|+||+++.+ +.++|+|||.+....... ..
T Consensus 81 ~~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~-~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 81 YVERTLLEL-LEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSES-GVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred cCCCCHHHH-HHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEEeeecccccCCCccccc
Confidence 998855544 44444558999999999999999999999999999999999999765 789999999987665443 22
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
....++..|+|||.+.+....+.++|+||||+++++|++|++||......+.+..+....++.+.
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 33456778999999988734445999999999999999999999988777777776665554443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=242.36 Aligned_cols=230 Identities=30% Similarity=0.480 Sum_probs=191.5
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||.|++|.||++.+..++..+++|.+..... ......+.+|+.+++.++|+||+++.+.+.+.+..++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 58999999999999999999999999999999865432 23456778899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-cc
Q psy3663 99 GDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LE 176 (259)
Q Consensus 99 ~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~ 176 (259)
+++++|.+++... ...+++..++.++.||+.|+.+||++|++|+||+|+||+++++ +.++++|||.+........ ..
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC-CcEEEcccCcceeecccccccc
Confidence 9999999988653 4458999999999999999999999999999999999999666 7899999998876543222 22
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc------------cccccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS------------CTCWWR 244 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------------~~~~~~ 244 (259)
...++..|+|||.+.+...+. ++|+||||+++|+|++|..||...+.......+......+ ...+|.
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~-~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccCCcCc-hhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence 345677899999998777665 9999999999999999999999877777766665544332 234566
Q ss_pred cCchhhh
Q psy3663 245 GRPRSRR 251 (259)
Q Consensus 245 ~~~~~~~ 251 (259)
.+|.+|.
T Consensus 238 ~~P~~Rp 244 (255)
T cd08219 238 RNPRSRP 244 (255)
T ss_pred CCcccCC
Confidence 6666653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=242.70 Aligned_cols=215 Identities=23% Similarity=0.432 Sum_probs=180.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCc---eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.+.|++.+.||+|++|.||+|.+..+++ .|++|.+.... .......+..|+.+++.++||||+++.+++.+....+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 3569999999999999999999886665 59999986542 3444677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++||++.+++|.+++......++...++.++.|++.|+.+||++|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCC-CcEEECCCccccccccCc
Confidence 9999999999999998766678999999999999999999999999999999999999665 789999999886554322
Q ss_pred ccccc---c---CCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 174 KLETS---C---GSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 174 ~~~~~---~---~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
..... . .+..|+|||.+....++. ++|+||||+++|++++ |..||...+..+..+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~ 227 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD 227 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccc-hhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 21111 1 134699999998777765 9999999999999886 99999888877777776543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=261.39 Aligned_cols=212 Identities=25% Similarity=0.389 Sum_probs=183.3
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN 89 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (259)
..+=....++..+...||+|.||+||+|... ..||||+++.....+...+.++.|+..+++-+|.||+-+.+++...
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 3555666778899999999999999999844 3599999999998888889999999999999999999999998776
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
.. .+|+.||.|-+|..++.-....++....+.|++|+++++.|||.++|+|+|||..|||+..+ +.|+|+|||++...
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVK 538 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeee
Confidence 65 99999999999999998777779999999999999999999999999999999999999877 89999999998543
Q ss_pred ---CCCCccccccCCCccCCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q psy3663 170 ---NPGQKLETSCGSLAYSAPEILLG--DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227 (259)
Q Consensus 170 ---~~~~~~~~~~~~~~~~apE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (259)
..........+...|+|||+++. ....++.+||||||+|+|||++|.+||. .+..++
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq 600 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ 600 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh
Confidence 33344455568889999999864 3444569999999999999999999999 444443
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=242.15 Aligned_cols=204 Identities=31% Similarity=0.563 Sum_probs=174.2
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||.|++|.||+|.+..++..|++|.+.... ........+.+|+.+++.++||||+++++.+.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999876532 23334556788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 97 ELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 97 e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
|++.+++|.+++... ...+++..++.++.||+.|+.+||+++++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~-~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCC-CCEEECccccceeccchh
Confidence 999999999887642 3447899999999999999999999999999999999999766 789999999887654322
Q ss_pred c-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 174 K-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 174 ~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
. .....++..|+|||.+.+...+. ++|+||||+++++|++|+.||....
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCc-hhhHHHHHHHHHHHhcCCCCCcccc
Confidence 2 12335677899999998777765 9999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=246.32 Aligned_cols=223 Identities=34% Similarity=0.587 Sum_probs=186.9
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
.|++.+.||.|++|.||+|.+..++..|++|.+............+.+|++++++++||||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48999999999999999999998999999999876554444556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-cc
Q psy3663 99 GDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LE 176 (259)
Q Consensus 99 ~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~ 176 (259)
+.+ +|.+++... ...+++..++.++.|++.|+.+||+.+++|+||+|+||+++.+ +.++|+|||.+........ ..
T Consensus 81 ~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~-~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 81 LHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEeeccchhhcccCccccc
Confidence 965 888887654 3458999999999999999999999999999999999999776 7899999998865533221 22
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
...++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+.+.++.+..+.+...+|
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence 2345678999999877655445899999999999999999999988877777777766665554444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=245.51 Aligned_cols=221 Identities=17% Similarity=0.232 Sum_probs=180.1
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCccc-HHHHHHHHHHHHhCCCCCeEEEEEEEec----CCeEEEEEec
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-QDHLYQEVRCMKLVQHPNVVRLYEVIDT----NSKLYLILEL 98 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~ 98 (259)
..|++|+++.||+|.. +|+.|++|.+......... ...+.+|+.++.+++||||+++++++.+ ....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5789999999999984 7889999999765432222 4667799999999999999999999866 3568999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~ 177 (259)
+++++|.+++.... .++....+.++.|++.++.+||+ .+++|+||+|+||+++.+ +.++|+|||++...... ...
T Consensus 104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~-~~~kl~dfg~~~~~~~~--~~~ 179 (283)
T PHA02988 104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTEN-YKLKIICHGLEKILSSP--PFK 179 (283)
T ss_pred CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCC-CcEEEcccchHhhhccc--ccc
Confidence 99999999997654 48899999999999999999998 499999999999999776 78999999998765432 223
Q ss_pred ccCCCccCCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc-------------cccc
Q psy3663 178 SCGSLAYSAPEILLG--DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS-------------CTCW 242 (259)
Q Consensus 178 ~~~~~~~~apE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-------------~~~~ 242 (259)
..++..|+|||.+.+ ..++ .++||||||+++|+|++|+.||...+..+....+.+....+ ...+
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~-~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYT-IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred ccCcccccCHHHhhhcccccc-chhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 456788999999876 4555 49999999999999999999999888888877775443322 2345
Q ss_pred cccCchhhh
Q psy3663 243 WRGRPRSRR 251 (259)
Q Consensus 243 ~~~~~~~~~ 251 (259)
|..+|.+|.
T Consensus 259 l~~dp~~Rp 267 (283)
T PHA02988 259 TSHDSIKRP 267 (283)
T ss_pred hcCCcccCc
Confidence 666666654
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=240.65 Aligned_cols=204 Identities=32% Similarity=0.584 Sum_probs=175.3
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||+|.+..++..+++|.++.... .......+.+|+.++++++|++++++++.+.+....+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 689999999999999999999998999999999875332 2333667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 97 ELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 97 e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
||+.+++|.+++... ...+++..++.++.||+.++.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~-~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCC-CcEEEeccceeeeccCCC
Confidence 999999999988643 3448999999999999999999999999999999999999766 789999999886554322
Q ss_pred c-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 174 K-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 174 ~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
. .....++..|+|||.+.+..++. ++|+||||+++++|++|+.||....
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cccceecCCccccCHHHhccCCCCc-hhcHHHHHHHHHHHHHCCCCcccCC
Confidence 1 22345677899999998777765 9999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=249.24 Aligned_cols=215 Identities=25% Similarity=0.393 Sum_probs=175.1
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCce--EEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEK--VAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~--~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (259)
.++|++.+.||+|++|.||+|.+..++.. +++|.+... ........+.+|+.++.++ +|+||+++++++.+.+.++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 45899999999999999999998877764 466665432 2233456778899999999 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeE
Q psy3663 94 LILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVV 158 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i 158 (259)
+++||+++++|.+++.... ..+++..++.++.||+.|+.+||++|++|+||+|+||+++.+ +.+
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~-~~~ 163 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVA 163 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC-CcE
Confidence 9999999999999987542 247899999999999999999999999999999999999766 789
Q ss_pred EEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 159 KLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
+|+|||++..............+..|+|||.+.+..++. ++|+||||+++++|++ |..||......+..+.+...
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCCcc-cccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 999999875432211111222345799999887766664 9999999999999998 99999888777777666543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=244.40 Aligned_cols=224 Identities=30% Similarity=0.536 Sum_probs=191.1
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CeEEEEEe
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--SKLYLILE 97 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e 97 (259)
|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.+++.++|+|++++++++.+. ...+++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 7899999999999999999998899999999987653344456778899999999999999999999887 88999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--c
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK--L 175 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~--~ 175 (259)
|+.+ +|.+++......+++..++.++.||+.|+.+||+.|++|+||+|+||+++++ +.++|+|||.+........ .
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~-~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND-GVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC-CCEEEccccceeeccCCCcccc
Confidence 9976 8999887765569999999999999999999999999999999999999776 7899999999876654331 2
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
.....+..|+|||.+.+....+.++|+||||+++++|++|+.||......+.+..+.+..+.+....|..
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPG 228 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccc
Confidence 2334567899999877654444599999999999999999999999888888888888777766666643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=246.43 Aligned_cols=214 Identities=33% Similarity=0.528 Sum_probs=181.2
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||.|++|.||+|.+..++..+++|.+.... ......+.+|+.++++++|+||+++++.+..+...+++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 467999999999999999999998889999999986542 334566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-cc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~ 175 (259)
||+++++|.+++......+++..++.++.|++.++.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... ..
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC-CCEEEccCccchhhccccccc
Confidence 9999999999998776679999999999999999999999999999999999999666 789999999876543221 22
Q ss_pred ccccCCCccCCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 176 ETSCGSLAYSAPEILLG-----DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
....++..|+|||.+.. ..++ .++|+||||+++|+|++|++||...+.......+...
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~-~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 223 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS 223 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCC-ccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC
Confidence 33456778999998742 2334 4899999999999999999999887766655555543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=242.25 Aligned_cols=205 Identities=27% Similarity=0.509 Sum_probs=179.7
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.|+.|++|.||+|.+..++..+++|.+.... ....+.+|+.+++.++|+||+++++.+.+...+++++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 67999999999999999999998888999999986543 26788899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-ccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~~ 176 (259)
++.+++|.+++......+++..++.++.|++.++.+||+.+++|+||+|+||+++.+ +.++|+|||.+....... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE-GQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC-CcEEEcccccchhcccCccccc
Confidence 999999999998777779999999999999999999999999999999999999776 789999999987665433 222
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHH
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (259)
...++..|+|||.+.+...+. ++|+||||+++++|++|+.||.........
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~-~~Di~s~G~il~~l~~g~~p~~~~~~~~~~ 208 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNN-KADIWSLGITAIEMAEGKPPYSDIHPMRAI 208 (256)
T ss_pred cccCCccccCHHHHhcCCCCc-hhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence 334677899999988777665 999999999999999999999876554443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=243.23 Aligned_cols=211 Identities=27% Similarity=0.411 Sum_probs=176.3
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
..++|++.+.||+|++|.||+|.+..+++.+++|++.... ......+.+|+.+++.++||||+++++.+..+...+++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 3467999999999999999999999899999999986543 22345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-c
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-K 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~ 174 (259)
+||+.+++|.+++.... ++++..+..++.|++.++.+||+.||+|+||+|+||+++.+ +.++|+|||++....... .
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~-~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDN-GDVKLADFGVAAKITATIAK 162 (267)
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CCEEECcCccceeecccccc
Confidence 99999999999886544 48999999999999999999999999999999999999666 789999999987653322 1
Q ss_pred cccccCCCccCCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh
Q psy3663 175 LETSCGSLAYSAPEILLG---DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i 231 (259)
.....++..|+|||.+.. ...+ .++|+||+|+++++|++|+.||......+....+
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~ 221 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred cCccccCccccCHhHcccccCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhhhheee
Confidence 233456778999998742 3344 4899999999999999999999766554444333
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=243.34 Aligned_cols=222 Identities=33% Similarity=0.587 Sum_probs=186.6
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||.|++|.||+|.+..++..|++|.+..... ......+.+|+.+++.++|+||+++++.+.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 58999999999999999999999999999999876542 23345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-c
Q psy3663 99 GDGGDLYDYIMKHD--AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-L 175 (259)
Q Consensus 99 ~~~~sL~~~~~~~~--~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~ 175 (259)
+.+ +|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||++..+ +.++|+|||.+........ .
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKR-GELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC-CcEEEeecchhhhhcCCcccc
Confidence 986 8888887654 458999999999999999999999999999999999999766 7899999998865433221 1
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
....++..|++||.+.+....+.++|+||||+++++|++|+.||...+..+.+..+.+....+....|
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 22345678999999876554445999999999999999999999998888888888776665554444
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=247.02 Aligned_cols=215 Identities=33% Similarity=0.558 Sum_probs=183.2
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.+|++.+.||+|++|.||+|.+..+++.+++|.+....... .....+.+|+++++.++|+||+++++.+.+....+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999889999999997654332 24566888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-
Q psy3663 97 ELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK- 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~- 174 (259)
||+.+++|.+++... ...+++..++.++.|++.+|.+||+.|++|+||+|+||++..+ +.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCC-CCEEEeecchhhcccccccc
Confidence 999999999998764 3458999999999999999999999999999999999999766 7899999998765432211
Q ss_pred -----------------------------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 175 -----------------------------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 175 -----------------------------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
.....++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc-hHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 11224567899999998877765 999999999999999999999888877
Q ss_pred HHHHHhhhc
Q psy3663 226 ETLTMIMDV 234 (259)
Q Consensus 226 ~~~~~i~~~ 234 (259)
..+..+...
T Consensus 239 ~~~~~~~~~ 247 (316)
T cd05574 239 ETFSNILKK 247 (316)
T ss_pred HHHHHHhcC
Confidence 777666643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=243.94 Aligned_cols=231 Identities=25% Similarity=0.443 Sum_probs=191.6
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
-..+|++.+.||.|++|.||+|.+.. +..+++|.+.... ......+.+|+.+++.++|+||+++++++.+...++++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 34679999999999999999999886 8899999987643 22456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
|||+++++|.+++... +..++...++.++.||+.|+.+||++|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~-~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED-LVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCC-ceEEEccccchhhcCCccc
Confidence 9999999999999764 3458999999999999999999999999999999999999776 7899999998876543221
Q ss_pred c-ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc------------c
Q psy3663 175 L-ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC------------T 240 (259)
Q Consensus 175 ~-~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~------------~ 240 (259)
. .....+..|+|||.+.+..+.. ++|+||||+++|+|++ |+.||...+..+.+..+.+....+. .
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~-~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFST-KSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence 1 1223455799999988777765 9999999999999998 8999998888888877775533322 2
Q ss_pred cccccCchhhh
Q psy3663 241 CWWRGRPRSRR 251 (259)
Q Consensus 241 ~~~~~~~~~~~ 251 (259)
.+|..+|.+|.
T Consensus 239 ~~l~~~p~~Rp 249 (261)
T cd05148 239 ECWAAEPEDRP 249 (261)
T ss_pred HHcCCCchhCc
Confidence 56777777654
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=240.49 Aligned_cols=215 Identities=23% Similarity=0.392 Sum_probs=180.4
Q ss_pred cCeeEeeeecccccceEEEEEEeecCc---eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
.+|+..+.||+|++|.||+|.+..++. .+++|.+.... .......+..|+++++.++|+|++++.+++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 578999999999999999999876554 78999886542 23345678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+||++.+++|..++......+++..+..++.|++.|+.+||+.|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN-LECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCC-CcEEECCCccceecccccc
Confidence 999999999999998766668999999999999999999999999999999999999766 7899999998876543222
Q ss_pred ccc----ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 175 LET----SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 ~~~----~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
... ......|+|||.+....++. ++|+||||+++|++++ |+.||...+..+....+.+..
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~ 227 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcCh-HhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC
Confidence 111 11234699999988777665 9999999999999997 999998888777777776543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=260.36 Aligned_cols=238 Identities=31% Similarity=0.490 Sum_probs=206.6
Q ss_pred CCCCCCCCccccCeeEe--eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEE
Q psy3663 7 RSSDGHPTKIAGLYDLE--ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYE 84 (259)
Q Consensus 7 ~~~~~~~~~~~~~y~~~--~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (259)
..+-+.-.++..-|++. +.||+|-||+||-+++..+|+.|+||++.+..++...-.+++.|+.||+.+.||.|+.+--
T Consensus 551 ~~qiqe~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~ 630 (888)
T KOG4236|consen 551 NCQIQENVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLEC 630 (888)
T ss_pred chhhhhhhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 33444445566667665 8999999999999999999999999999999888888899999999999999999999999
Q ss_pred EEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC--CeEEEEe
Q psy3663 85 VIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL--GVVKLTD 162 (259)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~--~~i~l~d 162 (259)
.|++.+..++|||.+.|.-|.-++......+++..-..++.||+.||.|||.++|+||||||+|||+.+.. -+++|||
T Consensus 631 M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCD 710 (888)
T KOG4236|consen 631 MFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCD 710 (888)
T ss_pred eecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeecc
Confidence 99999999999999988444444555556688888889999999999999999999999999999997653 3899999
Q ss_pred ccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccc
Q psy3663 163 FGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCW 242 (259)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (259)
||+++.+....-....++++.|.|||++....++. .-|+||.|+++|--+.|.-|| +.++++-++|-...+-.|+.=
T Consensus 711 FGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNr-SLDMWSVGVIiYVsLSGTFPF--NEdEdIndQIQNAaFMyPp~P 787 (888)
T KOG4236|consen 711 FGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNR-SLDMWSVGVIIYVSLSGTFPF--NEDEDINDQIQNAAFMYPPNP 787 (888)
T ss_pred ccceeecchhhhhhhhcCCccccCHHHHhhccccc-cccceeeeEEEEEEecccccC--CCccchhHHhhccccccCCCc
Confidence 99999998888888889999999999999999987 899999999999999999999 467778888888888777766
Q ss_pred cccCc
Q psy3663 243 WRGRP 247 (259)
Q Consensus 243 ~~~~~ 247 (259)
|+...
T Consensus 788 W~eis 792 (888)
T KOG4236|consen 788 WSEIS 792 (888)
T ss_pred hhhcC
Confidence 76543
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=242.64 Aligned_cols=231 Identities=25% Similarity=0.389 Sum_probs=184.7
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCc----eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGE----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
..+|++.+.||.|++|.||+|....++. .|++|.+.... .......+.+|+.++..+.|+||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence 3589999999999999999999776766 47899986543 23345677889999999999999999999865 446
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++++++++++|.+++......+++..++.++.|++.||.+||+++++|+||+|+||++.++ +.++|+|||++......
T Consensus 84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~-~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSP-NHVKITDFGLARLLDID 162 (279)
T ss_pred EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC-CcEEECCCCceeecccc
Confidence 78999999999999998766668999999999999999999999999999999999999665 78999999998765432
Q ss_pred Ccc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc---------
Q psy3663 173 QKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC--------- 239 (259)
Q Consensus 173 ~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~--------- 239 (259)
... .....+..|+|||...+..++. ++|+||||+++|+|++ |..||...........+......+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTH-QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 221 1123356799999998777765 9999999999999998 9999987766665555544333222
Q ss_pred ---ccccccCchhhh
Q psy3663 240 ---TCWWRGRPRSRR 251 (259)
Q Consensus 240 ---~~~~~~~~~~~~ 251 (259)
..+|..+|..|.
T Consensus 242 ~li~~~l~~dp~~Rp 256 (279)
T cd05109 242 MIMVKCWMIDSECRP 256 (279)
T ss_pred HHHHHHcCCChhhCc
Confidence 256777777663
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=254.24 Aligned_cols=213 Identities=22% Similarity=0.396 Sum_probs=173.1
Q ss_pred ccCeeEeeeecccccceEEEEEE-----eecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCC
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARH-----VFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNS 90 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~-----~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (259)
.++|++.+.||+|+||.||+|.+ ..++..|++|++..... ......+.+|+.++..+ +||||+++++++.+.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 45899999999999999999974 33466899999865432 23346678899999999 7999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcC----------------------------------------------------------
Q psy3663 91 KLYLILELGDGGDLYDYIMKHD---------------------------------------------------------- 112 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~---------------------------------------------------------- 112 (259)
..+++|||+++++|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999886432
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 113 ----------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 113 ----------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
..+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++..........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-CcEEEecCccceeccCccccc
Confidence 136788899999999999999999999999999999999765 789999999987654322211
Q ss_pred ---cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhh
Q psy3663 177 ---TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIM 232 (259)
Q Consensus 177 ---~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~ 232 (259)
....+..|+|||.+.+..++. ++|+||||+++|+|++ |..||........+.+.+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~-~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~ 330 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI 330 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCC-CCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH
Confidence 122345799999998877775 9999999999999998 999998766544443333
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=251.65 Aligned_cols=193 Identities=25% Similarity=0.387 Sum_probs=166.7
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
..|++.+.||+|++|.||+|.+..++..|++|+..... ...|+.+++.++|+||+++++++......+++++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 36999999999999999999999899999999854322 2468999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~ 177 (259)
++.+ +|.+++......+++..++.++.||+.||.+||++||+|+||||+||++..+ +.++|+|||.+...........
T Consensus 138 ~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~ 215 (357)
T PHA03209 138 HYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDV-DQVCIGDLGAAQFPVVAPAFLG 215 (357)
T ss_pred ccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEecCccccccccCccccc
Confidence 9965 8888887776779999999999999999999999999999999999999766 7899999998875443333344
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCC
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQA-PFQE 221 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~-pf~~ 221 (259)
..++..|+|||.+.+..++. ++|+|||||++|+|+++.. +|..
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNS-KADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred ccccccccCCeecCCCCCCc-hhhHHHHHHHHHHHHHcCCccccC
Confidence 56788999999998887775 9999999999999998554 4443
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=246.80 Aligned_cols=228 Identities=29% Similarity=0.529 Sum_probs=190.4
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC---
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS--- 90 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 90 (259)
+...++|++.+.||.|++|.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45678999999999999999999999989999999999765444444566778999999999999999999886544
Q ss_pred -------eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEec
Q psy3663 91 -------KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDF 163 (259)
Q Consensus 91 -------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df 163 (259)
.+++++||+++ ++...+......+++..++.++.||+.||.+||+.||+|+||+|+||+++.+ +.++|+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~-~~~kl~df 160 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK-GQIKLADF 160 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CcEEeCcc
Confidence 78999999987 7878777665569999999999999999999999999999999999999766 78999999
Q ss_pred cccccCCCCCc--cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccc
Q psy3663 164 GFSNRFNPGQK--LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTC 241 (259)
Q Consensus 164 ~~~~~~~~~~~--~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (259)
|.+........ ......+..|+|||.+.+....+.++|+||||+++++|++|++||...+..+.+..+.+..+.++..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 98876543321 1222346679999988765443459999999999999999999999988888888888877666655
Q ss_pred cc
Q psy3663 242 WW 243 (259)
Q Consensus 242 ~~ 243 (259)
+|
T Consensus 241 ~~ 242 (302)
T cd07864 241 VW 242 (302)
T ss_pred hc
Confidence 55
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=241.94 Aligned_cols=222 Identities=30% Similarity=0.470 Sum_probs=178.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.+.|++.+.||+|++|.||.|.+..++..+++|.+..... ......+.+|+.+++.++|+||+++.+++.+....++++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3689999999999999999999999999999999865432 223345678999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-cc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~ 175 (259)
||+. +++.+.+......++...+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... ..
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL-GELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC-CcEEEeccccccccCCCCCCC
Confidence 9996 47877776655568889999999999999999999999999999999999766 789999999886543221 12
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-hHHHHHhhhcccccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND-SETLTMIMDVSESSCTC 241 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~ 241 (259)
....++..|+|||.+.+....+.++|+||||+++++|++|..||..... .+.+..+.+..+.+...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence 2234577899999987654333489999999999999999999976543 34455554444444333
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=245.84 Aligned_cols=209 Identities=28% Similarity=0.500 Sum_probs=179.1
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.+...++|++.+.||.|++|.||+|.+..++..|++|.+..... .....+.+|+.+++.++|+||+++++.+......
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 34566899999999999999999999998999999999875442 2346678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++|||+++++|.+++.+. .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 92 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~-~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEECcCccceEccCC
Confidence 9999999999999998653 37899999999999999999999999999999999999766 78999999988665433
Q ss_pred Cc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q psy3663 173 QK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227 (259)
Q Consensus 173 ~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (259)
.. .....++..|+|||.+.+..++. ++|+||||+++|++++|..||...+....
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slGvil~~l~tg~~pf~~~~~~~~ 223 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCcchh
Confidence 22 22345677899999998877764 99999999999999999999976654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=243.63 Aligned_cols=225 Identities=28% Similarity=0.475 Sum_probs=183.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCe-----
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSK----- 91 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~----- 91 (259)
++|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++ |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998765444444567788999999996 6999999999876554
Q ss_pred EEEEEeccCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 92 LYLILELGDGGDLYDYIMKHD----AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~----~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.+++|||+.+ +|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.+.+.++|+|||.+.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999987 8888876532 3489999999999999999999999999999999999998745899999999886
Q ss_pred cCCCCC-ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 168 RFNPGQ-KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 168 ~~~~~~-~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
...... ......++..|+|||.+.+....+.++|+||||+++|+|++|.+||...+....+..+.+....+....|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 543221 1122345678999998866544445999999999999999999999988877777777665555544444
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=239.15 Aligned_cols=207 Identities=29% Similarity=0.495 Sum_probs=173.3
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGD 103 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~s 103 (259)
+.||+|++|.||+|.+..+++.+++|.+.... .......+.+|+++++.++||||+++++++......+++|||+.+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46899999999999999899999999876432 33445678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc---cccC
Q psy3663 104 LYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE---TSCG 180 (259)
Q Consensus 104 L~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~---~~~~ 180 (259)
|.+++......+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.......... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEK-NVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCC-CcEEECccccCcccccccccccCCCCCC
Confidence 999987766668999999999999999999999999999999999999766 789999999886543221111 1112
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhh
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (259)
+..|+|||.+.+..++. ++|+||||+++|+|++ |..||...........+..
T Consensus 159 ~~~y~aPE~~~~~~~~~-~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~ 211 (252)
T cd05084 159 PVKWTAPEALNYGRYSS-ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ 211 (252)
T ss_pred ceeecCchhhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 34699999998777765 9999999999999998 9999987766665555544
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=238.84 Aligned_cols=212 Identities=27% Similarity=0.457 Sum_probs=175.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC---cccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CeE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD---PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--SKL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 92 (259)
..|++.+.||+|++|.||.+.+..++..|++|.+...... ......+.+|+.+++.++||||+++++.+.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999999999999999998643322 12345778899999999999999999998663 568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++||++++++|.+++.... .+++..+..++.|++.+|.+||+.+++|+||+|+||++..+ +.++|+|||.+......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSV-GNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCC-CCEEECcCccccccccc
Confidence 89999999999999987654 37899999999999999999999999999999999999766 78999999988654321
Q ss_pred C----ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 173 Q----KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 173 ~----~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
. ......++..|+|||.+.+...+. ++|+||||+++|+|++|+.||...........+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 222 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGR-KADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCc-chhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh
Confidence 1 112234677899999998777664 9999999999999999999998765555544433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=245.39 Aligned_cols=226 Identities=32% Similarity=0.566 Sum_probs=194.6
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEecc
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELG 99 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (259)
|++.+.||.|++|.||+|.+..+++.+++|.+......+.....+.+|+.+++.++|++|+++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999989999999998776555455677888999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-ccccc
Q psy3663 100 DGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETS 178 (259)
Q Consensus 100 ~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~~~~ 178 (259)
.+ +|.+++.....++++..++.++.||+.+|.+||+.+++|+||+|+||+++.+ +.++|+|||.+....... .....
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE-GVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC-CcEEEeeeeeeEecCCCcccccCc
Confidence 76 8888888766679999999999999999999999999999999999999766 789999999887665443 22233
Q ss_pred cCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCc
Q psy3663 179 CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRP 247 (259)
Q Consensus 179 ~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (259)
.+...|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+.+..+.+..+.+.+.+|..-.
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFT 227 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccch
Confidence 466789999998776344459999999999999999999999999888888888887777666665543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=223.91 Aligned_cols=226 Identities=30% Similarity=0.526 Sum_probs=204.3
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
..|+-.+.||+|.||+||+|.+..+++-|++|.......++..-....+|+-+++.++|.||++++++........+|+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35666789999999999999999999999999999887777777888999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-cc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~ 176 (259)
+++. .|+.+.....+.++.+.+..++.|+++++.+.|+.++.|+|+||.|.++..+ |.+++.|||+++...-... .+
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n-gelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN-GELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC-CcEEecccchhhhcCCceEeee
Confidence 9976 9999999888889999999999999999999999999999999999999777 8999999999987654321 23
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
..+.+..|++|.++.+...++...|+||.||+++|+.. |++.|.+++..++++.|...++++...-|-+
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps 229 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPS 229 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCc
Confidence 34567899999999998888779999999999999987 8899999999999999999999998888854
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=243.12 Aligned_cols=230 Identities=27% Similarity=0.439 Sum_probs=188.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.+.|+..+.||.|++|.||.|.+..++..+++|.+.... .......+.+|+.+++.++|+||+++++.+.+....+++|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 467889999999999999999999899999999987543 2334567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-c
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-L 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~ 175 (259)
||+.+++|.+++.. .++++..+..++.|++.++.+||+++++|+||+|+||+++.+ +.++|+|||.+........ .
T Consensus 82 e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred ecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCC-CCEEEcccccceeccCCcccc
Confidence 99999999998865 348999999999999999999999999999999999999766 7899999998866543221 2
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc------------cccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES------------SCTCWW 243 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~------------~~~~~~ 243 (259)
....++..|+|||.+.+...+. ++|+||||+++|+|++|+.||...........+.....+ ....+|
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~-~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDS-KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCcc-HHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 2234677899999988777665 999999999999999999999877665555444322211 122467
Q ss_pred ccCchhhh
Q psy3663 244 RGRPRSRR 251 (259)
Q Consensus 244 ~~~~~~~~ 251 (259)
..+|..|.
T Consensus 238 ~~~p~~Rp 245 (277)
T cd06640 238 NKDPSFRP 245 (277)
T ss_pred ccCcccCc
Confidence 77777663
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=248.04 Aligned_cols=219 Identities=28% Similarity=0.492 Sum_probs=175.3
Q ss_pred eeeecccccceEEEEEEe--ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCeEEEEEec
Q psy3663 23 EETLGRGHFAVVKLARHV--FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT--NSKLYLILEL 98 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~ 98 (259)
...||+|+||.||+|.+. .++..+++|.+.... ....+.+|+.+++.++||||+++++++.. ...+++++|+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999965 466799999986543 23456789999999999999999998854 4568999999
Q ss_pred cCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee---cCCeEEEEeccccc
Q psy3663 99 GDGGDLYDYIMKH--------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE---RLGVVKLTDFGFSN 167 (259)
Q Consensus 99 ~~~~sL~~~~~~~--------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~---~~~~i~l~df~~~~ 167 (259)
+.+ +|.+++... ...+++..++.++.||+.||.+||+.||+|+||||+||++.. ..+.++|+|||++.
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 965 888877532 224889999999999999999999999999999999999952 33689999999987
Q ss_pred cCCCCC----ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC---------hHHHHHhhhc
Q psy3663 168 RFNPGQ----KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND---------SETLTMIMDV 234 (259)
Q Consensus 168 ~~~~~~----~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~~~~~~i~~~ 234 (259)
...... ......++..|+|||.+.+....+.++|+||+||++|+|++|++||..... .+++..+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 654322 123345678899999998755444599999999999999999999975443 4667778888
Q ss_pred cccccccccccC
Q psy3663 235 SESSCTCWWRGR 246 (259)
Q Consensus 235 ~~~~~~~~~~~~ 246 (259)
.+.+....|...
T Consensus 241 ~~~~~~~~~~~~ 252 (317)
T cd07868 241 MGFPADKDWEDI 252 (317)
T ss_pred cCCCChHHhHHH
Confidence 877776666553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=253.81 Aligned_cols=217 Identities=22% Similarity=0.339 Sum_probs=178.2
Q ss_pred ccccCeeEeeeecccccceEEEEEEe--ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHV--FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.+..+|++.+.||.|++|.||+|... ..+..+++|.+.... ...+|+++++.++||||+++++.+......
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 45568999999999999999999754 345789999875432 345799999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++|+++.+ +|.+++.. ...+++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 162 ~lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~-~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 162 CMVMPKYKC-DLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEP-ENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEehhcCC-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEccCccccccCcc
Confidence 999999965 88888844 3458999999999999999999999999999999999999766 78999999998765433
Q ss_pred Ccc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---ChHHHHHhhhccccccccc
Q psy3663 173 QKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN---DSETLTMIMDVSESSCTCW 242 (259)
Q Consensus 173 ~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~ 242 (259)
... ....++..|+|||.+....++. ++|+|||||++|+|++|+.||.+.. ....+..+++..+..+..+
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 221 2345788999999998877775 9999999999999999999996644 4455666666555544443
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=240.87 Aligned_cols=214 Identities=29% Similarity=0.454 Sum_probs=179.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCc----eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGE----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.++|++.+.||+|++|.||+|.+..+++ .+++|.+..... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 4689999999999999999999876665 588888765532 3345677889999999999999999999877 778
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
++++|++.+++|.+++......+++..+..++.||+.|+.+||+++++|+||+|+||++.++ +.++|+|||.+......
T Consensus 84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCC-CeEEECCCcccccccCc
Confidence 99999999999999998876669999999999999999999999999999999999999766 78999999998765433
Q ss_pred Ccccc---ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 173 QKLET---SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 173 ~~~~~---~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
..... ...+..|+|||.+....++. ++|+||||++++++++ |+.||......+....+.+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 227 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTH-KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCc-hhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC
Confidence 22111 11245799999987777765 9999999999999998 99999988877777666654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=239.30 Aligned_cols=212 Identities=29% Similarity=0.454 Sum_probs=180.1
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC---CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
+|+..+.||+|++|.||+|.+..++..|++|.+..... .......+.+|+.+++.++|+||+++++.+.+...++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 57888999999999999999988999999999875432 223456788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
+||+++.+|.+++.... ++++..++.++.||+.++.+||+.|++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~-~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccceeccccccc
Confidence 99999999999987654 48999999999999999999999999999999999999776 78999999988765544333
Q ss_pred ccccCCCccCCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 176 ETSCGSLAYSAPEILLGDS-YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
....++..|++||.+.... ++ .++|+||||+++++|++|+.||...........+.+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~-~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 216 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYG-LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR 216 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCC-chhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh
Confidence 4455778899999987655 44 499999999999999999999987765555544443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=243.01 Aligned_cols=211 Identities=28% Similarity=0.500 Sum_probs=180.0
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.+....+|++.+.||.|++|.||+|.+..++..+++|.+...... ....+.+|+.+++.++|+||+++++.+..+...
T Consensus 15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 345567999999999999999999999989999999998765432 356788899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++|||+.+++|.+++... .++..++..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~-~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEECccccchhcccc
Confidence 9999999999999998653 37899999999999999999999999999999999999666 78999999987654332
Q ss_pred Cc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHH
Q psy3663 173 QK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229 (259)
Q Consensus 173 ~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (259)
.. .....++..|+|||.+.+...+. ++|+||||+++|+|++|+.||........+.
T Consensus 170 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~ 226 (296)
T cd06654 170 QSKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226 (296)
T ss_pred ccccCcccCCccccCHHHHcCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCCHHHhHH
Confidence 21 22345678899999998776664 9999999999999999999998766544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=239.11 Aligned_cols=208 Identities=26% Similarity=0.489 Sum_probs=172.5
Q ss_pred eecccccceEEEEEE--eecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCC
Q psy3663 25 TLGRGHFAVVKLARH--VFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGG 102 (259)
Q Consensus 25 ~i~~g~~~~vy~~~~--~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (259)
.||+|++|.||+|.. ..++..+++|++............+.+|+.+++.++|+||+++++++.. ...+++||++.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999964 4567899999987655444456778899999999999999999998754 4678999999999
Q ss_pred ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc----ccc
Q psy3663 103 DLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL----ETS 178 (259)
Q Consensus 103 sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~----~~~ 178 (259)
+|.+++.... .+++..+..++.|++.|+.+||++|++|+||+|.||++..+ +.++|+|||.+......... ...
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCC-CeEEECCCccccccCCCCCeeeecCCC
Confidence 9999987544 48999999999999999999999999999999999999766 78999999998765433221 111
Q ss_pred cCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 179 CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 179 ~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
.++..|+|||.+.....+. ++|+||||+++|+|++ |..||......+....+.+...
T Consensus 159 ~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~ 216 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSS-KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216 (257)
T ss_pred CCCccccCHhHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC
Confidence 2246899999987766665 9999999999999998 9999998888777777776544
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=238.65 Aligned_cols=217 Identities=29% Similarity=0.536 Sum_probs=186.2
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||+|++|.+|.+.+..++..+++|.+............+.+|+.+++.++|+||+++.+.+...+..++++|+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 59999999999999999999999999999999876544444566788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc-c
Q psy3663 99 GDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL-E 176 (259)
Q Consensus 99 ~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~-~ 176 (259)
+.+++|.+++... ...+++..++.++.|++.++.+||++|++|+||+|+||+++.+ +.++|+|||.+......... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEEeeccceeecCcchhhhh
Confidence 9999999988764 3357899999999999999999999999999999999999766 78999999988765433221 2
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
...++..|+|||.+.+...+. ++|+||||+++++|++|..||...+..+....++....+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP 219 (256)
T ss_pred hccCCccccCHHHhCCCCCCC-ccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC
Confidence 234677899999998777665 999999999999999999999888777777777655443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=243.28 Aligned_cols=222 Identities=34% Similarity=0.591 Sum_probs=186.1
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEecc
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELG 99 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (259)
|++.+.||.|++|.||+|.+..+|..|++|.+............+.+|+.+++.++|+|++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999999999999999999766544444566788999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-ccc
Q psy3663 100 DGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LET 177 (259)
Q Consensus 100 ~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~~ 177 (259)
. .+|.+++.... ..+++..++.++.|++.+|.+||+.+++|+||+|+||+++.+ +.++|+|||.+........ ...
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDRE-GALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CcEEEeecccccccCCCccccCc
Confidence 6 48999887654 358999999999999999999999999999999999999775 7899999999865532221 122
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
..++..|+|||.+.+......++|+||||+++|+|++|++||...+....+..+.+...++....|
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVW 224 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 244678999998866543345999999999999999999999988887777777777666655555
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=238.98 Aligned_cols=213 Identities=25% Similarity=0.411 Sum_probs=180.9
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
...|.+.+.||.|++|.||+|.+...+..+++|.+.... .....+.+|+++++.++|+||+++++++......+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 346999999999999999999999899999999986432 23567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
||+.+++|.+++... ...++...++.++.|++.+|.+||++|++|+||+|+||++.++ +.++|+|||.+.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CcEEeCCCccccccccceee
Confidence 999999999998754 3448899999999999999999999999999999999999766 78999999998765443222
Q ss_pred cc--ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 176 ET--SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 176 ~~--~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
.. ...+..|+|||.+.+...+. ++|+||||+++|+|++ |..||......+....+...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 221 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 11 12345799999988777765 9999999999999998 99999887777776666654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=241.29 Aligned_cols=211 Identities=31% Similarity=0.534 Sum_probs=180.6
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
...+|++.+.||.|++|.||+|.+..+++.+++|.+..... .....+.+|+.+++.++|+|++++++.+.....++++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 44679999999999999999999999999999999865432 2356778899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK- 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~- 174 (259)
+||+.+++|.+++... .+++.++..++.|++.++.+||+.|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 95 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 95 MEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD-GSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred EEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEccCccchhccccccc
Confidence 9999999999988654 38999999999999999999999999999999999999766 7899999998765543322
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
.....++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+.......+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~ 228 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 22335677899999998777765 9999999999999999999998877655544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=238.96 Aligned_cols=210 Identities=30% Similarity=0.482 Sum_probs=174.5
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc---ccHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCeEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP---VSQDHLYQEVRCMKLVQHPNVVRLYEVIDT--NSKLY 93 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 93 (259)
.|++.+.||+|++|.||+|.+..++..|++|.+....... .....+.+|+.+++.++||||+++++++.+ ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6899999999999999999999899999999987543222 234567889999999999999999998865 36788
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+++|++.+++|.+++..... +++..++.++.|++.++.+||+++++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 83 l~~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~-~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGA-LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEccCCCcccccccc
Confidence 99999999999999876543 8899999999999999999999999999999999999665 789999999886543211
Q ss_pred ----ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh
Q psy3663 174 ----KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231 (259)
Q Consensus 174 ----~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i 231 (259)
......++..|+|||.+.+..++. ++|+||+|+++|+|++|+.||...........+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~ 221 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGR-KADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCc-hhhhHHHHHHHHHHHHCCCCccccchHHHHHHH
Confidence 112234677899999998877765 999999999999999999999876555444433
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=239.98 Aligned_cols=228 Identities=31% Similarity=0.488 Sum_probs=196.3
Q ss_pred CCCccccCeeEe-eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEec-
Q psy3663 12 HPTKIAGLYDLE-ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDT- 88 (259)
Q Consensus 12 ~~~~~~~~y~~~-~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~- 88 (259)
....+.++|++. +.||-|-.|.|..+.++.+++++++|++.. ..+.++|+++-=..+ ||||+.++++|+.
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 445588899987 679999999999999999999999999853 345667777554444 9999999999854
Q ss_pred ---CCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCeEEEEe
Q psy3663 89 ---NSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTD 162 (259)
Q Consensus 89 ---~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~i~l~d 162 (259)
.....+|||++.|+.|.+.+++++ ..+++.+...+++||..|+.|||+.+|.|+||||+|+|+..+ +..++|+|
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 356789999999999999998874 459999999999999999999999999999999999999654 24699999
Q ss_pred ccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh----HHHHHhhhccccc
Q psy3663 163 FGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS----ETLTMIMDVSESS 238 (259)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~ 238 (259)
||++..........+.+.++.|.|||++....++- ..|+||+|++||-|++|.+||..++.. .+-.+|..+...+
T Consensus 208 fGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydk-scdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 208 FGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred cccccccCCCccccCCcccccccCHHHhCchhcCC-CCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 99998887777778888999999999999888875 899999999999999999999888754 4567888999999
Q ss_pred cccccccCc
Q psy3663 239 CTCWWRGRP 247 (259)
Q Consensus 239 ~~~~~~~~~ 247 (259)
|.+-|+.-.
T Consensus 287 P~pEWs~VS 295 (400)
T KOG0604|consen 287 PEPEWSCVS 295 (400)
T ss_pred CChhHhHHH
Confidence 999997543
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=242.05 Aligned_cols=210 Identities=28% Similarity=0.423 Sum_probs=176.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||.|.+..+++.|++|.+.... ......+.+|+.+++.++||||+++++.+...+.+++++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 458999999999999999999999999999999986543 223456778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-cc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~ 175 (259)
||+.+++|.+++...+ .+++..++.++.|++.++.+||+.|++|+||+|+||++..+ +.++|+|||.+....... ..
T Consensus 86 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 86 EFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDN-GHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred eccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEECcceeeeEccCccccc
Confidence 9999999999887655 48999999999999999999999999999999999999766 789999999886553221 12
Q ss_pred ccccCCCccCCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh
Q psy3663 176 ETSCGSLAYSAPEILL---GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i 231 (259)
....++..|+|||.+. ...++ .++|+||||+++|+|++|+.||...........+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~-~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~ 221 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred ccccCcccccChhhhccccCCCCC-chhhhHHHHHHHHHHhcCCCCcccccchhhHHhh
Confidence 3345778999999874 33344 4999999999999999999999766554444333
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=245.86 Aligned_cols=212 Identities=28% Similarity=0.452 Sum_probs=175.0
Q ss_pred cCeeEeeeecccccceEEEEEEeecCc----eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGE----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.+|++.+.||+|++|.||+|.+..+++ .|++|.+.... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 579999999999999999998766655 48999986432 233456788899999999999999999998764 567
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++++++.+++|.+++......++...++.++.||+.||.|||+.|++|+||+|+||++..+ +.++|+|||++.......
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~-~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGADE 163 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCC-CcEEEccccccccccCCC
Confidence 8999999999999998776668999999999999999999999999999999999999766 789999999997654332
Q ss_pred ccc---cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhh
Q psy3663 174 KLE---TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 174 ~~~---~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (259)
... ....+..|++||.+.+..++. ++|+||||+++|+|++ |..||.+....+....+..
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~ 226 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 226 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhC
Confidence 221 122345799999998877775 9999999999999997 9999987766655444433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=240.84 Aligned_cols=215 Identities=23% Similarity=0.397 Sum_probs=174.1
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCc----eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGE----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.++|++.+.||.|++|.||+|.+..++. ++++|.+.... .......+..|+..+..++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 3689999999999999999999876666 47777764322 22234567778888899999999999998754 456
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++++++.+++|.+++......+++..+..++.||+.|+.+||+++++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~-~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD-SIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEEcCCccceeccCC
Confidence 78999999999999998776679999999999999999999999999999999999999666 78999999998765332
Q ss_pred Ccc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 173 QKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 173 ~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
... ....++..|+|||.+.+..++. ++|+||||+++|++++ |..||.........+.+.+..
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 228 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTH-QSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE 228 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCc-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence 211 1223456899999998777765 9999999999999998 999998877666555554433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=238.39 Aligned_cols=209 Identities=32% Similarity=0.503 Sum_probs=180.9
Q ss_pred eeecccccceEEEEEEeec---CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccC
Q psy3663 24 ETLGRGHFAVVKLARHVFT---GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGD 100 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (259)
+.||.|++|.||.|.+... +..+++|.+....... ....+.+|+.+++.++|+|++++++++.+...++++|||+.
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 4689999999999998866 8899999997654332 46788899999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 101 GGDLYDYIMKH--------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 101 ~~sL~~~~~~~--------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++|.+++... ...+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDD 158 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC-CcEEEcccccccccccc
Confidence 99999999876 4669999999999999999999999999999999999999777 78999999998776543
Q ss_pred C---ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 173 Q---KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 173 ~---~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
. ......++..|+|||.+.....+. ++|+||||+++|+|++ |..||......+....+.+..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 224 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTS-KSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY 224 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcch-hhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 2 122334567899999988776664 9999999999999999 699999988888888877643
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=239.07 Aligned_cols=212 Identities=26% Similarity=0.485 Sum_probs=177.3
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc-------cHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV-------SQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~-------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
+|.+...||.|++|.||.|.+..++..+++|.+........ ....+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 57889999999999999999988899999998876543221 12457789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.++++||+++++|.+++.... .+++..+..++.|++.|+.+||++|++|+||+|+||+++++ +.++|+|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~-~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK-GGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCC-CCEEecccCCCccccc
Confidence 999999999999999997654 48899999999999999999999999999999999999666 7899999998876542
Q ss_pred CCc-------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 172 GQK-------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 172 ~~~-------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
... .....++..|+|||.+.+..++. ++|+||||+++++|++|+.||...+.......+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTR-KADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCc-hhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc
Confidence 211 11224567899999998777765 89999999999999999999987665555444444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=244.78 Aligned_cols=232 Identities=24% Similarity=0.419 Sum_probs=189.0
Q ss_pred cCeeEeeeecccccceEEEEEEee-----cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.+|++.+.||.|++|.||+|.+.. .+..+++|++.... .......+.+|+.++..++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 468889999999999999998753 35789999987543 223346688899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCe
Q psy3663 93 YLILELGDGGDLYDYIMKH---------------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV 157 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~---------------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~ 157 (259)
+++++|+.+.+|.+++... ...++...++.++.|++.||.+||++|++|+||||+||++.++ +.
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~ 162 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK-LN 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC-Cc
Confidence 9999999999999998532 1237888899999999999999999999999999999999766 78
Q ss_pred EEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhh
Q psy3663 158 VKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 158 i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (259)
++|+|||++......... .....+..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+..+.+.+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~ 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSI-DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCc-chhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999987655332211 1223456899999998777765 9999999999999998 8899998888888888877
Q ss_pred cccccc------------ccccccCchhhhh
Q psy3663 234 VSESSC------------TCWWRGRPRSRRR 252 (259)
Q Consensus 234 ~~~~~~------------~~~~~~~~~~~~~ 252 (259)
....+. ..+|..+|.+|..
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~ 272 (283)
T cd05091 242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPR 272 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHhCCCcccCCC
Confidence 654332 2578888877654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=239.66 Aligned_cols=217 Identities=24% Similarity=0.375 Sum_probs=177.6
Q ss_pred cccCeeEeeeecccccceEEEEEEee-----cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
..++|++.+.||+|++|.||.|.+.. .+..+++|.+.... .......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45789999999999999999998642 34679999886432 2223456788999999999999999999999889
Q ss_pred eEEEEEeccCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEE
Q psy3663 91 KLYLILELGDGGDLYDYIMKHD---------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLT 161 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~---------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~ 161 (259)
..+++|||+.+++|.+++.... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~-~~~~l~ 161 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIG 161 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCC-CCEEEC
Confidence 9999999999999999986532 225677899999999999999999999999999999999766 789999
Q ss_pred eccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 162 DFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 162 df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
|||++......... .....+..|+|||.+.+..++. ++|+||||+++|+|++ |..||.....++..+.+.+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG 238 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 99988654322211 1123356799999998777765 9999999999999999 799999888877777766544
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=238.14 Aligned_cols=215 Identities=22% Similarity=0.439 Sum_probs=180.9
Q ss_pred cCeeEeeeecccccceEEEEEEeec---CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFT---GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
++|++.+.||.|++|.||+|..... ...+++|.+.... .......+.+|+.+++.++|+||+++++.+.++...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 5799999999999999999987644 4579999886543 23345667889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+||++.+++|.+++......++...++.++.|++.|+.+||+++|+|+||+|+||+++.+ +.++|+|||.+........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~-~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CCEEECccchhhccccccc
Confidence 999999999999998766678999999999999999999999999999999999999766 7899999999877642111
Q ss_pred c---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 175 L---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 ~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
. .....+..|+|||.+....++. ++|+||||+++|+|++ |..||......+....+.+..
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~ 225 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY 225 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCcc-ccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC
Confidence 1 1122346799999988777765 9999999999999998 999998888777777776543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=240.83 Aligned_cols=232 Identities=23% Similarity=0.405 Sum_probs=184.1
Q ss_pred cCeeEeeeecccccceEEEEEEe----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHV----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.+|++.+.||+|++|.||+|... ..+..+++|.+.... .......+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 57899999999999999999853 355789999987533 2233467888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCe
Q psy3663 94 LILELGDGGDLYDYIMKHD----------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV 157 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~----------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~ 157 (259)
++|||+.+++|.+++.... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.+ +.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~-~~ 162 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ-LH 162 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC-Cc
Confidence 9999999999999985331 236788899999999999999999999999999999999766 78
Q ss_pred EEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhh
Q psy3663 158 VKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 158 i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (259)
++|+|||++........ .....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||...+..+..+.+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS-DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999876532211 12223455799999987777665 9999999999999998 9999987776666665554
Q ss_pred ccccc------------cccccccCchhhhh
Q psy3663 234 VSESS------------CTCWWRGRPRSRRR 252 (259)
Q Consensus 234 ~~~~~------------~~~~~~~~~~~~~~ 252 (259)
....+ ...+|..+|.+|..
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 272 (283)
T cd05090 242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPR 272 (283)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcccCcccCcC
Confidence 33221 13456666666653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=238.31 Aligned_cols=216 Identities=23% Similarity=0.437 Sum_probs=181.5
Q ss_pred cCeeEeeeecccccceEEEEEEeecCc---eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
++|++.+.||+|++|.||+|.+..++. .+++|.+.... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 579999999999999999999765544 79999886543 23345678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+||++++++|.+++......++..+++.++.|++.|+.+||+.+++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCC-CeEEeCCCCcccccccccc
Confidence 999999999999998776678999999999999999999999999999999999999766 7899999998876543321
Q ss_pred cc----cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 175 LE----TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 175 ~~----~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
.. ....+..|++||.+.+..++. ++|+||||+++|++++ |..||......+....+.+...
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~ 227 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR 227 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCc-hhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc
Confidence 11 111235799999998777665 9999999999999887 9999998888888777776543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=237.51 Aligned_cols=207 Identities=25% Similarity=0.467 Sum_probs=170.2
Q ss_pred eecccccceEEEEEEe--ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCC
Q psy3663 25 TLGRGHFAVVKLARHV--FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGG 102 (259)
Q Consensus 25 ~i~~g~~~~vy~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (259)
.||+|++|.||+|... ..+..+++|++.... .......+.+|+.+++.++|+||+++++++.. ...+++|||+.++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999765 334569999986543 33445678899999999999999999998754 5688999999999
Q ss_pred ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc----cc
Q psy3663 103 DLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE----TS 178 (259)
Q Consensus 103 sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~----~~ 178 (259)
+|.+++......+++..++.++.||+.|+.+||++|++|+||+|+||+++.+ +.++|+|||.+.......... ..
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ-HYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCC-CcEEeccCCccccccCCccceeccCCC
Confidence 9999998766679999999999999999999999999999999999999766 789999999887554332211 11
Q ss_pred cCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 179 CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 179 ~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
..+..|+|||.+....++. ++|+||||+++|++++ |..||......+....+.+..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 215 (257)
T cd05115 159 KWPLKWYAPECINFRKFSS-RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK 215 (257)
T ss_pred CCCcccCCHHHHccCCCCc-hhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC
Confidence 2245799999987777665 9999999999999996 999999888877776666544
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=237.31 Aligned_cols=214 Identities=27% Similarity=0.432 Sum_probs=181.6
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
..++|++.+.||.|++|.||+|.+. ++..+++|.+.... .....+.+|+.+++.++|+|++++++.+.+....+++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence 4578999999999999999999976 55789999987543 2456788999999999999999999999988899999
Q ss_pred EeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||++.+++|.+++.... ..++...+..++.|++.|+.+||++|++|+||+|+||+++++ +.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCC-CCEEECccccceeccchhh
Confidence 99999999999987653 458999999999999999999999999999999999999777 7899999998876543211
Q ss_pred c--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 175 L--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 ~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
. .....+..|+|||.+.+...+. ++|+||||++++++++ |+.||........+..+....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 221 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTI-KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY 221 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 1 1222345799999998776664 9999999999999998 999999888888888877643
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=242.30 Aligned_cols=219 Identities=25% Similarity=0.386 Sum_probs=182.6
Q ss_pred ccCeeEeeeecccccceEEEEEEee-----cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
.+.|.+.+.||+|++|.||+|.+.. ++..+++|.+..... ......+.+|+++++.++|+||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 3579999999999999999998653 357899999865432 2245778899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeE
Q psy3663 92 LYLILELGDGGDLYDYIMKHD-------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVV 158 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~-------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i 158 (259)
.+++|||+.+++|.+++...+ ..+++..+..++.|++.++.+||++|++|+||+|+||+++.+ +.+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~-~~~ 161 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD-LVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC-CeE
Confidence 999999999999999987642 337888999999999999999999999999999999999777 899
Q ss_pred EEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 159 KLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 159 ~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
+|+|||.+........ ......+..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+....+...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcch-hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999998865432221 11223456799999998877765 9999999999999998 99999888888888877765
Q ss_pred cccc
Q psy3663 235 SESS 238 (259)
Q Consensus 235 ~~~~ 238 (259)
..+.
T Consensus 241 ~~~~ 244 (280)
T cd05049 241 RLLQ 244 (280)
T ss_pred CcCC
Confidence 5443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=245.88 Aligned_cols=224 Identities=26% Similarity=0.449 Sum_probs=183.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-------
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN------- 89 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------- 89 (259)
.++|++.+.||.|++|.||+|.+..++..+++|.+..............+|+++++.++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 6899999999999999999999999999999999876543333345567899999999999999999887443
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
...+++++|+.+ ++...+......+++..+..++.||++||.+||+.|++|+||+|+||++.++ +.++|+|||++..
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~ 164 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQ-GILKIADFGLARP 164 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEECcCccchh
Confidence 346999999976 7888777666569999999999999999999999999999999999999766 7899999998876
Q ss_pred CCCCCccc------------cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 169 FNPGQKLE------------TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 169 ~~~~~~~~------------~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
........ ...++..|+|||.+.+....+.++|+||||+++|+|++|++||...+.......+.+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 54322211 113456799999887654444599999999999999999999999888888888877666
Q ss_pred cccccc
Q psy3663 237 SSCTCW 242 (259)
Q Consensus 237 ~~~~~~ 242 (259)
.+.+..
T Consensus 245 ~~~~~~ 250 (311)
T cd07866 245 TPTEET 250 (311)
T ss_pred CCChhh
Confidence 554433
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=243.71 Aligned_cols=217 Identities=33% Similarity=0.578 Sum_probs=180.9
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+++++.++||||+++++++.++...++++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47999999999999999999998889999999987654444345667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-cc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~ 176 (259)
|+.+.+|..+.... ..+++..++.++.||+.++.+||+.|++|+||+|+||+++++ +.++|+|||++........ ..
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~-~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC-CcEEEEeeeeeeeccCCccccC
Confidence 99988887765443 348999999999999999999999999999999999999776 7899999998876533222 22
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
...++..|+|||.+.+....+.++|+||||+++++|++|++||......+.+..+....+
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhC
Confidence 334677899999987654444589999999999999999999987776666666554433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=250.59 Aligned_cols=201 Identities=24% Similarity=0.372 Sum_probs=172.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-eEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS-KLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~ 96 (259)
+.|.-...||+|+||.||+|... ++..|+||.+....... ..++..|+.++.+++|||+++++++|.+.+ ..++|+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence 47777789999999999999866 44899999876654332 455999999999999999999999999888 599999
Q ss_pred eccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCCCCeEeeecCCeEEEEeccccccCCC-
Q psy3663 97 ELGDGGDLYDYIMKHDA-GLSETYAREYFAQIVRAISFCHKLH---VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP- 171 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~-~~~~~~i~~~~~ql~~al~~LH~~~---i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~- 171 (259)
||+..++|.+.+..... ++++..+.+|+.++++||+|||... |+|+|||++|||++.+ ...||+|||++.....
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~~~ 230 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGPEG 230 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCCcc
Confidence 99999999999987765 7999999999999999999999853 9999999999999866 6899999999965543
Q ss_pred CCccccc-cCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 172 GQKLETS-CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 172 ~~~~~~~-~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
....... .++.+|++||.......+. ++||||||++++|+++|+.|.....
T Consensus 231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~-KsDVySFGVvllElitgr~~~d~~~ 282 (361)
T KOG1187|consen 231 DTSVSTTVMGTFGYLAPEYASTGKLTE-KSDVYSFGVVLLELITGRKAVDQSR 282 (361)
T ss_pred ccceeeecCCCCccCChhhhccCCcCc-ccccccchHHHHHHHhCCcccCCCC
Confidence 3333333 7899999999998877765 9999999999999999999887543
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=236.13 Aligned_cols=205 Identities=31% Similarity=0.564 Sum_probs=177.1
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||.|+++.||.+.+..++..+++|.+............+.+|+.+++.++|+||+++++.+.+...+++++||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999988999999999987654445678889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc--
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE-- 176 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~-- 176 (259)
+.+++|.+++.... .+++..++.++.|++.++.+||+.|++|+||+|+||+++.+ +.++|+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~-~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEcccccccccCCCCCcccc
Confidence 99999999987654 37899999999999999999999999999999999999775 789999999887654332211
Q ss_pred ---cccCCCccCCcccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChH
Q psy3663 177 ---TSCGSLAYSAPEILLGDS---YDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226 (259)
Q Consensus 177 ---~~~~~~~~~apE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (259)
...++..|+|||.+.+.. .. .++|+||||++++++++|+.||.......
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~-~~~Dv~s~G~il~~l~~g~~pf~~~~~~~ 213 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHG-RAADIWSLGCVVLEMATGKRPWSELDNEF 213 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCC-cccchHHHHHHHHHHHhCCCCccCCcchH
Confidence 234677899999987655 44 49999999999999999999997654333
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=250.21 Aligned_cols=228 Identities=25% Similarity=0.446 Sum_probs=190.4
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe----cCCe
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID----TNSK 91 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~ 91 (259)
+..+|++.+.||.|++|.||+|.+..++..|++|.+............+.+|+.+++.++||||+++.+++. ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 458999999999999999999999999999999998765444445667788999999999999999998875 3357
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.++++||+.+ +|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 83 VYVVMDLMES-DLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED-CELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEEehhhh-hHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEecccccceeecc
Confidence 8999999965 8888876544 38999999999999999999999999999999999999766 8899999998865432
Q ss_pred CCc-----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 172 GQK-----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 172 ~~~-----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
... .....++..|+|||.+.+....+.++|+||||+++|+|++|++||...+....+..+....+.++.+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 211 122356778999999866443445999999999999999999999998888888888888887777666543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=247.16 Aligned_cols=204 Identities=26% Similarity=0.408 Sum_probs=168.8
Q ss_pred Eeeeeccc--ccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEecc
Q psy3663 22 LEETLGRG--HFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELG 99 (259)
Q Consensus 22 ~~~~i~~g--~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (259)
+.+.||+| +++.||++.+..+++.|++|.+............+.+|+.+++.++||||+++++++.+++..+++|||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 6789999999999999999999766544445567888999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc----
Q psy3663 100 DGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK---- 174 (259)
Q Consensus 100 ~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~---- 174 (259)
.+++|.+++... ...+++..++.++.|++.||.|||+++|+|+||+|+||+++.+ +.+++.||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~-~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC-CcEEEcccchhhccccccccccc
Confidence 999999998754 3458999999999999999999999999999999999999776 7899999986543221111
Q ss_pred ----cccccCCCccCCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q psy3663 175 ----LETSCGSLAYSAPEILLGD--SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227 (259)
Q Consensus 175 ----~~~~~~~~~~~apE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (259)
.....++..|+|||.+.+. .++ .++|+|||||++++|++|+.||........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~ 218 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQM 218 (327)
T ss_pred cccccccccceecccChHHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 0112345679999998753 344 499999999999999999999987654443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=238.08 Aligned_cols=215 Identities=30% Similarity=0.526 Sum_probs=183.5
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||.|+++.||++.+..++..+++|.+............+.+|+.+++.++|+||+++++.+.+.+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 58999999999999999999999999999999877554444566788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc-c
Q psy3663 99 GDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL-E 176 (259)
Q Consensus 99 ~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~-~ 176 (259)
+.+++|.+++.... ..+++..+..++.|++.++.+||+++++|+||+|+||+++++...++|+||+.+......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999999987643 347899999999999999999999999999999999999777556799999988765433222 2
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
...++..|+|||.+.+...+. ++|+||||+++++|++|..||...+..+....+.+.
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 217 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG 217 (257)
T ss_pred ccCCCccccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 234677899999987776665 999999999999999999999877766666555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=240.51 Aligned_cols=204 Identities=33% Similarity=0.579 Sum_probs=174.4
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||.|++|.||+|.+..++..+++|.+..... .......+.+|+.+++.++|+||+++++.+...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 579999999999999999999998999999998865432 2233467788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 97 ELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 97 e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
|++.+++|.+++... ...+++..++.++.||+.++.+||++|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEECcchhhhccccCC
Confidence 999999999988642 3458999999999999999999999999999999999999766 789999999887654332
Q ss_pred c-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 174 K-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 174 ~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
. .....++..|+|||.+.+...+. ++|+||||+++++|++|..||....
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccc-hhhHHHHHHHHHHHHhCCCCccccc
Confidence 2 22345778899999998777765 9999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=244.46 Aligned_cols=228 Identities=28% Similarity=0.457 Sum_probs=189.4
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-CC
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT-NS 90 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 90 (259)
+.-.+.++|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.+++.++||||+++.+++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557889999999999999999999999999999999986544334445677889999999999999999999865 56
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
..++++|++. .+|..++... ++++..+..++.||+.||.+||+++++|+||+|+||++..+ +.++|+|||.+....
T Consensus 84 ~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~-~~~~l~dfg~~~~~~ 159 (328)
T cd07856 84 DIYFVTELLG-TDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN-CDLKICDFGLARIQD 159 (328)
T ss_pred cEEEEeehhc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCC-CCEEeCccccccccC
Confidence 7889999995 4888877643 47888899999999999999999999999999999999765 789999999887543
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
.. .....++..|+|||.+.+....+.++|+||||+++|+|++|+.||........+..+.+.++.++.+|+..
T Consensus 160 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 160 PQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred CC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 22 22334567899999886644344599999999999999999999998888778888888877777666553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=235.50 Aligned_cols=212 Identities=25% Similarity=0.424 Sum_probs=179.0
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||.|++|.||+|.+. .+..|++|.+.... .....+.+|+.++++++|+||+++++++...+..+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 367999999999999999999865 45689999986543 23566888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
|++.+++|.+++.... ..++...+..++.|++.|+.+||++|++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCC-CCEEECCcceEEEccCCccc
Confidence 9999899999987653 458999999999999999999999999999999999999776 78999999988766432211
Q ss_pred c--cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 176 E--TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 176 ~--~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
. .......|+|||.+.+...+. ++|+||||+++++|++ |+.||.+......+..+.+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSI-KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220 (261)
T ss_pred ccCCCcCceeccCccccccCCCCc-hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 1 111234799999988777765 9999999999999999 99999988877777776554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=239.30 Aligned_cols=204 Identities=36% Similarity=0.661 Sum_probs=175.1
Q ss_pred ecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCCh
Q psy3663 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDL 104 (259)
Q Consensus 26 i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (259)
||.|++|.||+|.+..++..+++|++...... ......+.+|+.+++.++||||+++++.+.+....++++||+.+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999988999999999765432 23456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCCCcc
Q psy3663 105 YDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAY 184 (259)
Q Consensus 105 ~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~ 184 (259)
.+++..... +++..+..++.||+.+|.+||+++++|+||+|+||+++.+ +.++|+||+.+.............++..|
T Consensus 81 ~~~l~~~~~-l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 158 (262)
T cd05572 81 WTILRDRGL-FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTPEY 158 (262)
T ss_pred HHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCC-CCEEEeeCCcccccCcccccccccCCcCc
Confidence 999876543 8999999999999999999999999999999999999776 78999999998776544333334567889
Q ss_pred CCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--ChHHHHHhh
Q psy3663 185 SAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN--DSETLTMIM 232 (259)
Q Consensus 185 ~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~i~ 232 (259)
++||.+.+..++. ++|+||+|+++|+|++|..||.... ..+....+.
T Consensus 159 ~~PE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 207 (262)
T cd05572 159 VAPEIILNKGYDF-SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207 (262)
T ss_pred cChhHhcCCCCCC-hhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh
Confidence 9999987777665 9999999999999999999998776 455555555
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=236.75 Aligned_cols=211 Identities=25% Similarity=0.485 Sum_probs=177.7
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
.+|++.+.||+|++|.||+|.+. .+..+++|.+..... ....+.+|+++++.++|+||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 35889999999999999999876 566899999864332 34567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~ 177 (259)
++++++|.+++......+++..++.++.||+.++.+||++|++|+||+|+||+++.+ +.++|+|||.+...........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED-NVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC-CcEEECCcccceeccccccccc
Confidence 999999999988766668999999999999999999999999999999999999766 7899999998865533221111
Q ss_pred --ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 178 --SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 178 --~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
...+..|+|||.+.+..++. ++|+||||+++|++++ |+.||......+....+...
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 217 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSS-KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217 (256)
T ss_pred CCCCCCccccCHHHhccCCCCc-hhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC
Confidence 11234799999998877775 9999999999999998 89999888877777776654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=240.04 Aligned_cols=234 Identities=26% Similarity=0.431 Sum_probs=195.4
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecC----ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTG----EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID 87 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~----~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (259)
.-.+....|++.+.||.|.||.||+|....++ +.++||.++.+..........-+|+.+++.++|||++.+..++.
T Consensus 18 ~rve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 18 ERVEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred hhHHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 33456678999999999999999999644333 26899999766443334566679999999999999999999987
Q ss_pred c-CCeEEEEEeccCCCChHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec---CCeEE
Q psy3663 88 T-NSKLYLILELGDGGDLYDYIMKH----DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER---LGVVK 159 (259)
Q Consensus 88 ~-~~~~~lv~e~~~~~sL~~~~~~~----~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~---~~~i~ 159 (259)
. ...+++++||... +|.+++... ...++...+..++.||+.++.|||++-+.|+||||.||+|+.+ .|+|+
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 6 6789999999977 888888654 2448899999999999999999999999999999999999765 47999
Q ss_pred EEeccccccCCCCC----ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------ChH
Q psy3663 160 LTDFGFSNRFNPGQ----KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN---------DSE 226 (259)
Q Consensus 160 l~df~~~~~~~~~~----~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---------~~~ 226 (259)
|.|+|+++.+...- .....+-+..|+|||.+.+..+++++.|+|++||++.||++..+.|.+.. ..+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999998775432 22334568899999999999999999999999999999999999996532 457
Q ss_pred HHHHhhhccccccccccccC
Q psy3663 227 TLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 227 ~~~~i~~~~~~~~~~~~~~~ 246 (259)
++..|.++++++...-|-+-
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~l 276 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDL 276 (438)
T ss_pred HHHHHHHHcCCCccccchhh
Confidence 89999999999998888543
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=242.86 Aligned_cols=214 Identities=32% Similarity=0.582 Sum_probs=191.1
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-.++|++.+.||+|.||.|.++..+.+++.|++|++++.-. .......-..|-++|+.++||-+..+--.|..++..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 45689999999999999999999999999999999987643 33334555678899999999999888888999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc-CCCCC
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~-~~~~~ 173 (259)
||||.+|+.|--.+..... +++++...+...|+.||.|||+++|+++|||.+|.+++.+ |+++|.|||++.. +..+.
T Consensus 246 VMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkD-GHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKD-GHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccC-CceEeeecccchhcccccc
Confidence 9999999999887766554 9999999999999999999999999999999999999777 8999999999854 34556
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
.+.+.++++.|.|||++....+.. +.|.|.+|++||||++|++||.+.+.+..++.|+
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgr-aVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl 381 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGR-AVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL 381 (516)
T ss_pred eeccccCChhhcCchhhccccccc-eeehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence 677889999999999999999987 9999999999999999999999999999888887
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=234.51 Aligned_cols=210 Identities=30% Similarity=0.582 Sum_probs=182.3
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++|++++++.+++......++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 58899999999999999999988899999999876543 3467788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS 178 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~ 178 (259)
+++.+|.+++......+++..+..++.|++.++.+||++|++||||+|+||+++++ +.++|+|||.+............
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD-GEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccC-CeEEEeeccccccccccccccce
Confidence 99899999998775569999999999999999999999999999999999999776 78999999998776554323445
Q ss_pred cCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 179 CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 179 ~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
.++..|+|||.+.+...+. ++|+||||+++++|++|+.||...+.......+.
T Consensus 158 ~~~~~~~~PE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 210 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIA 210 (253)
T ss_pred ecCCcccCHHHHcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Confidence 6788999999988776654 9999999999999999999998775544444333
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=246.22 Aligned_cols=227 Identities=26% Similarity=0.462 Sum_probs=187.6
Q ss_pred ccccCeeE-eeeecccccceEEEEEEeecCceEEEEEcccCCCCccc------------HHHHHHHHHHHHhCCCCCeEE
Q psy3663 15 KIAGLYDL-EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS------------QDHLYQEVRCMKLVQHPNVVR 81 (259)
Q Consensus 15 ~~~~~y~~-~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~------------~~~~~~e~~~l~~l~~~~i~~ 81 (259)
.+.++|.. .+.||.|++|.||+|.+...++.|++|.+......... ...+.+|+.+++.++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 46778875 57799999999999999999999999998754322110 124678999999999999999
Q ss_pred EEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEE
Q psy3663 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLT 161 (259)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~ 161 (259)
+++++......+++||++.+ +|.+++.... .+++..+..++.||+.||.+||+.|++|+||+|+||++..+ +.++|+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~-~~~kl~ 161 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMAS-DLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK-GICKIA 161 (335)
T ss_pred eeEEEecCCcEEEEEecccc-CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCC-CCEEEC
Confidence 99999999999999999975 8999886544 38999999999999999999999999999999999999766 789999
Q ss_pred eccccccCCCC---------------CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH
Q psy3663 162 DFGFSNRFNPG---------------QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226 (259)
Q Consensus 162 df~~~~~~~~~---------------~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (259)
|||.+...... .......++..|+|||.+.+....+.++|+||||+++++|++|++||...+..+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99988655411 111122356689999998765544459999999999999999999999999988
Q ss_pred HHHHhhhccccccccccc
Q psy3663 227 TLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 227 ~~~~i~~~~~~~~~~~~~ 244 (259)
.+..+.+..+.+....|.
T Consensus 242 ~~~~i~~~~~~~~~~~~~ 259 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWP 259 (335)
T ss_pred HHHHHHHHhCCCchhhCc
Confidence 888888877777666554
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=235.97 Aligned_cols=212 Identities=29% Similarity=0.465 Sum_probs=176.8
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC---CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CeE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK---LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--SKL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 92 (259)
..|++.+.||+|++|.||+|.+..+++.+++|.+.... ........+.+|+.+++.++|+||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875432 1223456788899999999999999999998653 568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
++++|++.+++|.+++..... +++..+..++.|++.|+.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSA-GNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECccccccccccc
Confidence 899999999999999876544 8899999999999999999999999999999999999765 78999999988755321
Q ss_pred ----CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 173 ----QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 173 ----~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
.......++..|+|||.+.+...+. ++|+||||+++++|++|+.||..........++.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 222 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGR-KADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH
Confidence 1112234677899999998877665 9999999999999999999998776555555444
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=252.62 Aligned_cols=192 Identities=26% Similarity=0.349 Sum_probs=166.2
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
...|.+.+.||.|++|.||+|.+...+..|++|... ...+.+|++++++++|+||+++++++...+..+++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 458999999999999999999999999999999632 223568999999999999999999999889999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc-
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL- 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~- 175 (259)
+++.+ +|..++......+++..++.++.||+.+|.|||++||+|+||||+||+++.+ +.++|+|||++.........
T Consensus 240 e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~-~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 240 PKYRS-DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGP-EDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCC-CCEEEcccCCceecccccccc
Confidence 99965 8888887766669999999999999999999999999999999999999766 78999999998765332211
Q ss_pred --ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy3663 176 --ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPF 219 (259)
Q Consensus 176 --~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 219 (259)
....++..|+|||.+.+..++. ++|||||||++|||++|..|+
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~-~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTP-SVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCc-hHHHHHHHHHHHHHHHcCCCc
Confidence 2235788999999998887775 999999999999999987655
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=240.78 Aligned_cols=214 Identities=25% Similarity=0.408 Sum_probs=177.1
Q ss_pred cCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
++|.+.+.||+|++|.||+|.+. .++..+++|.+.... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 57999999999999999999754 234568888875432 22345688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCe
Q psy3663 93 YLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV 157 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~ 157 (259)
+++|||+.+++|.+++.... ..+++..++.++.||+.|+.+||++|++|+||+|+||+++.+ +.
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~-~~ 161 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN-LL 161 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-Cc
Confidence 99999999999999987542 237889999999999999999999999999999999999766 78
Q ss_pred EEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhh
Q psy3663 158 VKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 158 i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (259)
++|+|||.+......... ....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||...+..+..+.+..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 999999988655432211 1223456899999998877765 9999999999999998 9999988887777776655
Q ss_pred cc
Q psy3663 234 VS 235 (259)
Q Consensus 234 ~~ 235 (259)
..
T Consensus 241 ~~ 242 (291)
T cd05094 241 GR 242 (291)
T ss_pred CC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=238.94 Aligned_cols=208 Identities=28% Similarity=0.557 Sum_probs=176.0
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC---CCCeEEEEEEEecCCeEEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ---HPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv 95 (259)
.|++.+.||.|++|.||+|.+..++..+++|.+.... .......+.+|+.+++.++ |||++++++.+.+....+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 5888999999999999999999899999999986543 2334567888999999997 99999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK- 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~- 174 (259)
|||+.+++|.+++... .+++..++.++.|++.++.+||+.|++|+||+|+||+++++ +.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06917 81 MEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT-GNVKLCDFGVAALLNQNSSK 157 (277)
T ss_pred EecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC-CCEEEccCCceeecCCCccc
Confidence 9999999999988653 58999999999999999999999999999999999999775 7899999998876644332
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTM 230 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (259)
.....++..|+|||.+.+....+.++|+||||+++|+|++|..||...........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~ 213 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc
Confidence 22335677899999887654444599999999999999999999987665544433
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=248.48 Aligned_cols=209 Identities=27% Similarity=0.414 Sum_probs=170.6
Q ss_pred ccccCeeEeeeecccccceEEEEEEeec-----CceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEec
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFT-----GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDT 88 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 88 (259)
.-.++|.+.+.||.|+||.||+|.+... +..|++|.+.... .......+.+|++++..+. ||||+++++++.+
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3356888999999999999999986433 3469999986543 2333567889999999996 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC--------------------------------------------------------
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHD-------------------------------------------------------- 112 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~-------------------------------------------------------- 112 (259)
....+++|||+.+++|.+++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 999999999999999998875421
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee
Q psy3663 113 ---------------------------------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE 153 (259)
Q Consensus 113 ---------------------------------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~ 153 (259)
..+++..+..++.||+.||.+||+.+++|+||+|+||+++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 23677888999999999999999999999999999999976
Q ss_pred cCCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChH
Q psy3663 154 RLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSE 226 (259)
Q Consensus 154 ~~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (259)
+ +.++|+|||++........ .....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||.......
T Consensus 273 ~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 273 G-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT-LSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred C-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 6 7899999999875533221 11223456799999998877765 9999999999999997 999997755433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=235.81 Aligned_cols=214 Identities=31% Similarity=0.505 Sum_probs=181.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||.|++|.||+|.+..++..+++|++....... ....+.+|+.+++.++|+|++++++.+......++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 47999999999999999999988899999999987654333 56778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 98 LGDGGDLYDYIMKH--DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 98 ~~~~~sL~~~~~~~--~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
++.+++|.+++... ...+++..+..++.||+.|+.+||+.|++|+||+|+||+++++ +.++|+|||.+.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~-~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDR 158 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEcccchHHHhccCccc
Confidence 99999999998764 2458999999999999999999999999999999999999776 78999999988665433222
Q ss_pred -----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 176 -----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 176 -----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
....++..|+|||.+......+.++|+||||+++++|++|+.||...+....+.....
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 221 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ 221 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc
Confidence 2234677899999987763334599999999999999999999987766555555443
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=239.14 Aligned_cols=214 Identities=26% Similarity=0.426 Sum_probs=177.4
Q ss_pred cCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.+|.+.+.||+|++|.||+|... .++..+++|.+.... ......+.+|+++++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 47889999999999999999743 345688888876432 34456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeE
Q psy3663 93 YLILELGDGGDLYDYIMKHD--------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVV 158 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~--------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i 158 (259)
+++|||+.+++|.+++.... ..+++..++.++.||+.|+.+||++|++|+||+|+||++.++ +.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~-~~~ 161 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG-LVV 161 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC-CCE
Confidence 99999999999999987643 247889999999999999999999999999999999999765 789
Q ss_pred EEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 159 KLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 159 ~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
+|+|||++......... .....+..|+|||.+.+..++. ++|+||||+++|+|++ |.+||......+....+.+.
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT-ESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCc-hhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 99999988654332211 1122356799999988777765 9999999999999998 99999888777777766654
Q ss_pred c
Q psy3663 235 S 235 (259)
Q Consensus 235 ~ 235 (259)
.
T Consensus 241 ~ 241 (280)
T cd05092 241 R 241 (280)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=237.37 Aligned_cols=214 Identities=26% Similarity=0.409 Sum_probs=175.8
Q ss_pred eeEeeeecccccceEEEEEEeecC---ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC------
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTG---EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS------ 90 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 90 (259)
|++.+.||+|++|.||.|....++ ..+++|.+............+.+|+..++.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678899999999999999876543 78999998765544455677889999999999999999999875544
Q ss_pred eEEEEEeccCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKH-----DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~-----~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
..++++||+.+++|..++... ...+++..++.++.|++.||.+||+.+++|+||+|+||++.++ +.++|+|||.
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~ 159 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED-MTVCVADFGL 159 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCC-CeEEECCccc
Confidence 379999999999999988543 2348999999999999999999999999999999999999766 7899999999
Q ss_pred cccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 166 SNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 166 ~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
+......... .....+..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+.++.+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 232 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN 232 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 8765432211 1122346799999987776665 9999999999999999 999998888777777666543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=246.92 Aligned_cols=226 Identities=26% Similarity=0.432 Sum_probs=188.6
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC---
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS--- 90 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 90 (259)
..+.++|++.+.||+|++|.||.|.+..++..|++|.+............+.+|+.+++.++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 45788999999999999999999999999999999998654433334566889999999999999999999986543
Q ss_pred ---eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 91 ---KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 91 ---~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.++++++++ +.+|..++.. ..+++..++.++.||+.|+.+||+.||+|+||+|+||+++.+ +.++|+|||.+.
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~-~~~kl~dfg~~~ 166 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLAR 166 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeccccc
Confidence 468999999 6699888764 348999999999999999999999999999999999999766 789999999887
Q ss_pred cCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
..... .....++..|++||.+.+....+.++|+||||++++++++|+.||...+....+..+.+..++.+..|+..
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 167 QTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 55332 22335577899999987643334599999999999999999999998888888888888777766665544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=240.56 Aligned_cols=203 Identities=26% Similarity=0.473 Sum_probs=174.9
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|++|.||+|.+..++..+++|.+.... .......+.+|+++++.++||||+++++.+.+++.+++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 46999999999999999999999999999999986542 23345668899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
|+++++|.+++.... .+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.+ +.++|+|||.+...... ...
T Consensus 80 y~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~~~ 156 (308)
T cd06615 80 HMDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDS-MAN 156 (308)
T ss_pred ccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC-CcEEEccCCCccccccc-ccc
Confidence 999999999987654 48999999999999999999997 699999999999999766 78999999988654322 223
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
...++..|+|||.+.+..++. ++|+||||+++++|++|+.||...+..
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~~p~~~~~~~ 204 (308)
T cd06615 157 SFVGTRSYMSPERLQGTHYTV-QSDIWSLGLSLVEMAIGRYPIPPPDAK 204 (308)
T ss_pred cCCCCcCccChhHhcCCCCCc-cchHHHHHHHHHHHHhCCCCCCCcchh
Confidence 445778999999987766664 999999999999999999999765533
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=235.01 Aligned_cols=210 Identities=33% Similarity=0.565 Sum_probs=182.1
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||+|++|.+|++.+...++.|++|.+............+.+|++++.+++|+|++++.+++.+...+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 58999999999999999999998999999999987765545677889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-ccc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~~ 177 (259)
+.+.+|.+++... ..+++..++.++.|++.++.+||++|++|+||+|+||+++.+ +.++|+||+.+........ ...
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~ 158 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDAS 158 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC-CCEEEeccccceecCCCcccccc
Confidence 9999999998766 348999999999999999999999999999999999999775 7899999999877654333 123
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i 231 (259)
..++..|+|||...+...+ .++|+|++|+++++|++|..||...........+
T Consensus 159 ~~~~~~y~~pe~~~~~~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~ 211 (254)
T cd06627 159 VVGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI 211 (254)
T ss_pred cccchhhcCHhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 4567789999998776655 4999999999999999999999876654444443
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=247.37 Aligned_cols=226 Identities=27% Similarity=0.438 Sum_probs=187.1
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
++..+|++.+.||.|++|.||.|.+..++..|++|.+............+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 456789999999999999999999999999999999876543344456677899999999999999999987544
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
...++++||+.+ +|.+++.... .+++..+..++.|++.||.+||+++++|+||+|+||+++.+ +.++|+|||++...
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~-~~~kL~Dfg~~~~~ 158 (337)
T cd07858 82 NDVYIVYELMDT-DLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARTT 158 (337)
T ss_pred CcEEEEEeCCCC-CHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC-CCEEECcCcccccc
Confidence 347999999964 8888876544 49999999999999999999999999999999999999766 78999999998765
Q ss_pred CCC-CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 170 NPG-QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 170 ~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
... .......++..|+|||.+........++|+||||+++|+|++|++||...+....+..+.+..+.++...|
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 433 22233456778999998865333345999999999999999999999988877888888777776655554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=235.33 Aligned_cols=212 Identities=27% Similarity=0.478 Sum_probs=178.4
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||.|++|.||+|.+. ++..+++|.+.... .....+.+|+.+++.++|+||+++++.+.+....++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 468999999999999999999865 56679999876432 23567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
|++.+++|.+++... ...++...++.++.|++.||.+||+++++|+||+|+||+++.+ +.++|+|||.+.........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~-~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSES-LMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCC-CcEEECCCccceecCCCcee
Confidence 999999999998654 4558899999999999999999999999999999999999766 78999999998765432221
Q ss_pred --ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 176 --ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 176 --~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
....++..|+|||.+.+...+. ++|+||||+++|+|++ |..||......+....+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220 (261)
T ss_pred ccCCCccceecCCHHHhccCCCCh-hhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 1122355799999988777664 8999999999999998 99999887777777666544
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=234.16 Aligned_cols=215 Identities=31% Similarity=0.579 Sum_probs=187.6
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.||.|++|.||+|.+..++..+++|.+............+.+|+++++.++|+|++++.+.+......++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58999999999999999999998999999999987665556677888999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-c
Q psy3663 99 GDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-K 174 (259)
Q Consensus 99 ~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~ 174 (259)
+++++|.+++... ...+++..+..++.+++.++.+||++|++|+||+|+||+++++ +.++|+||+.+....... .
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC-CcEEECCccceeecccCcce
Confidence 9999999998875 3669999999999999999999999999999999999999766 789999999887654433 2
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
.....++..|+|||...+...+. ++|+||+|+++++|++|..||...+..+....+.+..
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~ 219 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNY-KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ 219 (258)
T ss_pred ecceeeeecccChhHhccCCCCc-cccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC
Confidence 23345677899999988777665 9999999999999999999998887777766666543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=240.06 Aligned_cols=217 Identities=27% Similarity=0.435 Sum_probs=180.9
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
......|+..+.||+|++|.||+|.+..++..+++|.+..... .......+.+|+++++.++|+|++++++++.+....
T Consensus 21 ~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (317)
T cd06635 21 EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA 100 (317)
T ss_pred CCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeE
Confidence 4444568999999999999999999998999999999875432 223345788899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++|||+.+ ++.+.+.....++++..+..++.|++.++.+||++|++|+||+|+||++..+ +.++|+|||.+.....
T Consensus 101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~-~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASIASP- 177 (317)
T ss_pred EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC-CCEEEecCCCccccCC-
Confidence 999999976 8888877666669999999999999999999999999999999999999665 7899999998765432
Q ss_pred CccccccCCCccCCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 173 QKLETSCGSLAYSAPEILL---GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
.....++..|+|||.+. ....+ .++|+||||+++++|++|+.||...........+.+...
T Consensus 178 --~~~~~~~~~y~aPE~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~ 241 (317)
T cd06635 178 --ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES 241 (317)
T ss_pred --cccccCCccccChhhhhcCCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC
Confidence 22345677899999874 23344 499999999999999999999988777666666665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=249.82 Aligned_cols=231 Identities=27% Similarity=0.434 Sum_probs=194.3
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS- 90 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 90 (259)
...++.++|++.+.||.|++|.||+|.+..++..|++|.+............+.+|+.+++.++|+|++++.+++....
T Consensus 9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 4557889999999999999999999999999999999998765433334566778999999999999999988775544
Q ss_pred -----eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 91 -----KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 91 -----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
..+++++++ +.+|.+++.. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||.
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~-~~~kL~dfg~ 164 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED-CELKILDFGL 164 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CCEEEccccc
Confidence 389999999 5599998865 348999999999999999999999999999999999999776 7899999999
Q ss_pred cccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 166 SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
+...... .....++..|+|||.+.+....+.++|+||||+++|+|++|+.||......+.+..+.+..+++++.+|.+
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 165 ARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 8765432 23335677899999986644444599999999999999999999999988899999999888887777665
Q ss_pred Cch
Q psy3663 246 RPR 248 (259)
Q Consensus 246 ~~~ 248 (259)
-+.
T Consensus 243 ~~~ 245 (343)
T cd07851 243 ISS 245 (343)
T ss_pred ccc
Confidence 543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=246.81 Aligned_cols=225 Identities=27% Similarity=0.458 Sum_probs=183.5
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
.+.++|++.+.||+|++|.||+|.+..+++.|++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 35689999999999999999999999999999999986432 222345677899999999999999999886543
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
...++++|++.+ +|.+.+.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~ 156 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTN-CDLKICDFGLARIA 156 (336)
T ss_pred ceEEEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC-CCEEECcccceeec
Confidence 357999999976 88777754 348999999999999999999999999999999999999766 78999999988665
Q ss_pred CCCCcc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 170 NPGQKL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 170 ~~~~~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
...... ....++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+.......+.+..+.+..+.|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 332211 223467789999987654433459999999999999999999999888888888887777766555544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=230.29 Aligned_cols=213 Identities=23% Similarity=0.523 Sum_probs=191.9
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecC--CeEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTN--SKLY 93 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~ 93 (259)
.++|++++.+|.|.++.||.|.+..++++++||+++.. ....+.+|+.||+.|+ +|||++++++..+. ..+.
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 46899999999999999999999999999999998765 4788999999999998 99999999998764 5688
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+|+|+++..+...+... ++...+..++.+|+.||.|+|+.||.|+|+||.|++++.....++|+|+|+|.....+.
T Consensus 112 LiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 99999998877776643 88899999999999999999999999999999999999888899999999999888777
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCChHHHHHhhhccccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPF-QEANDSETLTMIMDVSESS 238 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~ 238 (259)
.-...+.+-.|--||.+..-......-|+|||||+++.|...+.|| .+.++.+++.+|.+++|+.
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~ 253 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD 253 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence 7777777788899999988766666999999999999999988876 8889999999999999875
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=237.52 Aligned_cols=212 Identities=31% Similarity=0.496 Sum_probs=169.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHH-HHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR-CMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
++|++.+.||+|++|.||+|.+..+++.|++|.+........ ...+..|.. .++.++||||+++++.+......++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 479999999999999999999999999999999876533222 334444555 466678999999999999989999999
Q ss_pred eccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 97 ELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKL-HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 97 e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~-~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
||+++ +|.+++... ...+++..++.++.||+.++.+||++ +++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 80 EVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN-GQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecccccccccc
Confidence 99975 888877652 34589999999999999999999997 99999999999999766 78999999998765433
Q ss_pred CccccccCCCccCCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCC-CChHHHHHhhh
Q psy3663 173 QKLETSCGSLAYSAPEILLGD----SYDAPAVDVWSLGVILYMLVAGQAPFQEA-NDSETLTMIMD 233 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~i~~ 233 (259)
.......++..|+|||.+.+. .++ .++|+||||+++|+|++|+.||... ...+.+..+++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 222 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222 (283)
T ss_pred cccccccCCccccChhhcCCcccccccC-ccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh
Confidence 322334567789999988642 233 4899999999999999999999753 33344444443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=260.65 Aligned_cols=201 Identities=30% Similarity=0.472 Sum_probs=170.3
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEE-Ee---c---CC
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEV-ID---T---NS 90 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~---~---~~ 90 (259)
+++|.+.|.+|+|+.||+|.+...+..||+|.+... ++...+.+.+|+.++++|+ |+|||.+++. .. . .-
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 788999999999999999999988799999998765 5667888999999999998 9999999993 21 1 13
Q ss_pred eEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLH--VVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~--i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.+++.||||.|+.|.++++.+ ...+++.++++|+.|+++|+.+||..+ |||||||-+|||+..+ |.+||||||.++
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~-g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSAD-GNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCC-CCEEeCcccccc
Confidence 578999999989999999865 344999999999999999999999998 9999999999999777 789999999986
Q ss_pred cCCCCCccc----------cccCCCccCCcccc---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 168 RFNPGQKLE----------TSCGSLAYSAPEIL---LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 168 ~~~~~~~~~----------~~~~~~~~~apE~~---~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
......... ....++.|+|||.+ .+...+ +|+|||+|||++|.|+..++||....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~-eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIG-EKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCc-chhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 544332111 11368899999976 455555 59999999999999999999998763
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=240.03 Aligned_cols=212 Identities=28% Similarity=0.456 Sum_probs=176.5
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
....+|++.+.||.|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.++||||+++.+++.+....+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 334669999999999999999999998999999999865432 2233456888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+++||+.+ ++.+++......+++..+..++.||+.+|.+||+.|++|+||+|+||++.++ +.++|+|||++......
T Consensus 92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~-~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP-GTVKLADFGSASLVSPA- 168 (307)
T ss_pred EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC-CCEEEeecCcceecCCC-
Confidence 99999975 8888877666669999999999999999999999999999999999999766 78999999988654322
Q ss_pred ccccccCCCccCCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 174 KLETSCGSLAYSAPEILLG---DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
....++..|+|||.+.+ ..++ .++|+||||+++|+|++|+.||...+.......+.
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~ 227 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCC-cccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh
Confidence 23356778999998742 3344 49999999999999999999998766555544443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=238.84 Aligned_cols=214 Identities=30% Similarity=0.533 Sum_probs=179.7
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.+|++.+.||+|+++.||++.+...++.|++|.+...... ......+.+|+++++.++||||+++++.+..++..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3699999999999999999999999999999998765321 223456778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC---
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--- 173 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~--- 173 (259)
|++.+++|.+++.... .+++..+..++.|++.|+.+||+++++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC-CCEEEeeCCCccccCcCcccc
Confidence 9999999999997654 48999999999999999999999999999999999999665 789999999875311000
Q ss_pred -------------ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 174 -------------KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 174 -------------~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
......++..|+|||.+....++. ++|+||||+++|+|++|..||.+....+.+..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~ 231 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK-PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 231 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 001123566899999988777664 999999999999999999999887777777766543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=232.33 Aligned_cols=227 Identities=27% Similarity=0.483 Sum_probs=187.2
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
.+|++.+.||.|++|.||+|.+. ++..+++|.+..... ....+.+|+++++.++||+++++++.+......++++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 47999999999999999999875 577899998865432 34567889999999999999999999999899999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc--
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL-- 175 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~-- 175 (259)
++.+++|.+++......+++..++.++.|++.++.+||+.+++|+||+|+||++..+ +.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~-~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGEN-QVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCC-CeEEECCCcceeecccCccccc
Confidence 999999999988766668999999999999999999999999999999999999665 78999999988655332211
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc------------cccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS------------CTCW 242 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~------------~~~~ 242 (259)
.....+..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+.++.+.+..... ...+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSS-KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccCCcCh-HHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 1122346799999998777765 9999999999999998 999999888888787776543322 2345
Q ss_pred cccCchhh
Q psy3663 243 WRGRPRSR 250 (259)
Q Consensus 243 ~~~~~~~~ 250 (259)
|..+|.+|
T Consensus 238 l~~~p~~R 245 (256)
T cd05112 238 WKERPEDR 245 (256)
T ss_pred cccChhhC
Confidence 66666665
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=241.88 Aligned_cols=215 Identities=25% Similarity=0.398 Sum_probs=179.2
Q ss_pred ccCeeEeeeecccccceEEEEEEeecC----------------ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTG----------------EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~----------------~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 80 (259)
.++|++++.||+|++|.||+|.+...+ ..+++|.+..... ......+.+|+++++.++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEe
Confidence 468999999999999999999876544 4578998875432 23456788899999999999999
Q ss_pred EEEEEEecCCeEEEEEeccCCCChHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeE
Q psy3663 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHD----------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVV 150 (259)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIl 150 (259)
++++++...+..++++|++.+++|.+++.... ..+++..++.++.|++.||.+||++|++|+||+|+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 99999999899999999999999999987654 25899999999999999999999999999999999999
Q ss_pred eeecCCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCCh
Q psy3663 151 FFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA--GQAPFQEANDS 225 (259)
Q Consensus 151 v~~~~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~ 225 (259)
++.+ +.++|+|||.+........ ......+..|+|||.+.+...+. ++|+||||+++|+|++ +..||......
T Consensus 163 i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 163 VGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTT-KSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred ecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCc-cchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9777 7899999998875533221 11223456899999988776665 9999999999999998 78899887777
Q ss_pred HHHHHhhhc
Q psy3663 226 ETLTMIMDV 234 (259)
Q Consensus 226 ~~~~~i~~~ 234 (259)
+.+..+.+.
T Consensus 241 ~~~~~~~~~ 249 (296)
T cd05051 241 QVIENAGHF 249 (296)
T ss_pred HHHHHHHhc
Confidence 777666543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=238.18 Aligned_cols=209 Identities=27% Similarity=0.485 Sum_probs=175.9
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc----ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP----VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
.|+..+.||+|++|.||.+.+..+++.+++|.+....... .....+.+|+++++.++|+|++++++++.+...+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4888999999999999999999999999999987543211 134678889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
++||+.+++|.+++.... ++++..++.++.||+.||.+||++|++|+||+|+||+++.+...++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 999999999999987654 4899999999999999999999999999999999999976645799999998866543211
Q ss_pred -----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHH
Q psy3663 175 -----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229 (259)
Q Consensus 175 -----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (259)
.....++..|+|||.+.+..++. ++|+||||+++++|++|+.||..........
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 218 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGR-SCDVWSVGCVIIEMATAKPPWNAEKHSNHLA 218 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCcchHH
Confidence 12234677899999988776665 9999999999999999999997655443333
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=245.92 Aligned_cols=212 Identities=27% Similarity=0.433 Sum_probs=171.4
Q ss_pred ccCeeEeeeecccccceEEEEEEee-----cCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEec-C
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDT-N 89 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~ 89 (259)
.++|++.+.||.|++|.||+|.+.. +++.|++|.+.... .......+.+|+.+++.+ +|+||+++++++.. .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3589999999999999999997543 34789999987543 223345677899999999 79999999998764 4
Q ss_pred CeEEEEEeccCCCChHHHHHhcC---------------------------------------------------------
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHD--------------------------------------------------------- 112 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~--------------------------------------------------------- 112 (259)
...++++||+++++|.+++....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 56889999999999999885421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc---ccccCCCccCC
Q psy3663 113 ---AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSA 186 (259)
Q Consensus 113 ---~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~a 186 (259)
.+++...+..++.||+.||.+||++||+|+||+|+||+++++ +.++|+|||++..+...... ....++..|+|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 257889999999999999999999999999999999999766 78999999998765432211 12234567999
Q ss_pred cccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHh
Q psy3663 187 PEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231 (259)
Q Consensus 187 pE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i 231 (259)
||.+.+..++. ++|+|||||++|+|++ |..||.+....+.+...
T Consensus 244 PE~~~~~~~~~-~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~ 288 (337)
T cd05054 244 PESIFDKVYTT-QSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR 288 (337)
T ss_pred cHHhcCCCCCc-cccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH
Confidence 99998888876 9999999999999998 99999876655444433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=234.74 Aligned_cols=211 Identities=27% Similarity=0.454 Sum_probs=175.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||+|.+..+ ..+++|.+..... ....+.+|+++++.++|+||+++++.+.. ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEE
Confidence 57899999999999999999987644 4699999875332 34567889999999999999999998754 5578999
Q ss_pred eccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
|++.+++|.+++... +..+++..+..++.|++.||.+||+++++|+||+|+||++..+ +.++|+|||.+.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~-~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCC-CcEEeccCCceeeccccccc
Confidence 999999999999764 3457899999999999999999999999999999999999766 78999999998765433222
Q ss_pred c--cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 176 E--TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 176 ~--~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
. ...++..|+|||...+...+. ++|+||||+++|+|++ |..||......+....+...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~-~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 219 (262)
T ss_pred cccCCcccceecCHhHhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC
Confidence 1 223456799999988777765 9999999999999999 89999888777777666543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=233.53 Aligned_cols=211 Identities=26% Similarity=0.450 Sum_probs=175.1
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||.|++|.||+|.+... ..+++|.+.... .....+.+|+++++.++|++++++++++.. ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEE
Confidence 47899999999999999999987644 469999876433 234667889999999999999999998754 5578999
Q ss_pred eccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
|++.+++|.+++... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++++ +.++|+|||.+.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~-~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN-LVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCC-CeEEECCCccceEccCCccc
Confidence 999999999998764 3447899999999999999999999999999999999999766 78999999998765433221
Q ss_pred --ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 176 --ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 176 --~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
.....+..|+|||...+...+. ++|+||||+++|+|++ |+.||.+....+....+.+.
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcCh-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 1223456799999987777665 9999999999999999 99999988887777777654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=247.28 Aligned_cols=223 Identities=28% Similarity=0.492 Sum_probs=191.7
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----eEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS-----KLY 93 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 93 (259)
+|++.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.+++.++|+||+++.+++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 699999999999999999999988999999998765433445677889999999999999999999987664 789
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++|+|+.+ +|.+++.... ++++..++.++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDE 157 (330)
T ss_pred EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeecccc
Confidence 99999975 8888886554 59999999999999999999999999999999999999777 899999999988765443
Q ss_pred ----ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 174 ----KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 174 ----~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
......++..|+|||.+.+......++|+||||+++++|++|++||...+..+.+..+....+.++...|.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 12334567789999999877333459999999999999999999999999999999999888877766554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=242.81 Aligned_cols=210 Identities=30% Similarity=0.506 Sum_probs=178.0
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.+.|+..+.||.|++|.||+|.+..++..|++|.+..... ......+.+|+.+++.++|+||+++++.+..+...++++
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 4568888999999999999999988899999999865432 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-c
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-L 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~ 175 (259)
||+++++|.+++.. ..+++..+..++.||+.|+.+||++|++|+||+|+||++..+ +.++|+|||.+........ .
T Consensus 82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC-CCEEEccccccccccCcchhh
Confidence 99999999998764 348999999999999999999999999999999999999766 7899999998876543221 1
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i 231 (259)
....++..|+|||.+.+..++. ++|+||||+++++|++|+.||...........+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDF-KADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213 (277)
T ss_pred hcccCcccccCHHHhCcCCCch-hhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh
Confidence 2234677899999998877765 999999999999999999999866655544443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=235.21 Aligned_cols=207 Identities=28% Similarity=0.493 Sum_probs=172.9
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEE-ecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVI-DTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~ 96 (259)
.+|++.+.||+|++|.||++.. .+..+++|.+.... ....+.+|+.+++.++|++++++++++ ......++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 4799999999999999999974 57889999986432 345678899999999999999999875 4556789999
Q ss_pred eccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKHDA-GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~-~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
||+++++|.+++..... .+++..++.++.|++.+|.+||++|++|+||+|+||+++++ +.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~-~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCC-CcEEecCCccceeccccC--
Confidence 99999999999876543 47899999999999999999999999999999999999766 789999999886543322
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
.....+..|+|||.+.+..++. ++|+||||+++|+|++ |+.||......+....+.+.
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~ 215 (256)
T cd05082 157 DTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 215 (256)
T ss_pred CCCccceeecCHHHHccCCCCc-hhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 2223456799999998777765 9999999999999997 99999877766666665443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=233.05 Aligned_cols=206 Identities=27% Similarity=0.422 Sum_probs=173.4
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGD 103 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~s 103 (259)
+.||.|++|.||+|.+.. ++.+++|.+...... .....+.+|+++++.++|+||+++++++.+....++++|++.+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 468999999999999887 999999998765433 345678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc---cccC
Q psy3663 104 LYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE---TSCG 180 (259)
Q Consensus 104 L~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~---~~~~ 180 (259)
|.+++......++...+..++.+++.++.+||+++++|+||+|+||+++.+ +.++|+|||.+.......... ....
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCC-CcEEEeeccccccccCCcceeccccCcc
Confidence 999997766668999999999999999999999999999999999999766 789999999887554221111 1122
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhh
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (259)
+..|+|||.+.+..++. ++|+||||+++|+|++ |..||...........+..
T Consensus 158 ~~~y~~PE~~~~~~~~~-~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~ 210 (251)
T cd05041 158 PIKWTAPEALNYGRYTS-ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES 210 (251)
T ss_pred eeccCChHhhccCCCCc-chhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc
Confidence 45699999987777665 9999999999999998 8999988776666665544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=238.02 Aligned_cols=214 Identities=26% Similarity=0.420 Sum_probs=178.6
Q ss_pred cCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
..|.+.+.||.|++|.||++.+. .++..+++|.+.... ......+.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46899999999999999999852 345578889876532 33456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEE
Q psy3663 93 YLILELGDGGDLYDYIMKHD------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
++++||+.+++|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||++.++ +.++|
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~-~~~kl 161 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LLVKI 161 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC-CcEEe
Confidence 99999999999999987543 248999999999999999999999999999999999999766 78999
Q ss_pred EeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 161 TDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 161 ~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
+|||.+......... ....++..|+|||.+.+..++. ++|+||||+++|+|++ |.+||......+....+....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999988755332211 1122356799999998777765 9999999999999998 999998888887777777654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=240.37 Aligned_cols=223 Identities=35% Similarity=0.595 Sum_probs=190.5
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEecc
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELG 99 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (259)
|++.+.||+|.+|.||+|.+..+++.+++|.+............+..|+.+++.++|++++++++++.+.+..++++|++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999999999999999876544445667788999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-ccccc
Q psy3663 100 DGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETS 178 (259)
Q Consensus 100 ~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~~~~ 178 (259)
.+ +|.+++......+++..++.++.|++.+|.+||++|++|+||+|+||++..+ +.++|+|||.+....... .....
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC-CCEEEecCCcccccCCCccccCcc
Confidence 75 9999998775569999999999999999999999999999999999999776 789999999887654332 22233
Q ss_pred cCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 179 CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 179 ~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
..+..|+|||.+.+....+.++|+||||++++++++|++||......+.+..+.+..+.+...+|.
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP 224 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence 456679999998766333459999999999999999999999988888888888777766666554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=239.81 Aligned_cols=201 Identities=28% Similarity=0.492 Sum_probs=175.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||.|++|.||+|.+..+++.+++|.+..... ......+.+|+++++.++||||+++++.+.....+++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 468899999999999999999999999999999876542 2445678889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
++.+.+|.+++.....++++..+..++.|++.++.+||+ .|++|+||+|+||+++.+ +.++|+|||.+........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~-~~~~l~d~g~~~~~~~~~~-~ 157 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR-GQIKLCDFGVSGQLVNSLA-K 157 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCC-CCEEEeecccchhhHHHHh-h
Confidence 999899999998765669999999999999999999999 999999999999999775 7899999998765532211 1
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
...++..|+|||.+.+..++. ++|+||||+++++|++|..||...
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSV-KSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred cccCChhccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCcc
Confidence 255677899999998877665 999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=237.81 Aligned_cols=212 Identities=29% Similarity=0.494 Sum_probs=177.9
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
.|++.+.||+|++|.||+|.+..++..+++|.+.... ......+.+|+++++.++|+|++++++.+......++++||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 3788999999999999999999889999999986543 33456678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-cccc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~~~ 177 (259)
+.+++|..++.....++++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+....... ....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC-CCEEEcccccccccccccccccc
Confidence 99999999877655669999999999999999999999999999999999999666 789999999886543221 2233
Q ss_pred ccCCCccCCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 178 SCGSLAYSAPEILL-----GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 178 ~~~~~~~~apE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
..++..|+|||.+. +..++ .++|+||||+++|+|++|++||...+..+....+...
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~ 223 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 223 (282)
T ss_pred ccccccccCHhhccccCCCCCCCC-ccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc
Confidence 45678899999874 22343 4899999999999999999999887766666555543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=240.38 Aligned_cols=215 Identities=26% Similarity=0.426 Sum_probs=176.8
Q ss_pred ccCeeEeeeecccccceEEEEEEe-------ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEec
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHV-------FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDT 88 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~-------~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (259)
.++|++.+.||+|++|.||+|.+. .....+++|.+.... .......+.+|+++++.+ +||||+++++++.+
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 468999999999999999999753 234578999986543 233456678899999999 59999999999998
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE 153 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~ 153 (259)
.+.++++|||+.+++|.+++.... ..++...+..++.||+.||.+||++|++|+||+|+||++..
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence 899999999999999999997642 34788899999999999999999999999999999999976
Q ss_pred cCCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHH
Q psy3663 154 RLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLT 229 (259)
Q Consensus 154 ~~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (259)
+ +.++|+|||.+........ ......+..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+.++
T Consensus 170 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 170 D-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH-QSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred C-CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCc-cchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 6 7899999999875532211 11122335799999998777765 9999999999999999 899998887777777
Q ss_pred Hhhhc
Q psy3663 230 MIMDV 234 (259)
Q Consensus 230 ~i~~~ 234 (259)
.+.+.
T Consensus 248 ~~~~~ 252 (314)
T cd05099 248 LLREG 252 (314)
T ss_pred HHHcC
Confidence 76654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=241.48 Aligned_cols=218 Identities=29% Similarity=0.501 Sum_probs=171.9
Q ss_pred eeeecccccceEEEEEEee--cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe--cCCeEEEEEec
Q psy3663 23 EETLGRGHFAVVKLARHVF--TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID--TNSKLYLILEL 98 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~ 98 (259)
...||+|++|.||+|.+.. ++..|++|.+.... ....+.+|+.+++.++||||+++++++. .+...++++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3579999999999998653 55789999886543 2345778999999999999999999884 35678999999
Q ss_pred cCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee---ecCCeEEEEeccccc
Q psy3663 99 GDGGDLYDYIMKH--------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF---ERLGVVKLTDFGFSN 167 (259)
Q Consensus 99 ~~~~sL~~~~~~~--------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~---~~~~~i~l~df~~~~ 167 (259)
+.+ +|.+++... ...+++..++.++.||+.||.+||+.|++|+||+|+||++. .+.+.++|+|||++.
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 976 777776532 22478899999999999999999999999999999999994 234689999999987
Q ss_pred cCCCCCc----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC---------hHHHHHhhhc
Q psy3663 168 RFNPGQK----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND---------SETLTMIMDV 234 (259)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~~~~~~i~~~ 234 (259)
....... .....++..|+|||.+.+....+.++|+||||+++|+|++|++||..... ...+..+.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 6543221 22335678899999987755444599999999999999999999975432 3556677777
Q ss_pred ccccccccccc
Q psy3663 235 SESSCTCWWRG 245 (259)
Q Consensus 235 ~~~~~~~~~~~ 245 (259)
.+.+..+.|..
T Consensus 241 ~~~~~~~~~~~ 251 (317)
T cd07867 241 MGFPADKDWED 251 (317)
T ss_pred cCCCChhhhhh
Confidence 77666666643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=239.09 Aligned_cols=218 Identities=23% Similarity=0.373 Sum_probs=178.4
Q ss_pred CccccCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEe
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVID 87 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (259)
.-..++|.+.+.||+|++|.||+|.+. ..+..+++|.+..... ......+.+|+.+++++ +|+||+++++.+.
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 344558999999999999999999753 3455899998865432 23356788999999999 7999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
..+..+++|||+.+++|.+++.... ..+++..+..++.|++.+|.+||+++++|+||+|+||++..+ +.++++|||.+
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~l~dfg~~ 188 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHG-KIVKICDFGLA 188 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCC-CeEEECCCccc
Confidence 9999999999999999999987543 338999999999999999999999999999999999999665 78999999998
Q ss_pred ccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 167 NRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 167 ~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
........ .....++..|+|||.+.+...+. ++|+||||+++|+|++ |..||......+.+....+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~ 259 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCc-HhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc
Confidence 76543221 11123456799999998877765 9999999999999998 99999887766665555443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=235.75 Aligned_cols=216 Identities=23% Similarity=0.375 Sum_probs=177.8
Q ss_pred ccCeeEeeeecccccceEEEEEEee-----cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
.+.|++.+.||+|++|.||+|.+.. .+..|++|.+.... .......+.+|+.+++.++|+||+++++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4679999999999999999999876 67789999876443 22334567889999999999999999999988888
Q ss_pred EEEEEeccCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC--CeEEEEec
Q psy3663 92 LYLILELGDGGDLYDYIMKHD------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL--GVVKLTDF 163 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~--~~i~l~df 163 (259)
.+++||++.+++|.+++.... ..+++..++.++.||+.++.+||+++++|+||+|+||+++.+. ..++|+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 999999999999999987653 2488999999999999999999999999999999999997542 36899999
Q ss_pred cccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 164 GFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 164 ~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
|++......... .....+..|+|||.+.+..++. ++|||||||++|+|++ |..||......+....+...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTS-KTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 998765322111 1122345799999998777775 9999999999999997 99999987777766655543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=233.89 Aligned_cols=202 Identities=34% Similarity=0.561 Sum_probs=180.2
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CeEEEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--SKLYLIL 96 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 96 (259)
+|++.+.||+|++|.||.|.+..++..+++|.+............+.+|+.++++++|+||+++++.+.+. ..+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999998999999999977655455678888999999999999999999999888 8999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-- 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-- 174 (259)
|++.+++|.+++.... .+++..++.++.|++.++.+||+.+++|+||+|+||+++.+ +.++|+||+.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC-CCEEEcccccEEecccccccc
Confidence 9999999999988766 59999999999999999999999999999999999999776 7899999999887765543
Q ss_pred -cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 175 -LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 175 -~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
.....++..|+|||.+.+...+. ++|+||||+++++|++|..||....
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGR-AADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 34456788999999998776654 9999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=238.20 Aligned_cols=195 Identities=30% Similarity=0.492 Sum_probs=169.4
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|++|.||+|.+..++..+++|.+.... .......+.+|++++.+++||||+++++.+......++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 46889999999999999999999999999999986543 23345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~ 177 (259)
|+++++|..+. .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.+ +.++|+|||++...... ....
T Consensus 80 ~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~-~~~~l~dfg~~~~~~~~-~~~~ 152 (279)
T cd06619 80 FMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR-GQVKLCDFGVSTQLVNS-IAKT 152 (279)
T ss_pred cCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC-CCEEEeeCCcceecccc-cccC
Confidence 99998886542 37889999999999999999999999999999999999776 78999999988765432 2233
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
..++..|+|||.+.+..++. ++|+||||+++|+|++|+.||..
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGI-HSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CCCChhhcCceeecCCCCCC-cchHHHHHHHHHHHHhCCCCchh
Confidence 46778999999998877765 99999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=236.24 Aligned_cols=216 Identities=25% Similarity=0.382 Sum_probs=179.3
Q ss_pred ccCeeEeeeecccccceEEEEEEeecC-----ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTG-----EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~-----~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
.++|++.+.||.|++|.||+|.+...+ ..+++|.+.... .......+.+|+.++..++|+||+++++++.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 468999999999999999999876443 789999986443 22334567789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEe
Q psy3663 92 LYLILELGDGGDLYDYIMKHD---------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTD 162 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~---------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~d 162 (259)
.+++|||+.+++|.+++.... ..+++..++.++.|++.||.+||+++++|+||+|+||+++.+ +.++|+|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~-~~~kl~d 162 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAED-LTVKIGD 162 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCC-CCEEECC
Confidence 999999999999999986532 236778899999999999999999999999999999999776 7899999
Q ss_pred ccccccCCCCC---ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 163 FGFSNRFNPGQ---KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 163 f~~~~~~~~~~---~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
||.+....... ......++..|+|||.+.+...+. ++|+||||+++|++++ |..||...+..+..+.+.+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~ 238 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG 238 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCc-ccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence 99886543322 112233466899999987777664 9999999999999998 999999888877777777443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=233.92 Aligned_cols=210 Identities=25% Similarity=0.467 Sum_probs=174.6
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC----cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD----PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
+|++.+.||.|++|.||+|.+. ++..+++|.+...... ......+.+|+++++.++|+||+++.+++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5889999999999999999864 7889999988754321 1223567889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC--
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-- 172 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-- 172 (259)
++||+.+++|.+++.+.. ++++..++.++.|++.++.+||+.+++|+||+|+||+++++ +.++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCC-CeEEeccchhhHhhhhccc
Confidence 999999999999987654 48899999999999999999999999999999999999766 78999999988654211
Q ss_pred -----CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 173 -----QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 173 -----~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
.......++..|+|||.+.+..++. ++|+||||+++++|++|..||...+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 221 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGR-KSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcc-hhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh
Confidence 1112234677899999998777665 9999999999999999999998766554443333
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=236.29 Aligned_cols=206 Identities=30% Similarity=0.480 Sum_probs=173.8
Q ss_pred eeecccccceEEEEEEee-cCc--eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccC
Q psy3663 24 ETLGRGHFAVVKLARHVF-TGE--KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGD 100 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~-~~~--~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (259)
+.||+|++|.||+|.+.. ++. .+++|.+...... .....+.+|+.++++++|+||+++++.+.+ ...++++|++.
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998765 333 6899998776543 456778899999999999999999999988 88999999999
Q ss_pred CCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc----c
Q psy3663 101 GGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK----L 175 (259)
Q Consensus 101 ~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~----~ 175 (259)
+++|.+.+.... ..+++..++.++.|++.||.+||++|++|+||+|+||++..+ +.++|+|||.+........ .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD-DKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC-CEEEeccccccccccccccceecc
Confidence 999999998765 568999999999999999999999999999999999999777 7899999998876543221 1
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhh
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (259)
....++..|+|||.+.+...+. ++|+||||+++++|++ |+.||...+..+....+..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 215 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSH-ASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215 (257)
T ss_pred cCCCCCceecCHHHhcccCcCc-hhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 1223566899999988777775 9999999999999998 9999988777777666654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=233.35 Aligned_cols=202 Identities=31% Similarity=0.516 Sum_probs=177.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
.+|++.+.||.|+++.||+|.+..+++.+++|.+...... .....+.+|+..+..++|+|++++++.+......++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 3689999999999999999999999999999998765432 446778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
|+.+++|.+++... .++++..++.++.||+.++.+||+ .+++|+||+|+||++..+ +.++|+|||.+..........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~-~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC-CCEEEccCccceecccCCCcc
Confidence 99999999999765 448999999999999999999999 999999999999999776 789999999887664433322
Q ss_pred -cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 177 -TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 177 -~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
...+...|+|||.+.+...+. ++|+||||+++|+|++|+.||....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSY-AADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred cceeecccccCHhhhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccc
Confidence 345678899999998876665 9999999999999999999997774
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=233.56 Aligned_cols=212 Identities=26% Similarity=0.467 Sum_probs=177.2
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
..++|++.+.||+|++|.||+|.+. .+..+++|.+..... ....+.+|+.++++++|++++++++++.. ...+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIV 78 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEE
Confidence 3568999999999999999999866 566799999876443 24568899999999999999999998754 567899
Q ss_pred EeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||++.+++|.+++... ...+++..++.++.|++.||.+||+++++|+||+|+||+++++ +.++|+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~-~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG-LVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCC-ceEEeCCceeeeeccCccc
Confidence 9999999999998764 3448999999999999999999999999999999999999766 7899999999876543221
Q ss_pred c--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 175 L--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 175 ~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
. ....++..|+|||.+.+...+. ++|+||||+++|+|++ |.+||...+..+....+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcc-hhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 1 1223345799999987777664 9999999999999999 99999988888888877654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=236.05 Aligned_cols=215 Identities=28% Similarity=0.481 Sum_probs=176.2
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecC--
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTN-- 89 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-- 89 (259)
-....++|++.+.||+|++|.||+|.+..+++.+++|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 17 ~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 17 LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 3445789999999999999999999999999999999986532 2345677889999998 799999999998643
Q ss_pred ---CeEEEEEeccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEec
Q psy3663 90 ---SKLYLILELGDGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDF 163 (259)
Q Consensus 90 ---~~~~lv~e~~~~~sL~~~~~~---~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df 163 (259)
...++++||+.+++|.+++.. ....+++..++.++.|++.||.+||+.+++|+||+|+||+++.+ +.++|+||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~-~~~kl~df 172 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE-GGVKLVDF 172 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEeec
Confidence 468999999999999998763 34558999999999999999999999999999999999999766 78999999
Q ss_pred cccccCCCCCc-cccccCCCccCCcccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 164 GFSNRFNPGQK-LETSCGSLAYSAPEILLGDS-----YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 164 ~~~~~~~~~~~-~~~~~~~~~~~apE~~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
|.+........ .....++..|+|||.+.... .+ .++|+||||+++|+|++|++||........+..+.
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 173 GVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYD-ARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred ccchhcccccccccCccCCccccChhhhcCCCCcccccC-CccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 98876543221 12335677899999875432 33 49999999999999999999998776655555543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=239.79 Aligned_cols=213 Identities=25% Similarity=0.424 Sum_probs=177.4
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|++|.||+|.+..++..+++|.+.... .......+.+|+.++++++|+||+++++.+......++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 47899999999999999999999899999999886532 33345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 98 LGDGGDLYDYIMKH--DAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 98 ~~~~~sL~~~~~~~--~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
|+++++|.+++... ...+++..+..++.||+.++.+||+ .+++|+||+|+||+++.+ +.++|+|||.+...... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~-~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVAS-L 157 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCC-CCEEEeecCCcccccCC-c
Confidence 99999999988764 2358999999999999999999996 599999999999999775 78999999988655322 2
Q ss_pred cccccCCCccCCcccccCCCC-----CCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 175 LETSCGSLAYSAPEILLGDSY-----DAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
.....++..|+|||.+.+... .+.++|+||||+++|+|++|+.||...........+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 221 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA 221 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH
Confidence 233356778999999855432 23489999999999999999999977666555554443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=237.15 Aligned_cols=215 Identities=28% Similarity=0.516 Sum_probs=177.5
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecC-----
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~----- 89 (259)
..++|++.+.||.|++|.||+|.+..++..+++|++.... .....+.+|+.+++++ +|+||+++++++...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4589999999999999999999998889999999986543 2356788999999999 699999999998654
Q ss_pred -CeEEEEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
..++++|||+.+++|.+++... ...+++..++.++.|++.||.+||+.+++|+||+|+||+++.+ +.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~-~~~~l~d~~~ 159 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN-AEVKLVDFGV 159 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccC-CeEEECCCcc
Confidence 3589999999999999987653 3568999999999999999999999999999999999999776 7899999998
Q ss_pred cccCCCCC-ccccccCCCccCCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 166 SNRFNPGQ-KLETSCGSLAYSAPEILLGD----SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 166 ~~~~~~~~-~~~~~~~~~~~~apE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
+....... ......++..|+|||.+... ...+.++|+||||+++++|++|+.||...+....+.++.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 233 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc
Confidence 86543322 22234567789999987532 22234899999999999999999999877666666665543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=235.07 Aligned_cols=231 Identities=31% Similarity=0.509 Sum_probs=187.7
Q ss_pred CeeEeeeecccccceEEEEEEee-cCceEEEEEcccCCC--------CcccHHHHHHHHHHHHh-CCCCCeEEEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKL--------DPVSQDHLYQEVRCMKL-VQHPNVVRLYEVIDT 88 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~-~~~~~~lK~~~~~~~--------~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~ 88 (259)
.|++.+.||.|++|.||.|.+.. .++.+++|.+..... .......+.+|+.++.+ ++|+||+++++.+.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999887 678999998864321 22234556678887765 789999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEecc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFG 164 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~---~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~ 164 (259)
.+..+++|||+.+++|.+++.. ....+++..++.++.|++.++.+||+ .+++|+||+|+||++..+ +.++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~-~~~~l~dfg 159 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGED-DKVTITDFG 159 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCC-CcEEEeccc
Confidence 9999999999999999988754 34558999999999999999999996 789999999999999776 789999999
Q ss_pred ccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc----
Q psy3663 165 FSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT---- 240 (259)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 240 (259)
.+.............++..|++||.+.+..++. ++|+||||+++|+|++|+.||...........+.+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVKNEPYGE-KADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY 238 (269)
T ss_pred ceeecccccccccccCcccCcChhhhcCCCCch-HHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence 987765544344456788899999998777665 999999999999999999999887777777666655544322
Q ss_pred ---------cccccCchhhh
Q psy3663 241 ---------CWWRGRPRSRR 251 (259)
Q Consensus 241 ---------~~~~~~~~~~~ 251 (259)
.+|..+|..|.
T Consensus 239 ~~~l~~li~~cl~~~p~~Rp 258 (269)
T cd08528 239 SEDVTDVITSCLTPDAEARP 258 (269)
T ss_pred CHHHHHHHHHHCCCCCccCC
Confidence 36666666554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=240.57 Aligned_cols=224 Identities=29% Similarity=0.500 Sum_probs=178.3
Q ss_pred CeeEeeeecccccceEEEEEEee--cCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CeEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVF--TGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--SKLY 93 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~--~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 93 (259)
+|++.+.||+|++|.||+|.+.. .+..|++|.+.... ........+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 78999999987643 1222346677899999999999999999999887 8899
Q ss_pred EEEeccCCCChHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee---cCCeEEEEecccc
Q psy3663 94 LILELGDGGDLYDYIMKH----DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE---RLGVVKLTDFGFS 166 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~----~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~---~~~~i~l~df~~~ 166 (259)
+|||++.+ ++.+++... ...+++..++.++.||+.||.+||+.+++|+||+|+||+++. ..+.++|+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999976 777766543 225899999999999999999999999999999999999977 1378999999988
Q ss_pred ccCCCCCc----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH---------HHHHhhh
Q psy3663 167 NRFNPGQK----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE---------TLTMIMD 233 (259)
Q Consensus 167 ~~~~~~~~----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---------~~~~i~~ 233 (259)
........ .....++..|+|||.+.+....+.++|+||||+++++|++|++||....... .+..+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76533222 1223456789999988775544459999999999999999999998765433 4555555
Q ss_pred cccccccccc
Q psy3663 234 VSESSCTCWW 243 (259)
Q Consensus 234 ~~~~~~~~~~ 243 (259)
....+....|
T Consensus 240 ~l~~~~~~~~ 249 (316)
T cd07842 240 VLGTPTEKDW 249 (316)
T ss_pred HhCCCchhHH
Confidence 5554444333
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=237.39 Aligned_cols=213 Identities=27% Similarity=0.428 Sum_probs=174.4
Q ss_pred CeeEeeeecccccceEEEEEEeec-----CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFT-----GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
+|++.+.||+|++|.||+|.+... ...+++|.+..... ......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 478999999999999999987532 24688888765432 233567888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeE
Q psy3663 94 LILELGDGGDLYDYIMKHD-----------------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVV 150 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~-----------------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIl 150 (259)
+++||+.+++|.+++.... .+++...++.++.|++.+|.+||+++++|+||+|+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999999999999876421 24788999999999999999999999999999999999
Q ss_pred eeecCCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChH
Q psy3663 151 FFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSE 226 (259)
Q Consensus 151 v~~~~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (259)
+.++ +.++|+|||++........ ......+..|+|||.+.+...+. ++|+||||+++++|++ |..||.......
T Consensus 160 l~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 160 VAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT-QSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch-HhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9766 7899999999875432221 11223456899999987777665 9999999999999998 999998877777
Q ss_pred HHHHhhhc
Q psy3663 227 TLTMIMDV 234 (259)
Q Consensus 227 ~~~~i~~~ 234 (259)
..+.+.+.
T Consensus 238 ~~~~~~~~ 245 (290)
T cd05045 238 LFNLLKTG 245 (290)
T ss_pred HHHHHhCC
Confidence 66665543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=243.53 Aligned_cols=226 Identities=27% Similarity=0.454 Sum_probs=184.5
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
.+.++|.+.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.++++++|+||+++.+++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 456899999999999999999999998999999999876543333456677899999999999999999987532
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
...+++++++ +++|.+++... .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~-~~~kl~dfg~~~~ 169 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARH 169 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCC-CCEEEeccccccc
Confidence 3467888887 66998877643 48999999999999999999999999999999999999776 7899999998875
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
... ......++..|+|||.+.+....+.++|+||||+++++|++|+.||...+....+..+++.....+..++..-
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 432 2233456778999999876433345999999999999999999999888877777777776665555554333
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=232.53 Aligned_cols=213 Identities=27% Similarity=0.462 Sum_probs=177.8
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
..++|++.+.||+|++|.||+|... +++.+++|.+..... ....+.+|+.+++.++|+||+++++++. .+..+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 4578999999999999999999865 677899999865432 3567889999999999999999999874 4568999
Q ss_pred EeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||++.+++|.+++... ...++...+..++.|++.||.+||+.|++|+||+|+||+++++ +.++|+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~-~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSET-LCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCC-CCEEEccCcceeecCCCCc
Confidence 9999999999988654 3458999999999999999999999999999999999999776 7899999998876542221
Q ss_pred c--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 175 L--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 ~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
. ....++..|+|||.+.....+. ++|+||||+++|++++ |++||...+..+....+.+..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 220 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTI-KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY 220 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCc-ccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC
Confidence 1 1223456799999988777664 9999999999999998 999999888877777766543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=243.50 Aligned_cols=224 Identities=26% Similarity=0.452 Sum_probs=192.6
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC--CCC----eEEEEEEEec
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ--HPN----VVRLYEVIDT 88 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~----i~~~~~~~~~ 88 (259)
.+.++|++++.+|+|.||.|..++|...+..++||+++... ...+..+-|+++|++++ .|+ ++.+.++|+.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 34789999999999999999999999999999999997653 23555667899999995 233 7788889999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec-------------
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER------------- 154 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~------------- 154 (259)
.++.++|+|.+ |.++.+++.++ -.+++...+..|..||++++.+||+++++|.||||+||++.+.
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999999 66999998764 4568999999999999999999999999999999999998432
Q ss_pred ------CCeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHH
Q psy3663 155 ------LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228 (259)
Q Consensus 155 ------~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (259)
.-.|+++|||.+..-. ......+.+..|+|||++.+..++. .+|+||+||++.|+.+|...|.++++.+.+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~-pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQ-PCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCC-ccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 1258999999987543 3335667788999999999999997 999999999999999999999999999999
Q ss_pred HHhhhcccccccccccc
Q psy3663 229 TMIMDVSESSCTCWWRG 245 (259)
Q Consensus 229 ~~i~~~~~~~~~~~~~~ 245 (259)
..|..++|++|..-...
T Consensus 319 aMMerIlGp~P~~mi~r 335 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKK 335 (415)
T ss_pred HHHHHhhCCCcHHHhhh
Confidence 99999999877654433
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=234.35 Aligned_cols=214 Identities=27% Similarity=0.422 Sum_probs=174.7
Q ss_pred eeEeeeecccccceEEEEEEeecCc--eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC------Ce
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGE--KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN------SK 91 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~--~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 91 (259)
|.+.+.||+|++|.||+|.+..++. .+++|.+............+.+|+.+++.++|+||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999876665 689999876544455567788899999999999999999976321 24
Q ss_pred EEEEEeccCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 92 LYLILELGDGGDLYDYIMKH-----DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~-----~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
.+++++|+.+++|.+++... ...+++..+..++.||+.||.+||+++|+|+||+|+||+++.+ +.++|+|||.+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~ 159 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN-MNVCVADFGLS 159 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCC-CCEEECCCCcc
Confidence 68999999999999887432 2347899999999999999999999999999999999999666 78999999998
Q ss_pred ccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 167 NRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 167 ~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
......... .....+..|++||...+..++. ++|+||||+++|+|++ |+.||......+..+.+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTT-KSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcCh-HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 765432211 1223456799999998877765 9999999999999999 899998877777777776543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=235.66 Aligned_cols=216 Identities=28% Similarity=0.493 Sum_probs=176.6
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEe--
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVID-- 87 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~-- 87 (259)
.+-....++|++.+.||+|++|.||+|.+..+++.+++|++.... .....+..|+.+++.+ +|+||+++++.+.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 445667889999999999999999999999999999999875432 2245677899999999 6999999999873
Q ss_pred ---cCCeEEEEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEE
Q psy3663 88 ---TNSKLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLT 161 (259)
Q Consensus 88 ---~~~~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~ 161 (259)
.....+++|||+++++|.+++... ...+++..++.++.|++.|+.+||+.+++|+||+|+||++.++ +.++|+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~-~~~kl~ 166 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE-GGVKLV 166 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC-CCEEEc
Confidence 346789999999999999987532 3458899999999999999999999999999999999999776 779999
Q ss_pred eccccccCCCCC-ccccccCCCccCCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh
Q psy3663 162 DFGFSNRFNPGQ-KLETSCGSLAYSAPEILLG-----DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231 (259)
Q Consensus 162 df~~~~~~~~~~-~~~~~~~~~~~~apE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i 231 (259)
|||.+....... ......++..|+|||.+.. ..++ .++|+||||+++|+|++|+.||...+....+..+
T Consensus 167 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~ 241 (286)
T cd06638 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241 (286)
T ss_pred cCCceeecccCCCccccccCCCcccChhhhchhhhcccccc-chhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence 999887654322 2223357788999998753 2344 4999999999999999999999877655554443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=235.05 Aligned_cols=207 Identities=26% Similarity=0.417 Sum_probs=168.1
Q ss_pred eeecccccceEEEEEEeecCc--eEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEEEEEeccC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGE--KVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYLILELGD 100 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~--~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (259)
+.||+|++|.||+|.+..++. .+++|.+.... .......+.+|+++++++ +||||+++++++...+..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999999887765 46778776432 233456778899999999 79999999999999999999999999
Q ss_pred CCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 101 GGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 101 ~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
+++|.+++.... ..++...++.++.|++.|+.+||++|++|+||+|+||+++.+ +.++|+|||+
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~-~~~kl~dfgl 158 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGL 158 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC-CeEEECCCCC
Confidence 999999987542 237889999999999999999999999999999999999766 7899999998
Q ss_pred cccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhh
Q psy3663 166 SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (259)
+..............+..|+|||.+....++. ++|+||||+++++|++ |..||......+.+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~ 226 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCc-hhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhC
Confidence 75322111111122345699999987777665 9999999999999997 9999988777777766654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=244.18 Aligned_cols=223 Identities=26% Similarity=0.433 Sum_probs=183.6
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
.+..+|.+.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 356799999999999999999999998999999999876543344456678899999999999999999998654
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
..++++++++.. +|..+. ...+++..+..++.|++.|+.+||+.+++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~-~~~kL~dfg~~~~ 166 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED-CELKILDFGLARH 166 (342)
T ss_pred CceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCCCCcC
Confidence 346899999965 676654 2348999999999999999999999999999999999999776 7899999998865
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
... ......++..|+|||.+.+....+.++|+||||+++++|++|+.||...+....+..++...+.+.+++++
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 432 22233456789999998764433459999999999999999999999888788888888877766655544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=249.87 Aligned_cols=220 Identities=28% Similarity=0.464 Sum_probs=187.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCc---e-EEEEEcccC-CCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGE---K-VAVKVIDKT-KLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~---~-~~lK~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
++-.+.+.||+|+||.||.|.....+. . ||+|..... .........+.+|+++++.++||||++++++...+..+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445566999999999999998776533 3 899998763 34556678889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++||+++|++|.+++...+..++..+...++.+.+.+|+|||+++++|+||-.+|+|+..+ +.++|+|||++.....-
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~-~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKK-GVVKISDFGLSRAGSQY 315 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCC-CeEEeCccccccCCcce
Confidence 99999999999999999988779999999999999999999999999999999999999776 67899999998754311
Q ss_pred Cccc-cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc
Q psy3663 173 QKLE-TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 173 ~~~~-~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
.... .......|+|||.+....++. ++||||||++++|+++ |..||.+....+.-..|+....+++
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~s~-kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~ 383 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIFSF-KTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMP 383 (474)
T ss_pred eeccccccCcceecChhhhccCcccc-ccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCC
Confidence 1111 223568999999999887765 9999999999999999 8889999999999999965444443
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=233.17 Aligned_cols=216 Identities=25% Similarity=0.443 Sum_probs=186.2
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+|++.+.|+.|+++.||++.+..+++.+++|.+............+.+|+.+++.++|+||+++.+.+.+....++++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58999999999999999999998999999999876654555567778899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 99 GDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 99 ~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
+++.+|.+++... ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.+ +.++|+|||.+...... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~-~~~kl~d~g~~~~~~~~-~~ 158 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN-DLVKIGDLGISKVLKKN-MA 158 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC-CcEEEeeccchhhhccC-Cc
Confidence 9999999988663 3458999999999999999999999999999999999999776 78999999998766544 33
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
....++..|+|||.+.+...+. ++|+||||+++++|++|+.||...+..+....+.....+
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~-~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 219 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPYSY-KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP 219 (256)
T ss_pred ccccCCccccCHHHHCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Confidence 3345778999999998777664 899999999999999999999988777666665544443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=232.19 Aligned_cols=206 Identities=28% Similarity=0.494 Sum_probs=170.6
Q ss_pred eeecccccceEEEEEEeecC---ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccC
Q psy3663 24 ETLGRGHFAVVKLARHVFTG---EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGD 100 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (259)
+.||+|++|.||+|.....+ ..+++|.+...... .....+.+|+.+++.++|+||+++++++.. ..++++|+++.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCC
Confidence 46899999999999866554 78999998765433 345678889999999999999999998764 46799999999
Q ss_pred CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc---
Q psy3663 101 GGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET--- 177 (259)
Q Consensus 101 ~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~--- 177 (259)
+++|.+++.... .+++..++.++.|++.++.+||..+++|+||+|+||+++.+ +.++|+|||.+...........
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~-~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR-HQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC-CcEEeccccccceeecCCccccccc
Confidence 999999997765 58999999999999999999999999999999999999766 7899999998876543322111
Q ss_pred -ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 178 -SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 178 -~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
..++..|+|||.+.+..++. ++|+||||+++|++++ |.+||...+..+..+.+...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSS-KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG 214 (257)
T ss_pred CccccccccCHHHhcCCCCCc-cchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 11235799999998777765 9999999999999998 99999888777766666544
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=241.67 Aligned_cols=217 Identities=28% Similarity=0.512 Sum_probs=182.2
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
..+.+..+.|.....||+|++|.||++.+..++..++||.+.... ......+.+|+.+++.++|+|++++++.+...+
T Consensus 15 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~ 92 (292)
T cd06658 15 VSPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD 92 (292)
T ss_pred eccCchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC
Confidence 345566677887889999999999999999899999999986533 234566889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
..+++||++++++|.+++... .+++..++.++.||+.++.+||+++++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 93 ~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~-~~~kL~dfg~~~~~~ 169 (292)
T cd06658 93 ELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-GRIKLSDFGFCAQVS 169 (292)
T ss_pred eEEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC-CCEEEccCcchhhcc
Confidence 999999999999999987543 48999999999999999999999999999999999999766 789999999886543
Q ss_pred CCCc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 171 PGQK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 171 ~~~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
.... .....++..|+|||.+.+...+. ++|+||||+++|+|++|+.||........+..+..
T Consensus 170 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 232 (292)
T cd06658 170 KEVPKRKSLVGTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD 232 (292)
T ss_pred cccccCceeecCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 2221 22335678899999998777765 99999999999999999999987776665555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=234.98 Aligned_cols=212 Identities=33% Similarity=0.553 Sum_probs=178.6
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC---CCCCeEEEEEEEecCCe-----
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV---QHPNVVRLYEVIDTNSK----- 91 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~----- 91 (259)
|++.+.||.|++|.||+|.+..++..+++|.+............+.+|+.+++++ +|+|++++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999988899999999975543333334555677776665 59999999999987766
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
.+++||++.+ +|.+++.... ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcceecc
Confidence 9999999976 8888877643 358999999999999999999999999999999999999777 889999999987765
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
.........++..|+|||.+.+...+. ++|+||||+++|+|++|++||......+.+..+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSYAT-PVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDV 221 (287)
T ss_pred CCcccccccccccccChHHhccCCCCC-cchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHH
Confidence 444434445677899999998877765 999999999999999999999998888887777654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=238.67 Aligned_cols=213 Identities=26% Similarity=0.431 Sum_probs=173.2
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCc----eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGE----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.++|+..+.||+|++|.||+|.+..++. .+++|.+.... .......+.+|+.++..++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~ 83 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI 83 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence 3578999999999999999999877776 56888876543 223344678899999999999999999998654 46
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++++++.+++|.+++......+++..++.++.|++.||.+||++|++|+||+|+||++..+ +.++|+|||.+......
T Consensus 84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~-~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP-NHVKITDFGLARLLEGD 162 (303)
T ss_pred eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCC-CceEEccccccccccCc
Confidence 78999999999999988776668999999999999999999999999999999999999665 78999999998765432
Q ss_pred Ccc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhh
Q psy3663 173 QKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 173 ~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (259)
... .....+..|+|||.+.+...+. ++|+||||+++|++++ |..||.+....+..+.+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 226 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTH-QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 226 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCCh-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC
Confidence 221 1223456899999988777665 9999999999999997 9999987665554444443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=237.55 Aligned_cols=221 Identities=33% Similarity=0.520 Sum_probs=187.1
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEEec
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
|++.+.||.|++|.||+|.+..+++.++||.+...... .......+|+..+.+++ |+|++++++.+.+++..+++||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 78899999999999999999888999999998765322 22334457889999999 99999999999999999999999
Q ss_pred cCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc
Q psy3663 99 GDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~ 177 (259)
+ +++|.+.+.... ..+++..+..++.|++.+|.+||++|++|+||+|+||+++++ +.++|+|||.+...........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP-EVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CCEEEeecccceeccCCCCcCC
Confidence 9 568988887654 458999999999999999999999999999999999999776 7899999999876654444344
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
..++..|+|||.+.+....+.++|+||||+++++|++|++||...+..+.+..+.+..+.+....|
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 456778999998865544445999999999999999999999999999999888888777765544
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=237.10 Aligned_cols=219 Identities=26% Similarity=0.425 Sum_probs=177.8
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeec-------CceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFT-------GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYE 84 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~-------~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 84 (259)
.....++|.+.+.||+|++|.||.|.+... ...+++|.+.... .......+.+|+.+++.+ +|+||+++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 344567999999999999999999986532 2469999987543 233456788899999999 6999999999
Q ss_pred EEecCCeEEEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCe
Q psy3663 85 VIDTNSKLYLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENV 149 (259)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nI 149 (259)
.+...+..+++|||+.+++|.+++.... ..++...++.++.|++.||.+||++|++|+||+|+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 9999999999999999999999997642 2378899999999999999999999999999999999
Q ss_pred EeeecCCeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q psy3663 150 VFFERLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDS 225 (259)
Q Consensus 150 lv~~~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (259)
+++.+ +.++|+|||.+......... .....+..|+|||.+.+..++. ++|+||||+++|+|++ |..||......
T Consensus 172 ll~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 172 LVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred EEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc-HHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99766 78999999988655322111 1112345799999998777665 9999999999999998 89999877666
Q ss_pred HHHHHhhhc
Q psy3663 226 ETLTMIMDV 234 (259)
Q Consensus 226 ~~~~~i~~~ 234 (259)
+....+...
T Consensus 250 ~~~~~~~~~ 258 (307)
T cd05098 250 ELFKLLKEG 258 (307)
T ss_pred HHHHHHHcC
Confidence 666555443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=235.38 Aligned_cols=197 Identities=34% Similarity=0.572 Sum_probs=168.6
Q ss_pred ecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCCh
Q psy3663 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDL 104 (259)
Q Consensus 26 i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (259)
||+|++|.||+|.+..+++.+++|.+....... .....+..|+.+++.++||||+++++.+...+.++++|||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999999999999999987643221 2244556899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCCCc
Q psy3663 105 YDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA 183 (259)
Q Consensus 105 ~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~ 183 (259)
.+++.... ..+++..++.++.|++.++.+||++|++|+||+|+||++..+ +.++|+|||.+.............+...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 159 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDH-GNVRISDLGLAVELKGGKKIKGRAGTPG 159 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC-CCEEEccCcchhhhccCCccccccCCCC
Confidence 99987654 358999999999999999999999999999999999999766 7899999998876544333344456778
Q ss_pred cCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 184 ~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
|+|||.+.+..++. ++|+||||+++++|++|+.||.....
T Consensus 160 y~~PE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 160 YMAPEVLQGEVYDF-SVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred cCCHHHhcCCCCCc-hhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 99999988777664 99999999999999999999976554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=235.83 Aligned_cols=212 Identities=30% Similarity=0.536 Sum_probs=173.4
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEe------
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVID------ 87 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~------ 87 (259)
...+.|++.+.||.|++|.||+|.+..+++.+++|.+.... .....+..|+.+++++ +|+||+++++.+.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 35589999999999999999999999899999999986532 2345677888989888 5999999999984
Q ss_pred cCCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
....++++|||+.+++|.+++... ...+++..++.++.||+.|+.+||+.|++|+||+|+||++..+ +.++|+|||.+
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~-~~~~l~dfg~~ 168 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTEN-AEVKLVDFGVS 168 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEeeCcch
Confidence 246789999999999999998764 3448888999999999999999999999999999999999766 78999999987
Q ss_pred ccCCCCC-ccccccCCCccCCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh
Q psy3663 167 NRFNPGQ-KLETSCGSLAYSAPEILLG-----DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231 (259)
Q Consensus 167 ~~~~~~~-~~~~~~~~~~~~apE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i 231 (259)
....... ......++..|+|||.+.. ..++ .++|+||||+++|+|++|..||...........+
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred hhhhccccCCCcccccccccCHhhcCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 6543221 1223456778999998752 3344 4899999999999999999999776654444433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=234.40 Aligned_cols=212 Identities=31% Similarity=0.538 Sum_probs=174.8
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEec-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDT----- 88 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----- 88 (259)
...++|++.+.||.|++|.||+|.+..+++.+++|.+.... .....+.+|+.+++.+ +|+||+++.+.+..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45678999999999999999999999999999999986543 2345678899999988 69999999999864
Q ss_pred -CCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 89 -NSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 89 -~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
...++++|||+.+++|.+++... ...+++..+..++.|++.++.+||+.+++|+||+|+||+++++ +.++|+|||++
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~-~~~~l~Dfg~~ 158 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVS 158 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCC-CCEEEccCCCc
Confidence 24689999999999999998764 3458999999999999999999999999999999999999766 78999999998
Q ss_pred ccCCCCC-ccccccCCCccCCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh
Q psy3663 167 NRFNPGQ-KLETSCGSLAYSAPEILLG-----DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231 (259)
Q Consensus 167 ~~~~~~~-~~~~~~~~~~~~apE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i 231 (259)
....... ......++..|+|||.+.. ..++ .++|+||+|+++|+|++|+.||...........+
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~ 228 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCC-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 7553221 2223456778999999853 2344 4899999999999999999999766555444433
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=230.36 Aligned_cols=208 Identities=27% Similarity=0.496 Sum_probs=177.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
..+|++.+.||.|++|.||.|.. .+..+++|.+..... ....+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 45789999999999999999985 478999999876532 4567889999999999999999999999889999999
Q ss_pred eccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
|++.+++|.+++.... ..+++..++.++.|++.|+.+||++|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~-~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED-LVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCC-CCEEEcccccccccccccc-
Confidence 9999899999987654 258999999999999999999999999999999999999766 7899999998876532222
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhh
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (259)
.......|.|||.+....... ++|+||||++++++++ |..||......+....+.+
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 214 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK 214 (256)
T ss_pred -cCCCcccccCchhhcCCcCCc-HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc
Confidence 233456799999987777665 9999999999999997 9999988777666665554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=237.95 Aligned_cols=212 Identities=25% Similarity=0.424 Sum_probs=173.9
Q ss_pred cCeeEeeeecccccceEEEEEEeecC--------------ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTG--------------EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~--------------~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 83 (259)
.+|++.+.||+|++|.||+|.+...+ ..|++|.+.... .......+.+|++++.+++|+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 58999999999999999999875432 258999987542 333456788999999999999999999
Q ss_pred EEEecCCeEEEEEeccCCCChHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee
Q psy3663 84 EVIDTNSKLYLILELGDGGDLYDYIMKHD-----------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF 152 (259)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-----------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~ 152 (259)
+++......+++|||+.+++|.+++.... ..++...++.++.|++.|+.+||++|++|+||+|+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999999986532 1367889999999999999999999999999999999997
Q ss_pred ecCCeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCChHH
Q psy3663 153 ERLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA--GQAPFQEANDSET 227 (259)
Q Consensus 153 ~~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~~ 227 (259)
.+ +.++|+|||++......... .....+..|+|||.+.+..++. ++|+||||+++++|++ +..||...+..+.
T Consensus 164 ~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 164 NH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTT-ASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred CC-CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCc-hhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 65 78999999988654332211 1122356899999988777765 9999999999999988 7789988777766
Q ss_pred HHHhh
Q psy3663 228 LTMIM 232 (259)
Q Consensus 228 ~~~i~ 232 (259)
...+.
T Consensus 242 ~~~~~ 246 (295)
T cd05097 242 IENTG 246 (295)
T ss_pred HHHHH
Confidence 65543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=240.51 Aligned_cols=218 Identities=25% Similarity=0.430 Sum_probs=177.7
Q ss_pred CccccCeeEeeeecccccceEEEEEEeec-------CceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFT-------GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEV 85 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~-------~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 85 (259)
.-...+|++.+.||+|++|.||.|.+... +..+++|.+.... .......+.+|+++++++ +|+||+++++.
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 33445899999999999999999986432 2368999876432 233456788999999999 79999999999
Q ss_pred EecCCeEEEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeE
Q psy3663 86 IDTNSKLYLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVV 150 (259)
Q Consensus 86 ~~~~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIl 150 (259)
+......++++||+.+++|.+++.... ..++...+..++.|++.||.+||++|++|+||+|+||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 999899999999999999999987532 23677889999999999999999999999999999999
Q ss_pred eeecCCeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChH
Q psy3663 151 FFERLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSE 226 (259)
Q Consensus 151 v~~~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (259)
+..+ +.++|+|||.+......... .....+..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+
T Consensus 167 l~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 167 VTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCc-hhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9766 78999999988755432211 1122335799999998877775 9999999999999998 899998888777
Q ss_pred HHHHhhhc
Q psy3663 227 TLTMIMDV 234 (259)
Q Consensus 227 ~~~~i~~~ 234 (259)
....+.+.
T Consensus 245 ~~~~~~~~ 252 (334)
T cd05100 245 LFKLLKEG 252 (334)
T ss_pred HHHHHHcC
Confidence 77766543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=236.58 Aligned_cols=215 Identities=27% Similarity=0.462 Sum_probs=178.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeec-----CceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCC
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFT-----GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNS 90 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (259)
.++|++.+.||+|++|.||++..... ...+++|.+..... ......+.+|+.+++.+ +|+||+++++++...+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 46899999999999999999987643 36899999875432 23445678899999999 7999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC
Q psy3663 91 KLYLILELGDGGDLYDYIMKH---------------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL 155 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~---------------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~ 155 (259)
.++++|||+.+++|..++... ...+++..++.++.|++.||.+||+++|+|+||+|+||++.++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~- 168 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED- 168 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC-
Confidence 999999999999999998643 2458899999999999999999999999999999999999766
Q ss_pred CeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHh
Q psy3663 156 GVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231 (259)
Q Consensus 156 ~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i 231 (259)
+.++|+|||.+......... .....+..|+|||.+.+..++. ++|+|||||++|+|++ |..||......+..+.+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCc-ccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 89999999988765432211 1122345799999988777775 9999999999999997 99999988777777766
Q ss_pred hhc
Q psy3663 232 MDV 234 (259)
Q Consensus 232 ~~~ 234 (259)
...
T Consensus 248 ~~~ 250 (293)
T cd05053 248 KEG 250 (293)
T ss_pred HcC
Confidence 554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.91 Aligned_cols=224 Identities=26% Similarity=0.473 Sum_probs=186.2
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC--CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK--LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID 87 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (259)
+.+|.....+| ...||+|++-+||+|.|..+|..|+=..++... .++...+.+..|+.+|+.|+|+||+++++.|.
T Consensus 34 e~~p~gRy~k~--~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 34 EKDPTGRYLKF--DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred ccCCCCceeeh--hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 33444444444 478999999999999999999888755544332 34445688999999999999999999999997
Q ss_pred cCC--eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCCCCeEeeecCCeEEEEec
Q psy3663 88 TNS--KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH--VVHRDLKPENVVFFERLGVVKLTDF 163 (259)
Q Consensus 88 ~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~--i~H~dl~p~nIlv~~~~~~i~l~df 163 (259)
+.. ...+|+|.+..|+|..|+.+.+. .+..-+..|++||+++|.|||++. |+|+|||.+||||+.+.|.|||+|+
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDL 190 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDL 190 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecch
Confidence 654 48899999999999999988876 889999999999999999999885 9999999999999999999999999
Q ss_pred cccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH-HHHhhhcccccc
Q psy3663 164 GFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET-LTMIMDVSESSC 239 (259)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~ 239 (259)
|+|.......... ..|++.|||||.+. ..|+ +.+||||||+||+||+|+..||....+..+ ++++.++..|-.
T Consensus 191 GLAtl~r~s~aks-vIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 191 GLATLLRKSHAKS-VIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred hHHHHhhccccce-eccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 9998876543333 68999999999997 4444 599999999999999999999988666555 666665555443
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=243.99 Aligned_cols=223 Identities=30% Similarity=0.493 Sum_probs=184.2
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecC--C
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTN--S 90 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~ 90 (259)
..+.++|++.+.||.|++|.||+|.+..++..+++|.+............+.+|+.+++.+ +|+||+++++++... .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3577899999999999999999999988899999998865433333455677899999999 999999999988543 4
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
..+++||++.+ +|.+++... .+++..++.++.||+.+|.+||++||+|+||+|+||+++.+ +.++|+|||.+....
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~-~~~kl~d~g~~~~~~ 158 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD-CRVKLADFGLARSLS 158 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CcEEEeeccchhccc
Confidence 68999999975 998888654 57889999999999999999999999999999999999776 789999999887654
Q ss_pred CCCc------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 171 PGQK------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 171 ~~~~------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
.... .....++..|+|||.+.+......++|+||||+++|+|++|+.||......+....+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 3221 122346778999998866544445999999999999999999999988888888777766655443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=230.53 Aligned_cols=214 Identities=29% Similarity=0.477 Sum_probs=180.2
Q ss_pred eeEeeeecccccceEEEEEEeecC----ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTG----EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~----~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
+++.+.||.|++|.||+|.+...+ ..+++|.+..... ......+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 467889999999999999988766 8999999865432 22467888999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~-~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||++.+++|.+++...... +++..++.++.||+.||.+||+.+++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGEN-LVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccC-CeEEEcccCCceecccccc
Confidence 9999999999998765544 8999999999999999999999999999999999999766 7899999999876544322
Q ss_pred ccc--ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 175 LET--SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 175 ~~~--~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
... ..++..|+|||.+.+...+. ++|+||||+++++|++ |.+||...........+.....
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 222 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTS-KSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR 222 (258)
T ss_pred cccccCCCcccccChHHhccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Confidence 111 22457899999986666664 9999999999999998 8999988877777777765544
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=231.80 Aligned_cols=207 Identities=30% Similarity=0.507 Sum_probs=173.7
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||.+. .+++.+++|.+.... ....+.+|+.+++.++|||++++++.+..+. .+++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~ 77 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVM 77 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEE
Confidence 3679999999999999999986 578889999986532 3467788999999999999999999986654 68999
Q ss_pred eccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
||+.+++|.+++.... ..++...++.++.|++.|+.+||++|++|+||+|+||+++.+ +.++|+|||.+...... .
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~-~~~kl~Dfg~~~~~~~~--~ 154 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED-GVAKVSDFGLARVGSMG--V 154 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC-CcEEECCCccceecccc--C
Confidence 9999999999987653 347899999999999999999999999999999999999766 78999999988654322 1
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
.....+..|+|||.+.+..++. ++|+||||+++++|++ |++||...+..+....+.+.
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 213 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSS-KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG 213 (254)
T ss_pred CCCCCCceecCHHHhccCCcCc-hhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC
Confidence 2223356799999987777665 9999999999999997 99999888877776666544
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=256.66 Aligned_cols=208 Identities=28% Similarity=0.458 Sum_probs=187.8
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
.|.=.+.||.|+||.||.|.|..+.+.|+||.+..... +....+.+..|+.+|++++|||++.+-++|....+.++|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 34456789999999999999999999999999876543 44457899999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~ 177 (259)
||-| +-.++++=...++-+.+|..+..+.+++|.|||+.+.||+|||..|||+++. |.|+|.|||.+... .+...
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~-g~VKLaDFGSAsi~---~PAns 181 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEP-GLVKLADFGSASIM---APANS 181 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCC-Ceeeeccccchhhc---Cchhc
Confidence 9966 9999998888889999999999999999999999999999999999999776 89999999998764 34567
Q ss_pred ccCCCccCCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 178 SCGSLAYSAPEILL---GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 178 ~~~~~~~~apE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
.+|++.|+|||++. .+.|+. ++||||||++..||...++|+-+++....+..|.
T Consensus 182 FvGTPywMAPEVILAMDEGqYdg-kvDvWSLGITCIELAERkPPlFnMNAMSALYHIA 238 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 238 (948)
T ss_pred ccCCccccchhHheeccccccCC-ccceeeccchhhhhhhcCCCccCchHHHHHHHHH
Confidence 78999999999984 466776 9999999999999999999999999999999887
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=233.43 Aligned_cols=215 Identities=24% Similarity=0.379 Sum_probs=175.5
Q ss_pred ccCeeEeeeecccccceEEEEEEee-----cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
.++|++.+.||+|++|.||+|.+.. .+..|++|.+.... .......+.+|+.+++.++|+||+++++++.++..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4789999999999999999997552 34589999876443 22234456789999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEe
Q psy3663 92 LYLILELGDGGDLYDYIMKHD---------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTD 162 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~---------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~d 162 (259)
.+++|||+.+++|.+++.... ...+...+..++.||+.||.+||+++++|+||+|+||++..+ +.++|+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~-~~~~L~D 162 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD-FTVKIGD 162 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCC-CcEEECc
Confidence 999999999999999997532 234667889999999999999999999999999999999766 7899999
Q ss_pred ccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 163 FGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 163 f~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
||.+......... ....++..|+|||.+.+...+. ++|+||||+++|+|++ |..||......+..+.+.+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~-~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 237 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT-SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG 237 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCCh-HhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9988654332211 1122356799999988777765 9999999999999998 89999888877777766644
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=231.94 Aligned_cols=201 Identities=28% Similarity=0.445 Sum_probs=171.2
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCeEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT--NSKLYLI 95 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 95 (259)
++|+..+.||.|++|.||+|.+..++..+++|.+..... ......+.+|+++++.++||||+++++++.+ ...++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 478999999999999999999998999999999875432 2345678899999999999999999998854 3478999
Q ss_pred EeccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 96 LELGDGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~---~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
|||+++++|.+++.. ....+++..+..++.||+.+|.+||+.|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~-~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRK-GQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecC-CeEEEeecccccccccc
Confidence 999999999887653 34458899999999999999999999999999999999999766 78999999987654332
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
.. ....++..|+|||.+.+..++. ++|+||||+++|+|++|..||...
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQGKPYSI-TSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cc-ccccCCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCcc
Confidence 21 2334677899999998877775 999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=238.00 Aligned_cols=211 Identities=25% Similarity=0.443 Sum_probs=171.5
Q ss_pred ccCeeEeeeecccccceEEEEEEee----------------cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVF----------------TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~----------------~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 80 (259)
.++|++.+.||+|++|.||+|.+.. ++..+++|.+.... .......+.+|+++++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 3579999999999999999986432 34468999986542 233456788999999999999999
Q ss_pred EEEEEEecCCeEEEEEeccCCCChHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeE
Q psy3663 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHD----------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVV 150 (259)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIl 150 (259)
++++++...+..+++||++.+++|.+++.... ..+++..+..++.||+.|+.+||+.|++|+||+|+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999999987643 12667789999999999999999999999999999999
Q ss_pred eeecCCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCCCh
Q psy3663 151 FFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA--GQAPFQEANDS 225 (259)
Q Consensus 151 v~~~~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~ 225 (259)
++.+ +.++|+|||++........ ......+..|++||......++. ++|+||||+++|+|++ |..||......
T Consensus 163 i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 163 VGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT-ASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccc-hhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9765 7899999999876533221 11122356799999887777765 9999999999999998 78999876665
Q ss_pred HHHHH
Q psy3663 226 ETLTM 230 (259)
Q Consensus 226 ~~~~~ 230 (259)
+....
T Consensus 241 ~~~~~ 245 (296)
T cd05095 241 QVIEN 245 (296)
T ss_pred HHHHH
Confidence 55443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=242.76 Aligned_cols=217 Identities=29% Similarity=0.471 Sum_probs=178.4
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
++.++|++.+.||.|++|.||+|.+..++..|++|.+..... .....+.+|+.+++.++||||+++++.+...
T Consensus 2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 467899999999999999999999999999999999865442 3456788899999999999999999776443
Q ss_pred ---------CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEE
Q psy3663 90 ---------SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 90 ---------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
...++++||+.+ +|.+++... .+++..++.++.||+.|+.+||+.|++|+||+|+||+++.+++.++|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMET-DLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccccccceEEEEeecccc-cHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 357899999975 888877543 48999999999999999999999999999999999999766578999
Q ss_pred EeccccccCCCCCc----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 161 TDFGFSNRFNPGQK----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 161 ~df~~~~~~~~~~~----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
+|||.+........ .....++..|+|||.+........++|+|||||++|+|++|+.||...+..+....+++...
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99998865432211 12224567899999876544344599999999999999999999988887777777665543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=226.20 Aligned_cols=201 Identities=27% Similarity=0.420 Sum_probs=170.8
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CC
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT-----NS 90 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~ 90 (259)
=.+||++.+.+|+|+|+.||++....+++.|++|.+.... ....+..++|+...++++|||+++++++... ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3569999999999999999999999999999999998765 4567888999999999999999999987533 34
Q ss_pred eEEEEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLH--VVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~--i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
..|++++|...++|.+.++.. +..+++.+++.++.+|+++|.+||... +.|+||||.||++.+. +.+++.|||+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~-~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS-GLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC-CceEEEeccC
Confidence 589999999999999998865 445999999999999999999999998 9999999999999775 7899999999
Q ss_pred cccCCCCCccc----------cccCCCccCCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 166 SNRFNPGQKLE----------TSCGSLAYSAPEILL---GDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 166 ~~~~~~~~~~~----------~~~~~~~~~apE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
++...-..... ...-+..|+|||.+. .... ++++|||||||++|.||.|.-||.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti-~ertDIWSLGCtLYa~mf~~sPfe 242 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTI-TERTDIWSLGCTLYAMMFGESPFE 242 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccc-ccccchhhhhHHHHHHHHcCCcch
Confidence 87654221111 112467899999884 3333 459999999999999999999994
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=228.27 Aligned_cols=207 Identities=26% Similarity=0.441 Sum_probs=171.9
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGD 103 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~s 103 (259)
+.||+|++|.||+|... ++..+++|.+.... .......+.+|+++++.++||||+++++++...+..+++|||+.+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 36899999999999854 68899999986543 23334567889999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc--cccCC
Q psy3663 104 LYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE--TSCGS 181 (259)
Q Consensus 104 L~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~--~~~~~ 181 (259)
|.+++......+++..+..++.|++.+|.++|++|++|+||+|+||+++.+ +.++|+|||.+.......... .....
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCC-CeEEECCCccceeccccccccCCCCCCc
Confidence 999987766668999999999999999999999999999999999999766 789999999886543322111 11234
Q ss_pred CccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 182 LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 182 ~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
..|+|||.+.+..++. ++|+||||+++|++++ |..||...........+...
T Consensus 158 ~~y~aPE~~~~~~~~~-~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~ 210 (250)
T cd05085 158 IKWTAPEALNYGRYSS-ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210 (250)
T ss_pred ccccCHHHhccCCCCc-hhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence 5799999987777665 9999999999999998 99999887766666655543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=261.91 Aligned_cols=231 Identities=25% Similarity=0.426 Sum_probs=198.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCc-----eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGE-----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~-----~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
..-++.+.||+|+||.||.|.-..... .|++|.+.... +......+.+|+.++..++||||+++++++-+...+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 466788999999999999998654433 48999886653 556678899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 93 YLILELGDGGDLYDYIMKH------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
++++|||.+++|..++++. ...++..+++.++.|++++..||+++++||+||..+|+|++.. ..+||.|||+|
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKIaDFGlA 849 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKIADFGLA 849 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEEcccchh
Confidence 9999999999999999988 6779999999999999999999999999999999999999887 88999999999
Q ss_pred ccCCCCCccc---cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccccc--
Q psy3663 167 NRFNPGQKLE---TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSCT-- 240 (259)
Q Consensus 167 ~~~~~~~~~~---~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~-- 240 (259)
+.+....... .......|||||.+....+++ ++||||||+++||+++ |..||.+.++.+.+...+++++-.++
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFts-kSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTS-KSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhccccc-ccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 8554332221 124467999999999988887 9999999999999999 99999999999999988877654432
Q ss_pred ----------cccccCchhhh
Q psy3663 241 ----------CWWRGRPRSRR 251 (259)
Q Consensus 241 ----------~~~~~~~~~~~ 251 (259)
.||...|..|.
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP 949 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRP 949 (1025)
T ss_pred CChHHHHHHHHHccCChhhCc
Confidence 47888887654
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=232.26 Aligned_cols=215 Identities=25% Similarity=0.349 Sum_probs=177.1
Q ss_pred ccCeeEeeeecccccceEEEEEEee----cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCe
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVF----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT-NSK 91 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~----~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 91 (259)
.++|++.+.||+|++|.||.|.+.. .+..+++|.+... ........+.+|+.+++.++|+||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4689999999999999999999875 2578999987643 234446778899999999999999999998755 577
Q ss_pred EEEEEeccCCCChHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecc
Q psy3663 92 LYLILELGDGGDLYDYIMKHD-------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG 164 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~-------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~ 164 (259)
.+++++++.+++|.+++.... ..+++..++.++.||+.||.+||+++++|+||+|+||++.++ +.++|+|||
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~-~~~kl~d~g 162 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE-LQVKITDNA 162 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC-CcEEECCCC
Confidence 899999999889999987642 348899999999999999999999999999999999999766 789999999
Q ss_pred ccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 165 FSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
++..+...... ....++..|+|||.+.+..++. ++|+||||++++++++ |+.||...+..+....+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 235 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSS-ASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG 235 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCc-hhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC
Confidence 98755332211 1123456799999998777665 9999999999999999 99999887777766655544
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=235.60 Aligned_cols=219 Identities=30% Similarity=0.576 Sum_probs=185.0
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 95 (259)
++|.+.+.||.|++|.||+|.+..++..+++|++..... .......+.+|..++++++ |+||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 479999999999999999999999999999999876432 2233566788999999999 99999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK- 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~- 174 (259)
||++.+++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+||++..+ +.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~-~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC-CCEEecCCccccccCCcccc
Confidence 99999999999998765 49999999999999999999999999999999999999766 7899999998876543221
Q ss_pred --------------------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 175 --------------------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 175 --------------------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
.....++..|+|||.......+. ++|+||||++++++++|+.||........+..+.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK-SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL 237 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCCh-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc
Confidence 11224567899999988776664 999999999999999999999988776667776654
Q ss_pred ccccc
Q psy3663 235 SESSC 239 (259)
Q Consensus 235 ~~~~~ 239 (259)
....+
T Consensus 238 ~~~~~ 242 (280)
T cd05581 238 EYSFP 242 (280)
T ss_pred CCCCC
Confidence 44333
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=229.56 Aligned_cols=213 Identities=27% Similarity=0.444 Sum_probs=176.8
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
...++|++.+.||+|++|.||+|.+. .+..+++|.+.... .....+.+|+.+++.++|+||+++.+.+.+ ...++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 35689999999999999999999855 55679999876432 235678889999999999999999999877 77899
Q ss_pred EEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 95 ILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+|||+++++|.+++... ...++...+..++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCCcceeeccCCC
Confidence 99999999999998764 3447888999999999999999999999999999999999766 789999999887654322
Q ss_pred cc--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 174 KL--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 174 ~~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
.. ....++..|+|||.+.....+. ++|+||||+++|++++ |+.||...+..+....+...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCc-cccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence 21 1223446799999997766664 9999999999999998 99999988777777666543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=231.22 Aligned_cols=209 Identities=27% Similarity=0.449 Sum_probs=173.6
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc--------ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP--------VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
+|.+.+.||.|++|.||+|.+..+++.+++|.+....... ...+.+.+|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5889999999999999999998899999999886432111 11345778999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
..++++||+.+++|.+++.... .+++..+..++.||+.||.+||+++++|+||+|+||++..+ +.++|+||+.+....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~-~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCC-CeEEEeecccccccc
Confidence 9999999999999999987764 58999999999999999999999999999999999999766 889999999886543
Q ss_pred CCCc---cccccCCCccCCcccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy3663 171 PGQK---LETSCGSLAYSAPEILLGDS--YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTM 230 (259)
Q Consensus 171 ~~~~---~~~~~~~~~~~apE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (259)
.... .....++..|+|||.+.... .+ .++|+||||++++++++|..||......+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 223 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCC-ccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH
Confidence 2211 12234677899999987654 44 499999999999999999999976555444433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=230.79 Aligned_cols=215 Identities=26% Similarity=0.420 Sum_probs=176.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeec---CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFT---GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
..+|.+.+.||.|++|.||+|.+... ...+++|...... .......+.+|+.+++.++|+||+++++++.+. ..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcE
Confidence 35699999999999999999987643 3478889876443 233456788899999999999999999998764 567
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++||++.+++|.+++......++...++.++.|++.||.+||+.|++|+||+|+||++..+ +.++|+|||++.......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~-~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSP-DCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecC-CCeEEccCceeeeccccc
Confidence 9999999999999998766568999999999999999999999999999999999999776 789999999887654332
Q ss_pred ccc--cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 174 KLE--TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 174 ~~~--~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
... .......|+|||.+....++. ++|+||||++++++++ |..||......+....+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 225 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE 225 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCc-hhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence 111 112345799999987776665 9999999999999886 999998888777777766544
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=239.51 Aligned_cols=224 Identities=28% Similarity=0.434 Sum_probs=182.8
Q ss_pred CeeEeeeecccccceEEEEEEeec--CceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEec----CCe
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFT--GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDT----NSK 91 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~--~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----~~~ 91 (259)
+|++.+.||.|++|.||+|.+... +..|++|.+............+.+|+.++++++ ||||+++++.+.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 889999998754333334566778999999995 9999999987532 245
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.+++++++.+ +|.+.+.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~-~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD-CELKICDFGLARGFSE 157 (332)
T ss_pred EEEEEecccC-CHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCC-CCEEeCcCCCceeccc
Confidence 7889999864 8988886544 48999999999999999999999999999999999999766 7899999998876543
Q ss_pred CCc-----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 172 GQK-----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 172 ~~~-----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
... .....++..|+|||.+.+....+.++|+||||+++++|++|.+||...+..+.+..+++..+.++..++..
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 211 12235678899999876643333599999999999999999999999888899999998888776655443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=235.19 Aligned_cols=210 Identities=30% Similarity=0.513 Sum_probs=177.8
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
+...++|++.+.||+|++|.||++.+..++..+++|.+.... ......+.+|+.+++.++||||+++++.+......+
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~ 92 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW 92 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence 444689999999999999999999998889999999986433 223566788999999999999999999999989999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+++||+.+++|.+++.+. .++...+..++.|++.++.+||++|++|+||+|+||++..+ +.++|+|||.+.......
T Consensus 93 lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~-~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC-CCEEEccCcceecccccc
Confidence 999999999999998654 37899999999999999999999999999999999999766 789999999876543322
Q ss_pred c-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHH
Q psy3663 174 K-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229 (259)
Q Consensus 174 ~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (259)
. .....++..|++||.+....++. ++|+||||++++++++|+.||...+..+...
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~ 225 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALY 225 (293)
T ss_pred cccccccCChhhcCchhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChhhhee
Confidence 2 22335667899999988776664 9999999999999999999998766554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=235.07 Aligned_cols=219 Identities=25% Similarity=0.429 Sum_probs=179.4
Q ss_pred CCccccCeeEeeeecccccceEEEEEEe-------ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHV-------FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYE 84 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~-------~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 84 (259)
.....++|++.+.||+|++|.||+|... ..+..+++|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 4455779999999999999999999753 223478999886542 233456788999999999 7999999999
Q ss_pred EEecCCeEEEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCe
Q psy3663 85 VIDTNSKLYLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENV 149 (259)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nI 149 (259)
.+......+++|||+.+++|.+++.... ..++...+..++.||+.||.+||++|++|+||+|+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 9999999999999999999999987642 2367788999999999999999999999999999999
Q ss_pred EeeecCCeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q psy3663 150 VFFERLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDS 225 (259)
Q Consensus 150 lv~~~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (259)
++..+ +.++|+|||.+......... ....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......
T Consensus 169 li~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 169 LVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred EEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCc-hhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99766 78999999998765432211 1122345799999998877765 9999999999999998 88999888777
Q ss_pred HHHHHhhhc
Q psy3663 226 ETLTMIMDV 234 (259)
Q Consensus 226 ~~~~~i~~~ 234 (259)
+..+.+.+.
T Consensus 247 ~~~~~~~~~ 255 (304)
T cd05101 247 ELFKLLKEG 255 (304)
T ss_pred HHHHHHHcC
Confidence 777766543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=230.10 Aligned_cols=200 Identities=30% Similarity=0.447 Sum_probs=168.4
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
....||+|++|.||+|.+..++..+++|.+.... ......+.+|+.+++.++|+||+++++++...+..++++|++.+
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 3468999999999999998889999999886543 22456788999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-cccc
Q psy3663 102 GDLYDYIMKHDAGL--SETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LETS 178 (259)
Q Consensus 102 ~sL~~~~~~~~~~~--~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~~~ 178 (259)
++|..++......+ ++..+..++.||+.|+.+||++||+|+||+|+||+++.+.+.++|+|||.+........ ....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 169 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF 169 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccC
Confidence 99999988654445 88899999999999999999999999999999999977557899999998866533222 2233
Q ss_pred cCCCccCCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 179 CGSLAYSAPEILLGDS-YDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 179 ~~~~~~~apE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
.++..|+|||.+.+.. ....++|+||||+++++|++|+.||....
T Consensus 170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 4678999999986533 23359999999999999999999997644
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=241.01 Aligned_cols=207 Identities=25% Similarity=0.492 Sum_probs=187.1
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
+-|++++.||+|+||.||+|++..+|..++||.+.-. ...+.+..|+.++++++.|+++++|+.+..+...++|||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 4689999999999999999999999999999997544 368889999999999999999999999988899999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Cccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~~ 176 (259)
||..+++.+.++.+..+++++++..+++.-+++|+|||...-+|+|||..|||+..+ |..+|.|||.+..+... ....
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~-G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD-GIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc-chhhhhhccccchhhhhHHhhC
Confidence 999999999999999999999999999999999999999999999999999999777 89999999998765432 3345
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTM 230 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (259)
+..+++.|+|||++..-.+++ ++||||||++..||..|++||.+.+.-...-.
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~-~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM 240 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDT-KADIWSLGITAIEMAEGRPPYSDIHPMRAIFM 240 (502)
T ss_pred ccccCcccccHHHHHHhccch-hhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence 567999999999998888888 99999999999999999999998776655433
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=232.04 Aligned_cols=211 Identities=30% Similarity=0.533 Sum_probs=178.3
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
..|+..+.||.|++|.||++.+..++..+++|.+.... ......+.+|+.+++.++|+||+++++.+...+..++++|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 45666789999999999999998899999999886432 2335567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-cc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~ 176 (259)
++.+++|.+++.. ..++...+..++.|++.++.+||++|++|+||+|+||+++.+ +.++|+|||.+........ ..
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC-CcEEEcccccchhhccCCcccc
Confidence 9999999999876 348999999999999999999999999999999999999766 7899999998765433222 22
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
...++..|+|||.+.+..++. ++|+||||+++++|++|+.||...+.......+...
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~-~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~ 230 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230 (285)
T ss_pred cccCCccccCHHHhcCCCCCC-cccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc
Confidence 235678899999998777665 999999999999999999999877666666555544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=237.18 Aligned_cols=211 Identities=29% Similarity=0.536 Sum_probs=177.1
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
...-|+....||.|++|.||+|.+..++..|++|.+..... .....+.+|+.++..++|||++++++.+......+++
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 33445566789999999999999998999999999865432 2356678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-c
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-K 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~ 174 (259)
+||+++++|.+++.. ..+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+....... .
T Consensus 97 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~-~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 97 MEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred EecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccC-CcEEEeechhHhhccccccc
Confidence 999999999987755 348999999999999999999999999999999999999766 789999999886543322 1
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
.....++..|+|||.+.+...+. ++|+||||+++++|++|+.||......+.+..+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 230 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGT-EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230 (297)
T ss_pred ccceecCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 22345778999999998777665 9999999999999999999998776666555544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=231.38 Aligned_cols=211 Identities=29% Similarity=0.489 Sum_probs=178.2
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.+-|++.+.||.|++|.||+|.+..++..+++|.+..... ......+.+|+.++..++||||+++++.+......++++
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 3568889999999999999999988999999999865432 234567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-c
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-L 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~ 175 (259)
||+.+++|.+++... .++...+..++.|++.++.+||+.|++|+||+|+||+++.+ +.++|+|||.+........ .
T Consensus 82 e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~-~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 82 EYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC-CCEEEeecccceecccchhhh
Confidence 999999999988643 48999999999999999999999999999999999999766 7899999998865543221 1
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
....++..|+|||.+.+...+. ++|+||||+++++|++|..||...........+.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELAKGEPPHSELHPMKVLFLIP 214 (277)
T ss_pred ccccCCccccChhhhccCCCCc-hhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh
Confidence 2234677899999987776664 9999999999999999999998776665555543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=232.61 Aligned_cols=213 Identities=29% Similarity=0.523 Sum_probs=182.8
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
...+.|++...|++|++|.||.|.+..++..+++|.+..... ....+.+|+.+++.++|+|++++++.+......++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 456679999999999999999999998899999999876542 45677889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ- 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~- 173 (259)
++||+.+++|.+++......++...++.++.|++.+|.+||+.|++|+||+|+||+++.+ +.++|+||+.+.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~-~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCC-CCEEECccchhhhhccchh
Confidence 999999899999998876469999999999999999999999999999999999999766 789999999876543322
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
......++..|++||.+.+..++. ++|+||||+++|+|++|+.||...+.......+.
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~-~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~ 229 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGP-KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT 229 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCC-ccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 112234567899999988777665 9999999999999999999998776655555443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=233.11 Aligned_cols=201 Identities=31% Similarity=0.434 Sum_probs=165.7
Q ss_pred ccCe-eEeeeecccccceEEEEE----EeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec--C
Q psy3663 17 AGLY-DLEETLGRGHFAVVKLAR----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT--N 89 (259)
Q Consensus 17 ~~~y-~~~~~i~~g~~~~vy~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 89 (259)
.++| ++.+.||+|++|.||++. ...++..+++|.+..... ......+.+|+++++.++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 4667 999999999999998764 334677899999875432 2235667789999999999999999998754 3
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
...+++||++.+++|.+++... .+++..++.++.|++.|+.+||++|++|+||+|+||++..+ +.++|+|||.+...
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC-CcEEEeeccccccc
Confidence 4688999999999999998764 38999999999999999999999999999999999999766 78999999998765
Q ss_pred CCCCcc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 170 NPGQKL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 170 ~~~~~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
...... ....++..|+|||.+.+...+. ++|+||||+++++|++|..||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSY-ASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCc-ccccHHHHHHHHHHHhCCCCCCCC
Confidence 433221 1123455699999987776665 999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=235.26 Aligned_cols=202 Identities=26% Similarity=0.443 Sum_probs=174.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
.+|++.+.||+|++|.||+|.+..++..+++|++.... .......+.+|+++++.++||||+++++.+.....+++++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 57899999999999999999999889999999986543 23346778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
|+++++|.+++...+ .++...+..++.+++.++.+||+ .+++|+||+|+||++..+ +.++|+|||++...... ...
T Consensus 84 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~-~~~~l~d~gl~~~~~~~-~~~ 160 (284)
T cd06620 84 FMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSR-GQIKLCDFGVSGELINS-IAD 160 (284)
T ss_pred cCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCC-CcEEEccCCcccchhhh-ccC
Confidence 999999999887654 48999999999999999999997 589999999999999666 78999999987654222 223
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
...++..|+|||.+.+...+. ++|+||||++++++++|..||.....
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTV-KSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ccccCcccCCHHHHccCCCCc-cchHHHHHHHHHHHHhCCCCCcccch
Confidence 346788999999987776665 99999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=233.30 Aligned_cols=211 Identities=27% Similarity=0.429 Sum_probs=176.3
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
..+.|...+.||+|++|.||+|.+..++..+++|.+...... ......+.+|+.+++.++|||++++++++.+....++
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 344577788899999999999999999999999998754332 2234567889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+|||+.+ ++.+++.....++++..++.++.||+.++.+||++|++|+||+|+||++..+ +.++|+|||.+.... .
T Consensus 99 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~-~~~kL~dfg~~~~~~---~ 173 (313)
T cd06633 99 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP-GQVKLADFGSASKSS---P 173 (313)
T ss_pred EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC-CCEEEeecCCCcccC---C
Confidence 9999965 8888877666679999999999999999999999999999999999999766 789999999875432 2
Q ss_pred cccccCCCccCCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 175 LETSCGSLAYSAPEILL---GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
.....++..|+|||.+. ....+ .++|+||||+++++|++|..||...+.......+.
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 233 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 233 (313)
T ss_pred CCCccccccccChhhccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 23345678899999984 23444 48999999999999999999998777666555554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=229.14 Aligned_cols=199 Identities=22% Similarity=0.331 Sum_probs=160.2
Q ss_pred eeecccccceEEEEEEee------------cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 24 ETLGRGHFAVVKLARHVF------------TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~------------~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
+.||+|++|.||+++... ....+++|.+.... ......+.+|+.++..++||||+++++++.++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999998432 23368888876543 2234567788999999999999999999998888
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC------eEEEEeccc
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG------VVKLTDFGF 165 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~------~i~l~df~~ 165 (259)
.+++|||+.+++|..++......+++..++.++.||+.|+.|||+++++|+||+|+||++..+.. .++++|||.
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999999988776666999999999999999999999999999999999999965421 289999998
Q ss_pred cccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCChHH
Q psy3663 166 SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLV-AGQAPFQEANDSET 227 (259)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~ 227 (259)
+...... ....++..|+|||.+......+.++|+||||+++|+|+ +|..||......+.
T Consensus 159 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 218 (262)
T cd05077 159 PITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK 218 (262)
T ss_pred CccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH
Confidence 7654322 23345678999998874443345999999999999997 58899976654443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=240.62 Aligned_cols=213 Identities=29% Similarity=0.448 Sum_probs=173.8
Q ss_pred cCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSK 91 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 91 (259)
++|.+.+.||+|+||.||+|.+. ..++.|++|++..... ......+.+|+.++.++. ||||+++++.+...+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 57888899999999999999853 3456899999976532 223456889999999998 9999999999999899
Q ss_pred EEEEEeccCCCChHHHHHhcC-----------------------------------------------------------
Q psy3663 92 LYLILELGDGGDLYDYIMKHD----------------------------------------------------------- 112 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~----------------------------------------------------------- 112 (259)
.++++||+.+++|.+++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 999999999999999986432
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec
Q psy3663 113 --------------------------------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER 154 (259)
Q Consensus 113 --------------------------------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~ 154 (259)
..++...++.++.||+.||.|||+.+++|+||+|+||++..+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC
Confidence 125677889999999999999999999999999999999765
Q ss_pred CCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHH
Q psy3663 155 LGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTM 230 (259)
Q Consensus 155 ~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 230 (259)
+.++|+|||++........ .....++..|+|||.+.+..+.. ++|+||||+++++|++ |..||......+.+..
T Consensus 276 -~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~ 353 (401)
T cd05107 276 -KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT-LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353 (401)
T ss_pred -CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc-HhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence 7899999999875432211 11223567899999998877765 9999999999999998 8999987766666555
Q ss_pred hhh
Q psy3663 231 IMD 233 (259)
Q Consensus 231 i~~ 233 (259)
.+.
T Consensus 354 ~~~ 356 (401)
T cd05107 354 AIK 356 (401)
T ss_pred HHH
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=228.11 Aligned_cols=208 Identities=23% Similarity=0.380 Sum_probs=166.2
Q ss_pred eeecccccceEEEEEEeec---CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe-cCCeEEEEEecc
Q psy3663 24 ETLGRGHFAVVKLARHVFT---GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID-TNSKLYLILELG 99 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~ 99 (259)
+.||+|++|.||+|.+... +..+++|.+.... .......+.+|+.+++.++||||+++++++. .++..++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 4689999999999986533 3579999875432 2233567778999999999999999999764 456688999999
Q ss_pred CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-----
Q psy3663 100 DGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK----- 174 (259)
Q Consensus 100 ~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~----- 174 (259)
.+++|.+++.......+...+..++.|++.||.+||+.+++|+||+|+||+++++ +.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDES-FTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCC-CcEEECCccccccccCCcceeecc
Confidence 9999999998765557788889999999999999999999999999999999766 7899999998865432111
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
......+..|+|||.+.+..++. ++|+||||+++|+|++ |.+||...+..+....+.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~ 218 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG 218 (262)
T ss_pred cccCcCCccccChhHhccCccch-HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 11223456799999988777765 9999999999999999 57788877776666666544
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=229.56 Aligned_cols=195 Identities=34% Similarity=0.535 Sum_probs=159.8
Q ss_pred eecccccceEEEEEEeecCceEEEEEcccCCCCcccH-HHHHHH---HHHHHhCCCCCeEEEEEEEecCCeEEEEEeccC
Q psy3663 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQE---VRCMKLVQHPNVVRLYEVIDTNSKLYLILELGD 100 (259)
Q Consensus 25 ~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~-~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (259)
.||+|++|.||+|.+..+++.|++|.+.......... .....| ...++...||+|+.+.+.+.+.+..+++|||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4799999999999999899999999987654322221 122233 334445579999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccC
Q psy3663 101 GGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCG 180 (259)
Q Consensus 101 ~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~ 180 (259)
+++|..++.... .+++..+..++.|++.|+.+||+.+++|+||+|+||+++.+ +.++|+|||.+...... ......+
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~-~~~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCC-CCEEEccCcCccccCcc-CCcCcCC
Confidence 999998886544 48999999999999999999999999999999999999766 78999999988654332 2223467
Q ss_pred CCccCCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 181 SLAYSAPEILLGD-SYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 181 ~~~~~apE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
+..|+|||.+.+. .++ .++|+||+|+++|+|++|+.||....
T Consensus 158 ~~~y~aPE~~~~~~~~~-~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 158 THGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred CcCCcCcHHhcCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCC
Confidence 8899999998754 444 48999999999999999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=232.63 Aligned_cols=201 Identities=23% Similarity=0.371 Sum_probs=163.2
Q ss_pred eeecccccceEEEEEEeecCc-------eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 24 ETLGRGHFAVVKLARHVFTGE-------KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~-------~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
+.||.|+||.||+|.+...+. ++++|.+.... ......+.+|+.+++.++||||+++++++......+++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 368999999999998765443 47888765432 223456788999999999999999999998888899999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC-------eEEEEeccccccC
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG-------VVKLTDFGFSNRF 169 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~-------~i~l~df~~~~~~ 169 (259)
||+.+++|.+++......+++..+..++.||+.|+.+||++||+|+||+|+||+++.+.. .++++|||.+...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999999876666899999999999999999999999999999999999976633 2799999987654
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChHHHH
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAG-QAPFQEANDSETLT 229 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~ 229 (259)
.. .....++..|+|||.+.+....+.++|+||||+++|+|++| .+||...+......
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~ 216 (258)
T cd05078 159 LP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216 (258)
T ss_pred CC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH
Confidence 32 22334667899999997754334599999999999999998 57777665554443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=230.23 Aligned_cols=203 Identities=29% Similarity=0.507 Sum_probs=168.5
Q ss_pred CCCCccccCeeEeeee--cccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEe
Q psy3663 11 GHPTKIAGLYDLEETL--GRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVID 87 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i--~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (259)
++...+.+.|++.+.+ |+|++|.||++.+..++..+++|.+........ |......+ +|+|++++++.+.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEe
Confidence 3445566788888887 999999999999999999999999875432211 22222222 6999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
..+..+++|||+++++|.+++.... ++++..++.++.|+++|+.+||+.|++|+||+|+||++..+.+.++|+|||.+.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999999999987665 599999999999999999999999999999999999998774489999999886
Q ss_pred cCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
..... ....++..|+|||.+.+..++. ++|+||+|+++++|++|..||.....+
T Consensus 159 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~~l~~g~~p~~~~~~~ 212 (267)
T PHA03390 159 IIGTP---SCYDGTLDYFSPEKIKGHNYDV-SFDWWAVGVLTYELLTGKHPFKEDEDE 212 (267)
T ss_pred ecCCC---ccCCCCCcccChhhhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 55432 2235677899999998877765 999999999999999999999865544
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=227.29 Aligned_cols=204 Identities=32% Similarity=0.539 Sum_probs=167.8
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHH-HHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRC-MKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||.|++|.||+|.+..+++.+++|.+...... ......+..|..+ ....+|+|++++++.+...+.+++++||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999999989999999998654321 1122233444444 3445799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS 181 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~ 181 (259)
++|.+++.... ++++..+..++.|++.||.+||+.+++|+||+|+||++..+ +.++|+|||.+..... .....++
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~---~~~~~~~ 156 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT-GHLKLTDFGLSRNGLE---NKKFVGT 156 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC-CcEEEeecccceeccc---cccCCCC
Confidence 99999987654 48999999999999999999999999999999999999766 7899999998765432 2233467
Q ss_pred CccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 182 LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 182 ~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
..|++||.+.+..++ .++|+||||+++|+|++|..||...+....+..+..
T Consensus 157 ~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 207 (260)
T cd05611 157 PDYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207 (260)
T ss_pred cCccChhhhcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 789999998877655 499999999999999999999988877776666543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=244.52 Aligned_cols=202 Identities=29% Similarity=0.501 Sum_probs=171.9
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (259)
..|++.+.||.|+.+.||+|... +...|++|.+.....+......+..|+..|.+|+ |.+|++++++-...+..|+||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 37999999999999999999855 3346777777776667778889999999999997 899999999988899999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-- 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-- 174 (259)
||-+. +|..++.+...-++...+..++.||++|+.++|..||||.||||.|+++.+ |+++|+|||+|..+.....
T Consensus 440 E~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G~LKLIDFGIA~aI~~DTTsI 516 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--GRLKLIDFGIANAIQPDTTSI 516 (677)
T ss_pred ecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--eeEEeeeechhcccCccccce
Confidence 99865 999999988765666799999999999999999999999999999999855 5899999999988765433
Q ss_pred -cccccCCCccCCcccccCCCCC----------CCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 175 -LETSCGSLAYSAPEILLGDSYD----------APAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 175 -~~~~~~~~~~~apE~~~~~~~~----------~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
....+|+..||+||.+..-... ..++|||||||++|+|+-|++||..-.
T Consensus 517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 2455799999999988422111 238999999999999999999997543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=231.05 Aligned_cols=203 Identities=33% Similarity=0.591 Sum_probs=168.7
Q ss_pred CeeEeeeecccccceEEEEEEe---ecCceEEEEEcccCCC--CcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 92 (259)
.|++.+.||.|++|.||.|.+. .+|..|++|++..... .......+.+|+++++.+. |++|+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 3788999999875432 1223456778999999995 89999999999998999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
++++||+.+++|.+++.... ++++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCC-CCEEEeeCccceecccc
Confidence 99999999999999987654 48899999999999999999999999999999999999776 78999999988765432
Q ss_pred Cc--cccccCCCccCCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 173 QK--LETSCGSLAYSAPEILLGDS-YDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 173 ~~--~~~~~~~~~~~apE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
.. .....++..|+|||.+.... ..+.++|+||||+++|+|++|..||....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 21 12334678899999986532 22348999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=229.14 Aligned_cols=209 Identities=22% Similarity=0.372 Sum_probs=164.3
Q ss_pred eeecccccceEEEEEEee--cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVF--TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+.+++.++|+||+++++.+.+...++++|||+.+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 358999999999996432 34478888775433 233345677899999999999999999999999999999999999
Q ss_pred CChHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc---
Q psy3663 102 GDLYDYIMKHDA----GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK--- 174 (259)
Q Consensus 102 ~sL~~~~~~~~~----~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~--- 174 (259)
++|.+++..... ..++..+..++.||+.|+.+||+++|+|+||+|+||+++.+ +.++|+|||.+........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD-LSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC-CcEEEeccccccccccchheec
Confidence 999999876532 24577788999999999999999999999999999999776 7899999998754322211
Q ss_pred cccccCCCccCCcccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 175 LETSCGSLAYSAPEILLG------DSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~------~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
......+..|+|||.+.. ....+.++|+||||+++|+|++ |..||......+.+..++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 225 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc
Confidence 122234567999998743 1222349999999999999999 88999888777776665543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=266.40 Aligned_cols=221 Identities=33% Similarity=0.532 Sum_probs=193.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.++|.+++.||.|+||.|.++..+.+++-||+|++.+-. ........+..|-.++-.-+.+.|+.+...|.++.+.|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 358999999999999999999999999999999997621 2234566788888899888899999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
|||++||+|..++.+.. .+++...+.++..|..||..||+.|+||+||||+|||++.. |+++|.|||.+-.+......
T Consensus 154 MdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~-GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKS-GHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEeccc-CcEeeccchhHHhcCCCCcE
Confidence 99999999999999888 69999999999999999999999999999999999999766 99999999999888744333
Q ss_pred --ccccCCCccCCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 176 --ETSCGSLAYSAPEILLG-----DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 176 --~~~~~~~~~~apE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
...+|++.|.|||++.. +.|. +.+|.||+|+++|||+.|..||...+-.+.+.+|++....+.+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG-~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~F 302 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYG-RECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSF 302 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccC-CccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCC
Confidence 45689999999999842 3344 5899999999999999999999999999999999988444433
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=229.96 Aligned_cols=205 Identities=36% Similarity=0.586 Sum_probs=175.6
Q ss_pred ecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCCh
Q psy3663 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDL 104 (259)
Q Consensus 26 i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (259)
||.|++|.||+|.+..+++.+++|.+..... .......+.+|+++++.++|+||+++++.+......++++|++.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5889999999999998899999999875432 223456788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC---------cc
Q psy3663 105 YDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ---------KL 175 (259)
Q Consensus 105 ~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~---------~~ 175 (259)
.+++.... .+++..++.++.||+.+|.+||++|++|+||+|+||+++++ +.++|+|||++....... ..
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCC-CCEEEEecccchhcccCcccccccccccc
Confidence 99987755 58999999999999999999999999999999999999776 789999999886543321 12
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
....++..|++||.......+. ++|+||||++++++++|..||......+....+..
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQGHSK-TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN 215 (265)
T ss_pred cCcccCccccCHHHhcCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 2334677899999988777654 99999999999999999999998887777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=230.44 Aligned_cols=200 Identities=30% Similarity=0.460 Sum_probs=166.4
Q ss_pred cCeeEeeeecccccceEEEEE----EeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCe
Q psy3663 18 GLYDLEETLGRGHFAVVKLAR----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT--NSK 91 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 91 (259)
.+|++.+.||+|++|.||.|. +..++..|++|.+.... ......+.+|+++++.++||||+++.+++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 479999999999999999987 44578899999986543 3345678899999999999999999998643 356
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.++++||+.+++|.+++......+++..++.++.|++.||.+||++|++|+||+|+||++..+ +.++|+|||++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~-~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE-NRVKIGDFGLTKVLPQ 160 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCC-CeEEECCCcccccccC
Confidence 899999999999999997766668999999999999999999999999999999999999766 7899999999876543
Q ss_pred CCcc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 172 GQKL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 172 ~~~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
.... ........|+|||.+.+..++. ++|+||||+++++|+++..|+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcCh-HHHHHHHHHHHHHHhhcCCcCCC
Confidence 3221 1112334599999998777665 99999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=226.49 Aligned_cols=206 Identities=40% Similarity=0.678 Sum_probs=176.4
Q ss_pred ecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCCh
Q psy3663 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDL 104 (259)
Q Consensus 26 i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (259)
||.|++|.||.+.+..+++.+++|.+...... ......+..|+.+++.++|+|++++++.+......+++||++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999998765432 22456778899999999999999999999999999999999988899
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-CccccccCCCc
Q psy3663 105 YDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCGSLA 183 (259)
Q Consensus 105 ~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~~~~~~~~~ 183 (259)
.+++.... .+++..++.++.|++.++.+||+.+++|+||+|+||++..+ +.++|+|||.+...... .......++..
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCC-CcEEEeecCcceecccCCCcccCCcCCcc
Confidence 99987664 48999999999999999999999999999999999999766 78999999988765443 22334456778
Q ss_pred cCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 184 ~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
|++||...+...+. ++|+||||++++++++|..||...........+.+.
T Consensus 159 ~~~Pe~~~~~~~~~-~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 208 (250)
T cd05123 159 YLAPEVLLGKGYGK-AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208 (250)
T ss_pred ccChHHhCCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 99999998776664 999999999999999999999877766666666653
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=230.95 Aligned_cols=216 Identities=26% Similarity=0.393 Sum_probs=177.7
Q ss_pred ccCeeEeeeecccccceEEEEEEee-----cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
.++|++.+.||.|++|.||+|.+.. .+..+++|.+.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3579999999999999999998753 56789999986543 23335668889999999999999999999999889
Q ss_pred EEEEEeccCCCChHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeE
Q psy3663 92 LYLILELGDGGDLYDYIMKHD---------------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVV 150 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~---------------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIl 150 (259)
.++++||+.+++|.+++.... ..+++..++.++.||+.||.+||+++++|+||+|+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 999999999999999987532 23678889999999999999999999999999999999
Q ss_pred eeecCCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChH
Q psy3663 151 FFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSE 226 (259)
Q Consensus 151 v~~~~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (259)
+..+ +.++|+|||.+........ ......+..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+
T Consensus 163 ~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 163 VGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred ecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9766 7899999998865432221 11122345799999988777775 9999999999999997 888998777777
Q ss_pred HHHHhhhcc
Q psy3663 227 TLTMIMDVS 235 (259)
Q Consensus 227 ~~~~i~~~~ 235 (259)
....+.+..
T Consensus 241 ~~~~~~~~~ 249 (288)
T cd05050 241 VIYYVRDGN 249 (288)
T ss_pred HHHHHhcCC
Confidence 777665443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=230.65 Aligned_cols=213 Identities=30% Similarity=0.429 Sum_probs=175.7
Q ss_pred cCeeEeeeecccccceEEEEEEee-----cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
++|++.+.||.|++|.||+|.... ....+++|.+.... .......+.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 679999999999999999999653 34678889875432 222456788999999999999999999999998999
Q ss_pred EEEEeccCCCChHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecc
Q psy3663 93 YLILELGDGGDLYDYIMKHD--------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG 164 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~--------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~ 164 (259)
+++|||+.+++|.+++.... ..+++..+..++.||+.+|.+||+++++|+||+|+||+++.+ +.++++||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~~~~ 162 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQ-REVKVSLLS 162 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCC-CcEEEcccc
Confidence 99999999999999987654 148999999999999999999999999999999999999776 789999999
Q ss_pred ccccCCCCC--ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhh
Q psy3663 165 FSNRFNPGQ--KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 165 ~~~~~~~~~--~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~ 233 (259)
++....... ......++..|+|||.+.+..... ++|+||||+++|++++ |..||........+..+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~ 233 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFST-KSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA 233 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc
Confidence 875432211 112223456799999987776664 9999999999999998 8899987777776666653
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=253.73 Aligned_cols=231 Identities=28% Similarity=0.445 Sum_probs=197.8
Q ss_pred CeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
+-++.+.||+|+||.||+|... ....-|+||.++... +.....+|++|+.++..++|||||++++++...+..+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 4456789999999999999754 234589999997654 3336789999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcC---------C----CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEE
Q psy3663 94 LILELGDGGDLYDYIMKHD---------A----GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~---------~----~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
+|+||+..++|.+++.... . +++..+.+.++.||+.++.||-++.+||+||-+.|.||.++ ..|||
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~-l~VKI 644 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN-LVVKI 644 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc-eEEEe
Confidence 9999999999999997652 2 27889999999999999999999999999999999999777 78999
Q ss_pred EeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 161 TDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 161 ~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
+|||+++..-..+.- .+.+...+|||||.+.-..+++ +|||||+|++++|+++ |+-||.+.++++.++.|.++.-
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTt-eSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTT-ESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccc-hhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 999999765433222 2345678999999999999997 9999999999999999 9999999999999999996654
Q ss_pred cc------------cccccccCchhhhh
Q psy3663 237 SS------------CTCWWRGRPRSRRR 252 (259)
Q Consensus 237 ~~------------~~~~~~~~~~~~~~ 252 (259)
-+ ..+||...|++|+.
T Consensus 724 L~~Pe~CP~~vY~LM~~CW~~~P~~RPs 751 (774)
T KOG1026|consen 724 LSCPENCPTEVYSLMLECWNENPKRRPS 751 (774)
T ss_pred ccCCCCCCHHHHHHHHHHhhcCcccCCC
Confidence 33 34689999988764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=228.62 Aligned_cols=195 Identities=33% Similarity=0.525 Sum_probs=158.6
Q ss_pred eecccccceEEEEEEeecCceEEEEEcccCCCCccc-HHHHHHHHHH---HHhCCCCCeEEEEEEEecCCeEEEEEeccC
Q psy3663 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-QDHLYQEVRC---MKLVQHPNVVRLYEVIDTNSKLYLILELGD 100 (259)
Q Consensus 25 ~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~-~~~~~~e~~~---l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (259)
.||+|++|.||+|.+..++..+++|.+......... .....++..+ +...+|++++.+.+.+...+..+++|||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999989999999998765432222 2223344333 333468999999999998899999999999
Q ss_pred CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccC
Q psy3663 101 GGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCG 180 (259)
Q Consensus 101 ~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~ 180 (259)
+++|.+++.... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.+ +.++|+|||++....... .....+
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~-~~~~l~dfg~~~~~~~~~-~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKKK-PHASVG 157 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCC-CCEEEccCCcceeccccC-ccCcCC
Confidence 999999887654 48999999999999999999999999999999999999766 789999999886554322 223457
Q ss_pred CCccCCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 181 SLAYSAPEILLGD-SYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 181 ~~~~~apE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
+..|+|||.+.+. .++ .++|+||+|+++|+|++|..||....
T Consensus 158 ~~~y~aPE~~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 158 THGYMAPEVLQKGTAYD-SSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred CcCccCHHHhcCCCCCC-chhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 8899999998643 344 49999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=228.31 Aligned_cols=198 Identities=22% Similarity=0.300 Sum_probs=159.7
Q ss_pred eecccccceEEEEEEeec------------------------CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeE
Q psy3663 25 TLGRGHFAVVKLARHVFT------------------------GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80 (259)
Q Consensus 25 ~i~~g~~~~vy~~~~~~~------------------------~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 80 (259)
+||+|+||.||++....+ ...+++|.+.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 689999999999974322 2468888876432 22345677889999999999999
Q ss_pred EEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC-----
Q psy3663 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL----- 155 (259)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~----- 155 (259)
++++++.+....++||||+++++|..++......+++..+..++.||+.||.|||+++++|+||+|+||++....
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999999877666689999999999999999999999999999999999996531
Q ss_pred -CeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCCChHH
Q psy3663 156 -GVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLV-AGQAPFQEANDSET 227 (259)
Q Consensus 156 -~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~ 227 (259)
..++++|||.+...... ....++..|+|||.+.+....+.++|+||||+++|+++ +|+.||......+.
T Consensus 160 ~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 24899999987543221 22345678999998876443345999999999999985 69999987665543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=226.01 Aligned_cols=197 Identities=21% Similarity=0.316 Sum_probs=162.4
Q ss_pred eeecccccceEEEEEEeecC----------ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 24 ETLGRGHFAVVKLARHVFTG----------EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~----------~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
+.||+|++|.||+|.+...+ ..+++|.+..... ....+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999988666 3577777654331 25777889999999999999999999877 7789
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC------eEEEEeccccc
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG------VVKLTDFGFSN 167 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~------~i~l~df~~~~ 167 (259)
+++||+.+++|.+++......++...+..++.||+.||.+||++||+|+||+|+||+++.+.. .++|+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 999999999999999877656899999999999999999999999999999999999976631 69999999887
Q ss_pred cCCCCCccccccCCCccCCcccccCC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHH
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGD-SYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSET 227 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (259)
.... .....+...|+|||.+.+. ...+.++|+||||+++++|++ |..||...+..+.
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~ 215 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH
Confidence 6543 2233456689999998776 233359999999999999999 6888977654443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=233.79 Aligned_cols=213 Identities=28% Similarity=0.445 Sum_probs=177.2
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
....|+..+.||.|++|.||+|.+..++..+++|.+..... .......+.+|+++++.++|+|++++.+++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 45568889999999999999999998999999999865322 22334567789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
++||+.+ ++...+.....++++..+..++.|++.++.+||+.+++|+||+|+||++..+ +.++|+|||.+......
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC-CcEEECCcccceeecCc--
Confidence 9999975 8888776666668999999999999999999999999999999999999766 78999999988655332
Q ss_pred cccccCCCccCCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 175 LETSCGSLAYSAPEILLG---DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
....++..|+|||.+.+ ...+ .++|+||||+++++|++|..||...+..+....+...
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 229 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCC-cccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc
Confidence 23356778999998742 3344 4999999999999999999999877666555555543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=231.22 Aligned_cols=199 Identities=28% Similarity=0.443 Sum_probs=166.5
Q ss_pred CeeEeeeecccccceEEEEEE----eecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--CeE
Q psy3663 19 LYDLEETLGRGHFAVVKLARH----VFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--SKL 92 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~----~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 92 (259)
-|++.+.||+|++|.||+|.. ..++..|++|.+.... .......+.+|+.+++.++|+|++++.+++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 468999999999999999973 3567899999986543 233456788999999999999999999998764 568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++|||+++++|.+++......++...++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCC-CCEEECCCccccccccC
Confidence 99999999999999987765568999999999999999999999999999999999999766 78999999988765433
Q ss_pred Ccc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 173 QKL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 173 ~~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
... ....++..|+|||.+.+..++. ++|+||||+++|+|+++..|+.
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYI-ASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCc-cccchhhhhhhhhhhcCCCCCc
Confidence 221 1233456799999988777665 9999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=236.07 Aligned_cols=208 Identities=27% Similarity=0.442 Sum_probs=167.1
Q ss_pred ccCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEec-C
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDT-N 89 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~ 89 (259)
.++|++.+.||.|+||.||+|.+. .+++.|++|.+.... .......+.+|+.++..+ +|+||+++++.+.. .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 368999999999999999999843 456789999987543 223356678899999999 58999999998754 4
Q ss_pred CeEEEEEeccCCCChHHHHHhcC---------------------------------------------------------
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHD--------------------------------------------------------- 112 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~--------------------------------------------------------- 112 (259)
...+++|||+++++|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56789999999999999886431
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc---ccccC
Q psy3663 113 ---------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL---ETSCG 180 (259)
Q Consensus 113 ---------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~---~~~~~ 180 (259)
..++...+..++.||+.||.+||++||+|+||+|+||++..+ +.++|+|||++......... ....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEecccccccccCcchhhcCCCCC
Confidence 125778889999999999999999999999999999999766 78999999988764322111 11223
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHH
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSET 227 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (259)
+..|+|||.+.+..++. ++|+||||+++++|++ |..||........
T Consensus 244 ~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 290 (343)
T cd05103 244 PLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290 (343)
T ss_pred CcceECcHHhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCccccHH
Confidence 45799999988777765 9999999999999997 9999987654433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=249.48 Aligned_cols=206 Identities=30% Similarity=0.480 Sum_probs=178.2
Q ss_pred cccCeeEe-----eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 16 IAGLYDLE-----ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 16 ~~~~y~~~-----~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
+.-+|+.. -.||+|.||+||.|.|..+.-+.+||.+.... ....+-+.+|+.+-+.++|.||+++++.+..++
T Consensus 568 iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG 645 (1226)
T KOG4279|consen 568 IEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENG 645 (1226)
T ss_pred eEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCC
Confidence 44455554 47999999999999999999999999986543 234456789999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGL--SETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~--~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.+-+.||-++|++|.++++..=+|+ ++..+-.+.+||+++|.|||.+.|||+|||-+|+++..-.|-++|+|||-+..
T Consensus 646 f~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKR 725 (1226)
T KOG4279|consen 646 FFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKR 725 (1226)
T ss_pred eEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchh
Confidence 9999999999999999999875567 88999999999999999999999999999999999988889999999998866
Q ss_pred CC-CCCccccccCCCccCCccccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 169 FN-PGQKLETSCGSLAYSAPEILL-GDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 169 ~~-~~~~~~~~~~~~~~~apE~~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
+. -++-+.+..|+..|||||++. +..-+..++|||||||++.||.||++||....
T Consensus 726 LAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 726 LAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred hccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 54 345567788999999999984 33344459999999999999999999997654
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=247.82 Aligned_cols=220 Identities=32% Similarity=0.580 Sum_probs=200.0
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-..+.+.+..||-|+||.|=++........+++|++++... .....+.+..|-+|+..++.|.|+++|..|.++.+.|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 34577888999999999999998665554589999987654 33346778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+||.|-|+.|...+..++. +++.....+...+++|++|||.+||+++||||+|.+++.+ |-++|.|||++..+..+..
T Consensus 498 LmEaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~-Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR-GYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hHHhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC-CceEEeehhhHHHhccCCc
Confidence 9999999999999998877 9999999999999999999999999999999999999665 8999999999999999999
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
+.+.++++.|.|||++.+..++. ++|.||||+++|||++|.+||.+.+.--.++.|+++..-.
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~-avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i 638 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDR-AVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI 638 (732)
T ss_pred eeeecCCcccccchhhhccCcch-hhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh
Confidence 99999999999999999999997 9999999999999999999999999999999999887654
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=237.15 Aligned_cols=210 Identities=31% Similarity=0.548 Sum_probs=186.7
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc-cHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV-SQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
...|+.-+.||.|+||.||-++...+|+-|++|.+.+...... .-.....|..+|++++.+-||.+--.|++.+..++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 3578899999999999999999999999999999876543222 234456789999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+..|+|++|.-.+.+.+ ..+++.+++.++.+|+.+|++||+.+||++|+||+|||+++. |+++|+|+|+|..+..+.+
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~-GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH-GHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC-CCeEeeccceEEecCCCCc
Confidence 99999999999887764 459999999999999999999999999999999999999666 8999999999999999988
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHH
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (259)
....+|+.+|||||++.+..++. ..|.|||||++|+|+.|+-||.........
T Consensus 343 ~~~rvGT~GYMAPEvl~ne~Y~~-s~Dwf~lGCllYemi~G~sPFr~~KeKvk~ 395 (591)
T KOG0986|consen 343 IRGRVGTVGYMAPEVLQNEVYDF-SPDWFSLGCLLYEMIAGHSPFRQRKEKVKR 395 (591)
T ss_pred cccccCcccccCHHHHcCCcccC-CccHHHHHhHHHHHHcccCchhhhhhhhhH
Confidence 88889999999999999988775 999999999999999999999765544443
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=231.10 Aligned_cols=208 Identities=29% Similarity=0.509 Sum_probs=173.4
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
.|+-...||+|++|.||++.+..+++.+++|.+.... ......+.+|+.+++.++|+|++++++.+...+..+++|||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 3444578999999999999999899999999975432 23456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-ccc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~~ 177 (259)
+++++|.+++... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.+ +.++|+|||.+........ ...
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~-~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 99 LEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CCEEEcccccceecccccccccc
Confidence 9999999987543 47999999999999999999999999999999999999766 7899999998765543221 122
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
..++..|++||.+.+..++. ++|+||+|+++|+|++|..||......+....+.
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~-~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~ 229 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR 229 (292)
T ss_pred cccCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 34677899999987766664 9999999999999999999998766555444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=228.42 Aligned_cols=202 Identities=28% Similarity=0.478 Sum_probs=170.8
Q ss_pred cCeeEeeeecccccceEEEEEEe----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHV----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT--NSK 91 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 91 (259)
..|++.+.||+|++|.||+|... .+++.+++|.+...... .....+.+|+++++.++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 57888999999999999999854 34789999998765432 346778899999999999999999999876 567
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.+++|||+.+++|.+++......++...+..++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLAKVLPE 161 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC-CCEEEccccccccccc
Confidence 899999999999999998776669999999999999999999999999999999999999776 7899999998876653
Q ss_pred CCccc----cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 172 GQKLE----TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 172 ~~~~~----~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
..... .......|++||.+.+...+. ++|+||||+++++|++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSS-ASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCc-ccchHHHhhhhheeeccCCCcccc
Confidence 22211 122345699999988777665 999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=229.37 Aligned_cols=214 Identities=29% Similarity=0.432 Sum_probs=172.3
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 94 (259)
-.+.|++.+.||+|++|.||+|.+..++..+++|.+....... ....+..|+.++.... |+||+++++++.+....++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 4578999999999999999999998889999999987654222 3344555666565554 9999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+||++.+ ++..++.....++++..+..++.||+.++.+||+ .||+|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~-~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDSK 169 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCC-CCEEECccccchhccCCC
Confidence 9999965 7888877666678999999999999999999997 599999999999999665 789999999987654433
Q ss_pred ccccccCCCccCCcccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCC-hHHHHHhhh
Q psy3663 174 KLETSCGSLAYSAPEILLGDS----YDAPAVDVWSLGVILYMLVAGQAPFQEAND-SETLTMIMD 233 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~i~~ 233 (259)
......++..|+|||.+.+.. .+ .++|+||||+++|+|++|+.||..... .+.+..++.
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 233 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ 233 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccc-cchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc
Confidence 333345677899999986543 44 489999999999999999999976332 344444443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=226.96 Aligned_cols=207 Identities=29% Similarity=0.476 Sum_probs=168.8
Q ss_pred eeecccccceEEEEEEeecC------ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 24 ETLGRGHFAVVKLARHVFTG------EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~------~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
+.||+|++|.||+|.+.... ..+++|.+.... .......+.+|+.+++.++||||+++++++.+....+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 36899999999999876443 689999886542 22345678889999999999999999999999899999999
Q ss_pred ccCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC----CeEEEEeccccc
Q psy3663 98 LGDGGDLYDYIMKH------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL----GVVKLTDFGFSN 167 (259)
Q Consensus 98 ~~~~~sL~~~~~~~------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~----~~i~l~df~~~~ 167 (259)
++++++|.+++... ...+++..+..++.||+.++.+||+++++|+||+|+||+++.+. ..++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999998653 23378899999999999999999999999999999999997762 179999999886
Q ss_pred cCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhh
Q psy3663 168 RFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIM 232 (259)
Q Consensus 168 ~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~ 232 (259)
........ .....+..|+|||.+.+...+. ++|+||||+++|+|++ |+.||...+..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 227 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTT-QSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCccc-chhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh
Confidence 55332211 1223456899999998777764 9999999999999998 999998777666655544
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=226.20 Aligned_cols=213 Identities=26% Similarity=0.446 Sum_probs=172.1
Q ss_pred eeEeeeecccccceEEEEEEee---cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC------
Q psy3663 20 YDLEETLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS------ 90 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~---~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 90 (259)
|++.+.||+|++|.||+|.... ++..+++|.+............+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998653 4678999999776555555677889999999999999999999875432
Q ss_pred eEEEEEeccCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKH-----DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~-----~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
..+++++|..+++|..++... ...++...++.++.|++.++.+||++||+|+||+|+||++..+ +.++|+|||.
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~-~~~kl~dfg~ 159 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN-MTVCVADFGL 159 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCC-CCEEECcccc
Confidence 247888999999998876432 1247889999999999999999999999999999999999665 7899999998
Q ss_pred cccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 166 SNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 166 ~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
+........ .........|++||.+.+...+. ++|+||||+++|+|++ |++||......+....+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 231 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTT-HSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccch-hhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC
Confidence 876543221 11222346799999988777765 9999999999999999 89999877766666666544
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=245.60 Aligned_cols=233 Identities=27% Similarity=0.414 Sum_probs=202.6
Q ss_pred CCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC------CCeEE
Q psy3663 8 SSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH------PNVVR 81 (259)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~ 81 (259)
|+..-++.+.++|.+....|+|-|+.|..|.|+..|..||||+|.++.. -...=+.|++||++|+. -|++.
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 3444456778899999999999999999999999999999999987642 23344679999999963 46889
Q ss_pred EEEEEecCCeEEEEEeccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEE
Q psy3663 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHD--AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVK 159 (259)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~ 159 (259)
++..|...++.++|+|.+. ++|.+++...+ -++....+..++.||+.||..|-++||+|+||||+||||....+.++
T Consensus 499 l~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence 9999999999999999994 59999998874 44778889999999999999999999999999999999999888999
Q ss_pred EEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 160 LTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 160 l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
|||||.|.....+.. .+..-+-.|.|||++.+.++++ ..|+||.||++|||.||+..|.+..++.+|...+++.+.+|
T Consensus 578 LCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~yd~-~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 578 LCDFGSASFASENEI-TPYLVSRFYRAPEIILGLPYDY-PIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred eccCccccccccccc-cHHHHHHhccCcceeecCcccC-CccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 999999987665433 3444566899999999999998 89999999999999999999999999999999999999998
Q ss_pred ccccccC
Q psy3663 240 TCWWRGR 246 (259)
Q Consensus 240 ~~~~~~~ 246 (259)
..-+.+.
T Consensus 656 ~KmlRKg 662 (752)
T KOG0670|consen 656 NKMLRKG 662 (752)
T ss_pred HHHhhhc
Confidence 7766544
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=224.03 Aligned_cols=207 Identities=24% Similarity=0.352 Sum_probs=163.4
Q ss_pred eeecccccceEEEEEEe--ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHV--FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||+|... .++..+++|.+..... ......+.+|+.+++.++||||+++++.+.+....+++|||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 36899999999999754 3446799998865542 22345678899999999999999999999988889999999999
Q ss_pred CChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc---
Q psy3663 102 GDLYDYIMKHD----AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK--- 174 (259)
Q Consensus 102 ~sL~~~~~~~~----~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~--- 174 (259)
++|.+++.... ...+...+..++.|++.|+.+||+.+++|+||+|+||++..+ +.++|+|||.+........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD-LTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC-CcEEECCccccccccCcceeec
Confidence 99999986532 235667788999999999999999999999999999999766 7899999998864332211
Q ss_pred cccccCCCccCCcccccCCC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhh
Q psy3663 175 LETSCGSLAYSAPEILLGDS------YDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIM 232 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~ 232 (259)
.....++..|+|||.+.+.. ..+.++|+||||+++++|++ |+.||......+......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~ 223 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV 223 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh
Confidence 11223466799999885421 12349999999999999996 999998777666554433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=246.01 Aligned_cols=219 Identities=25% Similarity=0.410 Sum_probs=164.0
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCc-eEEEEE--------------ccc-CCCCcccHHHHHHHHHHHHhCCCCC
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGE-KVAVKV--------------IDK-TKLDPVSQDHLYQEVRCMKLVQHPN 78 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~-~~~lK~--------------~~~-~~~~~~~~~~~~~e~~~l~~l~~~~ 78 (259)
.+.++|++.+.||+|+||.||+|....... ..+.|. +.+ ..........+.+|+.+++.++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 456799999999999999999987543322 111111 111 1111223456788999999999999
Q ss_pred eEEEEEEEecCCeEEEEEeccCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec
Q psy3663 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHD----AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER 154 (259)
Q Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~----~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~ 154 (259)
|+++++++.+.+..+++++++.+ +|.+++.... .......+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999999999999999999965 7777664432 123456788899999999999999999999999999999766
Q ss_pred CCeEEEEeccccccCCCCCc--cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCC--ChHHHH
Q psy3663 155 LGVVKLTDFGFSNRFNPGQK--LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQA-PFQEAN--DSETLT 229 (259)
Q Consensus 155 ~~~i~l~df~~~~~~~~~~~--~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~-pf~~~~--~~~~~~ 229 (259)
+.++|+|||++........ .....++..|+|||.+.+..++. ++|||||||++|+|++|.. ||.... ....+.
T Consensus 304 -~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 -GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCE-ITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred -CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 7899999999876543322 22346789999999998887775 9999999999999999876 454332 334444
Q ss_pred Hhhhccc
Q psy3663 230 MIMDVSE 236 (259)
Q Consensus 230 ~i~~~~~ 236 (259)
.+++...
T Consensus 382 ~~~~~~~ 388 (501)
T PHA03210 382 KIIDSLS 388 (501)
T ss_pred HHHHhcc
Confidence 4444433
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=232.39 Aligned_cols=209 Identities=24% Similarity=0.381 Sum_probs=168.7
Q ss_pred eeeccc--ccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRG--HFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g--~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
..||.| +++.||+|.+..+++.|++|++............+.+|+.+++.++||||+++++++..++..++++|++.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 899999999999999999999876554444557788999999999999999999999999999999999999
Q ss_pred CChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc----
Q psy3663 102 GDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE---- 176 (259)
Q Consensus 102 ~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~---- 176 (259)
+++.+++... ...+++..+..++.||+.||.+||++|++|+||+|+||++..+ +.++++||+............
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC-CcEEEechHHHhhhhccCccccccc
Confidence 9999998764 3458999999999999999999999999999999999999766 789999997543322111100
Q ss_pred ----cccCCCccCCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 177 ----TSCGSLAYSAPEILLGDS-YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 177 ----~~~~~~~~~apE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
.......|+|||.+.+.. ..+.++|+||||+++++|++|++||............+.
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 224 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK 224 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc
Confidence 112345699999987642 223599999999999999999999988776655544443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=227.08 Aligned_cols=202 Identities=27% Similarity=0.437 Sum_probs=166.7
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.+|+..+.||+|++|.||++.+..++..+++|.+...... .....+.+|+.++.++. |+||+++++++......+++|
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 3566778999999999999999999999999998765432 34566788999999996 999999999998888899999
Q ss_pred eccCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 97 ELGDGGDLYDYIMK----HDAGLSETYAREYFAQIVRAISFCHKL-HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 97 e~~~~~sL~~~~~~----~~~~~~~~~i~~~~~ql~~al~~LH~~-~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
|++.. ++..+... ....+++..+..++.|++.|+++||+. +++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVD 160 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccC-CcEEEeecchhHHhcc
Confidence 99865 66554321 234589999999999999999999974 99999999999999766 7899999998866543
Q ss_pred CCccccccCCCccCCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 172 GQKLETSCGSLAYSAPEILLGD---SYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
........++..|+|||.+.+. .++ .++|+||||+++++|++|+.||....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCc-chhhhhHHHHHHHHHHhCCCCchhcc
Confidence 3333334567789999998766 344 59999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=242.07 Aligned_cols=190 Identities=27% Similarity=0.543 Sum_probs=167.0
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCC
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGG 102 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (259)
.+.||.|+.|.||++. -.++.|+||.++.-. ..+++-|++|+|+||+.+.++|...-.|++|||||..+
T Consensus 129 LeWlGSGaQGAVF~Gr--l~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGR--LHNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhccCcccceeeee--ccCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 5789999999999998 568889999875432 14688899999999999999999989999999999999
Q ss_pred ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCCC
Q psy3663 103 DLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182 (259)
Q Consensus 103 sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~ 182 (259)
-|.+++..... ++...+..|..+|+.++.|||.+.|||+|||.=|||+..+ ..|+|+|||-+.........-...++.
T Consensus 198 qL~~VLka~~~-itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~-d~VKIsDFGTS~e~~~~STkMSFaGTV 275 (904)
T KOG4721|consen 198 QLYEVLKAGRP-ITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYD-DVVKISDFGTSKELSDKSTKMSFAGTV 275 (904)
T ss_pred cHHHHHhccCc-cCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeecc-ceEEeccccchHhhhhhhhhhhhhhhH
Confidence 99999976654 9999999999999999999999999999999999999777 689999999887665543334457899
Q ss_pred ccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH
Q psy3663 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226 (259)
Q Consensus 183 ~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (259)
.|||||++.+.+... |+||||||+|++||+||..||.+.+...
T Consensus 276 aWMAPEvIrnePcsE-KVDIwSfGVVLWEmLT~EiPYkdVdssA 318 (904)
T KOG4721|consen 276 AWMAPEVIRNEPCSE-KVDIWSFGVVLWEMLTGEIPYKDVDSSA 318 (904)
T ss_pred hhhCHHHhhcCCccc-ccceehhHHHHHHHHhcCCCccccchhe
Confidence 999999999988885 9999999999999999999998765544
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=221.10 Aligned_cols=209 Identities=22% Similarity=0.374 Sum_probs=163.2
Q ss_pred eeecccccceEEEEEEeecC--ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTG--EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~--~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|++|.||++.....+ ..+++|.+.... .......+.+|+.+++.++||||+++++.+.+....+++|||+.+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 36899999999999754332 356667665433 223456788899999999999999999999999999999999999
Q ss_pred CChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC---cc
Q psy3663 102 GDLYDYIMKHD---AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ---KL 175 (259)
Q Consensus 102 ~sL~~~~~~~~---~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~---~~ 175 (259)
++|.+++.+.. ...+...++.++.||+.||.+||+.+++|+||+|+||+++.+ +.++|+|||.+....... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD-LTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCC-ccEEecccccccccCcchhhhcc
Confidence 99999987642 235677788999999999999999999999999999999766 789999999875322111 11
Q ss_pred ccccCCCccCCcccccCCC------CCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 176 ETSCGSLAYSAPEILLGDS------YDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
....++..|+|||.+.... ..+.++|+||||+++|+|++ +..||...+..+.+..++..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~ 224 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhh
Confidence 2335677899999874321 12348999999999999996 67799888877777766543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=224.99 Aligned_cols=205 Identities=14% Similarity=0.221 Sum_probs=154.6
Q ss_pred cccCeeEeeeecccccceEEEEEEeec---CceEEEEEcccCCCCcccH---------HHHHHHHHHHHhCCCCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFT---GEKVAVKVIDKTKLDPVSQ---------DHLYQEVRCMKLVQHPNVVRLY 83 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~---~~~~~lK~~~~~~~~~~~~---------~~~~~e~~~l~~l~~~~i~~~~ 83 (259)
..++|++.+.||+|+||.||+|.+..+ +..+++|+........... .....+...+..+.|++++.++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 447999999999999999999998766 6677777644322111000 0111233445566899999999
Q ss_pred EEEecCC----eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEE
Q psy3663 84 EVIDTNS----KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVK 159 (259)
Q Consensus 84 ~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~ 159 (259)
+.+.... ..+++++.... ++.+.+.... ..++..+..++.|++.|+.+||+.+++|+||||+||+++.+ +.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~-~~~~ 166 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN-NRGY 166 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CcEE
Confidence 8764432 34677777744 7777665433 36788899999999999999999999999999999999766 7899
Q ss_pred EEeccccccCCCCC--------ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 160 LTDFGFSNRFNPGQ--------KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 160 l~df~~~~~~~~~~--------~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
|+|||++....... ......++..|+|||.+.+..++. ++|||||||++++|++|+.||.....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~-~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTR-RGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCc-HHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999987653211 112235788999999998887775 99999999999999999999987643
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=227.10 Aligned_cols=196 Identities=26% Similarity=0.414 Sum_probs=162.5
Q ss_pred ccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCChHHHHH
Q psy3663 30 HFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIM 109 (259)
Q Consensus 30 ~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~ 109 (259)
+.+.+|.+.+..+++.|++|.+............+.+|+.+++.++|+||+++++++.++...+++|||+.+++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44567777777889999999998764455567789999999999999999999999999999999999999999999987
Q ss_pred hc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--------cccccC
Q psy3663 110 KH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK--------LETSCG 180 (259)
Q Consensus 110 ~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~--------~~~~~~ 180 (259)
.. ...+++..+..++.|++.||.|||+++|+|+||+|+||+++.+ +.++++||+.+........ .....+
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecC-CceEEecCccceeeccccccccccccccccccc
Confidence 64 4458999999999999999999999999999999999999766 7899999998765432211 112234
Q ss_pred CCccCCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q psy3663 181 SLAYSAPEILLGD--SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227 (259)
Q Consensus 181 ~~~~~apE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (259)
+..|+|||.+... .++ .++|+||+|+++++|++|+.||........
T Consensus 171 ~~~y~aPE~~~~~~~~~~-~~~Diws~G~il~el~~g~~pf~~~~~~~~ 218 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQM 218 (314)
T ss_pred cccccCHHHhcCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5679999998653 344 489999999999999999999987654443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=263.75 Aligned_cols=234 Identities=27% Similarity=0.472 Sum_probs=192.9
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
+.-++.-...||.|.||.||.|.+..+|+-.++|.+............+.+|..+++.++|||+++++++=.+.+..++.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 33467777899999999999999999999999999987655556677888999999999999999999998888889999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC--
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-- 173 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-- 173 (259)
||||.+++|.++++.... .++.....+..|++.++.+||+.||||+||||.||+++.+ |.+|++|||.|..+....
T Consensus 1313 MEyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~-g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN-GLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC-CcEEeecccceeEecCchhc
Confidence 999999999999876544 6677778888999999999999999999999999999777 799999999998876553
Q ss_pred ---ccccccCCCccCCcccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh-------------hc
Q psy3663 174 ---KLETSCGSLAYSAPEILLGDS---YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM-------------DV 234 (259)
Q Consensus 174 ---~~~~~~~~~~~~apE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~-------------~~ 234 (259)
......|++.|||||++.+.. ... |.||||||||+.||+||+-||...+++=+.--.+ ..
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~-A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGG-AADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCc-chhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 223457999999999997654 344 8999999999999999999998766543332222 23
Q ss_pred cccccccccccCchhhhhc
Q psy3663 235 SESSCTCWWRGRPRSRRRT 253 (259)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~ 253 (259)
+.-+..-|+-.+|+.| |+
T Consensus 1470 g~dFle~Cl~~dP~~R-w~ 1487 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMR-WT 1487 (1509)
T ss_pred HHHHHHHHHhcCchhh-hH
Confidence 3334455677777766 54
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=231.31 Aligned_cols=223 Identities=26% Similarity=0.474 Sum_probs=189.7
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----eE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS-----KL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 92 (259)
.+-+-.+.||.|+||+||.+.|..+|+.+++|.+......-.....+.+|.++|...+|.|++..+++..-.. ..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3455678999999999999999999999999999776666666788889999999999999999888865432 35
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
|+++|.+.. +|..++... ..++.+.+..+++||+++|.|||+.+|.|+||||.|.+|+++ -.++|||||+++.-...
T Consensus 133 YV~TELmQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN-CvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN-CILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC-ceEEecccccccccchh
Confidence 677777754 676666543 449999999999999999999999999999999999999887 68999999999764332
Q ss_pred --CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 173 --QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 173 --~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
..+...+-+..|+|||.+.+...++.+.||||.||++.||+..+..|...+.-.+++.|.+.++++..+--
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 22334456789999999999888878999999999999999999999999999999999999999876643
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=244.52 Aligned_cols=214 Identities=27% Similarity=0.438 Sum_probs=188.0
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
+-|+|.+.||.|+||.||+|.++..+-..+-|++.-. ++.....+.-|+.||..|+||+|+++++.|...+..+++.|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 4578899999999999999998877777777876532 45567888899999999999999999999988899999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC-CCCCccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~-~~~~~~~ 176 (259)
||.|+....++-..+.+++++.|..+++|++.||.|||+++|+|+||+..|||++.+ |.++|.|||.+... .......
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld-GdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD-GDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec-CcEeeecccccccchhHHhhhc
Confidence 999999999998888889999999999999999999999999999999999999888 89999999987653 3334556
Q ss_pred cccCCCccCCcccc-----cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 177 TSCGSLAYSAPEIL-----LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 177 ~~~~~~~~~apE~~-----~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
...|+++|+|||+. ...+|++ ++||||||+++.+|..+.+|....+....+-+|.+--
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDy-kaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe 251 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE 251 (1187)
T ss_pred cccCCcccccchheeeccccCCCchh-hhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC
Confidence 77899999999976 3456665 9999999999999999999999999888877776543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=222.00 Aligned_cols=213 Identities=27% Similarity=0.450 Sum_probs=175.1
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC---CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
+|.+.+.||+|++|.||+|.+...+..+++|+++.... .......+..|+.+++.++||||+++++.+.++...+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 69999999999999999999887777777777654322 223345566789999999999999999999888899999
Q ss_pred EeccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 96 LELGDGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~---~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+||+.+.+|..++.. ....+++..++.++.|++.|+.+||+.|++|+||+|+||++.+ +.++|+|||.+......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~--~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN--NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec--CCEeecccCceeecCCC
Confidence 999999999988764 2455899999999999999999999999999999999999954 46999999988665433
Q ss_pred Cc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 173 QK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 173 ~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
.. .....++..|+|||.+.+..++. ++|+||||+++++|++|..||...........+...
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 220 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDS-KSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG 220 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC
Confidence 22 22344677899999987766665 899999999999999999999876666655555443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=236.40 Aligned_cols=233 Identities=26% Similarity=0.441 Sum_probs=199.0
Q ss_pred CeeEeeeecccccceEEEEEEee--cC--ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVF--TG--EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~--~~--~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
.-++.++||.|-||.||.|.-.. .| ..|+||+.+.+... ...+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 44556899999999999997542 23 37999998876644 458899999999999999999999999976 46899
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
|||.++.+.|.++++.+...++...+..+..||+.|+.|||+..+||+||-..||+|.+. ..++|.|||+++.+.....
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp-~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSP-QCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCc-ceeeecccchhhhccccch
Confidence 999999999999999988889999999999999999999999999999999999999877 6899999999987765433
Q ss_pred c--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccccc-----------
Q psy3663 175 L--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSCT----------- 240 (259)
Q Consensus 175 ~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~----------- 240 (259)
- .......-|+|||.+.=..+++ ++|+|-||++|+|++. |..||.+..+.+..-.|.++-+.+.+
T Consensus 547 YkaS~~kLPIKWmaPESINfRrFTt-ASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslm 625 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRFTT-ASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLM 625 (974)
T ss_pred hhccccccceeecCccccchhcccc-hhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHH
Confidence 2 2334567899999987777887 9999999999999876 99999999999999999988877654
Q ss_pred -cccccCchhhhhccc
Q psy3663 241 -CWWRGRPRSRRRTTR 255 (259)
Q Consensus 241 -~~~~~~~~~~~~~~~ 255 (259)
.+|.=+|..|+|-++
T Consensus 626 skcWayeP~kRPrfte 641 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTE 641 (974)
T ss_pred HHHhccCcccCCcHHH
Confidence 478888887776543
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=238.46 Aligned_cols=201 Identities=31% Similarity=0.535 Sum_probs=178.2
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc------cHHHHHHHHHHHHhCC---CCCeEEEEEEEec
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV------SQDHLYQEVRCMKLVQ---HPNVVRLYEVIDT 88 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~------~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~ 88 (259)
..|+..+.+|.|+||.|++|+++.+...|+||.+.++..-.. ....+-.|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 369999999999999999999999999999999987653111 1222446899999997 9999999999999
Q ss_pred CCeEEEEEeccC-CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 89 NSKLYLILELGD-GGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 89 ~~~~~lv~e~~~-~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
++.+|++||.-. |.+|-++++..+. +++.+...+++|+..++++||+.||+|+|||-+|+.++.+ |-++|+|||.+.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~-g~~klidfgsaa 718 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSN-GFVKLIDFGSAA 718 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhccccccccCceecccccccEEEecC-CeEEEeeccchh
Confidence 999999998763 6788899987766 9999999999999999999999999999999999999777 899999999987
Q ss_pred cCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
... ..+.....|+..|.|||++.+..+.....|||+||+++|.+.-...||.+
T Consensus 719 ~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 664 45667788999999999999999998899999999999999999999975
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-31 Score=211.56 Aligned_cols=216 Identities=43% Similarity=0.688 Sum_probs=182.1
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEecc
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELG 99 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (259)
|++.+.|+.|+++.||++.+..+++.+++|.+...... .....+.+|+..++.++|+|++++++.+......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 67889999999999999999888899999999865433 24677888999999999999999999998888999999999
Q ss_pred CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC--cccc
Q psy3663 100 DGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--KLET 177 (259)
Q Consensus 100 ~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~--~~~~ 177 (259)
.+++|.+++......+++..++.++.+++.++.+||+.+++|+||+|.||+++.+ +.++|+|||.+....... ....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcccccccc
Confidence 9999999987755437899999999999999999999999999999999999776 789999999887765443 2234
Q ss_pred ccCCCccCCcccc-cCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCCh-HHHHHhhhccccc
Q psy3663 178 SCGSLAYSAPEIL-LGDSYDAPAVDVWSLGVILYMLVAGQAPFQE-ANDS-ETLTMIMDVSESS 238 (259)
Q Consensus 178 ~~~~~~~~apE~~-~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~-~~~~~i~~~~~~~ 238 (259)
..+...|++||.+ ....++. ++|+|+||+++++|++|+.||.. .+.. .+.+.+..+...+
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 221 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLL 221 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccc
Confidence 4567789999998 5555554 99999999999999999999977 3444 6666666655443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=216.33 Aligned_cols=211 Identities=29% Similarity=0.450 Sum_probs=178.1
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEEec
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
-+++..||.|..|.|+++....+|.-.+||.+....-. .....++..+.+..... .|+|++++++|..+...++-||.
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 35568899999999999999999999999999876533 34556666677666554 89999999999998888999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~ 177 (259)
+.. -+..++..-..++++..+-.+...++.||.||-. .||+|+|+||+|||++.. |.++|||||++..+-.......
T Consensus 173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~-GniKlCDFGIsGrlvdSkAhtr 250 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GNIKLCDFGISGRLVDSKAHTR 250 (391)
T ss_pred HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC-CCEEeecccccceeeccccccc
Confidence 954 6677777667779999999999999999999985 589999999999999666 8899999999988766666666
Q ss_pred ccCCCccCCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCChHHHHHhhhc
Q psy3663 178 SCGSLAYSAPEILLG---DSYDAPAVDVWSLGVILYMLVAGQAPFQE-ANDSETLTMIMDV 234 (259)
Q Consensus 178 ~~~~~~~~apE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~i~~~ 234 (259)
..|...|+|||.+.. ..++ .++|+||||+.++||.||+.||.+ +.+.+.+.++++-
T Consensus 251 sAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ 310 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE 310 (391)
T ss_pred ccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc
Confidence 778999999999853 3444 499999999999999999999987 4588999999973
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-32 Score=222.00 Aligned_cols=202 Identities=35% Similarity=0.602 Sum_probs=167.0
Q ss_pred CeeEeeeecccccceEEEEEEe---ecCceEEEEEcccCCC--CcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~--~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 92 (259)
+|++.+.||.|++|.||+|.+. .+++.+++|++..... .......+.+|+.+++.++ |++|+++.+.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 4568899999875432 1223456778999999995 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++|||+.+++|.+++.... .+++..+..++.|++.+|.+||+.+++|+||+|+||++..+ +.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC-CCEEEEECccccccccc
Confidence 99999999999999886543 48899999999999999999999999999999999999766 78999999988765433
Q ss_pred Ccc--ccccCCCccCCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 173 QKL--ETSCGSLAYSAPEILLGDS-YDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 173 ~~~--~~~~~~~~~~apE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
... ....++..|++||.+.+.. ....++|+||||+++++|++|..||...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 221 2234678899999986644 1234899999999999999999999654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=219.36 Aligned_cols=224 Identities=26% Similarity=0.446 Sum_probs=197.8
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
..-.+|.-.+.++.|+. .|..|.|...+.+|++|................+|...+..++|+||+.++++|.-+
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 34458888999999999 788999999999999999877655555677888999999999999999999998543
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
...|++||+++. +|.+.+. -.++-.++..++.|++.++.+||+.||+|+||||+||++..+ ..++|.|||++..
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~-~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSD-CTLKILDFGLART 167 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecch-hheeeccchhhcc
Confidence 357899999976 9999887 237889999999999999999999999999999999999777 7899999999987
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
-...-.+...+.+-.|+|||++.+..+. +.+||||+||++.||++|+..|.+...-+++.++.+.++++.+.+-+.
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cCcccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 6665566677788899999999998866 499999999999999999999999999999999999999999887654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-31 Score=239.14 Aligned_cols=149 Identities=29% Similarity=0.515 Sum_probs=133.4
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.++|.+.+.||.|+||.||+|.+..+++.|+||++..... .......+..|+.++..++|+||++++..+......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 5789999999999999999999999999999999875432 223346788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
|||+.+++|.+++..... +++..++.++.||+.||.|||.++|+|+||+|+||++..+ +.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~-l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~-g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC-CCEEEEeCCCCc
Confidence 999999999999876543 8899999999999999999999999999999999999766 789999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=224.67 Aligned_cols=222 Identities=32% Similarity=0.504 Sum_probs=188.7
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc-cHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCe
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV-SQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSK 91 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~-~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 91 (259)
..-..+|.++..||.|+||.|.+|..+.+.+-|+||++++.-.-+. ..+--..|.++|..-. .|-++++..+|.+-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4456689999999999999999999999999999999987643222 2333345666666554 5667778888888899
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc-CC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR-FN 170 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~-~~ 170 (259)
.|+||||++|++|--.+++.+. +.+.....++..|+-+|-+||++||+++|||.+||+++.+ |+++|.|||++.. +.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e-GHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC-CceEeeeccccccccc
Confidence 9999999999999988887776 8899999999999999999999999999999999999777 8999999999854 23
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
.+..+.+.++++.|+|||++.=.++.. ++|.||+|+++|||+.|++||.+.+..+.+..|.+..-..
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgk-svDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsy 569 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGK-SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSY 569 (683)
T ss_pred CCcceeeecCCCcccccceEEeccccc-chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcC
Confidence 344556678999999999998888875 9999999999999999999999999999999998655443
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=221.18 Aligned_cols=232 Identities=25% Similarity=0.459 Sum_probs=199.3
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-----
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT----- 88 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 88 (259)
-...+.|+-...||+|.||.||+|....+|+.|++|....+...+..-....+|+.+|+.++|+|++.++++|..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 345567888899999999999999999999999999877655444444556789999999999999988887642
Q ss_pred ---CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 89 ---NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 89 ---~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
..++++||+++.. +|..++.+....++..+|..++.+++.+|.|+|.+.|+|+|+|+.|++++.+ +.++|.|||.
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~d-gilklADFGl 170 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKD-GILKLADFGL 170 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCC-ceEEeecccc
Confidence 3568999999976 8999988876779999999999999999999999999999999999999877 8999999999
Q ss_pred cccCCCCCcc-----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 166 SNRFNPGQKL-----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 166 ~~~~~~~~~~-----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
++.+...... .+.+-+..|++||.+.+...+.++.|+|+.||+|.+|+++.+.|.++....++..|..+.+....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9765433322 22345789999999999888888999999999999999999999999999999999999999988
Q ss_pred cccccCc
Q psy3663 241 CWWRGRP 247 (259)
Q Consensus 241 ~~~~~~~ 247 (259)
+-|-+.-
T Consensus 251 evWP~~d 257 (376)
T KOG0669|consen 251 EVWPNVD 257 (376)
T ss_pred ccCCCcc
Confidence 8886543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=214.67 Aligned_cols=182 Identities=27% Similarity=0.384 Sum_probs=152.6
Q ss_pred cccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCChHHHH
Q psy3663 29 GHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYI 108 (259)
Q Consensus 29 g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~ 108 (259)
|.++.||+|.+..+++.+++|.+.... ...+|...+....||||+++++.+.+....+++|||+.+++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 889999999999999999999987543 1223444444556999999999999999999999999999999998
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCCCccCCcc
Q psy3663 109 MKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPE 188 (259)
Q Consensus 109 ~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE 188 (259)
..... +++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++++|||.+...... ......+..|+|||
T Consensus 77 ~~~~~-l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE 152 (237)
T cd05576 77 SKFLN-IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR-GHIQLTYFSRWSEVEDS--CDGEAVENMYCAPE 152 (237)
T ss_pred HHhcC-CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC-CCEEEecccchhccccc--cccCCcCccccCCc
Confidence 76543 8999999999999999999999999999999999999776 78999999977554332 22233456799999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 189 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
...+...+. ++|+||+|+++|+|++|+.||...
T Consensus 153 ~~~~~~~~~-~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 153 VGGISEETE-ACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred ccCCCCCCc-hhhHHHHHHHHHHHHHCcchhhcC
Confidence 987766664 999999999999999999988643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=214.23 Aligned_cols=204 Identities=35% Similarity=0.592 Sum_probs=180.8
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCe
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSK 91 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 91 (259)
+.-.++|++.+.||.|+|++|.++....+..-|++|+++++-... ......+.|..+.+... ||.++-+..+|.+.+.
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 344569999999999999999999999999999999998765433 34667778888877764 8999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc-CC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR-FN 170 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~-~~ 170 (259)
.++|.||++|++|--..+++.. ++++....+...|+.||.|||++||+++|||.+|++++.. |+++|+|+|++.. +.
T Consensus 326 lffvieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldae-ghikltdygmcke~l~ 403 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAE-GHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccC-CceeecccchhhcCCC
Confidence 9999999999999777765554 9999999999999999999999999999999999999777 8999999999865 45
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
.+..+++.++++.|.|||++++..+.- ..|.|+||++|+|||.|+-||.
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygf-svdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGF-SVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCc-eehHHHHHHHHHHHHcCCCCcc
Confidence 667778889999999999999998885 9999999999999999999994
|
|
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=230.51 Aligned_cols=207 Identities=34% Similarity=0.569 Sum_probs=176.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
..|...+.||-|+||.|.+|....+..-|++|.+.+.. ........++.|-.||..-+++.||++|-.|.+.+..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 36788899999999999999988888999999997643 23334556777889999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-----
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP----- 171 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~----- 171 (259)
+|++|+++-.++-+.+- +.++..+.++.+|..|+++.|+.|+||+||||+|||++.+ |+|+|+|||++..+..
T Consensus 709 dYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrd-GHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD-GHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred eccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccC-Cceeeeeccccccceeccccc
Confidence 99999999999887775 8888889999999999999999999999999999999777 8999999999865520
Q ss_pred ----CC-----cc-----------------------------ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHH
Q psy3663 172 ----GQ-----KL-----------------------------ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLV 213 (259)
Q Consensus 172 ----~~-----~~-----------------------------~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~ 213 (259)
+. .+ ...+++..|+|||++....++. .+|.||.|+++|||+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q-~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ-LCDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc-cchhhHhhHHHHHHh
Confidence 00 00 0113788999999999888886 899999999999999
Q ss_pred hCCCCCCCCCChHH
Q psy3663 214 AGQAPFQEANDSET 227 (259)
Q Consensus 214 ~g~~pf~~~~~~~~ 227 (259)
.|++||......+.
T Consensus 866 ~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 866 VGQPPFLADTPGET 879 (1034)
T ss_pred hCCCCccCCCCCcc
Confidence 99999976655443
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=200.81 Aligned_cols=212 Identities=28% Similarity=0.454 Sum_probs=175.3
Q ss_pred eEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEEecc
Q psy3663 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLILELG 99 (259)
Q Consensus 21 ~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~ 99 (259)
.....||.|++|.|-+..+..+|.-.++|.+...- ......++.+|+.+..+.. .|.++.+++.+......++-||-+
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 34577999999999999999999999999987643 3345667778888877765 899999999988889999999999
Q ss_pred CCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 100 DGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 100 ~~~sL~~~~~~---~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
+. +|..+..+ .+..+++.-+-+++..+.+|+.+||+ ..++|+|+||+|||++.+ |++++||||.+..+-+....
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~-GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYD-GQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccC-CcEEEcccccceeehhhhHH
Confidence 65 88887654 36669999999999999999999996 589999999999999777 89999999998776554444
Q ss_pred ccccCCCccCCcccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCChHHHHHhhhccc
Q psy3663 176 ETSCGSLAYSAPEILLG----DSYDAPAVDVWSLGVILYMLVAGQAPFQE-ANDSETLTMIMDVSE 236 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~i~~~~~ 236 (259)
..-.+...|+|||.+.. ..++ .++||||||+++.||.+++.||.. ....++++++++...
T Consensus 206 t~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred HHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 44568889999999843 2444 499999999999999999999965 556777777775443
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=237.92 Aligned_cols=219 Identities=22% Similarity=0.418 Sum_probs=194.6
Q ss_pred CeeEeeeecccccceEEEEEEeecC---ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTG---EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.-++.+.||.|.||.|+.+..+..+ ..|+||.++.. +.+.....++.|+.|+-+++||||+++.++........+|
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 3478899999999999999987665 48999999654 4667788899999999999999999999999998999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
+|||..++|..+++++..+++..++..|++-|+.++.||-+.++||+||...||||+.+ -.+|++|||+++.+..+...
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccceeecccCCCc
Confidence 99999999999999998889999999999999999999999999999999999999887 68999999999877555422
Q ss_pred cc----ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccccc
Q psy3663 176 ET----SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 176 ~~----~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
.. .....+|.|||.+.-.++++ ++|+||+|++|+|.|+ |.-||=+.++++.++.|.++-+.+++
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTs-ASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpP 856 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPP 856 (996)
T ss_pred cccccCCccceeecChhHhhhcccCc-hhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCC
Confidence 11 12357999999998888887 9999999999999887 99999999999999999987766543
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=246.07 Aligned_cols=226 Identities=27% Similarity=0.461 Sum_probs=180.7
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-----
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT----- 88 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 88 (259)
+....+|+....||+|+||.||+|.++-+|..||||.|.... +......+.+|+..+.+|+||||++++..|..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 456678899999999999999999999999999999998776 66678889999999999999999999853200
Q ss_pred --------------------------------------------------------------------------------
Q psy3663 89 -------------------------------------------------------------------------------- 88 (259)
Q Consensus 89 -------------------------------------------------------------------------------- 88 (259)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------C--------CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q psy3663 89 --------------------------N--------SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134 (259)
Q Consensus 89 --------------------------~--------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~L 134 (259)
+ ...|+-||||...++..++..+...-.....|.++++|++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 135788899988667666665543225788999999999999999
Q ss_pred HHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC------------------CCC-ccccccCCCccCCcccccCCC-
Q psy3663 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN------------------PGQ-KLETSCGSLAYSAPEILLGDS- 194 (259)
Q Consensus 135 H~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~------------------~~~-~~~~~~~~~~~~apE~~~~~~- 194 (259)
|+.||||+||||.|||++.+ +.|+|+|||++.... .+. .....+|+..|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSR-NSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HhCceeeccCCcceeEEcCC-CCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 99999999999999999877 789999999997721 111 223446889999999997765
Q ss_pred -CCCCchhHHHHHHHHHHHHhCCCCCCCC-CChHHHHHhhhccccccccccc
Q psy3663 195 -YDAPAVDVWSLGVILYMLVAGQAPFQEA-NDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 195 -~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
.++.|+|+||||+|++||+ .||.+. ..-..++.+.++..+.+.-+|+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~ 841 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFD 841 (1351)
T ss_pred ccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCccccc
Confidence 4445999999999999998 458664 4556688888777766644444
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=228.95 Aligned_cols=209 Identities=35% Similarity=0.565 Sum_probs=174.1
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (259)
.+.+.|++...+|.|+++.|-.+.+..++...++|++.... ....+|+.++... .|||+++..+.+.++...+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 46778999999999999999999999999999999997652 2233566555555 4999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+|||.++|+-+.+.+..... ...++..|+++|+.|+.+||.+|++||||||+|||+..+.++++|+|||.+......
T Consensus 393 ~v~e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeehhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999887777765443 337778899999999999999999999999999999644488999999999876554
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHhhhc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS-ETLTMIMDV 234 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~i~~~ 234 (259)
....+.+..|+|||+.....++ +++|+||||+++|+|++|+.||...... ++.+.|..+
T Consensus 470 -~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~ 529 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP 529 (612)
T ss_pred -hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC
Confidence 3445678899999999976666 5999999999999999999999877666 455555444
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=224.12 Aligned_cols=215 Identities=24% Similarity=0.428 Sum_probs=183.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.+.-.+++.||+|.||.|.+|.-. .+..||+|.++..... .....+.+|+++|.+|+||||+.++++|..++.+.+|+
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 446788999999999999999833 3589999999876532 34688999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKHDAGL-SETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~-~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
||+..++|.+++..+..+. .-.....++.||+.+++||.+.++||+||.+.|+|++.+ .++||+|||+++.+-.++..
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e-~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE-FTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-ccEEecCcccccccccCCce
Confidence 9999999999999875433 556677899999999999999999999999999999777 78999999999876555443
Q ss_pred c---cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHH--hCCCCCCCCCChHHHHHhhhcc
Q psy3663 176 E---TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLV--AGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 176 ~---~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~--~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
. ..+...+|+|+|.+....+++ ++|+|+||+++||++ +...||...+++...+..-+..
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFtt-aSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~ 757 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTT-ASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFF 757 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccc-hhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhc
Confidence 2 235578999999999999997 999999999999975 5999999999888877665443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=207.23 Aligned_cols=203 Identities=46% Similarity=0.765 Sum_probs=173.2
Q ss_pred ccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCChHHHHH
Q psy3663 30 HFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIM 109 (259)
Q Consensus 30 ~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~ 109 (259)
++|.||+|.+..+++.+++|.+........ ...+.+|++.+++++|++++++.+.+......++++|++.+++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 478999999988899999999876543221 6788899999999999999999999998899999999999989999987
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCCCccCCccc
Q psy3663 110 KHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEI 189 (259)
Q Consensus 110 ~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~ 189 (259)
.... ++...++.++.+++.++.+||+.+++|+||+|+||+++.+ +.++|+||+.+.............+...|++||.
T Consensus 80 ~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 80 KRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEV 157 (244)
T ss_pred hccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCC-CcEEEccccceeeeccccccccccCCcCCCCHHH
Confidence 6554 8999999999999999999999999999999999999777 7899999999987765544455567789999999
Q ss_pred ccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCChHHHHHhhhccc
Q psy3663 190 LLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE-ANDSETLTMIMDVSE 236 (259)
Q Consensus 190 ~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~i~~~~~ 236 (259)
..+...+. ++|+|+||++++++++|..||.. .+.....+.+.+...
T Consensus 158 ~~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~ 204 (244)
T smart00220 158 LLGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP 204 (244)
T ss_pred HccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC
Confidence 98777765 99999999999999999999987 444555554444433
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=228.48 Aligned_cols=230 Identities=29% Similarity=0.457 Sum_probs=194.6
Q ss_pred cCeeEeeeecccccceEEEEEEeec-Cc--eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFT-GE--KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~-~~--~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
++-++.++||+|.||+|+++..+.. |+ .|+||++....... ....+++|+.++.+|+|+|++++|++..+ ...-+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3566778999999999999976533 33 89999998765443 67889999999999999999999999887 56778
Q ss_pred EEeccCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 95 ILELGDGGDLYDYIMK-HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~-~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
|||.+.+++|.+.+.+ ....+....+-.++.||+.|+.||..+++||+||-..|+++... ..|||+|||+.+.+..+.
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasp-rtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASP-RTVKICDFGLMRALGENE 266 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheeccc-ceeeeecccceeccCCCC
Confidence 9999999999999987 45568888999999999999999999999999999999999775 789999999999887776
Q ss_pred ccccc----cCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccccc--------
Q psy3663 174 KLETS----CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSCT-------- 240 (259)
Q Consensus 174 ~~~~~----~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~-------- 240 (259)
..... ...+.|||||.+....++. ++|+|++|++++||++ |+.||.+...-.+++.|-++-..+.+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFSh-aSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSH-ASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccc-cchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 65433 3467899999999999997 9999999999999999 88899999999999998854443322
Q ss_pred ----cccccCchhhh
Q psy3663 241 ----CWWRGRPRSRR 251 (259)
Q Consensus 241 ----~~~~~~~~~~~ 251 (259)
.||...|-+|+
T Consensus 346 ~imk~cWah~paDRp 360 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRP 360 (1039)
T ss_pred HHHHHhccCCccccc
Confidence 36766666553
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=222.15 Aligned_cols=215 Identities=29% Similarity=0.533 Sum_probs=185.2
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEe-----c
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVID-----T 88 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-----~ 88 (259)
...+.|++...||.|.+|.||++....++...++|+..... .....+..|.++++.+. |||++.++++|. .
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 34567899999999999999999999999999999987654 34567778889998886 999999999984 3
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.++.++|||||.|+|.-+++... +..+.++.|..+++.++.++.+||++.++|+||+-.|||++.+ +.|+|+|||.+.
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e-~~VKLvDFGvSa 171 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTEN-AEVKLVDFGVSA 171 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEecc-CcEEEeeeeeee
Confidence 57899999999999999998765 4558999999999999999999999999999999999999887 789999999987
Q ss_pred cCCCC-CccccccCCCccCCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 168 RFNPG-QKLETSCGSLAYSAPEILL-----GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~apE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
.+... ....+..+++.|+|||++. ...++. ++|+||||++..||..|.+|+-+++....+-+|-.-
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~-R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN 243 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDY-RSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 243 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCccc-ccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence 76543 3456678999999999984 345554 999999999999999999999999988877666543
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=216.20 Aligned_cols=214 Identities=31% Similarity=0.489 Sum_probs=178.3
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-----ccHHHHHHHHHHHHhCCCCCeEEEEE
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-----VSQDHLYQEVRCMKLVQHPNVVRLYE 84 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (259)
=-|-..+.++|-+..+||.|+|+.||+|.|...+..|++|+-.....+. ......-+|..|-+.|+||.|+++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 3455668889999999999999999999999999999999876544322 23455678999999999999999999
Q ss_pred EEe-cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--CcEeccCCCCCeEeeec--CCeEE
Q psy3663 85 VID-TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL--HVVHRDLKPENVVFFER--LGVVK 159 (259)
Q Consensus 85 ~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~--~i~H~dl~p~nIlv~~~--~~~i~ 159 (259)
+|. +++.++-|.||++|.+|.-++.+... +++.+...++.||..||.||... .|+|.||||.|||+... .|.++
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 984 67888999999999999888877665 99999999999999999999965 59999999999998654 36899
Q ss_pred EEeccccccCCCCCcc--------ccccCCCccCCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 160 LTDFGFSNRFNPGQKL--------ETSCGSLAYSAPEILLGD---SYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 160 l~df~~~~~~~~~~~~--------~~~~~~~~~~apE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
|+|||++..+...... ....++..|++||+|.-. +..+.++|+||+|+++|..+-|+.||..+..
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 9999999877544332 334678899999998533 2223499999999999999999999987553
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-29 Score=208.37 Aligned_cols=226 Identities=27% Similarity=0.460 Sum_probs=180.4
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-----C---CCeEEEEEEEec-
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-----H---PNVVRLYEVIDT- 88 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~---~~i~~~~~~~~~- 88 (259)
++|-+.++||=|.|++||+|+|+.+...||+|+.+-. +...+....|+.+|++++ + .+|+++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 6888999999999999999999999999999998643 234566788999999986 2 459999999964
Q ss_pred ---CCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeccCCCCCeEeeec---------
Q psy3663 89 ---NSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCH-KLHVVHRDLKPENVVFFER--------- 154 (259)
Q Consensus 89 ---~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH-~~~i~H~dl~p~nIlv~~~--------- 154 (259)
..++++|+|++ |.+|..++... ..+++...+.+|++||+.+|.||| ++||+|.||||+|||+..+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence 46899999999 66898888765 455999999999999999999999 5799999999999999000
Q ss_pred --------------------------------------------------------------------------------
Q psy3663 155 -------------------------------------------------------------------------------- 154 (259)
Q Consensus 155 -------------------------------------------------------------------------------- 154 (259)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred ----------------------------------------------------------------------------CCeE
Q psy3663 155 ----------------------------------------------------------------------------LGVV 158 (259)
Q Consensus 155 ----------------------------------------------------------------------------~~~i 158 (259)
.-++
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 0024
Q ss_pred EEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC------CCChHHHHHhh
Q psy3663 159 KLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE------ANDSETLTMIM 232 (259)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~------~~~~~~~~~i~ 232 (259)
+|.|||-|+-... ....-..+..|+|||++.+..|.+ .+||||++|+++||+||...|.. ..+++.+.+|+
T Consensus 394 KIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY~~-~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ 470 (590)
T KOG1290|consen 394 KIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGYST-SADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIM 470 (590)
T ss_pred EEeeccchhhhhh--hhchhhhhhhccCcceeecCCCCC-chhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHH
Confidence 4445544432211 111112456899999999999997 89999999999999999999954 45889999999
Q ss_pred hccccccccccccCchhh
Q psy3663 233 DVSESSCTCWWRGRPRSR 250 (259)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~ 250 (259)
++++.+|.....+---+|
T Consensus 471 ELLG~iPr~ia~~Gk~SR 488 (590)
T KOG1290|consen 471 ELLGKIPRKIALGGKYSR 488 (590)
T ss_pred HHHhhccHHHHhcCcchH
Confidence 999999887766544433
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=209.74 Aligned_cols=208 Identities=26% Similarity=0.431 Sum_probs=168.0
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHh-CCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKL-VQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
.+.||.|+||+|++..++..|+..+||.+..... +....+++.|.....+ -+.|||+++++..-.++.+++-||.++-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 4689999999999999999999999999987654 4456677777665444 4589999999999888999999999965
Q ss_pred CChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 102 GDLYDYIMK----HDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 102 ~sL~~~~~~----~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
+|..+... +...+++..+-.+......||.||-. ..|+|+|+||+|||++.. |.++|||||++..+-......
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~-G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH-GDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC-CCEeeecccchHhHHHHHHhh
Confidence 87776432 24458999999999999999999985 589999999999999666 899999999997765554455
Q ss_pred cccCCCccCCcccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCC-CCChHHHHHhhh
Q psy3663 177 TSCGSLAYSAPEILLGDSY-DAPAVDVWSLGVILYMLVAGQAPFQE-ANDSETLTMIMD 233 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~i~~ 233 (259)
.-.|...|+|||.+..... +..++|+||||+++||++||+-||.. ++..+++.++..
T Consensus 226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~ 284 (361)
T KOG1006|consen 226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI 284 (361)
T ss_pred hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence 5578889999999965433 34599999999999999999999975 334444444443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=238.57 Aligned_cols=190 Identities=25% Similarity=0.350 Sum_probs=156.9
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
+.+.|+....||+|++|.||+|.+..++..|++|.+..... ...+|++.+++++||||+++++++.+....++|
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 34567777899999999999999988999999999864331 112457889999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH---KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH---~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
|||+++++|.+++.. +++..+..++.|++.|+.||| +.+++|+||+|+||+++.+ +..++. ++.......
T Consensus 762 ~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~-~~~~~~-~~~~~~~~~- 834 (968)
T PLN00113 762 HEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK-DEPHLR-LSLPGLLCT- 834 (968)
T ss_pred EeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-CceEEE-ecccccccc-
Confidence 999999999999863 788999999999999999999 6799999999999999765 445554 443322211
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
.....++..|+|||.+.+..++. ++||||||+++|||++|+.||..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~-~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITE-KSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred --CCCccccccccCcccccCCCCCc-ccchhhHHHHHHHHHhCCCCCCc
Confidence 11225678999999998877775 99999999999999999999953
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=220.36 Aligned_cols=228 Identities=26% Similarity=0.474 Sum_probs=189.0
Q ss_pred eEeeeecccccceEEEEEEeec-------CceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeE
Q psy3663 21 DLEETLGRGHFAVVKLARHVFT-------GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 21 ~~~~~i~~g~~~~vy~~~~~~~-------~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 92 (259)
++.+.||+|+||.|++|..... ...|++|.+...... .....+..|+++++.+. |+||+.+++.+...+..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 5667999999999999974411 347999999776544 67888999999999996 99999999999998999
Q ss_pred EEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCe
Q psy3663 93 YLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV 157 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~ 157 (259)
++|+||+..++|.+++.... ..++...++.+..||+.+++||++.+++|+||-..||++..+ ..
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~-~~ 456 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN-KV 456 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC-CE
Confidence 99999999999999998877 348899999999999999999999999999999999999777 78
Q ss_pred EEEEeccccccCCCCCccc-c-cc--CCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC-ChHHHHHh
Q psy3663 158 VKLTDFGFSNRFNPGQKLE-T-SC--GSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEAN-DSETLTMI 231 (259)
Q Consensus 158 i~l~df~~~~~~~~~~~~~-~-~~--~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~-~~~~~~~i 231 (259)
++++|||+++......... . .. ....|+|||.+....++. ++|+||+|+++||+++ |..||.+.. ..+.++.+
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~-kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l 535 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTS-KSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFL 535 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccc-cchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHH
Confidence 9999999998644332222 1 11 356799999999977776 9999999999999999 899999866 67777767
Q ss_pred hhccccc------------cccccccCchhhh
Q psy3663 232 MDVSESS------------CTCWWRGRPRSRR 251 (259)
Q Consensus 232 ~~~~~~~------------~~~~~~~~~~~~~ 251 (259)
.++.+.. ...||..+|.+|+
T Consensus 536 ~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP 567 (609)
T KOG0200|consen 536 KEGNRMEQPEHCSDEIYDLMKSCWNADPEDRP 567 (609)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhCCCcccCC
Confidence 7655422 2457788887664
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=212.34 Aligned_cols=229 Identities=24% Similarity=0.409 Sum_probs=193.5
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
+-.+...||.|-||.||.+..+...-.|+||.++.+. ...+.++.|+.+++.+.|||+++++++|...-.+|+|+||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 3456789999999999999999999999999997643 4578899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc
Q psy3663 99 GDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~ 177 (259)
|..++|.+++.+.. ...+.-.++.|+.||..|++||.++++||+||-..|.||..+ +.+++.|||+++.+........
T Consensus 345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEn-hiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccccc-ceEEeeccchhhhhcCCceecc
Confidence 99999999998763 446777789999999999999999999999999999999766 7899999999988765544432
Q ss_pred --ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccc------------ccccc
Q psy3663 178 --SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSES------------SCTCW 242 (259)
Q Consensus 178 --~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~------------~~~~~ 242 (259)
......|.|||-+.=..+.. ++|+|+||++++|+.| |--||.+.+-...+..+.++-+- ..+-|
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSi-KSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraC 502 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRAC 502 (1157)
T ss_pred cCccCcccccCccccccccccc-chhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHH
Confidence 23567899999987777775 9999999999999999 77799998888777777754321 13447
Q ss_pred cccCchhhhh
Q psy3663 243 WRGRPRSRRR 252 (259)
Q Consensus 243 ~~~~~~~~~~ 252 (259)
|.=+|..|.+
T Consensus 503 W~WsPsDRPs 512 (1157)
T KOG4278|consen 503 WNWSPSDRPS 512 (1157)
T ss_pred hcCCcccCcc
Confidence 8878876653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=217.35 Aligned_cols=201 Identities=21% Similarity=0.267 Sum_probs=142.6
Q ss_pred CccccCeeEeeeecccccceEEEEEEeec----CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEE----
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFT----GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV---- 85 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~----~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~---- 85 (259)
..-.++|++.+.||+|+||.||+|.+..+ +..|++|.+..... ......+ . ++...+.++..+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e-~-l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE-R-VRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH-H-HHhhchhhHHHHHHhhhcc
Confidence 34567999999999999999999999888 89999998754321 1111111 1 111112222111111
Q ss_pred --EecCCeEEEEEeccCCCChHHHHHhcCCCC-------------------CHHHHHHHHHHHHHHHHHHHHCCcEeccC
Q psy3663 86 --IDTNSKLYLILELGDGGDLYDYIMKHDAGL-------------------SETYAREYFAQIVRAISFCHKLHVVHRDL 144 (259)
Q Consensus 86 --~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~-------------------~~~~i~~~~~ql~~al~~LH~~~i~H~dl 144 (259)
.......+++++|+.+++|.+++.....+. ....+..++.||+.+|.|||+.+|+|+||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 245567899999999999999887543211 23346789999999999999999999999
Q ss_pred CCCCeEeeecCCeEEEEeccccccCCCCC--ccccccCCCccCCcccccCCCCC---------------------CCchh
Q psy3663 145 KPENVVFFERLGVVKLTDFGFSNRFNPGQ--KLETSCGSLAYSAPEILLGDSYD---------------------APAVD 201 (259)
Q Consensus 145 ~p~nIlv~~~~~~i~l~df~~~~~~~~~~--~~~~~~~~~~~~apE~~~~~~~~---------------------~~~~D 201 (259)
||+||+++.+.+.++|+|||++..+.... ......++..|+|||.+...... ..++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999998766789999999997553321 22334677899999976432211 12569
Q ss_pred HHHHHHHHHHHHhCCCCCC
Q psy3663 202 VWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 202 i~slG~~l~~l~~g~~pf~ 220 (259)
||||||++|+|+++..|+.
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999998766543
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=217.89 Aligned_cols=215 Identities=28% Similarity=0.428 Sum_probs=183.8
Q ss_pred eeEeeeecccccceEEEEEEeecCc----eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGE----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.+-.+.||+|+||.||++..--.++ +|++|++... ........+.+|+-++.+++|||++++++++.... .-+|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 4446889999999999998765555 7777777543 34556788889999999999999999999986644 7789
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
++|+++++|.+++++....+-...++.|..||++++.|||.++++||||-..||||..- +.+++.|||.+..+......
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP-~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSP-NHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCC-CeEEEEecchhhccCccccc
Confidence 99999999999999998889999999999999999999999999999999999999666 78999999999887654433
Q ss_pred cc---ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc
Q psy3663 176 ET---SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 176 ~~---~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
.. ....+.|+|-|.+....++. ++|+||+|++++|+|| |..||.+...+++-+.+.++.+-+
T Consensus 855 y~~~~gK~pikwmale~i~~~~~th-qSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLs 920 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTH-QSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLS 920 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCc-hhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCC
Confidence 22 23467899999999888886 9999999999999999 999999999999988888766533
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=206.05 Aligned_cols=213 Identities=27% Similarity=0.475 Sum_probs=180.7
Q ss_pred CCccccCeeEeeeecccccceEEEEEEee---cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEec
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDT 88 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~---~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 88 (259)
...+...|+++.+||.|.|+.||+|.+.. .++.|++|.+.... .-..+..|++.|..+. +.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----~p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----SPSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----CchHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 45567789999999999999999999887 78899999987655 3455889999999997 8999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
+++..+|+||+......++... ++..++..+++.++.||.++|++||+|+||||.|++++...++-.|+|||++..
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999999888888865 778999999999999999999999999999999999999989999999998861
Q ss_pred CC--------------CC-------------------------------CccccccCCCccCCcccccCCCCCCCchhHH
Q psy3663 169 FN--------------PG-------------------------------QKLETSCGSLAYSAPEILLGDSYDAPAVDVW 203 (259)
Q Consensus 169 ~~--------------~~-------------------------------~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~ 203 (259)
.. .. .......|+.+|+|||++..-.-.++++|+|
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10 00 0001123789999999998877777799999
Q ss_pred HHHHHHHHHHhCCCCC-CCCCChHHHHHhhh
Q psy3663 204 SLGVILYMLVAGQAPF-QEANDSETLTMIMD 233 (259)
Q Consensus 204 slG~~l~~l~~g~~pf-~~~~~~~~~~~i~~ 233 (259)
|.|+++..++++..|| ...++-+.+.+|.-
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~t 293 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIAT 293 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHH
Confidence 9999999999999998 44556666666653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-27 Score=186.20 Aligned_cols=186 Identities=42% Similarity=0.720 Sum_probs=158.9
Q ss_pred ecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCChH
Q psy3663 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLY 105 (259)
Q Consensus 26 i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~ 105 (259)
||+|.++.||++.+..+++.+++|.+....... ....+.+|++.++.++|++|+++++++......++++|++.+.+|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 688999999999988779999999987654322 3567889999999999999999999999989999999999988999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-ccccccCCCcc
Q psy3663 106 DYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAY 184 (259)
Q Consensus 106 ~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~~~~~~~~~~ 184 (259)
+++......++...++.++.+++.++.+||+.|++|+||+|.||++....+.++|+||+.+....... ..........|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 99987644589999999999999999999999999999999999997723789999999987654432 12334567889
Q ss_pred CCcccccCCCCCCCchhHHHHHHHHHHH
Q psy3663 185 SAPEILLGDSYDAPAVDVWSLGVILYML 212 (259)
Q Consensus 185 ~apE~~~~~~~~~~~~Di~slG~~l~~l 212 (259)
.+||.+......+.++|+|++|++++++
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 9999987762333599999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-30 Score=198.96 Aligned_cols=204 Identities=28% Similarity=0.535 Sum_probs=168.1
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEE-Eec
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEV-IDT 88 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~~ 88 (259)
-....+.+.|++.+.+|+|-||.+.+|.+..++..+++|.++... .....+.+|..---.|. |.||+.-|++ |++
T Consensus 17 l~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 17 LKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred ccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 345677889999999999999999999999999999999997764 35677888887655565 8899887765 677
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee-cCCeEEEEeccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE-RLGVVKLTDFGFSN 167 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~-~~~~i~l~df~~~~ 167 (259)
.+.|++++||++.++|.+.+... ++-+.-...+..|++.||.|||++++||+|||.+|||+.+ +.-+++|||||...
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred CceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 78999999999999999988764 4788999999999999999999999999999999999864 34489999999887
Q ss_pred cCCCCCccccccCCCccCCcccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGD----SYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
..+.... .......|++||.+... -...+.+|+|.||++++..++|.+||..
T Consensus 172 k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 172 KVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred ccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 6543322 22345678999977432 2223489999999999999999999974
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=198.86 Aligned_cols=224 Identities=23% Similarity=0.446 Sum_probs=173.4
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC--CCCCeEEEEEEEecC---
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV--QHPNVVRLYEVIDTN--- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~--- 89 (259)
.+..+-.+.+.||+|.||.||++. ..|+.||||++.-.. -..-.+|.+|.+.. +|+||+.+++.-...
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~--wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGR--WRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhhheeEEEEEecCccccceeecc--ccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 356788999999999999999998 679999999986432 33445677776654 899999998875322
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----C---CcEeccCCCCCeEeeecCCeEEE
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-----L---HVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-----~---~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
.+.++|++|.+.+||.+++... .++.+..+.++..++.+|++||- . .|.|+|||..||+|..+ +..-|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn-~~C~I 357 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCI 357 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC-CcEEE
Confidence 3589999999999999999873 48999999999999999999994 2 39999999999999666 89999
Q ss_pred EeccccccCCCCC-----ccccccCCCccCCcccccCC-----CCCCCchhHHHHHHHHHHHHh----------CCCCCC
Q psy3663 161 TDFGFSNRFNPGQ-----KLETSCGSLAYSAPEILLGD-----SYDAPAVDVWSLGVILYMLVA----------GQAPFQ 220 (259)
Q Consensus 161 ~df~~~~~~~~~~-----~~~~~~~~~~~~apE~~~~~-----~~~~~~~Di~slG~~l~~l~~----------g~~pf~ 220 (259)
.|+|+|....... .....+|+.+|+|||++... -.+...+||||||.|++|++. -++||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 9999997655442 23456899999999998543 111238999999999999876 467886
Q ss_pred CCC-----ChHHHHHhh-hccccccccccccCch
Q psy3663 221 EAN-----DSETLTMIM-DVSESSCTCWWRGRPR 248 (259)
Q Consensus 221 ~~~-----~~~~~~~i~-~~~~~~~~~~~~~~~~ 248 (259)
+.- .+++.+-+. +-.++..+.+|.-+|-
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~ 471 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPA 471 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHH
Confidence 533 233332222 5566777777777664
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=201.25 Aligned_cols=199 Identities=25% Similarity=0.433 Sum_probs=160.8
Q ss_pred CCCCCCCcccc--CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC--CCCCeEEEE
Q psy3663 8 SSDGHPTKIAG--LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV--QHPNVVRLY 83 (259)
Q Consensus 8 ~~~~~~~~~~~--~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~ 83 (259)
+..+.++.+.+ .-++.+.||+|.||.||+|+ -+++.||||++... ..+.++.|-+|.... +|+||++++
T Consensus 198 ~~~~~sspl~~l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi 270 (534)
T KOG3653|consen 198 SGPAPSSPLLELDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFI 270 (534)
T ss_pred CCCCCCcccccCCchhhHHHhhcCccceeehhh--ccCceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhh
Confidence 33344444443 45667899999999999998 55689999998654 467778888877765 599999999
Q ss_pred EEEecCC----eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---------CCcEeccCCCCCeE
Q psy3663 84 EVIDTNS----KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK---------LHVVHRDLKPENVV 150 (259)
Q Consensus 84 ~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~---------~~i~H~dl~p~nIl 150 (259)
..-.... .+++|++|.+.++|.+++..+- ++..+..+++..|+++|+|||. -.|+|+|||..|||
T Consensus 271 ~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVL 348 (534)
T KOG3653|consen 271 GAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVL 348 (534)
T ss_pred chhccCCccccceeEEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceE
Confidence 8854433 7999999999999999998765 7999999999999999999995 35999999999999
Q ss_pred eeecCCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCC-----CchhHHHHHHHHHHHHhCC
Q psy3663 151 FFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDA-----PAVDVWSLGVILYMLVAGQ 216 (259)
Q Consensus 151 v~~~~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~-----~~~Di~slG~~l~~l~~g~ 216 (259)
|..| .+..|+|||++.++..+.+ ....+|+.+|||||++.+.-.-. .+.|+||+|.|++|++++-
T Consensus 349 vK~D-lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 349 VKND-LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred EccC-CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 9666 8999999999988764433 34468999999999996643222 2789999999999999843
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=204.76 Aligned_cols=204 Identities=19% Similarity=0.302 Sum_probs=148.3
Q ss_pred ccCeeEeeeecccccceEEEEEEe----------------ecCceEEEEEcccCCCCc------------ccHHHHHHHH
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHV----------------FTGEKVAVKVIDKTKLDP------------VSQDHLYQEV 68 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~----------------~~~~~~~lK~~~~~~~~~------------~~~~~~~~e~ 68 (259)
.++|++.+.||+|+||.||+|.+. ..+..|+||.+....... ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999742 244679999986532110 0011122356
Q ss_pred HHHHhCCCCCe-----EEEEEEEec--------CCeEEEEEeccCCCChHHHHHhcC-----------------------
Q psy3663 69 RCMKLVQHPNV-----VRLYEVIDT--------NSKLYLILELGDGGDLYDYIMKHD----------------------- 112 (259)
Q Consensus 69 ~~l~~l~~~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~~----------------------- 112 (259)
.++.+++|.++ +++++++.. .+..++|+||+.+++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 66666665543 556666532 356899999999999999886431
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccc--ccCCCccCCcccc
Q psy3663 113 AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET--SCGSLAYSAPEIL 190 (259)
Q Consensus 113 ~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~--~~~~~~~~apE~~ 190 (259)
..++...++.++.|++.+|.+||+.+|+|+||||+||+++.+ +.++|+|||++........... ...++.|+|||.+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 123566788999999999999999999999999999999776 7899999999865543322222 2346789999987
Q ss_pred cCCCCC---------------------CCchhHHHHHHHHHHHHhCCC-CCCC
Q psy3663 191 LGDSYD---------------------APAVDVWSLGVILYMLVAGQA-PFQE 221 (259)
Q Consensus 191 ~~~~~~---------------------~~~~Di~slG~~l~~l~~g~~-pf~~ 221 (259)
...... ..+.|+||+||++++|+++.+ ||.+
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 542211 124699999999999999886 7754
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=214.07 Aligned_cols=196 Identities=32% Similarity=0.516 Sum_probs=160.7
Q ss_pred eeEeeeecccccce-EEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEEe
Q psy3663 20 YDLEETLGRGHFAV-VKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 20 y~~~~~i~~g~~~~-vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 97 (259)
|.-.+.+|.|..|+ ||++. ..|+.||||.+-... ...+++|+..|+..+ ||||++++..-.+.+..|+..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGV--YEGREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEe--eCCceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 44456777777664 67776 789999999986543 567789999999886 9999999999888899999999
Q ss_pred ccCCCChHHHHHhcCCC--C-CHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec----CCeEEEEeccccccCC
Q psy3663 98 LGDGGDLYDYIMKHDAG--L-SETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER----LGVVKLTDFGFSNRFN 170 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~--~-~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~----~~~i~l~df~~~~~~~ 170 (259)
.|.. +|.++++..... . .....+.++.|++.+|++||+.+|+|+||||.|||+... ..+++|+|||++..+.
T Consensus 584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9976 999999874111 1 114468889999999999999999999999999999772 2479999999998886
Q ss_pred CCCc----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCC
Q psy3663 171 PGQK----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAG-QAPFQEAND 224 (259)
Q Consensus 171 ~~~~----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~ 224 (259)
.+.. .....|+.+|+|||.+....... ++|||||||++|+.++| .+||.+.-.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~-avDiFslGCvfyYvltgG~HpFGd~~~ 720 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSLE 720 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCc-ccchhhcCceEEEEecCCccCCCchHH
Confidence 5543 34457899999999999888876 99999999999998885 999976443
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=181.42 Aligned_cols=220 Identities=20% Similarity=0.306 Sum_probs=183.7
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC-CCeEEEEEEEec
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH-PNVVRLYEVIDT 88 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~ 88 (259)
.......++.|++++.||+|+||.+|+|....+|+.||||+=.. .....++..|..+.+.+++ ..|+.+..+..+
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~----~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS----KAKHPQLLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecc----cCCCcchhHHHHHHHHhccCCCCchhhhhccc
Confidence 34455678999999999999999999999999999999999543 3356778899999999985 678888888888
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCeEEEEecccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTDFGFS 166 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~i~l~df~~~ 166 (259)
...-.+||+.. |.+|.++.+.....++..+++.++.|++.-++|+|.++++|+||||+|+++.-+ .+++.++|||++
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 88889999999 779999999887779999999999999999999999999999999999998533 357999999999
Q ss_pred ccCCCCCc--------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 167 NRFNPGQK--------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 167 ~~~~~~~~--------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
........ .....++.+|.+--...+...+. +.|+-|+|+++++..-|.+||.+..+....++..+.+
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSR-RDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~ 237 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSR-RDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS 237 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhh-hhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence 76542211 12335788888877777666665 8999999999999999999999988777766665544
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-26 Score=189.46 Aligned_cols=216 Identities=22% Similarity=0.270 Sum_probs=174.4
Q ss_pred CeeEeeeecccccceEEEEEEeecC-ceEEEEEcccCCCCcccHHHHHHHHHHHHhCC----CCCeEEEEEEE-ecCCeE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTG-EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ----HPNVVRLYEVI-DTNSKL 92 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~-~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~ 92 (259)
+|++.+.||+|+||.||.|.+...+ ..+++|+-....... ...+..|..++..+. ..++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 8999999999999999999988664 578888876543221 126777888888886 36899999998 477888
Q ss_pred EEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC----CeEEEEeccccc
Q psy3663 93 YLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL----GVVKLTDFGFSN 167 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~----~~i~l~df~~~~ 167 (259)
++||+.+ |.+|.++....+ ..++..++..++.|++.+|.+||+.|++|+||||.|+.+.... ..+.|.|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999999 779999987665 6799999999999999999999999999999999999997653 469999999998
Q ss_pred --cCCCCC------c---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 168 --RFNPGQ------K---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 168 --~~~~~~------~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
...... . .....++..|+++....+..... +.|+|||++++.++..|.+||...........+.+...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r-~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGR-RDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCC-chhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 321111 1 12234889999999999888886 99999999999999999999988776555555554443
Q ss_pred cc
Q psy3663 237 SS 238 (259)
Q Consensus 237 ~~ 238 (259)
..
T Consensus 255 ~~ 256 (322)
T KOG1164|consen 255 KL 256 (322)
T ss_pred hh
Confidence 33
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=191.44 Aligned_cols=231 Identities=23% Similarity=0.344 Sum_probs=191.5
Q ss_pred cCeeEeeeecccccceEEEEEEeec-----CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEE-ecCCe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFT-----GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVI-DTNSK 91 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~ 91 (259)
.+++....+-+|.||.||.|+..+. .+.+.+|.++... ++.....+..|.-.+..+.|||++++.++. ++...
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 4788888999999999999965432 3467778876543 555667788898999999999999999986 45678
Q ss_pred EEEEEeccCCCChHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecc
Q psy3663 92 LYLILELGDGGDLYDYIMKH-------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG 164 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~-------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~ 164 (259)
.++++++..-++|+.++... ...++-.++..++.|++.|+++||+.|++|.||-..|.++++. -+++|+|-.
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVkltDsa 441 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKLTDSA 441 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEeccch
Confidence 89999999988999999843 2336677788999999999999999999999999999999666 789999999
Q ss_pred ccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc------
Q psy3663 165 FSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV------ 234 (259)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~------ 234 (259)
+++.+...+.. .+......|++||.+....++. ++|+||||++|+||+| |+.||.+.+..++..-++++
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yss-asDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP 520 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSS-ASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP 520 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcc-hhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence 99887655443 2334567899999999988886 9999999999999999 99999999999998888854
Q ss_pred ------cccccccccccCchhhh
Q psy3663 235 ------SESSCTCWWRGRPRSRR 251 (259)
Q Consensus 235 ------~~~~~~~~~~~~~~~~~ 251 (259)
+++-..+||.-.|.+|+
T Consensus 521 ~NCPDeLf~vMacCWallpeeRP 543 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERP 543 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCC
Confidence 44556788988887765
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-25 Score=177.48 Aligned_cols=215 Identities=20% Similarity=0.357 Sum_probs=181.0
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 92 (259)
..++-.|++++.||+|+||..+.+.+..++++||||.=... ....++..|.+..+.|. .++|..++-+....-+-
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 34556999999999999999999999999999999985433 35678889999999887 68999999888887788
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee----cCCeEEEEecccccc
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE----RLGVVKLTDFGFSNR 168 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~----~~~~i~l~df~~~~~ 168 (259)
.+|+|.+ |.+|.++..-++..++..++..++.|++.-++++|.+.+|++||||+|+|+.. +.+.|-++|||++..
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8999999 77999999988888999999999999999999999999999999999999953 345799999999976
Q ss_pred CCCCCcc--------ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 169 FNPGQKL--------ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 169 ~~~~~~~--------~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
....... -...++.+||+.-...+...+. +.|+-|||=|+++.+-|.+||.+......=++..++
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSR-RDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhh-hhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 6432211 1235889999999998888876 999999999999999999999886654444444433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=182.38 Aligned_cols=168 Identities=21% Similarity=0.218 Sum_probs=128.0
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEee-cCceEEEEEcccCCC---CcccHHHHHHHHHHHHhCCCCCeEEEEEEEe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLVQHPNVVRLYEVID 87 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~-~~~~~~lK~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (259)
....+.+.|++.+.||+|+||.||+|++.. ++..++||.+..... .......+.+|+++++.++|+++++.+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 345678899999999999999999999876 677789998753311 122356688999999999999988533222
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccC-CCCCeEeeecCCeEEEEecccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDL-KPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl-~p~nIlv~~~~~~i~l~df~~~ 166 (259)
+..+++|||+.|.+|... . . .. ...++.|++++|.+||++||+|+|| ||+||+++.+ +.++|+|||++
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~--~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~-~~ikLiDFGlA 159 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-R--P--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPD-GEAAVIDFQLA 159 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-C--c--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCC-CCEEEEECccc
Confidence 457999999999888632 1 1 11 1467899999999999999999999 9999999655 78999999999
Q ss_pred ccCCCCCcc---------ccccCCCccCCccccc
Q psy3663 167 NRFNPGQKL---------ETSCGSLAYSAPEILL 191 (259)
Q Consensus 167 ~~~~~~~~~---------~~~~~~~~~~apE~~~ 191 (259)
......... ....++..|.+||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 865433211 2234567789999874
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-26 Score=197.32 Aligned_cols=220 Identities=26% Similarity=0.396 Sum_probs=191.2
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
.-.++|+....+|.|.+|.||+|.|..+++..++|+++... ......+++|+-+++.++||||+.+++-+...+..++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 34579999999999999999999999999999999998764 3467788899999999999999999999988899999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-C
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-Q 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~ 173 (259)
.|||+.+++|++...- ..++++.++..+.+.-+++++|||+.|-+|+|||-.||++++. |.+++.|||.+..+... .
T Consensus 90 cMEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~-gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE-GDVKLADFGVSAQITATIA 167 (829)
T ss_pred EEEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc-CceeecccCchhhhhhhhh
Confidence 9999999999997643 3459999999999999999999999999999999999999776 89999999988765433 2
Q ss_pred ccccccCCCccCCcccc---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 174 KLETSCGSLAYSAPEIL---LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~---~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
......|++.|+|||+- +...+. ..+|+|++|+...|+..-++|.-+.+....+..+-+-++.++
T Consensus 168 KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp 235 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP 235 (829)
T ss_pred hhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence 23445799999999975 344555 499999999999999999999988999888888887776554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=168.15 Aligned_cols=173 Identities=16% Similarity=0.128 Sum_probs=131.5
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccH-HH------HHHHHHHHHhCCCCCeEEEEEEEec
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DH------LYQEVRCMKLVQHPNVVRLYEVIDT 88 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~-~~------~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (259)
+.++|++.+.++.|++|.||++.+ ++..+++|++.......... .. +.+|++.+.+++|++|..+.+++..
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 568999999999999999999764 46689999997654332221 22 5688999999999999999888653
Q ss_pred C--------CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEE
Q psy3663 89 N--------SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 89 ~--------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
. ...+++|||++|.+|.++.. +++ ..+.++..++..+|..|++|||++|+||+++++ + ++|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~-g-i~l 175 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN-G-LRI 175 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC-C-EEE
Confidence 3 35789999999999988732 333 346699999999999999999999999999766 6 999
Q ss_pred EeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHH
Q psy3663 161 TDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLV 213 (259)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~ 213 (259)
+|||............. ......+. .++|+|+||+.+..+.
T Consensus 176 iDfg~~~~~~e~~a~d~-----------~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAKDR-----------IDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhHHH-----------HHHHhHhc-ccccccceeEeehHHH
Confidence 99997754422111111 22333455 4899999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-21 Score=161.57 Aligned_cols=214 Identities=37% Similarity=0.646 Sum_probs=176.5
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc-cHHHHHHHHHHHHhCCCC-CeEEEEEEEecCCeEEEEEe
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV-SQDHLYQEVRCMKLVQHP-NVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 97 (259)
|.+...||.|+++.||.+.+. ..+++|.+........ ....+.+|+.++..+.++ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999977 8899999877654433 577788999999999988 79999999987777899999
Q ss_pred ccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC--
Q psy3663 98 LGDGGDLYDYIMKHD--AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-- 173 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~--~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-- 173 (259)
++.+.++.+++.... ..++......++.|++.++.++|+.+++|+|++|+||++......++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997766554 2589999999999999999999999999999999999997773379999999887554332
Q ss_pred -----ccccccCCCccCCcccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----hHHHHHhhhccc
Q psy3663 174 -----KLETSCGSLAYSAPEILLGD--SYDAPAVDVWSLGVILYMLVAGQAPFQEAND----SETLTMIMDVSE 236 (259)
Q Consensus 174 -----~~~~~~~~~~~~apE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~i~~~~~ 236 (259)
......++..|++||.+.+. .......|+|++|++++++++|..||..... ....+.+.....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC
Confidence 23455788999999999873 3344599999999999999999999887764 344444444443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-23 Score=159.50 Aligned_cols=141 Identities=23% Similarity=0.279 Sum_probs=109.1
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCccc------------------------HHHHHHHHHHHHhCCCCC
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS------------------------QDHLYQEVRCMKLVQHPN 78 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~~~ 78 (259)
...||+|++|.||+|.+. +|+.|++|+++........ ......|++.+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999999765332111 112345889999998777
Q ss_pred eEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEeccCCCCCeEeeecCCe
Q psy3663 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC-HKLHVVHRDLKPENVVFFERLGV 157 (259)
Q Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~L-H~~~i~H~dl~p~nIlv~~~~~~ 157 (259)
+..+..+.... .+++|||+.+.++...... ..+++...+..++.|++.+|.++ |+.||+|+||||+||+++ + +.
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~-~~ 155 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-D-GK 155 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-C-Cc
Confidence 64443332222 3799999998766554332 23589999999999999999999 799999999999999996 3 68
Q ss_pred EEEEeccccccC
Q psy3663 158 VKLTDFGFSNRF 169 (259)
Q Consensus 158 i~l~df~~~~~~ 169 (259)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=192.90 Aligned_cols=143 Identities=24% Similarity=0.244 Sum_probs=107.7
Q ss_pred CCeEEEEEEE-------ecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCe
Q psy3663 77 PNVVRLYEVI-------DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENV 149 (259)
Q Consensus 77 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nI 149 (259)
.||..+++.+ ......++++|+..+ +|.+++......+++.+++.++.||++||.|||++||+|+||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDV-SLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCc-cHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 3555555554 223457788898844 99999976666699999999999999999999999999999999999
Q ss_pred Eeeec------------------CCeEEEEeccccccCCCCC-----------------ccccccCCCccCCcccccCCC
Q psy3663 150 VFFER------------------LGVVKLTDFGFSNRFNPGQ-----------------KLETSCGSLAYSAPEILLGDS 194 (259)
Q Consensus 150 lv~~~------------------~~~i~l~df~~~~~~~~~~-----------------~~~~~~~~~~~~apE~~~~~~ 194 (259)
|+... .+.++++|||++....... ......++..|+|||.+.+..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 99542 2345566666554321000 000123567799999998888
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 195 YDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 195 ~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
++. ++|||||||++|||+++.+|+..
T Consensus 192 ~~~-~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 192 SNC-ASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred CCc-hhhhhhHHHHHHHHhhCCCchhh
Confidence 765 99999999999999999998764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=152.03 Aligned_cols=142 Identities=22% Similarity=0.231 Sum_probs=110.8
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCccc------------------------HHHHHHHHHHHHhCCCCC
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS------------------------QDHLYQEVRCMKLVQHPN 78 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~~~~ 78 (259)
.+.||+|++|.||+|.+. +|+.|+||++......... ...+..|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 8999999999865322111 122357888999999888
Q ss_pred eEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCe
Q psy3663 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGV 157 (259)
Q Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~ 157 (259)
+..+..+.... .+++|||+.|.++....... .+++......++.|++.++.++|+ .||+|+||+|+||+++ + +.
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~-~~ 155 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D-GK 155 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C-CC
Confidence 75444443332 37999999887554432222 347888999999999999999999 9999999999999997 4 78
Q ss_pred EEEEeccccccCC
Q psy3663 158 VKLTDFGFSNRFN 170 (259)
Q Consensus 158 i~l~df~~~~~~~ 170 (259)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=145.26 Aligned_cols=187 Identities=19% Similarity=0.132 Sum_probs=137.9
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc--cHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEE
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV--SQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~--~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (259)
+.++..|+.|.||.||.+. ..+.+++.+.+........ ....+.+|+++++++. +++++.++++ ...+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 3467899999999999776 4677888887766543211 2235778999999996 5789988886 3468999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccC-CCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDL-KPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl-~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
+|+.|.+|.+.... . ...++.|++.+|.++|.+||+|+|| +|+||+++.+ +.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~-g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQED-GSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred eeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCC-CCEEEEECCCceecCCcchH
Confidence 99999888654321 1 2357789999999999999999999 7999999765 78999999999755433321
Q ss_pred ----c----------cccCCCccCCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 176 ----E----------TSCGSLAYSAPEILLGD-SYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 176 ----~----------~~~~~~~~~apE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
. ....+..++.|+...-. ..+-.+.+.++.|+.+|.++|+..++-+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 11235566666654322 2222478999999999999999988743
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=176.53 Aligned_cols=196 Identities=19% Similarity=0.293 Sum_probs=157.9
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccH-HHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~-~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-++.|.|.+.||+|+||.||.|.... |+.||||+-+....++... .++...++ ..--+.|.++......++..++
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHccCCccee
Confidence 35689999999999999999999875 9999999988776655442 33332222 1113556666666666788899
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee------cCCeEEEEecccccc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE------RLGVVKLTDFGFSNR 168 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~------~~~~i~l~df~~~~~ 168 (259)
+++|.+.+||.++++.. ..+++..+..++.||+..++.||..+||||||||+|+++.. +.-.++|+|||.+..
T Consensus 772 v~ey~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 99999999999999844 44999999999999999999999999999999999999953 223699999998865
Q ss_pred CC---CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q psy3663 169 FN---PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQA 217 (259)
Q Consensus 169 ~~---~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 217 (259)
+. .+......+.+-.+-.+|...+..|++ .+|.|.|+.+++-|+.|+.
T Consensus 851 m~lfp~~~~F~~~~~td~f~C~EM~~grpWtY-q~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPWTY-QIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeEcCCCcEEeeeeccccchhHHHhcCCCCch-hhhhHHHHHHHHHHHHHHH
Confidence 53 333445557788899999999999997 9999999999999998763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=146.85 Aligned_cols=117 Identities=28% Similarity=0.398 Sum_probs=96.0
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS 181 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~ 181 (259)
++|.+++...+.++++..++.++.|++.||.|||+.+ ||+||+++.+ +.+++ ||.+....... ..++
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~~----~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPEQ----SRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeecccc----CCCc
Confidence 4899999877777999999999999999999999999 9999998666 77888 99886654322 2567
Q ss_pred CccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-hHHHHHhh
Q psy3663 182 LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND-SETLTMIM 232 (259)
Q Consensus 182 ~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~i~ 232 (259)
..|+|||.+.+..++. ++|||||||++|+|++|+.||..... ...+..+.
T Consensus 68 ~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~ 118 (176)
T smart00750 68 PYFMAPEVIQGQSYTE-KADIYSLGITLYEALDYELPYNEERELSAILEILL 118 (176)
T ss_pred ccccChHHhcCCCCcc-hhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH
Confidence 8999999998888775 99999999999999999999976543 33333433
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=156.11 Aligned_cols=201 Identities=27% Similarity=0.364 Sum_probs=134.1
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCC----------CCCeEEEEEEEe
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQ----------HPNVVRLYEVID 87 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~----------~~~i~~~~~~~~ 87 (259)
....++.||.|+++.||.|.|..+++.+++|++..... .....+.+++|......+. |-.++.+++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 56778999999999999999999999999999876543 2234667777665554432 223444554432
Q ss_pred ------------cCC-----eEEEEEeccCCCChHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHHCCcEeccC
Q psy3663 88 ------------TNS-----KLYLILELGDGGDLYDYIMK---HDAG---LSETYAREYFAQIVRAISFCHKLHVVHRDL 144 (259)
Q Consensus 88 ------------~~~-----~~~lv~e~~~~~sL~~~~~~---~~~~---~~~~~i~~~~~ql~~al~~LH~~~i~H~dl 144 (259)
+.. ..+++|+-+.+ +|..++.. .... +...-...+..|+++.+++||..|++||||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 111 24778888865 88887543 2221 222334556689999999999999999999
Q ss_pred CCCCeEeeecCCeEEEEeccccccCCCCCccccccCCCccCCcccccCC-------CCCCCchhHHHHHHHHHHHHhCCC
Q psy3663 145 KPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD-------SYDAPAVDVWSLGVILYMLVAGQA 217 (259)
Q Consensus 145 ~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-------~~~~~~~Di~slG~~l~~l~~g~~ 217 (259)
+|+|++++.+ |.+.|+||+.....+.. ......+..|.|||..... ...+.+.|.|+||+++|.|+|+..
T Consensus 172 ~~~nfll~~~-G~v~Lg~F~~~~r~g~~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQD-GGVFLGDFSSLVRAGTR--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TT-S-EEE--GGGEEETTEE--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCC-CCEEEcChHHHeecCce--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999777 89999999977655432 2224455789999976332 122348999999999999999999
Q ss_pred CCCCCC
Q psy3663 218 PFQEAN 223 (259)
Q Consensus 218 pf~~~~ 223 (259)
||....
T Consensus 249 Pf~~~~ 254 (288)
T PF14531_consen 249 PFGLSS 254 (288)
T ss_dssp STCCCG
T ss_pred CCCCCC
Confidence 997543
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=176.46 Aligned_cols=201 Identities=27% Similarity=0.378 Sum_probs=154.9
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC--CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK--LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
..+..+|..++.||.+.|=+|.+|.+. +|. +++|++.+.. .+-....+..+|++ ....++||++++..+...+..
T Consensus 19 sd~~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 19 SDLSVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA 95 (1431)
T ss_pred hcCccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH
Confidence 344558899999999999999999855 444 9999997654 23334555556666 666689999999888878888
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC--
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-- 169 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~-- 169 (259)
.|+|.+|... +|.+.+..++. +..-+.+-++.||+.||..+|+.||+|||||.+|||++.- |-+.|+||..-...
T Consensus 96 AylvRqyvkh-nLyDRlSTRPF-L~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW-NW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLSTRPF-LVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW-NWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHHHHHhh-hhhhhhccchH-HHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee-chhhhhcccccCCccC
Confidence 8889999966 88888776665 7788888999999999999999999999999999999776 78999999854221
Q ss_pred CCCCcc------ccccCCCccCCcccccCCC---------C-CCCchhHHHHHHHHHHHHh-CCCCCC
Q psy3663 170 NPGQKL------ETSCGSLAYSAPEILLGDS---------Y-DAPAVDVWSLGVILYMLVA-GQAPFQ 220 (259)
Q Consensus 170 ~~~~~~------~~~~~~~~~~apE~~~~~~---------~-~~~~~Di~slG~~l~~l~~-g~~pf~ 220 (259)
....+. .+......|.|||+|.... . -+++-||||+||+++||++ |++||.
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 111111 1112356899999985421 1 2458899999999999988 799993
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=173.60 Aligned_cols=209 Identities=28% Similarity=0.479 Sum_probs=165.8
Q ss_pred ccccCe-eEeeeecccccceEEEEEEeecCceEEEEEccc----CCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Q psy3663 15 KIAGLY-DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDK----TKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN 89 (259)
Q Consensus 15 ~~~~~y-~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~----~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (259)
.+...| .-...+|.|++|.++.+......+.+..|.+.. ..........+..|+-+-..+.|++++..+....+.
T Consensus 314 ~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~ 393 (601)
T KOG0590|consen 314 GFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI 393 (601)
T ss_pred ccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc
Confidence 334445 567899999999888888776666666665542 111111222266788888888999998888877776
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
......|||+++ +|..++.... .++..++-.++.||+.++.|+|+.||.|+|+|++|+++..+ +.++++|||.+...
T Consensus 394 ~~~~~~mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~-g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 394 DGILQSMEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTEN-GILKIIDFGAASVF 470 (601)
T ss_pred ccchhhhhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecC-CceEEeecCcceee
Confidence 666666999998 8988887653 38899999999999999999999999999999999999777 79999999988665
Q ss_pred CCCCc-----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH
Q psy3663 170 NPGQK-----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226 (259)
Q Consensus 170 ~~~~~-----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (259)
..... .....++..|.|||++.+..++....||||.|++++.|.+|+.||.-....+
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~ 532 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD 532 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence 43322 2344688899999999999999989999999999999999999996655443
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-21 Score=167.96 Aligned_cols=208 Identities=34% Similarity=0.521 Sum_probs=169.4
Q ss_pred ecccccceEEEEE---EeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 26 LGRGHFAVVKLAR---HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 26 i~~g~~~~vy~~~---~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+|+|.+|.|+++. -...+.-|++|+.++..........-..|..++..++ +|.++.+...+......+++.++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6889999999864 2345778899988776543333334456778888887 99999999999999999999999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCC
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS 181 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~ 181 (259)
+.|...+.+... +++.....+...++.+++++|+.+|+|+|+|++||+++.+ |++++.|||.+...-.... .+++
T Consensus 82 g~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~-Ghi~~tdfglske~v~~~~---~cgt 156 (612)
T KOG0603|consen 82 GDLFTRLSKEVM-FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLE-GHIKLTDFGLSKEAVKEKI---ACGT 156 (612)
T ss_pred chhhhccccCCc-hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeeccc-CccccCCchhhhHhHhhhh---cccc
Confidence 888776655444 7888889999999999999999999999999999999777 8999999998865433222 2789
Q ss_pred CccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 182 LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 182 ~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
..|+|||++. .+.. ++|.||+|+++++|++|..||.. +....|++....+|.+.|.-
T Consensus 157 ~eymApEI~~--gh~~-a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~ 213 (612)
T KOG0603|consen 157 YEYRAPEIIN--GHLS-AADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAE 213 (612)
T ss_pred hhhhhhHhhh--ccCC-cccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHH
Confidence 9999999998 3443 89999999999999999999998 88888888777666666543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-20 Score=145.37 Aligned_cols=145 Identities=21% Similarity=0.195 Sum_probs=112.6
Q ss_pred CeeEeeeecccccceEEEEE-EeecCceEEEEEcccCCCCcc----------------------cHHHHHHHHHHHHhCC
Q psy3663 19 LYDLEETLGRGHFAVVKLAR-HVFTGEKVAVKVIDKTKLDPV----------------------SQDHLYQEVRCMKLVQ 75 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~-~~~~~~~~~lK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~ 75 (259)
.|++.+.||+|++|.||.|. +..+|..|++|++........ ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 667899999999976432110 0123567999999997
Q ss_pred CC--CeEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-cEeccCCCCCeEee
Q psy3663 76 HP--NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH-VVHRDLKPENVVFF 152 (259)
Q Consensus 76 ~~--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~-i~H~dl~p~nIlv~ 152 (259)
+. .++++++. . ..++|||++.+.+|....... .+........++.||+.++.+||+.| ++|+||+|+||+++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 53 34455543 2 247999999998877654332 23666778899999999999999999 99999999999997
Q ss_pred ecCCeEEEEeccccccCC
Q psy3663 153 ERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 153 ~~~~~i~l~df~~~~~~~ 170 (259)
+ +.++|+|||.+....
T Consensus 184 -~-~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -D-GKVVIIDVSQSVELD 199 (237)
T ss_pred -C-CCEEEEEChhhhccC
Confidence 4 789999999876443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-19 Score=137.83 Aligned_cols=136 Identities=14% Similarity=0.216 Sum_probs=105.3
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-----CCCCeEEEEEEEecCC---e-E
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-----QHPNVVRLYEVIDTNS---K-L 92 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~-~ 92 (259)
-.+.||+|+++.||. +..+... +||++..... .....+.+|+.+++.+ +||||+++++++.++. . +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 357899999999995 5555555 6898866432 2456789999999999 5799999999998763 3 3
Q ss_pred EEEEec--cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCcEeccCCCCCeEeeec---CCeEEEEecccc
Q psy3663 93 YLILEL--GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI-SFCHKLHVVHRDLKPENVVFFER---LGVVKLTDFGFS 166 (259)
Q Consensus 93 ~lv~e~--~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al-~~LH~~~i~H~dl~p~nIlv~~~---~~~i~l~df~~~ 166 (259)
.+|+|| ..+++|.+++.+.. +++. ..++.|++.++ .|||+++|+|+||||+||++... ..+++|+|++.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 378999 44689999996632 5555 35678888777 99999999999999999999743 237999994433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-18 Score=136.91 Aligned_cols=136 Identities=21% Similarity=0.259 Sum_probs=112.1
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCcc------cHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV------SQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
+.||+|++|.||+|.. .+..+++|.......... ....+.+|+.++..+.++++..+..++.+....+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5789999999999985 777899998764332211 12456789999999999988777777666777899999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
|++|.+|.+++.... . ....++.+++.++.++|+.|++|+|++|.||++. + +.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C-CCEEEEECCcccC
Confidence 999999999886532 2 7889999999999999999999999999999997 4 6899999998765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.6e-18 Score=132.63 Aligned_cols=132 Identities=22% Similarity=0.284 Sum_probs=104.7
Q ss_pred eecccccceEEEEEEeecCceEEEEEcccCCCCcc------cHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV------SQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 25 ~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
.||+|++|.||++. ..+..+++|.......... ....+.+|+++++.++++++..+.-++......+++||+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 47999999999998 5678899999654332111 135567899999999887765554444555667899999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
++|.+|.+++..... .++.+++.+|.+||+.|++|+|++|.||++. + +.++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C-CcEEEEECCCCcC
Confidence 999999988754211 7889999999999999999999999999997 4 7899999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.4e-18 Score=131.71 Aligned_cols=139 Identities=20% Similarity=0.210 Sum_probs=107.2
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc--------------------cHHHHHHHHHHHHhCCCC-
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV--------------------SQDHLYQEVRCMKLVQHP- 77 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~~~- 77 (259)
.|.+.+.||+|++|.||.+... +|+.+++|++........ .......|..++..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999875 799999999765431110 112356788888888776
Q ss_pred -CeEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC
Q psy3663 78 -NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 78 -~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~ 156 (259)
.++.+++. ...+++|||+.|.+|...... .....++.+++.++.++|..|++|+||+|+||+++.+ +
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~ 162 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-E 162 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-C
Confidence 34444432 345899999999888765421 3456788999999999999999999999999999765 7
Q ss_pred eEEEEeccccccCC
Q psy3663 157 VVKLTDFGFSNRFN 170 (259)
Q Consensus 157 ~i~l~df~~~~~~~ 170 (259)
.++|+|||.+....
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 89999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=6e-18 Score=138.53 Aligned_cols=144 Identities=26% Similarity=0.393 Sum_probs=111.2
Q ss_pred CCCCeEEEEEEEec---------------------------CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHH
Q psy3663 75 QHPNVVRLYEVIDT---------------------------NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQI 127 (259)
Q Consensus 75 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql 127 (259)
+||||+.+...|.+ +.+.|++|..++. +|.+++-.+. .+......++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 48999999877532 2468999999966 9999986544 5777888899999
Q ss_pred HHHHHHHHHCCcEeccCCCCCeEeeecC---CeEEEEeccccccCCCCCc-------cccccCCCccCCcccccCC----
Q psy3663 128 VRAISFCHKLHVVHRDLKPENVVFFERL---GVVKLTDFGFSNRFNPGQK-------LETSCGSLAYSAPEILLGD---- 193 (259)
Q Consensus 128 ~~al~~LH~~~i~H~dl~p~nIlv~~~~---~~i~l~df~~~~~~~~~~~-------~~~~~~~~~~~apE~~~~~---- 193 (259)
++|+.+||+.|+.|+|+|.+||++.-+. -.+++.|||++-.-..... .-..-++..-+|||+...-
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 9999999999999999999999996442 2688999998743222101 0111256778999988532
Q ss_pred -CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 194 -SYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 194 -~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
..+..++|.|+.|.+.||+++...||..
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 2334599999999999999999999976
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.5e-17 Score=145.69 Aligned_cols=139 Identities=19% Similarity=0.201 Sum_probs=109.5
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc------ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP------VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
..|...+.||+|++|.||++... +..+++|......... .....+.+|+++++.++|++++.+..++.+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34566889999999999998754 3344544432221111 123557789999999999998887777766667
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
.+++|||+++.+|.+++. ....++.+++.++.+||+.|++|+||+|+||++ ++ +.++|+|||.+...
T Consensus 411 ~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~-~~~~liDFGla~~~ 477 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RD-DRLYLIDFGLGKYS 477 (535)
T ss_pred CEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-EC-CcEEEEeCcccccC
Confidence 789999999999999875 346789999999999999999999999999999 44 68999999998654
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.3e-17 Score=124.56 Aligned_cols=138 Identities=22% Similarity=0.265 Sum_probs=97.8
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHH----------------------HHHHHHHHhCCCCC--
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL----------------------YQEVRCMKLVQHPN-- 78 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~~~~-- 78 (259)
.+.||+|++|.||.|.+. +++.|++|++............. ..|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 88999999987643222111111 24555555554332
Q ss_pred eEEEEEEEecCCeEEEEEeccCCCChHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCC
Q psy3663 79 VVRLYEVIDTNSKLYLILELGDGGDLYD-YIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~ 156 (259)
+.+++.. ...+++|||+.++++.. .+.... . ......++.+++.++.++|. .+|+|+||+|+||+++ + +
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-G 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-C
Confidence 4445443 23589999999843321 111111 1 16678899999999999999 9999999999999997 4 7
Q ss_pred eEEEEeccccccCC
Q psy3663 157 VVKLTDFGFSNRFN 170 (259)
Q Consensus 157 ~i~l~df~~~~~~~ 170 (259)
.++++|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 89999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-17 Score=130.27 Aligned_cols=215 Identities=20% Similarity=0.336 Sum_probs=165.2
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
+...+..+|.+...|..|++..+ |..++.|++.-..........+.+|.-.|+.+.||||+++++.+...-...+|..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 45677788999999999999855 5557788887655555556778889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCCCCeEeeecC-CeEEEEeccccccCCCCC
Q psy3663 98 LGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLH--VVHRDLKPENVVFFERL-GVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~--i~H~dl~p~nIlv~~~~-~~i~l~df~~~~~~~~~~ 173 (259)
|++.++|..++.+.. .-.+..+..+++.++++++.|||+.. |---.|+...++++++. .++...|--++..
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 999999999987653 23566788999999999999999875 44567888889887662 1333444433321
Q ss_pred ccccccCCCccCCcccccCCCCC--CCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh-hhccccccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYD--APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI-MDVSESSCT 240 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~--~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i-~~~~~~~~~ 240 (259)
.......+.|++||.+...+.+ ..++|+|||+++++||.|...||.+-+..+.--+| +++++.-.+
T Consensus 343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip 411 (448)
T KOG0195|consen 343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP 411 (448)
T ss_pred -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC
Confidence 1123456789999999765544 23899999999999999999999998888775554 355555433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.3e-16 Score=122.88 Aligned_cols=136 Identities=18% Similarity=0.236 Sum_probs=102.0
Q ss_pred eeec-ccccceEEEEEEeecCceEEEEEcccCC-----------CCcccHHHHHHHHHHHHhCCCCCe--EEEEEEEecC
Q psy3663 24 ETLG-RGHFAVVKLARHVFTGEKVAVKVIDKTK-----------LDPVSQDHLYQEVRCMKLVQHPNV--VRLYEVIDTN 89 (259)
Q Consensus 24 ~~i~-~g~~~~vy~~~~~~~~~~~~lK~~~~~~-----------~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~ 89 (259)
..|| .|+.+.+|.+.. .+..++||.+.... .+......+.+|+.++..+++++| +.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4565 788888888874 47889999885321 112234567889999999998774 6666654322
Q ss_pred -C---eEEEEEeccCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecc
Q psy3663 90 -S---KLYLILELGDG-GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG 164 (259)
Q Consensus 90 -~---~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~ 164 (259)
. ..++|+|+++| .+|.+++... .+++. .+.+|+.++.+||.+||+|+||+|.||+++.+ +.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~-~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPD-GKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCC-CCEEEEECC
Confidence 2 23599999997 6898887653 24543 35789999999999999999999999999766 689999999
Q ss_pred cccc
Q psy3663 165 FSNR 168 (259)
Q Consensus 165 ~~~~ 168 (259)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8765
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-15 Score=113.26 Aligned_cols=131 Identities=20% Similarity=0.272 Sum_probs=109.0
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC--CCeEEEEEEEecCCeEEEEEecc
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH--PNVVRLYEVIDTNSKLYLILELG 99 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~ 99 (259)
+++.|+.|.++.||++.+. +..+++|....... ...+.+|+.+++.+++ .++++++......+..++++||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 4678999999999999964 47899999765432 4567889999999976 58899998888778899999999
Q ss_pred CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 100 DGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL---HVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 100 ~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~---~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.+.++..+ +......++.+++.++..+|.. +++|+|++|+||++.+. +.++++||+.+.
T Consensus 76 ~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~-~~~~l~Df~~~~ 137 (155)
T cd05120 76 EGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG-KILGIIDWEYAG 137 (155)
T ss_pred CCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC-cEEEEEeccccc
Confidence 88666543 4566778889999999999985 69999999999999774 789999999765
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.2e-16 Score=141.69 Aligned_cols=190 Identities=27% Similarity=0.447 Sum_probs=137.5
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
.....-.+|+..++|..|++|.||++.++.+..++++|+ ++.. .+.+ +++....+|-++
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-------lilR--nilt~a~npfvv----------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-------LILR--NILTFAGNPFVV----------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-------hhhh--ccccccCCccee-----------
Confidence 445566799999999999999999999999999999844 3221 1111 022222233333
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
-++ ...+..- ++++.+. +.+++|||+.||+|+|++|+|.++..- |++++.|||+......
T Consensus 136 ----gDc------~tllk~~-g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ----GDC------ATLLKNI-GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ----chh------hhhcccC-CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhh
Confidence 222 2222221 2233322 678999999999999999999999666 8999999997754321
Q ss_pred CCcc----------------ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 172 GQKL----------------ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 172 ~~~~----------------~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
.... ...++++.|.|||++....|.. .+|.|++|+++|+.+.|..||.+...++.+.+.+..-
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygk-pvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGK-PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCC-CccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 1111 1225889999999998888875 8999999999999999999999999999999998766
Q ss_pred cccccccc
Q psy3663 236 ESSCTCWW 243 (259)
Q Consensus 236 ~~~~~~~~ 243 (259)
...+++=|
T Consensus 275 i~wpE~de 282 (1205)
T KOG0606|consen 275 IEWPEEDE 282 (1205)
T ss_pred ccccccCc
Confidence 65555533
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.1e-16 Score=131.60 Aligned_cols=162 Identities=23% Similarity=0.415 Sum_probs=132.2
Q ss_pred HHhCCCCCeEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-EeccCCCCCe
Q psy3663 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV-VHRDLKPENV 149 (259)
Q Consensus 71 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i-~H~dl~p~nI 149 (259)
++.+.|.|+.++++.+.+....+.|.+++..++|.+.+.....+++..-...++++|+.++.|||+..| +||.++..|-
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 356789999999999999999999999999999999999887779999999999999999999998876 9999999999
Q ss_pred EeeecCCeEEEEeccccccCCC---CCccccccCCCccCCcccccCCCC------CCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 150 VFFERLGVVKLTDFGFSNRFNP---GQKLETSCGSLAYSAPEILLGDSY------DAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 150 lv~~~~~~i~l~df~~~~~~~~---~~~~~~~~~~~~~~apE~~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
+++.. -.+++.|||+...... ............|.|||.+..... .+.+.|+||+|++++|+++...||.
T Consensus 81 lvd~~-w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~ 159 (484)
T KOG1023|consen 81 LVDSR-WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD 159 (484)
T ss_pred eeeee-EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence 99777 5799999998876632 011112224568999999976411 2347999999999999999999997
Q ss_pred CCC----ChHHHHHhhh
Q psy3663 221 EAN----DSETLTMIMD 233 (259)
Q Consensus 221 ~~~----~~~~~~~i~~ 233 (259)
... ..+....+.+
T Consensus 160 ~~~~~~~~~eii~~~~~ 176 (484)
T KOG1023|consen 160 LRNLVEDPDEIILRVKK 176 (484)
T ss_pred cccccCChHHHHHHHHh
Confidence 622 2345555556
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.8e-15 Score=127.02 Aligned_cols=180 Identities=21% Similarity=0.277 Sum_probs=140.0
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCCCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGD 103 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~s 103 (259)
....-++.+.+-.+..+.++.++.+..+..... .....+.+.++.++.++||||+++++.++..+..|+|+|.+. .
T Consensus 18 e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--P 93 (690)
T KOG1243|consen 18 EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--P 93 (690)
T ss_pred ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--c
Confidence 333444444332466667889999999876543 345677888999999999999999999999999999999986 7
Q ss_pred hHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-cccccCC
Q psy3663 104 LYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LETSCGS 181 (259)
Q Consensus 104 L~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH-~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~~~~~~ 181 (259)
|..++.+ +....+.--+.||+.||.+|| +++++||+|+.+.|+|+.. |..+|.+|..+........ .......
T Consensus 94 l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~-GeWkLggle~v~~~~~~~~~~~~~~~~ 168 (690)
T KOG1243|consen 94 LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNES-GEWKLGGLELVSKASGFNAPAKSLYLI 168 (690)
T ss_pred HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCC-CcEEEeeeEEEeccccCCcccccchhh
Confidence 8888876 446777888899999999997 6789999999999999877 8999999998866543332 2222334
Q ss_pred CccCCcccccCCCCCCCchhHHHHHHHHHHHHhC
Q psy3663 182 LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAG 215 (259)
Q Consensus 182 ~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g 215 (259)
..|..|+.+....+ ..|.|.|||++++++.|
T Consensus 169 ~s~~~P~~~~~s~~---s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 169 ESFDDPEEIDPSEW---SIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcccChhhcCcccc---chhhhhHHHHHHHHhCc
Confidence 45667776544432 57999999999999999
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.9e-14 Score=106.95 Aligned_cols=146 Identities=21% Similarity=0.220 Sum_probs=115.1
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc------cHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV------SQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
....+.+|+-+.|+.+. ..|+..+||.-....+... ......+|+++|.++.--.|.-+.-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 56789999999999988 6788888887654433221 234456799999999877777666666677777899
Q ss_pred EeccCC-CChHHHHHhcCCCCCHHHH-HHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeE--EEEeccccccC
Q psy3663 96 LELGDG-GDLYDYIMKHDAGLSETYA-REYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVV--KLTDFGFSNRF 169 (259)
Q Consensus 96 ~e~~~~-~sL~~~~~~~~~~~~~~~i-~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i--~l~df~~~~~~ 169 (259)
|||++| .++.+++.....+-.++.. ..++.+|-+.+.-||.++|+||||.++||++.++.+++ .++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 5888888776444444444 88999999999999999999999999999998887765 89999987643
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-16 Score=141.85 Aligned_cols=209 Identities=32% Similarity=0.577 Sum_probs=171.3
Q ss_pred ccCeeEeeeecccccceEEEEEEeec-CceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFT-GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~-~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 94 (259)
...|.+.+.||+|+++.+-.+.+..+ ...++.|.+............+..|..+...+. |.|++.+++...+.+.+++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 67899999999999999988886544 335666666554444555666777888888888 9999999999999999999
Q ss_pred EEeccCCCChHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeccCCCCCeEeeecCC-eEEEEeccccccCCC
Q psy3663 95 ILELGDGGDLYDYI-MKHDAGLSETYAREYFAQIVRAISFCH-KLHVVHRDLKPENVVFFERLG-VVKLTDFGFSNRFNP 171 (259)
Q Consensus 95 v~e~~~~~sL~~~~-~~~~~~~~~~~i~~~~~ql~~al~~LH-~~~i~H~dl~p~nIlv~~~~~-~i~l~df~~~~~~~~ 171 (259)
+.++..|+++...+ .......+......++.|+..++.|+| ..++.|+|++|+|.+++.. + .+++.||+++.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s-~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDES-GSALKIADFGLATAYRN 177 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccC-CCcccCCCchhhccccc
Confidence 99999998888877 333325778888999999999999999 9999999999999998766 5 899999999987655
Q ss_pred -CCc---cccccC-CCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH
Q psy3663 172 -GQK---LETSCG-SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226 (259)
Q Consensus 172 -~~~---~~~~~~-~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (259)
... .....+ +..|.|||...+..+..+..|+||.|+++..+++|..||.......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 211 223356 8899999999987777779999999999999999999997655444
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.7e-14 Score=108.91 Aligned_cols=140 Identities=19% Similarity=0.205 Sum_probs=100.5
Q ss_pred eeeecccccceEEEEEEee------cCceEEEEEcccCCC-----------C---------cccHHHHH----HHHHHHH
Q psy3663 23 EETLGRGHFAVVKLARHVF------TGEKVAVKVIDKTKL-----------D---------PVSQDHLY----QEVRCMK 72 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~------~~~~~~lK~~~~~~~-----------~---------~~~~~~~~----~e~~~l~ 72 (259)
...||.|.-+.||.|.... .+..++||+++-... + ......+. +|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998653 357999998863210 0 11122333 7999999
Q ss_pred hCCC--CCeEEEEEEEecCCeEEEEEeccCCCChHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCcEeccCCCCC
Q psy3663 73 LVQH--PNVVRLYEVIDTNSKLYLILELGDGGDLYD-YIMKHDAGLSETYAREYFAQIVRAISFC-HKLHVVHRDLKPEN 148 (259)
Q Consensus 73 ~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~~~~~~~~~~~~~i~~~~~ql~~al~~L-H~~~i~H~dl~p~n 148 (259)
++.. -+++.++++ ..-+++||++.+..+.. .+.+ ..++......++.+++.++..| |+.|++||||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 9875 456667765 33479999997643321 1222 1255566778889999999988 89999999999999
Q ss_pred eEeeecCCeEEEEeccccccCC
Q psy3663 149 VVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 149 Ilv~~~~~~i~l~df~~~~~~~ 170 (259)
|++.+ +.+.|+||+.+....
T Consensus 156 IL~~~--~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD--GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC--CcEEEEECCCceeCC
Confidence 99953 579999999876553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=7.5e-14 Score=104.09 Aligned_cols=134 Identities=19% Similarity=0.239 Sum_probs=104.0
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCccc------HHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS------QDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
..+.+|+-+.+|.+. .-|.++++|.-.+..+.... ...-.+|+.++.+++...|..+.=+..+.+...++||
T Consensus 2 ~~i~~GAEa~i~~~~--~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTD--FLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeee--ccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 357899999999885 35666888876554432222 2334568999999987777766666667778899999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
|+.|..|++.+... ...++..+-..+.-||++||+||||.++||++..+ .+.++|||++...
T Consensus 80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCccccc
Confidence 99999999888764 24667788888999999999999999999999665 4999999998643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=5.4e-14 Score=121.79 Aligned_cols=151 Identities=26% Similarity=0.342 Sum_probs=100.3
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCccc------------------------H--------H
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS------------------------Q--------D 62 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~------------------------~--------~ 62 (259)
++...|+ .+.|+.|++|.||+|... +|+.|+||+.+........ . .
T Consensus 115 ~~F~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 192 (437)
T TIGR01982 115 ELFAEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEK 192 (437)
T ss_pred HHHhhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHH
Confidence 4444555 478999999999999865 7899999998654210000 0 0
Q ss_pred ------HHHHHHHHHHhCC-----CCCeEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHH-H
Q psy3663 63 ------HLYQEVRCMKLVQ-----HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVR-A 130 (259)
Q Consensus 63 ------~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~-a 130 (259)
.+.+|+..+.+++ ++++.-+.-++...+..+++|||++|.+|.++........+ ...++.+++. .
T Consensus 193 ~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~ 269 (437)
T TIGR01982 193 TLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSF 269 (437)
T ss_pred HHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHH
Confidence 1223444333332 34433222222333456899999999999887654322232 3345555555 4
Q ss_pred HHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 131 l~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
+..+|..|++|+|++|.||++..+ ++++++|||++..+..
T Consensus 270 l~ql~~~g~~H~D~hPgNilv~~~-g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 270 LNQVLRDGFFHADLHPGNIFVLKD-GKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHhCCceeCCCCcccEEECCC-CcEEEEeCCCeeECCH
Confidence 788999999999999999999666 7899999999877653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.2e-15 Score=126.58 Aligned_cols=119 Identities=30% Similarity=0.569 Sum_probs=103.4
Q ss_pred eEEEEEeccCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKH--DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
..++.|+++...+|.+++... ....+...+..++.|+..++.| ++.+|.|++|.||+...+ ..++|.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhheee
Confidence 578999999999999999643 3446778899999999999999 999999999999998666 6899999999887
Q ss_pred CCCCC-------ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh
Q psy3663 169 FNPGQ-------KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA 214 (259)
Q Consensus 169 ~~~~~-------~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~ 214 (259)
..... ......++..|++||.+.+..+.. ++||||||++++||+.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~-kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSE-KVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhh-hcchhhHHHHHHHHHH
Confidence 76555 445557899999999999999986 9999999999999986
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.2e-13 Score=103.33 Aligned_cols=127 Identities=20% Similarity=0.203 Sum_probs=94.3
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCe-EEEEEEEecCCeEEEEEeccCC
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV-VRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
.+.++.|..+.||.+.. .+..+++|....... ....+..|+.+++.+...++ ++++.... ...+++|||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 46788999999999984 478899999765431 12345678888888865443 44554433 234799999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----EeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV-----VHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i-----~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.++.... . .....+.+++.++..||..++ +|||++|.||+++ + +.++++||+.+.
T Consensus 76 ~~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~-~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D-GRLWLIDWEYAG 135 (170)
T ss_pred Ccccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-CeEEEEeccccc
Confidence 8776430 1 123456789999999999985 9999999999997 4 579999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.2e-14 Score=123.53 Aligned_cols=157 Identities=22% Similarity=0.233 Sum_probs=98.7
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC--------------------c------------
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD--------------------P------------ 58 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~--------------------~------------ 58 (259)
.+..++...|+. +.|+.|++|.||.|....+|+.|+||+.++.-.. +
T Consensus 113 ~~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~ 191 (537)
T PRK04750 113 GPVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA 191 (537)
T ss_pred CCHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence 345566778887 8999999999999998877999999999754210 0
Q ss_pred ccHHHH------HHHHHHHHhCC----CCCeEEEEEEE-ecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHH
Q psy3663 59 VSQDHL------YQEVRCMKLVQ----HPNVVRLYEVI-DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQI 127 (259)
Q Consensus 59 ~~~~~~------~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql 127 (259)
.....+ .+|+.-+.+++ +...+.+-.++ +.....+++|||+.|.++.++-.-...+.+...+.....+
T Consensus 192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~- 270 (537)
T PRK04750 192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE- 270 (537)
T ss_pred HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH-
Confidence 001112 23333333332 22222222222 2244568999999999998753221122232222221111
Q ss_pred HHHHHHHHHCCcEeccCCCCCeEeeecCC----eEEEEeccccccCCC
Q psy3663 128 VRAISFCHKLHVVHRDLKPENVVFFERLG----VVKLTDFGFSNRFNP 171 (259)
Q Consensus 128 ~~al~~LH~~~i~H~dl~p~nIlv~~~~~----~i~l~df~~~~~~~~ 171 (259)
..+..+...|++|+|++|.||+++.+ + +++++|||+...++.
T Consensus 271 -~~~~Qif~~GffHaDpHPGNIlv~~~-g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 -VFFTQVFRDGFFHADMHPGNIFVSYD-PPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -HHHHHHHhCCeeeCCCChHHeEEecC-CCCCCeEEEEecceEEECCH
Confidence 12334456999999999999999776 5 899999999877653
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.38 E-value=5e-13 Score=115.14 Aligned_cols=204 Identities=24% Similarity=0.283 Sum_probs=162.9
Q ss_pred cccCeeEeeeecc--cccceEEEEEE--eecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCC
Q psy3663 16 IAGLYDLEETLGR--GHFAVVKLARH--VFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNS 90 (259)
Q Consensus 16 ~~~~y~~~~~i~~--g~~~~vy~~~~--~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 90 (259)
+...+.+...+|. |.++.+|.+.. ..++..+++|.-+.....+.....=.+|+.-..+++ |++.++.+..|...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3457788899999 99999999988 788889998885443332223333335555555555 889999888899999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVR----AISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~----al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
..++-+|.+. .+|.++......-++...++..+.+... |+.++|+.+++|.|++|.||+..++....+++||+..
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 9999999995 5999988877776889999999999999 9999999999999999999999777567999999988
Q ss_pred ccCCCCCccc-cc-----cCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 167 NRFNPGQKLE-TS-----CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 167 ~~~~~~~~~~-~~-----~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
..+..+.... .. .+...|++||...+... .++|+|+||.++++..++-.+....
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~--~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT--FASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccc--hHhhhcchhhhhHhhHhhcccccCC
Confidence 8776554221 11 56788999999877654 3899999999999998887776544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.7e-11 Score=97.32 Aligned_cols=140 Identities=12% Similarity=0.030 Sum_probs=98.5
Q ss_pred ecccccceEEEEEEeecCceEEEEEcccCCCCc---------ccHHHHHHHHHHHHhCCCCCe--EEEEEEEec-----C
Q psy3663 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP---------VSQDHLYQEVRCMKLVQHPNV--VRLYEVIDT-----N 89 (259)
Q Consensus 26 i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~-----~ 89 (259)
+..-....|+.+. .+|+.|.||......... .......+|...+.+|...+| ++++.+.+. .
T Consensus 30 v~~~~~rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 30 FRELEGRRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EecCCCceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 3333444466653 567889999764333111 112246788888888864443 344445432 2
Q ss_pred CeEEEEEeccCCC-ChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee------cCCeEEEE
Q psy3663 90 SKLYLILELGDGG-DLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE------RLGVVKLT 161 (259)
Q Consensus 90 ~~~~lv~e~~~~~-sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~------~~~~i~l~ 161 (259)
...++|+|++++. +|.+++... ..+.+......++.+++..+..||.+|++|+|+++.||++.. +...+.|+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI 187 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI 187 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence 3578999999875 899988643 233567778899999999999999999999999999999974 23579999
Q ss_pred eccccc
Q psy3663 162 DFGFSN 167 (259)
Q Consensus 162 df~~~~ 167 (259)
||+.+.
T Consensus 188 Dl~r~~ 193 (268)
T PRK15123 188 DLHRAQ 193 (268)
T ss_pred ECCccc
Confidence 999774
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.1e-12 Score=99.39 Aligned_cols=138 Identities=21% Similarity=0.243 Sum_probs=103.9
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCC------------------C--cccHHHHHHHHHHHHhCCCC--
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL------------------D--PVSQDHLYQEVRCMKLVQHP-- 77 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~------------------~--~~~~~~~~~e~~~l~~l~~~-- 77 (259)
+.+...||.|.-|.||.|.+. +|.+++||.=....+ + ..+.....+|.++|++|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999987 788999996432111 1 12234467899999999865
Q ss_pred CeEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCe
Q psy3663 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV 157 (259)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~ 157 (259)
.|++++++ +.-.++||+++|..|.... ++......++..|++-+.-+-..|++|||+++-||+++++ |.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d-g~ 240 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED-GD 240 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC-CC
Confidence 67888877 3346999999997666543 2344455566666777777779999999999999999777 78
Q ss_pred EEEEeccccccC
Q psy3663 158 VKLTDFGFSNRF 169 (259)
Q Consensus 158 i~l~df~~~~~~ 169 (259)
+.++||..+...
T Consensus 241 ~~vIDwPQ~v~~ 252 (304)
T COG0478 241 IVVIDWPQAVPI 252 (304)
T ss_pred EEEEeCcccccC
Confidence 999999976543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.5e-11 Score=92.92 Aligned_cols=128 Identities=25% Similarity=0.281 Sum_probs=82.5
Q ss_pred eEEEEEEeecCceEEEEEcccCCCC-------------------cc-----cHHHHHHHHHHHHhCCCC--CeEEEEEEE
Q psy3663 33 VVKLARHVFTGEKVAVKVIDKTKLD-------------------PV-----SQDHLYQEVRCMKLVQHP--NVVRLYEVI 86 (259)
Q Consensus 33 ~vy~~~~~~~~~~~~lK~~~~~~~~-------------------~~-----~~~~~~~e~~~l~~l~~~--~i~~~~~~~ 86 (259)
.||.|... +|..+++|+......+ .. ......+|.+.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888865 6779999988642210 00 123356799999999876 467777653
Q ss_pred ecCCeEEEEEeccC--CCChHHHHHhcCCCCCHHHHHHHHHHHHHH-HHHHHHCCcEeccCCCCCeEeeecCCeEEEEec
Q psy3663 87 DTNSKLYLILELGD--GGDLYDYIMKHDAGLSETYAREYFAQIVRA-ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDF 163 (259)
Q Consensus 87 ~~~~~~~lv~e~~~--~~sL~~~~~~~~~~~~~~~i~~~~~ql~~a-l~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df 163 (259)
. -+++|||+. |..+..+.... ++.+....++.+++.. ...+|+.||+||||++.||++.++ .+.++||
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf 150 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDF 150 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--G
T ss_pred --C--CEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEec
Confidence 2 269999998 76666554321 1234566777788884 444689999999999999999665 7999999
Q ss_pred cccccCC
Q psy3663 164 GFSNRFN 170 (259)
Q Consensus 164 ~~~~~~~ 170 (259)
+.+....
T Consensus 151 ~qav~~~ 157 (188)
T PF01163_consen 151 GQAVDSS 157 (188)
T ss_dssp TTEEETT
T ss_pred CcceecC
Confidence 9876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.1e-11 Score=100.62 Aligned_cols=169 Identities=20% Similarity=0.246 Sum_probs=130.9
Q ss_pred ccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec----CCeEEEEEeccCC-CCh
Q psy3663 30 HFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT----NSKLYLILELGDG-GDL 104 (259)
Q Consensus 30 ~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~-~sL 104 (259)
...++|+|+...+|..|++|.++..... ...+...-+++++++.|+||+++.+++.. ....++|++|.++ .+|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 4578999999999999999999544321 22333456788999999999999999862 3568999999984 466
Q ss_pred HHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 105 YDYIMKH--------------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 105 ~~~~~~~--------------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
.++.... +.+.++..+|.++.||..||..+|+.|+...-|.+.+|++..+ .+++|...|....+.
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~-~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGK-MRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCc-ceEEEecccceeeec
Confidence 6664332 2337889999999999999999999999999999999999887 489999998876665
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAP 218 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 218 (259)
... . |.+.+ ..+.|.=.||.++..|.||..-
T Consensus 445 ~d~-~------------~~le~----~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDP-T------------EPLES----QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC-C------------cchhH----HhhhhHHHHHHHHHHHhhcccc
Confidence 433 0 11111 1278999999999999999653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.8e-11 Score=94.33 Aligned_cols=141 Identities=19% Similarity=0.274 Sum_probs=103.0
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCC--CeEEEEEEEecC---CeEEEEEec
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP--NVVRLYEVIDTN---SKLYLILEL 98 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~---~~~~lv~e~ 98 (259)
+.|+.|..+.+|++... +|+.+++|........ .....+..|..+++.+++. .+++++.+.... +..+++|++
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 57889999999999864 3589999997654321 2355678999999999764 356677776553 267899999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK------------------------------------------ 136 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~------------------------------------------ 136 (259)
+.|.++...... ..++......++.++++++..||+
T Consensus 82 i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 82 VDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred eCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 999877664421 235666666677777777777763
Q ss_pred --------------CCcEeccCCCCCeEeeec-CCeEEEEecccccc
Q psy3663 137 --------------LHVVHRDLKPENVVFFER-LGVVKLTDFGFSNR 168 (259)
Q Consensus 137 --------------~~i~H~dl~p~nIlv~~~-~~~i~l~df~~~~~ 168 (259)
..++|||+++.||+++.+ .+.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236899999999999773 35688999997653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.1e-11 Score=97.36 Aligned_cols=145 Identities=17% Similarity=0.329 Sum_probs=109.1
Q ss_pred hCCCCCeEEEEEEEecCC-----eEEEEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--cEec
Q psy3663 73 LVQHPNVVRLYEVIDTNS-----KLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLH--VVHR 142 (259)
Q Consensus 73 ~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~--i~H~ 142 (259)
.+.|.|++++..+|.+.. ...++.+|+..+++.+++.+- ...+......+|+.||+.||.|||+.. |+||
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg 202 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG 202 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence 345888999999986643 478999999999999998753 344788889999999999999999885 9999
Q ss_pred cCCCCCeEeeecCCeEEEEeccccccCCC------CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCC
Q psy3663 143 DLKPENVVFFERLGVVKLTDFGFSNRFNP------GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQ 216 (259)
Q Consensus 143 dl~p~nIlv~~~~~~i~l~df~~~~~~~~------~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 216 (259)
++..+.|++..+ +-+++.... ...... ........+..+|.+||.-...+.+. ++|||++|++..+|..+.
T Consensus 203 nlTc~tifiq~n-gLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~-a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 203 NLTCDTIFIQHN-GLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTG-ASDIYKFGMCALEMAILE 279 (458)
T ss_pred CcchhheeecCC-ceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCccccccc-chhhhhhhHHHHHHHHhe
Confidence 999999999754 545543322 111110 11112234577899999877767666 999999999999999877
Q ss_pred CCCC
Q psy3663 217 APFQ 220 (259)
Q Consensus 217 ~pf~ 220 (259)
.--.
T Consensus 280 iq~t 283 (458)
T KOG1266|consen 280 IQST 283 (458)
T ss_pred eccC
Confidence 6543
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-11 Score=106.86 Aligned_cols=203 Identities=23% Similarity=0.187 Sum_probs=148.5
Q ss_pred CCccccCeeEeeeecccccceEEEEEEe-ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCC
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHV-FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNS 90 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~-~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 90 (259)
.....++|-.+..|+.+.++.++.+... .++-.|++|.+.+..........-..|+-+...+. |.+++..+..|...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 4556678999999999999999987744 66779999988776655444444455666666664 888888888887777
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
..++--||+.++++.....- ..-+++..++.+..|++.++.++|+..++|.|++|+||++..+.+-..+.||+....+.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred cccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 78899999988777666532 22388899999999999999999999999999999999996654567789998876422
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQA 217 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 217 (259)
-..... .-.+..|-..|.+........+.|++|||.-+.+..++..
T Consensus 419 ~~~~~~-~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 419 FSSGVF-HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred eecccc-cccccccccchhhccccccccccccccccccccccccCcc
Confidence 111111 1122233124544444444459999999999998887655
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=8e-10 Score=92.32 Aligned_cols=192 Identities=14% Similarity=0.125 Sum_probs=129.7
Q ss_pred eEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEE-------ecCC-eE
Q psy3663 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVI-------DTNS-KL 92 (259)
Q Consensus 21 ~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-------~~~~-~~ 92 (259)
...+.||+|+-+.+|..- .-+ ..+-|+++.... ....+...|+ ...=.||-+.. .-.| .+.+ ..
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~-d~VAKIYh~Ppp--a~~aqk~a~l--a~~p~~p~~~~-rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVR-DQVAKIYHAPPP--AAQAQKVAEL--AATPDAPLLNY-RVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecc--hhh-chhheeecCCCc--hHHHHHHHHh--ccCCCCcchhh-hhcccHHHhhCCCcccee
Confidence 346789999999999664 222 344588776542 2222222221 11112443221 1111 1222 36
Q ss_pred EEEEeccCCC-ChHHHHH-----hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 93 YLILELGDGG-DLYDYIM-----KHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 93 ~lv~e~~~~~-sL~~~~~-----~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
-++|+.+.+. .+..++. +.....+.+-+....+.|+.+...||..|.+-||++++|++|.++ +.+.|+|-+.-
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LVdsDsf 164 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLVDSDSF 164 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEEcccce
Confidence 7888888764 2222211 112336778899999999999999999999999999999999776 88999998865
Q ss_pred ccCCCCCccccccCCCccCCccccc-----CCCCCCCchhHHHHHHHHHHHHhC-CCCCCCC
Q psy3663 167 NRFNPGQKLETSCGSLAYSAPEILL-----GDSYDAPAVDVWSLGVILYMLVAG-QAPFQEA 222 (259)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~apE~~~-----~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~ 222 (259)
..-.++....+.++...|.+||... +..- ++..|.|.||+++++++.| ++||.+.
T Consensus 165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eeccCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcc
Confidence 5555666677788999999999864 2222 3478999999999999886 9999763
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.7e-10 Score=86.10 Aligned_cols=139 Identities=19% Similarity=0.227 Sum_probs=91.5
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCccc-HHH------HHHHHHHHHhCCCCC---eEEEEE-
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-QDH------LYQEVRCMKLVQHPN---VVRLYE- 84 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~-~~~------~~~e~~~l~~l~~~~---i~~~~~- 84 (259)
+.++|++.+.+....-..|.+.. .+++.+++|........... ... ..+.+..+.+++..+ .+.++-
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 45689999999888766665554 78899999998764321111 111 223333344443222 222222
Q ss_pred ----EEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEE
Q psy3663 85 ----VIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 85 ----~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
.+.-...++++|||++|..|.+... +++ .+...|.+++..||+.|++|||++|.|+++.++ .+++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~i 175 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRI 175 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEE
Confidence 2333456678999999988876542 332 234567778999999999999999999998654 5999
Q ss_pred Eeccccc
Q psy3663 161 TDFGFSN 167 (259)
Q Consensus 161 ~df~~~~ 167 (259)
+|++...
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.4e-09 Score=83.85 Aligned_cols=108 Identities=21% Similarity=0.242 Sum_probs=84.0
Q ss_pred cHHHHHHHHHHHHhCCCCC--eEEEEEEEecC----CeEEEEEeccCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q psy3663 60 SQDHLYQEVRCMKLVQHPN--VVRLYEVIDTN----SKLYLILELGDG-GDLYDYIMKHDAGLSETYAREYFAQIVRAIS 132 (259)
Q Consensus 60 ~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~----~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~ 132 (259)
......+|...+..|...+ +++++.+.... ...++|++++++ .+|.+++..... .+......++.+++..+.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIA 132 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHH
Confidence 3456778888777776433 45556655432 346899999987 479998876444 667778899999999999
Q ss_pred HHHHCCcEeccCCCCCeEeeecC--CeEEEEecccccc
Q psy3663 133 FCHKLHVVHRDLKPENVVFFERL--GVVKLTDFGFSNR 168 (259)
Q Consensus 133 ~LH~~~i~H~dl~p~nIlv~~~~--~~i~l~df~~~~~ 168 (259)
.||.+|++|+|+++.|||+..+. -.+.++||+.+..
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999997773 2799999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.1e-09 Score=80.13 Aligned_cols=139 Identities=17% Similarity=0.203 Sum_probs=100.6
Q ss_pred cccccceEEEEEEeecCceEEEEEcccCCC-C---cccHHHHHHHHHHHHhCCCCC--eEEEEEEEe--c--CCeEEEEE
Q psy3663 27 GRGHFAVVKLARHVFTGEKVAVKVIDKTKL-D---PVSQDHLYQEVRCMKLVQHPN--VVRLYEVID--T--NSKLYLIL 96 (259)
Q Consensus 27 ~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~---~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~--~--~~~~~lv~ 96 (259)
+.|+.|.|+... .+|..+-+|.-..... + +.....+.+|...++.+...+ ++++...-. . ....++|+
T Consensus 27 ~rgG~SgV~r~~--~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVE--RNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEE--eCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 348888898876 4455788887652211 1 345677889999999887433 444442211 1 23467888
Q ss_pred eccCC-CChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCe--EEEEecccccc
Q psy3663 97 ELGDG-GDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV--VKLTDFGFSNR 168 (259)
Q Consensus 97 e~~~~-~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~--i~l~df~~~~~ 168 (259)
+-+.+ .+|.+++.+.. .+.+......++.+++.++..||..|+.|+|+.+.||++..+ +. +.++||.-+..
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 87753 58888886643 346778888999999999999999999999999999999654 45 99999996654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=4.3e-09 Score=92.24 Aligned_cols=152 Identities=22% Similarity=0.295 Sum_probs=102.3
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC--------------------cc----cH--------H
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD--------------------PV----SQ--------D 62 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~--------------------~~----~~--------~ 62 (259)
++...|+ ...|+.++.|.||.|... +|+.|+||+.++.-.. +. .. .
T Consensus 123 e~F~eF~-~~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 123 ELFSEFE-PEPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHcC-CCchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 3344444 478999999999999977 5999999998754210 00 00 0
Q ss_pred H------HHHHHHHHHhCC-----CCCeEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q psy3663 63 H------LYQEVRCMKLVQ-----HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131 (259)
Q Consensus 63 ~------~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al 131 (259)
. +.+|+.-+.+++ .+.|.-+.=+++-.+.-.++|||++|..+.+...-...+++...+...+.++. +
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~ 278 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--L 278 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--H
Confidence 0 233444444442 35544333344445556899999999999988654445577555554443332 3
Q ss_pred HHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 132 ~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
..+=..|++|+|.+|.||++..+ +++.+.|||+...+..
T Consensus 279 ~q~~~dgffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 279 RQLLRDGFFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHhcCccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence 44445899999999999999888 8999999998876653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1e-08 Score=80.48 Aligned_cols=141 Identities=21% Similarity=0.175 Sum_probs=95.0
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcccCCCCccc-----------------HH-----HHHHHHHHHHhCCCC--
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-----------------QD-----HLYQEVRCMKLVQHP-- 77 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~-----------------~~-----~~~~e~~~l~~l~~~-- 77 (259)
+...|+.|..+.||.|.. .++..+++|++......... .. ....|..-|.++...
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 456899999999999975 36889999998754321111 11 123466667766544
Q ss_pred CeEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCC
Q psy3663 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~ 156 (259)
.+++++.+... .++||++... -.....-...++...+...+..++++.+.-|-. .++|||||+..|||+. + +
T Consensus 131 rvP~Pi~~~~n----VLvMEfIg~~-g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~-~ 203 (268)
T COG1718 131 RVPEPIAFRNN----VLVMEFIGDD-GLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D-G 203 (268)
T ss_pred CCCCceeecCC----eEEEEeccCC-CCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C-C
Confidence 35566666432 6999999642 111000011123444677778888888888887 9999999999999997 4 6
Q ss_pred eEEEEeccccccCC
Q psy3663 157 VVKLTDFGFSNRFN 170 (259)
Q Consensus 157 ~i~l~df~~~~~~~ 170 (259)
.+.++|++-+....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 89999999876554
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.1e-10 Score=102.92 Aligned_cols=222 Identities=24% Similarity=0.318 Sum_probs=158.1
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.+.+.+.+.+..++++.++.+.-...+.-...++..... ........+..+-+++-.-.+|-++...--+......+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 346777779999999999988877677555555543321 1111222333333333333445555444444456678899
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC---
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG--- 172 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~--- 172 (259)
+++..+++|...+...+ +.+.+-....+..+.+++++||...+.|+|++|.|++...+ +...+.+|+.......-
T Consensus 883 ~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~-gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD-GHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhccc-CCcccCccccccccccccCc
Confidence 99999889988887655 36667777888889999999999999999999999998666 78888888622111100
Q ss_pred -----------------------------CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 173 -----------------------------QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 173 -----------------------------~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
.......++..|.+||...+..+.. ++|.|++|+++++.++|.+||....
T Consensus 961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs-~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS-AADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC-cchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0001123678899999999988886 8999999999999999999999999
Q ss_pred ChHHHHHhhhcccccccc
Q psy3663 224 DSETLTMIMDVSESSCTC 241 (259)
Q Consensus 224 ~~~~~~~i~~~~~~~~~~ 241 (259)
.+..++.|.....+-+..
T Consensus 1040 pq~~f~ni~~~~~~~p~g 1057 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEG 1057 (1205)
T ss_pred hhhhhhccccCCCCCCCC
Confidence 999998887665544433
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.4e-08 Score=78.38 Aligned_cols=72 Identities=17% Similarity=0.186 Sum_probs=55.3
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC--eEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN--VVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
..|++|..+.||+. .+.++++|...... ....+.+|.++++.+..-+ +++++.+..+.+...++|++++|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999974 35578899976432 4456789999999887433 56778887777778899999998
Q ss_pred CC
Q psy3663 102 GD 103 (259)
Q Consensus 102 ~s 103 (259)
.+
T Consensus 79 ~~ 80 (226)
T TIGR02172 79 KR 80 (226)
T ss_pred cc
Confidence 63
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.9e-07 Score=74.27 Aligned_cols=78 Identities=19% Similarity=0.195 Sum_probs=56.0
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCC--CeEEEEEEE---ecCCeEEEEEe
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP--NVVRLYEVI---DTNSKLYLILE 97 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~---~~~~~~~lv~e 97 (259)
++.++.|..+.+|.+... +..+++|..... .....+.+|..+++.+... .+++++... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~--~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD--DGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEET--TSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEEC--CcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 467899999999999854 358999996543 3467777888888888633 355666533 23446799999
Q ss_pred ccCCCChHH
Q psy3663 98 LGDGGDLYD 106 (259)
Q Consensus 98 ~~~~~sL~~ 106 (259)
+++|.++..
T Consensus 76 ~i~g~~~~~ 84 (239)
T PF01636_consen 76 YIPGRPLDD 84 (239)
T ss_dssp EESSEEHHH
T ss_pred Eeccccccc
Confidence 999987777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.1e-08 Score=84.18 Aligned_cols=156 Identities=22% Similarity=0.217 Sum_probs=100.0
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc---------------------cc--------
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP---------------------VS-------- 60 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~---------------------~~-------- 60 (259)
++.+.++...|+ .+.|+..+.+.|++|... +|+.|+||+-++.-... ..
T Consensus 154 G~~ie~if~~f~-~~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~ 231 (538)
T KOG1235|consen 154 GAPIEDIFSEFD-EEPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEI 231 (538)
T ss_pred CCCHHHHHHhcC-cchhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHH
Confidence 344555666666 689999999999999977 59999999987542111 00
Q ss_pred HHHH------HHHHH----HHHhCCCCC------eEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHH
Q psy3663 61 QDHL------YQEVR----CMKLVQHPN------VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYF 124 (259)
Q Consensus 61 ~~~~------~~e~~----~l~~l~~~~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~ 124 (259)
...+ .+|++ +.+.++|-+ |++++.. -...-.++|||++|..+.++-.-....++...+..-+
T Consensus 232 ~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l 309 (538)
T KOG1235|consen 232 AKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKL 309 (538)
T ss_pred HhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHH
Confidence 0111 12222 112222333 3333333 3445699999999987777654444447777555444
Q ss_pred HHHHHHHHHHHHCCcEeccCCCCCeEeee---cCCeEEEEeccccccCCC
Q psy3663 125 AQIVRAISFCHKLHVVHRDLKPENVVFFE---RLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 125 ~ql~~al~~LH~~~i~H~dl~p~nIlv~~---~~~~i~l~df~~~~~~~~ 171 (259)
.+.. ++.+=..|++|+|-+|.||++.+ ....+.+.|||+...+..
T Consensus 310 ~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 310 VEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 4433 23444678999999999999984 346899999998876543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.6e-07 Score=70.10 Aligned_cols=131 Identities=21% Similarity=0.303 Sum_probs=96.4
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeE-EEEEEEecCCeEEEEEe
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV-RLYEVIDTNSKLYLILE 97 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~e 97 (259)
.-++.+.|++|..|.||++. ..|..+++|+-..+. ....+..|+++|+.++-.++. +++.+..+ ++.||
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~--~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGE--WRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred hhhhhhhhhcccccEEEEee--ccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 34567889999999999998 557789999965543 577888999999999876654 45555333 35599
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCC-CCCeEeeecCCeEEEEecccccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK-PENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~-p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
|+.|.+|.+.... .+... +..++++..-|-..||-|+.|+ |..+++..+ +.+.|+||..|..
T Consensus 93 ~i~G~~L~~~~~~----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIG----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-RDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhc----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence 9999888876542 12233 3455666777888999999998 555554455 5899999998873
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.3e-07 Score=73.00 Aligned_cols=76 Identities=12% Similarity=0.100 Sum_probs=53.2
Q ss_pred eeccccc-ceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEEeccCCC
Q psy3663 25 TLGRGHF-AVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLILELGDGG 102 (259)
Q Consensus 25 ~i~~g~~-~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (259)
.|..|.. +.||++.. .+.++++|...... ...+.+|+.+++.+. +--+++++.+....+..+++|++++|.
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 3444544 78898874 34688889875432 335667888888875 344667788777666789999999997
Q ss_pred ChHHH
Q psy3663 103 DLYDY 107 (259)
Q Consensus 103 sL~~~ 107 (259)
++...
T Consensus 78 ~l~~~ 82 (244)
T cd05150 78 PAAAL 82 (244)
T ss_pred cHhHh
Confidence 77644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.8e-06 Score=64.44 Aligned_cols=132 Identities=23% Similarity=0.273 Sum_probs=95.3
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCC--------------CCcccHHHHHHHHHHHHhCC------CCCeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK--------------LDPVSQDHLYQEVRCMKLVQ------HPNVVRL 82 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------~~~i~~~ 82 (259)
...||+|+.-.||.- -.+...+||+..... .......+..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357899999988854 366678999987765 12223556667776666655 6889999
Q ss_pred EEEEecCCeEEEEEeccC------CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC
Q psy3663 83 YEVIDTNSKLYLILELGD------GGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~------~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~ 156 (259)
+++.+++....+++|.+. ..||.+++.+.. ++. .+ ...+-+...+|-..+|+..|++|.||++....+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999988889998875 358888885533 554 33 344455667788999999999999999976532
Q ss_pred ---eEEEEec
Q psy3663 157 ---VVKLTDF 163 (259)
Q Consensus 157 ---~i~l~df 163 (259)
.++|+|-
T Consensus 157 ~~~~lvlIDG 166 (199)
T PF10707_consen 157 GEFRLVLIDG 166 (199)
T ss_pred CceEEEEEeC
Confidence 4666664
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.9e-06 Score=78.26 Aligned_cols=80 Identities=18% Similarity=0.243 Sum_probs=57.3
Q ss_pred eeeecccccceEEEEEEeecC--ceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCe--EEEEEEEecC---CeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVFTG--EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNV--VRLYEVIDTN---SKLYL 94 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~--~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~l 94 (259)
++.++.|.+..+|++.....+ ..+++|....... ......+.+|+.+++.+. +.++ ++++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~-~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKL-LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCcc-CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 677899999999998754322 4788888644321 123457889999999996 5654 6777777654 46789
Q ss_pred EEeccCCCC
Q psy3663 95 ILELGDGGD 103 (259)
Q Consensus 95 v~e~~~~~s 103 (259)
|||+++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.2e-06 Score=67.62 Aligned_cols=73 Identities=11% Similarity=0.084 Sum_probs=46.1
Q ss_pred eeecccccc-eEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCC---CeEEEEEEEecC---CeEEEEE
Q psy3663 24 ETLGRGHFA-VVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP---NVVRLYEVIDTN---SKLYLIL 96 (259)
Q Consensus 24 ~~i~~g~~~-~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv~ 96 (259)
+.|+.|+.. .||.+ +..+++|..... .....+.+|.++++.+... .+..++...... ...+++|
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 456766655 48865 235888875432 2355788999999888632 344555443322 2457899
Q ss_pred eccCCCChH
Q psy3663 97 ELGDGGDLY 105 (259)
Q Consensus 97 e~~~~~sL~ 105 (259)
++++|.++.
T Consensus 74 ~~i~G~~l~ 82 (235)
T cd05155 74 RWLEGETAT 82 (235)
T ss_pred EeecCCCCC
Confidence 999986663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.6e-05 Score=63.41 Aligned_cols=75 Identities=21% Similarity=0.189 Sum_probs=48.3
Q ss_pred eeeecccccceEEEEEEee-cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCe-EEEEEEEecCCeEEEEEeccC
Q psy3663 23 EETLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV-VRLYEVIDTNSKLYLILELGD 100 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~-~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~ 100 (259)
.+.|..|-...+|++.... .++.|++|+...... ......+|+.+++.+...++ ++++.... . .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence 4567788888999997442 357899998754321 11234478888888864443 34443332 2 37999999
Q ss_pred CCCh
Q psy3663 101 GGDL 104 (259)
Q Consensus 101 ~~sL 104 (259)
|.++
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=98.26 E-value=5.6e-07 Score=73.55 Aligned_cols=138 Identities=14% Similarity=0.163 Sum_probs=98.2
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc--------------------ccHHHHHHHHHHHHhCCCCC
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP--------------------VSQDHLYQEVRCMKLVQHPN 78 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~~~~ 78 (259)
-+.++..||-|.-+.+|.+-+. +|.+.++|.=....++. .+.-...+|...++.+....
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4678899999999999999866 67888888644322111 11223456888888876433
Q ss_pred --eEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC
Q psy3663 79 --VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 79 --i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~ 156 (259)
|++++++ +.-++||+.+.|-+|.+...- ...-.+...+...+-.|.+.|+||||++--||++.++ +
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~ 239 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD-D 239 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec-------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecC-C
Confidence 4455544 345789999999888775422 1233455667777888999999999999999999766 6
Q ss_pred eEEEEeccccccC
Q psy3663 157 VVKLTDFGFSNRF 169 (259)
Q Consensus 157 ~i~l~df~~~~~~ 169 (259)
.++++||.-+...
T Consensus 240 ~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 240 KIVVIDFPQMVST 252 (465)
T ss_pred CEEEeechHhhcc
Confidence 8999999866433
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.6e-06 Score=68.16 Aligned_cols=145 Identities=23% Similarity=0.285 Sum_probs=97.2
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCC--------------------CcccH----HHHHHHHHHHHhCC
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--------------------DPVSQ----DHLYQEVRCMKLVQ 75 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~--------------------~~~~~----~~~~~e~~~l~~l~ 75 (259)
-++..+|+.|.-+.||.|... +|..++||+++-+-. ..... -....|++-|.+++
T Consensus 146 ~~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~ 224 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN 224 (520)
T ss_pred eecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999999855 788899999863211 00111 11334677777777
Q ss_pred CCCeEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeccCCCCCeEeeec
Q psy3663 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KLHVVHRDLKPENVVFFER 154 (259)
Q Consensus 76 ~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH-~~~i~H~dl~p~nIlv~~~ 154 (259)
...|+-+--+... .-++||+++.+ .=.....-....++...+..+-.|++.-+..|- .+++||.||+--|+|+.+
T Consensus 225 ~aGIP~PePIlLk--~hVLVM~FlGr-dgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd- 300 (520)
T KOG2270|consen 225 NAGIPCPEPILLK--NHVLVMEFLGR-DGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD- 300 (520)
T ss_pred hcCCCCCCceeee--cceEeeeeccC-CCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-
Confidence 6665533333322 23789999953 111111112234777788888888887777664 689999999999999855
Q ss_pred CCeEEEEeccccccCC
Q psy3663 155 LGVVKLTDFGFSNRFN 170 (259)
Q Consensus 155 ~~~i~l~df~~~~~~~ 170 (259)
|.+.++|.+-+....
T Consensus 301 -G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 301 -GKLYIIDVSQSVEHD 315 (520)
T ss_pred -CEEEEEEccccccCC
Confidence 589999999765443
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.3e-07 Score=82.09 Aligned_cols=95 Identities=33% Similarity=0.562 Sum_probs=71.5
Q ss_pred HHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc----------cccCCCccCCcccccCCC
Q psy3663 126 QIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE----------TSCGSLAYSAPEILLGDS 194 (259)
Q Consensus 126 ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~----------~~~~~~~~~apE~~~~~~ 194 (259)
+...++.++|. .++||++|.|++|.++.. +.++|+.|+++.......... .......|.+||.+....
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 34488999995 689999999999999776 889999999886554321111 012356899999998855
Q ss_pred CCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy3663 195 YDAPAVDVWSLGVILYMLVA-GQAPFQEA 222 (259)
Q Consensus 195 ~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 222 (259)
.. +++|+||+|+++|.+.. |+.-+..+
T Consensus 186 ~~-~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 186 NT-PASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred cc-ccccceeeeeEEEEEecCCcchhhcc
Confidence 44 59999999999999994 55555444
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.3e-05 Score=63.28 Aligned_cols=77 Identities=13% Similarity=0.078 Sum_probs=56.0
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC---CCeEEEEEEEec---CCeEEEE
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH---PNVVRLYEVIDT---NSKLYLI 95 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~~~lv 95 (259)
-.+.|+.|..+.||...+. +.++++|..+.. .....+..|+..++.+.. -.++++++++.+ .+..++|
T Consensus 18 ~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 18 RVECISEQPYAALWALYDS--QGNPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeeecCCccceeEEEEEcC--CCCEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3578999999999998633 336788884321 123577889999988864 357788887654 3668999
Q ss_pred EeccCCCCh
Q psy3663 96 LELGDGGDL 104 (259)
Q Consensus 96 ~e~~~~~sL 104 (259)
||+++|.++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998654
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.2e-05 Score=66.58 Aligned_cols=138 Identities=18% Similarity=0.181 Sum_probs=81.5
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC--eEEEEEE------EecCCeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN--VVRLYEV------IDTNSKLYL 94 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~l 94 (259)
.+.+..|....+|++. .++..+++|+... .....+..|+.+++.+...+ +++++.. ....+..++
T Consensus 19 i~~i~~G~~n~~y~v~--~~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 19 FEGISAGIENTNYFVT--TDSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred eecccCccccceEEEE--eCCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 5677788888999986 3456799998754 13455667777777775332 4444432 123456789
Q ss_pred EEeccCCCChHH----H-------HHh---cCCCCC--------HHHHH------------HHHHHHHHHHHHHHH----
Q psy3663 95 ILELGDGGDLYD----Y-------IMK---HDAGLS--------ETYAR------------EYFAQIVRAISFCHK---- 136 (259)
Q Consensus 95 v~e~~~~~sL~~----~-------~~~---~~~~~~--------~~~i~------------~~~~ql~~al~~LH~---- 136 (259)
++++++|.++.. . +.. ....+. ..... .....+..++..+.+
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999998865421 0 100 000000 00000 011112233444443
Q ss_pred ---CCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 137 ---LHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 137 ---~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.+++|||++|.||+++++ +.+.|+||+.+..
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~~ 205 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGD-ELSGVIDFYFACT 205 (296)
T ss_pred cCCCcCCccCcCcccEEEeCC-ceEEEeehhhhcC
Confidence 469999999999999765 5568999997653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.15 E-value=7.6e-05 Score=63.96 Aligned_cols=77 Identities=18% Similarity=0.188 Sum_probs=54.3
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccC-----CCCcccHHHHHHHHHHHHhCC---CCCeEEEEEEEecCCeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKT-----KLDPVSQDHLYQEVRCMKLVQ---HPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~-----~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 94 (259)
.+.||.|.+..||++.+...++.++||.-... ...+........|.+.|+.+. ..++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46899999999999997643358999985421 111234566677888888764 3457777777 4455789
Q ss_pred EEeccCC
Q psy3663 95 ILELGDG 101 (259)
Q Consensus 95 v~e~~~~ 101 (259)
+||++++
T Consensus 109 VME~L~~ 115 (401)
T PRK09550 109 VMEDLSD 115 (401)
T ss_pred EEecCCC
Confidence 9999875
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.3e-05 Score=63.49 Aligned_cols=135 Identities=19% Similarity=0.179 Sum_probs=78.2
Q ss_pred eecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCe-EEEEEEEecCCeEEEEEeccCCCC
Q psy3663 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV-VRLYEVIDTNSKLYLILELGDGGD 103 (259)
Q Consensus 25 ~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~s 103 (259)
.+..|-...+|++. .+++++++|......... .....+|..+++.+....+ ++++... . -++|++|++|.+
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~ 74 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV 74 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence 45667888899887 567789999865432111 1235678888888874433 3444443 2 268999998865
Q ss_pred hHH-----------H---HHh-cC-----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCcEeccCC
Q psy3663 104 LYD-----------Y---IMK-HD-----AGLSE-TYAREYFAQI---------VRAISFCHK--------LHVVHRDLK 145 (259)
Q Consensus 104 L~~-----------~---~~~-~~-----~~~~~-~~i~~~~~ql---------~~al~~LH~--------~~i~H~dl~ 145 (259)
+.. + +.+ +. .+++. ..+..+..++ ...+..+-. ..++|+|++
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 432 1 111 11 11121 1222222222 112222222 248999999
Q ss_pred CCCeEeeecCCeEEEEeccccccC
Q psy3663 146 PENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 146 p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
|.||+++++ + +.|+||+.+..-
T Consensus 155 ~~Nil~~~~-~-~~lIDwE~a~~g 176 (256)
T TIGR02721 155 AYNLVVTPQ-G-LKLIDWEYASDG 176 (256)
T ss_pred cCcEEEeCC-C-CEEEeccccCcC
Confidence 999999765 4 899999987543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.06 E-value=4.7e-07 Score=79.68 Aligned_cols=203 Identities=20% Similarity=0.189 Sum_probs=140.1
Q ss_pred CCCCCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC-eEEE
Q psy3663 4 SGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN-VVRL 82 (259)
Q Consensus 4 ~~~~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~ 82 (259)
|+|.++.-.-.+-..-|.....++++++..+++.....+..-+ .+.+... ..+.-++++|.+++||| .+..
T Consensus 228 TkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~ 299 (829)
T KOG0576|consen 228 TKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRY 299 (829)
T ss_pred hccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccc
Confidence 3444544444444556677778889999999988766444433 4444322 34456788999999999 5555
Q ss_pred EEEEecCCeEEEEEeccCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEE
Q psy3663 83 YEVIDTNSKLYLILELGDGG-DLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLT 161 (259)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~ 161 (259)
++-++.++...+.++++.++ +-........-.+.........+.-+++++++|+..-+|+| ||+... +..+..
T Consensus 300 ~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~--~~~~~~ 373 (829)
T KOG0576|consen 300 LEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE--EEVKLL 373 (829)
T ss_pred cccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc--cccccc
Confidence 56666677888899998764 11111110011133444556667777889999988767877 777533 578999
Q ss_pred eccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 162 DFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
+|+....+..........++..++|||+........ +.|.|++|.-..++.-|-+|-..
T Consensus 374 ~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~-~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 374 DFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDG-CPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccCCcccCcccccccCCCCCCCCCchhhccccccc-CCCccCCCcchhhcCCCCCCCCC
Confidence 999888776655555667889999999998888886 89999999877777777777654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00012 Score=60.96 Aligned_cols=139 Identities=17% Similarity=0.144 Sum_probs=79.6
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC--eEEEEEE------EecCCeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN--VVRLYEV------IDTNSKLYL 94 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~l 94 (259)
.+.++.|....+|++.. ++..+++|+..... ....+..|.++++.|...+ +++++.. ....+..++
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 45677787889998863 35578899875422 2344556677777764322 3444432 122456789
Q ss_pred EEeccCCCChH-----------HHHHh---cCCCC--C-----HHHHH----------------HHHHHHHHHHHHHH--
Q psy3663 95 ILELGDGGDLY-----------DYIMK---HDAGL--S-----ETYAR----------------EYFAQIVRAISFCH-- 135 (259)
Q Consensus 95 v~e~~~~~sL~-----------~~~~~---~~~~~--~-----~~~i~----------------~~~~ql~~al~~LH-- 135 (259)
+++|++|..+. +.+.. ....+ + ....+ .....+...+.++.
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999885431 11111 00101 0 00000 00111223444443
Q ss_pred -----HCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 136 -----KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 136 -----~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
..+++|||+++.||+++.+ +.+.|+||+.+..
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~~ 217 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGD-SVKGVIDFYFACT 217 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECC-ceEEEeecccccC
Confidence 2679999999999999766 5568999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.97 E-value=9.3e-05 Score=61.46 Aligned_cols=76 Identities=17% Similarity=0.088 Sum_probs=48.8
Q ss_pred eeeecccccceEEEEEEee------cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCe-EEEEEEEecCCeEEEE
Q psy3663 23 EETLGRGHFAVVKLARHVF------TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV-VRLYEVIDTNSKLYLI 95 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~------~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv 95 (259)
++.+..|-...+|++.... .++.+++|+..... .......+|..+++.+...++ ++++..+. + ..|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 4566778888999887442 25789999965432 123456688888888864443 34455543 2 257
Q ss_pred EeccCCCChH
Q psy3663 96 LELGDGGDLY 105 (259)
Q Consensus 96 ~e~~~~~sL~ 105 (259)
++|++|.++.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 8888876553
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00041 Score=58.08 Aligned_cols=73 Identities=12% Similarity=0.042 Sum_probs=43.1
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC--eEEEEEE------EecCCeEEEE
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN--VVRLYEV------IDTNSKLYLI 95 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv 95 (259)
+.++.|....+|.+.. ++..+++|++. . . ....+..+..+++.|...+ +++++.. ....+..+++
T Consensus 28 ~~l~~G~~n~~y~v~t--~~g~~vLK~~~-~-~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l 100 (319)
T PRK05231 28 KGIAEGIENSNFFLTT--TQGEYVLTLFE-R-L---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAI 100 (319)
T ss_pred chhccccccceEEEEe--CCCcEEEEEec-c-C---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEE
Confidence 5566777788998873 34479999875 1 1 1233444555555553212 3343321 1234567899
Q ss_pred EeccCCCC
Q psy3663 96 LELGDGGD 103 (259)
Q Consensus 96 ~e~~~~~s 103 (259)
++|++|..
T Consensus 101 ~~~l~G~~ 108 (319)
T PRK05231 101 VTFLEGKW 108 (319)
T ss_pred EEecCCCC
Confidence 99998854
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.7e-05 Score=57.73 Aligned_cols=94 Identities=17% Similarity=0.194 Sum_probs=75.4
Q ss_pred HHHHHHHhCCC-CCeEEEEEEEecCCeEEEEEeccCCCChH-------HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-
Q psy3663 66 QEVRCMKLVQH-PNVVRLYEVIDTNSKLYLILELGDGGDLY-------DYIMKHDAGLSETYAREYFAQIVRAISFCHK- 136 (259)
Q Consensus 66 ~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~-------~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~- 136 (259)
.|.-+++.+.+ ++++++++.+.. +++.|+...+++. ++. ..++..+..++.++++.++.|+.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~-----~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFL-----QSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCcccccccccccccc-----ccCHHHHHHHHHHHHHHHHHHhcC
Confidence 57788888875 699999999843 5688888755443 332 26889999999999999999997
Q ss_pred --CCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 137 --LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 137 --~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
..+..+|++++|+-+.++ ++++++|.+.....
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~-~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDD-GRLKLIDLDDVFVE 112 (188)
T ss_pred CCCcEEEeecchHHeEEeCC-CcEEEEechhcchh
Confidence 457889999999999766 78999999976543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00025 Score=58.75 Aligned_cols=142 Identities=15% Similarity=0.171 Sum_probs=87.2
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCC--CeEEEEEEEecCC--eEEEE
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP--NVVRLYEVIDTNS--KLYLI 95 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~--~~~lv 95 (259)
-.+++.+..|....+|...+. +++++++ .......-.......+|+.+++.+..- .+...++.+.+.. ..+.+
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 345566666777777777744 8889999 432222333567777888888887642 3444555555544 67999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHH-HHHHHHHHHHHH--------------------------------------
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYF-AQIVRAISFCHK-------------------------------------- 136 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~-~ql~~al~~LH~-------------------------------------- 136 (259)
|+|+.|..+...... .+.. .+++ ..+...|..||+
T Consensus 104 ~~~veGe~~~~~~~~----~~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 104 MEWVEGEVVWSALPP----ESLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEEecceeccCcCCc----ccch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 999988322111100 0000 1111 133444444443
Q ss_pred --------------------CCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 137 --------------------LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 137 --------------------~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
-.++|||+++.||++.++ +-+=++||+.+..-..
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~-~~~gVlDwe~~~lGDP 231 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPG-RPTGVLDWELATLGDP 231 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCC-CeeEEEeccccccCCc
Confidence 247999999999999777 4588999998876543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00027 Score=59.45 Aligned_cols=140 Identities=17% Similarity=0.172 Sum_probs=81.0
Q ss_pred eeeecccccceEEEEEEeec---CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeE-EEEEEEecCCeEEEEEec
Q psy3663 23 EETLGRGHFAVVKLARHVFT---GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV-RLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~e~ 98 (259)
++.|..|-...+|++..... +..|++|+...... ..-...+|..+++.+...++. +++.++ .++ ++.+|
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~f 91 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSF 91 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEe-CCc---Eeehh
Confidence 45566688888998864422 33899998765321 223345788888888765553 455554 333 48888
Q ss_pred cCCCChHH----------HHHh-----cCCC------C-CHHHHHHHHHHH----------------------HHHHHHH
Q psy3663 99 GDGGDLYD----------YIMK-----HDAG------L-SETYAREYFAQI----------------------VRAISFC 134 (259)
Q Consensus 99 ~~~~sL~~----------~~~~-----~~~~------~-~~~~i~~~~~ql----------------------~~al~~L 134 (259)
+++.++.. .+.. +..+ . ....+..++.++ ...+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 88765422 1111 0111 1 112233333222 1112222
Q ss_pred HH----CC----cEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 135 HK----LH----VVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 135 H~----~~----i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
.. .+ ++|+|+.+.||++.++.+.++++||..+..-
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 21 12 7999999999999766568999999988543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00041 Score=58.75 Aligned_cols=139 Identities=17% Similarity=0.157 Sum_probs=81.9
Q ss_pred eeeecccccceEEEEEEee----cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeE-EEEEEEecCCeEEEEEe
Q psy3663 23 EETLGRGHFAVVKLARHVF----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV-RLYEVIDTNSKLYLILE 97 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~----~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~e 97 (259)
...+..|-...+|++.... .++.+++|+..... . ..-...+|..+++.+...++. ++++.+.. + .+.+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~e 113 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEE 113 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--C-eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEE
Confidence 4566668899999986432 24689999876543 1 222236788888888755543 45555533 2 4788
Q ss_pred ccCCCChHHH----------HHh-----cCC-------CCCHHHHHHHHHHHH-----------------HHHHHHH---
Q psy3663 98 LGDGGDLYDY----------IMK-----HDA-------GLSETYAREYFAQIV-----------------RAISFCH--- 135 (259)
Q Consensus 98 ~~~~~sL~~~----------~~~-----~~~-------~~~~~~i~~~~~ql~-----------------~al~~LH--- 135 (259)
|+.+.++... +.. +.. +....++..++.++. ..+..|.
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 8877665321 100 000 011223333332221 1121221
Q ss_pred -----HCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 136 -----KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 136 -----~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
...++|+|+++.||+++++++.+.++||.++..
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 225899999999999976556899999998754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00078 Score=56.77 Aligned_cols=74 Identities=16% Similarity=0.114 Sum_probs=50.3
Q ss_pred eecccccceEEEEEEeecCceEEEEEccc-----CCCCcccHHHHHHHHHHHHhCC--CC-CeEEEEEEEecCCeEEEEE
Q psy3663 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDK-----TKLDPVSQDHLYQEVRCMKLVQ--HP-NVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 25 ~i~~g~~~~vy~~~~~~~~~~~~lK~~~~-----~~~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv~ 96 (259)
.||.|....||++.+...++.++||.-.. ....+.......-|...|+... .| .+++++.+ +.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47899999999999764336899997542 1123445566667778777765 34 45666665 455667899
Q ss_pred eccC
Q psy3663 97 ELGD 100 (259)
Q Consensus 97 e~~~ 100 (259)
|+++
T Consensus 80 EdL~ 83 (370)
T TIGR01767 80 EDLS 83 (370)
T ss_pred hhCc
Confidence 9885
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.002 Score=49.83 Aligned_cols=128 Identities=23% Similarity=0.259 Sum_probs=86.7
Q ss_pred ccCeeEeeeeccccc-ceEEEEEEeecCceEEEEEccc---CCC-------Cc---------ccHHHHHHHHHHHHhCC-
Q psy3663 17 AGLYDLEETLGRGHF-AVVKLARHVFTGEKVAVKVIDK---TKL-------DP---------VSQDHLYQEVRCMKLVQ- 75 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~-~~vy~~~~~~~~~~~~lK~~~~---~~~-------~~---------~~~~~~~~e~~~l~~l~- 75 (259)
...++..+.||.|.- |.||++. -.|..|+||++.. ... .. ....-+..|.+..-+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 9999998 6788999999321 111 00 11223455666555554
Q ss_pred --CCCe--EEEEEEEecC------------------CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q psy3663 76 --HPNV--VRLYEVIDTN------------------SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133 (259)
Q Consensus 76 --~~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~ 133 (259)
+.++ ++++++..-. ....+|.||+.... .+.... +.+|.+-+..
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~ 179 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKI 179 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHHH
Confidence 4455 8888886211 12467888876532 133333 4556666888
Q ss_pred HHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 134 LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
+|+.||+-.|+++.|.. + -+|+||+.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc---C---CEEEecccC
Confidence 99999999999999975 2 489999854
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0016 Score=55.83 Aligned_cols=76 Identities=12% Similarity=0.148 Sum_probs=52.0
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcccCC-----CCcccHHHHHHHHHHHHhCC---CCCeEEEEEEEecCCeEE
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-----LDPVSQDHLYQEVRCMKLVQ---HPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-----~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~ 93 (259)
..+.||.|....||++.+ .+..++||.-.... ..+........|.+.|+.+. ...+++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 377889999999999986 34579999865211 11223444445667676664 357888888876 4457
Q ss_pred EEEeccCC
Q psy3663 94 LILELGDG 101 (259)
Q Consensus 94 lv~e~~~~ 101 (259)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999965
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00064 Score=57.98 Aligned_cols=76 Identities=17% Similarity=0.150 Sum_probs=53.5
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEccc----CCCCcccHHHHHHHHHHHHhCC--CC-CeEEEEEEEecCCeEEEE
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDK----TKLDPVSQDHLYQEVRCMKLVQ--HP-NVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~----~~~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv 95 (259)
.+.||.|+...||++.+...++.++||.-.. ....+.......-|.+.|+... .| ++++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6788999999999999753356799986532 2223556677777888888765 34 56667766 45556788
Q ss_pred EeccC
Q psy3663 96 LELGD 100 (259)
Q Consensus 96 ~e~~~ 100 (259)
||+++
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 88875
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0014 Score=53.64 Aligned_cols=32 Identities=28% Similarity=0.332 Sum_probs=24.9
Q ss_pred CcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 138 ~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
.++|||+++.||+++++....-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 37999999999999764233569999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0038 Score=52.04 Aligned_cols=30 Identities=17% Similarity=0.151 Sum_probs=25.9
Q ss_pred CcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 138 ~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
+++|||+.++||+++++ +.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~-~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDET-RGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCC-CCEEEEEhhhccc
Confidence 69999999999999666 6789999997753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0098 Score=49.50 Aligned_cols=29 Identities=21% Similarity=0.394 Sum_probs=24.5
Q ss_pred CCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 137 ~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.+++|||+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 57899999999999865 468999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.00088 Score=52.57 Aligned_cols=30 Identities=37% Similarity=0.657 Sum_probs=19.7
Q ss_pred CcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 138 ~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
-++|+|+.+.||++....+.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 479999999999994444789999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.013 Score=55.91 Aligned_cols=151 Identities=19% Similarity=0.244 Sum_probs=105.0
Q ss_pred HHHHHHHhCCCCCeEEEEEEEecCC----eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Q psy3663 66 QEVRCMKLVQHPNVVRLYEVIDTNS----KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141 (259)
Q Consensus 66 ~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H 141 (259)
.|..-+.+..|+|+..++.+..... ...+..+++...++...++..+. .+....+.+..++.+++.++|+....|
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~-i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS-IPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc-cCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 4666777788999999988864332 12244567777788887776554 888999999999999999999997666
Q ss_pred ccCCCC---CeEeeecCCeEEEE--eccccccCCCCCccccccCCCccCCcccccCCCCCC-CchhHHHHHHHHHHHHhC
Q psy3663 142 RDLKPE---NVVFFERLGVVKLT--DFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDA-PAVDVWSLGVILYMLVAG 215 (259)
Q Consensus 142 ~dl~p~---nIlv~~~~~~i~l~--df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~-~~~Di~slG~~l~~l~~g 215 (259)
..+..+ +..++.+ +.+... ||+....+..............+.++|......... .+.|+|.+|.....+..+
T Consensus 310 v~L~~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred eEEecccccccccCcc-ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhc
Confidence 666555 3222233 445555 888877766555555545556677777765443332 146999999999998886
Q ss_pred CCC
Q psy3663 216 QAP 218 (259)
Q Consensus 216 ~~p 218 (259)
..+
T Consensus 389 ~~i 391 (1351)
T KOG1035|consen 389 EDI 391 (1351)
T ss_pred Ccc
Confidence 654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0063 Score=51.05 Aligned_cols=137 Identities=15% Similarity=0.134 Sum_probs=78.6
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCe--EEE-E---EE--EecCC--eEE
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV--VRL-Y---EV--IDTNS--KLY 93 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~-~---~~--~~~~~--~~~ 93 (259)
..|.+ .-..+|.+. .++.++++|+.... .....+..|...++.+....| +.+ . +- ..-+. ..+
T Consensus 32 ~~l~s-~eN~~f~~~--~~~g~~iLki~~~~----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 32 RGLNS-EENSNFRVQ--TEDGRYILKIYRPG----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred ccccc-ccCceEEEE--ecCCCeEEEEecCC----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 34444 556788887 34455699998664 246677788888888853222 222 1 11 11234 788
Q ss_pred EEEeccCCCChHH-----HHHh------------cCCC------C---CHH----H---------HHHHHHHHHHHHHHH
Q psy3663 94 LILELGDGGDLYD-----YIMK------------HDAG------L---SET----Y---------AREYFAQIVRAISFC 134 (259)
Q Consensus 94 lv~e~~~~~sL~~-----~~~~------------~~~~------~---~~~----~---------i~~~~~ql~~al~~L 134 (259)
.+++|++|..+.. .++. .+.+ + ... . -.....++...+..+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 8999999876662 0100 0000 0 000 0 011222333444444
Q ss_pred HH--------CC--cEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 135 HK--------LH--VVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 135 H~--------~~--i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.. .+ +||+|+.|+||+++.++.-+-++||+-+.
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 42 33 99999999999997773347799999764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0062 Score=50.14 Aligned_cols=74 Identities=19% Similarity=0.198 Sum_probs=48.5
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC---CCCeEEEEEEEecCCeEEEEEec
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ---HPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
-.+.++.|..+.+|... .+++.+++|+-... ....+..|+.-|+.|. .-.+++++.+...++..++++||
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 35678889999999988 67889999996522 3456677888777774 45578899988777777999999
Q ss_pred cCCC
Q psy3663 99 GDGG 102 (259)
Q Consensus 99 ~~~~ 102 (259)
++..
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 9753
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.016 Score=49.75 Aligned_cols=77 Identities=16% Similarity=0.084 Sum_probs=46.0
Q ss_pred EeeeecccccceEEEEEEeecC-ce-----EEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeE-EEEEEEecCCeEEE
Q psy3663 22 LEETLGRGHFAVVKLARHVFTG-EK-----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV-RLYEVIDTNSKLYL 94 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~-~~-----~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~l 94 (259)
..+.|..|-...+|++...... .. |.++..... ....-...+|.++++.+...++. ++++.+. + .+
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~-~---g~ 126 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG-D---FT 126 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEeccHHHHHHHHHHHhCCCCCeEEEecC-C---EE
Confidence 3456666888999998744321 22 444443211 11223345788999998766554 4555543 2 48
Q ss_pred EEeccCCCChH
Q psy3663 95 ILELGDGGDLY 105 (259)
Q Consensus 95 v~e~~~~~sL~ 105 (259)
+.+|++|.+|.
T Consensus 127 l~efIeGr~l~ 137 (383)
T PTZ00384 127 IQEWVEGNTMG 137 (383)
T ss_pred EEEEeccccCC
Confidence 89999886553
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.06 Score=45.27 Aligned_cols=71 Identities=13% Similarity=0.097 Sum_probs=43.3
Q ss_pred cccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC--eEEEEE-----EEecCCeEEEEEeccCC
Q psy3663 29 GHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN--VVRLYE-----VIDTNSKLYLILELGDG 101 (259)
Q Consensus 29 g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~-----~~~~~~~~~lv~e~~~~ 101 (259)
+....||.+... ++..+++|+..... .....+..|...+..+.... ++.+.. +...++.++.+++++.|
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~~---~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPER---WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCccc---CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 344568888633 56689999975332 34667778888887775322 222221 12224567889999987
Q ss_pred CC
Q psy3663 102 GD 103 (259)
Q Consensus 102 ~s 103 (259)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 53
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.042 Score=48.14 Aligned_cols=76 Identities=13% Similarity=0.014 Sum_probs=47.8
Q ss_pred EeeeecccccceEEEEEEeec--------CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeE-EEEEEEecCCeE
Q psy3663 22 LEETLGRGHFAVVKLARHVFT--------GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV-RLYEVIDTNSKL 92 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~--------~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~ 92 (259)
-++.|..|-...+|++..... ++.|++|+...... ..-...+|..+++.+...++. ++++.+. +
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te---~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g--- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD---ELYNPISEFEVYKTMSKYRIAPQLLNTFS-G--- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc---ceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---
Confidence 356677788888998874421 56899999755431 122445678888877755554 4455543 2
Q ss_pred EEEEeccCCCCh
Q psy3663 93 YLILELGDGGDL 104 (259)
Q Consensus 93 ~lv~e~~~~~sL 104 (259)
..+.+|++|.+|
T Consensus 182 g~I~efi~g~~l 193 (442)
T PTZ00296 182 GRIEEWLYGDPL 193 (442)
T ss_pred CEEEEeeCCccC
Confidence 357888887543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.053 Score=52.61 Aligned_cols=32 Identities=25% Similarity=0.322 Sum_probs=25.3
Q ss_pred CCcEeccCCCCCeEeeecC-CeEE-EEecccccc
Q psy3663 137 LHVVHRDLKPENVVFFERL-GVVK-LTDFGFSNR 168 (259)
Q Consensus 137 ~~i~H~dl~p~nIlv~~~~-~~i~-l~df~~~~~ 168 (259)
.++||+|++++||+++.+. +++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999997663 1555 999996643
|
|
| >KOG1236|consensus | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.044 Score=47.01 Aligned_cols=60 Identities=20% Similarity=0.180 Sum_probs=42.9
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeccCCCCCeEeeec
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KLHVVHRDLKPENVVFFER 154 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH-~~~i~H~dl~p~nIlv~~~ 154 (259)
.++-+|..|.++..++.... .++.-...+..-..+|+..+- --+++|.|++|.||++...
T Consensus 321 vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred eeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 45667888889988887655 345556666666666655444 4579999999999999544
|
|
| >KOG1093|consensus | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.044 Score=48.32 Aligned_cols=121 Identities=23% Similarity=0.357 Sum_probs=77.4
Q ss_pred HHHHHHHHHHHHhCCCCCeEEEEEEEecC-CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q psy3663 61 QDHLYQEVRCMKLVQHPNVVRLYEVIDTN-SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139 (259)
Q Consensus 61 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i 139 (259)
..++.-..++++.+.|++...++++.... ....+|+|++ +.+|.+.+.... .-.....
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s~~------------------ 84 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDESLL------------------ 84 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhhhc------------------
Confidence 44556668999999999999999997643 4578899999 458888876533 1111111
Q ss_pred EeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy3663 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPF 219 (259)
Q Consensus 140 ~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 219 (259)
.|+-+ +-| ++..+| .++... .. ...+++||||+|.++.++.-|.-.|
T Consensus 85 ~~~~~-~~~--------~~~~td-~~~t~~------~~-----------------~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 85 AHGVL-HLN--------IIYITD-HFLTKY------PS-----------------PIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred ccccc-eeh--------hhhccc-cccccC------CC-----------------CCCcchhhhhHHHHHHHHHHhhHHH
Confidence 22211 112 223333 111100 00 0013999999999999999999999
Q ss_pred CCCCChHHHHHhhhcc
Q psy3663 220 QEANDSETLTMIMDVS 235 (259)
Q Consensus 220 ~~~~~~~~~~~i~~~~ 235 (259)
......+.++.|.+.-
T Consensus 132 ~~~~~s~~l~~i~k~~ 147 (725)
T KOG1093|consen 132 AELTESEYLEILLKYY 147 (725)
T ss_pred HHHHHHHHHHHHHHhc
Confidence 8888888877777543
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.02 E-value=0.039 Score=45.05 Aligned_cols=48 Identities=25% Similarity=0.414 Sum_probs=35.0
Q ss_pred HHHHHHHHHHHHHHHHHC--CcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 120 AREYFAQIVRAISFCHKL--HVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 120 i~~~~~ql~~al~~LH~~--~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
+...+..+-.++.-.+.. -++|+|+.|+|++.++. +.++|+||..+..
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~-~~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDK-GGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCC-CcEEEEecccCCC
Confidence 333444555555555544 48999999999998775 6899999998754
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.22 Score=39.56 Aligned_cols=75 Identities=20% Similarity=0.199 Sum_probs=51.0
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC---CCeEEEEEEEecCCeEEEEEeccC
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH---PNVVRLYEVIDTNSKLYLILELGD 100 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~~~~~lv~e~~~ 100 (259)
+.+..|.....|.+. ....++++|+=... ....+..|+.-|+.+.. -.+.+++.+..++++.|+|++|++
T Consensus 22 ~~v~gG~inea~~v~--dg~~~~FvK~n~~~-----~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~ 94 (286)
T COG3001 22 EEVSGGDINEAWRLR--DGTDPFFVKCNQRE-----QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLP 94 (286)
T ss_pred cccCCccccceeEee--cCCcceEEEecchh-----hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeecc
Confidence 445556666666665 33458899983322 24556677776666653 457788888889999999999998
Q ss_pred CCChH
Q psy3663 101 GGDLY 105 (259)
Q Consensus 101 ~~sL~ 105 (259)
.+++.
T Consensus 95 ~~~~d 99 (286)
T COG3001 95 TGPLD 99 (286)
T ss_pred CCCCC
Confidence 65544
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.2 Score=42.47 Aligned_cols=74 Identities=22% Similarity=0.239 Sum_probs=54.7
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL-HVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~-~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
++.+.|++|++- |++|...-. ....++..++.+-+..+.-+.++ ..-|+++...||+++ + |.|.|+||.++
T Consensus 297 e~~y~yl~~kdh-gt~is~ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISIIKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-GNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeeeeec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c-CceEEEEeeee
Confidence 345567777776 445543322 35677888888888877777754 688999999999996 4 78999999998
Q ss_pred ccC
Q psy3663 167 NRF 169 (259)
Q Consensus 167 ~~~ 169 (259)
+.-
T Consensus 369 Rl~ 371 (488)
T COG5072 369 RLS 371 (488)
T ss_pred ecc
Confidence 743
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 259 | ||||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-63 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-63 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-61 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-60 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-60 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-60 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-60 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-60 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-59 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-57 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-47 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-47 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-47 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-47 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-47 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-46 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-46 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-44 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-43 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-39 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-39 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-37 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-36 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-36 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-36 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-36 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-36 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-36 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-36 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-36 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-36 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-36 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-36 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-36 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-36 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-36 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-36 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-36 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-36 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-35 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-35 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-35 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-35 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-35 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-35 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-35 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-35 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-35 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-35 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-35 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-35 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-35 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-35 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-35 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-35 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-35 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-35 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-35 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-34 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-34 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-34 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-34 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-34 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-34 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-34 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-34 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-34 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-34 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-34 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-33 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-33 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-33 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-33 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-33 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-33 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-33 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-33 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-33 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-33 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-33 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-33 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-33 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-33 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-33 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-33 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-33 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-33 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-33 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-33 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-33 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-33 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-33 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-33 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-33 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-33 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-33 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-33 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-33 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-33 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-33 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-33 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-33 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-33 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-33 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-33 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-33 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-33 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-33 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-33 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-33 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-33 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-33 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-33 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-33 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-33 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-33 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-33 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-33 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-33 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-33 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-33 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-33 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-33 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-33 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-33 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-33 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-32 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-32 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-32 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-32 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-32 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-32 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-32 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-32 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-32 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-32 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-32 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-32 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-32 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-32 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-32 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-32 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-32 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-32 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-32 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-32 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-32 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-32 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-32 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-32 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-32 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-32 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-32 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-32 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-31 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-31 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-31 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-31 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-31 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-31 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-31 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-31 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-31 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-31 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-31 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-31 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-31 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-31 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-31 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-31 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-31 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-31 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-31 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-31 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-31 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-31 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-31 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-31 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-31 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-31 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-31 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-31 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-30 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-30 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-30 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-30 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-30 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-30 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-30 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-30 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-30 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-30 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-30 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-30 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-30 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-30 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-30 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-30 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-30 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-30 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-30 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-30 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-30 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-30 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-30 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-30 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-29 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-29 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-29 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-29 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-29 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-29 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-29 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-29 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-29 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-29 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-29 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-29 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-29 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-29 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-29 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-29 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-29 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-29 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-29 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-29 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-28 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-28 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-28 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-28 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-28 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-28 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-28 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-28 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-28 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-28 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-28 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-28 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-28 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-28 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-28 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-28 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-28 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-28 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-28 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-28 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-28 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-28 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-28 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-28 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-28 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-28 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-28 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-28 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-28 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-28 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-27 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-27 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-27 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-27 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-27 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-27 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-27 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-27 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-27 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-27 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-27 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-27 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-27 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-27 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-27 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-27 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-27 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-27 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-27 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-27 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-27 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-27 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-27 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-27 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-27 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-27 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-27 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-27 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-27 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-27 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-27 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-27 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-27 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-27 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-27 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-27 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-27 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-26 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-26 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-26 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-26 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-26 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-26 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-26 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-26 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-26 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-26 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-26 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-26 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-25 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-25 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-24 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-24 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-24 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-24 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-24 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-24 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-24 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-23 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-23 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-23 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-23 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-23 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-23 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-23 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-23 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-23 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-23 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-23 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-23 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-23 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-23 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-23 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-23 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-22 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-22 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-22 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-22 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-22 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-22 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-22 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-22 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-22 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-22 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-22 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-22 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-22 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-22 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-22 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-22 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-22 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-22 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-22 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-22 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-22 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-22 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-21 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-21 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-21 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-21 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-21 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-21 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-21 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-21 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-21 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-20 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-20 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-20 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-20 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-20 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-20 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-20 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-20 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-20 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-20 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-20 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-20 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-20 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-20 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-20 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-20 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-20 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-20 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-20 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-20 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-20 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-20 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-20 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-20 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-19 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-19 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-19 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-19 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-19 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-19 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-19 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-19 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-19 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-19 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-19 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-19 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-19 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-19 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-19 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-19 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-19 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-19 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-19 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-19 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-19 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-19 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-19 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-19 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-19 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-19 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-19 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-19 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-19 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-19 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-19 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-19 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-19 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-19 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-19 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-19 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-19 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-19 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-19 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-19 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-19 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-19 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-18 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-18 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-18 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-18 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-18 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-18 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-17 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-17 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-17 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-17 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-17 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-17 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-17 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-17 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-17 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-17 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-17 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-17 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-16 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-16 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-16 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-16 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-16 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-15 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-15 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-15 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-15 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 9e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-14 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-14 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-14 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-14 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-14 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-14 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-14 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-14 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-14 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-14 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-14 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-14 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-14 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-14 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-14 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-14 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-14 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-14 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-14 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-14 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-13 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-13 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-13 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 9e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-12 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-12 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 9e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-11 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 7e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 8e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-08 |
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 351 bits (903), Expect = e-122
Identities = 110/229 (48%), Positives = 151/229 (65%), Gaps = 2/229 (0%)
Query: 5 GSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL 64
S +S G Y L +T+G+G+FA VKLARH+ TG +VA+K+IDKT+L+P S L
Sbjct: 2 NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL 61
Query: 65 YQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYF 124
++EVR MK++ HPN+V+L+EVI+T LYLI+E GG+++DY++ H + E AR F
Sbjct: 62 FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKF 120
Query: 125 AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAY 184
QIV A+ +CH+ +VHRDLK EN++ +K+ DFGFSN F G KL+ CG+ Y
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAPPY 179
Query: 185 SAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
+APE+ G YD P VDVWSLGVILY LV+G PF N E ++
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-109
Identities = 71/228 (31%), Positives = 115/228 (50%), Gaps = 12/228 (5%)
Query: 1 MSRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---- 56
+ G + +G + + Y LG G F V A ++V VK I K K+
Sbjct: 10 VELEGLAACEG---EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 57 --DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL-GDGGDLYDYIMKHDA 113
+ + E+ + V+H N++++ ++ + L++E G G DL+ +I +H
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP- 125
Query: 114 GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173
L E A F Q+V A+ + ++HRD+K EN+V E +KL DFG + G+
Sbjct: 126 RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGK 184
Query: 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221
T CG++ Y APE+L+G+ Y P +++WSLGV LY LV + PF E
Sbjct: 185 LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 310 bits (797), Expect = e-106
Identities = 88/222 (39%), Positives = 135/222 (60%), Gaps = 5/222 (2%)
Query: 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-QDHLYQEVRCM 71
I G Y + ETLG G F VKLA H T +KVA+K I + L + +E+ +
Sbjct: 5 KRHI-GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63
Query: 72 KLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
KL++HP++++LY+VI T + + +++E GG+L+DYI++ ++E R +F QI+ AI
Sbjct: 64 KLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAI 121
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL 191
+CH+ +VHRDLKPEN++ + VK+ DFG SN G L+TSCGS Y+APE++
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
G Y P VDVWS G++LY+++ G+ PF + +
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS 222
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 305 bits (784), Expect = e-104
Identities = 77/229 (33%), Positives = 123/229 (53%), Gaps = 7/229 (3%)
Query: 1 MSRSGSRSSDGHPTKIA--GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP 58
M R+ + + YD + +G G+F V +L R T E VAVK I++
Sbjct: 1 MDRAPVTTGPLDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI- 59
Query: 59 VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSET 118
+++ +E+ + ++HPN+VR EVI T + L +I+E GG+LY+ I SE
Sbjct: 60 --DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSED 116
Query: 119 YAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE-RLGVVKLTDFGFSNRFNPGQKLET 177
AR +F Q++ +S+CH + + HRDLK EN + +K+ DFG+S + ++
Sbjct: 117 EARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176
Query: 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226
+ G+ AY APE+LL YD DVWS GV LY+++ G PF++ +
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-104
Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 12/265 (4%)
Query: 5 GSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL 64
G S PT+ G ++++E LG G F V H TGE+VA+K + +L P +++
Sbjct: 1 GGGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKNRERW 59
Query: 65 YQEVRCMKLVQHPNVVRLYEVIDTNSKL------YLILELGDGGDLYDYIMKHD--AGLS 116
E++ MK + HPNVV EV D KL L +E +GGDL Y+ + + GL
Sbjct: 60 CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 117 ETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVF--FERLGVVKLTDFGFSNRFNPGQK 174
E R + I A+ + H+ ++HRDLKPEN+V + + K+ D G++ + G+
Sbjct: 120 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
G+L Y APE+L Y VD WS G + + + G PF +
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238
Query: 235 SESSCTCWWRGRPRSRRRTTRKPSP 259
+ + + + ++ P+P
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTP 263
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = e-104
Identities = 94/217 (43%), Positives = 136/217 (62%), Gaps = 4/217 (1%)
Query: 8 SSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-QDHLYQ 66
S KI G Y L +TLG G F VK+ H TG KVAVK++++ K+ + + +
Sbjct: 2 SKHDGRVKI-GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 67 EVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQ 126
E++ +KL +HP++++LY+VI T + ++++E GG+L+DYI KH + E AR F Q
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQ 119
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSA 186
I+ A+ +CH+ VVHRDLKPENV+ K+ DFG SN + G+ L TSCGS Y+A
Sbjct: 120 ILSAVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAA 178
Query: 187 PEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223
PE++ G Y P VD+WS GVILY L+ G PF + +
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 303 bits (777), Expect = e-104
Identities = 73/232 (31%), Positives = 101/232 (43%), Gaps = 11/232 (4%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ 61
Y L LG+G F V + +VA+KVI + ++ S
Sbjct: 15 GTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP 74
Query: 62 D----HLYQEVRCMKLV----QHPNVVRLYEVIDTNSKLYLILELG-DGGDLYDYIMKHD 112
EV + V HP V+RL + +T L+LE DL+DYI +
Sbjct: 75 LSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG 134
Query: 113 AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172
L E +R +F Q+V AI CH VVHRD+K EN++ R G KL DFG
Sbjct: 135 P-LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA-LLHD 192
Query: 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224
+ G+ YS PE + Y A VWSLG++LY +V G PF+ +
Sbjct: 193 EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-104
Identities = 93/229 (40%), Positives = 138/229 (60%), Gaps = 4/229 (1%)
Query: 5 GSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-QDH 63
+ KI G Y L +TLG G F VK+ +H TG KVAVK++++ K+ +
Sbjct: 4 AEKQKHDGRVKI-GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62
Query: 64 LYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREY 123
+ +E++ +KL +HP++++LY+VI T S +++++E GG+L+DYI K+ L E +R
Sbjct: 63 IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRL 121
Query: 124 FAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA 183
F QI+ + +CH+ VVHRDLKPENV+ K+ DFG SN + G+ L TSCGS
Sbjct: 122 FQQILSGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPN 180
Query: 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
Y+APE++ G Y P VD+WS GVILY L+ G PF + + I
Sbjct: 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC 229
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 295 bits (756), Expect = e-100
Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 9/229 (3%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ 61
+ + + Y + LG G F V V VA+K ++K ++ +
Sbjct: 27 LHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE 86
Query: 62 D----HLYQEVRCMKLVQH--PNVVRLYEVIDTNSKLYLILELGDG-GDLYDYIMKHDAG 114
+ EV +K V V+RL + + LILE + DL+D+I + A
Sbjct: 87 LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA- 145
Query: 115 LSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174
L E AR +F Q++ A+ CH V+HRD+K EN++ G +KL DFG
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTV 204
Query: 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223
G+ YS PE + Y + VWSLG++LY +V G PF+
Sbjct: 205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = e-100
Identities = 74/218 (33%), Positives = 121/218 (55%), Gaps = 6/218 (2%)
Query: 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKL 73
+DL +TLG G + V+LA + T E VAVK++D + +++ +E+ K+
Sbjct: 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKM 61
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ H NVV+ Y + YL LE GG+L+D I G+ E A+ +F Q++ + +
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEIL 190
H + + HRD+KPEN++ ER +K++DFG + F + L CG+L Y APE+L
Sbjct: 121 LHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
+ A VDVWS G++L ++AG+ P+ + +DS
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 2e-99
Identities = 74/218 (33%), Positives = 121/218 (55%), Gaps = 6/218 (2%)
Query: 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKL 73
+DL +TLG G + V+LA + T E VAVK++D + +++ +E+ K+
Sbjct: 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKM 61
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ H NVV+ Y + YL LE GG+L+D I G+ E A+ +F Q++ + +
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVY 120
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEIL 190
H + + HRD+KPEN++ ER +K++DFG + F + L CG+L Y APE+L
Sbjct: 121 LHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
+ A VDVWS G++L ++AG+ P+ + +DS
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 5e-94
Identities = 60/236 (25%), Positives = 99/236 (41%), Gaps = 15/236 (6%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G + L+ L + LG+G A V RH TG+ A+KV + D +E
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEV 60
Query: 71 MKLVQHPNVVRLYEVID--TNSKLYLILELGDGGDLYDYIMKH--DAGLSETYAREYFAQ 126
+K + H N+V+L+ + + T LI+E G LY + + GL E+
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERL---GVVKLTDFGFSNRFNPGQKLETSCGSLA 183
+V ++ + +VHR++KP N++ V KLTDFG + ++ + G+
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 184 YSAPEILLGDSYDA-------PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
Y P++ VD+WS+GV Y G PF+ +M
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 2e-93
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 15/227 (6%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ L + LG+G A V RH TG+ A+KV + D +E +K + H N+
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNI 69
Query: 80 VRLYEVID--TNSKLYLILELGDGGDLYDYIMKH--DAGLSETYAREYFAQIVRAISFCH 135
V+L+ + + T LI+E G LY + + GL E+ +V ++
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 136 KLHVVHRDLKPENVVFFERL---GVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLG 192
+ +VHR++KP N++ V KLTDFG + ++ + G+ Y P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYER 189
Query: 193 DSYDA-------PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
VD+WS+GV Y G PF+ +M
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-93
Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 4/217 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH-LYQEVRCMKLVQHPN 78
+ + LG+G FA V A + TG +VA+K+IDK + + EV+ ++HP+
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++ LY + ++ +YL+LE+ G++ Y+ SE AR + QI+ + + H
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG 132
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDA 197
++HRDL N + R +K+ DFG + + P +K T CG+ Y +PEI ++
Sbjct: 133 ILHRDLTLSN-LLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG- 190
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
DVWSLG + Y L+ G+ PF TL ++
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 9e-93
Identities = 82/256 (32%), Positives = 125/256 (48%), Gaps = 33/256 (12%)
Query: 5 GSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ--- 61
GS S G ++ Y L++ +G+G + VVKLA + A+KV+ K KL +
Sbjct: 1 GSSGSSGDCVQL-NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPR 59
Query: 62 ---------------------DHLYQEVRCMKLVQHPNVVRLYEVID--TNSKLYLILEL 98
+ +YQE+ +K + HPNVV+L EV+D LY++ EL
Sbjct: 60 RPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFEL 119
Query: 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVV 158
+ G + + LSE AR YF +++ I + H ++HRD+KP N++ E G +
Sbjct: 120 VNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED-GHI 176
Query: 159 KLTDFGFSNRFNPGQK-LETSCGSLAYSAPEILLGDS--YDAPAVDVWSLGVILYMLVAG 215
K+ DFG SN F L + G+ A+ APE L + A+DVW++GV LY V G
Sbjct: 177 KIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 216 QAPFQEANDSETLTMI 231
Q PF + + I
Sbjct: 237 QCPFMDERIMCLHSKI 252
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 1e-92
Identities = 64/219 (29%), Positives = 112/219 (51%), Gaps = 13/219 (5%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMK 72
K+ G Y + + LG G + VK T + AVK++ K KL P + ++ +E++ ++
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 73 LVQHPNVVRLYEVID--TNSKLYLILELGDGG--DLYDYIMKHDAGLSETYAREYFAQIV 128
++H NV++L +V+ K+Y+++E G ++ D + + A YF Q++
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK--RFPVCQAHGYFCQLI 119
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN---RFNPGQKLETSCGSLAYS 185
+ + H +VH+D+KP N++ G +K++ G + F TS GS A+
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 186 APEILLG-DSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223
PEI G D++ VD+WS GV LY + G PF+ N
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 272 bits (699), Expect = 3e-92
Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 5/219 (2%)
Query: 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH-LYQEVRCMKLVQH 76
Y LG+G FA T E A K++ K+ L Q + E+ + + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
+VV + + N ++++LEL L + + A L+E AR Y QIV + H+
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHR 133
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSY 195
V+HRDLK N +F VK+ DFG + + G++ + CG+ Y APE+L +
Sbjct: 134 NRVIHRDLKLGN-LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 196 DAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
VDVWS+G I+Y L+ G+ PF+ + ET I
Sbjct: 193 S-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 1e-91
Identities = 68/216 (31%), Positives = 107/216 (49%), Gaps = 5/216 (2%)
Query: 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQH 76
Y LG+G FA T E A K++ K+ L P ++ + E+ + + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
+VV + + N ++++LEL L + + A L+E AR Y QIV + H+
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLHR 159
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSY 195
V+HRDLK N +F VK+ DFG + + G++ + CG+ Y APE+L +
Sbjct: 160 NRVIHRDLKLGN-LFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 196 DAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
VDVWS+G I+Y L+ G+ PF+ + ET I
Sbjct: 219 S-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 4e-90
Identities = 81/221 (36%), Positives = 123/221 (55%), Gaps = 4/221 (1%)
Query: 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKL 73
TK + YD++E LG+G F+VV+ H TG + A K+I+ KL L +E R +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+QHPN+VRL++ I S YL+ +L GG+L++ I+ + SE A QI+ +I++
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAY 120
Query: 134 CHKLHVVHRDLKPENVVFFERL--GVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL 191
CH +VHR+LKPEN++ + VKL DFG + N + G+ Y +PE+L
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
D Y VD+W+ GVILY+L+ G PF + + I
Sbjct: 181 KDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 220
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 6e-90
Identities = 71/216 (32%), Positives = 120/216 (55%), Gaps = 5/216 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPN 78
+D+ LG+G F V LAR +A+KV+ K++L+ L +E+ ++HPN
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++R+Y ++YL+LE G+LY + KH E + + ++ A+ +CH+
Sbjct: 76 ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCHERK 134
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
V+HRD+KPEN++ + G +K+ DFG+S P + T CG+L Y PE++ G ++D
Sbjct: 135 VIHRDIKPENLLMGYK-GELKIADFGWSV-HAPSLRRRTMCGTLDYLPPEMIEGKTHD-E 191
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
VD+W GV+ Y + G PF + +ET I++V
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 268 bits (686), Expect = 3e-89
Identities = 81/223 (36%), Positives = 122/223 (54%), Gaps = 4/223 (1%)
Query: 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM 71
TK + YD++E LG+G F+VV+ H TG + A K+I+ KL L +E R
Sbjct: 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 72 KLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
+ +QHPN+VRL++ I S YL+ +L GG+L++ I+ SE A QI+ +I
Sbjct: 83 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESI 141
Query: 132 SFCHKLHVVHRDLKPENVVFFERL--GVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEI 189
++CH +VHR+LKPEN++ + VKL DFG + N + G+ Y +PE+
Sbjct: 142 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEV 201
Query: 190 LLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
L D Y VD+W+ GVILY+L+ G PF + + I
Sbjct: 202 LKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 243
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 3e-89
Identities = 51/240 (21%), Positives = 99/240 (41%), Gaps = 29/240 (12%)
Query: 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---------------DPVSQD 62
Y + TL +G F + L + A+K +K+ L D
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-------DAGL 115
E++ + +++ + +I ++Y+I E + + + +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 116 SETYAREYFAQIVRAISFCH-KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174
+ ++ + S+ H + ++ HRD+KP N + ++ G VKL+DFG S + +K
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN-ILMDKNGRVKLSDFGESE-YMVDKK 206
Query: 175 LETSCGSLAYSAPEILLG-DSYDAPAVDVWSLGVILYMLVAGQAPFQ-EANDSETLTMIM 232
++ S G+ + PE SY+ VD+WSLG+ LY++ PF + + E I
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 8e-89
Identities = 69/235 (29%), Positives = 117/235 (49%), Gaps = 8/235 (3%)
Query: 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD 62
S R + I L+ + LG G F V L +G + +K I+K + V +
Sbjct: 7 HSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPME 65
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG---LSETY 119
+ E+ +K + HPN+++++EV + +Y+++E +GG+L + I+ A LSE Y
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY 125
Query: 120 AREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTDFGFSNRFNPGQKLET 177
E Q++ A+++ H HVVH+DLKPEN++F + +K+ DFG + F +
Sbjct: 126 VAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN 185
Query: 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ G+ Y APE+ D+WS GV++Y L+ G PF + E
Sbjct: 186 AAGTALYMAPEVFKR-DVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT 238
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 2e-88
Identities = 78/227 (34%), Positives = 122/227 (53%), Gaps = 12/227 (5%)
Query: 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH------LY 65
+P + Y + +TLG G VKLA T +KVA+K+I K K S +
Sbjct: 4 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVE 63
Query: 66 QEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA 125
E+ +K + HP ++++ D Y++LEL +GG+L+D ++ + L E + YF
Sbjct: 64 TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR-LKEATCKLYFY 121
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRFNPGQKLETSCGSLA 183
Q++ A+ + H+ ++HRDLKPENV+ E ++K+TDFG S + T CG+
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181
Query: 184 YSAPEILLGDSYDA--PAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
Y APE+L+ AVD WSLGVIL++ ++G PF E +L
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 2e-88
Identities = 74/216 (34%), Positives = 115/216 (53%), Gaps = 5/216 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPN 78
+++ LG+G F V LAR + +A+KV+ K +L+ L +EV ++HPN
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++RLY +++YLILE G +Y + K E Y ++ A+S+CH
Sbjct: 71 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKR 129
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
V+HRD+KPEN++ G +K+ DFG+S P + CG+L Y PE++ G +D
Sbjct: 130 VIHRDIKPENLLLGSA-GELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMHD-E 186
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
VD+WSLGV+ Y + G+ PF+ ET I V
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 4e-88
Identities = 82/232 (35%), Positives = 128/232 (55%), Gaps = 5/232 (2%)
Query: 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD 62
S R + A Y++ LG+G F V + T ++ AVKVI+K
Sbjct: 7 HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE 122
+ +EV +K + HPN+++L+E+++ +S Y++ EL GG+L+D I+K SE A
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAAR 125
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRFNPGQKLETSCG 180
Q+ I++ HK ++VHRDLKPEN++ E+ +K+ DFG S F K++ G
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ Y APE+L G +YD DVWS GVILY+L++G PF N+ + L +
Sbjct: 186 TAYYIAPEVLRG-TYD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 5e-88
Identities = 85/225 (37%), Positives = 126/225 (56%), Gaps = 8/225 (3%)
Query: 11 GHPT-KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR 69
G I Y LE T+GRG + VK+A T + A K I K ++ D QE+
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIE 58
Query: 70 CMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVR 129
MK + HPN++RLYE + N+ +YL++EL GG+L++ ++ E+ A ++
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLS 117
Query: 130 AISFCHKLHVVHRDLKPENVVFFER--LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAP 187
A+++CHKL+V HRDLKPEN +F +KL DFG + RF PG+ + T G+ Y +P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
++L G Y P D WS GV++Y+L+ G PF DSE + I
Sbjct: 178 QVLEG-LYG-PECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR 220
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 2e-87
Identities = 81/232 (34%), Positives = 127/232 (54%), Gaps = 5/232 (2%)
Query: 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD 62
S R + A Y++ LG+G F V + T ++ AVKVI+K
Sbjct: 7 HSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE 122
+ +EV +K + HPN+++L+E+++ +S Y++ EL GG+L+D I+K SE A
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEHDAAR 125
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTDFGFSNRFNPGQKLETSCG 180
Q+ I++ HK ++VHRDLKPEN++ + +K+ DFG S F K++ G
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ Y APE+L G +YD DVWS GVILY+L++G PF N+ + L +
Sbjct: 186 TAYYIAPEVLRG-TYD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 7e-87
Identities = 73/226 (32%), Positives = 132/226 (58%), Gaps = 9/226 (3%)
Query: 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL----DPVSQDHLYQEVR 69
+ + Y++ E LG G FA+V+ R TG++ A K I K +L VS++ + +EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 70 CMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVR 129
++ ++HPN++ L+++ + + + LILEL GG+L+D++ + ++ L+E A ++ QI+
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTEDEATQFLKQILD 119
Query: 130 AISFCHKLHVVHRDLKPENVVFFER---LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSA 186
+ + H + H DLKPEN++ ++ +KL DFG +++ G + + G+ + A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 187 PEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
PEI+ + D+WS+GVI Y+L++G +PF ETLT I
Sbjct: 180 PEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNIS 224
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 3e-86
Identities = 78/244 (31%), Positives = 127/244 (52%), Gaps = 14/244 (5%)
Query: 1 MSRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS 60
M + YD ++ +GRG +VV+ H TG + AVK+++ T
Sbjct: 77 MGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSP 136
Query: 61 QDH------LYQEVRCMK-LVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDA 113
+ +E ++ + HP+++ L + +++S ++L+ +L G+L+DY+ + A
Sbjct: 137 EQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA 196
Query: 114 GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173
LSE R ++ A+SF H ++VHRDLKPEN++ + + ++L+DFGFS PG+
Sbjct: 197 -LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGE 254
Query: 174 KLETSCGSLAYSAPEILLGDSYDA-----PAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
KL CG+ Y APEIL + VD+W+ GVIL+ L+AG PF L
Sbjct: 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML 314
Query: 229 TMIM 232
MIM
Sbjct: 315 RMIM 318
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 3e-86
Identities = 86/244 (35%), Positives = 133/244 (54%), Gaps = 15/244 (6%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS- 60
+R + Y+ +E LGRG +VV+ H T ++ AVK+ID T S
Sbjct: 1 TRDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60
Query: 61 ------QDHLYQEVRCMK-LVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDA 113
++ +EV ++ + HPN+++L + +TN+ +L+ +L G+L+DY+ +
Sbjct: 61 EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 120
Query: 114 GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173
LSE R+ ++ I HKL++VHRDLKPEN++ + + +KLTDFGFS + +PG+
Sbjct: 121 -LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGE 178
Query: 174 KLETSCGSLAYSAPEILLGDSYDA-----PAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
KL CG+ +Y APEI+ D VD+WS GVI+Y L+AG PF L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 229 TMIM 232
MIM
Sbjct: 239 RMIM 242
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 5e-86
Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 5/219 (2%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
++ Y + E LGRG F +V + + K + D Q + +E+ + +
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIA 58
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
+H N++ L+E ++ +L +I E G D+++ I L+E Y Q+ A+ F
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 135 HKLHVVHRDLKPENVVFFERLG-VVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD 193
H ++ H D++PEN+++ R +K+ +FG + + PG + Y APE+ D
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
A D+WSLG ++Y+L++G PF + + + IM
Sbjct: 179 VVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 5e-86
Identities = 77/225 (34%), Positives = 127/225 (56%), Gaps = 9/225 (4%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL----DPVSQDHLYQEVRC 70
K+ YD+ E LG G FA+VK R TG + A K I K + VS++ + +EV
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
++ V H NV+ L++V + + + LILEL GG+L+D++ + ++ LSE A + QI+
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILDG 127
Query: 131 ISFCHKLHVVHRDLKPENVVFFER---LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAP 187
+++ H + H DLKPEN++ ++ + +KL DFG ++ G + + G+ + AP
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
EI+ + D+WS+GVI Y+L++G +PF ETL I
Sbjct: 188 EIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 8e-86
Identities = 80/225 (35%), Positives = 129/225 (57%), Gaps = 9/225 (4%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL----DPVSQDHLYQEVRC 70
+ YD E LG G FAVVK R TG + A K I K + VS++ + +EV
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 71 MKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
+K +QHPNV+ L+EV + + + LILEL GG+L+D++ + ++ L+E A E+ QI+
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNG 126
Query: 131 ISFCHKLHVVHRDLKPENVVFFER---LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAP 187
+ + H L + H DLKPEN++ +R +K+ DFG +++ + G + + G+ + AP
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
EI+ + D+WS+GVI Y+L++G +PF ETL +
Sbjct: 187 EIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 257 bits (658), Expect = 9e-86
Identities = 60/249 (24%), Positives = 113/249 (45%), Gaps = 21/249 (8%)
Query: 1 MSRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS 60
+ + +Y + + +G G + V + + A+K ++ + D +
Sbjct: 11 VDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQT 69
Query: 61 QDHLYQEVRCMKLVQHPN--VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSET 118
D E+ + +Q + ++RLY+ T+ +Y+++E G DL ++ K + +
Sbjct: 70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS-IDPW 127
Query: 119 YAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK---L 175
+ Y+ ++ A+ H+ +VH DLKP N + + G++KL DFG +N+ P
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVK 185
Query: 176 ETSCGSLAYSAPEILLGDSYDA----------PAVDVWSLGVILYMLVAGQAPFQEANDS 225
++ G++ Y PE + S P DVWSLG ILY + G+ PFQ+ +
Sbjct: 186 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 245
Query: 226 -ETLTMIMD 233
L I+D
Sbjct: 246 ISKLHAIID 254
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 2e-85
Identities = 63/248 (25%), Positives = 115/248 (46%), Gaps = 21/248 (8%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ 61
S S++ + +Y + + +G G + V + + A+K ++ + D +
Sbjct: 40 DDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTL 98
Query: 62 DHLYQEVRCMKLVQHPN--VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETY 119
D E+ + +Q + ++RLY+ T+ +Y+++E G DL ++ K +
Sbjct: 99 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK-SIDPWE 156
Query: 120 AREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK---LE 176
+ Y+ ++ A+ H+ +VH DLKP N + + G++KL DFG +N+ P +
Sbjct: 157 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKD 214
Query: 177 TSCGSLAYSAPEILLGDSYDA----------PAVDVWSLGVILYMLVAGQAPFQE-ANDS 225
+ G++ Y PE + S P DVWSLG ILY + G+ PFQ+ N
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 226 ETLTMIMD 233
L I+D
Sbjct: 275 SKLHAIID 282
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 2e-85
Identities = 76/234 (32%), Positives = 125/234 (53%), Gaps = 14/234 (5%)
Query: 6 SRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL------DPV 59
+P + Y + +TLG G VKLA T +KVA+++I K K +
Sbjct: 123 VDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREAD 182
Query: 60 SQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETY 119
++ E+ +K + HP ++++ D Y++LEL +GG+L+D ++ + L E
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK-RLKEAT 240
Query: 120 AREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTDFGFSNRFNPGQKLET 177
+ YF Q++ A+ + H+ ++HRDLKPENV+ + ++K+TDFG S + T
Sbjct: 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300
Query: 178 SCGSLAYSAPEILLGD---SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
CG+ Y APE+L+ Y+ AVD WSLGVIL++ ++G PF E +L
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-85
Identities = 64/232 (27%), Positives = 114/232 (49%), Gaps = 4/232 (1%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ 61
+ + + + YD+ E LG G F VV TG K I+ + +
Sbjct: 35 KKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDK 92
Query: 62 DHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAR 121
+ E+ M + HP ++ L++ + ++ LILE GG+L+D I D +SE
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 152
Query: 122 EYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG-VVKLTDFGFSNRFNPGQKLETSCG 180
Y Q + H+ +VH D+KPEN++ + VK+ DFG + + NP + ++ +
Sbjct: 153 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 212
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ ++APEI+ + D+W++GV+ Y+L++G +PF +D ETL +
Sbjct: 213 TAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 263
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 5e-85
Identities = 76/226 (33%), Positives = 127/226 (56%), Gaps = 9/226 (3%)
Query: 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL----DPVSQDHLYQEVR 69
K+ YD+ E LG G FA+VK R TG + A K I K + V ++ + +EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 70 CMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVR 129
++ V HPN++ L++V + + + LILEL GG+L+D++ + ++ LSE A + QI+
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEEATSFIKQILD 126
Query: 130 AISFCHKLHVVHRDLKPENVVFFER---LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSA 186
+++ H + H DLKPEN++ ++ + +KL DFG ++ G + + G+ + A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 187 PEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
PEI+ + D+WS+GVI Y+L++G +PF ETL I
Sbjct: 187 PEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 257 bits (660), Expect = 2e-84
Identities = 80/222 (36%), Positives = 118/222 (53%), Gaps = 5/222 (2%)
Query: 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKL 73
T+ Y L E LG+G F+VV+ V G++ A +I+ KL L +E R +L
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
++HPN+VRL++ I YLI +L GG+L++ I+ SE A QI+ A+
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLH 125
Query: 134 CHKLHVVHRDLKPENVVFFERL--GVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEIL 190
CH++ VVHR+LKPEN++ +L VKL DFG + Q G+ Y +PE+L
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
D Y VD+W+ GVILY+L+ G PF + + I
Sbjct: 186 RKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 2e-84
Identities = 77/221 (34%), Positives = 123/221 (55%), Gaps = 5/221 (2%)
Query: 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKL 73
++ +Y + LG G + V L R T + A+K+I KT + S L +EV +KL
Sbjct: 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ HPN+++LY+ + YL++E GG+L+D I+ +E A Q++ +++
Sbjct: 93 LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTY 151
Query: 134 CHKLHVVHRDLKPENVVFFER--LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL 191
HK ++VHRDLKPEN++ + ++K+ DFG S F +K++ G+ Y APE+L
Sbjct: 152 LHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR 211
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
YD DVWS+GVIL++L+AG PF D E L +
Sbjct: 212 K-KYD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 2e-84
Identities = 71/223 (31%), Positives = 115/223 (51%), Gaps = 6/223 (2%)
Query: 15 KIAGLYDLE-ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKL 73
Y L + LGRG FAVV+ TG++ A K + K + + + E+ ++L
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 74 VQH-PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAI 131
+ P V+ L+EV + S++ LILE GG+++ + A +SE QI+ +
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 132 SFCHKLHVVHRDLKPENVVFFER--LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEI 189
+ H+ ++VH DLKP+N++ LG +K+ DFG S + +L G+ Y APEI
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204
Query: 190 LLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
L D A D+W++G+I YML+ +PF ++ ET I
Sbjct: 205 LNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 9e-84
Identities = 80/222 (36%), Positives = 126/222 (56%), Gaps = 6/222 (2%)
Query: 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMK 72
+ Y + LG+G F V L + TG++ AVKVI K ++ ++ L +EV+ +K
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 73 LVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAIS 132
+ HPN+++LYE + YL+ E+ GG+L+D I+ SE A Q++ I+
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGIT 140
Query: 133 FCHKLHVVHRDLKPENVVFFER--LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
+ HK +VHRDLKPEN++ + +++ DFG S F +K++ G+ Y APE+L
Sbjct: 141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL 200
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
G +YD DVWS GVILY+L++G PF AN+ + L +
Sbjct: 201 HG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 1e-83
Identities = 60/230 (26%), Positives = 110/230 (47%), Gaps = 21/230 (9%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN- 78
Y + + +G G + V + + A+K ++ + D + D E+ + +Q +
Sbjct: 11 YSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 79 -VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
++RLY+ T+ +Y+++E G DL ++ K + + + Y+ ++ A+ H+
Sbjct: 70 KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIHQH 127
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDS 194
+VH DLKP N + + G++KL DFG +N+ P ++ G++ Y PE + S
Sbjct: 128 GIVHSDLKPANFLIVD--GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 195 YDA----------PAVDVWSLGVILYMLVAGQAPFQEANDS-ETLTMIMD 233
P DVWSLG ILY + G+ PFQ+ + L I+D
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-83
Identities = 72/224 (32%), Positives = 122/224 (54%), Gaps = 6/224 (2%)
Query: 12 HPTKIAGLYDLE--ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR 69
+ Y + E LG G F V TG K+A K+I + ++ + E+
Sbjct: 81 KQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK--DKEEVKNEIS 138
Query: 70 CMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVR 129
M + H N+++LY+ ++ + + L++E DGG+L+D I+ L+E + QI
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE 198
Query: 130 AISFCHKLHVVHRDLKPENVVFFERLG-VVKLTDFGFSNRFNPGQKLETSCGSLAYSAPE 188
I H+++++H DLKPEN++ R +K+ DFG + R+ P +KL+ + G+ + APE
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE 258
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
++ D D+WS+GVI YML++G +PF ND+ETL I+
Sbjct: 259 VVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 250 bits (642), Expect = 2e-83
Identities = 74/223 (33%), Positives = 119/223 (53%), Gaps = 7/223 (3%)
Query: 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM 71
T I + E LG G F+ V L + TG+ A+K I K+ L E+ +
Sbjct: 3 QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVL 60
Query: 72 KLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
K ++H N+V L ++ ++ + YL+++L GG+L+D I++ +E A Q++ A+
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV-YTEKDASLVIQQVLSAV 119
Query: 132 SFCHKLHVVHRDLKPENVVFFERLG--VVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEI 189
+ H+ +VHRDLKPEN+++ + +TDFG S + + T+CG+ Y APE+
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLS-KMEQNGIMSTACGTPGYVAPEV 178
Query: 190 LLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
L Y AVD WS+GVI Y+L+ G PF E +S+ I
Sbjct: 179 LAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK 220
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 6e-83
Identities = 67/232 (28%), Positives = 122/232 (52%), Gaps = 4/232 (1%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ 61
+ + + + YD+ E LG G F VV TG A K + +
Sbjct: 141 KQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DK 198
Query: 62 DHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAR 121
+ + +E++ M +++HP +V L++ + ++++ +I E GG+L++ + +SE A
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV 258
Query: 122 EYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG-VVKLTDFGFSNRFNPGQKLETSCG 180
EY Q+ + + H+ + VH DLKPEN++F + +KL DFG + +P Q ++ + G
Sbjct: 259 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 318
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ ++APE+ G D+WS+GV+ Y+L++G +PF ND ETL +
Sbjct: 319 TAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 1e-82
Identities = 71/222 (31%), Positives = 115/222 (51%), Gaps = 11/222 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLVQH 76
Y+L E +G+G F+VV+ + TG++ AVK++D K +S + L +E +++H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISF 133
P++V L E ++ LY++ E DG DL I+K SE A Y QI+ A+ +
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 134 CHKLHVVHRDLKPENVVFFERLG--VVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEIL 190
CH +++HRD+KP V+ + VKL FG + + G G+ + APE++
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ Y VDVW GVIL++L++G PF I+
Sbjct: 206 KREPYG-KPVDVWGCGVILFILLSGCLPFY-GTKERLFEGII 245
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 255 bits (652), Expect = 2e-82
Identities = 73/232 (31%), Positives = 117/232 (50%), Gaps = 16/232 (6%)
Query: 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-----------DPVSQD 62
KI Y LG G + V L + + A+KVI K++ +
Sbjct: 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 63 HLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE 122
+Y E+ +K + HPN+++L++V + YL+ E +GG+L++ I+ E A
Sbjct: 92 EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAAN 150
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTDFGFSNRFNPGQKLETSCG 180
QI+ I + HK ++VHRD+KPEN++ + L +K+ DFG S+ F+ KL G
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ Y APE+L Y+ DVWS GVI+Y+L+ G PF ND + + +
Sbjct: 211 TAYYIAPEVLKK-KYN-EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE 260
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 4e-81
Identities = 75/229 (32%), Positives = 118/229 (51%), Gaps = 16/229 (6%)
Query: 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM 71
+ + Y+++E +G G ++V K H T + AVK+IDK+K DP +E+ +
Sbjct: 16 NSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP------TEEIEIL 69
Query: 72 -KLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
+ QHPN++ L +V D +Y++ EL GG+L D I++ SE A I +
Sbjct: 70 LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTITKT 128
Query: 131 ISFCHKLHVVHRDLKPENVVFF---ERLGVVKLTDFGFSNRFNPGQK-LETSCGSLAYSA 186
+ + H VVHRDLKP N+++ +++ DFGF+ + L T C + + A
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 187 PEILLGDSYDAPAVDVWSLGVILYMLVAGQAPF---QEANDSETLTMIM 232
PE+L YD A D+WSLGV+LY ++ G PF + E L I
Sbjct: 189 PEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 7e-81
Identities = 78/281 (27%), Positives = 121/281 (43%), Gaps = 51/281 (18%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DP 58
R G ++ Y L+ +G+G + VV++A T A+K+++K K+ +P
Sbjct: 10 GRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69
Query: 59 VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMK-------- 110
+ + EVR MK + HPN+ RLYEV + + L++EL GG L D +
Sbjct: 70 KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129
Query: 111 -------------------------------HDAGLSETYAREYFAQIVRAISFCHKLHV 139
D E QI A+ + H +
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189
Query: 140 VHRDLKPENVVFFERLG-VVKLTDFGFSNRFNP-----GQKLETSCGSLAYSAPEILLGD 193
HRD+KPEN +F +KL DFG S F + T G+ + APE+L
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 194 --SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
SY P D WS GV+L++L+ G PF ND++T++ ++
Sbjct: 250 NESYG-PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL 289
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 1e-80
Identities = 77/227 (33%), Positives = 128/227 (56%), Gaps = 10/227 (4%)
Query: 10 DGHPT-KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEV 68
DG ++ +++E LGRG ++V + T + A+KV+ KT + + E+
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEI 99
Query: 69 RCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIV 128
+ + HPN+++L E+ +T +++ L+LEL GG+L+D I++ SE A + QI+
Sbjct: 100 GVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY-YSERDAADAVKQIL 158
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLG--VVKLTDFGFSNRFNPGQKLETSCGSLAYSA 186
A+++ H+ +VHRDLKPEN+++ +K+ DFG S ++T CG+ Y A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218
Query: 187 PEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ-EANDSETLTMIM 232
PEIL G +Y P VD+WS+G+I Y+L+ G PF E D I+
Sbjct: 219 PEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL 264
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-78
Identities = 73/236 (30%), Positives = 113/236 (47%), Gaps = 21/236 (8%)
Query: 8 SSDGHPTKIAGLYDL-EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ 66
S+D + +Y L E+ LG G A V+ ++ T ++ AVK+I+K + +++
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFR 59
Query: 67 EVRCMKLVQ-HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA 125
EV + Q H NV+ L E + + YL+ E GG + +I K +E A
Sbjct: 60 EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVVQ 118
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRFNPG--------QKL 175
+ A+ F H + HRDLKPEN++ ++ VK+ DF + +L
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 176 ETSCGSLAYSAPEILLG-----DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226
T CGS Y APE++ YD D+WSLGVILY+L++G PF S+
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSD 233
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-78
Identities = 83/220 (37%), Positives = 128/220 (58%), Gaps = 11/220 (5%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HP 77
L ++ LG G F++ + H + + AVK+I K + E+ +KL + HP
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK-----EITALKLCEGHP 66
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
N+V+L+EV +L++EL +GG+L++ I K SET A ++V A+S H +
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH-FSETEASYIMRKLVSAVSHMHDV 125
Query: 138 HVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRFNP-GQKLETSCGSLAYSAPEILLGDS 194
VVHRDLKPEN++F +K+ DFGF+ P Q L+T C +L Y+APE+L +
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
YD + D+WSLGVILY +++GQ PFQ + S T T +++
Sbjct: 186 YD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI 224
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-76
Identities = 69/241 (28%), Positives = 109/241 (45%), Gaps = 17/241 (7%)
Query: 2 SRSGSRSSDGHPTKIAGLYDL-EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS 60
I Y + + LG G V + T EK A+K++
Sbjct: 45 QFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK---- 100
Query: 61 QDHLYQEVRCMK-LVQHPNVVRLYEV----IDTNSKLYLILELGDGGDLYDYIM-KHDAG 114
+EV Q P++VR+ +V L +++E DGG+L+ I + D
Sbjct: 101 ---ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA 157
Query: 115 LSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG--VVKLTDFGFSNRFNPG 172
+E A E I AI + H +++ HRD+KPEN+++ + ++KLTDFGF+
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
L T C + Y APE+L + YD + D+WSLGVI+Y+L+ G PF + +
Sbjct: 218 NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276
Query: 233 D 233
Sbjct: 277 T 277
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 2e-76
Identities = 72/241 (29%), Positives = 113/241 (46%), Gaps = 18/241 (7%)
Query: 2 SRSGSRSSDGHPTKIAGLYDL-EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS 60
+ + + Y L ++ LG G V H TG+K A+K++ +
Sbjct: 12 LEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---- 67
Query: 61 QDHLYQEVRCM-KLVQHPNVVRLYEV----IDTNSKLYLILELGDGGDLYDYIM-KHDAG 114
QEV + P++V + +V L +I+E +GG+L+ I + D
Sbjct: 68 ---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA 124
Query: 115 LSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRFNPG 172
+E A E I AI F H ++ HRD+KPEN+++ E+ V+KLTDFGF+
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
Query: 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
L+T C + Y APE+L + YD + D+WSLGVI+Y+L+ G PF +
Sbjct: 185 -ALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
Query: 233 D 233
Sbjct: 243 R 243
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 4e-76
Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 34/241 (14%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
++ LG+G F V AR+ A+K I T+ + EV + + H V
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---LSTILSEVMLLASLNHQYV 64
Query: 80 VRLYEV-------------IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQ 126
VR Y + S L++ +E + G LYD I + F Q
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN---------------P 171
I+ A+S+ H ++HRDLKP N +F + VK+ DFG + +
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMN-IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
L ++ G+ Y A E+L G + +D++SLG+I + ++ L +
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKL 241
Query: 232 M 232
Sbjct: 242 R 242
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-71
Identities = 72/224 (32%), Positives = 109/224 (48%), Gaps = 13/224 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y++ T+G G + + R G+ + K +D + + L EV ++ ++HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 80 VRLYEVI--DTNSKLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFC 134
VR Y+ I TN+ LY+++E +GGDL I K L E + Q+ A+ C
Sbjct: 68 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 135 HKLH-----VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL-ETSCGSLAYSAPE 188
H+ V+HRDLKP N VF + VKL DFG + N +T G+ Y +PE
Sbjct: 128 HRRSDGGHTVLHRDLKPAN-VFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPE 186
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ SY+ + D+WSLG +LY L A PF + E I
Sbjct: 187 QMNRMSYNEKS-DIWSLGCLLYELCALMPPFTAFSQKELAGKIR 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 3e-71
Identities = 62/254 (24%), Positives = 102/254 (40%), Gaps = 40/254 (15%)
Query: 6 SRSSDGH--PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH 63
SR ++ + L E+ LG G V F G VAVK + D
Sbjct: 1 SRIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALM-- 57
Query: 64 LYQEVRCM-KLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHD------AGLS 116
E++ + + HPNV+R Y T+ LY+ LEL +L D + +
Sbjct: 58 ---EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQK 113
Query: 117 ETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV------------VKLTDFG 164
E QI ++ H L ++HRDLKP+N++ + ++DFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 165 FSNRFNPGQ-----KLETSCGSLAYSAPEILLGDSYDA------PAVDVWSLGVILY-ML 212
+ + GQ L G+ + APE+L + ++D++S+G + Y +L
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 213 VAGQAPFQEANDSE 226
G+ PF + E
Sbjct: 234 SKGKHPFGDKYSRE 247
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-69
Identities = 57/215 (26%), Positives = 105/215 (48%), Gaps = 4/215 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + +G G F L + G + +K I+ +++ ++ +EV + ++HPN+
Sbjct: 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKLH 138
V+ E + N LY++++ +GGDL+ I E ++F QI A+ H
Sbjct: 86 VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCGSLAYSAPEILLGDSYDA 197
++HRD+K +N +F + G V+L DFG + N + G+ Y +PEI Y+
Sbjct: 146 ILHRDIKSQN-IFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN 204
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ D+W+LG +LY L + F+ + + I+
Sbjct: 205 KS-DIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 7e-69
Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 23/233 (9%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + LG G F+ V L + G A+K I + ++ +E +L HPN+
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ--DREEAQREADMHRLFNHPNI 88
Query: 80 VRLYEVI----DTNSKLYLILELGDGGDLYDYIMKHDAG---LSETYAREYFAQIVRAIS 132
+RL + +L+L G L++ I + L+E I R +
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 133 FCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG----------QKLETSCGSL 182
H HRDLKP N + G L D G N+ Q ++
Sbjct: 149 AIHAKGYAHRDLKPTN-ILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 183 AYSAPEILLGDSYDA--PAVDVWSLGVILYMLVAGQAPFQEANDS-ETLTMIM 232
+Y APE+ S+ DVWSLG +LY ++ G+ P+ +++ + +
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-67
Identities = 53/236 (22%), Positives = 96/236 (40%), Gaps = 19/236 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQHPN 78
+ ++ LG G + + R +F VAVK I + EV+ ++ +HPN
Sbjct: 26 FCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFADR-----EVQLLRESDEHPN 79
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
V+R + Y+ +EL L +Y+ + D Q ++ H L+
Sbjct: 80 VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 139 VVHRDLKPENVVFFER----LGVVKLTDFGFSNRFNPGQ----KLETSCGSLAYSAPEIL 190
+VHRDLKP N++ ++DFG + G+ + G+ + APE+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 191 LGDSYDA--PAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243
D + VD++S G + Y ++ G PF ++ + ++ S
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK 254
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-65
Identities = 61/203 (30%), Positives = 80/203 (39%), Gaps = 6/203 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM-KLVQHPN 78
+ LG G + V R G AVK P + EV K+ QHP
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
VRL + + LYL EL G L + A L E Y + A++ H
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG 177
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
+VH D+KP N +F G KL DFG E G Y APE+L G Y
Sbjct: 178 LVHLDVKPAN-IFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS-YG-T 234
Query: 199 AVDVWSLGVILY-MLVAGQAPFQ 220
A DV+SLG+ + + + P
Sbjct: 235 AADVFSLGLTILEVACNMELPHG 257
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 8e-64
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 37/222 (16%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM-KLVQHPN 78
+ LG G V + T EK A+K++ +EV + Q P+
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRASQCPH 72
Query: 79 VVRLYEV----IDTNSKLYLILELGDGGDLYDYIM-KHDAGLSETYAREYFAQIVRAISF 133
+VR+ +V L +++E DGG+L+ I + D +E A E I AI +
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 134 CHKLHVVHRDLKPENVVFFERLG--VVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL 191
H +++ HRD+KPEN+++ + ++KLTDFGF A E
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKET-T 171
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
G+ YD + D+WSLGVI+Y+L+ G PF + +
Sbjct: 172 GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-63
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 26/222 (11%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ E +G G F V A+H G+ +K + + +EV+ + + H N+
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNI 66
Query: 80 VRLYE----------------VIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYARE 122
V L++ +E D G L +I K L + A E
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
F QI + + + H +++RDLKP N +F VK+ DFG K S G+L
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSN-IFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEAN 223
Y +PE + Y VD+++LG+IL +L F+ +
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFETSK 226
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-62
Identities = 40/231 (17%), Positives = 76/231 (32%), Gaps = 25/231 (10%)
Query: 20 YDLEETLGRGHFAVVKLARH-----VFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
+ LG G FA V A +K +KV P Q + +K
Sbjct: 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPS 124
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH----DAGLSETYAREYFAQIVRA 130
++ Y + L+ EL G L + I + + + + + +++
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184
Query: 131 ISFCHKLHVVHRDLKPENVVFFERL----------GVVKLTDFGFS---NRFNPGQKLET 177
I H ++H D+KP+N + + L D G S F G
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
C + + E+L ++ +D + + +Y ++ G + E
Sbjct: 245 KCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECK 294
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 2e-62
Identities = 65/231 (28%), Positives = 100/231 (43%), Gaps = 30/231 (12%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQHPN 78
+ L G FA V A+ V +G + A+K + + + QEV MK L HPN
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPN 87
Query: 79 VVRLY-------EVIDTNSKLYLILELGDGGDLYDYIMKHDAG--LSETYAREYFAQIVR 129
+V+ E DT +L+L G L +++ K ++ LS + F Q R
Sbjct: 88 IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCR 147
Query: 130 AISFCHKLH--VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-------------QK 174
A+ H+ ++HRDLK EN + G +KL DFG + + ++
Sbjct: 148 AVQHMHRQKPPIIHRDLKVEN-LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 175 LETSCGSLAYSAPEI--LLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223
T + Y PEI L + D+W+LG ILY+L Q PF++
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-62
Identities = 69/206 (33%), Positives = 107/206 (51%), Gaps = 7/206 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPN 78
+ +E+ +GRG F+ V A + G VA+K + L D ++ +E+ +K + HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYI---MKHDAGLSETYAREYFAQIVRAISFCH 135
V++ Y +++L ++LEL D GDL I K + E +YF Q+ A+ H
Sbjct: 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLETSCGSLAYSAPEILLGDS 194
V+HRD+KP N VF GVVKL D G F+ + G+ Y +PE + +
Sbjct: 154 SRRVMHRDIKPAN-VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 212
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQ 220
Y+ D+WSLG +LY + A Q+PF
Sbjct: 213 YNF-KSDIWSLGCLLYEMAALQSPFY 237
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-58
Identities = 40/264 (15%), Positives = 72/264 (27%), Gaps = 36/264 (13%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPN 78
L E L G +VV L R V E A+KV + L++ + +
Sbjct: 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123
Query: 79 VVRLYEVI--------------------------DTNSKLYLILE-----LGDGGDLYDY 107
+ + L++ L D+
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183
Query: 108 IMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167
+ AQ++R + +VH P+N+ G + L D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD-GRLMLGDVSALW 242
Query: 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDA-PAVDVWSLGVILYMLVAGQAPFQEANDSE 226
+ G + S + Y+ E L + A++ W LG+ +Y + PF
Sbjct: 243 K--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 227 TLTMIMDVSESSCTCWWRGRPRSR 250
+ T +
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTP 324
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 189 bits (480), Expect = 2e-58
Identities = 44/278 (15%), Positives = 86/278 (30%), Gaps = 54/278 (19%)
Query: 7 RSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-QDHLY 65
S G + LG+ A TGE V V T+ P + +
Sbjct: 65 ESELGERPR---TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 121
Query: 66 QEVRCMKLVQ-------------------------HPNVVRLYEVIDTNS--KLYLILEL 98
+EV ++L++ ++R+ + +
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 181
Query: 99 --GDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE 153
+ + ++ H L + Q++R ++ H +VH L+P ++V +
Sbjct: 182 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 241
Query: 154 RLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL----------LGDSYDAPAVDVW 203
R G V LT F R S S + PE+ + + D W
Sbjct: 242 R-GGVFLTGFEHLVRDG---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297
Query: 204 SLGVILYMLVAGQAPFQEANDSETLTMIM----DVSES 237
+LG+++Y + P + I ++ +
Sbjct: 298 ALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIPQP 335
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-56
Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 36/243 (14%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
++ + LGRG F VV A++ A+K I + ++++ + +EV+ + ++HP +
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE-LAREKVMREVKALAKLEHPGI 65
Query: 80 VRLYEVIDTNSK------------LYLILELGDGGDLYDYI--MKHDAGLSETYAREYFA 125
VR + + LY+ ++L +L D++ + F
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS-------------NRFNPG 172
QI A+ F H ++HRDLKP N +FF VVK+ DFG
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSN-IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEAND-SETLTM 230
+ G+ Y +PE + G+SY VD++SLG+IL+ +L PF + TLT
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY----PFSTQMERVRTLTD 239
Query: 231 IMD 233
+ +
Sbjct: 240 VRN 242
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-54
Identities = 72/219 (32%), Positives = 113/219 (51%), Gaps = 11/219 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKT---KLDPVSQDHLYQEVRCMKLVQH 76
+ + LG G F+ V LAR + T + A+K+++K K + V ++ +E M + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKV--PYVTRERDVMSRLDH 89
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
P V+LY + KLY L G+L YI + ET R Y A+IV A+ + H
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE---TSCGSLAYSAPEILLGD 193
++HRDLKPEN++ +++TDFG + +P K + G+ Y +PE+L
Sbjct: 149 KGIIHRDLKPENIL-LNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
S + D+W+LG I+Y LVAG PF+ N+ I+
Sbjct: 208 SAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 245
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-53
Identities = 64/223 (28%), Positives = 108/223 (48%), Gaps = 10/223 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPN 78
+++ + +GRG F+ V + + TG+ A+K+++K + + +E +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+ +L+ + LYL++E GGDL + K + AR Y A+IV AI H+L
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILLGDSYD 196
VHRD+KP+N++ +R G ++L DFG + + + G+ Y +PEIL
Sbjct: 183 YVHRDIKPDNIL-LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 197 A------PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
P D W+LGV Y + GQ PF + +ET I+
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 2e-53
Identities = 64/221 (28%), Positives = 113/221 (51%), Gaps = 8/221 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPN 78
+++ + +GRG F V + + + A+K+++K ++ ++ +E +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+ L+ ++ LYL+++ GGDL + K + L E AR Y A++V AI H+LH
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILLGDSYD 196
VHRD+KP+N++ + G ++L DFG + +++S G+ Y +PEIL
Sbjct: 196 YVHRDIKPDNIL-MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 197 A----PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
P D WSLGV +Y ++ G+ PF + ET IM+
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-52
Identities = 68/216 (31%), Positives = 119/216 (55%), Gaps = 3/216 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y+ +G G + VV R+ TG+ VA+K +++ DPV + +E+R +K ++HPN+
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V L EV +L+L+ E D + + ++ G+ E + Q ++A++FCHK +
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGDSYDAP 198
+HRD+KPEN + + V+KL DFGF+ P + + Y +PE+L+GD+ P
Sbjct: 124 IHRDVKPEN-ILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
VDVW++G + L++G + +D + L +I
Sbjct: 183 PVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT 218
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-52
Identities = 68/220 (30%), Positives = 115/220 (52%), Gaps = 9/220 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPN 78
Y++ + +GRG F V+L RH T + A+K++ K ++ S ++E M P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
VV+L+ + LY+++E GGDL + + +D + E +AR Y A++V A+ H +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIHSMG 188
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILLGDSYD 196
+HRD+KP+N++ ++ G +KL DFG + N + G+ Y +PE+L D
Sbjct: 189 FIHRDVKPDNML-LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 197 A---PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
D WS+GV LY ++ G PF + T + IM+
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN 287
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-52
Identities = 70/222 (31%), Positives = 110/222 (49%), Gaps = 15/222 (6%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKL 73
Y+ +G G + +V R+ TG VA+K K +E++ +K
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIA---MREIKLLKQ 80
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
++H N+V L EV + YL+ E D + D + GL ++Y QI+ I F
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLG 192
CH +++HRD+KPEN + + GVVKL DFGF+ PG+ + + Y APE+L+G
Sbjct: 140 CHSHNIIHRDIKPEN-ILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG 198
Query: 193 DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
D AVDVW++G ++ + G+ F +D + L IM
Sbjct: 199 DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-52
Identities = 46/237 (19%), Positives = 88/237 (37%), Gaps = 25/237 (10%)
Query: 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEV 68
+ G ++ + E +G G F V G A+K K V + + +EV
Sbjct: 2 AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREV 61
Query: 69 RCM-KLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG---LSETYAREYF 124
L QH +VVR + + + + E +GG L D I ++ E ++
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121
Query: 125 AQIVRAISFCHKLHVVHRDLKPENV------------------VFFERLGVVKLTDFGFS 166
Q+ R + + H + +VH D+KP N+ + + K+ D G
Sbjct: 122 LQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 167 NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223
R + + G + A E+L + P D+++L + + + + +
Sbjct: 182 TRIS---SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 7e-52
Identities = 77/214 (35%), Positives = 123/214 (57%), Gaps = 6/214 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPN 78
+D +TLG G F V L +H +G A+K++DK K+ + Q +H E R ++ V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V+L NS LY+++E GG+++ ++ + SE +AR Y AQIV + H L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHSLD 161
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
+++RDLKPEN++ ++ G +++TDFGF+ R + T CG+ APEI+L Y+
Sbjct: 162 LIYRDLKPENLL-IDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN-K 217
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
AVD W+LGV++Y + AG PF + I+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 2e-50
Identities = 64/215 (29%), Positives = 118/215 (54%), Gaps = 8/215 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPN 78
+ + TLG G F V L R G A+KV+ K + + Q +H E + +V HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKL 137
++R++ ++++I++ +GG+L+ + K + A+ Y A++ A+ + H
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK 125
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDA 197
+++RDLKPEN++ ++ G +K+TDFGF+ T CG+ Y APE++ Y+
Sbjct: 126 DIIYRDLKPENIL-LDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAPEVVSTKPYN- 181
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
++D WS G+++Y ++AG PF ++N +T I+
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-50
Identities = 57/217 (26%), Positives = 115/217 (52%), Gaps = 11/217 (5%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD---HLYQEVRCMKLVQHP 77
++ +G+G F V + + T + A+K ++K K V ++ ++++E++ M+ ++HP
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC--VERNEVRNVFKELQIMQGLEHP 75
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
+V L+ ++++++L GGDL Y ++ + E + + ++V A+ +
Sbjct: 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLR-YHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL---GDS 194
++HRD+KP+N++ E G V +TDF + ++ T G+ Y APE+ G
Sbjct: 135 RIIHRDMKPDNILLDEH-GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
Y AVD WSLGV Y L+ G+ P+ + + + ++
Sbjct: 194 YS-FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-49
Identities = 76/213 (35%), Positives = 113/213 (53%), Gaps = 9/213 (4%)
Query: 26 LGRGHFAVVKLARHVF---TGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLVQHPNVV 80
LG+G + V R V TG+ A+KV+ K + + H E ++ V+HP +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
L T KLYLILE GG+L+ ++ + E A Y A+I A+ H+ ++
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGELF-MQLEREGIFMEDTACFYLAEISMALGHLHQKGII 143
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFS-NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPA 199
+RDLKPEN++ G VKLTDFG + G T CG++ Y APEIL+ ++ A
Sbjct: 144 YRDLKPENIM-LNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN-RA 201
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
VD WSLG ++Y ++ G PF N +T+ I+
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-49
Identities = 43/256 (16%), Positives = 81/256 (31%), Gaps = 44/256 (17%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-QDHLYQEVRCMKL---- 73
LG+ A TGE V V T+ P + + +EV ++L
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 74 ------------------VQHPNVVRLYEVIDTNSKLYLILEL-------GDGGDLYDYI 108
V+ P ++ V ++++ + + +
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 109 MKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165
+ H L + Q++R ++ H +VH L+P + + ++ G V LT F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD-IVLDQRGGVFLTGFEH 257
Query: 166 SNRFNPGQKLETSCGSL----AYSAPEILLGDSYDA----PAVDVWSLGVILYMLVAGQA 217
R G + G +A +L + A D W+LG+ +Y +
Sbjct: 258 LVR--DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 218 PFQEANDSETLTMIMD 233
P + I
Sbjct: 316 PNTDDAALGGSEWIFR 331
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 6e-49
Identities = 70/211 (33%), Positives = 114/211 (54%), Gaps = 7/211 (3%)
Query: 26 LGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRL 82
LG+G F V L + + + A+KV+ K L + E + V HP +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
+ T KLYLIL+ GGDL+ + + +E + Y A++ A+ H L +++R
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLF-TRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 150
Query: 143 DLKPENVVFFERLGVVKLTDFGFS-NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVD 201
DLKPEN++ + G +KLTDFG S + +K + CG++ Y APE++ + + D
Sbjct: 151 DLKPENIL-LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSAD 208
Query: 202 VWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
WS GV+++ ++ G PFQ + ET+TMI+
Sbjct: 209 WWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-49
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 4/210 (1%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPNVVRLYE 84
LG+G F V + TG+ A K ++K ++ E + ++ V VV L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 85 VIDTNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
+T L L+L L +GGDL +I AG E A Y A+I + H+ +V+RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVW 203
LKPEN++ + G ++++D G + GQ ++ G++ Y APE++ + Y + D W
Sbjct: 312 LKPENIL-LDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT-FSPDWW 369
Query: 204 SLGVILYMLVAGQAPFQEANDSETLTMIMD 233
+LG +LY ++AGQ+PFQ+ +
Sbjct: 370 ALGCLLYEMIAGQSPFQQRKKKIKREEVER 399
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 7e-49
Identities = 70/211 (33%), Positives = 114/211 (54%), Gaps = 9/211 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLVQHPNVVRL 82
LG+G F V L R TG A+K++ K + D V H E R ++ +HP + L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEV--AHTVTESRVLQNTRHPFLTAL 70
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHR 142
T+ +L ++E +GG+L+ + + + +E AR Y A+IV A+ + H VV+R
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELF-FHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 143 DLKPENVVFFERLGVVKLTDFGFS-NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVD 201
D+K EN++ + G +K+TDFG + G ++T CG+ Y APE+L + Y AVD
Sbjct: 130 DIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVD 187
Query: 202 VWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
W LGV++Y ++ G+ PF + +I+
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-48
Identities = 74/216 (34%), Positives = 109/216 (50%), Gaps = 18/216 (8%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMK--------LVQHP 77
+G+G F V LARH AVKV+ K + + E + + V+HP
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQK---KAILKKK---EEKHIMSERNVLLKNVKHP 99
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
+V L+ T KLY +L+ +GG+L+ Y ++ + E AR Y A+I A+ + H L
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELF-YHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYSAPEILLGDSYD 196
++V+RDLKPEN++ + G + LTDFG T CG+ Y APE+L YD
Sbjct: 159 NIVYRDLKPENILLDSQ-GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
VD W LG +LY ++ G PF N +E I+
Sbjct: 218 -RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-48
Identities = 67/223 (30%), Positives = 114/223 (51%), Gaps = 16/223 (7%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKL 73
Y+ E +G G + V A++ T E VA+K + +LD P S +E+ +K
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSA---LREICLLKE 57
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
++H N+VRL++V+ ++ KL L+ E D DL Y + L + + Q+++ + F
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLG 192
CH +V+HRDLKP+N + R G +KL +FG + F P + +L Y P++L G
Sbjct: 117 CHSRNVLHRDLKPQN-LLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 193 DSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMDV 234
+ ++D+WS G I + AG+ F + + L I +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-47
Identities = 71/212 (33%), Positives = 109/212 (51%), Gaps = 10/212 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLV-QHPNVVR 81
LG+G F V L+ T E AVK++ K + D V + E R + L + P + +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV--ECTMVEKRVLALPGKPPFLTQ 85
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
L+ T +LY ++E +GGDL +I + E +A Y A+I + F +++
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIY 144
Query: 142 RDLKPENVVFFERLGVVKLTDFGFS-NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAV 200
RDLK +NV+ G +K+ DFG G +T CG+ Y APEI+ Y +V
Sbjct: 145 RDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSV 202
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
D W+ GV+LY ++AGQAPF+ ++ E IM
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-47
Identities = 70/212 (33%), Positives = 107/212 (50%), Gaps = 10/212 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLV-QHPNVVR 81
LG+G F V LA T + A+K + K + D V + E R + L +HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 82
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
++ T L+ ++E +GGDL +I + A Y A+I+ + F H +V+
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKGIVY 141
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDAPAV 200
RDLK +N++ + G +K+ DFG K T CG+ Y APEILLG Y+ +V
Sbjct: 142 RDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-HSV 199
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
D WS GV+LY ++ GQ+PF ++ E I
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-47
Identities = 66/221 (29%), Positives = 114/221 (51%), Gaps = 14/221 (6%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-----PVSQDHLYQEVRCMKLV 74
Y + LG G +A V + T VA+K + +L+ P + +EV +K +
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALK---EIRLEHEEGAPCTA---IREVSLLKDL 57
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
+H N+V L+++I T L L+ E D DL Y+ ++ + + Q++R +++C
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGD 193
H+ V+HRDLKP+N++ ER G +KL DFG + + P + + +L Y P+ILLG
Sbjct: 117 HRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
+ + +D+W +G I Y + G+ F + E L I +
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-47
Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 11/201 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLVQHPNVVRL 82
LGRG F V + TG+ A K ++K +L E + + V +V L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY--QGAMVEKKILAKVHSRFIVSL 250
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYI---MKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
+T + L L++ + +GGD+ +I + + G E A Y AQIV + H+ ++
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDAP 198
++RDLKPENV+ + G V+++D G + K + G+ + APE+LLG+ YD
Sbjct: 311 IYRDLKPENVL-LDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD-F 368
Query: 199 AVDVWSLGVILYMLVAGQAPF 219
+VD ++LGV LY ++A + PF
Sbjct: 369 SVDYFALGVTLYEMIAARGPF 389
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-47
Identities = 79/212 (37%), Positives = 112/212 (52%), Gaps = 10/212 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLV-QHPNVVR 81
LG+G F V LAR TG+ AVKV+ K + D V + E R + L HP + +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDV--ECTMTEKRILSLARNHPFLTQ 88
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
L+ T +L+ ++E +GGDL +I K E AR Y A+I+ A+ F H +++
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKGIIY 147
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDAPAV 200
RDLK +NV+ G KL DFG G T CG+ Y APEIL Y PAV
Sbjct: 148 RDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG-PAV 205
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
D W++GV+LY ++ G APF+ N+ + I+
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-46
Identities = 72/244 (29%), Positives = 119/244 (48%), Gaps = 19/244 (7%)
Query: 1 MSRSGSRSSDGHPTKIAGL---YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD 57
M SS GL Y E +G G + VV A+ G VA+K + +LD
Sbjct: 1 MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALK---RIRLD 56
Query: 58 ------PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH 111
P + +E+ +K + HPN+V L +VI + L L+ E + DL + ++
Sbjct: 57 AEDEGIPSTA---IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN 112
Query: 112 DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN- 170
GL ++ + Y Q++R ++ CH+ ++HRDLKP+N + G +KL DFG + F
Sbjct: 113 KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQN-LLINSDGALKLADFGLARAFGI 171
Query: 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTM 230
P + +L Y AP++L+G + +VD+WS+G I ++ G+ F D + L
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK 231
Query: 231 IMDV 234
I +
Sbjct: 232 IFSI 235
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-46
Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKL 73
Y LG G + V A T E VA+K + +L+ P + +EV +K
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGTA---IREVSLLKE 89
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+QH N++ L VI N +L+LI E + DL Y M + +S + + Q++ ++F
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKY-MDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 134 CHKLHVVHRDLKPEN----VVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPE 188
CH +HRDLKP+N V V+K+ DFG + F P ++ +L Y PE
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
ILLG + + +VD+WS+ I ++ F ++ + L I +V
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-46
Identities = 72/205 (35%), Positives = 113/205 (55%), Gaps = 6/205 (2%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLV-QHPNVVRLY 83
+GRG +A V L R T A+KV+ K D D + E + HP +V L+
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
T S+L+ ++E +GGDL ++ + L E +AR Y A+I A+++ H+ +++RD
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRD 135
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDV 202
LK +NV+ G +KLTD+G PG T CG+ Y APEIL G+ Y +VD
Sbjct: 136 LKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDW 193
Query: 203 WSLGVILYMLVAGQAPFQEANDSET 227
W+LGV+++ ++AG++PF S+
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDN 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-46
Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 17/232 (7%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLE-----ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL 56
S + D + Y+ + LG+G + +V R + ++A+K I +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 57 DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-- 114
L++E+ K ++H N+V+ N + + +E GG L +++ G
Sbjct: 61 RYSQP--LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA-LLRSKWGPL 117
Query: 115 -LSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173
+E Y QI+ + + H +VHRD+K +NV+ GV+K++DFG S R
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177
Query: 174 KLETSC-GSLAYSAPEILLGDS--YDAPAVDVWSLG-VILYMLVAGQAPFQE 221
+ G+L Y APEI+ Y A D+WSLG I+ M G+ PF E
Sbjct: 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAA-DIWSLGCTIIEMA-TGKPPFYE 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-46
Identities = 71/212 (33%), Positives = 115/212 (54%), Gaps = 10/212 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLVQHPNVVRL 82
LG+G F V L + TG A+K++ K + D V H E R ++ +HP + L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV--AHTLTENRVLQNSRHPFLTAL 213
Query: 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH-VVH 141
T+ +L ++E +GG+L+ ++ + SE AR Y A+IV A+ + H VV+
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 142 RDLKPENVVFFERLGVVKLTDFGFS-NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAV 200
RDLK EN++ ++ G +K+TDFG G ++T CG+ Y APE+L + Y AV
Sbjct: 273 RDLKLENLML-DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG-RAV 330
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
D W LGV++Y ++ G+ PF + + +I+
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-46
Identities = 69/222 (31%), Positives = 117/222 (52%), Gaps = 16/222 (7%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKL 73
Y E +G G + VV A++ GE A+K K +L+ P + +E+ +K
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALK---KIRLEKEDEGIPSTT---IREISILKE 56
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
++H N+V+LY+VI T +L L+ E D DL + + GL A+ + Q++ I++
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLG 192
CH V+HRDLKP+N++ G +K+ DFG + F P +K +L Y AP++L+G
Sbjct: 116 CHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 193 DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
+ +D+WS+G I +V G F ++++ L I +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-46
Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 20/226 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + +G G F VV A+ +GE VA+K K D + +E++ M+ + H N+
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KVLQD---KRFKNRELQIMRKLDHCNI 109
Query: 80 VRLYEVIDTNS------KLYLILELGDGGDLYDYIMKHDAG---LSETYAREYFAQIVRA 130
VRL ++ L L+L+ +Y + L Y + Y Q+ R+
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPE 188
+++ H + HRD+KP+N++ V+KL DFG + + G+ S C S Y APE
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYIC-SRYYRAPE 226
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
++ G + ++DVWS G +L L+ GQ F + + L I+ V
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-45
Identities = 77/226 (34%), Positives = 122/226 (53%), Gaps = 19/226 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-----PVSQDHLYQEVRCMKLV 74
+ E LG G +A V + TG VA+K + KLD P + +E+ MK +
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALK---EVKLDSEEGTPSTA---IREISLMKEL 60
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-----DAGLSETYAREYFAQIVR 129
+H N+VRLY+VI T +KL L+ E D DL Y+ GL + + Q+++
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 130 AISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPE 188
++FCH+ ++HRDLKP+N++ +R G +KL DFG + F P + +L Y AP+
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
+L+G + ++D+WS G IL ++ G+ F ND E L +I D+
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 71/213 (33%), Positives = 110/213 (51%), Gaps = 10/213 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLV-QHPNVVR 81
LG+G F V L+ T E AVK++ K + D V + E R + L + P + +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV--ECTMVEKRVLALPGKPPFLTQ 406
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
L+ T +LY ++E +GGDL +I + E +A Y A+I + F +++
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 142 RDLKPENVVFFERLGVVKLTDFGFS-NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAV 200
RDLK +NV+ G +K+ DFG G +T CG+ Y APEI+ Y +V
Sbjct: 466 RDLKLDNVMLDSE-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSV 523
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
D W+ GV+LY ++AGQAPF+ ++ E IM+
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-45
Identities = 70/224 (31%), Positives = 116/224 (51%), Gaps = 15/224 (6%)
Query: 21 DLEETLGRGHFAVVKLARHVF---TGEKVAVKVIDK----TKLDPVSQDHLYQEVRCMKL 73
+L + LG G + V L R + TG+ A+KV+ K K +H E + ++
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTT--EHTRTERQVLEH 114
Query: 74 VQH-PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAIS 132
++ P +V L+ T +KL+LIL+ +GG+L+ + +E + Y +IV A+
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELF-THLSQRERFTEHEVQIYVGEIVLALE 173
Query: 133 FCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS--NRFNPGQKLETSCGSLAYSAPEIL 190
HKL +++RD+K EN++ + G V LTDFG S + ++ CG++ Y AP+I+
Sbjct: 174 HLHKLGIIYRDIKLENIL-LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 191 LGDSY-DAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
G AVD WSLGV++Y L+ G +PF + + I
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 70/207 (33%), Positives = 116/207 (56%), Gaps = 10/207 (4%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLV-QHPNVVR 81
+GRG +A V L R T A++V+ K + + + D + E + HP +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDI--DWVQTEKHVFEQASNHPFLVG 117
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
L+ T S+L+ ++E +GGDL ++ + L E +AR Y A+I A+++ H+ +++
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIY 176
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDAPAV 200
RDLK +NV+ + G +KLTD+G PG T CG+ Y APEIL G+ Y +V
Sbjct: 177 RDLKLDNVL-LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG-FSV 234
Query: 201 DVWSLGVILYMLVAGQAPFQEANDSET 227
D W+LGV+++ ++AG++PF S+
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDN 261
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-45
Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 21/226 (9%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + +G G F VV A+ V + E VA+K K D +E++ M++V+HPNV
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIK---KVLQDK---RFKNRELQIMRIVKHPNV 94
Query: 80 VRLYEVIDTNS------KLYLILELGDGGDLYDYI---MKHDAGLSETYAREYFAQIVRA 130
V L +N L L+LE +Y K + + Y Q++R+
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPE 188
+++ H + + HRD+KP+N++ GV+KL DFG + G+ S C S Y APE
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYIC-SRYYRAPE 211
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
++ G + +D+WS G ++ L+ GQ F + + L I+ V
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-45
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 12/222 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL------YQEVRCMKL 73
Y+ + LG G FA V AR T + VA+K K KL S+ +E++ ++
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIK---KIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ HPN++ L + S + L+ + + DL I + L+ ++ + Y ++ + +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLG 192
H+ ++HRDLKP N++ E GV+KL DFG + F P + + Y APE+L G
Sbjct: 128 LHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 186
Query: 193 DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
VD+W++G IL L+ +D + LT I +
Sbjct: 187 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-44
Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 9/215 (4%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLV---QH 76
+ +GRG F V R TG+ A+K +DK ++ E + LV
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
P +V + T KL IL+L +GGDL+ ++ +H SE R Y A+I+ + H
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHN 310
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL-GDSY 195
VV+RDLKP N++ + G V+++D G + F +K S G+ Y APE+L G +Y
Sbjct: 311 RFVVYRDLKPANILL-DEHGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 196 DAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTM 230
D + D +SLG +L+ L+ G +PF++ + +
Sbjct: 369 D-SSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-44
Identities = 61/211 (28%), Positives = 106/211 (50%), Gaps = 16/211 (7%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
++EE +GRG F VV A+ + + VA+K I+ + E+R + V HPN+V
Sbjct: 11 EVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESE----RKAFIVELRQLSRVNHPNIV 64
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREY-FA-QIVRAISFCHKLH 138
+LY + + L++E +GG LY+ + + T A + Q + +++ H +
Sbjct: 65 KLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 139 ---VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSY 195
++HRDLKP N++ V+K+ DFG + + + GS A+ APE+ G +Y
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA-CDIQ-THMTNNKGSAAWMAPEVFEGSNY 180
Query: 196 DAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226
DV+S G+IL+ ++ + PF E
Sbjct: 181 S-EKCDVFSWGIILWEVITRRKPFDEIGGPA 210
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-44
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
+++E +G G F V A + G VAVK++ + + +EV MK ++HPN+V
Sbjct: 40 NIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG--LSETYAREYFAQIVRAISFCHKLH 138
+ L ++ E G LY + K A L E + + +++ H +
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 139 --VVHRDLKPENVVFFERLGVVKLTDFGFSNRF--NPGQKLETSCGSLAYSAPEILLGDS 194
+VHR+LK N++ ++ VK+ DFG S R + +++ G+ + APE+L +
Sbjct: 158 PPIVHRNLKSPNLLVDKK-YTVKVCDFGLS-RLKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQE 221
+ DV+S GVIL+ L Q P+
Sbjct: 216 SN-EKSDVYSFGVILWELATLQQPWGN 241
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-44
Identities = 68/248 (27%), Positives = 120/248 (48%), Gaps = 20/248 (8%)
Query: 1 MSRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS 60
MS + + ++D K + +E G+G F V+L + TG VA+K K DP
Sbjct: 6 MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---KVIQDPRF 62
Query: 61 QDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK-------LYLILELGDGGDLYDYI---MK 110
++ Q ++ + ++ HPN+V+L T + L +++E L+ +
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYR 121
Query: 111 HDAGLSETYAREYFAQIVRAISFCHK--LHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168
+ + Q++R+I H ++V HRD+KP NV+ E G +KL DFG + +
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 169 FNPGQKLETS--CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226
+P + + C S Y APE++ G+ + AVD+WS+G I ++ G+ F+ N +
Sbjct: 182 LSPSEPN-VAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239
Query: 227 TLTMIMDV 234
L I+ V
Sbjct: 240 QLHEIVRV 247
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-43
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
E LG+G F H TGE + +K + + D +Q +EV+ M+ ++HPNV++
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
V+ + +L I E GG L I D+ + + I +++ H ++++H
Sbjct: 72 FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIH 131
Query: 142 RDLKPENVVFFERLGVVKLTDFGFS---------------NRFNPGQKLETSCGSLAYSA 186
RDL N + E V + DFG + + +K T G+ + A
Sbjct: 132 RDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 187 PEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220
PE++ G SYD VDV+S G++L ++
Sbjct: 191 PEMINGRSYDE-KVDVFSFGIVLCEIIGRVNADP 223
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-43
Identities = 56/240 (23%), Positives = 106/240 (44%), Gaps = 6/240 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
++ LG G+ VV H +G +A K+I + P ++ + +E++ + P +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYI 93
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KLH 138
V Y ++ ++ + +E DGG L D ++K + E + +++ +++ K
Sbjct: 94 VGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
++HRD+KP N++ R G +KL DFG S + + G+ +Y +PE L G Y
Sbjct: 153 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSVQ 210
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSRRRTTRKPS 258
+ D+WS+G+ L + G+ P + E M E R +
Sbjct: 211 S-DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-43
Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 17/230 (7%)
Query: 1 MSRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS 60
+ + D + + +GRG F V + TG + AVK +
Sbjct: 41 LLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL------- 93
Query: 61 QDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYA 120
+ +E+ + P +V LY + + + +EL +GG L ++K L E A
Sbjct: 94 EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRA 152
Query: 121 REYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC- 179
Y Q + + + H ++H D+K +NV+ L DFG + P ++
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 180 -----GSLAYSAPEILLGDSYDAPAVDVWSLG-VILYMLVAGQAPFQEAN 223
G+ + APE+++G D VD+WS ++L+ML G P+ +
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHML-NGCHPWTQYF 260
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-43
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH-----LYQEVRCMKLVQ 75
+ E+ +G+G F +V R V VA+K + + ++ +EV M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
HPN+V+LY + ++ +++E GDLY ++ + + I I +
Sbjct: 82 HPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 136 KLH--VVHRDLKPENVVFFERLG----VVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEI 189
+ +VHRDL+ N+ K+ DFG S + + + G+ + APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-QQSV-HSVSGLLGNFQWMAPET 197
Query: 190 LLGDS--YDAPAVDVWSLGVILYMLVAGQAPFQE 221
+ + Y D +S +ILY ++ G+ PF E
Sbjct: 198 IGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-43
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 10/206 (4%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
+ +GRG F V T +VA + KL + +E +K +QHPN+VR
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 82 LY----EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-- 135
Y + + L+ EL G L Y+ + + R + QI++ + F H
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTR 148
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSY 195
++HRDLK +N+ G VK+ D G + + G+ + APE + + Y
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFMAPE-MYEEKY 206
Query: 196 DAPAVDVWSLGVILYMLVAGQAPFQE 221
D +VDV++ G+ + + + P+ E
Sbjct: 207 D-ESVDVYAFGMCMLEMATSEYPYSE 231
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-42
Identities = 73/245 (29%), Positives = 111/245 (45%), Gaps = 29/245 (11%)
Query: 5 GSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL 64
GS ++ Y+ +G G + V AR +G VA+K ++
Sbjct: 4 GSMATSR--------YEPVAEIGVGAYGTVYKARDPHSGHFVALK---SVRVPNGGGGGG 52
Query: 65 Y------QEVRCMK---LVQHPNVVRLYEVI-----DTNSKLYLILELGDGGDLYDYIMK 110
+EV ++ +HPNVVRL +V D K+ L+ E D DL Y+ K
Sbjct: 53 GLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK 111
Query: 111 H-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169
GL ++ Q +R + F H +VHRDLKPEN + G VKL DFG + +
Sbjct: 112 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPEN-ILVTSGGTVKLADFGLARIY 170
Query: 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229
+ L +L Y APE+LL +Y A VD+WS+G I + + F ++++ L
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 229
Query: 230 MIMDV 234
I D+
Sbjct: 230 KIFDL 234
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-42
Identities = 65/231 (28%), Positives = 113/231 (48%), Gaps = 9/231 (3%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ 61
G ++ P ++ + E +G+G F V T + VA+K+ID + + +
Sbjct: 9 GLPGMQNLKADPEEL---FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE 65
Query: 62 DHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAR 121
D + QE+ + P V + Y ++KL++I+E GG D +++ L ET
Sbjct: 66 D-IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG-PLDETQIA 122
Query: 122 EYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCG 180
+I++ + + H +HRD+K NV+ E G VKL DFG + + + K T G
Sbjct: 123 TILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVG 181
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
+ + APE++ +YD+ A D+WSLG+ L G+ P E + + L +I
Sbjct: 182 TPFWMAPEVIKQSAYDSKA-DIWSLGITAIELARGEPPHSELHPMKVLFLI 231
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-42
Identities = 62/223 (27%), Positives = 101/223 (45%), Gaps = 12/223 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR-CMKLVQHPN 78
+ LGRG + VV+ RHV +G+ +AVK I T ++ Q L ++ M+ V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTVDCPF 67
Query: 79 VVRLYEVIDTNSKLYLILELGDGG--DLYDYIMKHDAGLSETYAREYFAQIVRAISFCH- 135
V Y + +++ +EL D Y ++ + E + IV+A+ H
Sbjct: 68 TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD-- 193
KL V+HRD+KP NV+ G VK+ DFG S + G Y APE + +
Sbjct: 128 KLSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELN 186
Query: 194 --SYDAPAVDVWSLGVILYMLVAGQAPFQE-ANDSETLTMIMD 233
Y + D+WSLG+ + L + P+ + L +++
Sbjct: 187 QKGYSVKS-DIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-42
Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 18/213 (8%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ--DHLYQEVRCMKLVQHPN 78
LEE +G G F V A + G++VAVK + +SQ +++ QE + +++HPN
Sbjct: 10 TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++ L V L L++E GG L + + + QI R +++ H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEA 125
Query: 139 ---VVHRDLKPENVVFFERLG-------VVKLTDFGFSNRFNPGQKLETSCGSLAYSAPE 188
++HRDLK N++ +++ ++K+TDFG + R ++ G+ A+ APE
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTKMSAAGAYAWMAPE 184
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221
++ + DVWS GV+L+ L+ G+ PF+
Sbjct: 185 VIRASMFS-KGSDVWSYGVLLWELLTGEVPFRG 216
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-42
Identities = 64/250 (25%), Positives = 102/250 (40%), Gaps = 33/250 (13%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
++ E +G+G F V R + GE VA+++ID + + +EV + +H NVV
Sbjct: 36 EIGELIGKGRFGQVYHGR--WHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
+ L +I L G LY + L R+ +IV+ + + H ++
Sbjct: 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFS------NRFNPGQKLETSCGSLAYSAPEILLGDS 194
H+DLK +NV + G V +TDFG KL G L + APEI+ S
Sbjct: 153 HKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 195 YDAP--------AVDVWSLGVILYMLVAGQAPFQEANDSETLTMI-----MDVSESSC-- 239
D DV++LG I Y L A + PF+ + + ++S+
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270
Query: 240 -------TCW 242
CW
Sbjct: 271 EISDILLFCW 280
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-42
Identities = 59/219 (26%), Positives = 110/219 (50%), Gaps = 13/219 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQHPN 78
Y L LGRG ++ V A ++ EKV VK L PV + + +E++ ++ L PN
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIKREIKILENLRGGPN 92
Query: 79 VVRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
++ L +++ + L+ E + D L++ R Y +I++A+ +CH
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS 148
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYD 196
+ ++HRD+KP NV+ ++L D+G + ++PGQ+ S + PE+L+
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 208
Query: 197 APAVDVWSLGVILYMLVAGQAP-FQEANDSETLTMIMDV 234
++D+WSLG +L ++ + P F ++ + L I V
Sbjct: 209 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-42
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 10/210 (4%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
+ + +G G F V + + G+ VAVK+++ T P EV ++ +H N++
Sbjct: 28 VGQRIGSGSFGTVYKGK--WHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 84
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
T +L ++ + +G LY ++ + + Q R + + H ++H
Sbjct: 85 FMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 142 RDLKPENVVFFERLGVVKLTDFGFS---NRFNPGQKLETSCGSLAYSAPEILLGDSYDA- 197
RDLK N+ E VK+ DFG + +R++ + E GS+ + APE++ +
Sbjct: 144 RDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 198 -PAVDVWSLGVILYMLVAGQAPFQEANDSE 226
DV++ G++LY L+ GQ P+ N+ +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRD 232
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 6e-42
Identities = 54/230 (23%), Positives = 97/230 (42%), Gaps = 17/230 (7%)
Query: 17 AGLYDLEETLGRGH--FAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
G Y+L +G+G V LAR+ TGE V V+ I+ L E+ KL
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH--DAGLSETYAREYFAQIVRAIS 132
HPN+V +++L+++ G D ++ G++E +++A+
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALD 142
Query: 133 FCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR-FNPGQKLETSCGSLAYS------ 185
+ H + VHR +K +++ G V L+ + + GQ+ YS
Sbjct: 143 YIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 186 -APEIL--LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+PE+L YD D++S+G+ L G PF++ ++ L +
Sbjct: 202 LSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-42
Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 10/234 (4%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKT-KLDPVS 60
+++ G Y L +GRG V A VA+K++ +T DPV
Sbjct: 18 GSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVF 77
Query: 61 QDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYA 120
+ + +E R +Q P+VV +++ + + +LY+ + L +G DL + + L+ A
Sbjct: 78 RTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRA 136
Query: 121 REYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC- 179
QI A+ H HRD+KPEN++ L DFG ++ + +
Sbjct: 137 VAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATTDEKLTQLGNT 195
Query: 180 -GSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
G+L Y APE D+++L +LY + G P+ + L+++
Sbjct: 196 VGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPY----QGDQLSVMG 244
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-42
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 8/211 (3%)
Query: 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DPVSQDHLYQEVRCM 71
I Y + + LG G + V LA KVA+K I + +EV
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNS 65
Query: 72 KLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
+ H N+V + +V + + YL++E +G L +YI H LS A + QI+ I
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGI 124
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC--GSLAYSAPEI 189
H + +VHRD+KP+N++ +K+ DFG + + +T+ G++ Y +PE
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 190 LLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220
G++ D D++S+G++LY ++ G+ PF
Sbjct: 184 AKGEATD-ECTDIYSIGIVLYEMLVGEPPFN 213
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-41
Identities = 78/251 (31%), Positives = 124/251 (49%), Gaps = 34/251 (13%)
Query: 1 MSRSG-SRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHV-FTGEKVAVKVIDKTKLD- 57
M + G R+ Y+ +G G + V AR + G VA+K + ++
Sbjct: 1 MEKDGLCRADQQ--------YECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQT 49
Query: 58 -----PVSQDHLYQEVRCMK---LVQHPNVVRLYEVI-----DTNSKLYLILELGDGGDL 104
P+S +EV ++ +HPNVVRL++V D +KL L+ E D DL
Sbjct: 50 GEEGMPLST---IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DL 105
Query: 105 YDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDF 163
Y+ K + G+ ++ Q++R + F H VVHRDLKP+N++ G +KL DF
Sbjct: 106 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADF 164
Query: 164 GFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223
G + ++ L + +L Y APE+LL SY A VD+WS+G I + + F+ ++
Sbjct: 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSS 223
Query: 224 DSETLTMIMDV 234
D + L I+DV
Sbjct: 224 DVDQLGKILDV 234
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-40
Identities = 65/224 (29%), Positives = 117/224 (52%), Gaps = 10/224 (4%)
Query: 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEV 68
G P + D +G G +V LAR +G +VAVK++D K ++ L+ EV
Sbjct: 39 DQGDPRLL---LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEV 93
Query: 69 RCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIV 128
M+ QH NVV +Y+ +L++++E GG L D I+ L+E ++
Sbjct: 94 VIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVR-LNEEQIATVCEAVL 151
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAP 187
+A+++ H V+HRD+K ++++ G VKL+DFGF + + K ++ G+ + AP
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
E++ Y VD+WSLG+++ +V G+ P+ + + + +
Sbjct: 211 EVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-40
Identities = 42/218 (19%), Positives = 81/218 (37%), Gaps = 14/218 (6%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
+ L H + R + G + VKV+ +E +++ HPNV+
Sbjct: 13 NFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 81 RLYEVIDT--NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKL 137
+ + LI G LY+ + + + + FA + R ++F H L
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130
Query: 138 H--VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSY 195
+ L +V+ E + +++ + + A+ APE L
Sbjct: 131 EPLIPRHALNSRSVMIDEDM-TARISMADVK-FS---FQSPGRMYAPAWVAPEALQKKPE 185
Query: 196 DAP--AVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
D + D+WS V+L+ LV + PF + ++ E +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-40
Identities = 66/224 (29%), Positives = 115/224 (51%), Gaps = 10/224 (4%)
Query: 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEV 68
S G P K Y E +G+G V A V TG++VA++ ++ + ++ + E+
Sbjct: 14 SVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEI 68
Query: 69 RCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIV 128
M+ ++PN+V + +L++++E GG L D ++ + E + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETC-MDEGQIAAVCRECL 126
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAP 187
+A+ F H V+HRD+K +N++ G VKLTDFGF + P Q K T G+ + AP
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
E++ +Y P VD+WSLG++ ++ G+ P+ N L +I
Sbjct: 186 EVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-40
Identities = 58/232 (25%), Positives = 109/232 (46%), Gaps = 10/232 (4%)
Query: 1 MSRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS 60
+ + S P + ++D+ E LG G + V A H TG+ VA+K + ++
Sbjct: 15 LKKLDEDSLTKQPEE---VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDL 68
Query: 61 QDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYA 120
Q+ + +E+ M+ P+VV+ Y N+ L++++E G + D I + L+E
Sbjct: 69 QE-IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEI 127
Query: 121 REYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLETSC 179
++ + + H + +HRD+K N++ G KL DFG + + K T
Sbjct: 128 ATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTMAKRNTVI 186
Query: 180 GSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
G+ + APE++ Y+ D+WSLG+ + G+ P+ + + + MI
Sbjct: 187 GTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-40
Identities = 72/246 (29%), Positives = 110/246 (44%), Gaps = 22/246 (8%)
Query: 1 MSRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS 60
MS S Y+L+E +G G AVV+ A EKVA+K I+ K S
Sbjct: 1 MSEDSSALPWSIN---RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-S 56
Query: 61 QDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYA 120
D L +E++ M HPN+V Y +L+L+++L GG + D I+KH E +
Sbjct: 57 MDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKS 115
Query: 121 R----EYFAQIVR----AISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS------ 166
A I+R + + HK +HRD+K N++ E G V++ DFG S
Sbjct: 116 GVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIADFGVSAFLATG 174
Query: 167 NRFNPGQKLETSCGSLAYSAPE-ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225
+ +T G+ + APE + YD D+WS G+ L G AP+ +
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPM 233
Query: 226 ETLTMI 231
+ L +
Sbjct: 234 KVLMLT 239
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-39
Identities = 67/251 (26%), Positives = 106/251 (42%), Gaps = 27/251 (10%)
Query: 1 MSRSGSRSSDGHPTKIAGLYDLE--ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP 58
+ SG DL+ +GRG + V H +G+ +AVK I T +D
Sbjct: 3 IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDE 61
Query: 59 VSQDHLYQEVR-CMKLVQHPNVVRLYEVIDTNSKLYLILELGDGG--DLYDYIMKHDAG- 114
Q L ++ M+ P +V+ Y + ++ +EL Y Y+
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV 121
Query: 115 LSETYAREYFAQIVRAISFCH-KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173
+ E + V+A++ L ++HRD+KP N++ G +KL DFG S GQ
Sbjct: 122 IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGIS-----GQ 175
Query: 174 KLETSC------GSLAYSAPEIL----LGDSYDAPAVDVWSLGVILYMLVAGQAPFQE-A 222
L S G Y APE + YD + DVWSLG+ LY L G+ P+ +
Sbjct: 176 -LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRS-DVWSLGITLYELATGRFPYPKWN 233
Query: 223 NDSETLTMIMD 233
+ + LT ++
Sbjct: 234 SVFDQLTQVVK 244
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-39
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 12/222 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR-CMKLVQHPN 78
+ +G G V R TG +AVK + ++ + + ++ +K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVLKSHDCPY 85
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KL 137
+V+ + TN+ +++ +EL + E + IV+A+ + K
Sbjct: 86 IVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQG-PIPERILGKMTVAIVKALYYLKEKH 144
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL-----LG 192
V+HRD+KP N++ + G +KL DFG S R + + S G AY APE +
Sbjct: 145 GVIHRDVKPSNIL-LDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203
Query: 193 DSYDAPAVDVWSLGVILYMLVAGQAPFQE-ANDSETLTMIMD 233
YD A DVWSLG+ L L GQ P++ D E LT ++
Sbjct: 204 PDYDIRA-DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-39
Identities = 62/240 (25%), Positives = 104/240 (43%), Gaps = 25/240 (10%)
Query: 1 MSRSGSRSSDGHPTKIAGLYDLE-ETLGRGHFAVVKLAR--HVFTGEKVAVKVIDKTKLD 57
M ++ L++ E +GRG + V A+ + A+K I+ T +
Sbjct: 3 MDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS 62
Query: 58 PVSQDHLYQEVRCMKLVQHPNVVRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHDAG- 114
+ +E+ ++ ++HPNV+ L +V + K++L+ + + DL+ I H A
Sbjct: 63 MSAC----REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASK 117
Query: 115 -------LSETYAREYFAQIVRAISFCHKLHVVHRDLKPENV---VFFERLGVVKLTDFG 164
L + QI+ I + H V+HRDLKP N+ G VK+ D G
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 165 FSNRFNPGQKLETSCGS----LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220
F+ FN K Y APE+LLG + A+D+W++G I L+ + F
Sbjct: 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-39
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 10/221 (4%)
Query: 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
++++ LG G F V A++ TG A KVI+ + + E+ + H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YIVEIEILATCDH 75
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
P +V+L + KL++++E GG + +++ D GL+E + Q++ A++F H
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQKLETSCGSLAYSAPEILLGDS- 194
++HRDLK NV+ G ++L DFG S + QK ++ G+ + APE+++ ++
Sbjct: 136 KRIIHRDLKAGNVLMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 195 ----YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
YD D+WSLG+ L + + P E N L I
Sbjct: 195 KDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 234
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-39
Identities = 59/231 (25%), Positives = 109/231 (47%), Gaps = 27/231 (11%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKL 73
Y+ +G+G F V ARH TG+KVA+K K ++ P++ +E++ ++L
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITA---LREIKILQL 72
Query: 74 VQHPNVVRLYEVIDTNS--------KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA 125
++H NVV L E+ T + +YL+ + + DL + + + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---- 181
++ + + H+ ++HRD+K NV+ GV+KL DFG + F+ + + + +
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 182 -LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
L Y PE+LLG+ P +D+W G I+ + Q + L +I
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-39
Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 14/218 (6%)
Query: 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DPVSQDHLYQEVRC 70
P+ ++ Y+L E LG G + V LAR + VAVKV+ + L DP +E +
Sbjct: 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQN 65
Query: 71 MKLVQHPNVVRLYEV----IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQ 126
+ HP +V +Y+ Y+++E DG L D + ++ A E A
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIAD 124
Query: 127 IVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC----GSL 182
+A++F H+ ++HRD+KP N++ VK+ DFG + T G+
Sbjct: 125 ACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220
Y +PE GDS D DV+SLG +LY ++ G+ PF
Sbjct: 184 QYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFT 220
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 12/221 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + +G G +V A VA+K + + + Y+E+ MK V H N+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 80 VRLYEVI------DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ L V + +YL++EL D +L I L Q++ I
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKH 179
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD 193
H ++HRDLKP N+V +K+ DFG + + + Y APE++LG
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
Y VD+WS+G I+ +V + F + + +++
Sbjct: 239 GYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 62/258 (24%), Positives = 111/258 (43%), Gaps = 52/258 (20%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y L +TLG G F +V + +G++ A+K K DP + +E+ MK++ H N+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQDPRYK---NRELDIMKVLDHVNI 62
Query: 80 VRLYEVIDTNSK--------------------------------------LYLILELGDG 101
++L + T L +I+E
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 102 GDLYDYI---MKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVV 158
L+ + ++ + Y Q+ RA+ F H L + HRD+KP+N++ + +
Sbjct: 123 -TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL 181
Query: 159 KLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQ 216
KL DFG + + P + + C S Y APE++LG + P++D+WS+G + L+ G+
Sbjct: 182 KLCDFGSAKKLIPSEPS-VAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 217 APFQEANDSETLTMIMDV 234
F + L I+ +
Sbjct: 240 PLFSGETSIDQLVRIIQI 257
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-37
Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 19/229 (8%)
Query: 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQ 75
AG+++L E +G G + V RHV TG+ A+KV+D + ++ + QE+ +K
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSH 79
Query: 76 HPNVVRLYE------VIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIV 128
H N+ Y + +L+L++E G + D I L E + +I+
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAP 187
R +S H+ V+HRD+K +NV+ E VKL DFG S + + T G+ + AP
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 188 EILLGD-----SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
E++ D +YD + D+WSLG+ + G P + + L +I
Sbjct: 199 EVIACDENPDATYDFKS-DLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-37
Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 19/247 (7%)
Query: 1 MSRSGSRSSDGHPTKIAGL-------YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDK 53
M R ++ + +I Y + +G G +V A VA+K + +
Sbjct: 1 MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60
Query: 54 TKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVI------DTNSKLYLILELGDGGDLYDY 107
+ Y+E+ MK V H N++ L V + +Y+++EL D +L
Sbjct: 61 PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQV 119
Query: 108 IMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167
I L Q++ I H ++HRDLKP N+V +K+ DFG +
Sbjct: 120 IQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLAR 175
Query: 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227
+ + Y APE++LG Y VD+WS+G I+ ++ G F + +
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 234
Query: 228 LTMIMDV 234
+++
Sbjct: 235 WNKVIEQ 241
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-36
Identities = 41/235 (17%), Positives = 61/235 (25%), Gaps = 34/235 (14%)
Query: 1 MSRSGSRSSDGHP--TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVID-KTKLD 57
S + P G Y L G A +VA+ +D + L
Sbjct: 12 ESSAPPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP 71
Query: 58 PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSE 117
+ + P V R+ +V+ T + ++ E GG L + D S
Sbjct: 72 DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSP 128
Query: 118 TYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177
A + A H+ V P V G V L
Sbjct: 129 VGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPA------------- 174
Query: 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
P D+ +G LY L+ + P EA L
Sbjct: 175 ------TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-36
Identities = 60/227 (26%), Positives = 114/227 (50%), Gaps = 15/227 (6%)
Query: 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ 75
+A Y++ + +G+G F V A + VA+K++ + + +E+R ++ ++
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV---RNEKRFHRQAAEEIRILEHLR 151
Query: 76 H------PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMK-HDAGLSETYAREYFAQIV 128
NV+ + E + + + EL +LY+ I K G S R++ I+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLG-VVKLTDFGFSNRFNPGQKLETSCGSLAYSAP 187
+ + HK ++H DLKPEN++ ++ +K+ DFG S+ + Q++ T S Y AP
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYE-HQRVYTYIQSRFYRAP 268
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
E++LG Y P +D+WSLG IL L+ G ++ + L ++++
Sbjct: 269 EVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 51/213 (23%), Positives = 90/213 (42%), Gaps = 21/213 (9%)
Query: 16 IAGLYDLEETLGRGHFAVVKLAR-HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
+AG Y+++ + G + LA G V +K + D +Q E + + V
Sbjct: 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEV 136
Query: 75 QHPNVVRLYEV-----IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVR 129
HP++V+++ + Y+++E G L + L A Y +I+
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILP 193
Query: 130 AISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAP 187
A+S+ H + +V+ DLKPEN++ E +KL D G +R N G+ + AP
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTE--EQLKLIDLGAVSRIN-----SFGYLYGTPGFQAP 246
Query: 188 EILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220
EI+ A D++++G L L
Sbjct: 247 EIVRTGP--TVATDIYTVGRTLAALTLDLPTRN 277
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-35
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 17/229 (7%)
Query: 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ-E 67
P K+ + +G G F V AR V E VA+K + + + E
Sbjct: 48 FKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE 104
Query: 68 VRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQI 127
VR ++ ++HPN ++ +L++E G D + H L E
Sbjct: 105 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 128 VRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--KLETSCGSLAYS 185
++ +++ H +++HRD+K N++ E G+VKL DFG + + G+ +
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSA-----SIMAPANSFVGTPYWM 217
Query: 186 APEILLGD---SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
APE++L YD VDVWSLG+ L + P N L I
Sbjct: 218 APEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 265
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 1e-34
Identities = 49/202 (24%), Positives = 78/202 (38%), Gaps = 23/202 (11%)
Query: 49 KVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYI 108
+ D P D ++R M N V + LY+ ++L +L D++
Sbjct: 93 ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152
Query: 109 --MKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166
F QI A+ F H ++HRDLKP N +FF VVK+ DFG
Sbjct: 153 NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSN-IFFTMDDVVKVGDFGLV 211
Query: 167 -------------NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILY-ML 212
G+ Y +PE + G++Y VD++SLG+IL+ +L
Sbjct: 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH-KVDIFSLGLILFELL 270
Query: 213 VAGQAPFQEAND-SETLTMIMD 233
F + +T + +
Sbjct: 271 Y----SFSTQMERVRIITDVRN 288
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-09
Identities = 16/65 (24%), Positives = 35/65 (53%), Gaps = 1/65 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
++ + +GRG F VV A++ A+K I ++++ + +EV+ + ++HP +
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGI 66
Query: 80 VRLYE 84
VR +
Sbjct: 67 VRYFN 71
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 17/229 (7%)
Query: 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ 75
Y+++ +G+G F V A E VA+K+I K + EVR ++L+
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII---KNKKAFLNQAQIEVRLLELMN 108
Query: 76 HP------NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIV 128
+V L + L L+ E+ +LYD + + G+S R++ Q+
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 129 RAISFCH--KLHVVHRDLKPENVVFFERL-GVVKLTDFGFSNRFNPGQKLETSCGSLAYS 185
A+ F +L ++H DLKPEN++ +K+ DFG S+ GQ++ S Y
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQL-GQRIYQYIQSRFYR 225
Query: 186 APEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
+PE+LLG YD +D+WSLG IL + G+ F AN+ + + I++V
Sbjct: 226 SPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEV 273
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-34
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
+ LG G F V + GEK VA+K + + +++ L E M V +P
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNP 77
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
+V RL + S + LI +L G L DY+ +H + Y + QI + +++
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDS 194
+VHRDL NV+ VK+TDFG + +K + G + + A E +L
Sbjct: 137 RLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 195 YDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMI 231
Y DVWS GV ++ ++ G P+ SE +++
Sbjct: 196 YTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 51/229 (22%), Positives = 91/229 (39%), Gaps = 17/229 (7%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ---DHL------YQEVRC 70
Y ++ + G + V G VA+K + T D + +E+R
Sbjct: 24 YTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 71 MKLVQHPNVVRLYEVI-----DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA 125
+ HPN++ L ++ KLYL+ EL DL I +S + + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYS 185
I+ + H+ VVHRDL P N++ + + + DF + Y
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADN-NDITICDFNLAREDTADANKTHYVTHRWYR 200
Query: 186 APEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
APE+++ VD+WS G ++ + +A F+ + L I++V
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV 249
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y +G G + V A +GEKVA+K + + + Y+E+ +K +QH NV
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 80 VRLYEVI------DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ L +V YL++ DL IM SE + Q+++ + +
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQK-IMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA---YSAPEIL 190
H VVHRDLKP N+ E +K+ DFG + + G + Y APE++
Sbjct: 142 IHSAGVVHRDLKPGNLAVNED-CELKILDFGLARHADA-----EMTGYVVTRWYRAPEVI 195
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
L + VD+WS+G I+ ++ G+ F+ + + LT I+ V
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-33
Identities = 47/223 (21%), Positives = 90/223 (40%), Gaps = 36/223 (16%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y++ +G G + V A VA+K I + D + + +E+ + + H +V
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 80 VRLYEVI-----DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
V++ +++ + +LY++LE+ D D L+E + + ++ + +
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVY-LTELHIKTLLYNLLVGVKYV 172
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA----------- 183
H ++HRDLKP N + + VK+ DFG + + + +
Sbjct: 173 HSAGILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 184 -----------------YSAPEILLGDSYDAPAVDVWSLGVIL 209
Y APE++L A+DVWS+G I
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-33
Identities = 60/239 (25%), Positives = 116/239 (48%), Gaps = 35/239 (14%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLVQH 76
Y + LG G +V A ++VA+K K+ DP S H +E++ ++ + H
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRLDH 67
Query: 77 PNVVRLYEVIDTNSK--------------LYLILELGDGGDLYDYIMKHDAGLSETYARE 122
N+V+++E++ + +Y++ E + DL + + + L E +AR
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGP--LLEEHARL 124
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
+ Q++R + + H +V+HRDLKP N+ V+K+ DFG + +P + G L
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH---YSHKGHL 181
Query: 183 A-------YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
+ Y +P +LL + A+D+W+ G I ++ G+ F A++ E + +I++
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 9e-33
Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 31/236 (13%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL----YQEVRCMKLVQ 75
+ L+ LG G + VV A H TGE VA+K K++P + +E++ +K +
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIK-----KIEPFDKPLFALRTLREIKILKHFK 67
Query: 76 HPNVVRLYEVI-----DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVR 129
H N++ ++ + + +++Y+I EL DL+ I LS+ + + YF Q +R
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQM--LSDDHIQ-YFIYQTLR 123
Query: 130 AISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA------ 183
A+ H +V+HRDLKP N++ +K+ DFG + + +
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 184 -----YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
Y APE++L + + A+DVWS G IL L + F + L +I +
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + +G G + V A TG KVA+K + + + Y+E+R +K ++H NV
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 80 VRLYEVI------DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ L +V D + YL++ DL + L E + Q+++ + +
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEK--LGEDRIQFLVYQMLKGLRY 143
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA---YSAPEIL 190
H ++HRDLKP N+ E +K+ DFG + + + G + Y APE++
Sbjct: 144 IHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQADSEMT-----GYVVTRWYRAPEVI 197
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
L VD+WS+G I+ ++ G+ F+ ++ + L IM V
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 241
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 9/217 (4%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
L E +GRG+F V R VAVK +T + L QE R +K HPN+VR
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHPNIVR 176
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVH 141
L V +Y+++EL GGD ++ A L + + + +H
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 142 RDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAY----SAPEILLGDSYDA 197
RDL N + E+ V+K++DFG S R S G +APE L Y +
Sbjct: 237 RDLAARNCLVTEKN-VLKISDFGMS-REEADGVYAASGGLRQVPVKWTAPEALNYGRY-S 293
Query: 198 PAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
DVWS G++L+ G +P+ ++ +T +
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 18/224 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y +G G + V A TG +VAVK + + + Y+E+R +K ++H NV
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 80 VRLYEVI------DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ L +V + + +YL+ L DL + + L++ + + QI+R + +
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQK--LTDDHVQFLIYQILRGLKY 147
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE---TSCGSLAYSAPEIL 190
H ++HRDLKP N+ E +K+ DFG + R + T Y APEI+
Sbjct: 148 IHSADIIHRDLKPSNLAVNED-CELKILDFGLA-RHTADEMTGYVATR----WYRAPEIM 201
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
L + VD+WS+G I+ L+ G+ F + + L +I+ +
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-32
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
+ LG G F V + GEK VA+K + + +++ L E M V +P
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNP 77
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
+V RL + S + LI +L G L DY+ +H + Y + QI + +++
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDS 194
+VHRDL NV+ VK+TDFG + +K + G + + A E +L
Sbjct: 137 RLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 195 YDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMI 231
Y DVWS GV ++ ++ G P+ SE +++
Sbjct: 196 YTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-32
Identities = 55/231 (23%), Positives = 104/231 (45%), Gaps = 28/231 (12%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP----VSQDHLYQEVRCMKLVQ 75
Y +G G + +V A +VA+K K+ P +E++ + +
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLRFR 83
Query: 76 HPNVVRLYEVI-----DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
H N++ + ++I + +Y++ +L + DLY + LS + + QI+R
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRG 140
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA------- 183
+ + H +V+HRDLKP N++ +K+ DFG + +P G L
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHD---HTGFLTEYVATRW 196
Query: 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
Y APEI+L ++D+WS+G IL +++ + F + + L I+ +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-32
Identities = 55/245 (22%), Positives = 104/245 (42%), Gaps = 33/245 (13%)
Query: 16 IAGLYDLEETLGRGHFA-VVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
+ Y++ LG G F VV+ H +VA+K+I + ++ E+ +K +
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII---RNVGKYREAARLEINVLKKI 73
Query: 75 QHP------NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQI 127
+ V + + + + + + EL G + ++++ +++ + R Q+
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 128 VRAISFCHKLHVVHRDLKPENVVFFERLGV------------------VKLTDFGFSNRF 169
A+ F H+ + H DLKPEN++F +++ DFG S F
Sbjct: 133 CHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATF 191
Query: 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229
+ + T + Y PE++L + P DVWS+G IL+ G FQ + E L
Sbjct: 192 D-HEHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLV 249
Query: 230 MIMDV 234
M+ +
Sbjct: 250 MMEKI 254
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 61/245 (24%), Positives = 108/245 (44%), Gaps = 33/245 (13%)
Query: 16 IAGLYDLEETLGRGHFA-VVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
++ Y++ +TLG G F VV+ H G VAVK++ K + E++ ++ +
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV---KNVDRYCEAARSEIQVLEHL 68
Query: 75 QHP------NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQI 127
V++ E + + + ++ EL G YD+I ++ + R+ QI
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 128 VRAISFCHKLHVVHRDLKPENVVFFERLGV------------------VKLTDFGFSNRF 169
++++F H + H DLKPEN++F + +K+ DFG S +
Sbjct: 128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATY 186
Query: 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229
+ + T + Y APE++L + P DVWS+G IL G F + E L
Sbjct: 187 D-DEHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244
Query: 230 MIMDV 234
M+ +
Sbjct: 245 MMERI 249
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-31
Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 12/218 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
+ LG G F V + GE V +KVI + K S + + + + H
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
++VRL + S L L+ + G L D++ +H L + QI + + + +
Sbjct: 76 HIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDS 194
+VHR+L NV+ V++ DFG ++ P K + + + A E +
Sbjct: 135 GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 195 YDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMI 231
Y DVWS GV ++ ++ G P+ +E ++
Sbjct: 194 YTH-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 54/243 (22%), Positives = 109/243 (44%), Gaps = 35/243 (14%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ---- 75
Y L LG GHF+ V LA+ + VA+K++ + D V + E++ ++ V
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 76 -------HPNVVRLYEVIDTNSK----LYLILELGDGGDLYDYIMK-HDAGLSETYAREY 123
++++L + + + ++ E+ G +L I K G+ Y ++
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI 136
Query: 124 FAQIVRAISFCHK-LHVVHRDLKPENVVFF-----ERLGVVKLTDFGFSNRFNPGQKLET 177
Q++ + + H+ ++H D+KPENV+ E L +K+ D G + + +
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWY-DEHYTN 194
Query: 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ------EANDSETLTMI 231
S + Y +PE+LLG + D+WS +++ L+ G F+ D + + I
Sbjct: 195 SIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 232 MDV 234
+++
Sbjct: 254 IEL 256
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-31
Identities = 54/270 (20%), Positives = 98/270 (36%), Gaps = 44/270 (16%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
L E +G+G + V + GE VAVK+ ++ E+ +++H N++
Sbjct: 12 LLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENILG 66
Query: 82 LY----EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-- 135
++++L+LI + G LYDY+ L I ++ H
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 136 ------KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE-----TSCGSLAY 184
K + HRDLK +N++ + G + D G + + G+ Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 185 SAPEILLGDSYDAPA-----VDVWSLGVILYMLVAG----------QAPFQEANDSETLT 229
APE+L VD+W+ G++L+ + + PF + ++
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 230 MIMDVSESSCTCWWRGRPRSRRRTTRKPSP 259
M C + RP R P+
Sbjct: 244 EDM----RKVVCVDQQRPNIPNRWFSDPTL 269
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-31
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 9/216 (4%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
++ LG G + V VAVK + K D + + +E MK ++HPN+V+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQ 280
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLHVV 140
L V Y+I E G+L DY+ + + Y A QI A+ + K + +
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 340
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAY--SAPEILLGDSYDAP 198
HR+L N + E +VK+ DFG S + +APE L + +
Sbjct: 341 HRNLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI- 398
Query: 199 AVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
DVW+ GV+L+ + G +P+ + S+ ++
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-31
Identities = 55/215 (25%), Positives = 105/215 (48%), Gaps = 13/215 (6%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
+ +G G F +V L + + KVA+K I + +S++ +E M + HP +V
Sbjct: 12 FVQEIGSGQFGLVHLG--YWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
+LY V + + L+ E + G L DY+ + + +++ + V+
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 126
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA---YSAPEILLGDSYDA 197
HRDL N + E V+K++DFG + RF + +S G+ +++PE+ Y +
Sbjct: 127 HRDLAARNCLVGENQ-VIKVSDFGMT-RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 198 PAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
DVWS GV+++ + + G+ P++ ++SE + I
Sbjct: 185 -KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-31
Identities = 63/217 (29%), Positives = 106/217 (48%), Gaps = 13/217 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
L + LG G F VVKL + G+ VAVK+I K +S+D +QE + M + HP +V
Sbjct: 12 LLKELGSGQFGVVKLG--KWKGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
+ Y V +Y++ E G L +Y+ H GL + E + ++F +
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA---YSAPEILLGDSYDA 197
HRDL N + L VK++DFG + R+ + +S G+ +SAPE+ Y +
Sbjct: 127 HRDLAARNCLVDRDL-CVKVSDFGMT-RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 198 PAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
DVW+ G++++ + G+ P+ +SE + +
Sbjct: 185 -KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-31
Identities = 57/249 (22%), Positives = 100/249 (40%), Gaps = 37/249 (14%)
Query: 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ 75
+ + + +G G F V L +H+ + AVKV+ + E +K +Q
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV---RNIKKYTRSAKIEADILKKIQ 89
Query: 76 H-----PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVR 129
+ N+V+ + + LI E G LY+ I +++ G + Y +I++
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 130 AISFCHKLHVVHRDLKPENVVFFERLGV------------------------VKLTDFGF 165
A+++ K+ + H DLKPEN++ + +KL DFG
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG- 207
Query: 166 SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225
F + + Y APE++L +D D+WS G +L L G F+
Sbjct: 208 CATFK-SDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 226 ETLTMIMDV 234
E L M+ +
Sbjct: 266 EHLAMMESI 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-30
Identities = 65/221 (29%), Positives = 93/221 (42%), Gaps = 16/221 (7%)
Query: 22 LEETLGRGHFAVVKLAR-HVFTGE--KVAVKVI--DKTKLDPVSQDHLYQEVRCMKLVQH 76
L E LG G F VV+ +G+ VAVK + D D + +EV M + H
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 80
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
N++RLY V+ + ++ EL G L D + KH Y Q+ + +
Sbjct: 81 RNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE--TSCGS---LAYSAPEILL 191
+HRDL N++ R +VK+ DFG R P A+ APE L
Sbjct: 140 KRFIHRDLAARNLLLATRD-LVKIGDFGLM-RALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 192 GDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMI 231
++ A D W GV L+ M GQ P+ N S+ L I
Sbjct: 198 TRTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-30
Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y ++ +GRG + V LA T + VA+K +++ D + + +E+ + ++ +
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 80 VRLYEVIDTNSK-----LYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISF 133
+RLY++I + LY++LE+ D DL + K L+E + + ++ +F
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIAD-SDLKK-LFKTPIFLTEEHIK-TILYNLLLGENF 144
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA---------- 183
H+ ++HRDLKP N + + VK+ DFG + N +
Sbjct: 145 IHESGIIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKN 203
Query: 184 -------------YSAPEILLGDSYDAPAVDVWSLGVIL 209
Y APE++L ++D+WS G I
Sbjct: 204 LKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-30
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 11/217 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
++ LG G + V VAVK + K D + + +E MK ++HPN+V+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLHVV 140
L V Y+I E G+L DY+ + + Y A QI A+ + K + +
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA---YSAPEILLGDSYDA 197
HRDL N + E +VK+ DFG S R G G+ ++APE L + +
Sbjct: 134 HRDLAARNCLVGENH-LVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 198 PAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
DVW+ GV+L+ + G +P+ + S+ ++
Sbjct: 192 -KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-30
Identities = 65/241 (26%), Positives = 110/241 (45%), Gaps = 31/241 (12%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQHPN 78
Y+L + LG+G + +V + TGE VAVK I + ++E+ + L H N
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 79 VVRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCH 135
+V L V+ D + +YL+ + + DL+ I + L + + Y Q+++ I + H
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI--LEPVHKQ-YVVYQLIKVIKYLH 126
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA------------ 183
++HRD+KP N++ VK+ DFG S F +++ +
Sbjct: 127 SGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 184 ----------YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
Y APEILLG + +D+WSLG IL ++ G+ F ++ L I+
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 234 V 234
V
Sbjct: 246 V 246
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-30
Identities = 49/247 (19%), Positives = 102/247 (41%), Gaps = 30/247 (12%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ 61
S SGS IA L+E++G+G F V + + GE+VAVK+ +
Sbjct: 26 SGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREE---RS 80
Query: 62 DHLYQEVRCMKLVQHPNVVRLY----EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSE 117
E+ +++H N++ + T ++L+L+ + + G L+DY+ ++ ++
Sbjct: 81 WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTV 138
Query: 118 TYAREYFAQIVRAISFCH--------KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169
+ ++ H K + HRDLK +N + ++ G + D G + R
Sbjct: 139 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKN-ILVKKNGTCCIADLGLAVRH 197
Query: 170 NPGQKLE-----TSCGSLAYSAPEILLG--DSYDAPA---VDVWSLGVILYMLVAGQAPF 219
+ G+ Y APE+L + + D++++G++ + + +
Sbjct: 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257
Query: 220 QEANDSE 226
D +
Sbjct: 258 GIHEDYQ 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-30
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 12/219 (5%)
Query: 22 LEETLGRGHFAVV---KLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
L LG G F V H VAVK K + + E MK + HP+
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAVIMKNLDHPH 74
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V+L +I ++I+EL G+L Y+ ++ L Y QI +A+++ ++
Sbjct: 75 IVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL---AYSAPEILLGDSY 195
VHRD+ N++ VKL DFG S R+ + + + + +PE + +
Sbjct: 134 CVHRDIAVRNILVASPE-CVKLGDFGLS-RYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 196 DAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
A DVW V ++ +L G+ PF + + + ++
Sbjct: 192 TT-ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-30
Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 44/290 (15%)
Query: 2 SRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ 61
S SGS IA + + +G+G + V + + + GEKVAVKV T+ +
Sbjct: 21 SGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEE---AS 75
Query: 62 DHLYQEVRCMKLVQHPNVVRLY----EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSE 117
E+ L++H N++ + + ++LYLI + + G LYDY+ L
Sbjct: 76 WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDA 133
Query: 118 TYAREYFAQIVRAISFCH--------KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169
+ V + H K + HRDLK +N++ + G + D G + +F
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKF 192
Query: 170 NPGQKLE-----TSCGSLAYSAPEILLG--DSYDAPA---VDVWSLGVILYMLVAG---- 215
T G+ Y PE+L + + D++S G+IL+ +
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252
Query: 216 ------QAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSRRRTTRKPSP 259
Q P+ + S+ M C + RP R +
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDM----REIVCIKKLRPSFPNRWSSDECL 298
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-30
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 12/219 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
L +G G F V ++ VA+K D V + L QE M+ HP+
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPH 77
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V+L VI T + +++I+EL G+L ++ L Y Q+ A+++
Sbjct: 78 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL---AYSAPEILLGDSY 195
VHRD+ NV+ VKL DFG S R+ + + APE + +
Sbjct: 137 FVHRDIAARNVLVSSND-CVKLGDFGLS-RYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 196 DAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
A DVW GV ++ +L+ G PFQ +++ + I +
Sbjct: 195 -TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-30
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 13/217 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
+ LG G F VVK + + G+ VA+K+I K +S+D +E + M + H +V
Sbjct: 28 FLKELGTGQFGVVKYGK--WRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
+LY V +++I E G L +Y+ + E + A+ + +
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA---YSAPEILLGDSYDA 197
HRDL N + ++ VVK++DFG S R+ + +S GS +S PE+L+ + +
Sbjct: 143 HRDLAARNCLVNDQG-VVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 198 PAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
D+W+ GV+++ + G+ P++ +SET I
Sbjct: 201 -KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-30
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 11/214 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
LE LG+G F V + T +VA+K + K +S + QE + MK ++H +V+
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTT-RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDA-GLSETYAREYFAQIVRAISFCHKLHVV 140
LY V+ + +Y++ E G L D++ L + AQI +++ +++ V
Sbjct: 244 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAY--SAPEILLGDSYDAP 198
HRDL+ N++ E L V K+ DFG + + +APE L +
Sbjct: 303 HRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 360
Query: 199 AVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
DVWS G++L L G+ P+ + E L +
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 11/214 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
LE LG+G F V + T +VA+K + K +S + QE + MK ++H +V+
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTT-RVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHDA-GLSETYAREYFAQIVRAISFCHKLHVV 140
LY V+ + +Y++ E G L D++ L + AQI +++ +++ V
Sbjct: 327 LYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 385
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAY--SAPEILLGDSYDAP 198
HRDL+ N++ E L V K+ DFG + + +APE L +
Sbjct: 386 HRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 443
Query: 199 AVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231
DVWS G++L L G+ P+ + E L +
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 53/217 (24%), Positives = 97/217 (44%), Gaps = 11/217 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE--KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
++ LG G+F VK + VAVK++ DP +D L E M+ + +P +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
VR+ + L++E+ + G L Y+ ++ + + E Q+ + + + +
Sbjct: 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF 138
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL-ETSCGS---LAYSAPEILLGDSY 195
VHRDL NV+ + K++DFG S + + + + APE + +
Sbjct: 139 VHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 196 DAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMI 231
+ DVWS GV+++ GQ P++ SE M+
Sbjct: 198 SS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-29
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 13/218 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE--KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ LG G+F V+ + + VA+KV+ K + + + +E + M + +P +
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
VRL V L L++E+ GG L+ +++ + + E Q+ + + + +
Sbjct: 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE--TSCGS---LAYSAPEILLGDS 194
VHRDL NV+ R K++DFG S + L + APE +
Sbjct: 132 VHRDLAARNVLLVNRH-YAKISDFGLS-KALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 195 YDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMI 231
+ + DVWS GV ++ L GQ P+++ E + I
Sbjct: 190 FSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 10/218 (4%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
L +G G F V ++ VA+K D V + L QE M+ HP+
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPH 452
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V+L VI T + +++I+EL G+L ++ L Y Q+ A+++
Sbjct: 453 IVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL--AYSAPEILLGDSYD 196
VHRD+ NV+ VKL DFG S + S G L + APE + +
Sbjct: 512 FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 197 APAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ A DVW GV ++ +L+ G PFQ +++ + I +
Sbjct: 571 S-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 57/250 (22%), Positives = 100/250 (40%), Gaps = 37/250 (14%)
Query: 4 SGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH 63
SG + + L E RG F V A+ E VAVK+ QD
Sbjct: 10 SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFP-------IQDK 60
Query: 64 LY----QEVRCMKLVQHPNVVRL--YEVIDTNSK--LYLILELGDGGDLYDYIMKHDAGL 115
EV + ++H N+++ E T+ L+LI + G L D++ +
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVV 118
Query: 116 SETYAREYFAQIVRAISFCH----------KLHVVHRDLKPENVVFFERLGVVKLTDFGF 165
S + R +++ H K + HRD+K +NV+ + + DFG
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL-LKNNLTACIADFGL 177
Query: 166 SNRFNPGQKLETS---CGSLAYSAPEILLGD-SYDAPA---VDVWSLGVILYMLVAGQAP 218
+ +F G+ + G+ Y APE+L G ++ A +D++++G++L+ L +
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA 237
Query: 219 FQEANDSETL 228
D L
Sbjct: 238 ADGPVDEYML 247
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-28
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 15/218 (6%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
L E LG G F V + + G KVAVK + K +S D E MK +QH +V
Sbjct: 17 LVERLGAGQFGEVWMG--YYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHV 139
RLY V+ T +Y+I E + G L D++ L+ + AQI ++F + +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA---YSAPEILLGDSYD 196
+HRDL+ N++ + L K+ DFG + R + G+ ++APE + ++
Sbjct: 131 IHRDLRAANILVSDTL-SCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 197 APAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
DVWS G++L +V G+ P+ + E + +
Sbjct: 189 I-KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-28
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 13/221 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
+++ +G G F V R +K VA+K + + +D L E M HPN
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPN 107
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++RL V+ + + ++ E + G L ++ KHDA + I + + +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRF---NPGQKLETSCGSLAY--SAPEILLGD 193
VHRDL N++ L V K++DFG R +P T G + ++PE +
Sbjct: 168 YVHRDLAARNILINSNL-VCKVSDFGLG-RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 194 SYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
+ A DVWS G++L+ +++ G+ P+ E ++ + + + +
Sbjct: 226 KF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 6e-28
Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 13/218 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE--KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ LG G+F V+ + + VA+KV+ K + + + +E + M + +P +
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
VRL V L L++E+ GG L+ +++ + + E Q+ + + + +
Sbjct: 399 VRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE--TSCGS---LAYSAPEILLGDS 194
VHR+L NV+ R K++DFG S + L + APE +
Sbjct: 458 VHRNLAARNVLLVNRH-YAKISDFGLS-KALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 195 YDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMI 231
+ + DVWS GV ++ L GQ P+++ E + I
Sbjct: 516 FSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-28
Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 13/221 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
+E+ +G G V R G+ VA+K + + +D L E M HPN
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQFDHPN 111
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++RL V+ ++ E + G L ++ HD + + + + L
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA-----YSAPEILLGD 193
VHRDL NV+ L V K++DFG S R + ++APE +
Sbjct: 172 YVHRDLAARNVLVDSNL-VCKVSDFGLS-RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 194 SYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
++ + A DVWS GV+++ +L G+ P+ + + ++ + +
Sbjct: 230 TF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-27
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
L +T+G+G F V L + G KVAVK I K D +Q L E M ++H N+V+
Sbjct: 25 LLQTIGKGEFGDVMLG--DYRGNKVAVKCI---KNDATAQAFL-AEASVMTQLRHSNLVQ 78
Query: 82 LYEVI-DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLHV 139
L VI + LY++ E G L DY+ + F+ + A+ + +
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS---LAYSAPEILLGDSYD 196
VHRDL NV+ E V K++DFG + + + T + ++APE L +
Sbjct: 139 VHRDLAARNVLVSEDN-VAKVSDFGLT-K----EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 197 APAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
DVWS G++L+ + + G+ P+ + + +
Sbjct: 193 T-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 14/222 (6%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
++ +G G F V + K VA+K + + D L E M H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFSHH 106
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
N++RL VI + +I E + G L ++ + D S I + + +
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRF---NPGQKLETSCGSLAY--SAPEILLG 192
+ VHRDL N++ L V K++DFG S R +P TS G + +APE +
Sbjct: 167 NYVHRDLAARNILVNSNL-VCKVSDFGLS-RVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 193 DSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
+ A DVWS G++++ ++ G+ P+ E ++ E + I D
Sbjct: 225 RKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-27
Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 21/219 (9%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR 81
L +T+G+G F V L + G KVAVK I K D +Q L E M ++H N+V+
Sbjct: 197 LLQTIGKGEFGDVMLG--DYRGNKVAVKCI---KNDATAQAFL-AEASVMTQLRHSNLVQ 250
Query: 82 LYEVIDTNSK--LYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLH 138
L VI K LY++ E G L DY+ + F+ + A+ + +
Sbjct: 251 LLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFS---NRFNPGQKLETSCGSLAYSAPEILLGDSY 195
VHRDL NV+ E V K++DFG + + KL + ++APE L +
Sbjct: 310 FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKF 363
Query: 196 DAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
DVWS G++L+ + + G+ P+ + + +
Sbjct: 364 ST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-27
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 16/200 (8%)
Query: 22 LEETLGRGHFAVVKLAR----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
+ LG+G+F V++ R TGE VAVK + + + +D +E+ +K +QH
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFE-REIEILKSLQHD 71
Query: 78 NVVRLYEVIDTNSK--LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
N+V+ V + + L LI+E G L DY+ KH + +Y +QI + + +
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYS-----APEIL 190
+HRDL N++ VK+ DFG + + P K S APE L
Sbjct: 132 TKRYIHRDLATRNILVENEN-RVKIGDFGLT-KVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 191 LGDSYDAPAVDVWSLGVILY 210
+ A DVWS GV+LY
Sbjct: 190 TESKFSV-ASDVWSFGVVLY 208
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-27
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 22/237 (9%)
Query: 1 MSRSGSRSSDGHPTKIAGLYD-----LEETLGRGHFAVVKLARHVF----TGEKVAVKVI 51
M + + + +++ LG+G+F V+L R+ TG VAVK +
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL 60
Query: 52 DKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK--LYLILELGDGGDLYDYIM 109
+ D Q +E++ +K + +V+ V + L L++E G L D++
Sbjct: 61 QHSGPD--QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ 118
Query: 110 KHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169
+H A L + Y +QI + + + VHRDL N++ VK+ DFG + +
Sbjct: 119 RHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLA-KL 176
Query: 170 NPGQKLETSCGSLAYS-----APEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQ 220
P K S APE L + + DVWS GV+LY +
Sbjct: 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR-QSDVWSFGVVLYELFTYCDKSCS 232
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 15/218 (6%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
LE+ LG G F V +A + KVAVK + K +S + E MK +QH +V
Sbjct: 192 LEKKLGAGQFGEVWMA--TYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA-QIVRAISFCHKLHV 139
+L+ V+ T +Y+I E G L D++ + F+ QI ++F + +
Sbjct: 247 KLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL---AYSAPEILLGDSYD 196
+HRDL+ N++ L V K+ DFG + R + G+ ++APE + S+
Sbjct: 306 IHRDLRAANILVSASL-VCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 197 APAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
DVWS G++L +V G+ P+ ++ E + +
Sbjct: 364 I-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 22 LEETLGRGHFAVVKLARHV----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
+ LG+G+F V++ R+ TGE VAVK + + + +D +E+ +K +QH
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHLRDFE-REIEILKSLQHD 102
Query: 78 NVVRLYEVIDTNSK--LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
N+V+ V + + L LI+E G L DY+ KH + +Y +QI + + +
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYS-----APEIL 190
+HRDL N++ VK+ DFG + + P K S APE L
Sbjct: 163 TKRYIHRDLATRNILVENEN-RVKIGDFGLT-KVLPQDKEYYKVKEPGESPIFWYAPESL 220
Query: 191 LGDSYDAPAVDVWSLGVILY 210
+ A DVWS GV+LY
Sbjct: 221 TESKFSV-ASDVWSFGVVLY 239
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-26
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 22 LEETLGRGHFAVVKLARHVF----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
LG GHF V+L R+ TGE+VAVK + K + L +E+ ++ + H
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHE 83
Query: 78 NVVRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
N+V+ + D + + LI+E G L +Y+ K+ ++ +Y QI + + +
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYS-----APEIL 190
VHRDL NV+ VK+ DFG + + K + S APE L
Sbjct: 144 SRQYVHRDLAARNVLVESEH-QVKIGDFGLT-KAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 191 LGDSYDAPAVDVWSLGVILY 210
+ + A DVWS GV L+
Sbjct: 202 MQSKFYI-ASDVWSFGVTLH 220
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 60/202 (29%), Positives = 89/202 (44%), Gaps = 21/202 (10%)
Query: 22 LEETLGRGHFAVVKLAR----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP 77
LG GHF V L + TGE VAVK + K P + QE+ ++ + H
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHE 93
Query: 78 NVVRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHDAGLSE--TYAREYFAQIVRAISF 133
++++ + L L++E G L DY+ +H GL++ +A QI +++
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA----QQICEGMAY 149
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYS-----APE 188
H H +HRDL NV+ +VK+ DFG + + P S APE
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLA-KAVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 189 ILLGDSYDAPAVDVWSLGVILY 210
L + A DVWS GV LY
Sbjct: 208 CLKEYKFYY-ASDVWSFGVTLY 228
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-26
Identities = 47/235 (20%), Positives = 85/235 (36%), Gaps = 36/235 (15%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-------KVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
E+LG+G F + G+ +V +KV+DK + + ++ M +
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY--SESFFEAASMMSKL 69
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
H ++V Y V + L+ E G L Y+ K+ ++ + E Q+ A+ F
Sbjct: 70 SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129
Query: 135 HKLHVVHRDLKPENVVFFERLG-------VVKLTDFGFSNRFNPGQKLETSCGSLAY--- 184
+ ++H ++ +N++ +KL+D G S P
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------ILQE 179
Query: 185 ----SAPE-ILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
PE I + + A D WS G L+ + G P + L D
Sbjct: 180 RIPWVPPECIENPKNLNL-ATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 52/222 (23%), Positives = 83/222 (37%), Gaps = 13/222 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
E +GRGHF V + K AVK + D E MK HPN
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 79 VVRLYEVI-DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
V+ L + + ++L GDL ++I + + Q+ + + +
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFS---NRFNPGQKLETSCGSLAYS--APEILLG 192
VHRDL N + E+ VK+ DFG + + L A E L
Sbjct: 148 KFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 193 DSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ DVWS GV+L+ ++ G P+ + N + ++
Sbjct: 207 QKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-25
Identities = 55/270 (20%), Positives = 91/270 (33%), Gaps = 54/270 (20%)
Query: 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
L E +GRG + V VAVKV + + + + L++H N+
Sbjct: 16 KLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINE---KNIYRVPLMEHDNIA 70
Query: 81 RLY-----EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
R D + L++E G L Y+ H + + R +++ H
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH 128
Query: 136 ---------KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-------- 178
K + HRDL N V + G ++DFG S R + +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRN-VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 179 -CGSLAYSAPEILLG------DSYDAPAVDVWSLGVILYMLVAG-------------QAP 218
G++ Y APE+L G VD+++LG+I + + Q
Sbjct: 188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
Query: 219 FQEANDSETLTMIMDVSESSCTCWWRGRPR 248
FQ + M + RP+
Sbjct: 248 FQTEVGNHPTFEDM----QVLVSREKQRPK 273
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-24
Identities = 48/222 (21%), Positives = 93/222 (41%), Gaps = 13/222 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
+ +G+GHF VV ++ + + A+K + + + +E M+ + HPN
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 79 VVRLYEV-IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
V+ L + + +++L GDL +I + + Q+ R + + +
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFS-----NRFNPGQKLETSCGSLAYSAPEILLG 192
VHRDL N + E VK+ DFG + + Q+ + + ++A E L
Sbjct: 144 KFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 193 DSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
+ DVWS GV+L+ L+ G P++ + + +
Sbjct: 203 YRFTT-KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 3e-24
Identities = 53/222 (23%), Positives = 83/222 (37%), Gaps = 13/222 (5%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
E +GRGHF V + K AVK + D E MK HPN
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 79 VVRLYEVI-DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
V+ L + + ++L GDL ++I + + Q+ + + F
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFS---NRFNPGQKLETSCGSLAYS--APEILLG 192
VHRDL N + E+ VK+ DFG + + L A E L
Sbjct: 212 KFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 193 DSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ DVWS GV+L+ ++ G P+ + N + ++
Sbjct: 271 QKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-23
Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 21/230 (9%)
Query: 22 LEETLGRGHF-AVVK-LARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
+ LG+G F V + +A+ V E +VA+K + + E MK
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNC 87
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE--------YFA-QI 127
+VVRL V+ +I+EL GDL Y+ ++ A +I
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 128 VRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS-NRFNPGQKLETSCGSLAYS- 185
+++ + VHRDL N + E VK+ DFG + + + + G L
Sbjct: 148 ADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 186 -APEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+PE L + DVWS GV+L+ + + P+Q ++ + L +M+
Sbjct: 207 MSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-22
Identities = 55/235 (23%), Positives = 92/235 (39%), Gaps = 30/235 (12%)
Query: 22 LEETLGRGHFAVV---KLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
L LG+G F V +L + + KVAVK++ + + +E CMK HP+
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 79 VVRLYEV------IDTNSKLYLILELGDGGDLYDYIMKH-----DAGLSETYAREYFAQI 127
V +L V +IL GDL+ +++ L + I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 128 VRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN--------RFNPGQKLETSC 179
+ + + +HRDL N + E + V + DFG S R KL
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCVADFGLSRKIYSGDYYRQGCASKL---- 201
Query: 180 GSLAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ + A E L + Y DVW+ GV ++ ++ GQ P+ ++E ++
Sbjct: 202 -PVKWLALESLADNLYTV-HSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-21
Identities = 56/234 (23%), Positives = 88/234 (37%), Gaps = 29/234 (12%)
Query: 22 LEETLGRGHFAVV---KLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
L + LG G F V L + T KVAVK + + E CMK HPN
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 79 VVRLYEVI-----DTNSKLYLILELGDGGDLYDYIMKH-----DAGLSETYAREYFAQIV 128
V+RL V K +IL GDL+ Y++ + ++ I
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN--------RFNPGQKLETSCG 180
+ + + +HRDL N + + + V + DFG S R K+
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYRQGRIAKM----- 211
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ + A E L Y + DVW+ GV ++ + G P+ + E ++
Sbjct: 212 PVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 3e-21
Identities = 61/295 (20%), Positives = 112/295 (37%), Gaps = 79/295 (26%)
Query: 12 HPTKI----AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQE 67
H KI G Y + LG GHF+ V L+ + + VA+KV+ K + E
Sbjct: 27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV---KSAEHYTETALDE 83
Query: 68 VRCMKLVQ-----HPN---VVRLYEVIDTNSK----LYLILELGDGGDLYDYIMK-HDAG 114
+R +K V+ PN VV+L + + + ++ E+ G L +I+K + G
Sbjct: 84 IRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQG 142
Query: 115 LSETYAREYFAQIVRAISFCH-KLHVVHRDLKPENVVF---------------------- 151
L ++ Q+++ + + H K ++H D+KPEN++
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 152 --------------------------FERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYS 185
VK+ D G + + + Y
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYR 260
Query: 186 APEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ------EANDSETLTMIMDV 234
+ E+L+G Y+ PA D+WS + + L G F+ D + + +I+++
Sbjct: 261 SLEVLIGSGYNTPA-DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 6e-21
Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 29/236 (12%)
Query: 22 LEETLGRGHFAVVKL--ARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
L+ LG G F V L ++ + VAVK + K + QD +E + ++QH
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQD-FQREAELLTMLQH 102
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE-------------Y 123
++VR + V L ++ E GDL ++ H E
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 124 FA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
A Q+ + + LH VHRDL N + + L VVK+ DFG S R G
Sbjct: 163 VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL-VVKIGDFGMS-RDIYSTDYYRVGGRT 220
Query: 183 A----YSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ PE +L + DVWS GV+L+ + G+ P+ + +++E + I
Sbjct: 221 MLPIRWMPPESILYRKFTT-ESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-20
Identities = 51/234 (21%), Positives = 86/234 (36%), Gaps = 29/234 (12%)
Query: 22 LEETLGRGHFAVV--KLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
L LG G F V + +VAVK + + + D L E + H
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNH 92
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH------DAGLSETYAREYFAQIVRA 130
N+VR V + ++++EL GGDL ++ + + L+ I
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 131 ISFCHKLHVVHRDLKPENV-VFFERLG-VVKLTDFGFSN--------RFNPGQKLETSCG 180
+ + H +HRD+ N + G V K+ DFG + R L
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML----- 207
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ + PE + + D WS GV+L+ + G P+ ++ E L +
Sbjct: 208 PVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-20
Identities = 50/234 (21%), Positives = 84/234 (35%), Gaps = 29/234 (12%)
Query: 22 LEETLGRGHFAVV--KLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
L LG G F V + +VAVK + + E + H
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNH 133
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH------DAGLSETYAREYFAQIVRA 130
N+VR V + +++LEL GGDL ++ + + L+ I
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 131 ISFCHKLHVVHRDLKPENV-VFFERLG-VVKLTDFGFSN--------RFNPGQKLETSCG 180
+ + H +HRD+ N + G V K+ DFG + R L
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML----- 248
Query: 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
+ + PE + + D WS GV+L+ + + G P+ ++ E L +
Sbjct: 249 PVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-20
Identities = 56/241 (23%), Positives = 95/241 (39%), Gaps = 33/241 (13%)
Query: 22 LEETLGRGHF-AVVK-LARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQ 75
+TLG G F VV+ A + + VAVK++ K ++ L E++ + L
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGN 85
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYF----------- 124
H N+V L +I E GDL +++ + +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 125 ------AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR--FNPGQKLE 176
Q+ + ++F + +HRDL N++ + K+ DFG + R N +
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLA-RDIKNDSNYVV 203
Query: 177 TSCGSLAYS--APEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQE-ANDSETLTMIM 232
L APE + Y + DVWS G+ L+ L + G +P+ DS+ MI
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFES-DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262
Query: 233 D 233
+
Sbjct: 263 E 263
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-20
Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 38/241 (15%)
Query: 22 LEETLGRGHFAVVKL--ARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
L+ LG G F V L ++ + VAVK + K +D +E + +QH
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKD-FQREAELLTNLQH 76
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE-------------- 122
++V+ Y V L ++ E GDL ++ H +
Sbjct: 77 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 123 YFA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN--------RFNPGQ 173
+ A QI + + H VHRDL N + L +VK+ DFG S R
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIM 232
L + + PE ++ + DVWS GVIL+ + G+ P+ + +++E + I
Sbjct: 196 ML-----PIRWMPPESIMYRKFTT-ESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249
Query: 233 D 233
Sbjct: 250 Q 250
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-19
Identities = 55/245 (22%), Positives = 96/245 (39%), Gaps = 45/245 (18%)
Query: 22 LEETLGRGHFAVVKL--ARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
E LG F V GE VA+K + P+ ++ E +QH
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRARLQH 71
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYF------------ 124
PNVV L V+ + L +I GDL+++++ +
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 125 ---AQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS 181
AQI + + HVVH+DL NV+ +++L VK++D G +++ +
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL-NVKISDLGLF------REVYA---A 181
Query: 182 LAYS------------APEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETL 228
Y APE ++ + D+WS GV+L+ + G P+ ++ + +
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSI-DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 229 TMIMD 233
MI +
Sbjct: 241 EMIRN 245
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 61/240 (25%), Positives = 96/240 (40%), Gaps = 32/240 (13%)
Query: 22 LEETLGRGHF-AVVK-LARHVFTGE-----KVAVKVIDKTKLDPVSQDHLYQEVRCMK-L 73
L + LG G F VV A + + VAVK++ K L E+ MK +
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMI 97
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE----------- 122
+H N++ L + LY+I+E G+L +Y+ E
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 123 ---YFA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR--FNPGQKLE 176
Q+ R + + +HRDL NV+ E V+K+ DFG + R N +
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLA-RDINNIDYYKK 215
Query: 177 TSCGSLAYS--APEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
T+ G L APE L Y DVWS GV+++ + G +P+ E ++ +
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-19
Identities = 56/258 (21%), Positives = 89/258 (34%), Gaps = 63/258 (24%)
Query: 22 LEETLGRGHFAVVKL--ARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
+G G F V A + E VAVK++ K + Q +E M +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDN 109
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE-------------- 122
PN+V+L V + L+ E GDL +++ + +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 123 --------YFA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173
A Q+ +++ + VHRDL N + E + VVK+ DFG S R
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLS-R----- 222
Query: 174 KLETSCGSLAYS-----------------APEILLGDSYDAPAVDVWSLGVILY-MLVAG 215
YS PE + + Y DVW+ GV+L+ + G
Sbjct: 223 --------NIYSADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYG 273
Query: 216 QAPFQEANDSETLTMIMD 233
P+ E + + D
Sbjct: 274 LQPYYGMAHEEVIYYVRD 291
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-19
Identities = 56/239 (23%), Positives = 93/239 (38%), Gaps = 30/239 (12%)
Query: 22 LEETLGRGHF-AVVK-LARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQ 75
L + LGRG F V++ A + VAVK++ K L E++ + +
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGH 89
Query: 76 HPNVVRLYEV-IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE------------ 122
H NVV L L +I+E G+L Y+
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 123 --YFA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS-NRFNPGQKLETS 178
++ Q+ + + F +HRDL N++ E+ VVK+ DFG + + + +
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKG 208
Query: 179 CGSLAYS--APEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQE-ANDSETLTMIMD 233
L APE + Y DVWS GV+L+ + + G +P+ D E + +
Sbjct: 209 DARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-19
Identities = 61/240 (25%), Positives = 96/240 (40%), Gaps = 32/240 (13%)
Query: 22 LEETLGRGHF-AVVK-LARHVFTGE-----KVAVKVIDKTKLDPVSQDHLYQEVRCMK-L 73
L + LG G F VV A + + VAVK++ K L E+ MK +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMI 143
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE----------- 122
+H N++ L + LY+I+E G+L +Y+ E
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 123 ---YFA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR--FNPGQKLE 176
Q+ R + + +HRDL NV+ E V+K+ DFG + R N +
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLA-RDINNIDYYKK 261
Query: 177 TSCGSLAYS--APEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
T+ G L APE L Y DVWS GV+++ + G +P+ E ++ +
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 320
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-19
Identities = 59/235 (25%), Positives = 97/235 (41%), Gaps = 30/235 (12%)
Query: 22 LEETLGRGHFAVVKLARHVFTGEK--VAVKVIDKTKLDPVSQDH--LYQEVRCMK-LVQH 76
++ +G G+F V AR G + A+K + K DH E+ + L H
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHH 85
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE-------------- 122
PN++ L + LYL +E G+L D++ K ++
Sbjct: 86 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 123 YFA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGS 181
+FA + R + + + +HRDL N++ E V K+ DFG S R ++ + G
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLS-R-GQEVYVKKTMGR 202
Query: 182 LA--YSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
L + A E L Y DVWS GV+L+ +V+ G P+ +E +
Sbjct: 203 LPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 256
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-19
Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 29/237 (12%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-----KVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQ 75
+TLG G F V A G+ KVAVK++ K+ ++ L E++ M L Q
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQ 108
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE------------Y 123
H N+V L + +I E GDL +++ + L A +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 124 FA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR--FNPGQKLETSCG 180
F+ Q+ + ++F + +HRD+ NV+ V K+ DFG + R N +
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIGDFGLA-RDIMNDSNYIVKGNA 226
Query: 181 SLAYS--APEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQ-EANDSETLTMIMD 233
L APE + Y DVWS G++L+ + + G P+ +S+ ++ D
Sbjct: 227 RLPVKWMAPESIFDCVYTV-QSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 9e-19
Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 32/240 (13%)
Query: 22 LEETLGRGHF-AVVK-LARHVFTGE-----KVAVKVIDKTKLDPVSQDHLYQEVRCMK-L 73
L + LG G F VV A + + KVAVK++ K+ L E+ MK +
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMI 131
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE----------- 122
+H N++ L + LY+I+E G+L +Y+ E
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 123 ---YFA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR--FNPGQKLE 176
A Q+ R + + +HRDL NV+ E V+K+ DFG + R + +
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLA-RDIHHIDYYKK 249
Query: 177 TSCGSLAYS--APEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMD 233
T+ G L APE L Y + DVWS GV+L+ + G +P+ E ++ +
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 308
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-18
Identities = 65/245 (26%), Positives = 99/245 (40%), Gaps = 37/245 (15%)
Query: 22 LEETLGRGHF-AVVK-LARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
L +TLG G F VVK A H+ VAVK++ K P L E +K V H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNH 85
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREY------------- 123
P+V++LY + L LI+E G L ++ +
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 124 ---------FA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR--FNP 171
FA QI + + + ++ +VHRDL N++ E +K++DFG S R +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR-KMKISDFGLS-RDVYEE 203
Query: 172 GQKLETSCGSLAYS--APEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETL 228
++ S G + A E L Y DVWS GV+L+ +V G P+
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 229 TMIMD 233
++
Sbjct: 263 NLLKT 267
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-17
Identities = 64/254 (25%), Positives = 93/254 (36%), Gaps = 54/254 (21%)
Query: 22 LEETLGRGHFAVVKLARHVFTGE-----KVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQ 75
+ LG G F V A + +VAVK++ K K D ++ L E++ M L
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGS 107
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE------------- 122
H N+V L + +YLI E GDL +Y+ SE
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 123 --------YFA-QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173
FA Q+ + + F VHRDL NV+ VVK+ DFG +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK-VVKICDFGLARDIM--- 223
Query: 174 KLETSCGSLAYS------------APEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQ 220
Y APE L Y DVWS G++L+ + + G P+
Sbjct: 224 ------SDSNYVVRGNARLPVKWMAPESLFEGIYTI-KSDVWSYGILLWEIFSLGVNPYP 276
Query: 221 E-ANDSETLTMIMD 233
D+ +I +
Sbjct: 277 GIPVDANFYKLIQN 290
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 7e-16
Identities = 37/161 (22%), Positives = 74/161 (45%), Gaps = 14/161 (8%)
Query: 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMK-LV 74
+ + + + +G G+F ++L ++++T E VA+K ++ K L+ E R K L
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMK---SRAPQLHLEYRFYKQLG 62
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLS-ETYAREYFA-QIVRAIS 132
+ ++Y ++LEL G L D D S +T A Q++ +
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLEL-LGPSLEDLFDLCDRTFSLKTVLM--IAIQLISRME 119
Query: 133 FCHKLHVVHRDLKPENVVF----FERLGVVKLTDFGFSNRF 169
+ H ++++RD+KPEN + + V+ + DF + +
Sbjct: 120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 4e-15
Identities = 35/158 (22%), Positives = 66/158 (41%), Gaps = 8/158 (5%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
++ + L +G G F + L ++ T E+VA+K+ + P L E + +++
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRIL 59
Query: 75 Q-HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
Q + + L+++L G L D LS Q++ + F
Sbjct: 60 QGGTGIPNVRWFGVEGDYNVLVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 134 CHKLHVVHRDLKPENVVF--FERLGVVKLTDFGFSNRF 169
H +HRD+KP+N + R V + DFG + ++
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 8e-15
Identities = 36/160 (22%), Positives = 69/160 (43%), Gaps = 12/160 (7%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDH--LYQEVRCMK 72
++ Y L +G G F + L + GE+VA+K+ + V H L+ E + K
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLHIESKIYK 59
Query: 73 LVQH-PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
++Q + + +++EL G L D S Q++ I
Sbjct: 60 MMQGGVGIPTIRWCGAEGDYNVMVMEL-LGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 132 SFCHKLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRF 169
+ H + +HRD+KP+N + ++ +V + DFG + ++
Sbjct: 119 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-14
Identities = 35/176 (19%), Positives = 65/176 (36%), Gaps = 22/176 (12%)
Query: 1 MSRSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS 60
MS + + Y + +G G F V+ ++ ++VA+K +P
Sbjct: 1 MSGQNNV--------VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------EPRR 46
Query: 61 QDH--LYQEVRCMK-LVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSE 117
D L E R K L + +Y L+++L G L D + S
Sbjct: 47 SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL-LGPSLEDLLDLCGRKFSV 105
Query: 118 TYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG----VVKLTDFGFSNRF 169
Q++ + H+ +V+RD+KP+N + ++ + DFG +
Sbjct: 106 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-13
Identities = 32/180 (17%), Positives = 70/180 (38%), Gaps = 25/180 (13%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
+ L + +G G F ++ LA EK A V+ K++ L+ E++ + V
Sbjct: 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV---KVEYQENGPLFSELKFYQRV 90
Query: 75 QHPNVVRLYEVIDTNSKL-------------------YLILELGDGGDLYDYIMKHDAGL 115
+ ++ + L ++++E G DL ++
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER-LGIDLQKISGQNGT-F 148
Query: 116 SETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVF-FERLGVVKLTDFGFSNRFNPGQK 174
++ + +++ + + H+ VH D+K N++ ++ V L D+G S R+ P
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 6e-13
Identities = 32/179 (17%), Positives = 66/179 (36%), Gaps = 22/179 (12%)
Query: 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ 75
A + + +G+G F + LA + E V K++P L+ E++ +
Sbjct: 33 AAAAWKVGLPIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAA 91
Query: 76 HPNVVRLYEVIDTNSKL-------------------YLILELGDGGDLYDYIMKHDAGLS 116
P ++ + L ++I++ G DL + S
Sbjct: 92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR-FGSDLQKIYEANAKRFS 150
Query: 117 ETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVF-FERLGVVKLTDFGFSNRFNPGQK 174
+ +I+ + + H+ VH D+K N++ ++ V L D+G + R+ P
Sbjct: 151 RKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 1e-12
Identities = 31/199 (15%), Positives = 57/199 (28%), Gaps = 51/199 (25%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKL 73
E +G G F V VA+K+I D + + + E+ K
Sbjct: 22 LQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 74 VQ---------HPNVVRLYEV------------------------------IDTNSKLYL 94
+ + L V + +L++
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFE 153
+LE GG + + + L+ A+ Q+ +++ L HRDL N V +
Sbjct: 140 VLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAEASLRFEHRDLHWGN-VLLK 196
Query: 154 RLGVVKLTDFGFSNRFNPG 172
+ + KL
Sbjct: 197 KTSLKKLHYTLNGKSSTIP 215
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-11
Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 16/212 (7%)
Query: 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHL--YQEVRCMKLVQHPNVVRLY 83
+G G F VV + VAVK + + QE++ M QH N+V L
Sbjct: 39 MGEGGFGVV--YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSET---YAREYFAQ-IVRAISFCHKLHV 139
L L+ G L D + + + R AQ I+F H+ H
Sbjct: 97 GFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS---CGSLAYSAPEILLGDSYD 196
+HRD+K N++ E K++DFG + + + G+ AY APE L G+
Sbjct: 155 IHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITP 213
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETL 228
D++S GV+L ++ G E + + L
Sbjct: 214 --KSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 30/131 (22%), Positives = 43/131 (32%), Gaps = 11/131 (8%)
Query: 22 LEETLGRGHFAVVKLAR-HVFTGEKVAVKVIDKT-KLDPVSQDH--LYQEVRCMK-LVQH 76
L + LGRG F V A V K K +H L E++ + + H
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 77 PNVVRLY-EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
NVV L L +I+E G+L Y+ Y + R
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV-----PYKTKGARFRQGKD 140
Query: 136 KLHVVHRDLKP 146
+ + DLK
Sbjct: 141 YVGAIPVDLKR 151
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 29/113 (25%), Positives = 50/113 (44%), Gaps = 7/113 (6%)
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLA-- 183
Q+ + + F +HRDL N++ E+ VVK+ DFG + +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 184 -YSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQE-ANDSETLTMIMD 233
+ APE + Y + DVWS GV+L+ + + G +P+ D E + +
Sbjct: 260 KWMAPETIFDRVYTIQS-DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-09
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 38/215 (17%)
Query: 26 LGRGHFAVV---KLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ---EVRCMKLVQHPNV 79
LGRG F V +LA G VAVK + + + +Q Q EV + + H N+
Sbjct: 38 LGRGGFGKVYKGRLA----DGTLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNL 89
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETY----AREYFAQ-IVRAISFC 134
+RL T ++ L+ G + + + S+ R+ A R +++
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 135 H---KLHVVHRDLKPENVVF---FERLGVVKLTDFGFSNRFNPGQKLETS---CGSLAYS 185
H ++HRD+K N++ FE + DFG + + + + G++ +
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEFE----AVVGDFGLA-KLMDYKDTHVTTAVRGTIGHI 202
Query: 186 APE-ILLGDSYDAPAVDVWSLGVILYMLVAGQAPF 219
APE + G S + DV+ GV+L L+ GQ F
Sbjct: 203 APEYLSTGKSSE--KTDVFGYGVMLLELITGQRAF 235
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-08
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 51/219 (23%)
Query: 26 LGRGHFAVV---KLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ-------EVRCMKLVQ 75
+G G F V L G KVA+K + P S Q E+ + +
Sbjct: 47 IGHGVFGKVYKGVLR----DGAKVALK-----RRTPESS----QGIEEFETEIETLSFCR 93
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETY----AREYFAQIV--- 128
HP++V L D +++ LI + + G+L ++ + + L R +I
Sbjct: 94 HPHLVSLIGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQR---LEICIGA 148
Query: 129 -RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS---CGSLAY 184
R + + H ++HRD+K N++ E V K+TDFG S + + S G+L Y
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 185 SAPE-----ILLGDSYDAPAVDVWSLGVILYMLVAGQAP 218
PE L S DV+S GV+L+ ++ ++
Sbjct: 208 IDPEYFIKGRLTEKS------DVYSFGVVLFEVLCARSA 240
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-07
Identities = 35/177 (19%), Positives = 67/177 (37%), Gaps = 26/177 (14%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTG--------EKVAVKVIDKTKLDPVSQDHLYQEVRCM 71
+ L+ R + ++ A T +K ++K +D ++ + +Q R
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQ--RAA 100
Query: 72 KLVQHPNVVRLYEV------------IDTNSKLYLILELGDGGDLYDYIMKHDAG-LSET 118
K +Q +LY + + +L+L G L + LSE
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS-LGRSLQSALDVSPKHVLSER 159
Query: 119 YAREYFAQIVRAISFCHKLHVVHRDLKPENVVF-FERLGVVKLTDFGFSNRFNPGQK 174
+ +++ A+ F H+ VH ++ EN+ E V L +GF+ R+ P K
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >1qzv_F Plant photosystem I: subunit PSAF; photosynthesis,plant photosynthetic reaction center, peripheral antenna; HET: CL1 PQN; 4.44A {Pisum sativum} SCOP: i.5.1.1 Length = 154 | Back alignment and structure |
|---|
Score = 38.0 bits (87), Expect = 9e-04
Identities = 10/30 (33%), Positives = 14/30 (46%), Gaps = 10/30 (33%)
Query: 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDV 202
+KL+ SL A DS APA+ +
Sbjct: 23 KKLQ---ASLKLYAD-----DS--APALAI 42
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 259 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.5 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.14 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.96 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.9 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.82 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.67 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.49 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.38 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.29 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.11 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.07 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.87 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.73 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.72 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.61 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.4 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.29 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.11 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.94 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.89 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.64 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.52 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.09 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 87.37 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 85.22 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 81.91 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=355.27 Aligned_cols=237 Identities=25% Similarity=0.460 Sum_probs=195.9
Q ss_pred CCCCCCCCCCCCCCc------cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC
Q psy3663 1 MSRSGSRSSDGHPTK------IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74 (259)
Q Consensus 1 ~~~~~~~~~~~~~~~------~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l 74 (259)
|+-+..-+|+-|.+. -.++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+++++++
T Consensus 1 ~~~~~~~ssgvd~gten~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l 80 (350)
T 4b9d_A 1 MHHHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80 (350)
T ss_dssp ---CCCC-------CCCCBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC
T ss_pred CCCcCCCCCCccCCCcccCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC
Confidence 555666555555432 23699999999999999999999999999999999988766666678899999999999
Q ss_pred CCCCeEEEEEEEecCCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee
Q psy3663 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE 153 (259)
Q Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~ 153 (259)
+||||+++++++.+++.+|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.
T Consensus 81 ~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 160 (350)
T 4b9d_A 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 160 (350)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECT
T ss_pred CCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC
Confidence 9999999999999999999999999999999999765 345799999999999999999999999999999999999977
Q ss_pred cCCeEEEEeccccccCCCCCc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 154 RLGVVKLTDFGFSNRFNPGQK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 154 ~~~~i~l~df~~~~~~~~~~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
+ +.++|+|||++........ ....+|++.|+|||++.+..++. ++|||||||++|+|++|++||...+..+.+..++
T Consensus 161 ~-g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~-~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 238 (350)
T 4b9d_A 161 D-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN-KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238 (350)
T ss_dssp T-CCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred C-CCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 6 8899999999987653322 23457999999999999888875 9999999999999999999999999999999998
Q ss_pred hcccccc
Q psy3663 233 DVSESSC 239 (259)
Q Consensus 233 ~~~~~~~ 239 (259)
+...++.
T Consensus 239 ~~~~~~~ 245 (350)
T 4b9d_A 239 SGSFPPV 245 (350)
T ss_dssp HTCCCCC
T ss_pred cCCCCCC
Confidence 8766543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=340.44 Aligned_cols=221 Identities=41% Similarity=0.763 Sum_probs=180.4
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|++++++++||||+++++++.+++.+++
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 358999999999999999999999999999999999765432 3345678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||||+ +++|.+++.+.+. +++.++..++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus 91 vmEy~-~g~L~~~l~~~~~-l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDK-MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH-LNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEECC-CEEHHHHHHHSCS-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-CCEEECCSSCC--------
T ss_pred EEeCC-CCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC-CCEEEeecCCCeecCCCCc
Confidence 99999 5599999877654 9999999999999999999999999999999999999766 7899999999987766555
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
.....|++.|+|||++.+..+++.++|||||||++|+|++|++||.+.+..+.++.+.+...+.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p 232 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP 232 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 66678999999999999888776699999999999999999999999888888888887765543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-53 Score=345.58 Aligned_cols=221 Identities=32% Similarity=0.561 Sum_probs=197.3
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.++|++.+.||+|+||.||+|.+..+++.||||++.+... .......+.+|+++++.++||||+++++++.+++.+|+|
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4679999999999999999999999999999999975432 233467889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC---
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG--- 172 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~--- 172 (259)
|||+.|++|.+++.+.+. +++.++..++.||+.||.|||++||+|+||||+|||++.+ +.++|+|||++..+...
T Consensus 111 mEy~~gG~L~~~i~~~~~-l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~-g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp ECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECCTTTTC
T ss_pred EecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCC-CCEEEEEcCCceecCCCCCc
Confidence 999999999999987654 9999999999999999999999999999999999999766 88999999999876433
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
......+|++.|+|||++.+..++. ++|||||||++|+|++|++||...+..+.+..|++....++.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~ 255 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE 255 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred ccccCcccCcccCCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 2334568999999999998888775 999999999999999999999999999999999987665543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=341.84 Aligned_cols=216 Identities=29% Similarity=0.490 Sum_probs=193.4
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
...+.|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 148 (346)
T 4fih_A 71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 148 (346)
T ss_dssp CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 345789999999999999999999999999999999976542 245668899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-C
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-Q 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~ 173 (259)
||||++|++|.+++... .+++.++..++.||+.||.|||++||+|+||||+|||++.+ +.+||+|||++..+... .
T Consensus 149 vmEy~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EECCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSC
T ss_pred EEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCC-CCEEEecCcCceecCCCCC
Confidence 99999999999998763 49999999999999999999999999999999999999766 89999999999876543 3
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
.....+|++.|+|||++.+..++. ++|||||||++|+|++|++||.+.+..+.+..|.+...
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~ 287 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 287 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC
T ss_pred cccccccCcCcCCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence 445678999999999998888875 99999999999999999999999988888888876543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-52 Score=340.43 Aligned_cols=219 Identities=33% Similarity=0.553 Sum_probs=187.4
Q ss_pred cCeeEeeeecccccceEEEEEEe---ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
++|++.+.||+|+||.||+|.+. .+++.||+|++.+..........+.+|+.++++++||||+++++++.+.+.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 68999999999999999999874 357789999998765444445578889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-C
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-Q 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~ 173 (259)
||||++|++|.+++.+.+. +++.++..++.||+.||.|||++||+|+||||+|||++.+ +.++|+|||++...... .
T Consensus 104 vmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~-g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM-FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-SCEEEESSEEEEC-----C
T ss_pred EEEcCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCC-CCEEecccccceeccCCCc
Confidence 9999999999999987654 9999999999999999999999999999999999999776 88999999999765333 3
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
.....+|++.|+|||++.+..++. ++|||||||++|+|++|++||.+.+..+.+..|.+...+++
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p 246 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred cccccccCcccCCHHHhccCCCCC-CCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence 345567999999999999888875 99999999999999999999999999999999987765544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=343.28 Aligned_cols=217 Identities=29% Similarity=0.488 Sum_probs=194.1
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
+...+.|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 147 ~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ 224 (423)
T 4fie_A 147 GDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 224 (423)
T ss_dssp SCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence 344578999999999999999999999999999999997654 234567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG- 172 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~- 172 (259)
+||||+.|++|.+++... .+++.++..++.||+.||.|||++||+|+||||+|||++.+ +.++|+|||++..+...
T Consensus 225 iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~-g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD-GRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTT-CCEEECCCTTCEECCSSC
T ss_pred EEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEecCccceECCCCC
Confidence 999999999999998754 39999999999999999999999999999999999999766 89999999999876543
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
......+|++.|+|||++.+..++. ++|||||||++|+|++|++||.+.+..+.+..|.+...
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~ 364 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 364 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred ccccccccCcCcCCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence 3445668999999999998888875 99999999999999999999999988888888876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=326.35 Aligned_cols=214 Identities=25% Similarity=0.461 Sum_probs=184.7
Q ss_pred ccCe-eEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec----CCe
Q psy3663 17 AGLY-DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT----NSK 91 (259)
Q Consensus 17 ~~~y-~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 91 (259)
.++| ++.+.||+|+||.||+|.+..++..|++|.+............+.+|++++++++||||+++++++.+ +..
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 3566 78889999999999999999999999999998776666667889999999999999999999999864 356
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH--VVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~--i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
+++||||++|++|.+++.+... +++..+..++.||+.||.|||+++ |+|+||||+|||++..++.++|+|||++...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEeCCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 8999999999999999987654 999999999999999999999998 9999999999999765589999999999754
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH-HHHhhhc
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET-LTMIMDV 234 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~i~~~ 234 (259)
. .......+|++.|+|||++.+ .++ .++|||||||++|+|++|++||.+.+.... ...+.+.
T Consensus 183 ~-~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~ 245 (290)
T 3fpq_A 183 R-ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 245 (290)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred C-CCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC
Confidence 3 344556689999999999875 455 499999999999999999999987665554 4444443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=334.36 Aligned_cols=211 Identities=24% Similarity=0.379 Sum_probs=184.9
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.+.|++.+.||+|+||.||+|.+..+|+.||||+++..... .+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35799999999999999999999999999999999765421 37999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-- 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-- 174 (259)
||++|++|.+++...+. +++.++..++.||+.||.|||++||+|+||||+|||++.+..+++|+|||++..+.....
T Consensus 130 Ey~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGC-LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CCCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred eccCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 99999999999987654 999999999999999999999999999999999999977744799999999987643321
Q ss_pred ----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 175 ----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 175 ----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
....+|++.|+|||++.+..++. ++|||||||++|+|++|++||.+.+..+.+..|.....
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~ 273 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDA-KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP 273 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC
T ss_pred ceecCCccccCccccCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC
Confidence 12246899999999999988875 99999999999999999999999888888888876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=338.62 Aligned_cols=228 Identities=27% Similarity=0.458 Sum_probs=199.4
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec------
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT------ 88 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 88 (259)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+++++.++||||+++++++..
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 45678999999999999999999999999999999998765555556778899999999999999999999754
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.+..|+||||+.| +|.+++...+ ++++.++..++.||+.||.|||++||+|+||||+|||++.+ +.++|+|||++..
T Consensus 131 ~~~~~ivmE~~~g-~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~-~~~Ki~DFGla~~ 207 (398)
T 4b99_A 131 FKSVYVVLDLMES-DLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNEN-CELKIGDFGMARG 207 (398)
T ss_dssp CCCEEEEEECCSE-EHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBC
T ss_pred CCEEEEEEeCCCC-CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCC-CCEEEeecceeee
Confidence 3678999999975 8999887654 49999999999999999999999999999999999999766 8899999999976
Q ss_pred CCCC-----CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 169 FNPG-----QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 169 ~~~~-----~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
+... ......+++..|+|||++.+..+.+.++||||+||++|+|++|++||.+.+..+++..|.+..++++...|
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 5332 22345679999999999988766556999999999999999999999999999999999999999888777
Q ss_pred cc
Q psy3663 244 RG 245 (259)
Q Consensus 244 ~~ 245 (259)
..
T Consensus 288 ~~ 289 (398)
T 4b99_A 288 QA 289 (398)
T ss_dssp C-
T ss_pred hh
Confidence 54
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=323.28 Aligned_cols=212 Identities=23% Similarity=0.435 Sum_probs=179.4
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.+++++.+.||+|+||.||+|.. ...|+||+++....+......+.+|+.++++++||||+++++++.+ +.+++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKW---HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEES---SSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEE---CCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 46889999999999999999974 3469999998766666667889999999999999999999998754 5688999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC---C
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG---Q 173 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~---~ 173 (259)
||+++++|.+++.....++++.++..++.||+.||.|||+++|+|+||||+|||++.+ +.+||+|||++...... .
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEG-LTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETT-EEEEECCCSSCBC--------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCC-CcEEEeeccCceecccCCcce
Confidence 9999999999998777779999999999999999999999999999999999999766 79999999999765432 2
Q ss_pred ccccccCCCccCCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 174 KLETSCGSLAYSAPEILLGD---SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
......|++.|+|||++.+. .++ .++|||||||++|||+||+.||.+.+....+..++..
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~-~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~ 252 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFS-FQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGR 252 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHT
T ss_pred eecccccCCCccCHHHhhccCCCCCC-cHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhc
Confidence 23445789999999998643 344 4999999999999999999999988877766666543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=326.44 Aligned_cols=230 Identities=26% Similarity=0.419 Sum_probs=190.1
Q ss_pred cCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.+|.+.+.||+|+||.||+|... .++..||||.++.. +....+.+.+|++++.+++||||+++++++.+....
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 57899999999999999999854 45789999998753 344567899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeE
Q psy3663 93 YLILELGDGGDLYDYIMKHD--------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVV 158 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~--------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i 158 (259)
++||||+++++|.+++.... .++++.+++.++.||+.||.|||+++|+|+||||+|||++.+ +.+
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~-~~~ 197 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-LVV 197 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC-CcE
Confidence 99999999999999987642 358999999999999999999999999999999999999766 899
Q ss_pred EEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 159 KLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 159 ~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
||+|||++........ .....++..|+|||.+.+..++. ++|||||||++|||+| |+.||.+.+..+.+..+.++
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~-~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT-ESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCH-HHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCc-cccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999976543322 22346788999999999888875 9999999999999999 89999999999999988876
Q ss_pred cccccc------------cccccCchhhh
Q psy3663 235 SESSCT------------CWWRGRPRSRR 251 (259)
Q Consensus 235 ~~~~~~------------~~~~~~~~~~~ 251 (259)
.....+ .+|..+|..|.
T Consensus 277 ~~~~~p~~~~~~~~~li~~cl~~dP~~RP 305 (329)
T 4aoj_A 277 RELERPRACPPEVYAIMRGCWQREPQQRH 305 (329)
T ss_dssp CCCCCCTTCCHHHHHHHHHHCCSSTTTSC
T ss_pred CCCCCcccccHHHHHHHHHHcCcChhHCc
Confidence 544332 26777777664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=321.85 Aligned_cols=232 Identities=25% Similarity=0.424 Sum_probs=194.9
Q ss_pred ccCeeEeeeecccccceEEEEEE-----eecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARH-----VFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~-----~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
.+++++.+.||+|+||.||+|.. ..++..||||.++... .....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 46899999999999999999984 3467799999997543 33456789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~ 156 (259)
.++||||+++++|.+++.... ..+++.++..++.||+.|+.|||+++|+||||||+|||++++ +
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~-~ 182 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK-L 182 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-G
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC-C
Confidence 999999999999999996532 348999999999999999999999999999999999999777 7
Q ss_pred eEEEEeccccccCCCCC---ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhh
Q psy3663 157 VVKLTDFGFSNRFNPGQ---KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIM 232 (259)
Q Consensus 157 ~i~l~df~~~~~~~~~~---~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~ 232 (259)
.+||+|||++....... ......++..|+|||.+.+..++. ++|||||||++|||+| |..||.+.+..+....+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~-ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~ 261 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSI-DSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 261 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCc-cchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 89999999987653322 223446788999999998888875 9999999999999998 899999999999999888
Q ss_pred hcccccc------------ccccccCchhhh
Q psy3663 233 DVSESSC------------TCWWRGRPRSRR 251 (259)
Q Consensus 233 ~~~~~~~------------~~~~~~~~~~~~ 251 (259)
+....+. ..||..+|..|+
T Consensus 262 ~~~~~~~p~~~~~~~~~li~~C~~~dP~~RP 292 (308)
T 4gt4_A 262 NRQVLPCPDDCPAWVYALMIECWNEFPSRRP 292 (308)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cCCCCCCcccchHHHHHHHHHHcCCChhHCc
Confidence 7654432 236777777664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=321.90 Aligned_cols=229 Identities=25% Similarity=0.414 Sum_probs=192.9
Q ss_pred cCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
++|.+.+.||+|+||.||+|... .++..||||.++.. +....+.+.+|++++++++||||+++++++.+.+..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 57999999999999999999864 35778999998754 344567889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEE
Q psy3663 93 YLILELGDGGDLYDYIMKHD------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
++||||+++++|.+++...+ ..+++.++..++.||+.||.|||+++|+|+||||+|||++.+ +.+||
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~-~~~Ki 169 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN-LLVKI 169 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC-CcEEE
Confidence 99999999999999997642 459999999999999999999999999999999999999777 78999
Q ss_pred EeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 161 TDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 161 ~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
+|||++......... ....++..|+|||.+.+..++. ++|||||||++|||+| |+.||.+.+..+.+..+.++..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~-k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999765433222 2235788999999999888875 9999999999999998 8999999999999998887654
Q ss_pred ccc------------ccccccCchhh
Q psy3663 237 SSC------------TCWWRGRPRSR 250 (259)
Q Consensus 237 ~~~------------~~~~~~~~~~~ 250 (259)
... ..+|..+|..|
T Consensus 249 ~~~p~~~~~~~~~li~~cl~~dP~~R 274 (299)
T 4asz_A 249 LQRPRTCPQEVYELMLGCWQREPHMR 274 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CCCCccchHHHHHHHHHHcCCChhHC
Confidence 332 23566666665
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=315.54 Aligned_cols=202 Identities=29% Similarity=0.518 Sum_probs=164.6
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS---- 90 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 90 (259)
.+.++|++.+.||+|+||.||+|.+..+|+.||||.+.... .......+.+|++++++++||||++++++|.+.+
T Consensus 2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 34578999999999999999999999999999999997654 3344577889999999999999999999986543
Q ss_pred --------eEEEEEeccCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEE
Q psy3663 91 --------KLYLILELGDGGDLYDYIMKHDA--GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 91 --------~~~lv~e~~~~~sL~~~~~~~~~--~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
..|++|||+.+++|.+++..... ..+...++.++.||++||.|||++||+|+||||+|||++.+ +.++|
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~-~~vKl 159 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKV 159 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEE
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCC-CcEEE
Confidence 36899999999999999986532 24566789999999999999999999999999999999776 78999
Q ss_pred EeccccccCCCCCcc-------------ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 161 TDFGFSNRFNPGQKL-------------ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 161 ~df~~~~~~~~~~~~-------------~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
+|||++......... ...+|++.|+|||++.+..++. ++|||||||++|||++ ||...
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyell~---Pf~~~ 230 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH-KVDIFSLGLILFELLY---PFSTQ 230 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCT-HHHHHHHHHHHHHHHS---CCSSH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCC-HHHHHHHHHHHHHHcc---CCCCc
Confidence 999999776543221 2246899999999999888875 9999999999999996 88643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=321.22 Aligned_cols=218 Identities=27% Similarity=0.495 Sum_probs=186.6
Q ss_pred CccccCeeEeeeecccccceEEEEEEe---ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecC
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTN 89 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (259)
..+.++|++.+.||+|+||.||+|.++ .+++.||+|.+.... ....+.+|+++++.+ +||||+++++++.++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 357889999999999999999999876 346789999986543 345678999999998 599999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
+.+++||||+++++|.+++. .+++.++..++.||+.||.|||++||+|+||||+|||++.+.+.++|+|||++...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999999999999999884 38999999999999999999999999999999999999877789999999999654
Q ss_pred CCCC-----------------------------ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-
Q psy3663 170 NPGQ-----------------------------KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPF- 219 (259)
Q Consensus 170 ~~~~-----------------------------~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf- 219 (259)
.... .....+|++.|+|||++.+...++.++||||+||++|+|++|+.||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY 248 (361)
T ss_dssp TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence 3221 1233468999999999988765556999999999999999999999
Q ss_pred CCCCChHHHHHhhhcccccc
Q psy3663 220 QEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 220 ~~~~~~~~~~~i~~~~~~~~ 239 (259)
.+.+..+++..|.+..+++.
T Consensus 249 ~~~~~~~~l~~I~~~~G~~~ 268 (361)
T 4f9c_A 249 KASDDLTALAQIMTIRGSRE 268 (361)
T ss_dssp CCSSHHHHHHHHHHHHCHHH
T ss_pred CCCCHHHHHHHHHHhcCCcc
Confidence 55667788999988877653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=337.41 Aligned_cols=229 Identities=30% Similarity=0.578 Sum_probs=207.2
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
..+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+++|+.++||||+++++++.+...++
T Consensus 153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 346689999999999999999999999999999999987643 334677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec-CCeEEEEeccccccCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER-LGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~-~~~i~l~df~~~~~~~~~ 172 (259)
++|||+.|++|.+++......+++.++..++.||+.||.|||++||+|+||||+||+++.+ .+.++|+|||++..+...
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999999999997666669999999999999999999999999999999999999754 468999999999988777
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
......+|+..|+|||++.+..++. ++|||||||++|+|++|++||.+.+..+.+..|.+....++.+.|.+
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~-~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 382 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGY-YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCH-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTT
T ss_pred CceeeeEECccccCHHHhCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccC
Confidence 7777778999999999999888875 99999999999999999999999999999999998887777666654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=310.06 Aligned_cols=233 Identities=47% Similarity=0.831 Sum_probs=203.7
Q ss_pred CCCCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEE
Q psy3663 5 GSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYE 84 (259)
Q Consensus 5 ~~~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (259)
++-.+.++.....++|++.+.||+|++|.||+|.+..+|+.|++|++............+.+|+++++.++||||+++++
T Consensus 2 ~s~~s~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~ 81 (328)
T 3fe3_A 2 NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81 (328)
T ss_dssp ---------CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34455566777889999999999999999999999999999999999877666666778899999999999999999999
Q ss_pred EEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecc
Q psy3663 85 VIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG 164 (259)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~ 164 (259)
++.+.+..++||||+.+++|.+++...+. +++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~-~~~kl~DFG 159 (328)
T 3fe3_A 82 VIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD-MNIKIADFG 159 (328)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTT
T ss_pred EEEECCEEEEEEECCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCC-CCEEEeecc
Confidence 99999999999999999999999977654 9999999999999999999999999999999999999766 789999999
Q ss_pred ccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 165 FSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
++.............++..|+|||.+.+..+.+.++|+||||+++|+|++|+.||.+.+..+....+.+.....+
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p 234 (328)
T 3fe3_A 160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP 234 (328)
T ss_dssp CCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred CceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 998776666666778999999999999888776699999999999999999999999998888888887665443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=313.42 Aligned_cols=232 Identities=26% Similarity=0.418 Sum_probs=189.3
Q ss_pred ccCeeEeeeecccccceEEEEEEeecC-----ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC-CCeEEEEEEEec-C
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTG-----EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH-PNVVRLYEVIDT-N 89 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~-----~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~-~ 89 (259)
.++|++.+.||+|+||.||+|.+...+ +.|++|.+.... .......+.+|++++.+++| |||+++++++.+ +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 368999999999999999999876543 579999987543 33446778899999999976 899999999865 4
Q ss_pred CeEEEEEeccCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec
Q psy3663 90 SKLYLILELGDGGDLYDYIMKH---------------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER 154 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~---------------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~ 154 (259)
+.+++||||+++++|.+++... ...+++.++..++.||+.|+.|||+++|+|+||||+|||++.+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 221 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence 5689999999999999999753 2348899999999999999999999999999999999999777
Q ss_pred CCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChH-HHH
Q psy3663 155 LGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSE-TLT 229 (259)
Q Consensus 155 ~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~-~~~ 229 (259)
+.+||+|||++........ .....++..|+|||++.+..++. ++|||||||++|||+| |+.||.+.+..+ ...
T Consensus 222 -~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~-ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 222 -NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp -GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred -CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCC-cccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7899999999986644332 22345788999999999888875 9999999999999998 999998876544 455
Q ss_pred Hhhhcccccc------------ccccccCchhhh
Q psy3663 230 MIMDVSESSC------------TCWWRGRPRSRR 251 (259)
Q Consensus 230 ~i~~~~~~~~------------~~~~~~~~~~~~ 251 (259)
.+.++..... ..||..+|..|.
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RP 333 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP 333 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCc
Confidence 5555443332 236777777664
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=325.95 Aligned_cols=205 Identities=32% Similarity=0.512 Sum_probs=175.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-ccHHHHH---HHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-VSQDHLY---QEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.++|++.+.||+|+||.||+|.+..+|+.||||++.+..... .....+. .++.+++.++||||++++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 468999999999999999999999999999999997543211 1222333 346677778899999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
|+||||+.|++|..++.+.+. +++..+..++.||+.||.|||++||+|+||||+|||++.+ |.++|+|||++......
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~-l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~-G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSSC
T ss_pred EEEEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCC-CCEEecccceeeecCCC
Confidence 999999999999999987654 9999999999999999999999999999999999999766 89999999999876543
Q ss_pred CccccccCCCccCCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 173 QKLETSCGSLAYSAPEILLGD-SYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
.....+|++.|+|||++.+. .++ .++|+|||||++|+|++|++||...+..
T Consensus 346 -~~~t~~GTp~YmAPEvl~~~~~y~-~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 346 -KPHASVGTHGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCC-THHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred -CCCCccCCcCccCHHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 34556899999999999754 555 4999999999999999999999765443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=302.47 Aligned_cols=235 Identities=33% Similarity=0.606 Sum_probs=208.2
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc----ccHHHHHHHHHHHHhCCCCCeEEEEEEEe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP----VSQDHLYQEVRCMKLVQHPNVVRLYEVID 87 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (259)
....+.++|++.+.||+|+||.||+|.+..+|..|++|++....... .....+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp BCSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cCCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 34678899999999999999999999999999999999998654322 23578899999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC---eEEEEecc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG---VVKLTDFG 164 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~---~i~l~df~ 164 (259)
+...+++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+|+||+|+||++..+.. .++|+|||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 9999999999999999999997654 4999999999999999999999999999999999999976632 79999999
Q ss_pred ccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 165 FSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
++.............++..|+|||++.+..++. ++|+||||+++|+|++|.+||.+.+..+.+..+.+....++.++|.
T Consensus 165 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp SCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred CceEcCCCCccccCCCCccEECchHHcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 998776665556677899999999998877775 9999999999999999999999999999999999888887777776
Q ss_pred cCch
Q psy3663 245 GRPR 248 (259)
Q Consensus 245 ~~~~ 248 (259)
.-+.
T Consensus 244 ~~s~ 247 (361)
T 2yab_A 244 QTSE 247 (361)
T ss_dssp TSCH
T ss_pred CCCH
Confidence 5543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=300.81 Aligned_cols=234 Identities=35% Similarity=0.603 Sum_probs=207.1
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
...+.++|++.+.||+|++|.||+|.+..++..|++|++............+.+|+.+++.++||||+++++++.+.+..
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34567799999999999999999999999999999999987766666677889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC--CeEEEEeccccccCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL--GVVKLTDFGFSNRFN 170 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~--~~i~l~df~~~~~~~ 170 (259)
++|||++.+++|.+.+.... .+++..++.++.||+.||.|||++||+|+||+|+||+++.+. +.++|+|||++....
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999999887654 489999999999999999999999999999999999997642 469999999998776
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCch
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPR 248 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (259)
.........++..|+|||++.+..++. ++|+||||+++|+|++|.+||...+..+.+..+......++.+.|..-+.
T Consensus 183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 183 DSEAWHGFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp TCCSCCCSCSCTTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred CCcccccCCCCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 555555567899999999998877775 99999999999999999999999998999999998887777766655443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=294.53 Aligned_cols=236 Identities=28% Similarity=0.508 Sum_probs=199.7
Q ss_pred CCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec
Q psy3663 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT 88 (259)
Q Consensus 9 ~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (259)
+...+..+.++|++.+.||+|++|.||+|.+. +++.|++|.+............+.+|+.+++.++||||+++++++.+
T Consensus 12 ~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 12 ENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp ---CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 34456678899999999999999999999985 58899999997765555556778899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
....++||||+.+ +|.+++......+++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++..
T Consensus 91 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~ 168 (311)
T 3niz_A 91 ERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD-GALKLADFGLARA 168 (311)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred CCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCC-CCEEEccCcCcee
Confidence 9999999999986 8989888777779999999999999999999999999999999999999776 7899999999977
Q ss_pred CCCC-CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCc
Q psy3663 169 FNPG-QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRP 247 (259)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (259)
.... .......++..|+|||.+.+....+.++|+||||+++|+|++|+.||......+.+..+.+..+.+.+..|....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 169 FGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp TTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGT
T ss_pred cCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhh
Confidence 6433 223344678899999999775544459999999999999999999999999999999999988888777766543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=297.02 Aligned_cols=197 Identities=21% Similarity=0.385 Sum_probs=159.6
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC----e
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS----K 91 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 91 (259)
+..+|.+.+.||+|+||.||+|.. +|+.||||++.... ........|+..+..++||||+++++++.+.+ .
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 456899999999999999999984 68999999986532 11122234666667889999999999987543 5
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeccCCCCCeEeeecCCeEEEEec
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL--------HVVHRDLKPENVVFFERLGVVKLTDF 163 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~--------~i~H~dl~p~nIlv~~~~~~i~l~df 163 (259)
+++||||+++++|.+++.... +++..+..++.|++.||.|||+. +|+||||||+|||++.+ +.++|+||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~-~~~Ki~DF 152 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADL 152 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTT-SCEEECCC
T ss_pred EEEEecCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCC-CCEEEEeC
Confidence 899999999999999997643 89999999999999999999987 99999999999999766 88999999
Q ss_pred cccccCCCCCcc-----ccccCCCccCCcccccCCCC-----CCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 164 GFSNRFNPGQKL-----ETSCGSLAYSAPEILLGDSY-----DAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 164 ~~~~~~~~~~~~-----~~~~~~~~~~apE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
|++......... ....++..|+|||++.+... .+.++|||||||++|||+||.+||.
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 998765433221 23468999999999976421 1248999999999999999987664
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=305.74 Aligned_cols=235 Identities=34% Similarity=0.585 Sum_probs=205.8
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
....+.++|++.+.||+|+||.||+|.+..+++.+++|++............+.+|+.+++.++||||+++++++.+.+.
T Consensus 5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 84 (444)
T 3soa_A 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH 84 (444)
T ss_dssp --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE
T ss_pred ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE
Confidence 45678899999999999999999999999999999999998776555567788999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee--cCCeEEEEeccccccC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE--RLGVVKLTDFGFSNRF 169 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~--~~~~i~l~df~~~~~~ 169 (259)
.+++||++.+++|.+.+..... +++..+..++.||+.||.|||++||+|+||||+||++.. +.+.++|+|||++...
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~~-~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVAREY-YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCSC-CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 9999999999999999887654 999999999999999999999999999999999999975 3468999999999766
Q ss_pred CCCCc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCch
Q psy3663 170 NPGQK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPR 248 (259)
Q Consensus 170 ~~~~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (259)
..... .....++..|+|||++.+..++. ++||||||+++|+|++|.+||.+.+..+.+..+.+....++.+.|...+.
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGK-PVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred cCCCceeecccCCcccCCHHHhcCCCCCC-ccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 54332 24457899999999998877775 99999999999999999999999999999999999888887777766544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=296.98 Aligned_cols=244 Identities=28% Similarity=0.441 Sum_probs=192.7
Q ss_pred CCCCCCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEE
Q psy3663 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRL 82 (259)
Q Consensus 3 ~~~~~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 82 (259)
++....+........++|++.+.||+|++|.||+|.+..+++.|++|++............+.+|+.+++.++||||+++
T Consensus 19 p~s~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 98 (329)
T 3gbz_A 19 PGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98 (329)
T ss_dssp -------------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCE
T ss_pred CCcceeccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceE
Confidence 33345566677888999999999999999999999999999999999998765555456677899999999999999999
Q ss_pred EEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee----cCCeE
Q psy3663 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE----RLGVV 158 (259)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~----~~~~i 158 (259)
++++.+....++||||+.+ +|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||++.. +.+.+
T Consensus 99 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 176 (329)
T 3gbz_A 99 KSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176 (329)
T ss_dssp EEEEEETTEEEEEEECCSE-EHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEE
T ss_pred EEEEecCCEEEEEEecCCC-CHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceE
Confidence 9999999999999999986 99999877654 999999999999999999999999999999999999953 23569
Q ss_pred EEEeccccccCCCC-CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 159 KLTDFGFSNRFNPG-QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 159 ~l~df~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
+|+|||++...... .......++..|+|||.+.+....+.++||||||+++|+|++|++||......+.+..+.+..+.
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp EECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 99999999765432 22334456889999999987664446999999999999999999999999999999999998888
Q ss_pred ccccccccCch
Q psy3663 238 SCTCWWRGRPR 248 (259)
Q Consensus 238 ~~~~~~~~~~~ 248 (259)
+....|.+...
T Consensus 257 ~~~~~~~~~~~ 267 (329)
T 3gbz_A 257 PDDTTWPGVTA 267 (329)
T ss_dssp CCTTTSTTGGG
T ss_pred Cchhhhhhhhh
Confidence 87777765544
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=295.04 Aligned_cols=228 Identities=25% Similarity=0.468 Sum_probs=202.6
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
++.++|++.+.||+|++|.||+|.+..++..+++|.+... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 4778999999999999999999999999999999998643 2345678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec-CCeEEEEeccccccCCCCC
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER-LGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~-~~~i~l~df~~~~~~~~~~ 173 (259)
+|||+.+++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ .+.++|+|||++.......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 999999999999998776679999999999999999999999999999999999999763 4789999999998876666
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
......+++.|+|||++.+..++. ++|+||||+++|+|++|.+||...+..+.+..+.+....++...|..-
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred ccccccCChhhcCcHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccC
Confidence 556667899999999998876665 999999999999999999999999999999999888777665555443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=294.29 Aligned_cols=232 Identities=31% Similarity=0.524 Sum_probs=197.7
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.++|++.+.||+|++|.||+|.+..+++.|++|++.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4789999999999999999999999999999999975421 223456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CCCc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~~~ 174 (259)
|||+.+++|..++..... +++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++.... ....
T Consensus 84 ~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTTCC
T ss_pred EeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCC-CCEEEeeccchhhcccCCCc
Confidence 999999999999876554 8999999999999999999999999999999999999766 789999999987533 2334
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc-----------cccc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC-----------TCWW 243 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------~~~~ 243 (259)
.....++..|+|||++.+..++. ++|+||||+++|+|++|+.||...+..+....+.......+ ..+|
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 240 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccChhhCChhhhcCCCCCc-hhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 45567899999999998877765 99999999999999999999998888888877775544332 2345
Q ss_pred ccCchhhh
Q psy3663 244 RGRPRSRR 251 (259)
Q Consensus 244 ~~~~~~~~ 251 (259)
..+|..|.
T Consensus 241 ~~dP~~R~ 248 (337)
T 1o6l_A 241 KKDPKQRL 248 (337)
T ss_dssp CSSTTTST
T ss_pred hcCHHHhc
Confidence 66666554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=290.71 Aligned_cols=230 Identities=35% Similarity=0.636 Sum_probs=200.7
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc----ccHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP----VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN 89 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (259)
..+.++|++.+.||+|++|.||+|.+..++..|++|++....... .....+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 467789999999999999999999999999999999997654322 2467889999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC---eEEEEecccc
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG---VVKLTDFGFS 166 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~---~i~l~df~~~ 166 (259)
...+++||++.+++|.+++.... .+++..++.++.||+.||.+||++||+|+||+|+||++..+.. .++|+|||++
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 99999999999999999987654 4999999999999999999999999999999999999976621 7999999999
Q ss_pred ccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 167 NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
.............++..|+|||++.+..++. ++|+||||+++|+|++|..||......+.+..+......++...|..
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCc-HHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence 8776555555667899999999998777765 99999999999999999999999888888888887766655544433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=285.23 Aligned_cols=228 Identities=28% Similarity=0.498 Sum_probs=198.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||+|.+..+++.|++|++............+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 36899999999999999999999999999999999877655556678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Ccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~ 175 (259)
|++.+ ++.+.+......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||.+...... ...
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCSCCSCC
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeecccceecCCccccc
Confidence 99987 7777777766679999999999999999999999999999999999999776 78999999999766433 223
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCCChHHHHHhhhccccccccccccC
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAP-FQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
....++..|+|||.+.+....+.++|+||||+++|+|++|..| |...+..+.+..+.+..+.+....|...
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 3456788999999998776445599999999999999987766 6778888889999998888877777553
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=283.11 Aligned_cols=231 Identities=35% Similarity=0.615 Sum_probs=204.6
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
+.+.++|++.+.||+|++|.||+|.+..++..|++|++............+.+|+.+++.++||||+++++++.+.+..+
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 57889999999999999999999999999999999999877666666788889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC--CeEEEEeccccccCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL--GVVKLTDFGFSNRFNP 171 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~--~~i~l~df~~~~~~~~ 171 (259)
++||++.+++|.+.+..... +++..++.++.||+.||.+||++|++|+||+|+||+++.+. +.++|+|||.+.....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREF-YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 99999999999998876654 89999999999999999999999999999999999997542 3499999999987766
Q ss_pred CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
........++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...........+.......+.+.|..-
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T 3kk8_A 161 SEAWHGFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 234 (284)
T ss_dssp SCBCCCSCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred CccccCCCCCcCCcCchhhcCCCCCc-ccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhccc
Confidence 55555667899999999998887765 999999999999999999999999988888888877766665544433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=295.96 Aligned_cols=221 Identities=34% Similarity=0.549 Sum_probs=187.9
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (259)
-.++|++.+.||+|++|.||+|.+..+++.|++|++.+... .......+.+|..+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 35789999999999999999999999999999999975421 223456678899999988 6999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PG 172 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~ 172 (259)
+||||+.+++|..++..... +++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++.... ..
T Consensus 101 lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~-g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCC--
T ss_pred EEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCC-CCEEEccccceeecccCC
Confidence 99999999999999977654 9999999999999999999999999999999999999766 889999999987533 22
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
.......++..|+|||++.+..++. ++|+|||||++|+|++|++||...+..+.+..+++.....+
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p 244 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGP-AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 244 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ccccccCCCcCeEChhhcCCCCcCC-ccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 3344557899999999998877775 99999999999999999999999999999998887665544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=285.43 Aligned_cols=225 Identities=31% Similarity=0.550 Sum_probs=191.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||+|.+ .+++.|++|.+............+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 36899999999999999999998 57899999999766544445577889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Ccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~ 175 (259)
|++.+ +|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++...... ...
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 157 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKY 157 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC-----
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEeECccccccCcccccc
Confidence 99987 9999998776779999999999999999999999999999999999999766 78999999998765432 222
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
....++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+.+..+.+..+.+....|.
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhch
Confidence 334678899999999775544459999999999999999999999999999999888877666555543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=284.02 Aligned_cols=218 Identities=27% Similarity=0.470 Sum_probs=184.6
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
+..+.++|++.+.||+|++|.||+|.+..++..|++|.+..... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 45678899999999999999999999999999999999865433 33345778899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.+++|||+++++|.+++.... ++++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN-KTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCSSSTTC--
T ss_pred EEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CCEEEEeCCCcccccc
Confidence 999999999999999998765 49999999999999999999999999999999999999766 7899999999876543
Q ss_pred CCc--cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 172 GQK--LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 172 ~~~--~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
... .....++..|+|||.+.+..++. ++|+||||+++|+|++|+.||......+.....+.
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 226 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDE-CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ 226 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCT-THHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS
T ss_pred ccccccCccccCccccCHhHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh
Confidence 322 22345789999999998887765 99999999999999999999988776665544443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=294.88 Aligned_cols=226 Identities=29% Similarity=0.520 Sum_probs=198.7
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.+.+.++|++.+.||+|++|.||+|.+..+++.+++|++.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 3567789999999999999999999999999999999987543 23456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec-CCeEEEEeccccccCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER-LGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~-~~~i~l~df~~~~~~~~ 171 (259)
+++|||+.+++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ .+.++|+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999999988766669999999999999999999999999999999999999643 46799999999987766
Q ss_pred CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccc
Q psy3663 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTC 241 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (259)
........++..|+|||++.+..++. ++|||||||++|+|++|..||...+..+.+..+.+....++..
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 272 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPVGF-YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED 272 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCH-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS
T ss_pred CcceeeeccCCCccCchhccCCCCCC-cccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Confidence 55555567899999999998877765 9999999999999999999999988888888887765554443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=306.48 Aligned_cols=227 Identities=25% Similarity=0.424 Sum_probs=194.9
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
.+.++|++.+.||+|+||.||+|.+..+++.|+||++............+.+|+.+++.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 456899999999999999999999999999999999987654555677888999999999999999999999654
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
...++||||+.+ +|.+.+. ..+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++..
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~-~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 213 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCCC--
T ss_pred CCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCC-CCEEEEEEEeeee
Confidence 467999999987 5666653 238999999999999999999999999999999999999776 7899999999987
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCc
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRP 247 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (259)
...........++..|+|||++.+..++. ++|||||||++|+|++|++||.+.+..+++..+++..+++++++|..-.
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CCCC----CCCTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCCcccCCCcccccccCHHHHcCCCCCH-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 76655556677899999999999887775 9999999999999999999999999999999999999999888886643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=284.00 Aligned_cols=215 Identities=28% Similarity=0.503 Sum_probs=188.9
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.+...++|++.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 34567899999999999999999999999999999999876542 3456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
++||||+.+++|.+++... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++......
T Consensus 93 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCST
T ss_pred EEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC-CCEEEeeCCCceecCCc
Confidence 9999999999999999765 38999999999999999999999999999999999999766 78999999998765543
Q ss_pred C-ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 173 Q-KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 173 ~-~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
. ......++..|+|||.+.+..++. ++||||||+++|+|++|+.||...+..+....+..
T Consensus 170 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 230 (297)
T 3fxz_A 170 QSKRSTMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (297)
T ss_dssp TCCBCCCCSCGGGCCHHHHHCSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ccccCCccCCcCccChhhhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 2 234457889999999998887775 99999999999999999999988877766665553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=304.09 Aligned_cols=233 Identities=35% Similarity=0.605 Sum_probs=203.3
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
..+.+.++|++.+.||+|++|.||+|.+..+++.|++|++............+.+|+.+++.++||||+++++++.+...
T Consensus 16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 44568899999999999999999999999999999999997654334457788999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCeEEEEeccccccC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTDFGFSNRF 169 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~i~l~df~~~~~~ 169 (259)
++++||++.+++|.+.+..... +++..++.++.||+.||.|||++||+|+||+|+||++..+ .+.++|+|||++...
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEcCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999999998876654 9999999999999999999999999999999999999643 357999999999877
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCc
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRP 247 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (259)
..........++..|+|||++.+. ++ .++|||||||++|+|++|.+||.+.+..+.+..+......+..+.|..-+
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~~~~-~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 250 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (486)
T ss_dssp CCC----CCTTGGGGCCGGGGGSC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred CCCCccCCCcCCCCCCCHHHhCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCC
Confidence 666666666789999999999764 54 49999999999999999999999999999999999988887777766544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=303.70 Aligned_cols=230 Identities=40% Similarity=0.722 Sum_probs=200.5
Q ss_pred CCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEE
Q psy3663 7 RSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEV 85 (259)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (259)
+.+...+....++|++.+.||+|++|.||+|.+..+|+.|+||++...... ......+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~ 84 (476)
T 2y94_A 5 EKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84 (476)
T ss_dssp ----CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 344556677889999999999999999999999999999999999754321 1235678899999999999999999999
Q ss_pred EecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 86 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
+.+.+..++||||+.+++|.+++...+ .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||+
T Consensus 85 ~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~-~~vkL~DFG~ 162 (476)
T 2y94_A 85 ISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGL 162 (476)
T ss_dssp EECSSEEEEEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTT-CCEEECCCSS
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecC-CCeEEEeccc
Confidence 999999999999999999999987554 49999999999999999999999999999999999999766 7899999999
Q ss_pred cccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc
Q psy3663 166 SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
+.............++..|+|||.+.+..+.+.++|+||||+++|+|++|+.||...+..+.+..+.+.....
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 235 (476)
T 2y94_A 163 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT 235 (476)
T ss_dssp CEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCC
T ss_pred hhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCC
Confidence 9887666556667789999999999887765569999999999999999999999999999888888765543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=293.62 Aligned_cols=216 Identities=40% Similarity=0.768 Sum_probs=187.2
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
....++|++.+.||+|++|.||+|.+..+++.|++|++...... ......+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 35678999999999999999999999999999999998653211 12345788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
++||||+ +++|.+++..... +++.+++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++......
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKR-MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDG 161 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTT-CCEEECCSSCTBTTTTS
T ss_pred EEEEECC-CCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCC-CCEEEEEeccceeccCC
Confidence 9999999 5589888876554 9999999999999999999999999999999999999766 78999999999877666
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
.......++..|+|||.+.+..+.++++||||||+++|+|++|+.||...........+.
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~ 221 (336)
T 3h4j_B 162 NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN 221 (336)
T ss_dssp BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC
T ss_pred cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 666667889999999999888775569999999999999999999998765554444433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=287.48 Aligned_cols=227 Identities=32% Similarity=0.585 Sum_probs=183.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||+|.+..+++.|++|.+.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 468999999999999999999999999999999997654 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 97 ELGDGGDLYDYIMKHD-----AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~-----~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
||+.+ +|.+++.... ..+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.....
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR-GQLKLGDFGLARAFGI 160 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCSSCEETTS
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCC-CCEEECcCccceecCC
Confidence 99986 9999887642 358999999999999999999999999999999999999766 7899999999976643
Q ss_pred CC-ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 172 GQ-KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 172 ~~-~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
.. ......++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+.+..+.+..+.+...+|...
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 32 2334567889999999977544445999999999999999999999999999999999998888877777543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=285.77 Aligned_cols=231 Identities=34% Similarity=0.602 Sum_probs=201.3
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc----ccHHHHHHHHHHHHhCCCCCeEEEEEEE
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP----VSQDHLYQEVRCMKLVQHPNVVRLYEVI 86 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (259)
-....+.++|++.+.||+|++|.||+|.+..++..|++|++....... .....+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 84 (321)
T 2a2a_A 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY 84 (321)
T ss_dssp CBCSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 344668889999999999999999999999999999999997654322 2467789999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC---eEEEEec
Q psy3663 87 DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG---VVKLTDF 163 (259)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~---~i~l~df 163 (259)
.+....+++||++.+++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||++..+.. .++|+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 85 ENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred ecCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999999999997654 4899999999999999999999999999999999999977632 7999999
Q ss_pred cccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 164 GFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
|.+.............++..|+|||.+.+..++. ++|+||||+++|+|++|..||......+.+..+.+.....+...+
T Consensus 164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (321)
T 2a2a_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242 (321)
T ss_dssp TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred ccceecCccccccccCCCCCccCcccccCCCCCC-ccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhh
Confidence 9998776655555667899999999998877765 999999999999999999999998888888888877665554433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=286.75 Aligned_cols=245 Identities=33% Similarity=0.511 Sum_probs=188.7
Q ss_pred CCCCCCCCCCCccccCeeEeeeecccccceEEEEEEe---ecCceEEEEEcccCCC--CcccHHHHHHHHHHHHhCCCCC
Q psy3663 4 SGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLVQHPN 78 (259)
Q Consensus 4 ~~~~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 78 (259)
+....+.+......++|++.+.||+|++|.||+|.+. .+++.|++|++..... .......+.+|+.+++.++|||
T Consensus 3 s~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~ 82 (327)
T 3a62_A 3 SETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82 (327)
T ss_dssp ----------CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTT
T ss_pred cccccCCCCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCC
Confidence 3344444555566789999999999999999999985 5788999999976532 2223456778999999999999
Q ss_pred eEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeE
Q psy3663 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVV 158 (259)
Q Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i 158 (259)
|+++++++.+.+..+++|||+.+++|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.+
T Consensus 83 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~-~~~ 160 (327)
T 3a62_A 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI-FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQ-GHV 160 (327)
T ss_dssp BCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT-SCE
T ss_pred ccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCC-CcE
Confidence 99999999999999999999999999999976654 8999999999999999999999999999999999999766 789
Q ss_pred EEEeccccccCCCC-CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 159 KLTDFGFSNRFNPG-QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 159 ~l~df~~~~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
+|+|||++...... .......++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+..+.+..+.+....
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 239 (327)
T 3a62_A 161 KLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNR-AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239 (327)
T ss_dssp EECCCSCC----------CTTSSCCTTSCHHHHTTSCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC
T ss_pred EEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCC-cccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999988654322 2334456889999999998877765 999999999999999999999998888888888765544
Q ss_pred cc-----------ccccccCchhhh
Q psy3663 238 SC-----------TCWWRGRPRSRR 251 (259)
Q Consensus 238 ~~-----------~~~~~~~~~~~~ 251 (259)
.+ ..+|..+|..|.
T Consensus 240 ~p~~~~~~~~~li~~~L~~dp~~R~ 264 (327)
T 3a62_A 240 LPPYLTQEARDLLKKLLKRNAASRL 264 (327)
T ss_dssp CCTTSCHHHHHHHHHHSCSCGGGST
T ss_pred CCCCCCHHHHHHHHHHHhcCHhhcc
Confidence 33 234556666553
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=284.68 Aligned_cols=230 Identities=31% Similarity=0.482 Sum_probs=194.7
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC---CcccHHHHHHHHHHHHhCC---CCCeEEEEEEEe
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL---DPVSQDHLYQEVRCMKLVQ---HPNVVRLYEVID 87 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~---~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~ 87 (259)
..+.++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 3567899999999999999999999999999999999875432 1122345667777777665 999999999987
Q ss_pred cCC-----eEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEE
Q psy3663 88 TNS-----KLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLT 161 (259)
Q Consensus 88 ~~~-----~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~ 161 (259)
... ..+++||++.+ +|.+++.... ..+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~ 162 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG-GTVKLA 162 (308)
T ss_dssp ECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTT-SCEEEC
T ss_pred ccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-CCEEEe
Confidence 654 58999999976 9999988764 338999999999999999999999999999999999999766 789999
Q ss_pred eccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccc
Q psy3663 162 DFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTC 241 (259)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (259)
|||++.............++..|+|||.+.+..++. ++||||||+++|+|++|++||...+..+.+..+.+..+.++..
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCS-THHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eCccccccCCCcccCCccccccccCchHHcCCCCCc-hHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 999998776665666677899999999998888775 9999999999999999999999999999999999988888877
Q ss_pred ccccC
Q psy3663 242 WWRGR 246 (259)
Q Consensus 242 ~~~~~ 246 (259)
.|...
T Consensus 242 ~~~~~ 246 (308)
T 3g33_A 242 DWPRD 246 (308)
T ss_dssp TSCSS
T ss_pred hccch
Confidence 77544
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=302.62 Aligned_cols=235 Identities=33% Similarity=0.612 Sum_probs=202.2
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
...+.+.++|++.+.||+|++|.||+|.+..++..|++|++............+.+|+.+++.++||||+++++++.+..
T Consensus 30 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 109 (494)
T 3lij_A 30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR 109 (494)
T ss_dssp CCBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 34556778999999999999999999999999999999999876655556778899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCeEEEEecccccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTDFGFSNR 168 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~i~l~df~~~~~ 168 (259)
.+++||||+.+++|.+.+..... +++..++.++.||+.||.|||++||+|+||+|+||++..+ .+.++|+|||++..
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999999998876654 8999999999999999999999999999999999999654 34699999999987
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCch
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPR 248 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (259)
...........++..|+|||++.+ .++ .++|||||||++|+|++|.+||......+.+..+.+....++.+.|..-+.
T Consensus 189 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 189 FENQKKMKERLGTAYYIAPEVLRK-KYD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp CBTTBCBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred CCCCccccccCCCcCeeCHHHHcc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 766656666778999999999864 455 499999999999999999999999999999999999988888887766543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=286.67 Aligned_cols=221 Identities=31% Similarity=0.535 Sum_probs=185.4
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
+.++|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 46899999999999999999999999999999999877665555567788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Cc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~ 174 (259)
||++.+++|..++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+...... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC-CCEEEeeCCCchhccCcccc
Confidence 99999988888776544 49999999999999999999999999999999999999766 78999999999766533 22
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
.....++..|+|||.+.+....+.++|+||||+++|+|++|.+||......+....+.+..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 222 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL 222 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccc
Confidence 3345678899999999875544469999999999999999999999998888888777655443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=302.85 Aligned_cols=239 Identities=34% Similarity=0.616 Sum_probs=207.8
Q ss_pred CCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEE
Q psy3663 7 RSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEV 85 (259)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (259)
.........+.++|++.+.||+|++|.||+|.+..+++.|+||++...... ......+.+|+.+++.++||||++++++
T Consensus 15 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 94 (484)
T 3nyv_A 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF 94 (484)
T ss_dssp ----CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred eeeccCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 344455677889999999999999999999999999999999999765433 3457788999999999999999999999
Q ss_pred EecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee--cCCeEEEEec
Q psy3663 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE--RLGVVKLTDF 163 (259)
Q Consensus 86 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~--~~~~i~l~df 163 (259)
+.+...++++||++.+++|.+.+..... +++..++.++.||+.||.|||++||+|+||+|+||++.. ..+.++|+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 95 FEDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDF 173 (484)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTCSC-CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence 9999999999999999999998876554 999999999999999999999999999999999999952 3468999999
Q ss_pred cccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 164 GFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
|++.............++..|+|||++.+ .++ .++||||||+++|+|++|.+||...+..+.+..+.+....+..+.|
T Consensus 174 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 251 (484)
T 3nyv_A 174 GLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 251 (484)
T ss_dssp THHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG
T ss_pred eeeEEcccccccccCCCCccccCceeecC-CCC-CcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 99987766666666678999999999876 455 4999999999999999999999999999999999998888777777
Q ss_pred ccCch
Q psy3663 244 RGRPR 248 (259)
Q Consensus 244 ~~~~~ 248 (259)
..-+.
T Consensus 252 ~~~s~ 256 (484)
T 3nyv_A 252 KKVSE 256 (484)
T ss_dssp GGSCH
T ss_pred ccCCH
Confidence 65443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=292.23 Aligned_cols=208 Identities=26% Similarity=0.514 Sum_probs=183.3
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
.....++|++.+.||+|+||.||+|.+..+++.|++|++.... ........+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3445689999999999999999999999999999999987542 122345778899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.++||||+.+++|..++.... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEH-GHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCC-CCEEEeccceeeeccC
Confidence 999999999999999987654 49999999999999999999999999999999999999766 8999999999988766
Q ss_pred CCccccccCCCccCCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 172 GQKLETSCGSLAYSAPEILLGD---SYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
........++..|+|||++... .++ .++|+|||||++|+|++|+.||....
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred CCceeccCCCccccCCeeeccCCCCCCC-ccceeechHHHHHHHHhCCCCCCCCC
Confidence 6666777899999999998643 344 49999999999999999999997543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=289.21 Aligned_cols=230 Identities=32% Similarity=0.603 Sum_probs=182.7
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
...+.++|++.+.||+|++|.||+|.+..+++.|++|++.... ....+.+|+.++++++||||+++++++.+....
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 4567788999999999999999999999899999999987543 345677899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee--cCCeEEEEeccccccCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE--RLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~--~~~~i~l~df~~~~~~~ 170 (259)
+++|||+.+++|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||++.. +.+.++|+|||++....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGY-YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSS-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999999999876544 899999999999999999999999999999999999964 24789999999987765
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH-HHHHhhhccccccccccccCch
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE-TLTMIMDVSESSCTCWWRGRPR 248 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~ 248 (259)
.........++..|+|||.+.+..++. ++|||||||++|+|++|..||....... .+..+.+.....+.++|.+-+.
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRGCAYGP-EVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred cccccccccCCCCccCHHHhcCCCCCc-ccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 544445567889999999998877765 9999999999999999999998766655 6777877777777777765443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=288.84 Aligned_cols=219 Identities=32% Similarity=0.513 Sum_probs=189.2
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (259)
.-.++|++.+.||+|++|.||+|.+..+++.|++|++.+... .......+..|..++..+ +||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 456799999999999999999999999999999999976421 122456677888888876 899999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP- 171 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~- 171 (259)
++||||+.+++|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCT
T ss_pred EEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCC-CCEEEeEChhhhhcccC
Confidence 999999999999999987554 9999999999999999999999999999999999999766 7899999999875432
Q ss_pred CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
........++..|+|||++.+..++. ++|+||||+++|+|++|..||...+..+.+..+.....
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~ 235 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNH-SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 235 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CCcccCCCCCcccCChhhhcCCCCCC-hhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC
Confidence 23345567899999999998887775 99999999999999999999998888888888776543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=287.50 Aligned_cols=232 Identities=25% Similarity=0.442 Sum_probs=201.1
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec----
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT---- 88 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 88 (259)
.....++|++.+.||+|++|.||+|.+..+++.|++|++............+.+|+.+++.++||||+++++++.+
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 12 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp TSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred ccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 3356789999999999999999999999999999999997766555556778899999999999999999999876
Q ss_pred ----CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecc
Q psy3663 89 ----NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG 164 (259)
Q Consensus 89 ----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~ 164 (259)
.+..++||||+.+ +|.+.+......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg 169 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFG 169 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCT
T ss_pred cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCC-CCEEEccch
Confidence 3568999999986 8888887776679999999999999999999999999999999999999766 789999999
Q ss_pred ccccCCCC-----CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 165 FSNRFNPG-----QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 165 ~~~~~~~~-----~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
++...... .......++..|+|||.+.+....+.++||||||+++|+|++|.+||......+.+..+.+..+.++
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 98765422 1223345688999999997755444599999999999999999999999999999999999999988
Q ss_pred ccccccC
Q psy3663 240 TCWWRGR 246 (259)
Q Consensus 240 ~~~~~~~ 246 (259)
..+|...
T Consensus 250 ~~~~~~~ 256 (351)
T 3mi9_A 250 PEVWPNV 256 (351)
T ss_dssp TTTSTTG
T ss_pred hhhcccc
Confidence 8887664
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=286.04 Aligned_cols=203 Identities=36% Similarity=0.585 Sum_probs=179.5
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (259)
-.++|++.+.||+|++|.||+|.+..+++.|++|++.+... .......+.+|..+++++ +||||+++++++.+....+
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 35789999999999999999999999999999999986543 233456678899999988 7999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PG 172 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~ 172 (259)
+||||+.+++|.+++..... +++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++.... ..
T Consensus 87 lv~e~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCGGGCBCSCCTT
T ss_pred EEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEEeccccccccCCC
Confidence 99999999999999876654 9999999999999999999999999999999999999766 789999999987532 33
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
.......++..|+|||++.+..++. ++|+|||||++|+|++|+.||..
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcccccCCCccccCccccCCCCCCh-HHhHHHHHHHHHHHHhCCCCcCC
Confidence 3445567899999999998877765 99999999999999999999965
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=277.87 Aligned_cols=229 Identities=37% Similarity=0.673 Sum_probs=199.9
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.+.+.++|++.+.||+|++|.||+|.+..++..+++|.+..... .....+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (277)
T 3f3z_A 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI 81 (277)
T ss_dssp --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence 35688999999999999999999999999999999999876542 3467788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee--ecCCeEEEEeccccccCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~--~~~~~i~l~df~~~~~~~ 170 (259)
+++|||+.+++|.+++..... +++..++.++.|++.||.+||++|++|+||+|+||++. +..+.++|+|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999999998876554 89999999999999999999999999999999999993 233789999999998776
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
.........++..|+|||.+.+. ++ .++|+||||+++|+|++|+.||......+....+.+.....+...|..-
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGL-YG-PECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNV 234 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTC-BC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS
T ss_pred CccchhccCCCCCccChHHhccc-CC-chhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcC
Confidence 66666667789999999998765 44 4999999999999999999999999999999998888777766554443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=294.40 Aligned_cols=227 Identities=28% Similarity=0.432 Sum_probs=187.0
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecC--C
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTN--S 90 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~ 90 (259)
..+.++|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.+. ||||+++++++... .
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 35678999999999999999999999999999999999766555566777889999999998 99999999999754 4
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
.+++||||+.+ +|..++... .+++..+..++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++....
T Consensus 85 ~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 85 DVYLVFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAE-CHVKVADFGLSRSFV 160 (388)
T ss_dssp CEEEEEECCSE-EHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEESS
T ss_pred EEEEEecccCc-CHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCC-CCEEecCCccccccc
Confidence 78999999976 899988763 48999999999999999999999999999999999999776 789999999987643
Q ss_pred CC----------------------CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHH
Q psy3663 171 PG----------------------QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228 (259)
Q Consensus 171 ~~----------------------~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (259)
.. .......++..|+|||++.+....+.++|||||||++|+|++|++||.+.+..+++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 11233467889999999987544445999999999999999999999999999999
Q ss_pred HHhhhccccccccccc
Q psy3663 229 TMIMDVSESSCTCWWR 244 (259)
Q Consensus 229 ~~i~~~~~~~~~~~~~ 244 (259)
..+++..+.+..+.+.
T Consensus 241 ~~i~~~~~~p~~~~~~ 256 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVE 256 (388)
T ss_dssp HHHHHHHCCCCHHHHH
T ss_pred HHHHHhcCCCCHHHHH
Confidence 9999988888776654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=292.84 Aligned_cols=226 Identities=26% Similarity=0.447 Sum_probs=192.0
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
.+.++|++.+.||+|++|.||+|.+..+|+.|+||.+............+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 467899999999999999999999999999999999976554555567788999999999999999999999765
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
..++++||++ +.+|.+++... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQ 177 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred CceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC-CCEEEEeeecccc
Confidence 3469999999 66999998763 48999999999999999999999999999999999999776 7899999999976
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
... ......++..|+|||.+.+....+.++|+|||||++++|++|++||.+.+..+++..+.+..++++.+++..-
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 543 2344567889999999987443445999999999999999999999999999999999999999888877654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=284.95 Aligned_cols=217 Identities=29% Similarity=0.581 Sum_probs=190.8
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-.++|++.+.||+|++|.||+|.+..+|+.|++|++.+... .......+.+|..+++.++||||+++++++.+....++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 35789999999999999999999999999999999975421 12245677889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+|||+.+++|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..... .
T Consensus 84 v~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~Dfg~a~~~~~--~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--V 159 (318)
T ss_dssp EECCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS--C
T ss_pred EEeCCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCC-CCEEEeecCcceecCC--c
Confidence 9999999999999987554 8999999999999999999999999999999999999766 8999999999976543 2
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
.....++..|+|||++.+..++. ++|+||||+++|+|++|+.||...+..+.+..+++....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 221 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR 221 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC
T ss_pred cccccCCccccCHhHhcCCCCCc-ccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 34457899999999998877775 999999999999999999999988888888888765443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=291.17 Aligned_cols=205 Identities=35% Similarity=0.591 Sum_probs=178.8
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCe
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (259)
..-.++|++.+.||+|+||.||+|.+..+++.|++|++.+.... ......+.+|..++.++ +||||+++++++.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 34467999999999999999999999999999999999865432 23345677889998876 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc-CC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR-FN 170 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~-~~ 170 (259)
.++||||+.+++|..++..... +++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++.. ..
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCC
T ss_pred EEEEEEcCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCC-CCEEEeecceeeeccc
Confidence 9999999999999999887654 9999999999999999999999999999999999999766 8999999999875 33
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
.........++..|+|||++.+..++. ++|+|||||++|+|++|++||..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~-~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CCCccccccCCcccCCchhhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCcc
Confidence 334455667899999999999888775 99999999999999999999964
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=288.87 Aligned_cols=222 Identities=31% Similarity=0.489 Sum_probs=191.4
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCe
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (259)
..-.++|++.+.||+|++|.||+|.+..+++.|++|++.+... .......+..|..++..+ +||+|+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 3456899999999999999999999998899999999976421 123456778899999887 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN- 170 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~- 170 (259)
.++||||+.|++|.+++..... +++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCC-CcEEEEeCCccccccc
Confidence 9999999999999999987654 9999999999999999999999999999999999999766 899999999987533
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
.........++..|+|||++.+..++. ++|+||||+++|+|++|+.||...+..+.+..+++.....
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~ 240 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYGK-SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 240 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBST-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred CCcccccccCCccccChhhhcCCCcCC-cccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 233445567899999999998887765 9999999999999999999999988888888888765443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=287.33 Aligned_cols=221 Identities=35% Similarity=0.570 Sum_probs=193.9
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
....++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++||||+++++++.+....
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 3456899999999999999999999999999999999865431 123456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
++||||+.+++|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++......
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSSC
T ss_pred EEEEcCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCC-CCEEEcccccceeccCC
Confidence 999999999999999987654 9999999999999999999999999999999999999766 78999999999866433
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
.....++..|+|||++.+..++. ++|+||||+++|+|++|.+||...+..+.+..+.+.....+
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p 258 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNK-AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred --cccccCCccccCHHHhcCCCCCC-cCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 33456889999999998877775 99999999999999999999999888888888887654443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.41 Aligned_cols=234 Identities=32% Similarity=0.582 Sum_probs=202.0
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-----------ccHHHHHHHHHHHHhCCCCCeE
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-----------VSQDHLYQEVRCMKLVQHPNVV 80 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~ 80 (259)
..+.+.++|++.+.||+|++|.||+|.+..++..|++|++....... .....+.+|+.+++.++||||+
T Consensus 30 ~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp ECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred cCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 44568899999999999999999999999999999999997654322 3457788999999999999999
Q ss_pred EEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC--eE
Q psy3663 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG--VV 158 (259)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~--~i 158 (259)
++++++.+...+++||||+.+++|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||++..+.. .+
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999999999999876654 999999999999999999999999999999999999976632 69
Q ss_pred EEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc
Q psy3663 159 KLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
+|+|||++.............++..|+|||++.+ .++ .++||||||+++|+|++|.+||...+..+.+..+.+....+
T Consensus 189 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYN-EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp EECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999999988776666666788999999999875 454 49999999999999999999999999999999999988877
Q ss_pred cccccccCch
Q psy3663 239 CTCWWRGRPR 248 (259)
Q Consensus 239 ~~~~~~~~~~ 248 (259)
+.+.|.+-+.
T Consensus 267 ~~~~~~~~s~ 276 (504)
T 3q5i_A 267 DFNDWKNISD 276 (504)
T ss_dssp CHHHHTTSCH
T ss_pred CccccCCCCH
Confidence 7766665443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=287.36 Aligned_cols=209 Identities=36% Similarity=0.641 Sum_probs=171.6
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
......++|++.+.||+|++|.||+|.+..+++.|++|++..... ....+.+|+.+++.++||||+++++++.+...
T Consensus 14 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTH 90 (361)
T ss_dssp CCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE
Confidence 344556899999999999999999999999999999999975432 34667899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC-CeEEEEeccccccCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL-GVVKLTDFGFSNRFN 170 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~-~~i~l~df~~~~~~~ 170 (259)
.++||||+.+++|.+++...+. +++..++.++.||+.||.+||++||+|+||+|+||+++.+. ++++|+|||++....
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAGR-FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEEEeCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 9999999999999999876554 99999999999999999999999999999999999997552 259999999987554
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
.........++..|+|||++.+..+...++||||||+++|+|++|+.||.....
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 444445567899999999998888776459999999999999999999987554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=287.64 Aligned_cols=227 Identities=31% Similarity=0.579 Sum_probs=192.7
Q ss_pred ccccCeeE--eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 15 KIAGLYDL--EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 15 ~~~~~y~~--~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.+.+.|++ .+.||+|++|.||+|.+..++..|++|++.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 84 ~~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp CGGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 34556666 578999999999999999999999999987643 23467788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee-cCCeEEEEeccccccCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE-RLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~-~~~~i~l~df~~~~~~~~ 171 (259)
++||||+++++|.+++......+++..++.++.||+.||.+||+.||+|+||+|+||++.. +.+.++|+|||++.....
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 9999999999999998876666999999999999999999999999999999999999854 346899999999988766
Q ss_pred CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
........++..|+|||.+.+..++. ++|+|||||++|+|++|..||...+..+.+..++.....++.+.|.
T Consensus 242 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 313 (373)
T 2x4f_A 242 REKLKVNFGTPEFLAPEVVNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQ 313 (373)
T ss_dssp TCBCCCCCSSCTTCCHHHHTTCBCCH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGT
T ss_pred ccccccccCCCcEeChhhccCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhc
Confidence 65556667899999999998777765 9999999999999999999999999999999988876655544443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=288.68 Aligned_cols=229 Identities=29% Similarity=0.500 Sum_probs=192.4
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||+|.+..+++.|++|++...... .....+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 36899999999999999999999999999999998754321 11223447899999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-cc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~ 175 (259)
||+.+ +|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++....... ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER-GELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT-CCEEECSSSEEECC-------
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC-CCEEEccCcccccccCCcccc
Confidence 99986 9999998877779999999999999999999999999999999999999766 789999999987654322 22
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCch
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPR 248 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (259)
....++..|+|||.+.+....+.++||||||+++|+|++|+.||.+.+..+.+..+.+..+.+..+.|.+...
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 3446788999999998755444599999999999999999999999999999999999999998888876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=289.95 Aligned_cols=230 Identities=31% Similarity=0.552 Sum_probs=192.8
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC---CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK---LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
..+.++|++.+.||+|++|.||+|.+..+++.|++|++.... ........+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 456789999999999999999999999999999999986432 12234678899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC--CeEEEEeccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL--GVVKLTDFGF 165 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~--~~i~l~df~~ 165 (259)
..++||||+.+++|.+.+... ...+++..++.++.||+.||.|||++||+|+||||+||+++.+. ..++|+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999998887653 33489999999999999999999999999999999999997652 3499999999
Q ss_pred cccCCCCCc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 166 SNRFNPGQK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 166 ~~~~~~~~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
+........ .....++..|+|||++.+..++. ++||||||+++|+|++|..||... ..+.+..+.+.........|.
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~ 257 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGK-PVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS 257 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcCCCCCc-hHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence 977654332 33456899999999998877765 999999999999999999999874 456667777666555544443
Q ss_pred c
Q psy3663 245 G 245 (259)
Q Consensus 245 ~ 245 (259)
.
T Consensus 258 ~ 258 (351)
T 3c0i_A 258 H 258 (351)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=296.74 Aligned_cols=216 Identities=31% Similarity=0.565 Sum_probs=188.1
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-.++|++.+.||+|+||.||+|.+..+++.|++|++.+... .......+.+|..+++.++||||+++++++.+....++
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999865321 11223457789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||||+.+++|.+++... .+++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus 147 V~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~-g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS-GHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp EECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSE
T ss_pred EEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCC-CCEEEeccceeEeeccCCc
Confidence 99999999999998764 48999999999999999999999999999999999999766 8999999999977654432
Q ss_pred --cccccCCCccCCcccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 175 --LETSCGSLAYSAPEILLGDS----YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 --~~~~~~~~~~~apE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
.....++..|+|||++.+.. ++ .++|+||||+++|+|++|++||...+..+.+..|++..
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 289 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYG-RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEE-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCC-CcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence 23557899999999997654 44 49999999999999999999999999899999888754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=289.81 Aligned_cols=226 Identities=24% Similarity=0.439 Sum_probs=188.3
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS---- 90 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 90 (259)
.+.++|++.+.||+|++|.||+|.+..+++.|+||++............+.+|+.+++.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 4568999999999999999999999999999999999866545555677889999999999999999999997654
Q ss_pred --eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 91 --KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 91 --~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
..++|||++.+ +|.+.+. ..+++..+..++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLART 176 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCCCC---
T ss_pred ccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCC-CCEEEEEeecccc
Confidence 78999999976 7888775 248999999999999999999999999999999999999766 7899999999977
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
...........++..|+|||.+.+..++. ++||||||+++|+|++|+.||.+.+..+.+..+++..+.+++++|..-
T Consensus 177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp -------------CTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred cccccccCCceecCCccCHHHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 65544445567889999999998877775 999999999999999999999999999999999999988887777543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=286.16 Aligned_cols=226 Identities=29% Similarity=0.472 Sum_probs=186.1
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEec
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT 88 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (259)
-..+..+.++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp CCCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred CCCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 34578899999999999999999999999999999999999976543 22335678899999999999999999999865
Q ss_pred CC----eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecc
Q psy3663 89 NS----KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFG 164 (259)
Q Consensus 89 ~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~ 164 (259)
.. ..++||||+.+++|.+++.... ++++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg 161 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFG 161 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETT-SCEEECCCS
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCC-CCEEEeecc
Confidence 43 3599999999999999997665 49999999999999999999999999999999999999766 789999999
Q ss_pred ccccCCCCCc----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc
Q psy3663 165 FSNRFNPGQK----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 165 ~~~~~~~~~~----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
++........ .....++..|+|||.+.+..++. ++||||||+++|+|++|+.||......+....+......+
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC
Confidence 9876543221 22345789999999998887775 9999999999999999999999888777776666554433
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=287.40 Aligned_cols=222 Identities=34% Similarity=0.570 Sum_probs=184.5
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHH-HHhCCCCCeEEEEEEEecCC
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRC-MKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~ 90 (259)
+..-.++|++.+.||+|++|.||+|.+..++..|++|++.+.... ......+.+|..+ ++.++||||+++++++.+.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 344567999999999999999999999999999999999765432 2234455666666 57789999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC-
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF- 169 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~- 169 (259)
..++||||+.|++|.+++..... +++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++...
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~-g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCBCGGGB
T ss_pred EEEEEEeCCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCC-CCEEEeeCccccccc
Confidence 99999999999999999877554 8999999999999999999999999999999999999766 89999999998753
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
..........++..|+|||++.+..++. ++|+|||||++|+|++|..||...+..+.+..+++....
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~ 257 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDR-TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ 257 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC
T ss_pred cCCCccccccCCccccCHHHhCCCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC
Confidence 2333445567899999999998887775 999999999999999999999998888888888765433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=294.86 Aligned_cols=240 Identities=23% Similarity=0.403 Sum_probs=197.8
Q ss_pred CCCCCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEE
Q psy3663 4 SGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83 (259)
Q Consensus 4 ~~~~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 83 (259)
.+...+....-.+.++|++.+.||+|++|.||+|.+..+++.|+||++............+.+|+.+++.++||||++++
T Consensus 12 ~~~~~Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 91 (432)
T 3n9x_A 12 ENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91 (432)
T ss_dssp CCCCTTCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhhhhcCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEE
Confidence 33455556667789999999999999999999999999999999999987655555667889999999999999999999
Q ss_pred EEEecC-----CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeE
Q psy3663 84 EVIDTN-----SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVV 158 (259)
Q Consensus 84 ~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i 158 (259)
+++... ...++|||++.+ +|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.+
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~-~~~ 168 (432)
T 3n9x_A 92 DLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQD-CSV 168 (432)
T ss_dssp EECCCSCTTTCCCEEEEEECCSE-EHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCE
T ss_pred EEEecCCCCcCCeEEEEEecCCc-CHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCC-CCE
Confidence 998765 579999999976 9999987543 49999999999999999999999999999999999999766 789
Q ss_pred EEEeccccccCCCCCc-----------------------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-
Q psy3663 159 KLTDFGFSNRFNPGQK-----------------------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA- 214 (259)
Q Consensus 159 ~l~df~~~~~~~~~~~-----------------------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~- 214 (259)
+|+|||++........ .....++..|+|||++......+.++|||||||++|+|++
T Consensus 169 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g 248 (432)
T 3n9x_A 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248 (432)
T ss_dssp EECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTT
T ss_pred EEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhc
Confidence 9999999987643321 2445678999999987554444459999999999999998
Q ss_pred ----------CCCCCCCCC-----------------ChHHHHHhhhccccccccccccC
Q psy3663 215 ----------GQAPFQEAN-----------------DSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 215 ----------g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
|.++|.+.+ ..+++..|.+..++++.+.|...
T Consensus 249 ~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~ 307 (432)
T 3n9x_A 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307 (432)
T ss_dssp CTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred ccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhc
Confidence 555555544 36888999999998887766543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=289.62 Aligned_cols=221 Identities=24% Similarity=0.383 Sum_probs=188.0
Q ss_pred CCCCccccCeeEeeeeccc--ccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec
Q psy3663 11 GHPTKIAGLYDLEETLGRG--HFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT 88 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g--~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (259)
.....-.++|++.+.||+| ++|.||+|.+..+++.|+||++............+.+|+.+++.++||||+++++++.+
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 3344557799999999999 99999999999999999999998776556667788899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.+..++||||+.+++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||.+.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~kl~dfg~~~ 176 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-GKVYLSGLRSNL 176 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCGGGCE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccccce
Confidence 99999999999999999999765 3459999999999999999999999999999999999999766 789999999875
Q ss_pred cCCCCC--------ccccccCCCccCCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 168 RFNPGQ--------KLETSCGSLAYSAPEILLG--DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 168 ~~~~~~--------~~~~~~~~~~~~apE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
...... ......++..|+|||++.+ ..++ .++|||||||++|+|++|+.||.+.+..+.+..++.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBC-THHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 432111 1122356778999999987 3455 499999999999999999999988777776655543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=280.97 Aligned_cols=241 Identities=25% Similarity=0.401 Sum_probs=189.9
Q ss_pred CCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEE
Q psy3663 7 RSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVI 86 (259)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (259)
..++.+.....++|++.+.||+|++|.||+|.+ ++..|++|++............+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 345556666778999999999999999999974 688999999987766666667889999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCCCCeEeeecCCeEEEEe
Q psy3663 87 DTNSKLYLILELGDGGDLYDYIMKHDA--GLSETYAREYFAQIVRAISFCHKLH--VVHRDLKPENVVFFERLGVVKLTD 162 (259)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~~~~~~~--~~~~~~i~~~~~ql~~al~~LH~~~--i~H~dl~p~nIlv~~~~~~i~l~d 162 (259)
.+....+++|||+.+++|.+++..... .+++..++.++.||+.||.+||++| |+|+||+|+||+++.+ +.++|+|
T Consensus 104 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~-~~~kL~D 182 (309)
T 3p86_A 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCD 182 (309)
T ss_dssp CSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTT-CCEEECC
T ss_pred EECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCC-CcEEECC
Confidence 999999999999999999999976432 3899999999999999999999999 9999999999999766 7899999
Q ss_pred ccccccCCCCC-ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc----
Q psy3663 163 FGFSNRFNPGQ-KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES---- 237 (259)
Q Consensus 163 f~~~~~~~~~~-~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~---- 237 (259)
||++....... ......++..|+|||.+.+..++. ++||||||+++|+|++|+.||...+..+....+......
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 261 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE-KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP 261 (309)
T ss_dssp CC-----------------CCTTSCHHHHTTCCCCT-THHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred CCCCccccccccccccCCCCccccChhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 99986543322 223446788999999998887765 999999999999999999999988877777666422221
Q ss_pred ---------ccccccccCchhhh
Q psy3663 238 ---------SCTCWWRGRPRSRR 251 (259)
Q Consensus 238 ---------~~~~~~~~~~~~~~ 251 (259)
....+|..+|.+|.
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rp 284 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRP 284 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred ccCCHHHHHHHHHHccCChhhCc
Confidence 22346777777653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=275.45 Aligned_cols=226 Identities=33% Similarity=0.646 Sum_probs=192.1
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc----ccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP----VSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
.+.++|++.+.||+|++|.||+|.+..+++.|++|++....... .....+.+|+.+++.++||||+++++++.+..
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 35678999999999999999999999999999999997654322 24678899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC---CeEEEEeccccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL---GVVKLTDFGFSN 167 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~---~~i~l~df~~~~ 167 (259)
..+++||++.+++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||++..+. ..++|+|||.+.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999999997654 489999999999999999999999999999999999997662 179999999998
Q ss_pred cCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccc
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCW 242 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (259)
............++..|+|||.+.+..++. ++|+||||+++++|++|..||......+.+..+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY 234 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCc-chhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchh
Confidence 776555555566888999999998877765 99999999999999999999999888888888776665544433
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=296.62 Aligned_cols=230 Identities=23% Similarity=0.396 Sum_probs=179.8
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-----
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT----- 88 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 88 (259)
-.+.++|++.+.||+|+||.||+|.+..+++.|+||++............+.+|+.+++.++||||+++++++..
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 356789999999999999999999999999999999997665555567788899999999999999999999843
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
....++|||++.+ +|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++..
T Consensus 129 ~~~~~lv~e~~~~-~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~-~~~kl~DFGla~~ 205 (458)
T 3rp9_A 129 FDELYVVLEIADS-DFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD-CSVKVCDFGLART 205 (458)
T ss_dssp CCCEEEEECCCSE-EHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-CCEEECCCTTCBC
T ss_pred CceEEEEEecccc-chhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCC-CCEeecccccchh
Confidence 3579999999865 8999886544 49999999999999999999999999999999999999776 7899999999976
Q ss_pred CCCCC----------------------------ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh------
Q psy3663 169 FNPGQ----------------------------KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA------ 214 (259)
Q Consensus 169 ~~~~~----------------------------~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~------ 214 (259)
..... ......++..|+|||++......+.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 54221 12234568889999987544434459999999999999998
Q ss_pred -----CCCCCCCCC--------------------ChHHHHHhhhccccccccccccC
Q psy3663 215 -----GQAPFQEAN--------------------DSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 215 -----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
|+++|.+.+ ..+++..|.+..++++.+.|...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~ 342 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL 342 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTS
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhc
Confidence 788886655 26788889998888887766543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=285.81 Aligned_cols=208 Identities=36% Similarity=0.649 Sum_probs=178.2
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
.+.++|++.+.||+|++|.||+|.+..+++.|++|++..... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 578999999999999999999999999999999999865432 2234567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ- 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~- 173 (259)
+|||+.+++|.+++.... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTE
T ss_pred EEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC-CCEEEEEeeccceeccCCc
Confidence 999999999999886544 39999999999999999999999999999999999999766 789999999987553222
Q ss_pred --ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 174 --KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 174 --~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
......++..|+|||.+.+..+.+.++||||||+++|+|++|+.||......
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 2234568899999999988776555899999999999999999999876554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=296.18 Aligned_cols=218 Identities=29% Similarity=0.505 Sum_probs=188.5
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
..++|++.+.||+|+||.||+|.+..+++.|++|++.+... .......+.+|..++..++||||+++++++.+....++
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 35789999999999999999999999999999999875321 11123447789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||||+.+++|.+++......+++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSC
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCC-CCEEEcchhhhhhcccCCC
Confidence 999999999999998766669999999999999999999999999999999999999766 7899999999976544332
Q ss_pred c--ccccCCCccCCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 175 L--ETSCGSLAYSAPEILL-----GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 ~--~~~~~~~~~~apE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
. ....++..|+|||++. ...++ .++|+|||||++|+|++|++||...+..+.+..+++..
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCC-CcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc
Confidence 2 2357899999999986 34455 49999999999999999999999998888888887543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=280.14 Aligned_cols=219 Identities=36% Similarity=0.588 Sum_probs=180.4
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc------------------------ccHHHHHHHHHH
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP------------------------VSQDHLYQEVRC 70 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~------------------------~~~~~~~~e~~~ 70 (259)
...++|++.+.||+|++|.||+|.+..+++.|++|++....... .....+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45689999999999999999999999999999999997653211 123568899999
Q ss_pred HHhCCCCCeEEEEEEEec--CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCC
Q psy3663 71 MKLVQHPNVVRLYEVIDT--NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPEN 148 (259)
Q Consensus 71 l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~n 148 (259)
++.++||||+++++++.+ ....+++||++.+++|.++.. ..++++..++.++.||+.||.+||++||+|+||+|+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999986 578999999999989887643 3458999999999999999999999999999999999
Q ss_pred eEeeecCCeEEEEeccccccCCCCC-ccccccCCCccCCcccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 149 VVFFERLGVVKLTDFGFSNRFNPGQ-KLETSCGSLAYSAPEILLGDSY--DAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 149 Ilv~~~~~~i~l~df~~~~~~~~~~-~~~~~~~~~~~~apE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
|+++.+ +.++|+|||++....... ......++..|+|||.+.+... .+.++|+||||+++|+|++|+.||......
T Consensus 168 il~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 168 LLVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EEECTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEECCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 999766 789999999987665432 2344568899999999976543 234899999999999999999999988777
Q ss_pred HHHHHhhhccc
Q psy3663 226 ETLTMIMDVSE 236 (259)
Q Consensus 226 ~~~~~i~~~~~ 236 (259)
.....+.....
T Consensus 247 ~~~~~~~~~~~ 257 (298)
T 2zv2_A 247 CLHSKIKSQAL 257 (298)
T ss_dssp HHHHHHHHCCC
T ss_pred HHHHHHhcccC
Confidence 77666665433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=285.26 Aligned_cols=207 Identities=21% Similarity=0.333 Sum_probs=180.2
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (259)
..+.++|++.+.||+|++|.||+|.+..+++.|+||++.... ....+.+|+.+++.+ +||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 80 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN 80 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence 346789999999999999999999999999999999987543 234577899999999 899999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCe-----EEEEeccccc
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV-----VKLTDFGFSN 167 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~-----i~l~df~~~~ 167 (259)
+++||++ +++|.+++......+++..++.++.||+.||.+||++||+|+||||+||+++.+ +. ++|+|||++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~-~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP-GNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTCTTSEEECCCTTCE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC-CCCCCceEEEEEcccce
Confidence 9999999 889999998776679999999999999999999999999999999999999766 54 9999999997
Q ss_pred cCCCCCc--------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q psy3663 168 RFNPGQK--------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227 (259)
Q Consensus 168 ~~~~~~~--------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (259)
....... .....++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~Pf~~~~~~~~ 225 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSR-RDDLEALGHMFMYFLRGSLPWQGLKADTL 225 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCc-hhHHHHHHHHHHHHhcCCCCccccccccH
Confidence 6543322 13456889999999999887765 99999999999999999999988655443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=280.60 Aligned_cols=202 Identities=27% Similarity=0.441 Sum_probs=178.7
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||+|.+..+++.|++|.+... .......+.+|+.+++.++||||+++++++.+....++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 57999999999999999999999999999999988543 3455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~ 176 (259)
||+.+++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||.+..........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTT-SCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCC-CCEEEeecccceecccccccc
Confidence 9999999999999877779999999999999999999999999999999999999766 789999999997654332221
Q ss_pred ---------------cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 177 ---------------TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 177 ---------------~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
...++..|+|||.+.+..++. ++||||||+++|+|++|..||...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE-KVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCc-HHHHHHHHHHHHHHhcCCCCCcch
Confidence 345788999999998877775 999999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=292.59 Aligned_cols=218 Identities=30% Similarity=0.489 Sum_probs=189.1
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
..++|++.+.||+|+||.||+|.+..+++.|++|++.+... .......+.+|..++..++||+|+++++++.+....++
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 35789999999999999999999999999999999975321 12234457789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||||+.+++|.+++...+..+++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~-g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRC-GHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCC-CCEEEeechhheeccCCCc
Confidence 999999999999998876669999999999999999999999999999999999999766 8899999999977654333
Q ss_pred --cccccCCCccCCccccc-------CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 175 --LETSCGSLAYSAPEILL-------GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 --~~~~~~~~~~~apE~~~-------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
.....++..|+|||++. ...++ .++|+|||||++|+|++|+.||...+..+.+..|++..
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYG-PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCC-hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 22357899999999986 23444 49999999999999999999999998888888887643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=286.12 Aligned_cols=232 Identities=27% Similarity=0.444 Sum_probs=190.5
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc---ccHHHHHHHHHHHHhCCCCCeEEEEEEEec
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP---VSQDHLYQEVRCMKLVQHPNVVRLYEVIDT 88 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (259)
+.....++|++.+.||+|++|.||+|.+..+++.|++|.+....... .....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 44566789999999999999999999999899999999997643222 123567899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.+..+++||++.+ +|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKS 161 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGST
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCC-CCEEEEeccccee
Confidence 9999999999987 8999888776679999999999999999999999999999999999999766 7899999999876
Q ss_pred CCCC-CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 169 FNPG-QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 169 ~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
.... .......++..|+|||.+.+....+.++|+||||+++|+|++|.+||...+..+.+..+.+..+.+...+|..
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred ccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 5433 2233456788999999997765444599999999999999999999999999999999998888777766643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=281.05 Aligned_cols=208 Identities=28% Similarity=0.485 Sum_probs=178.7
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--e
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS--K 91 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 91 (259)
..+.++|++.+.||+|++|.||+|.+..+++.|++|++..... ......+.+|++++++++||||+++++++.... .
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 3567899999999999999999999999999999999875432 234667789999999999999999999987654 7
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee---ecCCeEEEEecccc
Q psy3663 92 LYLILELGDGGDLYDYIMKHD--AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF---ERLGVVKLTDFGFS 166 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~--~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~---~~~~~i~l~df~~~ 166 (259)
.++||||+.+++|.+++.... ..+++..++.++.||+.||.+||++||+|+||+|+||++. +..+.++|+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999999999999998653 3389999999999999999999999999999999999982 22257999999999
Q ss_pred ccCCCCCccccccCCCccCCccccc--------CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 167 NRFNPGQKLETSCGSLAYSAPEILL--------GDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~apE~~~--------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
.............++..|+|||.+. +..++ .++||||||+++|+|++|+.||....
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBC-TTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eecCCCCceeecccCCCccCHHHhhhccccccccCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8876666556667899999999885 34444 49999999999999999999997544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=286.50 Aligned_cols=222 Identities=27% Similarity=0.446 Sum_probs=189.6
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-------
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT------- 88 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 88 (259)
..++|++.+.||+|++|.||+|.+..+++.||+|.+...... ..+|+.+++.++||||+++++++..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 457899999999999999999999999999999998654321 2379999999999999999999843
Q ss_pred -------------------------------CCeEEEEEeccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Q psy3663 89 -------------------------------NSKLYLILELGDGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFC 134 (259)
Q Consensus 89 -------------------------------~~~~~lv~e~~~~~sL~~~~~~---~~~~~~~~~i~~~~~ql~~al~~L 134 (259)
....++||||+.+ +|.+.+.. ....+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3448899999986 88777654 345699999999999999999999
Q ss_pred HHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh
Q psy3663 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA 214 (259)
Q Consensus 135 H~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~ 214 (259)
|++||+|+||+|+||+++.+.+.++|+|||++.............++..|+|||.+.+....+.++|||||||++|+|++
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 99999999999999999755689999999999877666666666788899999998876644459999999999999999
Q ss_pred CCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 215 GQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 215 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
|++||.+.+..+.+..+++..++++.+.|.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~ 267 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMI 267 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 999999999999999999988877655443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=283.19 Aligned_cols=230 Identities=25% Similarity=0.380 Sum_probs=199.7
Q ss_pred CCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-----CCCeEEEE
Q psy3663 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-----HPNVVRLY 83 (259)
Q Consensus 9 ~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~ 83 (259)
+-.....+.++|++.+.||+|++|.||+|.+..+++.|++|++... .........|+.+++.+. ||||++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3345557788999999999999999999999999999999998642 234566778999999997 99999999
Q ss_pred EEEecCCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee---------
Q psy3663 84 EVIDTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE--------- 153 (259)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~--------- 153 (259)
+++...+..++|||++ +++|.+++.... ..+++..++.++.||+.||.+||++||+|+||||+||++..
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccc
Confidence 9999999999999999 779999998764 45899999999999999999999999999999999999964
Q ss_pred ---------------cCCeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q psy3663 154 ---------------RLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAP 218 (259)
Q Consensus 154 ---------------~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 218 (259)
..+.++|+|||++..... ......++..|+|||++.+..++. ++|||||||++|+|++|+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDV-SSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCC-ccchHHHHHHHHHHHHCCCC
Confidence 247899999999976443 233456788999999999888775 99999999999999999999
Q ss_pred CCCCCChHHHHHhhhcccccccccccc
Q psy3663 219 FQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 219 f~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
|...+..+.+..+.+..++++..++..
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~ 285 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYE 285 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhh
Confidence 999999999999999888887766543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=283.77 Aligned_cols=232 Identities=25% Similarity=0.443 Sum_probs=193.8
Q ss_pred cccCeeEeeeecccccceEEEEEEee-------cCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEe
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVF-------TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVID 87 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (259)
..++|++.+.||+|+||.||+|.+.. ++..|++|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 35789999999999999999998752 34579999997543 334467788999999999 8999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF 152 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~ 152 (259)
+.+..++||||+.+++|.+++.... ..++...++.++.||+.||.|||++||+|+||||+||+++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 9999999999999999999998754 2478999999999999999999999999999999999997
Q ss_pred ecCCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHH
Q psy3663 153 ERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETL 228 (259)
Q Consensus 153 ~~~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 228 (259)
.+ +.++|+|||++........ .....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+..
T Consensus 238 ~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 238 EN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp TT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCc-HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 66 7899999999976543322 22234567899999998877775 9999999999999999 99999998888888
Q ss_pred HHhhhccccc------------cccccccCchhh
Q psy3663 229 TMIMDVSESS------------CTCWWRGRPRSR 250 (259)
Q Consensus 229 ~~i~~~~~~~------------~~~~~~~~~~~~ 250 (259)
..+.+..... ...+|..+|..|
T Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 349 (370)
T 2psq_A 316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQR 349 (370)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 8777654432 233667777665
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=271.92 Aligned_cols=229 Identities=25% Similarity=0.460 Sum_probs=194.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||+|.+. ++..|++|++.... .....+.+|+.++++++||||+++++++.+....+++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 468999999999999999999977 57789999997543 23567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-- 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-- 174 (259)
||+++++|.+++......+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-GCEEECCTTGGGGBCCHHHHS
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCC-CCEEecccccccccccccccc
Confidence 9999999999998877779999999999999999999999999999999999999776 7899999999876543221
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc------------cc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC------------TC 241 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~------------~~ 241 (259)
.....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+....+........ ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 242 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 242 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ccCcccccccCCHHHhcCCCCCc-hhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHH
Confidence 12223456799999998777765 9999999999999999 9999999988888888876644332 23
Q ss_pred ccccCchhhh
Q psy3663 242 WWRGRPRSRR 251 (259)
Q Consensus 242 ~~~~~~~~~~ 251 (259)
+|..+|.+|.
T Consensus 243 ~l~~~p~~Rp 252 (269)
T 4hcu_A 243 CWRERPEDRP 252 (269)
T ss_dssp HTCSSGGGSC
T ss_pred HccCCcccCc
Confidence 5666666553
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=281.13 Aligned_cols=227 Identities=30% Similarity=0.501 Sum_probs=191.2
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
-.-...++|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++.+.+.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 44557789999999999999999999999999999999997766555556778899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.+++||++.+++|..+.... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEEEECCSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCTTC-----
T ss_pred EEEEEecCCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCC-CcEEEEeCCCceeecC
Confidence 99999999987777765543 459999999999999999999999999999999999999766 7899999999876543
Q ss_pred C-CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 172 G-QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 172 ~-~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
. .......++..|+|||.+.+....+.++|+||||+++|+|++|++||......+.+..+....+..++
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP 246 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh
Confidence 2 22344567889999999987644445999999999999999999999999998888888877665544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=289.37 Aligned_cols=228 Identities=26% Similarity=0.445 Sum_probs=181.6
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
.+.++|++.+.||+|++|.||+|.+..+|+.|+||.+............+.+|+.+++.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 456899999999999999999999999999999999976554555567788999999999999999999998654
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
..++++++++ +++|.+++.. ..+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~-~~~kL~DFG~a~~ 181 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARH 181 (367)
T ss_dssp CCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECC------
T ss_pred CCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCC-CCEEEeecccccc
Confidence 5679999999 5699998865 348999999999999999999999999999999999999766 7899999999876
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCch
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPR 248 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (259)
... ......++..|+|||.+.+....+.++|||||||++|+|++|++||.+.+..+++..+++..+++..++|...+.
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 533 233456788999999998744444599999999999999999999999999999999999999988887776544
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=276.46 Aligned_cols=231 Identities=33% Similarity=0.602 Sum_probs=195.0
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
....+.++|++.+.||+|++|.||+|.+..+++.|++|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 3 QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp ---CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 35678899999999999999999999999999999999997543 2234568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee--ecCCeEEEEeccccccC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~--~~~~~i~l~df~~~~~~ 169 (259)
++++||++.+++|.+++..... +++..++.++.||+.||.+||++|++|+||+|+||++. ++.+.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGV-YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999999999876654 89999999999999999999999999999999999983 23478999999988654
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCc
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRP 247 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (259)
.. .......++..|+|||.+.+..++. ++|+||||+++|+|++|..||......+....+.+....++.+.|..-|
T Consensus 160 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 160 QN-GIMSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp CC-BTTHHHHSCCCBCCTTTBSSCSCCH-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred CC-CccccccCCCCccChHHhccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCC
Confidence 32 2333446788999999998877765 9999999999999999999999988888888888877666655555443
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=274.99 Aligned_cols=231 Identities=35% Similarity=0.612 Sum_probs=200.1
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.+.+.++|++.+.||+|++|.||+|.+..+++.|++|++............+.+|++++++++||||+++++++.+....
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 34567899999999999999999999998999999999977655555678899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC--CeEEEEeccccccCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL--GVVKLTDFGFSNRFN 170 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~--~~i~l~df~~~~~~~ 170 (259)
++++|++.+++|.+.+..... +++..++.++.||+.||.+||++|++|+||+|+||+++.+. ..++|+|||.+....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKR-FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999999998876554 89999999999999999999999999999999999997642 379999999988766
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
.........++..|+|||.+.+. ++ .++|+||||+++++|++|..||...+..+....+.+.....+.+.|..-
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTTC-CC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTS
T ss_pred CCCccccccCcccccChHHhcCC-CC-CchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhc
Confidence 55444445577889999998764 44 4999999999999999999999999888888888887766655544443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=293.97 Aligned_cols=233 Identities=30% Similarity=0.520 Sum_probs=188.0
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
..++|++.+.||+|+||.||+|.+..++..|++|++.... ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 4578999999999999999999999999999999997542 123345667789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CC
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PG 172 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~ 172 (259)
||||+.+++|..++..... +++..+..++.||+.||.|||+ +||+|+||||+||+++.+ +.++|+|||++.... ..
T Consensus 226 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EECCCSSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSS-SCEEECCCCCCCTTCC--
T ss_pred EEeeCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCC-CCEEEccCCCceeccCCC
Confidence 9999999999999876654 9999999999999999999998 999999999999999776 789999999987533 22
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc-----------cc
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC-----------TC 241 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------~~ 241 (259)
.......++..|+|||++.+..++. ++|+||||+++|+|++|+.||...+.......+......++ ..
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 382 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSG 382 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccccCCccccCHhhcCCCCCCC-ccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence 3344567899999999998888775 99999999999999999999998888888887775544333 33
Q ss_pred ccccCchhhh
Q psy3663 242 WWRGRPRSRR 251 (259)
Q Consensus 242 ~~~~~~~~~~ 251 (259)
+|..+|..|.
T Consensus 383 ~L~~dP~~R~ 392 (446)
T 4ejn_A 383 LLKKDPKQRL 392 (446)
T ss_dssp HTCSSTTTST
T ss_pred HcccCHHHhC
Confidence 5666666554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=272.71 Aligned_cols=224 Identities=41% Similarity=0.740 Sum_probs=184.3
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN 89 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (259)
..+....++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 4455677999999999999999999999998999999999865421 123456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
+..+++||++.+++|.+++..... +++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+...
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGR-VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMM 161 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTT-SCEEECCCCGGGCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCC-CCEEEeeccccccc
Confidence 999999999999999999977654 8999999999999999999999999999999999999766 78999999999876
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
..........++..|+|||.+.+....+.++|+||||+++++|++|+.||...+.......+.....
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 228 (276)
T 2h6d_A 162 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF 228 (276)
T ss_dssp CC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc
Confidence 6554445556788999999998876654599999999999999999999998887777777765543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=271.90 Aligned_cols=234 Identities=37% Similarity=0.605 Sum_probs=195.8
Q ss_pred CCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc-------ccHHHHHHHHHHHHhCC-CCCeE
Q psy3663 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP-------VSQDHLYQEVRCMKLVQ-HPNVV 80 (259)
Q Consensus 9 ~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-~~~i~ 80 (259)
.......+.++|++.+.||+|++|.||+|.+..+++.|++|++....... .....+.+|+.+++++. ||||+
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (298)
T 1phk_A 8 GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87 (298)
T ss_dssp -------CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred cccCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34446678899999999999999999999999999999999997653211 12456778999999996 99999
Q ss_pred EEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEE
Q psy3663 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
++++++.+....+++||++.+++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl 165 (298)
T 1phk_A 88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKL 165 (298)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEE
T ss_pred eeeeeeccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCC-CcEEE
Confidence 99999999999999999999999999998754 48999999999999999999999999999999999999766 78999
Q ss_pred EeccccccCCCCCccccccCCCccCCccccc------CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 161 TDFGFSNRFNPGQKLETSCGSLAYSAPEILL------GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~apE~~~------~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
+|||.+.............++..|+|||.+. ...++ .++|+||||+++++|++|..||...+..+....+.+.
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (298)
T 1phk_A 166 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYG-KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 244 (298)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ecccchhhcCCCcccccccCCccccCHHHhccccccccccCC-cccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC
Confidence 9999998776655556667889999999885 23344 5999999999999999999999988888888888877
Q ss_pred ccccccccccc
Q psy3663 235 SESSCTCWWRG 245 (259)
Q Consensus 235 ~~~~~~~~~~~ 245 (259)
....+.+.|..
T Consensus 245 ~~~~~~~~~~~ 255 (298)
T 1phk_A 245 NYQFGSPEWDD 255 (298)
T ss_dssp CCCCCTTTGGG
T ss_pred CcccCcccccc
Confidence 66655544443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=273.21 Aligned_cols=221 Identities=30% Similarity=0.595 Sum_probs=185.5
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
.-.+.+.++|++.+.||+|++|.||+|.+..++..+++|.+.... .......+.+|+++++.++||||+++++++.+..
T Consensus 15 ~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 93 (285)
T 3is5_A 15 YFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH 93 (285)
T ss_dssp EESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence 345578899999999999999999999999999999999997654 3345678899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCeEEEEeccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTDFGF 165 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~i~l~df~~ 165 (259)
..+++||++.+++|.+++... ...+++..++.++.||+.||.+||++||+|+||+|+||++..+ .+.++|+|||+
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~ 173 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence 999999999999999988653 3569999999999999999999999999999999999999543 36799999999
Q ss_pred cccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 166 SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
+.............++..|+|||.+.+ .++ .++|+||||+++|+|++|+.||......+....+...
T Consensus 174 a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~-~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 240 (285)
T 3is5_A 174 AELFKSDEHSTNAAGTALYMAPEVFKR-DVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK 240 (285)
T ss_dssp CCC----------CTTGGGCCHHHHTT-CCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ceecCCcccCcCcccccCcCChHHhcc-CCC-cccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC
Confidence 977665555556678899999999864 444 4999999999999999999999988777766655543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=274.01 Aligned_cols=217 Identities=29% Similarity=0.545 Sum_probs=166.0
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
+...++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (278)
T 3cok_A 7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV 86 (278)
T ss_dssp CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence 3456789999999999999999999988999999999865421 112356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++||++.+++|.+++.....++++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTT-CCEEECCCTTCEECC--
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCC-CCEEEEeecceeeccCC
Confidence 99999999999999998876779999999999999999999999999999999999999766 78999999998765432
Q ss_pred C-ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 173 Q-KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 173 ~-~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
. ......++..|+|||.+.+..++. ++|+||||+++|+|++|+.||......+.+..+.
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 225 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGL-ESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC
T ss_pred CCcceeccCCCCcCCcchhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh
Confidence 2 223345788999999998877765 9999999999999999999998877666655554
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=278.37 Aligned_cols=225 Identities=38% Similarity=0.658 Sum_probs=172.7
Q ss_pred CccccCeeEe---eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecC
Q psy3663 14 TKIAGLYDLE---ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTN 89 (259)
Q Consensus 14 ~~~~~~y~~~---~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 89 (259)
..+.++|++. +.||+|++|.||+|.+..+++.|++|++... ....+.+|+.+++.+. ||||+++++++.+.
T Consensus 4 ~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~ 78 (325)
T 3kn6_A 4 SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78 (325)
T ss_dssp CHHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CcchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence 4567889986 7899999999999999999999999998643 3567788999999998 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC--eEEEEeccccc
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG--VVKLTDFGFSN 167 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~--~i~l~df~~~~ 167 (259)
...++|||++.+++|.+++.... .+++..++.++.||+.||.+||++||+|+||+|+||++..+.+ .++|+|||++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred CEEEEEEEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999999999999999998764 4999999999999999999999999999999999999976522 79999999997
Q ss_pred cCCCC-CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-------hHHHHHhhhcccccc
Q psy3663 168 RFNPG-QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND-------SETLTMIMDVSESSC 239 (259)
Q Consensus 168 ~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~~~ 239 (259)
..... .......++..|+|||.+.+..++. ++|+||||+++|+|++|+.||..... .+.+..+.+....++
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQNGYDE-SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp ECCC----------------------CCCCH-HHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 65433 2234456788999999998887775 99999999999999999999976443 456677776666655
Q ss_pred cccccc
Q psy3663 240 TCWWRG 245 (259)
Q Consensus 240 ~~~~~~ 245 (259)
.+.|.+
T Consensus 237 ~~~~~~ 242 (325)
T 3kn6_A 237 GEAWKN 242 (325)
T ss_dssp SHHHHT
T ss_pred cccccC
Confidence 555443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=279.36 Aligned_cols=214 Identities=28% Similarity=0.447 Sum_probs=184.9
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
..++|++.+.||+|++|.||+|.+..++..|+||.+...... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 346799999999999999999999999999999999765332 2334678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||||+.| +|.+++.....++++..++.++.|++.||.+||++||+|+||+|+||+++.+ +.++|+|||++.....
T Consensus 132 v~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 132 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP--- 206 (348)
T ss_dssp EEECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---
T ss_pred EEecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC-CCEEEeeccCceecCC---
Confidence 9999975 8888887766779999999999999999999999999999999999999766 8999999999876543
Q ss_pred cccccCCCccCCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 175 LETSCGSLAYSAPEILL---GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
.....++..|+|||.+. ...++ .++||||||+++|+|++|+.||...+..+.+..+....
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 269 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred CCcccCCcceeCHhhhccccCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC
Confidence 23456889999999985 34444 49999999999999999999999888777777666543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=282.92 Aligned_cols=229 Identities=34% Similarity=0.612 Sum_probs=189.3
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecC
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTN 89 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (259)
.....+.++|++.+.||+|+||.||+|.+..+++.|++|++...... ..+|++++.++ +||||+++++++.+.
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~ 88 (342)
T 2qr7_A 15 RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDG 88 (342)
T ss_dssp ----CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred ccccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence 34557889999999999999999999999999999999999765421 34677888777 699999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC---eEEEEecccc
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG---VVKLTDFGFS 166 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~---~i~l~df~~~ 166 (259)
...++||||+.+++|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||++.++.+ .++|+|||++
T Consensus 89 ~~~~lv~E~~~gg~L~~~i~~~~~-~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 89 KYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCTT-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999999999876554 999999999999999999999999999999999999865433 5999999999
Q ss_pred ccCCCC-CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC---CCChHHHHHhhhccccccccc
Q psy3663 167 NRFNPG-QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE---ANDSETLTMIMDVSESSCTCW 242 (259)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~ 242 (259)
...... .......++..|+|||++.+..++. ++|+||||+++|+|++|..||.. ....+.+..+.+....++...
T Consensus 168 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 246 (342)
T 2qr7_A 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDA-ACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGY 246 (342)
T ss_dssp EECBCTTCCBCCSSCCSSCCCHHHHHHHHHHH-HHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTT
T ss_pred ccCcCCCCceeccCCCccccCHHHhcCCCCCC-ccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccc
Confidence 765433 2334556789999999997766664 99999999999999999999986 345566777777766666555
Q ss_pred cccCc
Q psy3663 243 WRGRP 247 (259)
Q Consensus 243 ~~~~~ 247 (259)
|..-+
T Consensus 247 ~~~~s 251 (342)
T 2qr7_A 247 WNSVS 251 (342)
T ss_dssp TTTSC
T ss_pred cccCC
Confidence 54433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=283.33 Aligned_cols=235 Identities=23% Similarity=0.405 Sum_probs=198.9
Q ss_pred CCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEE
Q psy3663 7 RSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVI 86 (259)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (259)
+...++.-.+.++|++.+.||+|++|.||+|.+..++..|++|.+.... .......+.+|+.+++.++||||+++++++
T Consensus 16 ~~~~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 94 (364)
T 3qyz_A 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDII 94 (364)
T ss_dssp CBCC-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred EEEccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEE
Confidence 4445556666789999999999999999999999999999999987533 333457788999999999999999999998
Q ss_pred ecC-----CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEE
Q psy3663 87 DTN-----SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLT 161 (259)
Q Consensus 87 ~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~ 161 (259)
... ...+++||++.+ +|.+++... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+
T Consensus 95 ~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~ 170 (364)
T 3qyz_A 95 RAPTIEQMKDVYIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKIC 170 (364)
T ss_dssp CCSSTTTCCCEEEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEEC
T ss_pred ecCCccccceEEEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCC-CCEEEE
Confidence 654 468999999976 999988764 38999999999999999999999999999999999999766 789999
Q ss_pred eccccccCCCCCc----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 162 DFGFSNRFNPGQK----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 162 df~~~~~~~~~~~----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
|||.+........ .....++..|+|||.+.+....+.++|+||||+++|+|++|++||.+.+..+.+..+.+..+.
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 250 (364)
T 3qyz_A 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250 (364)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCS
T ss_pred eCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999976543322 233467889999998766554445999999999999999999999999999999999998888
Q ss_pred ccccccccC
Q psy3663 238 SCTCWWRGR 246 (259)
Q Consensus 238 ~~~~~~~~~ 246 (259)
++.+.|...
T Consensus 251 ~~~~~~~~~ 259 (364)
T 3qyz_A 251 PSQEDLNCI 259 (364)
T ss_dssp CCHHHHHTC
T ss_pred CCHHHHHHh
Confidence 877766543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=280.25 Aligned_cols=233 Identities=30% Similarity=0.529 Sum_probs=197.6
Q ss_pred CCCccccCeeEe-eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecC
Q psy3663 12 HPTKIAGLYDLE-ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTN 89 (259)
Q Consensus 12 ~~~~~~~~y~~~-~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 89 (259)
....+.++|.+. +.||+|++|.||+|.+..+++.|++|++............+.+|+.+++.+. ||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 345678899998 8999999999999999999999999999877666666788999999999996 69999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee--cCCeEEEEecccc
Q psy3663 90 SKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE--RLGVVKLTDFGFS 166 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~--~~~~i~l~df~~~ 166 (259)
...++||||+.+++|.+++... ...+++..++.++.||+.||.+||++||+|+||+|+||+++. +.+.++|+|||++
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 9999999999999999987543 355999999999999999999999999999999999999976 2378999999999
Q ss_pred ccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 167 NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
.............++..|+|||.+.+..++. ++|+||||+++|+|++|+.||......+....+.......+.+.+..
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 182 RKIGHACELREIMGTPEYLAPEILNYDPITT-ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp EEC---------CCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred cccCCccccccccCCcCccCCeeecCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence 8776555555667899999999998877775 99999999999999999999999988888888887766665554443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=284.22 Aligned_cols=240 Identities=32% Similarity=0.543 Sum_probs=196.2
Q ss_pred CCCCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC---CCcccHHHHHHHHHHHHhCCCCCeEE
Q psy3663 5 GSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK---LDPVSQDHLYQEVRCMKLVQHPNVVR 81 (259)
Q Consensus 5 ~~~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~ 81 (259)
++.-|+++..++.++|++.+.||+|++|.||+|.+..++..|++|++.... ........+.+|+.+++.++||||++
T Consensus 13 ~~~~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 92 (345)
T 3hko_A 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92 (345)
T ss_dssp -CCCCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 345677777788899999999999999999999999999999999986542 23445678899999999999999999
Q ss_pred EEEEEecCCeEEEEEeccCCCChHHHHHhc---------------------------------------CCCCCHHHHHH
Q psy3663 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKH---------------------------------------DAGLSETYARE 122 (259)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~---------------------------------------~~~~~~~~i~~ 122 (259)
+++++.+.+..++||||+.+++|.+++... ...+++..++.
T Consensus 93 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (345)
T 3hko_A 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172 (345)
T ss_dssp EEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHH
T ss_pred eehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHH
Confidence 999999999999999999999999988521 11136778899
Q ss_pred HHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC-CeEEEEeccccccCCCCC-----ccccccCCCccCCcccccC--CC
Q psy3663 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERL-GVVKLTDFGFSNRFNPGQ-----KLETSCGSLAYSAPEILLG--DS 194 (259)
Q Consensus 123 ~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~-~~i~l~df~~~~~~~~~~-----~~~~~~~~~~~~apE~~~~--~~ 194 (259)
++.||+.||.+||++||+|+||+|+||+++.+. ..++|+|||.+....... ......++..|+|||.+.+ ..
T Consensus 173 i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence 999999999999999999999999999997652 279999999987543211 1234567889999999865 34
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 195 YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 195 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
++ .++||||||+++|+|++|+.||......+....+++.......+.|..
T Consensus 253 ~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (345)
T 3hko_A 253 YG-PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNV 302 (345)
T ss_dssp CC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGG
T ss_pred CC-cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCccccc
Confidence 44 599999999999999999999999999999988887776665554433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=281.28 Aligned_cols=229 Identities=35% Similarity=0.630 Sum_probs=196.3
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc------ccHHHHHHHHHHHHhC-CCCCeEEEEEEEe
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP------VSQDHLYQEVRCMKLV-QHPNVVRLYEVID 87 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~------~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (259)
.+.++|++.+.||.|++|.||+|.+..+|+.|+||++....... .....+.+|+.+++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34578999999999999999999998899999999987653211 1145677899999999 7999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.....+++|||+.+++|.+++..... +++..++.++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||++.
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~-l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~-~~ikl~DfG~~~ 248 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVA-LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSC 248 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC-CCEEEEecCccc
Confidence 99999999999999999999986544 9999999999999999999999999999999999999766 789999999998
Q ss_pred cCCCCCccccccCCCccCCcccccCC------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccc
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGD------SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTC 241 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (259)
............++..|+|||.+.+. .++ .++|+||||+++|+|++|..||...+....+..+.+....++.+
T Consensus 249 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 327 (365)
T 2y7j_A 249 HLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYG-KEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327 (365)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHH
T ss_pred ccCCCcccccCCCCCCccChhhccccccccCcCCC-chhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 77666666667789999999988532 344 49999999999999999999999988888888888877666655
Q ss_pred ccccC
Q psy3663 242 WWRGR 246 (259)
Q Consensus 242 ~~~~~ 246 (259)
.|...
T Consensus 328 ~~~~~ 332 (365)
T 2y7j_A 328 EWDDR 332 (365)
T ss_dssp HHSSS
T ss_pred ccccC
Confidence 55433
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=286.70 Aligned_cols=221 Identities=28% Similarity=0.433 Sum_probs=186.4
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec------C
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT------N 89 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 89 (259)
...+|++.+.||+|+||.||+|.+..+++.|+||.+..... ...+|+++++.++||||+++++++.. .
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 34579999999999999999999998999999999865431 12379999999999999999998743 2
Q ss_pred CeEEEEEeccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 90 SKLYLILELGDGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~---~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
...+++|||+.+ ++.+.+.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.+.+.++|+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 246789999976 66666543 34569999999999999999999999999999999999999867678999999999
Q ss_pred ccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 167 NRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
.............++..|+|||++.+....+.++|||||||++|+|++|++||.+.+..+++..+++..+++..+.|
T Consensus 205 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 205 KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp EECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 87665555555678899999999977644445999999999999999999999999999999999988777655444
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=271.69 Aligned_cols=232 Identities=32% Similarity=0.575 Sum_probs=194.2
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-.++|++.+.||+|++|.||+|.+..++..|++|++..... .......+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 46899999999999999999999999999999999865432 12235678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+|||+.+++|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++..... ..
T Consensus 87 v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~-~~~~l~Dfg~~~~~~~-~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPS-SR 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTT-SCEEECSCCEESCC-----
T ss_pred EEecCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCC-CCEEEEeccccccCCc-cc
Confidence 9999999999999877654 8999999999999999999999999999999999999766 7899999998865433 22
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc-----------cccc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC-----------TCWW 243 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------~~~~ 243 (259)
.....++..|+|||.+.+...+. ++|+||||+++|+|++|..||......+....+.......+ ..+|
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 242 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 242 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHC
T ss_pred ccccCCCCCccCHhHhccCCCCc-cchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHh
Confidence 34456788999999998877765 99999999999999999999999888888888776655433 2356
Q ss_pred ccCchhhh
Q psy3663 244 RGRPRSRR 251 (259)
Q Consensus 244 ~~~~~~~~ 251 (259)
..+|.+|.
T Consensus 243 ~~~p~~Rp 250 (279)
T 3fdn_A 243 KHNPSQRP 250 (279)
T ss_dssp CSSGGGSC
T ss_pred ccChhhCC
Confidence 66666553
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=286.44 Aligned_cols=230 Identities=26% Similarity=0.452 Sum_probs=199.6
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC------CCCCeEEEEEEE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV------QHPNVVRLYEVI 86 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~ 86 (259)
...+.++|++.+.||+|+||.||+|.+..+++.|+||++... ......+.+|+.+++.+ +|+||+++++.+
T Consensus 92 ~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 92 HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp TCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred CCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 345678999999999999999999999999999999998653 23346677788888877 467999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCe--EEEEec
Q psy3663 87 DTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV--VKLTDF 163 (259)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~--i~l~df 163 (259)
......+++||++.+ +|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.+ +. ++|+||
T Consensus 169 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~-~~~~vkL~DF 246 (429)
T 3kvw_A 169 TFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQ-GRSGIKVIDF 246 (429)
T ss_dssp EETTEEEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESST-TSCCEEECCC
T ss_pred ccCCeEEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccC-CCcceEEeec
Confidence 999999999999965 9999887664 458999999999999999999999999999999999999776 44 999999
Q ss_pred cccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 164 GFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
|++..... ......++..|+|||++.+..++. ++|||||||++|+|++|.+||...+..+.+..+++..+.++.++|
T Consensus 247 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 247 GSSCYEHQ--RVYTYIQSRFYRAPEVILGARYGM-PIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp TTCEETTC--CCCSSCSCGGGCCHHHHHTBCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccceecCC--cccccCCCCCccChHHHhCCCCCc-hHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 99876433 334456788999999998888775 999999999999999999999999999999999999999999888
Q ss_pred ccCchhh
Q psy3663 244 RGRPRSR 250 (259)
Q Consensus 244 ~~~~~~~ 250 (259)
+......
T Consensus 324 ~~~~~~~ 330 (429)
T 3kvw_A 324 DASKRAK 330 (429)
T ss_dssp HTBTTHH
T ss_pred Hhhhhhh
Confidence 7765533
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=275.28 Aligned_cols=230 Identities=31% Similarity=0.504 Sum_probs=193.8
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEe-ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC---CCCCeEEEEEEEe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHV-FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV---QHPNVVRLYEVID 87 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~-~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~ 87 (259)
......++|++.+.||+|++|.||+|.+. .+++.|++|++............+.+|+.+++.+ +||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred cccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 34567789999999999999999999985 6788999999976544333344556777766665 8999999999986
Q ss_pred -----cCCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEE
Q psy3663 88 -----TNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLT 161 (259)
Q Consensus 88 -----~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~ 161 (259)
.....+++||++.+ +|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~-~~~kl~ 162 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLA 162 (326)
T ss_dssp EEECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEEC
T ss_pred ecccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCC-CCEEEe
Confidence 56778999999985 9999988753 348999999999999999999999999999999999999766 789999
Q ss_pred eccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccc
Q psy3663 162 DFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTC 241 (259)
Q Consensus 162 df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (259)
|||.+.............++..|+|||.+.+..++. ++|+||||+++|+|++|++||......+.+..+++..+.+...
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred cCcccccccCCCCccccccccceeCHHHHhcCCCCc-chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 999987665444445566788999999998877775 9999999999999999999999999999999998877766555
Q ss_pred ccc
Q psy3663 242 WWR 244 (259)
Q Consensus 242 ~~~ 244 (259)
.|.
T Consensus 242 ~~~ 244 (326)
T 1blx_A 242 DWP 244 (326)
T ss_dssp GSC
T ss_pred cCc
Confidence 554
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=274.69 Aligned_cols=218 Identities=30% Similarity=0.462 Sum_probs=189.3
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
..++|++.+.||+|++|.||+|.+..+++.+++|++..... .......+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 45689999999999999999999999999999999876532 33446778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-C
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-Q 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~ 173 (259)
+|||+.+++|.+++.... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++...... .
T Consensus 119 v~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp EECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCSTTC
T ss_pred EEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCC-CCEEEeeccCceecccCcc
Confidence 999999999999887654 48999999999999999999999999999999999999766 78999999999766432 2
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
......++..|+|||.+.+..++. ++|+||||+++|+|++|+.||......+.+..+.+...
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 258 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 258 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred cccccCCCccccCHHHhccCCCCc-hhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC
Confidence 233456788999999998877765 99999999999999999999998877777766665443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=276.44 Aligned_cols=202 Identities=30% Similarity=0.384 Sum_probs=170.2
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l 94 (259)
+.++|++.+.||+|++|.||+|.+..+++.|+||++...............|+..+..+ +|+||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 44789999999999999999999999999999999876554444444555555555444 89999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+||++ +++|.+++......+++..++.++.||+.||.+||+.||+|+||||+||+++.+ +.++|+|||++........
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR-GRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGG-GCEEECCCTTCEECC----
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC-CCEEEccceeeeecccCCC
Confidence 99999 559999998877779999999999999999999999999999999999999776 7899999999887765555
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
.....++..|+|||.+.+ .++ .++||||||+++++|++|..||..
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYG-TAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCS-THHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CcccCCCccccCHhHhcC-CCC-chhhHHHHHHHHHHHHhCCCCCCC
Confidence 555668999999999876 455 499999999999999999776644
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=286.62 Aligned_cols=233 Identities=27% Similarity=0.444 Sum_probs=194.2
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
-.++|++.+.||+|++|.||+|.+..++..|++|.+.... .......+.+|+++++.++||||+++++++.+....++|
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 3579999999999999999999998899999999987542 333445678999999999999999999999998999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
|||+.+++|.+++...+..+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++.........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~-~~~kl~DfG~s~~~~~~~~~ 269 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGVYA 269 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCGGGCEECTTSEEE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCC-CcEEECcCCCceecCCCcee
Confidence 99999999999998776669999999999999999999999999999999999999766 78999999998764432211
Q ss_pred cc---ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc------------c
Q psy3663 176 ET---SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS------------C 239 (259)
Q Consensus 176 ~~---~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~------------~ 239 (259)
.. ..++..|+|||.+....++. ++|+||||+++|+|++ |..||......+....+.+....+ .
T Consensus 270 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 348 (377)
T 3cbl_A 270 ASGGLRQVPVKWTAPEALNYGRYSS-ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348 (377)
T ss_dssp CCSSCCEEEGGGSCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ecCCCCCCCcCcCCHhHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11 12355799999998777765 9999999999999998 999999988887777776554332 2
Q ss_pred ccccccCchhhh
Q psy3663 240 TCWWRGRPRSRR 251 (259)
Q Consensus 240 ~~~~~~~~~~~~ 251 (259)
..+|..+|.+|.
T Consensus 349 ~~cl~~dP~~Rp 360 (377)
T 3cbl_A 349 EQCWAYEPGQRP 360 (377)
T ss_dssp HHHTCSSGGGSC
T ss_pred HHHcCCCchhCc
Confidence 345666666553
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=281.81 Aligned_cols=224 Identities=32% Similarity=0.513 Sum_probs=177.8
Q ss_pred CCCccccCeeEe-eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHH-HhCCCCCeEEEEEEEec-
Q psy3663 12 HPTKIAGLYDLE-ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM-KLVQHPNVVRLYEVIDT- 88 (259)
Q Consensus 12 ~~~~~~~~y~~~-~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~- 88 (259)
....+.++|.+. +.||.|++|.||+|.+..+++.|+||++.. ...+.+|+.++ +..+||||+++++++..
T Consensus 55 ~~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~ 127 (400)
T 1nxk_A 55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENL 127 (400)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence 445677889887 789999999999999999999999999853 24566788876 45579999999999865
Q ss_pred ---CCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCeEEEEe
Q psy3663 89 ---NSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTD 162 (259)
Q Consensus 89 ---~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~i~l~d 162 (259)
....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.+ .+.++|+|
T Consensus 128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 567899999999999999998653 358999999999999999999999999999999999999763 47899999
Q ss_pred ccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH----HHHHhhhccccc
Q psy3663 163 FGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE----TLTMIMDVSESS 238 (259)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~ 238 (259)
||++.............++..|+|||++.+..++. ++|||||||++|+|++|+.||...+... ....+......+
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCCCCSSS-HHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCCCCCCC-cccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 99998766555555667899999999998887775 9999999999999999999997765432 455555554444
Q ss_pred ccccc
Q psy3663 239 CTCWW 243 (259)
Q Consensus 239 ~~~~~ 243 (259)
+.+.|
T Consensus 287 ~~~~~ 291 (400)
T 1nxk_A 287 PNPEW 291 (400)
T ss_dssp CTTTT
T ss_pred CCccc
Confidence 43333
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=277.90 Aligned_cols=235 Identities=22% Similarity=0.380 Sum_probs=195.1
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCc---eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
....++|++.+.||+|++|.||+|.+..++. .|+||.+.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 3456799999999999999999999886555 49999987543 3445677889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
..++||||+.+++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLE 202 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCSSCEECC
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCC-CCEEECCCCcccccc
Confidence 9999999999999999998776679999999999999999999999999999999999999666 789999999997764
Q ss_pred CCCcc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc-------
Q psy3663 171 PGQKL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS------- 238 (259)
Q Consensus 171 ~~~~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~------- 238 (259)
..... ....++..|+|||.+.+..++. ++||||||+++|+|++ |..||......+....+.+....+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH 281 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCc-HHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence 43221 1223456799999998777765 9999999999999999 999999999888888887664432
Q ss_pred -----cccccccCchhhh
Q psy3663 239 -----CTCWWRGRPRSRR 251 (259)
Q Consensus 239 -----~~~~~~~~~~~~~ 251 (259)
...+|..+|.+|.
T Consensus 282 ~l~~li~~~l~~dp~~Rp 299 (325)
T 3kul_A 282 ALHQLMLDCWHKDRAQRP 299 (325)
T ss_dssp HHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHccCChhhCc
Confidence 2345666666553
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=274.41 Aligned_cols=217 Identities=28% Similarity=0.403 Sum_probs=173.5
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
.++...++|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 456678899999999999999999999999999999999976532 2233577889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
..+++||++.+++|.+++.... ++++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++....
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~-~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD-DFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSCCC-----
T ss_pred eEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCC-CCEEEecCccCcccc
Confidence 9999999999999999998764 48999999999999999999999999999999999999766 789999999887654
Q ss_pred CCC--ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh
Q psy3663 171 PGQ--KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231 (259)
Q Consensus 171 ~~~--~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i 231 (259)
... ......++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...........+
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATY-RADIYALTCVLYECLTGSPPYQGDQLSVMGAHI 247 (309)
T ss_dssp -----------CCGGGCCGGGTCC----C-CCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCc-hHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh
Confidence 332 122345788999999998877765 999999999999999999999876655443333
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=281.26 Aligned_cols=207 Identities=33% Similarity=0.586 Sum_probs=182.6
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc------cHHHHHHHHHHHHhCCCCCeEEEEEEE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV------SQDHLYQEVRCMKLVQHPNVVRLYEVI 86 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (259)
.+.+.++|++.+.||+|++|.||+|.+..+++.|++|++........ ....+.+|+.+++.++||||+++++++
T Consensus 19 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 19 EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp TTHHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 35677899999999999999999999999999999999986543221 334567899999999999999999999
Q ss_pred ecCCeEEEEEeccCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 87 DTNSKLYLILELGDGG-DLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 87 ~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
.+.+..+++||++.++ +|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||+
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~ 176 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED-FTIKLIDFGS 176 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTCCC-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTT
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCC-CcEEEeeccc
Confidence 9999999999988655 99998876554 9999999999999999999999999999999999999776 7899999999
Q ss_pred cccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 166 SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
+.............++..|+|||.+.+..+.+.++||||||+++|+|++|..||..
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 98776666666667899999999998887755699999999999999999999965
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=300.17 Aligned_cols=221 Identities=31% Similarity=0.489 Sum_probs=192.8
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (259)
-.++|++.+.||+|+||.||+|.+..+++.||||++.+... .......+..|..++..+ +||+|+.+++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 35689999999999999999999999999999999875421 223456677888999887 5999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC-CC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PG 172 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~-~~ 172 (259)
+||||+.+++|..++..... +++..++.++.||+.||.|||++||+|+||||+|||++.+ +.++|+|||++.... ..
T Consensus 419 lV~E~~~gg~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~-g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSS-SCEEECCCTTCEECCCTT
T ss_pred EEEeCcCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCC-CcEEEeecceeeccccCC
Confidence 99999999999999987654 9999999999999999999999999999999999999776 899999999987533 33
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
.......++..|+|||++.+..++. ++|+||||+++|||++|++||...+..+.+..|++....++
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~-~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p 562 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGK-SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 562 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBST-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC
T ss_pred cccccccCCCcccCHhhhcCCCCCc-cceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 3445567899999999998888875 99999999999999999999999999999999987665544
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=273.96 Aligned_cols=209 Identities=26% Similarity=0.516 Sum_probs=180.5
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEec--CCeE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDT--NSKL 92 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~ 92 (259)
..++|++.+.||+|++|.||+|.+..+++.|++|++... ....+.+|+.+++.++ ||||+++++++.+ ....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 357899999999999999999999999999999998643 3577889999999998 9999999999987 6778
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++||++.+++|.+++.. +++..++.++.||+.||.+||++||+|+||+|+||+++.+...++|+|||++......
T Consensus 109 ~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 999999999999998754 8999999999999999999999999999999999999877558999999999877665
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCChHHHHHhhh
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE-ANDSETLTMIMD 233 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~i~~ 233 (259)
.......++..|+|||.+.+....+.++||||||+++|+|++|+.||.. ....+.+..+.+
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~ 246 (330)
T 3nsz_A 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246 (330)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence 5556667888999999998744444599999999999999999999944 344444444443
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=269.73 Aligned_cols=224 Identities=24% Similarity=0.388 Sum_probs=178.8
Q ss_pred CCCCCCccccCeeEeeeecccccceEEEEEEeec---CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEE
Q psy3663 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFT---GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85 (259)
Q Consensus 9 ~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (259)
+..+.....++|++.+.||+|++|.||+|.+..+ +..|++|.+.... .......+.+|+.+++.++||||++++++
T Consensus 6 s~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp ---CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence 4445667789999999999999999999998644 4469999986543 33446778899999999999999999999
Q ss_pred EecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 86 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
+. .+..+++||++.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||+
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~ 162 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGL 162 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC---
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCC-CCEEECcccc
Confidence 85 456789999999999999998877679999999999999999999999999999999999999777 7999999999
Q ss_pred cccCCCCCcc--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 166 SNRFNPGQKL--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 166 ~~~~~~~~~~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
+......... ....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+....+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~ 235 (281)
T 1mp8_A 163 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred ccccCcccccccccCCCcccccChhhcccCCCCC-ccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC
Confidence 8765433221 2234556899999998777765 9999999999999996 9999999988888888876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=267.58 Aligned_cols=219 Identities=30% Similarity=0.464 Sum_probs=189.7
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
...++|++.+.||+|++|.||+|.+..+++.+++|++..... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 456799999999999999999999999999999999876533 3344677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG- 172 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~- 172 (259)
++||++.+++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 92 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EEEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECCSTT
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCC-CCEEEEeccCceecccCc
Confidence 9999999999999887654 48999999999999999999999999999999999999766 78999999998765432
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
.......++..|+|||.+.+..++. ++|+||||+++|+|++|+.||......+....+.+...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 232 (294)
T 2rku_A 170 ERKKVLCGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 232 (294)
T ss_dssp CCBCCCCSCCSSCCHHHHTTSCBCT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred cccccccCCCCcCCcchhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccC
Confidence 2233456788999999998877765 99999999999999999999998877777666665443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=273.56 Aligned_cols=212 Identities=33% Similarity=0.574 Sum_probs=175.8
Q ss_pred CCCCCCccccCeeEe-eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEE
Q psy3663 9 SDGHPTKIAGLYDLE-ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVI 86 (259)
Q Consensus 9 ~~~~~~~~~~~y~~~-~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 86 (259)
.+...+.+.++|++. +.||+|++|.||+|.+..+++.|+||++.... ......+.+|+.++.++ +||||+++++++
T Consensus 3 ~~~~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 3 TDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp SCSSCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCccCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 344456788999995 78999999999999999999999999997653 33567788999999885 699999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC--eEEEEecc
Q psy3663 87 DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG--VVKLTDFG 164 (259)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~--~i~l~df~ 164 (259)
.+.+.+++|||++.+++|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||+++.+.. .++|+|||
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKRRH-FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhccCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 999999999999999999999987654 899999999999999999999999999999999999976632 39999999
Q ss_pred ccccCCCCC--------ccccccCCCccCCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 165 FSNRFNPGQ--------KLETSCGSLAYSAPEILLG-----DSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 165 ~~~~~~~~~--------~~~~~~~~~~~~apE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
++....... ......++..|+|||.+.+ ..++ .++||||||+++|+|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHT-TTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCC-cccccHhHHHHHHHHHHCCCCCccccc
Confidence 886543211 1223357889999999864 3344 499999999999999999999987653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=269.33 Aligned_cols=225 Identities=25% Similarity=0.421 Sum_probs=187.9
Q ss_pred CCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe
Q psy3663 8 SSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID 87 (259)
Q Consensus 8 ~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (259)
.+.+...--.++|++.+.||+|++|.||+|.+. ++..|++|++..... ....+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp --CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 334455556679999999999999999999866 677899999975532 3567889999999999999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
+....+++||++.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~ 168 (283)
T 3gen_A 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSR 168 (283)
T ss_dssp SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-SCEEECSTTGGG
T ss_pred cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCC-CCEEEccccccc
Confidence 9999999999999999999998766669999999999999999999999999999999999999766 789999999987
Q ss_pred cCCCCCcc--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc
Q psy3663 168 RFNPGQKL--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 168 ~~~~~~~~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
........ ....++..|+|||.+.+..++. ++|+||||+++|+|++ |+.||......+....+.+.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (283)
T 3gen_A 169 YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY 241 (283)
T ss_dssp GBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCccCcccCCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCC
Confidence 65432211 1223456799999998777765 9999999999999998 999999988888888888765444
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=271.39 Aligned_cols=211 Identities=30% Similarity=0.543 Sum_probs=185.5
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
.|+..+.||+|++|.||+|.+..+|+.|+||++.... ......+.+|+.+++.++||||+++++++......+++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 5888899999999999999999899999999987543 33467788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-cccc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~~~ 177 (259)
+.+++|.+++... .+++..++.++.||+.||.+||+.||+|+||+|+||+++.+ +.++|+|||++....... ....
T Consensus 124 ~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 124 LQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp CCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSSSCCBCC
T ss_pred CCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC-CcEEEeeeeeeeecccCcccccc
Confidence 9999999988653 48999999999999999999999999999999999999766 789999999987665432 2344
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
..++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+..+....+.+..
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 257 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYAT-EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP 257 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred ccCCccccCHhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 56889999999998877775 9999999999999999999999888777777776554
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=293.92 Aligned_cols=206 Identities=31% Similarity=0.515 Sum_probs=183.1
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-.++|++.+.||+|+||.||+|.+..+|+.|++|++.+... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 45789999999999999999999999999999999875421 12235667899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 95 ILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
||||+.|++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++.......
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~-g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDH-GHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEECCTTC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCC-CCeEEEecccceecccCc
Confidence 999999999999987653 348999999999999999999999999999999999999766 899999999998776655
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
......++..|+|||++.+..++. ++|+|||||++|+|++|+.||....
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~-~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTF-SPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESS-HHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred cccccCCCccccCHHHHcCCCCCc-cchHHHHHHHHHHHHhCCCCCcccc
Confidence 555668899999999998877775 9999999999999999999998754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=282.03 Aligned_cols=238 Identities=26% Similarity=0.425 Sum_probs=186.0
Q ss_pred CCCCCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEE
Q psy3663 4 SGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83 (259)
Q Consensus 4 ~~~~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 83 (259)
+.+...........++|++.+.||+|++|.||+|.+..++..|+||.+.... .......++++.+..++||||++++
T Consensus 9 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~ 85 (360)
T 3e3p_A 9 NAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQ 85 (360)
T ss_dssp ---CBSSHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEE
T ss_pred ccccChhhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHH
Confidence 3333344444566789999999999999999999999999999999986543 2234556778888889999999999
Q ss_pred EEEecCC-------eEEEEEeccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH--HCCcEeccCCCCCeEe
Q psy3663 84 EVIDTNS-------KLYLILELGDGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFCH--KLHVVHRDLKPENVVF 151 (259)
Q Consensus 84 ~~~~~~~-------~~~lv~e~~~~~sL~~~~~~---~~~~~~~~~i~~~~~ql~~al~~LH--~~~i~H~dl~p~nIlv 151 (259)
+++.... ..+++|||+.+ +|...+.. ....+++..++.++.||+.||.+|| ++||+|+||+|+||++
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll 164 (360)
T 3e3p_A 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV 164 (360)
T ss_dssp EEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEE
T ss_pred HhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEE
Confidence 9985433 27899999987 66555443 3455899999999999999999999 9999999999999999
Q ss_pred eecCCeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHh
Q psy3663 152 FERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231 (259)
Q Consensus 152 ~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i 231 (259)
+..++.++|+|||++.............++..|+|||.+.+....+.++||||||+++|+|++|++||...+..+.+..+
T Consensus 165 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 165 NEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp ETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred eCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 87458999999999987766655556678899999999977664445999999999999999999999999999999999
Q ss_pred hhcccccccccccc
Q psy3663 232 MDVSESSCTCWWRG 245 (259)
Q Consensus 232 ~~~~~~~~~~~~~~ 245 (259)
.+..+.++.++|..
T Consensus 245 ~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 245 VRVLGCPSREVLRK 258 (360)
T ss_dssp HHHHCCCCHHHHHH
T ss_pred HHHcCCCCHHHHHh
Confidence 99888887766643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=265.60 Aligned_cols=218 Identities=27% Similarity=0.463 Sum_probs=187.6
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.--.++|++.+.||+|++|.||+|.+. ++..|++|++..... ....+.+|+.+++.++||||+++++++.+....+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 345679999999999999999999766 566899999976442 3567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++||++++++|.+++......+++..++.++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTT-CCEEECCTTCEEECCTTC
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCC-CCEEEccCccceecchhh
Confidence 9999999999999998876679999999999999999999999999999999999999766 789999999987665433
Q ss_pred ccc--cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccc
Q psy3663 174 KLE--TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 174 ~~~--~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
... ...++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+....+......
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 224 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSS-KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL 224 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEET-THHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred hhcccCCCcCcccCCHHHHhccCCch-hhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC
Confidence 222 223455799999998777765 9999999999999999 99999988888887777765443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=265.96 Aligned_cols=211 Identities=26% Similarity=0.458 Sum_probs=179.0
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccH-----HHHHHHHHHHHhCCCCCeEEEEEE
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-----DHLYQEVRCMKLVQHPNVVRLYEV 85 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~-----~~~~~e~~~l~~l~~~~i~~~~~~ 85 (259)
.-+....++|++.+.||+|++|.||+|.+..+++.|++|.+.......... ..+.+|+.+++.++||||++++++
T Consensus 12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 345566789999999999999999999999999999999997654332222 678899999999999999999999
Q ss_pred EecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCCCCeEeeecCCe-----E
Q psy3663 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH--VVHRDLKPENVVFFERLGV-----V 158 (259)
Q Consensus 86 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~--i~H~dl~p~nIlv~~~~~~-----i 158 (259)
+.+.. +++|||+.+++|.+.+......+++..++.++.|++.||.+||++| ++|+||+|+||++..+ +. +
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~-~~~~~~~~ 168 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSL-DENAPVCA 168 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCC-CTTCSCCE
T ss_pred ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEecc-CCCCceeE
Confidence 97665 6899999989999998877777999999999999999999999999 9999999999999765 43 9
Q ss_pred EEEeccccccCCCCCccccccCCCccCCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q psy3663 159 KLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLG--DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227 (259)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (259)
+|+|||++..... ......++..|+|||.+.. ..++ .++|+||||+++|+|++|+.||........
T Consensus 169 kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 169 KVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp EECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEEC-HHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred EeCCCCccccccc--cccccCCCccccCchhhccCCCCcC-chhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 9999999875432 3444568899999999843 3334 499999999999999999999987665444
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=282.19 Aligned_cols=224 Identities=29% Similarity=0.430 Sum_probs=185.3
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS- 90 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 90 (259)
.......+|++.+.||+|+||.||+|.+..++. +++|.+...... ..+|+++++.++||||+++++++....
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 344567799999999999999999999876555 888877543311 127999999999999999999985432
Q ss_pred -----eEEEEEeccCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEe
Q psy3663 91 -----KLYLILELGDGGDLYDYIM---KHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTD 162 (259)
Q Consensus 91 -----~~~lv~e~~~~~sL~~~~~---~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~d 162 (259)
..+++|||+.+ ++...+. .....+++..++.++.||+.||.|||++||+|+||||+||+++...+.++|+|
T Consensus 107 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 107 KKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp SSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred CCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 37899999987 4444433 22456999999999999999999999999999999999999975558999999
Q ss_pred ccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccc
Q psy3663 163 FGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCW 242 (259)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (259)
||++.............++..|+|||.+.+....+.++|||||||++|+|++|++||.+.+..+++..+++.++++..+.
T Consensus 186 FG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 186 FGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99998776666666667889999999997765444599999999999999999999999999999999998877765543
Q ss_pred c
Q psy3663 243 W 243 (259)
Q Consensus 243 ~ 243 (259)
|
T Consensus 266 ~ 266 (394)
T 4e7w_A 266 I 266 (394)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=282.31 Aligned_cols=225 Identities=28% Similarity=0.427 Sum_probs=192.5
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE--
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL-- 92 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-- 92 (259)
.+.++|.+.+.||+|++|.||+|.+..+++.|++|++............+.+|+.+++.++||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 466899999999999999999999999999999999987665555677888999999999999999999999876654
Q ss_pred ----EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 93 ----YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 93 ----~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
+++||++.+ +|.+++. ..+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||.+..
T Consensus 119 ~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 119 FYDFYLVMPFMQT-DLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLARH 193 (371)
T ss_dssp CCCCEEEEECCCE-EHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECSTTCC--
T ss_pred ceeEEEEEccccc-cHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCC-CCEEEEecCcccc
Confidence 999999975 8877663 348999999999999999999999999999999999999766 7899999999875
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
... ......++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+..+.+..+++..+.++.+++..-
T Consensus 194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 194 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 533 3344567889999999987444445999999999999999999999999999999999998888887776654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=268.25 Aligned_cols=218 Identities=32% Similarity=0.629 Sum_probs=189.3
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
-..++|++.+.||+|++|.||+|.+..++..|++|++..... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 346899999999999999999999998999999999865421 1223567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++||++.+++|.+++..... +++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++..... .
T Consensus 91 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~-~ 167 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK-GELKIADFGWSVHAPS-L 167 (284)
T ss_dssp EEECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTT-CCEEECCCTTCEECSS-S
T ss_pred EEEEeCCCCcHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCC-CCEEEecccccccCcc-c
Confidence 99999999999999987654 8999999999999999999999999999999999999766 7899999998865543 2
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
......++..|+|||.+.+..++. ++|+||||+++|+|++|..||......+....+.+...
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 229 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDE-KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 229 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC
T ss_pred ccccccCCCCcCCHHHhccCCCCc-ccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc
Confidence 334456788999999998877765 99999999999999999999998888877777766543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=289.46 Aligned_cols=218 Identities=30% Similarity=0.491 Sum_probs=186.7
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-.++|++.+.||+|+||.||+|.+..+|+.|++|++.+... .......+.+|+.+++.++||||+++++++.+....++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 45789999999999999999999999999999999975432 12235678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 95 ILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
||||+.|++|..++... ...+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++.....
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~-g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDD-GNVRISDLGLAVELKA 341 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCEECCT
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCC-CCEEEeecceeeeccC
Confidence 99999999999998764 3459999999999999999999999999999999999999766 8999999999987654
Q ss_pred CCc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----ChHHHHHhhhcc
Q psy3663 172 GQK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN----DSETLTMIMDVS 235 (259)
Q Consensus 172 ~~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~~~~i~~~~ 235 (259)
... .....++..|+|||++.+..++. ++|+|||||++|+|++|++||.... ..+....+.+..
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~-~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~ 409 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDF-SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC
T ss_pred CCcccccccCCccccChhhhcCCCCCh-HHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc
Confidence 433 23447899999999998877775 9999999999999999999998753 244555555443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=265.94 Aligned_cols=214 Identities=24% Similarity=0.448 Sum_probs=185.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||+|.+. ++..|++|.+..... ....+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence 468999999999999999999986 677899999976542 3467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-- 174 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-- 174 (259)
|++.+++|.+++......+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGG-GCEEECCTTGGGGBCCHHHHS
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCC-CCEEEcccccccccccccccc
Confidence 9999999999998877779999999999999999999999999999999999999776 7899999999876543211
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
.....++..|+|||.+.+..++. ++|+||||+++|+|++ |+.||......+....+.....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~ 223 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR 223 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred cccccccccccChhhhcCCCccc-hhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc
Confidence 12223456899999998777764 9999999999999999 9999999888888887776543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=265.07 Aligned_cols=210 Identities=25% Similarity=0.460 Sum_probs=181.3
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec----CCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT----NSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 92 (259)
...|++.+.||+|++|.||+|.+..++..|++|.+............+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 446999999999999999999999999999999998776666667888999999999999999999998864 4568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH--VVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~--i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
+++|||+.+++|.+++..... +++..++.++.||+.||.+||+.+ ++|+||+|+||+++.+.+.++|+|||++....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEecCCCCHHHHHHHccC-CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999999987544 899999999999999999999999 99999999999997555899999999987544
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTM 230 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (259)
. .......++..|+|||.+.+. ++ .++|+||||+++|+|++|+.||...........
T Consensus 184 ~-~~~~~~~~t~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 240 (290)
T 1t4h_A 184 A-SFAKAVIGTPEFMAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240 (290)
T ss_dssp T-TSBEESCSSCCCCCGGGGGTC-CC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred c-cccccccCCcCcCCHHHHhcc-CC-CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH
Confidence 3 333445688999999988754 44 499999999999999999999988665544433
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=280.05 Aligned_cols=227 Identities=22% Similarity=0.327 Sum_probs=184.2
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc---------cHHHHHHHHHHHHhCCCCCeEEEEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV---------SQDHLYQEVRCMKLVQHPNVVRLYE 84 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (259)
..+.++|++.+.||+|++|.||+|.+. ++..|+||.+........ ....+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 456789999999999999999999986 489999999876433221 1367889999999999999999999
Q ss_pred EEe-----cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEE
Q psy3663 85 VID-----TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVK 159 (259)
Q Consensus 85 ~~~-----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~ 159 (259)
++. .....+++||++.+ +|.+.+......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~~~k 174 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN-NDIT 174 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEE
T ss_pred eEEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC-CCEE
Confidence 984 33478999999985 8989888776679999999999999999999999999999999999999766 7899
Q ss_pred EEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 160 LTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 160 l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
|+|||++.............++..|+|||.+.+....+.++|+||||+++|+|++|+.||......+.+..+.+..+.+.
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99999997655555555567788999999988744444599999999999999999999999999999999988777765
Q ss_pred cccc
Q psy3663 240 TCWW 243 (259)
Q Consensus 240 ~~~~ 243 (259)
.+++
T Consensus 255 ~~~~ 258 (362)
T 3pg1_A 255 IEDV 258 (362)
T ss_dssp HHHH
T ss_pred hHHh
Confidence 5443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=282.30 Aligned_cols=232 Identities=22% Similarity=0.398 Sum_probs=184.0
Q ss_pred ccCeeEeeeecccccceEEEEEEe---ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.++|++.+.||+|++|.||+|.+. ..+..|+||.+.... .......+.+|+.++++++||||+++++++.+....+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 458999999999999999999876 456789999987543 3445677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+||||+.+++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.......
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC----------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCC-CCEEECcCccccccccCC
Confidence 9999999999999998877779999999999999999999999999999999999999766 789999999987654332
Q ss_pred cc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc----------
Q psy3663 174 KL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS---------- 238 (259)
Q Consensus 174 ~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~---------- 238 (259)
.. ....++..|+|||.+.+..++. ++||||||+++|+|++ |+.||......+....+.+....+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 280 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY 280 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHH
T ss_pred ccceeccCCCcCCCccChhhhccCCcCc-hhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence 21 1122356799999998777775 9999999999999998 999999888888887776554322
Q ss_pred --cccccccCchhhh
Q psy3663 239 --CTCWWRGRPRSRR 251 (259)
Q Consensus 239 --~~~~~~~~~~~~~ 251 (259)
...+|..+|..|.
T Consensus 281 ~li~~cl~~dp~~RP 295 (373)
T 2qol_A 281 QLMLDCWQKDRNNRP 295 (373)
T ss_dssp HHHHHHTCSSGGGSC
T ss_pred HHHHHHhCcChhhCc
Confidence 2245667776653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=275.89 Aligned_cols=204 Identities=27% Similarity=0.481 Sum_probs=172.8
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC---
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS--- 90 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 90 (259)
+.+.++|++.+.||+|++|.||+|.+..+++.|+||++.... .......+.+|+.++++++||||+++++++.+..
T Consensus 2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 457789999999999999999999999999999999997654 3445678899999999999999999999885432
Q ss_pred ------------------------------------------------------eEEEEEeccCCCChHHHHHhcC--CC
Q psy3663 91 ------------------------------------------------------KLYLILELGDGGDLYDYIMKHD--AG 114 (259)
Q Consensus 91 ------------------------------------------------------~~~lv~e~~~~~sL~~~~~~~~--~~ 114 (259)
..+++|||+.+++|.+++.... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 3899999999999999998753 22
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-------------ccccccCC
Q psy3663 115 LSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-------------KLETSCGS 181 (259)
Q Consensus 115 ~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-------------~~~~~~~~ 181 (259)
.+...++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++....... ......++
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 5666789999999999999999999999999999999766 789999999998765432 12234588
Q ss_pred CccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 182 LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 182 ~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
..|+|||.+.+..++. ++|+||||+++|+|++|..|+.
T Consensus 240 ~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSH-KVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGGSCHHHHHCCCCCT-HHHHHHHHHHHHHHHSCCCCHH
T ss_pred cCccChHHhcCCCCcc-hhhHHHHHHHHHHHHHcCCChh
Confidence 9999999998887775 9999999999999999887763
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=267.27 Aligned_cols=216 Identities=29% Similarity=0.484 Sum_probs=188.0
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
...++|++.+.||+|++|.||+|.+..+++.|++|++..... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 455689999999999999999999999999999999976542 3456788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ- 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~- 173 (259)
+|||+.+++|.+++.. .++++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 98 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp EEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECBTTBC
T ss_pred EEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC-CCEEEeecccceecCcccc
Confidence 9999999999999865 348999999999999999999999999999999999999766 789999999987654332
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
......++..|+|||.+.+..++. ++|+||||+++++|++|+.||...........+.+..
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN 235 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred ccCccCCCcCccCHHHHhcCCCCc-hhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC
Confidence 233446788999999998877775 9999999999999999999999887777666665443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=268.95 Aligned_cols=206 Identities=20% Similarity=0.308 Sum_probs=178.8
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCe
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (259)
...+.++|++.+.||+|++|.||+|.+..+++.|++|++.... ....+.+|+.+++.+ +|++++.+++++.+...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 4567889999999999999999999999999999999986543 234577899999999 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC----CeEEEEeccccc
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL----GVVKLTDFGFSN 167 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~----~~i~l~df~~~~ 167 (259)
.+++||++ +++|.+++.....++++..++.++.||+.||.+||++||+|+||+|+||+++.+. +.++|+|||++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 8899999988777799999999999999999999999999999999999997652 239999999997
Q ss_pred cCCCCCc--------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 168 RFNPGQK--------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 168 ~~~~~~~--------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
....... .....++..|+|||.+.+..++. ++||||||+++|+|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCCh-HHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 6644322 23445789999999998877765 99999999999999999999987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=269.14 Aligned_cols=216 Identities=28% Similarity=0.415 Sum_probs=166.7
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
...++|++.+.||+|++|.||+|.+..+++.|++|.+............+.++...++.++||||+++++++.+.+..++
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 34689999999999999999999999999999999997654433344455566666888899999999999999999999
Q ss_pred EEeccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 95 ILELGDGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFCHKL-HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~---~~~~~~~~~i~~~~~ql~~al~~LH~~-~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
+||++.+ +|.+++.. ....+++..++.++.||+.||.+||++ |++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLV 161 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTT-CCEEBCCC-------
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC-CCEEEeecCCccccc
Confidence 9999986 88777654 355699999999999999999999998 99999999999999766 789999999997766
Q ss_pred CCCccccccCCCccCCcccc----cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CChHHHHHhhh
Q psy3663 171 PGQKLETSCGSLAYSAPEIL----LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA-NDSETLTMIMD 233 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~----~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~i~~ 233 (259)
.........++..|+|||.+ .+..++ .++|+||||+++|+|++|+.||... .....+....+
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 228 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CC-HHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH
T ss_pred ccccccccCCCccccChhhcChhhcCcCCC-cHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc
Confidence 55555555788999999997 334444 4999999999999999999999863 33344444443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=269.02 Aligned_cols=214 Identities=26% Similarity=0.484 Sum_probs=180.0
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
....++|++.+.||.|++|.||+|.+..++..|++|.+.... ....+.+|+.+++.++||||+++++++.+....+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 345678999999999999999999999899999999987643 3567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++||++.+++|.+++......+++..++.++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE-GHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECBTTB
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCC-CCEEEeecccchhhhhhc
Confidence 9999999999999998666679999999999999999999999999999999999999766 789999999987654332
Q ss_pred -ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 174 -KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 174 -~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
......++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+.......+..
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 239 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNC-VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT 239 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCT-THHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc
Confidence 223446788999999998877765 99999999999999999999988776665554443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=270.59 Aligned_cols=229 Identities=28% Similarity=0.457 Sum_probs=185.9
Q ss_pred CCCCCCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEE
Q psy3663 3 RSGSRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRL 82 (259)
Q Consensus 3 ~~~~~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 82 (259)
.+..-......-...++|++.+.||+|++|.||+|.+..++..+++|++.... ......+.+|+.++..++||||+++
T Consensus 4 ~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~ 81 (302)
T 2j7t_A 4 KSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKL 81 (302)
T ss_dssp ------CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cchhhcccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeee
Confidence 33444444556678899999999999999999999999899999999986543 3456788899999999999999999
Q ss_pred EEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEe
Q psy3663 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTD 162 (259)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~d 162 (259)
++++.+.+..+++||++.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~D 160 (302)
T 2j7t_A 82 LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLE-GDIRLAD 160 (302)
T ss_dssp EEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-SCEEECC
T ss_pred eeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCC-CCEEEEE
Confidence 999999999999999999999999988776779999999999999999999999999999999999999766 7899999
Q ss_pred ccccccCCCC-CccccccCCCccCCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 163 FGFSNRFNPG-QKLETSCGSLAYSAPEILL-----GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 163 f~~~~~~~~~-~~~~~~~~~~~~~apE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
||++...... .......++..|+|||.+. +..++ .++|+||||+++|+|++|..||...+..+....+.+..
T Consensus 161 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (302)
T 2j7t_A 161 FGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238 (302)
T ss_dssp CHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTT-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred CCCCccccccccccccccCChhhcCCeeeccccCCCCCCc-hhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC
Confidence 9986432111 1122345788999999983 44444 59999999999999999999999888777777666544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=274.29 Aligned_cols=225 Identities=34% Similarity=0.596 Sum_probs=181.9
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC------cccHHHHHHHHHHHHhCCCCCeEEEEEE
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKLVQHPNVVRLYEV 85 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (259)
.+..+.++|++.+.||+|++|.||+|.+..+++.|+||++...... ......+.+|+.+++.++||||++++++
T Consensus 4 ~~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 83 (322)
T 2ycf_A 4 YPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 83 (322)
T ss_dssp CCHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeE
Confidence 3567889999999999999999999999999999999998764321 1223457889999999999999999999
Q ss_pred EecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC--CeEEEEec
Q psy3663 86 IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL--GVVKLTDF 163 (259)
Q Consensus 86 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~--~~i~l~df 163 (259)
+.... ++++||++.+++|.+++.... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+. ..++|+||
T Consensus 84 ~~~~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 84 FDAED-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp EESSS-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred EcCCc-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence 97765 899999999999999887544 499999999999999999999999999999999999997652 24999999
Q ss_pred cccccCCCCCccccccCCCccCCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHhhhcccccc
Q psy3663 164 GFSNRFNPGQKLETSCGSLAYSAPEILL---GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS-ETLTMIMDVSESSC 239 (259)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~apE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~ 239 (259)
|++.............++..|+|||.+. ...++ .++|+||||+++|+|++|..||...... .....+.+......
T Consensus 162 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 162 GHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp TTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCT-THHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred ccceecccccccccccCCcCccCchhhccCCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 9998765544444556889999999974 33444 5999999999999999999999876544 34444544444433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=275.51 Aligned_cols=219 Identities=24% Similarity=0.357 Sum_probs=186.7
Q ss_pred ccccCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (259)
...++|++.+.||+|++|.||+|.+. .++..|++|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 34579999999999999999999987 345899999997543 334467788999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHD-----------------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKP 146 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~-----------------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p 146 (259)
+..+++|||+.+++|.+++.... ..+++.+++.++.||+.||.+||++||+|+||+|
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 99999999999999999998742 4589999999999999999999999999999999
Q ss_pred CCeEeeecCCeEEEEeccccccCCCCC---ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q psy3663 147 ENVVFFERLGVVKLTDFGFSNRFNPGQ---KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEA 222 (259)
Q Consensus 147 ~nIlv~~~~~~i~l~df~~~~~~~~~~---~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 222 (259)
+||+++.+ +.++|+|||++....... ......++..|+|||.+.+..++. ++|+||||+++|+|++ |..||...
T Consensus 203 ~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 203 RNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp GGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc-ccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999776 789999999986553221 122334677899999998777765 9999999999999999 99999998
Q ss_pred CChHHHHHhhhccc
Q psy3663 223 NDSETLTMIMDVSE 236 (259)
Q Consensus 223 ~~~~~~~~i~~~~~ 236 (259)
...+....+.+...
T Consensus 281 ~~~~~~~~~~~~~~ 294 (343)
T 1luf_A 281 AHEEVIYYVRDGNI 294 (343)
T ss_dssp CHHHHHHHHHTTCC
T ss_pred ChHHHHHHHhCCCc
Confidence 88888887776554
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=267.36 Aligned_cols=214 Identities=24% Similarity=0.464 Sum_probs=171.2
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
..-..++|++.+.||+|++|.||+|.+ ...+++|++............+.+|+.+++.++||||++++++. .....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 94 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL 94 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred CccCccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence 344456899999999999999999974 34699999987766666678889999999999999999999965 45668
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP- 171 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~- 171 (259)
+++||++.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-TEEEECCCC--------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC-CCEEEccceeccccccc
Confidence 89999999999999997777779999999999999999999999999999999999999776 8999999999865432
Q ss_pred --CCccccccCCCccCCccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhh
Q psy3663 172 --GQKLETSCGSLAYSAPEILL---GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232 (259)
Q Consensus 172 --~~~~~~~~~~~~~~apE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~ 232 (259)
........++..|+|||.+. +..++ .++||||||+++++|++|+.||......+.+..++
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 238 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSC-HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH
T ss_pred cccccccccCCCccccCchhhcccCCCCCC-cccchHHHHHHHHHHHHCCCCccccchHHHHHHHh
Confidence 12223346788999999986 34444 49999999999999999999998877766655554
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=272.15 Aligned_cols=230 Identities=28% Similarity=0.437 Sum_probs=185.2
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCce----EEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~----~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.++|++.+.||+|++|.||+|.+..++.. |++|.+.... .......+.+|+.++++++||||+++++++.+.. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 46899999999999999999998777764 4777775432 3345678889999999999999999999998765 7
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++++++.+++|.+++......+++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTHHHHHTTT
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCC-CCEEEccCcceeEccCC
Confidence 78999999999999998877779999999999999999999999999999999999999776 78999999999765433
Q ss_pred Ccc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc---------
Q psy3663 173 QKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC--------- 239 (259)
Q Consensus 173 ~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~--------- 239 (259)
... ....++..|+|||.+.+..++. ++||||||+++|+|++ |..||......+....+......+.
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 249 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred cccccccCCCccccccChHHhccCCCCc-hhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence 322 2223466899999998877775 9999999999999999 9999998888887777766544332
Q ss_pred ---ccccccCchhh
Q psy3663 240 ---TCWWRGRPRSR 250 (259)
Q Consensus 240 ---~~~~~~~~~~~ 250 (259)
..+|..+|.+|
T Consensus 250 ~li~~~l~~~p~~R 263 (327)
T 3poz_A 250 MIMVKCWMIDADSR 263 (327)
T ss_dssp HHHHHHTCSCGGGS
T ss_pred HHHHHHcCCChhhC
Confidence 34566667655
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=272.36 Aligned_cols=226 Identities=24% Similarity=0.367 Sum_probs=187.5
Q ss_pred CCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceE--EEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEE
Q psy3663 7 RSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKV--AVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLY 83 (259)
Q Consensus 7 ~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~--~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~ 83 (259)
-....+|..-.++|++.+.||+|++|.||+|.+..++..+ ++|.+.... .......+.+|+.+++++ +||||++++
T Consensus 14 ~~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 92 (327)
T 1fvr_A 14 PDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLL 92 (327)
T ss_dssp --CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred CCCcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhc
Confidence 3455666677789999999999999999999999888865 889886432 334456788999999999 899999999
Q ss_pred EEEecCCeEEEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCC
Q psy3663 84 EVIDTNSKLYLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPEN 148 (259)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~n 148 (259)
+++.+.+..+++||++.+++|.+++.... ..+++..++.++.||+.||.+||++||+|+||+|+|
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 172 (327)
T 1fvr_A 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172 (327)
T ss_dssp EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence 99999999999999999999999997653 458999999999999999999999999999999999
Q ss_pred eEeeecCCeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHH
Q psy3663 149 VVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSET 227 (259)
Q Consensus 149 Ilv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 227 (259)
|+++.+ +.++|+|||++.............++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+.
T Consensus 173 Il~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~pf~~~~~~~~ 250 (327)
T 1fvr_A 173 ILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250 (327)
T ss_dssp EEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEEcCC-CeEEEcccCcCccccccccccCCCCCccccChhhhccccCCc-hhcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence 999776 789999999987543333333345577899999998776665 9999999999999998 9999999888888
Q ss_pred HHHhhhcc
Q psy3663 228 LTMIMDVS 235 (259)
Q Consensus 228 ~~~i~~~~ 235 (259)
...+.+..
T Consensus 251 ~~~~~~~~ 258 (327)
T 1fvr_A 251 YEKLPQGY 258 (327)
T ss_dssp HHHGGGTC
T ss_pred HHHhhcCC
Confidence 87777653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.83 Aligned_cols=233 Identities=30% Similarity=0.499 Sum_probs=200.6
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CC-----CeEEEEE
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HP-----NVVRLYE 84 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~ 84 (259)
.....+.++|++.+.||+|++|.||+|.+..+++.|+||++... ......+..|+.+++.++ |+ +|+.+++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 34556788999999999999999999999999999999998643 233566777888888875 44 4999999
Q ss_pred EEecCCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCcEeccCCCCCeEeee-cCCeEEE
Q psy3663 85 VIDTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCH--KLHVVHRDLKPENVVFFE-RLGVVKL 160 (259)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH--~~~i~H~dl~p~nIlv~~-~~~~i~l 160 (259)
++...+..++|||++.+ +|.+++.... ..+++..++.++.||+.||.+|| +.||+|+||||+||++.. +.+.++|
T Consensus 124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999999976 9999988764 45899999999999999999999 579999999999999964 3468999
Q ss_pred EeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 161 TDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
+|||++..... ......++..|+|||++.+..++. ++|||||||++|+|++|++||...+..+.+..+++..+.++.
T Consensus 203 ~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 203 VDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDL-AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp CCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EeccCceeccc--ccccccCCccccChHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999977643 234456788999999998887775 999999999999999999999999999999999999999988
Q ss_pred cccccCchhh
Q psy3663 241 CWWRGRPRSR 250 (259)
Q Consensus 241 ~~~~~~~~~~ 250 (259)
.+|...|..+
T Consensus 280 ~~~~~~~~~~ 289 (382)
T 2vx3_A 280 HILDQAPKAR 289 (382)
T ss_dssp HHHTTCTTHH
T ss_pred HHHHhhHHHH
Confidence 8888777643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=284.16 Aligned_cols=232 Identities=33% Similarity=0.582 Sum_probs=180.7
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC------cccHHHHHHHHHHHHhCCCCCeEEEEE
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------PVSQDHLYQEVRCMKLVQHPNVVRLYE 84 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (259)
..+..+.++|++.+.||+|+||.||+|.+..+++.|++|++...... ......+.+|+.++++++||||+++++
T Consensus 128 ~~~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~ 207 (419)
T 3i6u_A 128 VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 207 (419)
T ss_dssp GSCHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCE
T ss_pred ccchhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34567788999999999999999999999999999999998764321 112335789999999999999999999
Q ss_pred EEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCeEEEEe
Q psy3663 85 VIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTD 162 (259)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~i~l~d 162 (259)
++.. ...++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||++..+ ...++|+|
T Consensus 208 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 208 FFDA-EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp EEES-SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred EEec-CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEee
Confidence 9865 45789999999999988876544 49999999999999999999999999999999999999654 23599999
Q ss_pred ccccccCCCCCccccccCCCccCCcccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHhhhccccc
Q psy3663 163 FGFSNRFNPGQKLETSCGSLAYSAPEILLG---DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS-ETLTMIMDVSESS 238 (259)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~apE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~ 238 (259)
||++.............++..|+|||.+.+ ..++ .++|+||||+++|+|++|++||...... .....+.......
T Consensus 286 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~ 364 (419)
T 3i6u_A 286 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN-RAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF 364 (419)
T ss_dssp SSTTTSCC-----------CTTCCTTTTC----CTTH-HHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred cccceecCCCccccccCCCCCccCceeeecCCCCCCC-chhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence 999987765555556678999999999854 3333 4999999999999999999999875543 4445555555555
Q ss_pred ccccccc
Q psy3663 239 CTCWWRG 245 (259)
Q Consensus 239 ~~~~~~~ 245 (259)
.++.|..
T Consensus 365 ~~~~~~~ 371 (419)
T 3i6u_A 365 IPEVWAE 371 (419)
T ss_dssp CHHHHTT
T ss_pred Cchhhcc
Confidence 5544443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=268.59 Aligned_cols=219 Identities=33% Similarity=0.512 Sum_probs=188.0
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe--cCCeEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID--TNSKLY 93 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~ 93 (259)
..++|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++. .....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 468999999999999999999999999999999999877666666788899999999999999999999874 467899
Q ss_pred EEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 94 LILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLH-----VVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~-----i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
++|||+.+++|.+++... ...+++..++.++.||+.||.+||+.+ ++|+||+|+||+++.+ +.++|+|||.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~-~~~kl~dfg~ 162 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGL 162 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSS-SCEEECCCCH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCC-CCEEEecCch
Confidence 999999999999998764 334899999999999999999999999 9999999999999766 7899999999
Q ss_pred cccCCCCCc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 166 SNRFNPGQK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 166 ~~~~~~~~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
+........ .....++..|+|||.+.+..++. ++|+||||+++|+|++|..||...+..+....+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~ 233 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNE-KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred heeeccccccccccCCCccccChHHhccCCCCc-hhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc
Confidence 876644322 22345788999999998877765 99999999999999999999998888777777776554
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=273.04 Aligned_cols=238 Identities=24% Similarity=0.419 Sum_probs=180.3
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCc---eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID 87 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (259)
.+.....++|++.+.||+|++|.||+|.+..++. .|++|++............+.+|+.+++.++||||+++++++.
T Consensus 16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 4445567799999999999999999999876665 8999999876555566788999999999999999999999997
Q ss_pred cCCeE------EEEEeccCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC
Q psy3663 88 TNSKL------YLILELGDGGDLYDYIMKHD-----AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 88 ~~~~~------~lv~e~~~~~sL~~~~~~~~-----~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~ 156 (259)
..... +++|||+.+++|.+++.... ..+++..++.++.||+.||.+||++||+|+||||+||+++.+ +
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~-~ 174 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-M 174 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-S
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC-C
Confidence 76554 99999999999999986542 248999999999999999999999999999999999999766 7
Q ss_pred eEEEEeccccccCCCCCccc---cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhh
Q psy3663 157 VVKLTDFGFSNRFNPGQKLE---TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIM 232 (259)
Q Consensus 157 ~i~l~df~~~~~~~~~~~~~---~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~ 232 (259)
.++|+|||++.......... ...++..|+|||.+.+..++. ++||||||+++|+|++ |.+||......+....+.
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTV-HSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCC-ccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 89999999987654432221 223456899999998877775 9999999999999999 999999998888888877
Q ss_pred hccccc------------cccccccCchhh
Q psy3663 233 DVSESS------------CTCWWRGRPRSR 250 (259)
Q Consensus 233 ~~~~~~------------~~~~~~~~~~~~ 250 (259)
...... ...+|..+|.+|
T Consensus 254 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 283 (323)
T 3qup_A 254 GGNRLKQPPECMEEVYDLMYQCWSADPKQR 283 (323)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGS
T ss_pred cCCCCCCCCccCHHHHHHHHHHccCChhhC
Confidence 654332 234566666665
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=278.47 Aligned_cols=225 Identities=27% Similarity=0.421 Sum_probs=190.8
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe--
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK-- 91 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 91 (259)
..+.++|++.+.||+|++|.||+|.+..+|+.|+||.+............+.+|+.+++.++||||+++++++.....
T Consensus 20 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 20 WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred cccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 356789999999999999999999999999999999997765555556778899999999999999999999976643
Q ss_pred ----EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 92 ----LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 92 ----~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
++++||++.+ +|.+++. ..+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~Dfg~~~ 174 (353)
T 3coi_A 100 NFYDFYLVMPFMQT-DLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED-CELKILDFGLAR 174 (353)
T ss_dssp GCCCCEEEEECCSE-EGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTT-CCEEECSTTCTT
T ss_pred cceeEEEEeccccC-CHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCC-CcEEEeeccccc
Confidence 5999999975 8877653 348999999999999999999999999999999999999766 789999999987
Q ss_pred cCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
.... ......++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+.+..+.+..+.++.+|+..
T Consensus 175 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 175 HADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp C----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 6432 233446788999999988744444599999999999999999999999999999999998888877776654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=272.04 Aligned_cols=222 Identities=29% Similarity=0.460 Sum_probs=163.8
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN 89 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (259)
........++|++.+.||+|++|.||+|.+..+++.|++|.+..... ......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS
T ss_pred ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 34445557899999999999999999999988999999999865432 23456778999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEe
Q psy3663 90 SKLYLILELGDGGDLYDYIMK-------HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTD 162 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~-------~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~d 162 (259)
+..+++||++.+++|.+++.. ....+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~d 164 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGED-GSVQIAD 164 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEECC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCC-CCEEEEe
Confidence 999999999999999999875 23458999999999999999999999999999999999999766 7899999
Q ss_pred ccccccCCCCCc------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 163 FGFSNRFNPGQK------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 163 f~~~~~~~~~~~------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
||.+........ .....++..|+|||.+.+....+.++|+||||+++|+|++|+.||........+.....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 241 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ 241 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc
Confidence 998876543221 12345788999999986533233599999999999999999999988777666655543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=265.00 Aligned_cols=231 Identities=24% Similarity=0.451 Sum_probs=191.0
Q ss_pred ccCeeEee-eecccccceEEEEEEe--ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 17 AGLYDLEE-TLGRGHFAVVKLARHV--FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 17 ~~~y~~~~-~i~~g~~~~vy~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.++|.+.+ .||+|++|.||+|.+. .++..|++|++.... .......+.+|+.+++.++||||+++++++. .+..+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 85 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALM 85 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcE
Confidence 46788887 9999999999999854 467789999997643 3445677889999999999999999999994 45689
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++||++.+++|.+++......+++..++.++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADD 164 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCC-CCEEECcccceeeeccCc
Confidence 9999999999999998776779999999999999999999999999999999999999776 799999999997764332
Q ss_pred cc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc---------
Q psy3663 174 KL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC--------- 239 (259)
Q Consensus 174 ~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~--------- 239 (259)
.. ....++..|+|||.+.+..++. ++|+||||+++|+|++ |+.||......+....+........
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 243 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeccccccccccccCHHHhccCCCCc-hhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHH
Confidence 22 1223467899999998777665 9999999999999998 9999999888888887776543322
Q ss_pred ---ccccccCchhhh
Q psy3663 240 ---TCWWRGRPRSRR 251 (259)
Q Consensus 240 ---~~~~~~~~~~~~ 251 (259)
..+|..+|.+|.
T Consensus 244 ~li~~~l~~~p~~Rp 258 (287)
T 1u59_A 244 ALMSDCWIYKWEDRP 258 (287)
T ss_dssp HHHHHTTCSSGGGSC
T ss_pred HHHHHHcCCChhhCc
Confidence 235666666553
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=273.63 Aligned_cols=216 Identities=25% Similarity=0.404 Sum_probs=178.9
Q ss_pred cccCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecC
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTN 89 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (259)
-.++|++.+.||+|++|.||+|.+. .++..|++|++.... .......+.+|+.+++++ +||||+++++++.+.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3579999999999999999999973 355689999997543 333457788999999999 899999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDA----------------------GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPE 147 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~----------------------~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~ 147 (259)
+..+++|||+.+++|.+++..... .+++..++.++.||+.||.+||++||+|+||+|+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 999999999999999999987543 2789999999999999999999999999999999
Q ss_pred CeEeeecCCeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q psy3663 148 NVVFFERLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEAN 223 (259)
Q Consensus 148 nIlv~~~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 223 (259)
||+++.+ +.++|+|||++......... ....++..|+|||.+.+..++. ++||||||+++|+|++ |..||....
T Consensus 202 NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 202 NVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI-KSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCCh-hHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999766 79999999998765433221 2233566899999998777765 9999999999999998 999998877
Q ss_pred ChHHHHHhhhc
Q psy3663 224 DSETLTMIMDV 234 (259)
Q Consensus 224 ~~~~~~~i~~~ 234 (259)
..+.+..++..
T Consensus 280 ~~~~~~~~~~~ 290 (344)
T 1rjb_A 280 VDANFYKLIQN 290 (344)
T ss_dssp CSHHHHHHHHT
T ss_pred cHHHHHHHHhc
Confidence 66665555543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=275.27 Aligned_cols=199 Identities=19% Similarity=0.297 Sum_probs=170.3
Q ss_pred ccCeeEeeeecccccceEEEE-----EEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC---CCCeEEEEEEEec
Q psy3663 17 AGLYDLEETLGRGHFAVVKLA-----RHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ---HPNVVRLYEVIDT 88 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~-----~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~ 88 (259)
.++|++.+.||+|+||.||+| .+..+++.|++|++... ....+..|.++++.++ |++|+.+++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 467999999999999999999 46778999999998654 3556777888888887 8999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec----------
Q psy3663 89 NSKLYLILELGDGGDLYDYIMK----HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER---------- 154 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~----~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~---------- 154 (259)
.+..++||||+.+++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.+
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999999975 24559999999999999999999999999999999999999761
Q ss_pred CCeEEEEeccccccCC---CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 155 LGVVKLTDFGFSNRFN---PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 155 ~~~i~l~df~~~~~~~---~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
.+.++|+|||++.... .........++..|+|||.+.+..++. ++|||||||++|+|++|+.||..
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY-QIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBST-HHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCc-cccHHHHHHHHHHHHhCCCcccc
Confidence 3789999999995432 333344557899999999998888775 99999999999999999999854
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=269.29 Aligned_cols=205 Identities=28% Similarity=0.443 Sum_probs=172.5
Q ss_pred CccccCeeEeeeecccccceEEEEE----EeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLAR----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT- 88 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 88 (259)
.-..++|++.+.||+|++|.||+|. +..+++.|++|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 3456799999999999999999998 5678899999998754 23445778899999999999999999999854
Q ss_pred -CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 89 -NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 89 -~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
....++||||+.+++|.+++......+++..++.++.||+.||.+||+.||+|+||+|+||+++.+ +.++|+|||++.
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTK 162 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCSCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCC-CeEEEccCcccc
Confidence 356899999999999999998877679999999999999999999999999999999999999777 899999999987
Q ss_pred cCCCCCc----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 168 RFNPGQK----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
....... .....++..|+|||.+.+..++. ++||||||+++++|++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCCh-HHHHHHHHHHHHHHHhcccccCCC
Confidence 6543322 12223456699999998877765 999999999999999999998653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=265.82 Aligned_cols=229 Identities=21% Similarity=0.318 Sum_probs=184.7
Q ss_pred cccCeeEeeeecccccceEEEEEEeecC-------ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTG-------EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT 88 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~-------~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (259)
..++|++.+.||+|++|.||+|.+..++ ..|++|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 4679999999999999999999988877 479999986543 3456778899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCe--------EEE
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV--------VKL 160 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~--------i~l 160 (259)
.+..+++|||+.+++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +. ++|
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~~~~~~kl 162 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE-EDRKTGNPPFIKL 162 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEEC-CBGGGTBCCEEEE
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecC-Ccccccccceeee
Confidence 999999999999999999998877669999999999999999999999999999999999999777 44 999
Q ss_pred EeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHhhhccc---
Q psy3663 161 TDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAG-QAPFQEANDSETLTMIMDVSE--- 236 (259)
Q Consensus 161 ~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~i~~~~~--- 236 (259)
+|||.+..... .....++..|+|||.+.+....+.++||||||+++|+|++| .+||.................
T Consensus 163 ~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (289)
T 4fvq_A 163 SDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239 (289)
T ss_dssp CCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred ccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCC
Confidence 99998865432 22334677899999998734334599999999999999995 555555544444433332211
Q ss_pred -------cccccccccCchhh
Q psy3663 237 -------SSCTCWWRGRPRSR 250 (259)
Q Consensus 237 -------~~~~~~~~~~~~~~ 250 (259)
.....+|..+|.+|
T Consensus 240 ~~~~~l~~li~~~l~~dp~~R 260 (289)
T 4fvq_A 240 PKAAELANLINNCMDYEPDHR 260 (289)
T ss_dssp CSSCTTHHHHHHHSCSSGGGS
T ss_pred CCCHHHHHHHHHHcCCChhHC
Confidence 12334566666665
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=271.79 Aligned_cols=230 Identities=23% Similarity=0.354 Sum_probs=188.3
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCce----EEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~----~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.++|++.+.||+|++|.||+|.+..++.. +++|.+.... .......+.+|+.+++.++||||+++++++.+ ...
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 89 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL 89 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence 46899999999999999999998878775 7777765432 22334556789999999999999999999864 568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++|+|+.+++|.+++......+++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP-SQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSS-SCEEECSCSGGGGSCCC
T ss_pred EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCC-CeEEECCCCcccccCcc
Confidence 89999999999999998766669999999999999999999999999999999999999666 78999999999876443
Q ss_pred Cc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc---------
Q psy3663 173 QK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC--------- 239 (259)
Q Consensus 173 ~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~--------- 239 (259)
.. .....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+....+.+......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTH-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVY 247 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTT
T ss_pred cccccccCCCCcccccChHHhccCCCCh-hhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHH
Confidence 22 22334667899999998777775 9999999999999999 9999999888888887776543332
Q ss_pred ---ccccccCchhh
Q psy3663 240 ---TCWWRGRPRSR 250 (259)
Q Consensus 240 ---~~~~~~~~~~~ 250 (259)
..+|..+|..|
T Consensus 248 ~li~~~l~~dp~~R 261 (325)
T 3kex_A 248 MVMVKCWMIDENIR 261 (325)
T ss_dssp HHHHHHTCSCTTTS
T ss_pred HHHHHHcCCChhhC
Confidence 34566666655
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=265.33 Aligned_cols=208 Identities=36% Similarity=0.649 Sum_probs=180.0
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
.+.++|++.+.||+|++|.||+|.+..+++.|++|++..... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 367899999999999999999999999999999999875442 2345778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ- 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~- 173 (259)
+||++.+++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.......
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEECEETTE
T ss_pred EEEecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC-CCEEEeeCCCccccCCCcc
Confidence 999999989999886543 48999999999999999999999999999999999999766 789999999987553221
Q ss_pred --ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 174 --KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 174 --~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
......++..|+|||.+.+..+.+.++|+||||+++|+|++|+.||......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 214 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH
Confidence 1234467889999999987766455899999999999999999999876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=273.31 Aligned_cols=234 Identities=26% Similarity=0.447 Sum_probs=194.8
Q ss_pred CccccCeeEeeeecccccceEEEEEEeec-------CceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFT-------GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEV 85 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~-------~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 85 (259)
....++|++.+.||+|++|.||+|.+... +..|++|++.... .......+.+|+++++.+ +||||++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 34567999999999999999999997643 3479999987543 344567788999999999 89999999999
Q ss_pred EecCCeEEEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeE
Q psy3663 86 IDTNSKLYLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVV 150 (259)
Q Consensus 86 ~~~~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIl 150 (259)
+.+.+..++|||++.+++|.+++.... ..+++..++.++.||+.||.+||++||+|+||||+||+
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 999999999999999999999998754 34899999999999999999999999999999999999
Q ss_pred eeecCCeEEEEeccccccCCCCC---ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChH
Q psy3663 151 FFERLGVVKLTDFGFSNRFNPGQ---KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSE 226 (259)
Q Consensus 151 v~~~~~~i~l~df~~~~~~~~~~---~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (259)
++.+ +.++|+|||++....... ......++..|+|||.+.+..++. ++||||||+++++|++ |..||......+
T Consensus 224 l~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 224 VTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp ECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9766 789999999987654332 222334567899999998877775 9999999999999999 999999988888
Q ss_pred HHHHhhhccccc------------cccccccCchhh
Q psy3663 227 TLTMIMDVSESS------------CTCWWRGRPRSR 250 (259)
Q Consensus 227 ~~~~i~~~~~~~------------~~~~~~~~~~~~ 250 (259)
....+.+..... ...+|..+|.+|
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 337 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 337 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhC
Confidence 888777654332 234566666655
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=276.95 Aligned_cols=235 Identities=22% Similarity=0.344 Sum_probs=192.2
Q ss_pred ccccCeeEeeeecccccceEEEEE-----EeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLAR-----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~-----~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (259)
...++|++.+.||+|+||.||+|. +..++..|+||.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 345789999999999999999999 45567799999986533 334456788899999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCeEEEE
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHD------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLT 161 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~i~l~ 161 (259)
...++||||+.+++|.+++.... ..+++..++.++.||+.||.+||++||+|+||||+||+++.+ ...++|+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999999998754 348999999999999999999999999999999999999743 2359999
Q ss_pred eccccccCCC---CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccc
Q psy3663 162 DFGFSNRFNP---GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 162 df~~~~~~~~---~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
|||++..... ........++..|+|||.+.+..++. ++|||||||++|+|++ |..||......+....+.+....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999864321 12223345678899999998777775 9999999999999998 99999999988888888776543
Q ss_pred c------------cccccccCchhhh
Q psy3663 238 S------------CTCWWRGRPRSRR 251 (259)
Q Consensus 238 ~------------~~~~~~~~~~~~~ 251 (259)
. ...+|..+|.+|.
T Consensus 306 ~~~~~~~~~l~~li~~~l~~dP~~Rp 331 (367)
T 3l9p_A 306 DPPKNCPGPVYRIMTQCWQHQPEDRP 331 (367)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCccCCHHHHHHHHHHcCCCHhHCc
Confidence 2 2345666666553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=284.98 Aligned_cols=219 Identities=27% Similarity=0.473 Sum_probs=182.2
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--e
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS--K 91 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 91 (259)
..+.++|++.+.||+|++|.||+|.+..+++.|++|++..... ......+.+|+.+++.++||||+++++++.+.. .
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 4567899999999999999999999999999999999975432 234567789999999999999999999987654 7
Q ss_pred EEEEEeccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee---ecCCeEEEEecccc
Q psy3663 92 LYLILELGDGGDLYDYIMKHD--AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF---ERLGVVKLTDFGFS 166 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~--~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~---~~~~~i~l~df~~~ 166 (259)
.++||||+.+++|.+++.... ..+++..++.++.||+.||.+||++||+|+||||+||++. +..+.++|+|||.+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999987643 3389999999999999999999999999999999999983 22257999999999
Q ss_pred ccCCCCCccccccCCCccCCcccccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCC----CChHHHHHhhhc
Q psy3663 167 NRFNPGQKLETSCGSLAYSAPEILLG--------DSYDAPAVDVWSLGVILYMLVAGQAPFQEA----NDSETLTMIMDV 234 (259)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~apE~~~~--------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----~~~~~~~~i~~~ 234 (259)
.............++..|+|||.+.+ ..++ .++|+||||+++|+|++|+.||... ...+....++..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHH-HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred eEccCCCccccccCCccccCHHHhhccccccccccCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 87766555556678999999999864 2333 3899999999999999999999653 334444444443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=261.99 Aligned_cols=223 Identities=23% Similarity=0.356 Sum_probs=185.3
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeec---CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEE
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFT---GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVI 86 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (259)
+.......++|++.+.||+|++|.||+|.+... +..|++|.+.... .......+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 82 (281)
T 3cc6_A 4 GPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82 (281)
T ss_dssp CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 344566778999999999999999999986643 3369999987653 334567788999999999999999999998
Q ss_pred ecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 87 DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
.++ ..+++||++.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+
T Consensus 83 ~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~ 160 (281)
T 3cc6_A 83 EEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP-ECVKLGDFGLS 160 (281)
T ss_dssp CSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEET-TEEEECCCCGG
T ss_pred cCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCC-CcEEeCccCCC
Confidence 754 4689999999999999998877779999999999999999999999999999999999999777 79999999998
Q ss_pred ccCCCCCc--cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 167 NRFNPGQK--LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 167 ~~~~~~~~--~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
........ .....++..|+|||.+.+..++. ++|+||||+++|+|++ |+.||......+....+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~ 232 (281)
T 3cc6_A 161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTT-ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR 232 (281)
T ss_dssp GCC---------CCCCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC
T ss_pred cccccccccccccCCCCcceeCchhhccCCCCc-hhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC
Confidence 76543322 12234566899999998777765 9999999999999998 9999998888887777765543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=268.90 Aligned_cols=222 Identities=27% Similarity=0.458 Sum_probs=181.0
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe----
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID---- 87 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 87 (259)
....+.++|++.+.||+|++|.||+|.+..+++.|++|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 5 HGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp -CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred ccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 34578899999999999999999999999899999999987542 445677889999999999999999999873
Q ss_pred ----------cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCe
Q psy3663 88 ----------TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGV 157 (259)
Q Consensus 88 ----------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~ 157 (259)
+....+++||++.+ +|.+++.. .++++..++.++.||+.||.+||++||+|+||+|+||+++.+.+.
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCSE-EHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTE
T ss_pred ccccccccccccCceeEEeeccCC-CHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCe
Confidence 34678999999985 99998865 348999999999999999999999999999999999999766579
Q ss_pred EEEEeccccccCCCCC----ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 158 VKLTDFGFSNRFNPGQ----KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 158 i~l~df~~~~~~~~~~----~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
++|+|||.+....... ......++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+....+.+
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999987654221 123335678899999987644444599999999999999999999999888888888876
Q ss_pred ccccc
Q psy3663 234 VSESS 238 (259)
Q Consensus 234 ~~~~~ 238 (259)
.....
T Consensus 240 ~~~~~ 244 (320)
T 2i6l_A 240 SIPVV 244 (320)
T ss_dssp HSCCC
T ss_pred hcCCC
Confidence 65443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=266.75 Aligned_cols=204 Identities=23% Similarity=0.336 Sum_probs=174.4
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEE-EecCCeE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV-IDTNSKL 92 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~ 92 (259)
..+.++|++.+.||+|++|.||+|.+..+++.|++|++.... ....+.+|+.+++.++|+++++.+.. .......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 357889999999999999999999999999999999986543 23467899999999998775555544 4667888
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee--ecCCeEEEEeccccccCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~--~~~~~i~l~df~~~~~~~ 170 (259)
+++||++ +++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||++. ++.+.++|+|||.+....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9999999 7799999987767799999999999999999999999999999999999995 344789999999987665
Q ss_pred CCCc--------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 171 PGQK--------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 171 ~~~~--------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
.... .....++..|+|||.+.+..++. ++||||||+++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCc-chhhHHHHHHHHHHHhCCCCCCCcC
Confidence 4322 23446788999999998877765 9999999999999999999998743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=263.61 Aligned_cols=207 Identities=22% Similarity=0.352 Sum_probs=179.3
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCe
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (259)
...+.++|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+..+..+ +||||+++++++.+.+.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 45678899999999999999999999999999999999987655555667788899999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--------------
Q psy3663 92 LYLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER-------------- 154 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~-------------- 154 (259)
.+++||++.+++|.+++... ...+++..++.++.||+.||.+||++||+|+||+|+||+++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999999765 2558999999999999999999999999999999999999743
Q ss_pred ----CCeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 155 ----LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 155 ----~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
...++|+|||.+....... ...++..|+|||.+.+....++++||||||+++++|++|.+|+...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 2479999999987665432 2357889999999987644445999999999999999999887543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=275.36 Aligned_cols=214 Identities=27% Similarity=0.421 Sum_probs=177.7
Q ss_pred cccCeeEeeeecccccceEEEEE-----EeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecC
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLAR-----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTN 89 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~-----~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (259)
..++|++.+.||+|++|.||+|. +..+++.|+||++.... .......+.+|+.++..+ +||||+++++++.+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 45799999999999999999998 44566899999997543 333456788999999999 689999999998775
Q ss_pred C-eEEEEEeccCCCChHHHHHhcCC-------------------------------------------------------
Q psy3663 90 S-KLYLILELGDGGDLYDYIMKHDA------------------------------------------------------- 113 (259)
Q Consensus 90 ~-~~~lv~e~~~~~sL~~~~~~~~~------------------------------------------------------- 113 (259)
+ ..+++|||+.+++|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 4 48999999999999999976532
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc---cccccC
Q psy3663 114 ----------GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK---LETSCG 180 (259)
Q Consensus 114 ----------~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~---~~~~~~ 180 (259)
.+++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++........ .....+
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEeccceeeecccccchhccccCC
Confidence 18899999999999999999999999999999999999766 7899999999976543322 223345
Q ss_pred CCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhh
Q psy3663 181 SLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIM 232 (259)
Q Consensus 181 ~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~ 232 (259)
+..|+|||.+.+..++. ++||||||+++|+|++ |..||......+.+...+
T Consensus 258 t~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 309 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309 (359)
T ss_dssp CGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred CceeEChhhhcCCCCCc-hhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHH
Confidence 67899999998877775 9999999999999998 999998877555444443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=264.33 Aligned_cols=209 Identities=32% Similarity=0.557 Sum_probs=168.8
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
+....++|++.+.||+|++|.||+|.+..++..|++|.+.... ........+.+|+.+++.++||||+++++++.+.+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 3456779999999999999999999999899999999997643 234456778899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 92 LYLILELGDGGDLYDYIMK---HDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~---~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.+++||++.+++|.+++.. ....+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++..
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~-~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT-GVVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCC-----
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCC-CCEEEEeccceee
Confidence 9999999999999999875 24558999999999999999999999999999999999999766 7899999999876
Q ss_pred CCCCCc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 169 FNPGQK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 169 ~~~~~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
...... .....++..|+|||.+.+..++. ++|+||||+++++|++|+.||....
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTC---
T ss_pred ecCCCccccccCCCeeEeChHHhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccc
Confidence 543322 23345788999999998877765 9999999999999999999997643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=278.47 Aligned_cols=226 Identities=26% Similarity=0.446 Sum_probs=189.0
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-eEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS-KLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~l 94 (259)
-.++|++.+.||+|+||.||+|.. .+..|+||+++... ....+.+|+.++++++||||+++++++.+.. ..++
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence 357899999999999999999985 47799999997543 4567889999999999999999999976654 7999
Q ss_pred EEeccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 95 ILELGDGGDLYDYIMKHDA-GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~-~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
||||+.+++|.+++...+. .+++..++.++.||+.||.|||++|++|+||+|+||+++.+ +.++|+|||++......
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST- 342 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-SCEEECCCTTCEECC---
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCC-CCEEEeeCCCccccccc-
Confidence 9999999999999987654 36999999999999999999999999999999999999766 78999999998754332
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc------------cc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS------------CT 240 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~------------~~ 240 (259)
.....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+....+.++.... ..
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~-~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 420 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMK 420 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCH-HHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred -ccCCCCCcceeCHHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence 22235677899999998887775 9999999999999998 999999988888888887654322 23
Q ss_pred cccccCchhhh
Q psy3663 241 CWWRGRPRSRR 251 (259)
Q Consensus 241 ~~~~~~~~~~~ 251 (259)
.+|..+|..|.
T Consensus 421 ~cl~~dp~~Rp 431 (450)
T 1k9a_A 421 NCWHLDAATRP 431 (450)
T ss_dssp HHTCSSGGGSC
T ss_pred HHcCCChhHCc
Confidence 46677776653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=269.36 Aligned_cols=217 Identities=28% Similarity=0.450 Sum_probs=179.1
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceE----EEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKV----AVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~----~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.++|++.+.||+|++|.||+|.+..+++.+ ++|.+.... .......+.+|+.+++.++||||+++++++.+.. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 478999999999999999999998888755 666654332 3445778889999999999999999999998765 7
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++++++.+++|.+++......+++..++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCTTC-------
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCC-CCEEEccCcceeEccCc
Confidence 88899999999999998877779999999999999999999999999999999999999776 78999999999765433
Q ss_pred Ccc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccc
Q psy3663 173 QKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 173 ~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
... ....++..|+|||.+.+..++. ++||||||+++|+|++ |..||......+....+......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC
T ss_pred cccccccCCCccccccCHHHHcCCCCCh-HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 222 2223466899999998877775 9999999999999999 99999998888887777765543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=263.27 Aligned_cols=220 Identities=25% Similarity=0.384 Sum_probs=190.3
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
......++|++.+.||+|++|.||+|.+..++..|++|.+.... .....+.+|+.+++.++||||+++++++.+...
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 44456789999999999999999999999999999999986543 346778899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 92 LYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
.+++||++.+++|.+++... ...+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGG-GCEEECCCCGGGTSC
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCC-CCEEEccCccceecc
Confidence 99999999999999999874 3458999999999999999999999999999999999999776 789999999997665
Q ss_pred CCCcc--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 171 PGQKL--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 171 ~~~~~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
..... ....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||...+.......+.+...
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~ 230 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 230 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred CCccccccCCccccCcCChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC
Confidence 43322 2223456799999998777765 9999999999999999 9999998888887777765543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=265.69 Aligned_cols=207 Identities=28% Similarity=0.423 Sum_probs=174.9
Q ss_pred CCCCcc-ccCeeEeeeecccccceEEEEE----EeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEE
Q psy3663 11 GHPTKI-AGLYDLEETLGRGHFAVVKLAR----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85 (259)
Q Consensus 11 ~~~~~~-~~~y~~~~~i~~g~~~~vy~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (259)
-++..+ ..+|++.+.||+|++|.||+|. +..+++.|++|.+.... .......+.+|+.+++.++||||++++++
T Consensus 13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGI 91 (302)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 333333 4579999999999999999998 56789999999997654 33456788999999999999999999999
Q ss_pred EecC--CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEec
Q psy3663 86 IDTN--SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDF 163 (259)
Q Consensus 86 ~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df 163 (259)
+.+. ...+++||++.+++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+||
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Df 170 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE-HQVKIGDF 170 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCC
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCC-CCEEECcc
Confidence 9776 66899999999999999997777779999999999999999999999999999999999999777 79999999
Q ss_pred cccccCCCCCc----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 164 GFSNRFNPGQK----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 164 ~~~~~~~~~~~----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
|++........ .....++..|+|||.+.+..++. ++|+||||+++|+|++|..|+.
T Consensus 171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYI-ASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccccCCCcceeccCCCCCCccccCCeeecCCCCCc-chhHHHHHHHHHHHHHccCCCc
Confidence 99977654432 12234566799999998877775 9999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=268.32 Aligned_cols=223 Identities=23% Similarity=0.358 Sum_probs=187.5
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEE
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYE 84 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (259)
........++|++.+.||+|++|.||+|.+. ..+..|++|.+.... .......+.+|+.+++.++||||+++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 3444566789999999999999999999877 457889999987543 3334566889999999999999999999
Q ss_pred EEecCCeEEEEEeccCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC
Q psy3663 85 VIDTNSKLYLILELGDGGDLYDYIMKHD---------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL 155 (259)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~---------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~ 155 (259)
++.+.+..+++||++.+++|.+++.... .++++..++.++.||+.||.+||++||+|+||+|+||+++.+
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~- 174 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED- 174 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC-
Confidence 9999999999999999999999987642 447999999999999999999999999999999999999766
Q ss_pred CeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHh
Q psy3663 156 GVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMI 231 (259)
Q Consensus 156 ~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i 231 (259)
+.++|+|||++......... ....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+....+
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCc-hhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 78999999998655332211 2223467899999998777765 9999999999999999 89999988888877777
Q ss_pred hhcc
Q psy3663 232 MDVS 235 (259)
Q Consensus 232 ~~~~ 235 (259)
.+..
T Consensus 254 ~~~~ 257 (322)
T 1p4o_A 254 MEGG 257 (322)
T ss_dssp HTTC
T ss_pred HcCC
Confidence 6544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=267.17 Aligned_cols=219 Identities=26% Similarity=0.420 Sum_probs=186.2
Q ss_pred CccccCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT 88 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (259)
.-..++|++.+.||+|++|.||+|.+. .++..|++|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 334679999999999999999999874 345789999987543 34456778899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCC
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDA-----------------------GLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~-----------------------~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~ 145 (259)
.+..+++|||+.+++|.+++..... .+++..++.++.||+.||.+||++||+|+||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 9999999999999999999986532 38899999999999999999999999999999
Q ss_pred CCCeEeeecCCeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy3663 146 PENVVFFERLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQE 221 (259)
Q Consensus 146 p~nIlv~~~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 221 (259)
|+||+++.+ +.++|+|||++......... ....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||..
T Consensus 178 p~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 178 ARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT-QSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp GGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCc-hhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999766 78999999998766443222 2234566799999998777665 9999999999999999 9999998
Q ss_pred CCChHHHHHhhhcc
Q psy3663 222 ANDSETLTMIMDVS 235 (259)
Q Consensus 222 ~~~~~~~~~i~~~~ 235 (259)
.........+....
T Consensus 256 ~~~~~~~~~~~~~~ 269 (314)
T 2ivs_A 256 IPPERLFNLLKTGH 269 (314)
T ss_dssp CCGGGHHHHHHTTC
T ss_pred CCHHHHHHHhhcCC
Confidence 88888877776554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=270.30 Aligned_cols=223 Identities=21% Similarity=0.324 Sum_probs=182.8
Q ss_pred CCCccccCeeEeeeecccccceEEEEE-----EeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEE
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLAR-----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVI 86 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~-----~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (259)
-+....++|++.+.||+|++|.||+|. +..++..|++|.+.... .......+.+|+.+++.++||||+++++++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 344567899999999999999999998 55678899999996433 344556788999999999999999999999
Q ss_pred ecCCeEEEEEeccCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCeE
Q psy3663 87 DTNSKLYLILELGDGGDLYDYIMKHD------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVV 158 (259)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~~~~~~------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~i 158 (259)
.+....+++||++.+++|.+++.... ..+++..++.++.||+.||.+||++||+|+||+|+||+++.+ ...+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 99999999999999999999998764 348999999999999999999999999999999999999743 3469
Q ss_pred EEEeccccccCCCCC---ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 159 KLTDFGFSNRFNPGQ---KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 159 ~l~df~~~~~~~~~~---~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
+|+|||.+....... ......++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+....+...
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence 999999886543221 122345677899999998777765 9999999999999998 99999988888888777765
Q ss_pred cc
Q psy3663 235 SE 236 (259)
Q Consensus 235 ~~ 236 (259)
..
T Consensus 262 ~~ 263 (327)
T 2yfx_A 262 GR 263 (327)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=268.38 Aligned_cols=219 Identities=22% Similarity=0.367 Sum_probs=180.5
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecC----ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTG----EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~----~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
...++|++.+.||+|++|.||+|.+..++ ..|++|.+.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 34568999999999999999999877553 359999987543 3344567889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
..+++||++.+++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLE 198 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC-----
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCC-CcEEECCCCcchhhc
Confidence 9999999999999999998876779999999999999999999999999999999999999766 789999999987654
Q ss_pred CCCcc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 171 PGQKL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 171 ~~~~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
..... ....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+....+.+...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 268 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 268 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred cccccccccCCCCccccccCchhcccCCCCc-hhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc
Confidence 33211 1223456799999998877775 9999999999999999 9999998888888887776543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=262.39 Aligned_cols=212 Identities=27% Similarity=0.497 Sum_probs=169.7
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC--cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD--PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
.++|++.+.||+|++|.||+|.+ .+..+++|++...... ......+.+|+.+++.++||||+++++++.+....++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 57899999999999999999995 4889999998765322 2335778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCCCCeEeeec-------CCeEEEEecc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH---VVHRDLKPENVVFFER-------LGVVKLTDFG 164 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~---i~H~dl~p~nIlv~~~-------~~~i~l~df~ 164 (259)
+|||+.+++|.+++.. ..+++..++.++.|++.||.+||++| ++|+||+|+||+++.+ .+.++|+|||
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999998854 35899999999999999999999999 8999999999999752 4689999999
Q ss_pred ccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 165 FSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
.+....... .....++..|+|||.+.+..++. ++|+||||+++++|++|+.||...+.......+...
T Consensus 162 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (271)
T 3dtc_A 162 LAREWHRTT-KMSAAGAYAWMAPEVIRASMFSK-GSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229 (271)
T ss_dssp C--------------CCGGGSCHHHHHHCCCSH-HHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred ccccccccc-ccCCCCccceeCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence 987654332 23446788999999998777765 999999999999999999999987776666655533
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=271.73 Aligned_cols=214 Identities=29% Similarity=0.437 Sum_probs=176.2
Q ss_pred CCCCCCCCCCCccccCe-eEeeeecccccceEEEEE----EeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC
Q psy3663 4 SGSRSSDGHPTKIAGLY-DLEETLGRGHFAVVKLAR----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78 (259)
Q Consensus 4 ~~~~~~~~~~~~~~~~y-~~~~~i~~g~~~~vy~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 78 (259)
+..+...+++..+.++| ++.+.||+|++|.||++. +..+++.|++|++.... .......+.+|+.+++.++|||
T Consensus 16 ~~~~~~pg~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ 94 (318)
T 3lxp_A 16 EVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEH 94 (318)
T ss_dssp --------CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTT
T ss_pred eeeecCCCCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcc
Confidence 44578889999999999 999999999999998774 44578899999997653 3445677889999999999999
Q ss_pred eEEEEEEEec--CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC
Q psy3663 79 VVRLYEVIDT--NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 79 i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~ 156 (259)
|+++++++.+ ...++++||++.+++|.+++.... +++..++.++.||+.+|.+||+.||+|+||+|+||+++.+ +
T Consensus 95 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~-~ 171 (318)
T 3lxp_A 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND-R 171 (318)
T ss_dssp BCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-C
T ss_pred hhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCC-C
Confidence 9999999976 467899999999999999987644 8999999999999999999999999999999999999766 7
Q ss_pred eEEEEeccccccCCCCCc----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 157 VVKLTDFGFSNRFNPGQK----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 157 ~i~l~df~~~~~~~~~~~----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
.++|+|||.+........ .....++..|+|||.+.+..++. ++||||||+++|+|++|..||...
T Consensus 172 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 172 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYY-ASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred CEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCccccc
Confidence 899999999987654432 12234566799999998877775 999999999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=269.50 Aligned_cols=223 Identities=28% Similarity=0.447 Sum_probs=187.0
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN-- 89 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 89 (259)
-...+.++|++.+.||+|++|.||+|.+..+++.|+||.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred cccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 34567899999999999999999999999899999999986432 333456778999999999999999999987653
Q ss_pred ---CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 90 ---SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 90 ---~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
...+++||++.+ +|.+++... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++
T Consensus 84 ~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~a 159 (353)
T 2b9h_A 84 ENFNEVYIIQELMQT-DLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN-CDLKVCDFGLA 159 (353)
T ss_dssp TTCCCEEEEECCCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTC
T ss_pred CccceEEEEEeccCc-cHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCC-CcEEEEecccc
Confidence 678999999975 999988763 48999999999999999999999999999999999999766 78999999998
Q ss_pred ccCCCCCc-----------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 167 NRFNPGQK-----------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 167 ~~~~~~~~-----------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
........ .....++..|+|||.+.+....+.++|+||||+++|+|++|++||.+.+..+.+..+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 76543221 1123568889999988664444459999999999999999999999999888888888766
Q ss_pred cccc
Q psy3663 236 ESSC 239 (259)
Q Consensus 236 ~~~~ 239 (259)
+.+.
T Consensus 240 ~~~~ 243 (353)
T 2b9h_A 240 GTPH 243 (353)
T ss_dssp CCCC
T ss_pred CCCc
Confidence 6554
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=282.23 Aligned_cols=230 Identities=24% Similarity=0.404 Sum_probs=194.6
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
-.++|++.+.||+|+||.||+|.+..++..|+||.+.... .....+.+|+.++++++||||+++++++.+....++|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3568999999999999999999999889999999997543 2467789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
|||+.+++|.+++... ...+++..++.++.||+.||.|||++||+|+||+|+||+++.+ +.++|+|||++........
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCEEECCTTCEECCTTCCE
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCC-CcEEEeecccceeccCCce
Confidence 9999999999999864 3458999999999999999999999999999999999999776 7899999999976643322
Q ss_pred c--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc------------c
Q psy3663 175 L--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS------------C 239 (259)
Q Consensus 175 ~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~------------~ 239 (259)
. ....++..|+|||.+....++. ++||||||+++|+|++ |..||...+..+....+.+..... .
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~-~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 452 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM 452 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred eecCCCcCCcceeCHhHHhcCCCCc-HHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 2 1223456899999998777765 9999999999999999 999999988888877776543322 2
Q ss_pred ccccccCchhh
Q psy3663 240 TCWWRGRPRSR 250 (259)
Q Consensus 240 ~~~~~~~~~~~ 250 (259)
..+|..+|..|
T Consensus 453 ~~cl~~dP~~R 463 (495)
T 1opk_A 453 RACWQWNPSDR 463 (495)
T ss_dssp HHHTCSSGGGS
T ss_pred HHHcCcChhHC
Confidence 34666677665
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=271.16 Aligned_cols=208 Identities=29% Similarity=0.458 Sum_probs=155.4
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEE--------ec
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVI--------DT 88 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~--------~~ 88 (259)
.+|++.+.||+|++|.||+|.+..+++.|++|.+.... ......+.+|+.+++++. ||||+++++++ ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 38999999999999999999999999999999985542 344567889999999996 99999999998 34
Q ss_pred CCeEEEEEeccCCCChHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCCCCeEeeecCCeEEEEecc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMK--HDAGLSETYAREYFAQIVRAISFCHKLH--VVHRDLKPENVVFFERLGVVKLTDFG 164 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~--~~~~~~~~~i~~~~~ql~~al~~LH~~~--i~H~dl~p~nIlv~~~~~~i~l~df~ 164 (259)
...++++||++.+ +|.+++.. ...++++..++.++.||+.||.+||+.| |+|+||+|+||+++.+ +.++|+|||
T Consensus 106 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT-SCEEBCCCT
T ss_pred CceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC-CCEEEecCc
Confidence 4568999999975 99998865 3445999999999999999999999999 9999999999999766 789999999
Q ss_pred ccccCCCCCcc-------------ccccCCCccCCcccc---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHH
Q psy3663 165 FSNRFNPGQKL-------------ETSCGSLAYSAPEIL---LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETL 228 (259)
Q Consensus 165 ~~~~~~~~~~~-------------~~~~~~~~~~apE~~---~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 228 (259)
++......... ....++..|+|||.+ .+..++ .++||||||+++|+|++|+.||.........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~ 262 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG-EKQDIWALGCILYLLCFRQHPFEDGAKLRIV 262 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSS-HHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC-hHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence 98766433221 133478889999998 344444 4999999999999999999999876555444
Q ss_pred HH
Q psy3663 229 TM 230 (259)
Q Consensus 229 ~~ 230 (259)
..
T Consensus 263 ~~ 264 (337)
T 3ll6_A 263 NG 264 (337)
T ss_dssp --
T ss_pred cC
Confidence 33
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=272.64 Aligned_cols=211 Identities=23% Similarity=0.355 Sum_probs=180.1
Q ss_pred CCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec
Q psy3663 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT 88 (259)
Q Consensus 9 ~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (259)
...+.....++|++.+.||+|++|.||+|.+. ++..|++|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34455667889999999999999999999964 68899999986543 3356778899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHD---AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGF 165 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~---~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~ 165 (259)
.+..+++|||+.+++|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||+
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~kl~Dfg~ 185 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN-FVPKITDFGI 185 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTT-CCEEECCCTT
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCC-CCEEEeeccc
Confidence 999999999999999999886543 348999999999999999999999999999999999999766 7899999999
Q ss_pred cccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 166 SNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 166 ~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
+........ .....++..|+|||.+.+..++. ++|+||||+++|+|++|+.||.....
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE-KSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCT-HHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCc-ccchHhHHHHHHHHHhCCCcccccCc
Confidence 876432211 22334688999999998777775 99999999999999999999976544
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=268.47 Aligned_cols=228 Identities=25% Similarity=0.406 Sum_probs=194.6
Q ss_pred CCCccccCeeEeeeecccccceEEEEEE-eecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCC------CeEEEEE
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARH-VFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP------NVVRLYE 84 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~-~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~ 84 (259)
.+..+.++|++.+.||+|++|.||+|.+ ..++..|++|++... ......+.+|+.+++.++|+ +++++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 4456778999999999999999999998 557889999998643 23456778899999888755 4999999
Q ss_pred EEecCCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec---------
Q psy3663 85 VIDTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--------- 154 (259)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--------- 154 (259)
++.+.+..+++||++ +++|.+++.... .++++..++.++.||+.||.+||++||+|+||+|+||++..+
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 999999999999999 679999987764 358999999999999999999999999999999999999663
Q ss_pred ---------CCeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 155 ---------LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 155 ---------~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
.+.++|+|||.+..... ......++..|+|||.+.+..++. ++|+||||+++|+|++|..||...+..
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQ-PCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCT-HHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 35799999999876433 233456788999999998877775 999999999999999999999999999
Q ss_pred HHHHHhhhccccccccccccC
Q psy3663 226 ETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 226 ~~~~~i~~~~~~~~~~~~~~~ 246 (259)
+....+.+..++.+..+|...
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~ 261 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKT 261 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHC
T ss_pred HHHHHHHHHhCCCCHHHHhhc
Confidence 999999888888777665433
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=260.43 Aligned_cols=215 Identities=20% Similarity=0.297 Sum_probs=184.9
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--Ce
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN--SK 91 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 91 (259)
..-.++|++.+.||+|++|.||+|.+ .+..+++|++............+.+|+.+++.++||||+++++++.+. ..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 44567999999999999999999996 488999999987766666677899999999999999999999999876 78
Q ss_pred EEEEEeccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 92 LYLILELGDGGDLYDYIMKHDA-GLSETYAREYFAQIVRAISFCHKLH--VVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~-~~~~~~i~~~~~ql~~al~~LH~~~--i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.+++|||+.+++|.+++..... .+++..++.++.||+.||.+||++| ++|+||+|+||+++.+ +.++|.||+++..
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~-~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFS 162 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTT-SCEEEEGGGSCCT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCC-cceeEEeccceee
Confidence 8999999999999999987643 4899999999999999999999999 9999999999999766 7899999987654
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCC--chhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAP--AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~--~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
... ....++..|+|||.+.+...... ++|+||||+++|+|++|+.||...+..+....+....
T Consensus 163 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 227 (271)
T 3kmu_A 163 FQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG 227 (271)
T ss_dssp TSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC
T ss_pred ecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC
Confidence 322 23457889999999987655432 7999999999999999999999888877766666443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=264.12 Aligned_cols=219 Identities=26% Similarity=0.439 Sum_probs=181.9
Q ss_pred CCccccCeeEee-eecccccceEEEEEE--eecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC
Q psy3663 13 PTKIAGLYDLEE-TLGRGHFAVVKLARH--VFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN 89 (259)
Q Consensus 13 ~~~~~~~y~~~~-~i~~g~~~~vy~~~~--~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (259)
...-.++|++.+ .||+|++|.||+|.+ ...++.|++|++............+.+|+.+++.++||||+++++++ ..
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 334457899998 999999999999954 45678999999987655555577889999999999999999999999 45
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
...+++||++.+++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKAL 167 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCC-CcEEEccCCcceee
Confidence 67889999999999999998754 49999999999999999999999999999999999999877 79999999998776
Q ss_pred CCCCccc----cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 170 NPGQKLE----TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 170 ~~~~~~~----~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
....... ...++..|+|||.+.+..++. ++|+||||+++|+|++ |+.||......+....+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 237 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 237 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCCh-hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 5433221 123456799999997776664 9999999999999999 999999888877777776554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=279.09 Aligned_cols=227 Identities=28% Similarity=0.509 Sum_probs=177.1
Q ss_pred ccccCeeEe-eeecccccceEEEEEEe--ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe--cC
Q psy3663 15 KIAGLYDLE-ETLGRGHFAVVKLARHV--FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID--TN 89 (259)
Q Consensus 15 ~~~~~y~~~-~~i~~g~~~~vy~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~ 89 (259)
.+.+.|++. +.||+|+||.||+|.+. .++..|++|.+.... ....+.+|+.+++.++||||+++++++. ..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 456778884 57999999999999965 568899999997543 2346779999999999999999999994 46
Q ss_pred CeEEEEEeccCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee---ecCCeE
Q psy3663 90 SKLYLILELGDGGDLYDYIMKH--------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF---ERLGVV 158 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~--------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~---~~~~~i 158 (259)
...++||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||++. ...+.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence 789999999976 888877532 12489999999999999999999999999999999999994 234789
Q ss_pred EEEeccccccCCCC----CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC---------h
Q psy3663 159 KLTDFGFSNRFNPG----QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND---------S 225 (259)
Q Consensus 159 ~l~df~~~~~~~~~----~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---------~ 225 (259)
+|+|||++...... .......++..|+|||++.+....+.++|||||||++|+|++|++||..... .
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999999765432 2223456788999999998765444599999999999999999999976554 5
Q ss_pred HHHHHhhhccccccccccccC
Q psy3663 226 ETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 226 ~~~~~i~~~~~~~~~~~~~~~ 246 (259)
+++..+.+..+.+....|...
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~ 272 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDI 272 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGG
T ss_pred HHHHHHHHhhCCCChhhcchh
Confidence 889999999999988888754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=264.93 Aligned_cols=221 Identities=30% Similarity=0.503 Sum_probs=179.6
Q ss_pred CCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEe
Q psy3663 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVID 87 (259)
Q Consensus 9 ~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (259)
+-.......++|++.+.||.|++|.||+|.+..+++.|++|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 34455667889999999999999999999999899999999986543 2356788999999998 7999999999987
Q ss_pred c------CCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEE
Q psy3663 88 T------NSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 88 ~------~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
. ....+++||++.+++|.+++... ...+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~kl 170 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTEN-AEVKL 170 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTT-CCEEE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCC-CCEEE
Confidence 6 46799999999999999999865 3458999999999999999999999999999999999999766 78999
Q ss_pred EeccccccCCCCC-ccccccCCCccCCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhc
Q psy3663 161 TDFGFSNRFNPGQ-KLETSCGSLAYSAPEILL-----GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 161 ~df~~~~~~~~~~-~~~~~~~~~~~~apE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (259)
+|||++....... ......++..|+|||.+. +..++ .++|+||||+++|+|++|..||...+.......+.+.
T Consensus 171 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 171 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp CCCTTTC-------------CCGGGCCHHHHC--------CC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred eeCcCceecCcCccccccccCCccccChhhhccccccCcCCC-ccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 9999987654322 223446788999999986 34444 4999999999999999999999887776666655543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=264.52 Aligned_cols=221 Identities=30% Similarity=0.460 Sum_probs=175.9
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeec-Cc--eEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEec
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFT-GE--KVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT 88 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~-~~--~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (259)
.....++|++.+.||+|++|.||+|.+... +. .|++|++..... .......+.+|+++++.++||||+++++++.+
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 344456999999999999999999986533 33 689999876543 23346778899999999999999999999977
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.. .++++|++.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++..
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRA 170 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEE
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCC-CCEEEcccccccc
Confidence 65 789999999999999998776669999999999999999999999999999999999999777 7899999999877
Q ss_pred CCCCCcc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 169 FNPGQKL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 169 ~~~~~~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
....... ....++..|+|||.+.+..++. ++|+||||+++|+|++ |+.||...+..+....+.....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC
Confidence 6543321 1224566799999998776664 9999999999999999 9999999888888877765543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=275.31 Aligned_cols=223 Identities=23% Similarity=0.435 Sum_probs=186.4
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC--------CCCeEEEEEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ--------HPNVVRLYEV 85 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~ 85 (259)
..+.++|++.+.||+|++|.||+|.+..+++.|+||++... ......+.+|+.+++.++ |+||++++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 34568999999999999999999999999999999998643 334567888999999986 7789999999
Q ss_pred Ee----cCCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCCCCeEeeecC----
Q psy3663 86 ID----TNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKL-HVVHRDLKPENVVFFERL---- 155 (259)
Q Consensus 86 ~~----~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~-~i~H~dl~p~nIlv~~~~---- 155 (259)
+. +....+++||++.+ +|.+.+... ...+++..++.++.||+.||.+||++ ||+|+||||+||+++.+.
T Consensus 110 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred eeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence 87 56789999999955 666666554 35699999999999999999999998 999999999999997552
Q ss_pred --------------------------------------------CeEEEEeccccccCCCCCccccccCCCccCCccccc
Q psy3663 156 --------------------------------------------GVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL 191 (259)
Q Consensus 156 --------------------------------------------~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~ 191 (259)
..++|+|||.+...... .....++..|+|||++.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhc
Confidence 27999999999765432 34456789999999998
Q ss_pred CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------ChHHHHHhhhcccccccccc
Q psy3663 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN------DSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 192 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~ 243 (259)
+..++. ++|||||||++|+|++|+.||...+ ..+.+..+.+..+.++..+|
T Consensus 267 ~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 323 (397)
T 1wak_A 267 GSGYNT-PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323 (397)
T ss_dssp TSCCCT-HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH
T ss_pred CCCCCc-HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh
Confidence 888775 9999999999999999999997655 45667778887777766554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=273.27 Aligned_cols=223 Identities=24% Similarity=0.419 Sum_probs=188.5
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCccc---------------HHHHHHHHHHHHhCCCC
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS---------------QDHLYQEVRCMKLVQHP 77 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~---------------~~~~~~e~~~l~~l~~~ 77 (259)
.....++|++.+.||+|++|.||+|.+ +++.|++|.+......... ...+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 345568999999999999999999997 8999999998754322111 17888999999999999
Q ss_pred CeEEEEEEEecCCeEEEEEeccCCCChHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCe
Q psy3663 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDY------IMKH-DAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENV 149 (259)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~------~~~~-~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nI 149 (259)
||+++++++.+.+..+++|||+.+++|.++ +... ...+++..++.++.||+.||.+||+ +|++|+||+|+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999987 5442 4569999999999999999999999 9999999999999
Q ss_pred EeeecCCeEEEEeccccccCCCCCccccccCCCccCCcccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-hHH
Q psy3663 150 VFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD-SYDAPAVDVWSLGVILYMLVAGQAPFQEAND-SET 227 (259)
Q Consensus 150 lv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~ 227 (259)
+++.+ +.++|+|||.+...... ......++..|+|||.+.+. .++..++|+||||+++++|++|..||..... .+.
T Consensus 184 l~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 184 LMDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp EECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EEcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99766 78999999998765433 34455688899999999877 4433389999999999999999999988777 777
Q ss_pred HHHhhhcccccc
Q psy3663 228 LTMIMDVSESSC 239 (259)
Q Consensus 228 ~~~i~~~~~~~~ 239 (259)
...+.......+
T Consensus 262 ~~~i~~~~~~~~ 273 (348)
T 2pml_X 262 FNNIRTKNIEYP 273 (348)
T ss_dssp HHHHTSCCCCCC
T ss_pred HHHHhccCcCCc
Confidence 777776644433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=265.05 Aligned_cols=205 Identities=22% Similarity=0.330 Sum_probs=168.1
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEE-EecCCeE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV-IDTNSKL 92 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~ 92 (259)
..+.++|++.+.||+|++|.||+|.+..+++.|++|++..... ...+.+|+.+++.++|++++..+.. +......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 4677899999999999999999999999999999998765432 2347789999999998775555554 4677888
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee--ecCCeEEEEeccccccCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~--~~~~~i~l~df~~~~~~~ 170 (259)
+++||++ +++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||++. ++.+.++|+|||++....
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 9999999 7799999987767799999999999999999999999999999999999993 333789999999997664
Q ss_pred CCCc--------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 171 PGQK--------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 171 ~~~~--------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
.... .....++..|+|||.+.+..++. ++||||||+++|+|++|+.||...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCc-hhHHHHHHHHHHHHhcCCCCCcccch
Confidence 4322 22446789999999998887765 99999999999999999999977543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=267.08 Aligned_cols=221 Identities=29% Similarity=0.488 Sum_probs=180.4
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC--CcccHHHHHHHHHHHHhCCCCCeEEEEEEE--ecC
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLVQHPNVVRLYEVI--DTN 89 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~ 89 (259)
+.+.++|++.+.||+|++|.||+|.+..++..+++|++..... .......+.+|+.+++.++||||+++++++ .+.
T Consensus 1 a~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (305)
T 2wtk_C 1 AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEK 80 (305)
T ss_dssp ----CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC--
T ss_pred CccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCC
Confidence 3578999999999999999999999999999999999875431 123457788999999999999999999998 445
Q ss_pred CeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 SKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
...+++|||+.+ +|.+++... ...+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+..
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~-~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 81 QKMYMVMEYCVC-GMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG-GTLKISALGVAEA 158 (305)
T ss_dssp -CEEEEEECCSE-EHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCEE
T ss_pred CeEEEEehhccC-CHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCC-CcEEeeccccccc
Confidence 688999999987 477777654 4558999999999999999999999999999999999999766 7899999999876
Q ss_pred CCCC---CccccccCCCccCCcccccCCCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 169 FNPG---QKLETSCGSLAYSAPEILLGDSY-DAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 169 ~~~~---~~~~~~~~~~~~~apE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
.... .......++..|+|||.+.+... .+.++|+||||+++|+|++|+.||...+..+....+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC
Confidence 5422 22234457889999999876433 23489999999999999999999998887777777765543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=272.21 Aligned_cols=212 Identities=28% Similarity=0.538 Sum_probs=175.4
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC--CCCeEEEEEEEecCCeEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ--HPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~~l 94 (259)
..+|++.+.||+|+||.||+|.+.. +..|+||++............+.+|+.+++.++ ||||+++++++...+..++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3469999999999999999999874 889999999876655556788899999999997 5999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+||+. +++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||++. + +.++|+|||++........
T Consensus 134 v~E~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~-~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 134 VMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEECC-SEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-S-SCEEECCCSSSCCC-----
T ss_pred EEecC-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-C-CeEEEEecCccccccCCCc
Confidence 99954 669999998765 489999999999999999999999999999999999994 3 6899999999976643321
Q ss_pred ---cccccCCCccCCcccccC-----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh-HHHHHhhhc
Q psy3663 175 ---LETSCGSLAYSAPEILLG-----------DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS-ETLTMIMDV 234 (259)
Q Consensus 175 ---~~~~~~~~~~~apE~~~~-----------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~i~~~ 234 (259)
.....++..|+|||++.+ ..++ .++|||||||++|+|++|+.||...... ..+..+++.
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 283 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCT
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCC-ChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCc
Confidence 234568999999999865 2344 4999999999999999999999875443 445555543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=264.70 Aligned_cols=217 Identities=22% Similarity=0.380 Sum_probs=183.0
Q ss_pred CccccCeeEeeeecccccceEEEEEE-----eecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEe
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARH-----VFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVID 87 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~-----~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 87 (259)
.-..++|++.+.||+|++|.||+|.+ ..++..|++|.+.... .......+.+|+.+++++ +||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 34457999999999999999999985 3466799999997543 233457788999999999 8999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeE
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDA-----------------GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVV 150 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~-----------------~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIl 150 (259)
+.+..+++||++.+++|.+++..... .+++..++.++.||+.||.+||++|++|+||+|+||+
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 99999999999999999999987543 3899999999999999999999999999999999999
Q ss_pred eeecCCeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChH
Q psy3663 151 FFERLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSE 226 (259)
Q Consensus 151 v~~~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 226 (259)
++.+ +.++|+|||++......... ....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||.......
T Consensus 178 ~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 178 LTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9766 89999999998766543321 1223456799999998777765 9999999999999998 999998877666
Q ss_pred HHHHhhh
Q psy3663 227 TLTMIMD 233 (259)
Q Consensus 227 ~~~~i~~ 233 (259)
.+...++
T Consensus 256 ~~~~~~~ 262 (313)
T 1t46_A 256 KFYKMIK 262 (313)
T ss_dssp HHHHHHH
T ss_pred HHHHHhc
Confidence 5555544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=268.69 Aligned_cols=230 Identities=22% Similarity=0.366 Sum_probs=193.7
Q ss_pred CCCCCCccccCeeEeeeecccccceEEEEEEeecC-ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC------eEE
Q psy3663 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTG-EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN------VVR 81 (259)
Q Consensus 9 ~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~-~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~ 81 (259)
...-+..+.++|++.+.||+|++|.||+|.+..++ ..|++|++... ......+.+|+.+++.++|++ ++.
T Consensus 10 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred ccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 33445567889999999999999999999998776 68999998643 234567788999999887655 899
Q ss_pred EEEEEecCCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee--------
Q psy3663 82 LYEVIDTNSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF-------- 152 (259)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~-------- 152 (259)
+.+++...+..+++||++.+ ++.+.+.... .++++..++.++.||+.||.+||++||+|+||+|+||++.
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEEEETTEEEEEEECCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeeeeeCCeEEEEEeccCC-ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 99999999999999999955 7777766553 5699999999999999999999999999999999999993
Q ss_pred ----------ecCCeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 153 ----------ERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 153 ----------~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
...+.++|+|||++..... ......++..|+|||.+.+..++. ++|+||||+++|+|++|..||...
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQ-PCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCC-ccchHHHHHHHHHHHhCCCCCCCC
Confidence 2347899999999876433 233456889999999998887775 999999999999999999999999
Q ss_pred CChHHHHHhhhcccccccccccc
Q psy3663 223 NDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
...+.+..+.+..++.+..++..
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~ 265 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHR 265 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CHHHHHHHHHHHcCCCcHHHhhh
Confidence 99999999999888877766543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=267.62 Aligned_cols=204 Identities=27% Similarity=0.540 Sum_probs=171.1
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC--CCeEEEEEEEecCCeE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH--PNVVRLYEVIDTNSKL 92 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~ 92 (259)
....+|++.+.||+|++|.||+|.+. ++..|++|++............+.+|+.+++.++| +||+++++++.+....
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 34678999999999999999999985 68899999998766555566788999999999986 9999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++||+. +++|.+++.... .+++.+++.++.||+.||.+||++||+|+||+|+||++. + +.++|+|||++......
T Consensus 85 ~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~-~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 85 YMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEECCC-SEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T-TEEEECCCSSSCCC---
T ss_pred EEEEeCC-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-C-CcEEEeecccccccCcc
Confidence 9999965 669999998754 499999999999999999999999999999999999995 3 68999999999766433
Q ss_pred Cc---cccccCCCccCCcccccC-----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 173 QK---LETSCGSLAYSAPEILLG-----------DSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 173 ~~---~~~~~~~~~~~apE~~~~-----------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
.. .....++..|+|||.+.+ ..++ .++||||||+++|+|++|+.||.....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~ 225 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIIN 225 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCC-chhhHHHHHHHHHHHHhCCCcchhhhh
Confidence 22 234468999999999854 3344 499999999999999999999986544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=283.55 Aligned_cols=228 Identities=18% Similarity=0.219 Sum_probs=174.7
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHH---HHHhCCCCCeEEEE-------EE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVR---CMKLVQHPNVVRLY-------EV 85 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~---~l~~l~~~~i~~~~-------~~ 85 (259)
.++|++.+.||+|++|.||+|.+..+++.|+||++..... .......+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 5789999999999999999999988999999999976532 3345677889995 45555799999888 76
Q ss_pred EecCC-----------------eEEEEEeccCCCChHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHHHCCcEe
Q psy3663 86 IDTNS-----------------KLYLILELGDGGDLYDYIMKHDAGLS-------ETYAREYFAQIVRAISFCHKLHVVH 141 (259)
Q Consensus 86 ~~~~~-----------------~~~lv~e~~~~~sL~~~~~~~~~~~~-------~~~i~~~~~ql~~al~~LH~~~i~H 141 (259)
+.+.+ ..+++|||+. ++|.+++..... ++ +..++.++.||+.||.|||++||+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCS-EEHHHHHHHHHH-TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccC-CCHHHHHHhccc-cccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 66553 3889999995 599999986532 33 4888899999999999999999999
Q ss_pred ccCCCCCeEeeecCCeEEEEeccccccCCCCCccccccCCCccCCcccccCC-----------CCCCCchhHHHHHHHHH
Q psy3663 142 RDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD-----------SYDAPAVDVWSLGVILY 210 (259)
Q Consensus 142 ~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~-----------~~~~~~~Di~slG~~l~ 210 (259)
+||||+||+++.+ +.++|+|||++..... ......+ ..|+|||.+.+. .++. ++||||||+++|
T Consensus 230 rDikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~-~~DvwSlG~il~ 304 (377)
T 3byv_A 230 TYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF-SFDAWALGLVIY 304 (377)
T ss_dssp SCCCGGGEEECTT-CCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH-HHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCC-CCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCCh-hhhHHHHHHHHH
Confidence 9999999999766 7999999999876432 3344456 899999999876 5654 999999999999
Q ss_pred HHHhCCCCCCCCCChHHHHHhhhccc-------cccccccccCchhhh
Q psy3663 211 MLVAGQAPFQEANDSETLTMIMDVSE-------SSCTCWWRGRPRSRR 251 (259)
Q Consensus 211 ~l~~g~~pf~~~~~~~~~~~i~~~~~-------~~~~~~~~~~~~~~~ 251 (259)
+|++|+.||...........+..... .....+|..+|..|.
T Consensus 305 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred HHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCC
Confidence 99999999987665554444443221 123345666666553
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=264.64 Aligned_cols=218 Identities=29% Similarity=0.422 Sum_probs=165.4
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
-.++|++.+.||+|++|.||+|.+..+++.|++|++............+.++..+++.++||||+++++++.+.+..+++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 45689999999999999999999998999999999977654333344555666678888999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL-HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~-~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||++ +..+..+.......+++..++.++.||+.||.+||+. |++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER-GQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTT-SCEEECCCTTC--------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCC-CCEEEEECCCchhccCCcc
Confidence 9999 5467666665566799999999999999999999995 99999999999999766 7899999999876655544
Q ss_pred cccccCCCccCCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CChHHHHHhhhccc
Q psy3663 175 LETSCGSLAYSAPEILL-----GDSYDAPAVDVWSLGVILYMLVAGQAPFQEA-NDSETLTMIMDVSE 236 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-~~~~~~~~i~~~~~ 236 (259)
.....++..|+|||.+. ...++ .++||||||+++|+|++|+.||... ...+.+..+.....
T Consensus 181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 181 KDRSAGCAAYMAPERIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP 247 (318)
T ss_dssp ------CCTTCCHHHHC--------CC-THHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC
T ss_pred ccccCCCccccChhhcccccccccCCc-cccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC
Confidence 45556889999999985 33444 5999999999999999999999874 44455666655443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=266.01 Aligned_cols=216 Identities=25% Similarity=0.453 Sum_probs=183.2
Q ss_pred ccCeeEeeeecccccceEEEEEEe-------ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEec
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHV-------FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDT 88 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~-------~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (259)
.++|++.+.||+|++|.||+|.+. .++..|++|++.... .......+.+|+.+++.+ +||||+++++++.+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 579999999999999999999875 456789999987543 344567788999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDA---------------GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE 153 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~---------------~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~ 153 (259)
.+..++|||++.+++|.+++..... .+++..++.++.||+.||.+||++||+|+||+|+||+++.
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence 9999999999999999999986542 3899999999999999999999999999999999999976
Q ss_pred cCCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHH
Q psy3663 154 RLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLT 229 (259)
Q Consensus 154 ~~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (259)
+ +.++|+|||++........ .....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+...
T Consensus 193 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 193 N-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp T-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred C-CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh-HHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 6 7899999999876654322 12234567899999998777665 9999999999999999 999999888888777
Q ss_pred Hhhhcc
Q psy3663 230 MIMDVS 235 (259)
Q Consensus 230 ~i~~~~ 235 (259)
.+.+..
T Consensus 271 ~~~~~~ 276 (334)
T 2pvf_A 271 LLKEGH 276 (334)
T ss_dssp HHHHTC
T ss_pred HHhcCC
Confidence 776554
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=282.95 Aligned_cols=230 Identities=23% Similarity=0.458 Sum_probs=188.2
Q ss_pred cCeeEee-eecccccceEEEEEEee--cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 18 GLYDLEE-TLGRGHFAVVKLARHVF--TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 18 ~~y~~~~-~i~~g~~~~vy~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
+.+.+.+ .||+|+||.||+|.+.. ++..|+||+++... .......+.+|+++++.++||||+++++++.+ ...++
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 3556666 89999999999998763 45579999997653 33456788999999999999999999999976 56899
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||||+.+++|.+++......+++..++.++.||+.||.|||++||+|+||+|+||+++.+ +.++|+|||++........
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNR-HYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCSTTTTCC----
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCC-CcEEEeeccCcccccCCCc
Confidence 999999999999998777779999999999999999999999999999999999999777 7999999999976543322
Q ss_pred c----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc----------
Q psy3663 175 L----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC---------- 239 (259)
Q Consensus 175 ~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~---------- 239 (259)
. ....++..|+|||.+.+..++. ++||||||+++|||++ |+.||...+..+....+.++.....
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~-~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1 1223456899999998777775 9999999999999998 9999999999998888877654332
Q ss_pred --ccccccCchhhh
Q psy3663 240 --TCWWRGRPRSRR 251 (259)
Q Consensus 240 --~~~~~~~~~~~~ 251 (259)
..+|..+|.+|.
T Consensus 571 li~~cl~~dP~~RP 584 (613)
T 2ozo_A 571 LMSDCWIYKWEDRP 584 (613)
T ss_dssp HHHHTTCSSTTTSC
T ss_pred HHHHHcCCChhHCc
Confidence 236777776653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=270.94 Aligned_cols=211 Identities=25% Similarity=0.448 Sum_probs=182.4
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-..++|++.+.||+|++|.||+|.+..++..|++|++.... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 45679999999999999999999999999999999997653 34456778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL-HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~-~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+|||+.+++|.+++..... +++..+..++.|++.+|.+||+. ||+|+||+|+||+++.+ +.++|+|||++..... .
T Consensus 109 v~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~-~ 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID-S 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHH-H
T ss_pred EEECCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCC-CCEEEEECCCCccccc-c
Confidence 9999999999999987654 89999999999999999999986 99999999999999776 7899999998865422 1
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTM 230 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (259)
......++..|+|||.+.+..++. ++|+||||+++|+|++|+.||...+..+....
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 241 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 241 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSH-HHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHH
T ss_pred cccCCCCCCCeECHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 223346788999999998887775 99999999999999999999998766655433
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=268.74 Aligned_cols=201 Identities=23% Similarity=0.342 Sum_probs=167.7
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS---- 90 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 90 (259)
--.++|++.+.||+|++|.||+|.+ .++.|+||++.... ........|+.+++.++||||+++++++.+..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cchhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 3346999999999999999999985 47899999986532 23445566888999999999999999987643
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CcEeccCCCCCeEeeecCCeEEE
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL----------HVVHRDLKPENVVFFERLGVVKL 160 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~----------~i~H~dl~p~nIlv~~~~~~i~l 160 (259)
.++++|||+.+++|.+++.... +++..++.++.||+.||.|||+. ||+|+||||+||+++.+ +.++|
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~-~~~kL 172 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACI 172 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT-CCEEE
T ss_pred eEEEEEecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC-CeEEE
Confidence 4799999999999999997644 89999999999999999999999 99999999999999766 78999
Q ss_pred EeccccccCCCCCc---cccccCCCccCCcccccCCCCC----CCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 161 TDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYD----APAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 161 ~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~----~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
+|||++........ .....++..|+|||.+.+.... +.++||||||+++|+|++|+.||....
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 242 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence 99999976543322 2234678999999998764221 237899999999999999999997643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=263.68 Aligned_cols=219 Identities=26% Similarity=0.392 Sum_probs=176.3
Q ss_pred cccCeeEeeeecccccceEEEEEEee---cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS-- 90 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~---~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 90 (259)
-.++|++.+.||+|++|.||+|.+.. ++..|++|.+............+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 34699999999999999999998775 3448999999876655556678899999999999999999999987654
Q ss_pred ---eEEEEEeccCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEe
Q psy3663 91 ---KLYLILELGDGGDLYDYIMKH-----DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTD 162 (259)
Q Consensus 91 ---~~~lv~e~~~~~sL~~~~~~~-----~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~d 162 (259)
..+++||++.+++|.+++... ...+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kl~D 190 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD-MTVCVAD 190 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTT-SCEEECS
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEEee
Confidence 459999999999999998532 3458999999999999999999999999999999999999766 7899999
Q ss_pred ccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 163 FGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 163 f~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
||++........ .....++..|+|||.+.+..++. ++|+||||+++|+|++ |.+||......+....+.+...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccc-hhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 999876543321 12234567899999998877775 9999999999999999 9999999888888887776543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=271.59 Aligned_cols=203 Identities=18% Similarity=0.246 Sum_probs=165.3
Q ss_pred CeeEeeeecccccceEEEEEEeec-----CceEEEEEcccCCCCc---------ccHHHHHHHHHHHHhCCCCCeEEEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFT-----GEKVAVKVIDKTKLDP---------VSQDHLYQEVRCMKLVQHPNVVRLYE 84 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~-----~~~~~lK~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (259)
+|++.+.||+|+||.||+|.+..+ ++.|++|++....... ........|+..+..++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 899999999999999999998754 5789999986543100 01112334555667778999999999
Q ss_pred EEecC----CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee-cCCeEE
Q psy3663 85 VIDTN----SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE-RLGVVK 159 (259)
Q Consensus 85 ~~~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~-~~~~i~ 159 (259)
++... ...+++|||+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++. +.+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~k 194 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY 194 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEE
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEE
Confidence 98654 5589999999 88999999887677999999999999999999999999999999999999972 337899
Q ss_pred EEeccccccCCCCCcc--------ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 160 LTDFGFSNRFNPGQKL--------ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 160 l~df~~~~~~~~~~~~--------~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
|+|||++......... ....++..|+|||.+.+..++. ++||||||+++|+|++|+.||....
T Consensus 195 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 195 LVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR-RGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred EEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCc-hhhHHHHHHHHHHHHhCCCCccccc
Confidence 9999999765432111 2234889999999998887765 9999999999999999999998643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=260.80 Aligned_cols=199 Identities=28% Similarity=0.465 Sum_probs=176.1
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-----
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT----- 88 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 88 (259)
..+.++|++.+.||+|++|.||+|.+..+++.|++|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 457789999999999999999999999899999999987543 346689999999999999999998754
Q ss_pred -----------CCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC
Q psy3663 89 -----------NSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 89 -----------~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~ 156 (259)
....+++|||+.+++|.+++... ...+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~ 159 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT-K 159 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-T
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC-C
Confidence 45589999999999999999765 3569999999999999999999999999999999999999776 7
Q ss_pred eEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 157 VVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 157 ~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
.++|+|||.+.............++..|+|||.+.+..++. ++|+||||+++|+|++|..||.
T Consensus 160 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGK-EVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCT-HHHHHHHHHHHHHHHSCCSSHH
T ss_pred CEEECcchhheeccccccccccCCcccccChhhhccCCCcc-hhhhHHHHHHHHHHHhcCCcch
Confidence 99999999988776555555567889999999998877765 9999999999999999999885
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=261.42 Aligned_cols=211 Identities=27% Similarity=0.459 Sum_probs=173.1
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCeE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT-NSKL 92 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 92 (259)
..-.++|++.+.||+|++|.||+|.+ .+..|++|++.... ....+.+|+.+++.++||||+++++++.+ .+..
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 34468999999999999999999985 58899999986543 45678899999999999999999998754 4578
Q ss_pred EEEEeccCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDA-GLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~-~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
+++||++.+++|.+++..... .+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASS 169 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCC-CcEEEeeccccccccc
Confidence 999999999999999876532 37899999999999999999999999999999999999766 7899999998875543
Q ss_pred CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhc
Q psy3663 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDV 234 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~ 234 (259)
. .....++..|+|||.+.+..++. ++|+||||+++++|++ |..||......+....+.+.
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~ 230 (278)
T 1byg_A 170 T--QDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 230 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred c--ccCCCccccccCHHHhCCCCCCc-hhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 2 22335677899999998777765 9999999999999998 99999998888888777655
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=266.10 Aligned_cols=204 Identities=27% Similarity=0.436 Sum_probs=153.1
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHH-HHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVR-CMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
-.++|++.+.||+|++|.||+|.+..+++.|++|++..... ......+..|+. +++.++||||+++++++.+.+..++
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 35799999999999999999999998999999999976532 223344445554 7777899999999999999999999
Q ss_pred EEeccCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 95 ILELGDGGDLYDYIMK----HDAGLSETYAREYFAQIVRAISFCHKL-HVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~----~~~~~~~~~i~~~~~ql~~al~~LH~~-~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
+||++.+ +|.+++.. ....+++..++.++.|++.||.+||+. |++|+||+|+||+++.+ +.++|+|||++...
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS-GNIKLCDFGISGQL 176 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETT-TEEEECCCSSSCC-
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCC-CCEEEccCCCceec
Confidence 9999987 88887764 245589999999999999999999999 99999999999999766 89999999998776
Q ss_pred CCCCccccccCCCccCCccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 170 NPGQKLETSCGSLAYSAPEILL----GDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
..........++..|+|||.+. +..++ .++|+||||+++|+|++|+.||....
T Consensus 177 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp -----------------------------CC-SHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ccccccccCCCCccccCceeeccccCcCCCC-chhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 5544444456888999999983 44455 49999999999999999999997643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=271.16 Aligned_cols=229 Identities=24% Similarity=0.369 Sum_probs=180.7
Q ss_pred CeeEeeeecccccceEEEEEEeecC---ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe-cCCeEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTG---EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID-TNSKLYL 94 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~l 94 (259)
.|++.+.||+|+||.||+|.+..++ ..+++|.+.... .......+.+|+.++++++||||+++++++. ..+..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 5889999999999999999876543 368899886532 3345677889999999999999999999864 4567899
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+|||+.+++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++........
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC-----------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC-CCEEEeecccccccccccc
Confidence 999999999999998777778999999999999999999999999999999999999766 7899999999876533221
Q ss_pred c-----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc---------
Q psy3663 175 L-----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC--------- 239 (259)
Q Consensus 175 ~-----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~--------- 239 (259)
. ....++..|+|||.+.+..++. ++|+||||+++|+|++ |.+||...+..+....+.+......
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~ 326 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 326 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccCCCCCcccccChHHhcCCCCCc-HHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 1 2223556899999998877775 9999999999999999 8889998888877777776554332
Q ss_pred ---ccccccCchhh
Q psy3663 240 ---TCWWRGRPRSR 250 (259)
Q Consensus 240 ---~~~~~~~~~~~ 250 (259)
..+|..+|.+|
T Consensus 327 ~li~~cl~~dp~~R 340 (373)
T 3c1x_A 327 EVMLKCWHPKAEMR 340 (373)
T ss_dssp HHHHHHTCSSGGGS
T ss_pred HHHHHHcCCChhhC
Confidence 34566666665
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=276.51 Aligned_cols=231 Identities=26% Similarity=0.442 Sum_probs=187.3
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
..-.++|++.+.||+|+||.||+|.+. .+..|+||++.... .....+.+|+.++++++||||+++++++.+ ...+
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 344678999999999999999999976 45679999997644 235678899999999999999999999876 6689
Q ss_pred EEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 94 LILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+||||+.+++|.+++... ...+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC-----
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCC-CCEEECCCccceecCCC
Confidence 999999999999999753 3458999999999999999999999999999999999999766 78999999998765432
Q ss_pred Ccc--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc-----------
Q psy3663 173 QKL--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS----------- 238 (259)
Q Consensus 173 ~~~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~----------- 238 (259)
... ....++..|+|||.+....++. ++||||||+++|+|++ |..||.+....+....+.+....+
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 412 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 412 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred ceecccCCcccccccCHhHHhcCCCCc-cccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 221 2223567899999998777765 9999999999999999 999999988888888877654322
Q ss_pred -cccccccCchhhh
Q psy3663 239 -CTCWWRGRPRSRR 251 (259)
Q Consensus 239 -~~~~~~~~~~~~~ 251 (259)
...+|..+|..|.
T Consensus 413 li~~cl~~dP~~Rp 426 (452)
T 1fmk_A 413 LMCQCWRKEPEERP 426 (452)
T ss_dssp HHHHHTCSSGGGSC
T ss_pred HHHHHccCChhhCc
Confidence 3346666776553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=270.10 Aligned_cols=204 Identities=34% Similarity=0.598 Sum_probs=172.2
Q ss_pred cCeeEeeeecccccceEEEEEEe---ecCceEEEEEcccCCC--CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~--~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (259)
++|++.+.||+|+||.||+|.+. .+++.|+||++..... .......+.+|+.+++.+ .||||+++++++.+...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 79999999999999999999984 4789999999875432 122345566889999999 59999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.++||||+.+++|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.....
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~a~~~~~ 211 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVA 211 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEECCG
T ss_pred EEEEeecCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC-CcEEEeeCCCCeeccc
Confidence 9999999999999999987654 9999999999999999999999999999999999999766 7899999999876533
Q ss_pred CC--ccccccCCCccCCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 172 GQ--KLETSCGSLAYSAPEILLGDS-YDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 172 ~~--~~~~~~~~~~~~apE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
.. ......++..|+|||.+.+.. ..+.++||||||+++|+|++|+.||....
T Consensus 212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 22 223346889999999997632 23359999999999999999999997543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=264.45 Aligned_cols=215 Identities=27% Similarity=0.433 Sum_probs=177.8
Q ss_pred cccCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecC
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTN 89 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (259)
..++|++.+.||+|++|.||+|.+. .+++.|++|++.... .......+.+|+.++..+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 4579999999999999999999853 456799999987543 333456788999999999 689999999998765
Q ss_pred -CeEEEEEeccCCCChHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee
Q psy3663 90 -SKLYLILELGDGGDLYDYIMKHDAG---------------LSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE 153 (259)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~~~~~~~~---------------~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~ 153 (259)
..++++|||+.+++|.+++...... +++..++.++.||+.||.+||++||+|+||+|+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 4589999999999999999876432 789999999999999999999999999999999999976
Q ss_pred cCCeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHH-
Q psy3663 154 RLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETL- 228 (259)
Q Consensus 154 ~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~- 228 (259)
+ +.++|+|||++......... ....++..|+|||.+.+..++. ++|+||||+++|+|++ |..||......+.+
T Consensus 184 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 184 K-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp G-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred C-CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccc-hhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 6 78999999998765433221 2234567899999998777765 9999999999999998 99999877654443
Q ss_pred HHhhh
Q psy3663 229 TMIMD 233 (259)
Q Consensus 229 ~~i~~ 233 (259)
..+..
T Consensus 262 ~~~~~ 266 (316)
T 2xir_A 262 RRLKE 266 (316)
T ss_dssp HHHHH
T ss_pred HHhcc
Confidence 44433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=264.61 Aligned_cols=216 Identities=24% Similarity=0.403 Sum_probs=181.1
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCc-----eEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecC
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGE-----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTN 89 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~-----~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (259)
..++|++.+.||+|++|.||+|.+..++. .|++|.+.... .......+.+|+.+++.+ +||||+++++++.+.
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 34689999999999999999999876554 79999986543 333467788999999999 899999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKH-------------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~-------------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~ 156 (259)
+..+++||++.+++|.+++... ...+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~-~ 201 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG-H 201 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG-G
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC-C
Confidence 9999999999999999998754 2357999999999999999999999999999999999999776 7
Q ss_pred eEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhh
Q psy3663 157 VVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIM 232 (259)
Q Consensus 157 ~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~ 232 (259)
.++|+|||++......... ....++..|+|||.+.+..++. ++||||||+++|+|++ |..||........+..++
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 280 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV-QSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCCh-HHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence 8999999998755332221 1223456899999998777765 9999999999999998 999998877766665555
Q ss_pred hc
Q psy3663 233 DV 234 (259)
Q Consensus 233 ~~ 234 (259)
..
T Consensus 281 ~~ 282 (333)
T 2i1m_A 281 KD 282 (333)
T ss_dssp HH
T ss_pred hc
Confidence 43
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=261.01 Aligned_cols=219 Identities=23% Similarity=0.369 Sum_probs=180.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecC---ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEE-ecCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTG---EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVI-DTNSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 92 (259)
..+|++.+.||+|++|.||+|.+..++ ..+++|.+.... .......+.+|+.++++++||||+++++++ ...+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 458999999999999999999865433 358888886532 334457788999999999999999999985 456678
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++||++.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSCGGGCCCSCG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCC-CCEEECccccccccccc
Confidence 99999999999999998777779999999999999999999999999999999999999666 78999999998765432
Q ss_pred Cc-----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc
Q psy3663 173 QK-----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 173 ~~-----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
.. .....++..|+|||.+.+..++. ++|+||||+++|+|++ +.+||...+..+....+.+.....
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCC
T ss_pred chhccccccCCCCCccccChHHhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCC
Confidence 21 12223456799999998777775 9999999999999999 788888888888877777665544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=259.47 Aligned_cols=207 Identities=29% Similarity=0.481 Sum_probs=172.2
Q ss_pred cccCeeEee-----eecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 16 IAGLYDLEE-----TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 16 ~~~~y~~~~-----~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
+...|++.+ .||+|++|.||+|.+..++..|++|.+.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 15 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 15 LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp CCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 333455444 9999999999999999999999999987643 334577889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKHD--AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
..+++||++.+++|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++...+.++|+|||.+..
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence 9999999999999999998763 34678999999999999999999999999999999999987458999999999876
Q ss_pred CCCCC-ccccccCCCccCCcccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 169 FNPGQ-KLETSCGSLAYSAPEILLGDS--YDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 169 ~~~~~-~~~~~~~~~~~~apE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
..... ......++..|+|||.+.+.. ++ .++|+||||+++|+|++|+.||......
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~ 231 (295)
T 2clq_A 173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYG-KAADIWSLGCTIIEMATGKPPFYELGEP 231 (295)
T ss_dssp SCC-----CCCCCCGGGCCHHHHHHGGGGCS-HHHHHHHHHHHHHHHHHTSCTTGGGSSH
T ss_pred cCCCCCcccccCCCccccChhhhcCCCCCCC-cHHHHHHHHHHHHHHHHCCCCccCCCch
Confidence 54322 233446788999999986543 44 4999999999999999999999765443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=282.35 Aligned_cols=224 Identities=25% Similarity=0.469 Sum_probs=185.2
Q ss_pred eeecccccceEEEEEEe--ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHV--FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~--~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|+||.||+|.+. ..+..|+||++............+.+|+++++.++||||+++++++.+ ...++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 48999999999999654 456789999998765555567889999999999999999999999975 457899999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc----cc
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL----ET 177 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~----~~ 177 (259)
++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++......... ..
T Consensus 454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCTTHHHHTTC----------
T ss_pred CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCC-CCEEEEEcCCccccccCccccccccC
Confidence 99999997654 49999999999999999999999999999999999999777 79999999999766443221 12
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc------------ccccc
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC------------TCWWR 244 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~------------~~~~~ 244 (259)
..++..|+|||.+.+..++. ++||||||+++|+|++ |+.||.+....+....+.+...... ..+|.
T Consensus 532 ~~~t~~y~APE~~~~~~~~~-~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 610 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 610 (635)
T ss_dssp ---CGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeeeChhhhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 23456799999998877775 9999999999999998 9999999988888888877654432 23677
Q ss_pred cCchhhh
Q psy3663 245 GRPRSRR 251 (259)
Q Consensus 245 ~~~~~~~ 251 (259)
.+|.+|.
T Consensus 611 ~dP~~RP 617 (635)
T 4fl3_A 611 YDVENRP 617 (635)
T ss_dssp SSTTTSC
T ss_pred CCHhHCc
Confidence 7776654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=260.69 Aligned_cols=219 Identities=29% Similarity=0.459 Sum_probs=175.3
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec------
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT------ 88 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 88 (259)
.+.++|++.+.||+|++|.||+|.+..+++.|++|.+... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 4678999999999999999999999999999999998643 2345778899999999999999999998754
Q ss_pred -------CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEE
Q psy3663 89 -------NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLT 161 (259)
Q Consensus 89 -------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~ 161 (259)
....+++||++.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~-~~~kl~ 158 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES-RNVKIG 158 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEEC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCC-CCEEEe
Confidence 457899999999999999998776668899999999999999999999999999999999999766 789999
Q ss_pred eccccccCCCC---------------CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CCCh
Q psy3663 162 DFGFSNRFNPG---------------QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE-ANDS 225 (259)
Q Consensus 162 df~~~~~~~~~---------------~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~ 225 (259)
|||.+...... .......++..|+|||.+.+....+.++|+||||+++|+|++ ||.. ....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 99998765422 112334578899999999866444459999999999999998 6643 2334
Q ss_pred HHHHHhhhccccccc
Q psy3663 226 ETLTMIMDVSESSCT 240 (259)
Q Consensus 226 ~~~~~i~~~~~~~~~ 240 (259)
.....+.+.....+.
T Consensus 236 ~~~~~~~~~~~~~~~ 250 (303)
T 1zy4_A 236 NILKKLRSVSIEFPP 250 (303)
T ss_dssp HHHHHHHSTTCCCCT
T ss_pred HHHHhccccccccCc
Confidence 445555544443333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=257.16 Aligned_cols=216 Identities=22% Similarity=0.372 Sum_probs=179.3
Q ss_pred CeeEeeeecccccceEEEEEEeecCc---eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE-EE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL-YL 94 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-~l 94 (259)
.|++.+.||+|++|.||+|.+..++. .+++|.+.... .......+.+|+.+++.++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 67778999999999999999765554 79999986533 333457788999999999999999999999765554 89
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ- 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~- 173 (259)
+|+++.+++|.+++......+++..++.++.|++.||.+||++|++|+||+|+||+++.+ +.++|+|||++.......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~-~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES-FTVKVADFGLARDILDREY 179 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECCTTSSCTTTTGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCC-CcEEeCcCCCcccccCCcc
Confidence 999999999999998877779999999999999999999999999999999999999666 789999999987553321
Q ss_pred ----ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccc
Q psy3663 174 ----KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 174 ----~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
......++..|+|||.+.+..++. ++|+||||+++|+|++ +.+||...+..+....+......
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTT-KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL 247 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC
T ss_pred cccccCcCCCCCccccChhhhccCCCCh-hhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC
Confidence 122334567899999998887775 9999999999999999 66667777777777766655543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=263.97 Aligned_cols=201 Identities=28% Similarity=0.425 Sum_probs=174.2
Q ss_pred cCeeEeeeecccccceEEEEE----EeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe--cCCe
Q psy3663 18 GLYDLEETLGRGHFAVVKLAR----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID--TNSK 91 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~ 91 (259)
++|++.+.||+|++|.||+|. +..++..|++|.+.... ......+.+|+.+++.++||||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 599999999999999999998 56788999999987543 344567889999999999999999999886 4567
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.+++|||+.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-AHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCGGGCEECCT
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCC-CCEEEcccccceeccc
Confidence 899999999999999998766669999999999999999999999999999999999999777 8999999999987654
Q ss_pred CCcc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy3663 172 GQKL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEA 222 (259)
Q Consensus 172 ~~~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 222 (259)
.... ....++..|+|||.+.+..++. ++||||||+++|+|++|..||...
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSR-QSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred CCccceeeccCCccccccCHHHhccCCCCh-HHhHHHHHHHHHHHHhCCCCCccc
Confidence 3321 2234566799999998777665 999999999999999999999653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=268.51 Aligned_cols=204 Identities=23% Similarity=0.343 Sum_probs=173.9
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.....++|++.+.||+|++|.||+|.+. ++..|++|.+...... .....+.+|+.+++.++||||+++++++.+....
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 3445679999999999999999999854 6889999999765422 2234688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 93 YLILELGDGGDLYDYIMKHD---AGLSETYAREYFAQIVRAISFCHKL---HVVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~---~~~~~~~i~~~~~ql~~al~~LH~~---~i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
+++|||+.+++|.+++.... .++++..++.++.|++.||.+||+. ||+|+||+|+||+++.+ +.++|+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~-~~~kl~Dfg~~ 181 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE-FEAVVGDFGLA 181 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT-CCEEECCCSSC
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC-CCEEeccCccc
Confidence 99999999999999998653 3489999999999999999999999 99999999999999766 78999999999
Q ss_pred ccCCCCCc--cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 167 NRFNPGQK--LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 167 ~~~~~~~~--~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
........ .....++..|+|||.+.+..++. ++||||||+++|+|++|+.||.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHHSEECH-HHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccCcccccccccccCCcCccCHHHhccCCCCc-cccchhHHHHHHHHHhCCCccc
Confidence 76543322 23345789999999997777765 9999999999999999999995
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=273.95 Aligned_cols=205 Identities=22% Similarity=0.357 Sum_probs=176.1
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC-CCeEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH-PNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 93 (259)
.+.++|++.+.||+|+||.||+|.+..+++.|+||++..... ...+.+|+++++.++| +++..+..++......+
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 577899999999999999999999999999999998765442 3347789999999986 55666666677788899
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEee--ecCCeEEEEeccccccCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~--~~~~~i~l~df~~~~~~~~ 171 (259)
++||++ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+||++. ++.+.++|+|||++.....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 7799999987777799999999999999999999999999999999999995 3447899999999976644
Q ss_pred CCcc--------ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 172 GQKL--------ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 172 ~~~~--------~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
.... ....++..|+|||.+.+..++. ++|||||||++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-~sDvwSlGvil~elltG~~Pf~~~~~~ 219 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAG 219 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCccccch
Confidence 3221 2456889999999998888775 999999999999999999999886653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=255.72 Aligned_cols=217 Identities=27% Similarity=0.432 Sum_probs=182.3
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
+-....++|++.+.||+|++|.||+|.+. ++..|++|.+.... .....+.+|+++++.++||||+++++++.+ +.
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 34455689999999999999999999965 56789999986543 246778899999999999999999999865 45
Q ss_pred EEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
.+++||++.+++|.+++.... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||.+....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIE 160 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCC-CCEEECCCccccccc
Confidence 889999999999999986542 248999999999999999999999999999999999999766 789999999987765
Q ss_pred CCCcc--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcc
Q psy3663 171 PGQKL--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 171 ~~~~~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~ 235 (259)
..... ....++..|+|||.+.+..++. ++|+||||+++++|++ |..||......+....+.+..
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~ 227 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTI-KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred CcccccccCCCCccCccChhhhccCCCCc-hhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc
Confidence 43222 2223466899999998776664 9999999999999999 999999888887777776543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=256.09 Aligned_cols=197 Identities=30% Similarity=0.557 Sum_probs=163.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|++|.||+|.+ .++.|++|.+... .....+.+|+.++++++||||+++++++.+ ..+++|
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEE
Confidence 46899999999999999999985 5788999998643 346778899999999999999999998764 368999
Q ss_pred eccCCCChHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 97 ELGDGGDLYDYIMKHDA--GLSETYAREYFAQIVRAISFCHK---LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~--~~~~~~i~~~~~ql~~al~~LH~---~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
||+.+++|.+++..... .++...++.++.|+++||.+||+ +||+|+||+|+||+++.+...++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999999976542 37899999999999999999999 89999999999999977744589999999875533
Q ss_pred CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
. .....++..|+|||.+.+..++. ++||||||+++|+|++|+.||.....
T Consensus 159 ~--~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~ 208 (307)
T 2eva_A 159 H--MTNNKGSAAWMAPEVFEGSNYSE-KCDVFSWGIILWEVITRRKPFDEIGG 208 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCT-HHHHHHHHHHHHHHHHTCCTTTTTCS
T ss_pred c--cccCCCCCceEChhhhCCCCCCc-HHHHHHHHHHHHHHHHCCCCchhhCc
Confidence 2 23345788999999998877775 99999999999999999999986543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=265.58 Aligned_cols=220 Identities=26% Similarity=0.330 Sum_probs=181.3
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
..--.++|++.+.||+|++|.||+|.+. ..+++|++............+.+|+.+++.++||||+++++++.+....
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~---~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEES---SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEc---CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3445679999999999999999999854 3599999987655555556677899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++||++.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++ + +.++|+|||++......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~-~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-N-GKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC-----
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-C-CCEEEeecCCccccccc
Confidence 999999999999999987776799999999999999999999999999999999999996 3 68999999987654211
Q ss_pred ------CccccccCCCccCCcccccCC--------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 173 ------QKLETSCGSLAYSAPEILLGD--------SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 173 ------~~~~~~~~~~~~~apE~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
.......++..|+|||.+... ...+.++||||||+++|+|++|+.||...........+.....+
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC
Confidence 122233467889999998642 22234999999999999999999999988888877777655443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=271.86 Aligned_cols=230 Identities=27% Similarity=0.452 Sum_probs=190.8
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
..-.++|++.+.||+|+||.||+|.+. .+..|+||.+.... .....+.+|+.+++.++||||+++++++. ....+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 344578999999999999999999875 56789999987543 34678899999999999999999999986 56689
Q ss_pred EEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 94 LILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+||||+.+++|.+++... ...++...++.++.||+.||.|||+++|+|+||+|+||+++.+ +.++|+|||++......
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTT-CCEEECSTTGGGGBCCH
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCC-CcEEEeeCCCceEcCCC
Confidence 999999999999999754 2348899999999999999999999999999999999999766 78999999999765432
Q ss_pred Ccc--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc-----------
Q psy3663 173 QKL--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS----------- 238 (259)
Q Consensus 173 ~~~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~----------- 238 (259)
... ....++..|+|||.+....++. ++||||||+++|+|++ |+.||.+.+..+....+.+....+
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 416 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 416 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred ceeccCCCcccccccCHHHhccCCCCc-HHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 211 1223456899999998777765 9999999999999999 999999988888888777654322
Q ss_pred -cccccccCchhh
Q psy3663 239 -CTCWWRGRPRSR 250 (259)
Q Consensus 239 -~~~~~~~~~~~~ 250 (259)
...+|..+|.+|
T Consensus 417 li~~cl~~dp~~R 429 (454)
T 1qcf_A 417 IMMRCWKNRPEER 429 (454)
T ss_dssp HHHHHTCSSGGGS
T ss_pred HHHHHccCChhHC
Confidence 234666777665
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=260.52 Aligned_cols=199 Identities=25% Similarity=0.450 Sum_probs=165.1
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHh--CCCCCeEEEEEEEec---
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKL--VQHPNVVRLYEVIDT--- 88 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~--- 88 (259)
..+.++|++.+.||+|++|.||+|.+ +++.|++|++... ......+|.+++.. ++||||+++++++.+
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 35778999999999999999999985 6889999998643 34555667777776 789999999998643
Q ss_pred -CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEeccCCCCCeEeeecCCeEE
Q psy3663 89 -NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH--------KLHVVHRDLKPENVVFFERLGVVK 159 (259)
Q Consensus 89 -~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH--------~~~i~H~dl~p~nIlv~~~~~~i~ 159 (259)
....+++|||+.+++|.+++... .+++..++.++.||+.||.+|| +.||+|+||||+||+++.+ +.++
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~-~~~k 153 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCC 153 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT-SCEE
T ss_pred CCceeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC-CCEE
Confidence 35689999999999999999543 4899999999999999999999 9999999999999999766 7899
Q ss_pred EEeccccccCCCCCcc-----ccccCCCccCCcccccCCCCC-----CCchhHHHHHHHHHHHHhC----------CCCC
Q psy3663 160 LTDFGFSNRFNPGQKL-----ETSCGSLAYSAPEILLGDSYD-----APAVDVWSLGVILYMLVAG----------QAPF 219 (259)
Q Consensus 160 l~df~~~~~~~~~~~~-----~~~~~~~~~~apE~~~~~~~~-----~~~~Di~slG~~l~~l~~g----------~~pf 219 (259)
|+|||++......... ....++..|+|||.+.+.... +.++||||||+++|+|++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 9999998654433222 223678999999999776322 1389999999999999999 8999
Q ss_pred CCC
Q psy3663 220 QEA 222 (259)
Q Consensus 220 ~~~ 222 (259)
...
T Consensus 234 ~~~ 236 (301)
T 3q4u_A 234 YDV 236 (301)
T ss_dssp TTT
T ss_pred ccc
Confidence 653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=279.27 Aligned_cols=231 Identities=26% Similarity=0.438 Sum_probs=191.1
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
....++|++.+.||+|+||.||+|.+. .+..|+||++.... .....+.+|+.+++.++|+||+++++++.+ ...+
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ecchhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 345678999999999999999999976 45679999997644 235678999999999999999999999876 6689
Q ss_pred EEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 94 LILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+||||+.+++|.+++... ...+++..++.++.||+.||.|||+++|+|+||+|+||+++.+ +.++|+|||++......
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCTTSTTTCCCH
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCC-CcEEEcccccceecCCC
Confidence 999999999999999754 3458999999999999999999999999999999999999766 78999999998765432
Q ss_pred Cc--cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccc------------
Q psy3663 173 QK--LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSES------------ 237 (259)
Q Consensus 173 ~~--~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~------------ 237 (259)
.. .....++..|+|||.+....++. ++||||||+++|+|++ |+.||.+....+.+..+.+....
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 495 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 495 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ceecccCCcCcccccCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11 11223456899999998777765 9999999999999999 99999998888888887765332
Q ss_pred ccccccccCchhhh
Q psy3663 238 SCTCWWRGRPRSRR 251 (259)
Q Consensus 238 ~~~~~~~~~~~~~~ 251 (259)
....+|..+|.+|.
T Consensus 496 li~~cl~~dP~~RP 509 (535)
T 2h8h_A 496 LMCQCWRKEPEERP 509 (535)
T ss_dssp HHHHHTCSSGGGSC
T ss_pred HHHHHcCCChhHCc
Confidence 23456777776653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=267.57 Aligned_cols=202 Identities=19% Similarity=0.268 Sum_probs=164.2
Q ss_pred ccCeeEeeeecccccceEEEEEEee---cCceEEEEEcccCCCCc---------ccHHHHHHHHHHHHhCCCCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDP---------VSQDHLYQEVRCMKLVQHPNVVRLYE 84 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~---~~~~~~lK~~~~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (259)
.++|++.+.||+|++|.||+|.+.. ++..+++|.+....... .....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3589999999999999999999887 78899999987653211 11233557788899999999999999
Q ss_pred EEec----CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC-CeEE
Q psy3663 85 VIDT----NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL-GVVK 159 (259)
Q Consensus 85 ~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~-~~i~ 159 (259)
++.+ ....+++||++ +++|.+++.... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+. +.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9877 67899999999 889999987665 599999999999999999999999999999999999997662 2899
Q ss_pred EEeccccccCCCCC--------ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 160 LTDFGFSNRFNPGQ--------KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 160 l~df~~~~~~~~~~--------~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
|+|||++....... ......++..|+|||.+.+..++. ++||||||+++|+|++|+.||..
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR-RSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCccc
Confidence 99999997653221 113446889999999998877765 99999999999999999999954
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=285.52 Aligned_cols=216 Identities=34% Similarity=0.581 Sum_probs=177.0
Q ss_pred CCCCCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEE
Q psy3663 6 SRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV 85 (259)
Q Consensus 6 ~~~~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (259)
+++....++...++|++.+.||.|++|.||+|.+..++..|++|++... ........+.+|+.+++.++||||++++++
T Consensus 2 GG~~p~~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v 80 (676)
T 3qa8_A 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREV 80 (676)
T ss_dssp ---------------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEEC
T ss_pred CCCCCCCCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeee
Confidence 3455566777889999999999999999999999989999999998754 244456778899999999999999999999
Q ss_pred Eec------CCeEEEEEeccCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC-
Q psy3663 86 IDT------NSKLYLILELGDGGDLYDYIMKHD--AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG- 156 (259)
Q Consensus 86 ~~~------~~~~~lv~e~~~~~sL~~~~~~~~--~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~- 156 (259)
+.. .+..++||||+.+++|.+++.... ..+++..++.++.||+.||.+||+.||+|+||+|+||+++.+.+
T Consensus 81 ~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~ 160 (676)
T 3qa8_A 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQR 160 (676)
T ss_dssp CTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSS
T ss_pred ecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCc
Confidence 755 677899999999999999998654 25899999999999999999999999999999999999976522
Q ss_pred -eEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy3663 157 -VVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN 223 (259)
Q Consensus 157 -~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 223 (259)
.++|+|||.+.............++..|+|||.+.+..++. ++|+||||+++|+|++|..||....
T Consensus 161 ~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~-ksDIwSLGviLyeLltG~~Pf~~~~ 227 (676)
T 3qa8_A 161 LIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTV-TVDYWSFGTLAFECITGFRPFLPNW 227 (676)
T ss_dssp CEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCST-THHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred eeEEEcccccccccccccccccccCCcccCChHHhccCCCCc-hhHHHHHHHHHHHHHHCCCCCCccc
Confidence 48999999998876665556667899999999998877775 9999999999999999999997653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=269.02 Aligned_cols=202 Identities=20% Similarity=0.231 Sum_probs=155.4
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhC--CCCCeEEEE-------EEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLV--QHPNVVRLY-------EVI 86 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l--~~~~i~~~~-------~~~ 86 (259)
...|++.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3469999999999999999999999999999999987654 233456677775444444 699988755 444
Q ss_pred ecC-----------------CeEEEEEeccCCCChHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHHCCcEecc
Q psy3663 87 DTN-----------------SKLYLILELGDGGDLYDYIMKHDAGLSETYA------REYFAQIVRAISFCHKLHVVHRD 143 (259)
Q Consensus 87 ~~~-----------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i------~~~~~ql~~al~~LH~~~i~H~d 143 (259)
... ..+++||||+. ++|.+++......++...+ +.++.||+.||.|||++||+|+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 322 34899999998 6999999876444555555 67779999999999999999999
Q ss_pred CCCCCeEeeecCCeEEEEeccccccCCCCCccccccCCCccCCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLG--DSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 144 l~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
|||+||+++.+ +.++|+|||++...... .....++..|+|||.+.+ ..++ .++||||||+++|+|++|+.||..
T Consensus 220 ikp~NIll~~~-~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPD-GRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFT-HALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTT-SCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCC-CCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcC-ccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999766 78999999999866432 223445689999999976 4565 499999999999999999999977
Q ss_pred CC
Q psy3663 222 AN 223 (259)
Q Consensus 222 ~~ 223 (259)
..
T Consensus 296 ~~ 297 (371)
T 3q60_A 296 VT 297 (371)
T ss_dssp CC
T ss_pred cC
Confidence 63
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=263.87 Aligned_cols=211 Identities=34% Similarity=0.534 Sum_probs=167.0
Q ss_pred CCCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc----ccHHHHHHHHHHHHhC----CCCCeE
Q psy3663 9 SDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP----VSQDHLYQEVRCMKLV----QHPNVV 80 (259)
Q Consensus 9 ~~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~----~~~~~~~~e~~~l~~l----~~~~i~ 80 (259)
...+...+.++|++.+.||+|++|.||+|.+..+++.|++|++....... .....+.+|+.++.++ +|+||+
T Consensus 22 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~ 101 (312)
T 2iwi_A 22 GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101 (312)
T ss_dssp -----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred CccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence 34456778899999999999999999999999899999999997654322 1223445688888888 899999
Q ss_pred EEEEEEecCCeEEEEEec-cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEE
Q psy3663 81 RLYEVIDTNSKLYLILEL-GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVK 159 (259)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~-~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~ 159 (259)
++++++.+.+..++++++ +.+++|.+++..... +++..++.++.||+.||.+||++||+|+||+|+||+++.+.+.++
T Consensus 102 ~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~-~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp CEEEEC-----CEEEEECCSSEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEE
T ss_pred eEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEE
Confidence 999999988889999999 778899999987554 999999999999999999999999999999999999974558999
Q ss_pred EEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 160 LTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 160 l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
|+|||++...... ......++..|+|||.+.+......++|+||||+++|+|++|+.||..
T Consensus 181 l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 181 LIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp ECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 9999998776543 334456788999999987766654589999999999999999999964
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=262.34 Aligned_cols=209 Identities=31% Similarity=0.520 Sum_probs=177.0
Q ss_pred CCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc----cHHHHHHHHHHHHhCC--CCCeEEEEE
Q psy3663 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV----SQDHLYQEVRCMKLVQ--HPNVVRLYE 84 (259)
Q Consensus 11 ~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~----~~~~~~~e~~~l~~l~--~~~i~~~~~ 84 (259)
.....+.++|++.+.||+|++|.||+|.+..++..|++|.+........ ....+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 3445678899999999999999999999999999999999976543321 2244567899999997 599999999
Q ss_pred EEecCCeEEEEEeccCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEec
Q psy3663 85 VIDTNSKLYLILELGDG-GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDF 163 (259)
Q Consensus 85 ~~~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df 163 (259)
++.+.+..++++|++.+ ++|.+++.... .+++..++.++.||+.||.+||++||+|+||+|+||+++.+.+.++|+||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999999999975 79999987754 48999999999999999999999999999999999999755589999999
Q ss_pred cccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 164 GFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
|++...... ......++..|+|||.+.+....+.++|+||||+++|+|++|+.||..
T Consensus 195 g~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 195 GSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp TTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 998776533 333456788999999987766655589999999999999999999965
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=260.63 Aligned_cols=202 Identities=27% Similarity=0.402 Sum_probs=169.0
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEe----cCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVID----TNSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~ 92 (259)
.++|++.+.||+|++|.||+|.+..+++.|++|++.... ......+.+|+.+++.++||||+++++++. .....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 358999999999999999999999999999999986532 345677889999999999999999999986 34578
Q ss_pred EEEEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 93 YLILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
+++||++.+++|.+++... ...+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||.+...
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~-~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCSSCEES
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCC-CCEEEEecCcchhc
Confidence 9999999999999998763 5569999999999999999999999999999999999999766 78999999987654
Q ss_pred CCCCcc----------ccccCCCccCCcccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 170 NPGQKL----------ETSCGSLAYSAPEILLGDSY--DAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 170 ~~~~~~----------~~~~~~~~~~apE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
...... ....++..|+|||.+.+... .+.++||||||+++|+|++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 321111 12235788999999876542 23499999999999999999999953
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=260.95 Aligned_cols=207 Identities=32% Similarity=0.544 Sum_probs=151.5
Q ss_pred CCccccCeeEee-eecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec---
Q psy3663 13 PTKIAGLYDLEE-TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT--- 88 (259)
Q Consensus 13 ~~~~~~~y~~~~-~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 88 (259)
...+.++|++.+ .||+|++|.||+|.+..+++.|++|++... .....+....++.++||||+++++++..
T Consensus 23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 356788999965 699999999999999999999999998642 2223333445677789999999999865
Q ss_pred -CCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCeEEEEecc
Q psy3663 89 -NSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTDFG 164 (259)
Q Consensus 89 -~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~i~l~df~ 164 (259)
....++||||+.+++|.+++.... ..+++..++.++.||+.||.+||++||+|+||+|+||++..+ .+.++|+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 456899999999999999998764 359999999999999999999999999999999999999753 3469999999
Q ss_pred ccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH
Q psy3663 165 FSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET 227 (259)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 227 (259)
++..... .......++..|+|||.+.+..++. ++|+||||+++|+|++|..||........
T Consensus 177 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 177 FAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp TCEEC-----------------------CHHHH-HHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cceeccc-cccccCCCCcCccChhhhCCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 9876543 2334456788999999997777765 99999999999999999999977665443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=269.69 Aligned_cols=218 Identities=26% Similarity=0.414 Sum_probs=162.6
Q ss_pred CCCCCCCCCCCCCC----ccc--cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC
Q psy3663 1 MSRSGSRSSDGHPT----KIA--GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74 (259)
Q Consensus 1 ~~~~~~~~~~~~~~----~~~--~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l 74 (259)
||++.+..++.... ... .+|++.+.||+|++|.||. ....+++.|+||.+..... ..+.+|+.+++.+
T Consensus 1 M~ss~s~~~~~~~~~~~~~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l 74 (432)
T 3p23_A 1 MGSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRES 74 (432)
T ss_dssp -----------------CEEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHS
T ss_pred CCCCcccccCcCcccCCcEEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhc
Confidence 77777644333321 122 3699999999999999764 3446889999999865432 2345899999999
Q ss_pred -CCCCeEEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee
Q psy3663 75 -QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE 153 (259)
Q Consensus 75 -~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~ 153 (259)
+||||+++++++.+....+++||++.+ +|.+++.......++..++.++.||+.||.|||++||+|+||||+||++..
T Consensus 75 ~~HpnIv~l~~~~~~~~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~ 153 (432)
T 3p23_A 75 DEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM 153 (432)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECC
T ss_pred cCCCCcCeEEEEEecCCEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEec
Confidence 799999999999999999999999976 999999877666677778899999999999999999999999999999953
Q ss_pred c----CCeEEEEeccccccCCCCC----ccccccCCCccCCcccccC---CCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q psy3663 154 R----LGVVKLTDFGFSNRFNPGQ----KLETSCGSLAYSAPEILLG---DSYDAPAVDVWSLGVILYMLVA-GQAPFQE 221 (259)
Q Consensus 154 ~----~~~i~l~df~~~~~~~~~~----~~~~~~~~~~~~apE~~~~---~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 221 (259)
+ ...++|+|||++....... ......++..|+|||++.+ ..++ .++|||||||++|+|++ |.+||..
T Consensus 154 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t-~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp CBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCC-THHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred CCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCC-cHHHHHHHHHHHHHHHcCCCCCcch
Confidence 2 1258899999997665332 2234568999999999974 3344 49999999999999999 9999976
Q ss_pred CCChH
Q psy3663 222 ANDSE 226 (259)
Q Consensus 222 ~~~~~ 226 (259)
.....
T Consensus 233 ~~~~~ 237 (432)
T 3p23_A 233 SLQRQ 237 (432)
T ss_dssp TTTHH
T ss_pred hhHHH
Confidence 54433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=258.72 Aligned_cols=201 Identities=27% Similarity=0.380 Sum_probs=170.2
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCC--CCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK--LDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
|...+.||+|++|.||+|.+ ++..|++|.+.... ........+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44458999999999999984 68899999987543 223346778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-
Q psy3663 98 LGDGGDLYDYIMKH--DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK- 174 (259)
Q Consensus 98 ~~~~~sL~~~~~~~--~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~- 174 (259)
++.+++|.+++... ..++++..++.++.||+.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~-~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA-FTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECCSCSSC
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCC-CcEEEeeccccccccccccc
Confidence 99999999998743 3458999999999999999999999999999999999999766 7899999999876543222
Q ss_pred --cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCh
Q psy3663 175 --LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDS 225 (259)
Q Consensus 175 --~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 225 (259)
.....++..|+|||.+.+. ++ .++|+||||+++|+|++|.+||......
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~-~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGE-IT-PKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTE-EC-THHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred ccccccCCCcCcCChHHhcCC-CC-ccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 2234578899999988653 44 4999999999999999999999876543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=265.03 Aligned_cols=197 Identities=20% Similarity=0.264 Sum_probs=167.3
Q ss_pred ccCeeEeeeecccccceEEEEEEee--------cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEE-------
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVF--------TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVR------- 81 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~--------~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~------- 81 (259)
.++|++.+.||+|++|.||+|.+.. .+..|++|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 4799999999999999999999887 4889999998654 35778999999999988876
Q ss_pred --------EEEEEec-CCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEe
Q psy3663 82 --------LYEVIDT-NSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVF 151 (259)
Q Consensus 82 --------~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv 151 (259)
+++++.. ....+++|||+ +++|.+++... ...+++..++.++.||+.||.+||++||+|+||+|+||++
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 5666654 68899999999 88999999875 3559999999999999999999999999999999999999
Q ss_pred eecCC--eEEEEeccccccCCCCCc--------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 152 FERLG--VVKLTDFGFSNRFNPGQK--------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 152 ~~~~~--~i~l~df~~~~~~~~~~~--------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
+.+ + .++|+|||++........ .....++..|+|||.+.+..++. ++|+||||+++|+|++|+.||..
T Consensus 193 ~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 193 DPE-DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR-RSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp ETT-EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSCCTTGG
T ss_pred cCC-CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCccc
Confidence 766 5 899999999976543211 12336788999999998877765 99999999999999999999987
Q ss_pred CC
Q psy3663 222 AN 223 (259)
Q Consensus 222 ~~ 223 (259)
..
T Consensus 271 ~~ 272 (352)
T 2jii_A 271 CL 272 (352)
T ss_dssp GT
T ss_pred CC
Confidence 64
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=265.02 Aligned_cols=223 Identities=24% Similarity=0.480 Sum_probs=185.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-----------CCCeEEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-----------HPNVVRLYEV 85 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~ 85 (259)
.++|++.+.||+|++|.||+|.+..+++.|++|++... ......+.+|+.++++++ |+||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 46899999999999999999999999999999998643 234566788999888886 7899999999
Q ss_pred EecCC----eEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCCCCeEeeec-----
Q psy3663 86 IDTNS----KLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKL-HVVHRDLKPENVVFFER----- 154 (259)
Q Consensus 86 ~~~~~----~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~-~i~H~dl~p~nIlv~~~----- 154 (259)
+...+ .++++||++ +++|.+++... ...+++..++.++.||+.||.+||++ ||+|+||+|+||++..+
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 87543 789999999 77999999874 34599999999999999999999998 99999999999999643
Q ss_pred CCeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------ChHHH
Q psy3663 155 LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN------DSETL 228 (259)
Q Consensus 155 ~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~ 228 (259)
.+.++|+|||++..... ......++..|+|||.+.+..++. ++||||||+++|+|++|+.||.... ..+.+
T Consensus 174 ~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGC-GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCT-HHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 23799999999876543 233446788999999998887765 9999999999999999999998654 55678
Q ss_pred HHhhhccccccccccccC
Q psy3663 229 TMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 229 ~~i~~~~~~~~~~~~~~~ 246 (259)
..+.+..+..+..+|...
T Consensus 251 ~~~~~~~~~~p~~~~~~~ 268 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNG 268 (373)
T ss_dssp HHHHHHHCSCCHHHHHHC
T ss_pred HHHHHhcCCCCHHHHhcc
Confidence 888888888877766543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=261.40 Aligned_cols=200 Identities=27% Similarity=0.468 Sum_probs=164.4
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC--CCCCeEEEEEEEecC-
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV--QHPNVVRLYEVIDTN- 89 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~~- 89 (259)
...+.++|++.+.||+|++|.||+|.+ .++.|++|++.... ......|.+++... +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 345668999999999999999999985 48899999985432 34444555555554 899999999998776
Q ss_pred ---CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CcEeccCCCCCeEeeecCCeE
Q psy3663 90 ---SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL--------HVVHRDLKPENVVFFERLGVV 158 (259)
Q Consensus 90 ---~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~--------~i~H~dl~p~nIlv~~~~~~i 158 (259)
...+++|||+.+++|.+++... .+++..++.++.|++.||.+||+. ||+|+||||+||+++.+ +.+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~-~~~ 181 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTC 181 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT-SCE
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC-CCE
Confidence 7899999999999999999764 489999999999999999999998 99999999999999766 789
Q ss_pred EEEeccccccCCCCCcc-----ccccCCCccCCcccccCCCCCCC-----chhHHHHHHHHHHHHhC----------CCC
Q psy3663 159 KLTDFGFSNRFNPGQKL-----ETSCGSLAYSAPEILLGDSYDAP-----AVDVWSLGVILYMLVAG----------QAP 218 (259)
Q Consensus 159 ~l~df~~~~~~~~~~~~-----~~~~~~~~~~apE~~~~~~~~~~-----~~Di~slG~~l~~l~~g----------~~p 218 (259)
+|+|||++......... ....++..|+|||.+.+...... ++||||||+++|+|++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999998665433222 23468899999999987766642 39999999999999999 778
Q ss_pred CCCC
Q psy3663 219 FQEA 222 (259)
Q Consensus 219 f~~~ 222 (259)
|...
T Consensus 262 ~~~~ 265 (337)
T 3mdy_A 262 YHDL 265 (337)
T ss_dssp TTTT
T ss_pred Hhhh
Confidence 8653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=257.90 Aligned_cols=202 Identities=29% Similarity=0.457 Sum_probs=173.1
Q ss_pred cccCeeEeeeecccccceEEEEE----EeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC--
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLAR----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN-- 89 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~----~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 89 (259)
..++|++.+.||+|++|.||+|. +..+++.|++|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 34579999999999999999998 4568899999998754 234567788999999999999999999998654
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
...+++||++.+++|.+++......+++..++.++.||+.||.+||++|++|+||+|+||+++.+ +.++|+|||++...
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~-~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-NRVKIGDFGLTKVL 195 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEEC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCC-CcEEEecCcchhhc
Confidence 36899999999999999998877779999999999999999999999999999999999999777 79999999999776
Q ss_pred CCCCcc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 170 NPGQKL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 170 ~~~~~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
...... ....++..|+|||.+.+..++. ++|+||||+++++|++|..||..
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHHTTCGGGS
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCc-hhhHHHHHHHHHHHHhcCCCCCC
Confidence 543321 2223556799999998777664 99999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=254.42 Aligned_cols=209 Identities=27% Similarity=0.514 Sum_probs=172.4
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC--CCCeEEEEEEEe
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ--HPNVVRLYEVID 87 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~ 87 (259)
-+......++|++.+.||+|++|.||+|.+. ++..|++|++............+.+|+.++++++ |+||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 3344455678999999999999999999986 5889999999876655566788899999999997 599999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
+....+++||+. +++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||++. + +.++|+|||++.
T Consensus 99 ~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 99 TDQYIYMVMECG-NIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-D-GMLKLIDFGIAN 174 (313)
T ss_dssp CSSEEEEEECCC-SEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-T-TEEEECCCSSSC
T ss_pred cCCEEEEEEecC-CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-C-CeEEEeeccccc
Confidence 999999999955 669999998765 489999999999999999999999999999999999994 4 789999999987
Q ss_pred cCCCCCc---cccccCCCccCCcccccC-----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy3663 168 RFNPGQK---LETSCGSLAYSAPEILLG-----------DSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224 (259)
Q Consensus 168 ~~~~~~~---~~~~~~~~~~~apE~~~~-----------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 224 (259)
....... .....++..|+|||.+.+ ..++ .++|+||||+++|+|++|+.||.....
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~ 244 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIIN 244 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCC-HHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCC-chHHHHHHHHHHHHHHhCCCchhhHHH
Confidence 6543322 123457889999999865 2343 499999999999999999999976544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=255.51 Aligned_cols=197 Identities=23% Similarity=0.459 Sum_probs=168.0
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHh--CCCCCeEEEEEEEecCC---
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKL--VQHPNVVRLYEVIDTNS--- 90 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~--- 90 (259)
+.++|++.+.||+|++|.||+|.+ +++.|++|++... ....+.+|.+++.. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 457999999999999999999986 5889999998543 34667788888887 68999999999998765
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcEeccCCCCCeEeeecCCeEEEE
Q psy3663 91 -KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH--------KLHVVHRDLKPENVVFFERLGVVKLT 161 (259)
Q Consensus 91 -~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH--------~~~i~H~dl~p~nIlv~~~~~~i~l~ 161 (259)
..+++|||+.+++|.+++... .+++..++.++.||+.||.+|| +.||+|+||+|+||+++.+ +.++|+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~-~~~kL~ 189 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIA 189 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTT-SCEEEC
T ss_pred ceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCC-CCEEEE
Confidence 799999999999999999764 4899999999999999999999 8999999999999999766 789999
Q ss_pred eccccccCCCCCc-----cccccCCCccCCcccccCCCCCC-----CchhHHHHHHHHHHHHhC----------CCCCCC
Q psy3663 162 DFGFSNRFNPGQK-----LETSCGSLAYSAPEILLGDSYDA-----PAVDVWSLGVILYMLVAG----------QAPFQE 221 (259)
Q Consensus 162 df~~~~~~~~~~~-----~~~~~~~~~~~apE~~~~~~~~~-----~~~Di~slG~~l~~l~~g----------~~pf~~ 221 (259)
|||++........ .....++..|+|||.+.+..... .++||||||+++|+|++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 9999876544332 23346788999999987653321 389999999999999999 889976
Q ss_pred C
Q psy3663 222 A 222 (259)
Q Consensus 222 ~ 222 (259)
.
T Consensus 270 ~ 270 (342)
T 1b6c_B 270 L 270 (342)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=273.91 Aligned_cols=219 Identities=24% Similarity=0.396 Sum_probs=183.0
Q ss_pred ccccCeeEeeeecccccceEEEEEEeec---CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFT---GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~---~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
...++|++.+.||+|+||.||+|.+... +..+++|.+.... .......+.+|+.+++.++||||+++++++.+ +.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 464 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NP 464 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-Cc
Confidence 3457899999999999999999997644 3479999886532 33445778899999999999999999999854 56
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~ 171 (259)
.++||||+.+++|.+++......+++..++.++.||+.||.+||++||+|+||+|+||+++.+ +.++|+|||++.....
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~-~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMED 543 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECCCCCCCSCCC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCC-CCEEEEecCCCeecCC
Confidence 889999999999999998777679999999999999999999999999999999999999777 8999999999876643
Q ss_pred CCcc--ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccc
Q psy3663 172 GQKL--ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 172 ~~~~--~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
.... ....++..|+|||.+.+..++. ++||||||+++|+|++ |..||.+....+....+.+....
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~ 611 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 611 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCc-hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 3222 2234557899999998777765 9999999999999997 99999999888888888766543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=251.52 Aligned_cols=180 Identities=20% Similarity=0.171 Sum_probs=155.8
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
+.++|++.+.||+|++|.||+|.+..+++.|+||++...... ......+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 568899999999999999999999988999999999865432 3345778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||||+.|++|.+++... ....++..++.||+.||.+||++||+|+||||+||+++.+ +.++|++++.
T Consensus 109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~-g~~kl~~~~~--------- 175 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPAT--------- 175 (286)
T ss_dssp EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT-SCEEECSCCC---------
T ss_pred EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC-CCEEEEeccc---------
Confidence 99999999999998542 4667889999999999999999999999999999999766 7888875432
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (259)
++| ++ .++||||||+++|+|++|+.||...+..+
T Consensus 176 ----------~~~-------~~-~~~Di~slG~il~elltg~~Pf~~~~~~~ 209 (286)
T 3uqc_A 176 ----------MPD-------AN-PQDDIRGIGASLYALLVNRWPLPEAGVRS 209 (286)
T ss_dssp ----------CTT-------CC-HHHHHHHHHHHHHHHHHSEECSCCCSBCC
T ss_pred ----------cCC-------CC-chhHHHHHHHHHHHHHHCCCCCCcCCcch
Confidence 221 33 49999999999999999999998766543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=278.15 Aligned_cols=196 Identities=26% Similarity=0.413 Sum_probs=167.3
Q ss_pred ccccCeeEeeeecccccceEEEEEEee-cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe--
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK-- 91 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~-~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 91 (259)
.+.++|++.+.||+|++|.||+|.+.. +++.|+||.+.... .......+.+|+.++.+++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 456899999999999999999999976 68899999986542 33445677899999999999999999999976554
Q ss_pred ---EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 92 ---LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 92 ---~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.++||||+.+++|.+++.. .+++..++.++.||+.+|.|||++||+|+||||+||+++.+ .++|+|||++..
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~ 230 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSR 230 (681)
T ss_dssp CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEE
T ss_pred CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchh
Confidence 7999999999999987654 58999999999999999999999999999999999999664 799999999876
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
.... ....++..|+|||.+.+.. +.++||||||+++++|++|.+||..
T Consensus 231 ~~~~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 231 INSF---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TTCC---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred cccC---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcc
Confidence 6443 3446889999999987654 3599999999999999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=259.25 Aligned_cols=198 Identities=25% Similarity=0.413 Sum_probs=158.3
Q ss_pred CCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHH--HHhCCCCCeEEEEEEEe--
Q psy3663 12 HPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC--MKLVQHPNVVRLYEVID-- 87 (259)
Q Consensus 12 ~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~--l~~l~~~~i~~~~~~~~-- 87 (259)
.+.--.++|++.+.||+|++|.||+|. .+++.|++|++.... ......|.++ +..++||||+++++.+.
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEE--ETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCCcChHHhheeeecccCCCeEEEEEE--ECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 345567899999999999999999997 478999999986432 3334444444 44588999999997543
Q ss_pred ---cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CcEeccCCCCCeEeeecC
Q psy3663 88 ---TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL---------HVVHRDLKPENVVFFERL 155 (259)
Q Consensus 88 ---~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~---------~i~H~dl~p~nIlv~~~~ 155 (259)
....+++||||+.+++|.+++.... .++..++.++.||+.||.+||+. ||+|+||||+||+++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~- 156 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND- 156 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT-
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC-
Confidence 2346789999999999999997655 58899999999999999999999 99999999999999766
Q ss_pred CeEEEEeccccccCCCCC---------ccccccCCCccCCcccccCC-------CCCCCchhHHHHHHHHHHHHhCCCCC
Q psy3663 156 GVVKLTDFGFSNRFNPGQ---------KLETSCGSLAYSAPEILLGD-------SYDAPAVDVWSLGVILYMLVAGQAPF 219 (259)
Q Consensus 156 ~~i~l~df~~~~~~~~~~---------~~~~~~~~~~~~apE~~~~~-------~~~~~~~Di~slG~~l~~l~~g~~pf 219 (259)
+.++|+|||++....... ......++..|+|||.+.+. .++ .++||||||+++|+|++|..||
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESAL-KQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHH-HHHHHHHHHHHHHHHHTTBGGG
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccc-cccchHHHHHHHHHHHhcCCcC
Confidence 789999999997654321 11233588999999999763 222 3899999999999999997766
Q ss_pred C
Q psy3663 220 Q 220 (259)
Q Consensus 220 ~ 220 (259)
.
T Consensus 236 ~ 236 (336)
T 3g2f_A 236 F 236 (336)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=245.35 Aligned_cols=191 Identities=31% Similarity=0.543 Sum_probs=159.7
Q ss_pred CCCCCCCCccccCeeEe-eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHH-HhCCCCCeEEEEE
Q psy3663 7 RSSDGHPTKIAGLYDLE-ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM-KLVQHPNVVRLYE 84 (259)
Q Consensus 7 ~~~~~~~~~~~~~y~~~-~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~ 84 (259)
...+-..+.+.++|.+. +.||+|++|.||+|.+..+++.|++|++.. .....+|+.++ +..+||||+++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~ 78 (299)
T 3m2w_A 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVD 78 (299)
T ss_dssp CCCCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred ccccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHh
Confidence 34455677888999998 789999999999999999999999999853 24566788877 6668999999999
Q ss_pred EEec----CCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCe
Q psy3663 85 VIDT----NSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGV 157 (259)
Q Consensus 85 ~~~~----~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~ 157 (259)
++.. ....+++|||+.+++|.+++.... ..+++..++.++.||+.||.+||++||+|+||+|+||+++.+ .+.
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~ 158 (299)
T 3m2w_A 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 158 (299)
T ss_dssp EEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC
T ss_pred hhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCc
Confidence 9876 677999999999999999998764 459999999999999999999999999999999999999763 478
Q ss_pred EEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH
Q psy3663 158 VKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226 (259)
Q Consensus 158 i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (259)
++|+|||++..... ..++ .++|+||||+++|+|++|+.||.......
T Consensus 159 ~kl~Dfg~a~~~~~---------------------~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~ 205 (299)
T 3m2w_A 159 LKLTDFGFAKETTG---------------------EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLA 205 (299)
T ss_dssp EEECCCTTCEECTT---------------------CGGG-GHHHHHHHHHHHHHHHHSSCSCCC-----
T ss_pred EEEecccccccccc---------------------ccCC-chhhHHHHHHHHHHHHHCCCCCCCCcchh
Confidence 99999998764331 2233 49999999999999999999997655443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-35 Score=253.25 Aligned_cols=208 Identities=28% Similarity=0.487 Sum_probs=163.3
Q ss_pred CCCCCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEec
Q psy3663 10 DGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDT 88 (259)
Q Consensus 10 ~~~~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (259)
+.....+.+.|.+.+.||+|++|.||.+. ..+|+.||||.+... ....+.+|+.+++++ +||||+++++++.+
T Consensus 7 p~~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~ 80 (434)
T 2rio_A 7 PNFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT 80 (434)
T ss_dssp -CCSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred cchhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec
Confidence 34456677888999999999999998754 457999999998653 245677899999876 79999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--------
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHDAG------LSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER-------- 154 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~~~------~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~-------- 154 (259)
....+++||++.+ +|.+++...... .++..++.++.||+.||.+||++||+|+||||+||+++.+
T Consensus 81 ~~~~~lv~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 81 DRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp SSEEEEEECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT
T ss_pred CCeEEEEEecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc
Confidence 9999999999975 999999765421 1233457899999999999999999999999999999653
Q ss_pred ----CCeEEEEeccccccCCCCCc-----cccccCCCccCCcccccC-------CCCCCCchhHHHHHHHHHHHHh-CCC
Q psy3663 155 ----LGVVKLTDFGFSNRFNPGQK-----LETSCGSLAYSAPEILLG-------DSYDAPAVDVWSLGVILYMLVA-GQA 217 (259)
Q Consensus 155 ----~~~i~l~df~~~~~~~~~~~-----~~~~~~~~~~~apE~~~~-------~~~~~~~~Di~slG~~l~~l~~-g~~ 217 (259)
...++|+|||++........ .....++..|+|||++.+ ..++ .++|||||||++|+|++ |..
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT-RSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCC-THHHHHHHHHHHHHHHTTSCC
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcc-hhhhhHhHHHHHHHHHhCCCC
Confidence 24899999999987654322 223468899999999865 3344 59999999999999999 999
Q ss_pred CCCCCCCh
Q psy3663 218 PFQEANDS 225 (259)
Q Consensus 218 pf~~~~~~ 225 (259)
||......
T Consensus 239 Pf~~~~~~ 246 (434)
T 2rio_A 239 PFGDKYSR 246 (434)
T ss_dssp TTCSTTTH
T ss_pred CCCCchhh
Confidence 99765543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=258.07 Aligned_cols=228 Identities=19% Similarity=0.202 Sum_probs=167.9
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCC-CCcccHHHHHHHHHHHHhCCC-CC---------eEE-----
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLVQH-PN---------VVR----- 81 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~-~~~~~~~~~~~e~~~l~~l~~-~~---------i~~----- 81 (259)
..|+..+.||+|+||.||+|.+..+|+.|+||++.... ........+.+|+.+++.++| .+ ++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45889999999999999999999999999999987433 233346778899999999976 21 111
Q ss_pred -------EEEEEec-----CCeEEEEEeccCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Q psy3663 82 -------LYEVIDT-----NSKLYLILELGDGGDLYDYIMKH------DAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143 (259)
Q Consensus 82 -------~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~d 143 (259)
+...+.. ...++++|+... ++|.+++... ...+++..++.++.||+.||.|||++||+|+|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 234678888875 5999988522 33467888999999999999999999999999
Q ss_pred CCCCCeEeeecCCeEEEEeccccccCCCCCccccccCCCccCCcccc----------cCCCCCCCchhHHHHHHHHHHHH
Q psy3663 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL----------LGDSYDAPAVDVWSLGVILYMLV 213 (259)
Q Consensus 144 l~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~----------~~~~~~~~~~Di~slG~~l~~l~ 213 (259)
|||+||+++.+ +.++|+|||++...... .....+ ..|+|||.+ .+..++ .++|||||||++|+|+
T Consensus 237 iKp~NILl~~~-~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQR-GGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMT-FAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTT-CCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC-HHHHHHHHHHHHHHHH
T ss_pred cccceEEEecC-CeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCC-chhhHHHHHHHHHHHH
Confidence 99999999777 78999999998765432 444566 899999998 444444 4999999999999999
Q ss_pred hCCCCCCCCCChHHHHHhhhcccc-------ccccccccCchhhh
Q psy3663 214 AGQAPFQEANDSETLTMIMDVSES-------SCTCWWRGRPRSRR 251 (259)
Q Consensus 214 ~g~~pf~~~~~~~~~~~i~~~~~~-------~~~~~~~~~~~~~~ 251 (259)
+|+.||......+....+...... ....+|..+|..|.
T Consensus 312 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred HCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCc
Confidence 999999876655554444432221 22346666666553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=252.74 Aligned_cols=194 Identities=20% Similarity=0.224 Sum_probs=161.9
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC------CcccHHHHHHHHHHHHhCC---------CCCeEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL------DPVSQDHLYQEVRCMKLVQ---------HPNVVR 81 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------~~~i~~ 81 (259)
.++|++.+.||+|++|.||+|.+ +++.||||++..... .......+.+|+.+++.++ ||||+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 47899999999999999999996 689999999986542 2334577889999988886 888888
Q ss_pred EEEEEe------------------------------cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q psy3663 82 LYEVID------------------------------TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131 (259)
Q Consensus 82 ~~~~~~------------------------------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al 131 (259)
+.+++. +....++||||+.++++.+.+.. ..+++..++.++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 877642 26789999999988866665533 4489999999999999999
Q ss_pred HHHH-HCCcEeccCCCCCeEeeecCC--------------------eEEEEeccccccCCCCCccccccCCCccCCcccc
Q psy3663 132 SFCH-KLHVVHRDLKPENVVFFERLG--------------------VVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190 (259)
Q Consensus 132 ~~LH-~~~i~H~dl~p~nIlv~~~~~--------------------~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~ 190 (259)
.||| ++||+|+||||+||+++.+ + .++|+|||++...... ...++..|+|||++
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~-~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEEC-SCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGG
T ss_pred HHHHHhCCEeECCCCHHHEEEecc-CCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhh
Confidence 9999 9999999999999999876 4 8999999999765432 34688999999999
Q ss_pred cCCCCCCCchhHHHHHHH-HHHHHhCCCCCCC
Q psy3663 191 LGDSYDAPAVDVWSLGVI-LYMLVAGQAPFQE 221 (259)
Q Consensus 191 ~~~~~~~~~~Di~slG~~-l~~l~~g~~pf~~ 221 (259)
.+.. + .++|||||+++ .+++++|..||.+
T Consensus 250 ~g~~-~-~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 250 TGDG-D-YQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCCS-S-HHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cCCC-c-cceehhhhhCCCCcccccccCCCcc
Confidence 8776 4 49999998776 7778889999954
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=236.30 Aligned_cols=184 Identities=17% Similarity=0.112 Sum_probs=129.5
Q ss_pred cccccceEEEEEEeecCceEEEEEcccCCC--------CcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEEEEEe
Q psy3663 27 GRGHFAVVKLARHVFTGEKVAVKVIDKTKL--------DPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 27 ~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~--------~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
+.|..+....+.....|+.+++|++.+... .+.....+.+|+++|+++ .|+||+++++++++++..|+|||
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME 322 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME 322 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence 344444444555556789999999976532 122346688999999999 59999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Cccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~~ 176 (259)
|++|++|.+++...+. +++. .++.||+.||.|+|++||+|+||||+|||++.+ +++||+|||++...... ....
T Consensus 323 yv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~d-g~vKL~DFGlAr~~~~~~~~~~ 397 (569)
T 4azs_A 323 KLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDAR-QHARLIDFGSIVTTPQDCSWPT 397 (569)
T ss_dssp CCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTT-SCEEECCCTTEESCC---CCSH
T ss_pred cCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCC-CCEEEeecccCeeCCCCCcccc
Confidence 9999999999987654 6665 478999999999999999999999999999766 89999999998765433 3334
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQA 217 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 217 (259)
..++++.|+|||++.+... .++|+||+|++++.+.++..
T Consensus 398 t~vGTp~YmAPE~l~g~~~--~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 398 NLVQSFFVFVNELFAENKS--WNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred CceechhhccHHHhCCCCC--Ccccccccccchhhhccccc
Confidence 4578999999999977543 37999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-27 Score=209.41 Aligned_cols=185 Identities=20% Similarity=0.208 Sum_probs=140.6
Q ss_pred eEeeeecccccceEEEEEEeecCceEEEEEcccCCCCccc------HHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 21 DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS------QDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 21 ~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
...+.||+|+||.||+|. ..+..+++|........... .+.+.+|++++++++||||+++..++.+.+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 345689999999999994 67888999987654332221 3447899999999999999954444445566799
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
+|||+++++|.+++.. +..++.||+++|.+||++||+|+||||+||+++. .++|+|||++........
T Consensus 417 VmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCccc
Confidence 9999998999998864 5689999999999999999999999999999966 799999999987654322
Q ss_pred c--------ccccCCCccCCcccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 175 L--------ETSCGSLAYSAPEILLG--DSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 175 ~--------~~~~~~~~~~apE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
. ....++..|+|||++.. ..+.. ..|+|+..+-..+-..++-+|.
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~-~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKS-VYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHH-HCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHH-HHhHHHHHHHHHHHHHhccccC
Confidence 1 24467899999999975 44443 7899998888888877777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.6e-23 Score=167.19 Aligned_cols=136 Identities=18% Similarity=0.167 Sum_probs=107.3
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc----------------ccHHHHHHHHHHHHhCCCCCeEEE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP----------------VSQDHLYQEVRCMKLVQHPNVVRL 82 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~~~~i~~~ 82 (259)
.|.+.+.||+|++|.||+|.+ .+|..|++|++....... .....+.+|+.+++.++| +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 445559999999999999998 789999999997543211 134568899999999984 444
Q ss_pred EEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEe
Q psy3663 83 YEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTD 162 (259)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~d 162 (259)
.+++.. +..+++|||++|++|.+ +. ......++.|++.|+.+||++||+|+||||+||+++ + +.++|+|
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vkl~D 235 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIWIID 235 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEEECC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEEEEE
Confidence 444433 44589999999989988 31 123557999999999999999999999999999998 4 8999999
Q ss_pred ccccccC
Q psy3663 163 FGFSNRF 169 (259)
Q Consensus 163 f~~~~~~ 169 (259)
||++...
T Consensus 236 FG~a~~~ 242 (282)
T 1zar_A 236 FPQSVEV 242 (282)
T ss_dssp CTTCEET
T ss_pred CCCCeEC
Confidence 9988643
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.7e-21 Score=154.97 Aligned_cols=140 Identities=21% Similarity=0.251 Sum_probs=107.8
Q ss_pred CeeEeeeecccccceEEEEEEeecCce--EEEEEcccCCCCcc----------------------cHHHHHHHHHHHHhC
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEK--VAVKVIDKTKLDPV----------------------SQDHLYQEVRCMKLV 74 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~--~~lK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l 74 (259)
.|++.+.||+|++|.||+|.+..+|.. |+||++........ ....+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778988 99999754321110 113577899999999
Q ss_pred CCCCe--EEEEEEEecCCeEEEEEeccCC-----CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeccCCC
Q psy3663 75 QHPNV--VRLYEVIDTNSKLYLILELGDG-----GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KLHVVHRDLKP 146 (259)
Q Consensus 75 ~~~~i--~~~~~~~~~~~~~~lv~e~~~~-----~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH-~~~i~H~dl~p 146 (259)
.|+++ +.++.. ...++||||+.+ .+|.++... .++..+..++.||+.++.+|| ++||+|+||+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 87754 344433 245899999942 267665432 234567889999999999999 99999999999
Q ss_pred CCeEeeecCCeEEEEeccccccC
Q psy3663 147 ENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 147 ~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
+||+++. .++|+|||++...
T Consensus 200 ~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS---SEEECCCTTCEET
T ss_pred HHEEEcC---cEEEEECcccccC
Confidence 9999965 7999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.8e-18 Score=145.36 Aligned_cols=140 Identities=14% Similarity=0.150 Sum_probs=101.4
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc------------ccH--------HHHHHHHHHHHhCCCCC
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP------------VSQ--------DHLYQEVRCMKLVQHPN 78 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~------------~~~--------~~~~~e~~~l~~l~~~~ 78 (259)
-|++.+.||.|++|.||+|.+. +|+.||||+++....+. ... ....+|...+.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999986 78999999976432110 000 11234667777775444
Q ss_pred e--EEEEEEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC
Q psy3663 79 V--VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG 156 (259)
Q Consensus 79 i--~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~ 156 (259)
+ ..+++.. . .+++|||+.|.+|.++.. ......++.||+.++.+||++|||||||||.|||+.++..
T Consensus 175 v~vp~p~~~~--~--~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 175 FPVPEPIAQS--R--HTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp CSCCCEEEEE--T--TEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCCeeeecc--C--ceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 3 3333331 1 269999999988865431 2234577899999999999999999999999999977621
Q ss_pred ---------eEEEEeccccccCC
Q psy3663 157 ---------VVKLTDFGFSNRFN 170 (259)
Q Consensus 157 ---------~i~l~df~~~~~~~ 170 (259)
.+.|+||+-+....
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEETT
T ss_pred cccccccccceEEEEeCCcccCC
Confidence 48999999775543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.4e-13 Score=110.59 Aligned_cols=141 Identities=17% Similarity=0.122 Sum_probs=110.1
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l 94 (259)
..+.|++...++.++.+.||++.. .+..+++|....... .....+.+|+.+++.+. +..++++++++.+.+..++
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 346799999999999999999973 468999999865321 12345788999999885 5678889999888889999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-------------------------------------- 136 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-------------------------------------- 136 (259)
+|++++|.+|.+... +......++.++.+++..||+
T Consensus 88 v~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 999999998877531 122344778899999999998
Q ss_pred ---------------------CCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 137 ---------------------LHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 137 ---------------------~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
..++|||++|.||+++++ +.+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETT-EEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECC-cEEEEEEchhcc
Confidence 448999999999999543 445699999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=8.9e-12 Score=99.65 Aligned_cols=137 Identities=18% Similarity=0.113 Sum_probs=98.9
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC--eEEEEEEEecCCeE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN--VVRLYEVIDTNSKL 92 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~ 92 (259)
.....|.+....+.|..+.||++.. .+|..+++|..... ....+.+|+.+++.+.+.+ +++++.+..+.+..
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred HhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 3445678766555677799999964 35678999997543 2245678888888886444 55688888887889
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH---------------------------------- 138 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~---------------------------------- 138 (259)
+++||+++|.++. .. ..+. ..++.++..++..||+..
T Consensus 91 ~~v~e~i~G~~l~--~~----~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SS----HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEEECCSSEETT--TS----CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEEEecCCcccC--cC----cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 9999999998774 11 1222 255677777777777643
Q ss_pred ------------------------cEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 139 ------------------------VVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 139 ------------------------i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
++|||++|.||+++++ +.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~-~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG-RFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC-cEEEEEcchhcc
Confidence 9999999999999544 445599999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.29 E-value=1.7e-11 Score=102.97 Aligned_cols=141 Identities=21% Similarity=0.317 Sum_probs=104.7
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcc--cCCCCcccHHHHHHHHHHHHhCCC--CCeEEEEEEEecC---CeEEE
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVID--KTKLDPVSQDHLYQEVRCMKLVQH--PNVVRLYEVIDTN---SKLYL 94 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~--~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~~~l 94 (259)
-.+.|+.|.++.||++.. .+..+++|... .... ......+.+|+.+++.+.. ..+++++.++.+. +..++
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 467889999999999874 45689999875 3221 1234567889999999974 4578888887765 45899
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-------------------------------------- 136 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-------------------------------------- 136 (259)
+||+++|.++.+. ....++......++.++..+|..||+
T Consensus 119 vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999999776431 12237788889999999999999997
Q ss_pred --------------------CCcEeccCCCCCeEeeecCCe-EEEEecccccc
Q psy3663 137 --------------------LHVVHRDLKPENVVFFERLGV-VKLTDFGFSNR 168 (259)
Q Consensus 137 --------------------~~i~H~dl~p~nIlv~~~~~~-i~l~df~~~~~ 168 (259)
..++|||+++.||+++.+... +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 358999999999999766433 58999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.14 E-value=3.1e-11 Score=99.07 Aligned_cols=186 Identities=15% Similarity=0.161 Sum_probs=121.4
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCC--eEEEEEEEecCC---eEEEEE
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPN--VVRLYEVIDTNS---KLYLIL 96 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~lv~ 96 (259)
.+.++.|....||++. ..+++|+.... .....+.+|..+++.+. +.. ++.++....... ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3558899999999763 56999985422 34567889999998874 333 445555443332 357899
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK---------------------------------------- 136 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~---------------------------------------- 136 (259)
++++|.++..... ..++..+...++.++...+..||+
T Consensus 96 ~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 96 TKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp ECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred cccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9999988875332 236788888888899988888886
Q ss_pred ------------------CCcEeccCCCCCeEeeec-CCeEEEEeccccccCCCCCccccccCCCccCCccccc------
Q psy3663 137 ------------------LHVVHRDLKPENVVFFER-LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL------ 191 (259)
Q Consensus 137 ------------------~~i~H~dl~p~nIlv~~~-~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~------ 191 (259)
..++|||++|.||+++++ .+.+.|+||+.+.................-..++...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 136999999999999774 3567899999876543221111111100001222110
Q ss_pred CCCC----C---CCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 192 GDSY----D---APAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 192 ~~~~----~---~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
+... . ....+.|+++.+++.+.+|..+|.
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0000 0 002589999999999999988874
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=1.7e-08 Score=81.17 Aligned_cols=133 Identities=12% Similarity=0.124 Sum_probs=97.4
Q ss_pred eecccccc-eEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEEEEEeccCCC
Q psy3663 25 TLGRGHFA-VVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLYLILELGDGG 102 (259)
Q Consensus 25 ~i~~g~~~-~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (259)
.+..|..+ .||+......+..+++|.-... ....+.+|...++.+. +-.+.+++.++.+.+..+++|++++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34445444 6898887767788999985432 4567888999998886 333678888888888999999999998
Q ss_pred ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q psy3663 103 DLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL--------------------------------------------- 137 (259)
Q Consensus 103 sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~--------------------------------------------- 137 (259)
++.+..... ......+..++...|..||..
T Consensus 106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 888765432 223345666777777777741
Q ss_pred -------------CcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 138 -------------HVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 138 -------------~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.++|||+++.||+++++ +.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~-~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEG-KLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECC-eEEEEEECccccc
Confidence 16899999999999654 5556999997753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.82 E-value=5.4e-08 Score=79.80 Aligned_cols=135 Identities=17% Similarity=0.191 Sum_probs=94.5
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCC---CeEEEEEEEe-cCCeEEEEEec
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP---NVVRLYEVID-TNSKLYLILEL 98 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e~ 98 (259)
.+.++.|....||.+ +..+++|+.. .......+.+|..+++.+.+. .+.+++.+.. ..+..+++|++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 455788888899987 5779999842 123456788999999998742 3566666664 45667899999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL----------------------------------------- 137 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~----------------------------------------- 137 (259)
++|.++....- ..++......+..++...+..||+.
T Consensus 95 i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 95 VQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred cCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 99988876321 1145555555666666666666642
Q ss_pred -------------------CcEeccCCCCCeEeee---cCCeEEEEeccccccC
Q psy3663 138 -------------------HVVHRDLKPENVVFFE---RLGVVKLTDFGFSNRF 169 (259)
Q Consensus 138 -------------------~i~H~dl~p~nIlv~~---~~~~i~l~df~~~~~~ 169 (259)
.++|||+++.||++.. +...+.|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3489999999999976 3234579999977654
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.8e-07 Score=78.27 Aligned_cols=85 Identities=13% Similarity=0.129 Sum_probs=55.7
Q ss_pred eEeeee-cccccceEEEEEEe--e----cCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCC---CCeEEEEEEEecC
Q psy3663 21 DLEETL-GRGHFAVVKLARHV--F----TGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQH---PNVVRLYEVIDTN 89 (259)
Q Consensus 21 ~~~~~i-~~g~~~~vy~~~~~--~----~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~~ 89 (259)
...+.| +.|....+|++... . ++..+++|....... .......+.+|+.+++.+.. -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345677 88999999988643 1 256899998654320 00012456778888887752 3467777776654
Q ss_pred ---CeEEEEEeccCCCChH
Q psy3663 90 ---SKLYLILELGDGGDLY 105 (259)
Q Consensus 90 ---~~~~lv~e~~~~~sL~ 105 (259)
+..+++|++++|.++.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 4578999999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.4e-06 Score=73.95 Aligned_cols=77 Identities=14% Similarity=0.060 Sum_probs=49.5
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCC-----CcccHHHHHHHHHHHHhCCC--C-CeEEEEEEEecCCeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-----DPVSQDHLYQEVRCMKLVQH--P-NVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-----~~~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~~l 94 (259)
.+.+|.|..+.||++.....+..+++|....... .......+..|.++++.+.. + .+++++.+. ....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 5689999999999997666678899998653211 01234556778888887742 2 344565543 334579
Q ss_pred EEeccCC
Q psy3663 95 ILELGDG 101 (259)
Q Consensus 95 v~e~~~~ 101 (259)
+||++.+
T Consensus 113 vmE~l~g 119 (397)
T 2olc_A 113 VMEDLSH 119 (397)
T ss_dssp EECCCTT
T ss_pred EEEeCCC
Confidence 9999976
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.29 E-value=4.6e-06 Score=68.96 Aligned_cols=74 Identities=14% Similarity=0.196 Sum_probs=41.5
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC--CCeEEEEE------EEecCCeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH--PNVVRLYE------VIDTNSKLYL 94 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~------~~~~~~~~~l 94 (259)
.+.|+.|..+.+|++.. .+..+++|..... ...+..|..+++.+.. -.+++++. +....+..++
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRP------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSC------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCC------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 34566677889999873 3456999998642 2334445555555431 12333332 1123567899
Q ss_pred EEeccCCCCh
Q psy3663 95 ILELGDGGDL 104 (259)
Q Consensus 95 v~e~~~~~sL 104 (259)
+++|++|.++
T Consensus 109 l~~~i~G~~~ 118 (346)
T 2q83_A 109 VYDWIEGRPF 118 (346)
T ss_dssp EEECCCCBCC
T ss_pred EEEeecCccC
Confidence 9999998543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.11 E-value=3.5e-05 Score=63.10 Aligned_cols=75 Identities=20% Similarity=0.267 Sum_probs=59.6
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC---CCCeEEEEEEEecCCeEEEEEecc
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ---HPNVVRLYEVIDTNSKLYLILELG 99 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~ 99 (259)
.+.|+.|....+|++.. ++..+++|+.... ....+..|+..++.+. ...+++++.+....+..+++||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 57789999999999973 5778999986532 3566788988888875 356788888888888899999999
Q ss_pred CCCCh
Q psy3663 100 DGGDL 104 (259)
Q Consensus 100 ~~~sL 104 (259)
+|.++
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.07 E-value=1.5e-05 Score=64.88 Aligned_cols=71 Identities=10% Similarity=-0.004 Sum_probs=44.9
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCe-EEEEEEEecCCeEEEEEecc-C
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV-VRLYEVIDTNSKLYLILELG-D 100 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~-~ 100 (259)
.+.|+.|....+|++ ..+++|+....... .....+|..+++.+...++ .+++... ...-+++++|+ +
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 678889999999998 56999997653211 1223457777776653232 4555543 33346899999 7
Q ss_pred CCCh
Q psy3663 101 GGDL 104 (259)
Q Consensus 101 ~~sL 104 (259)
|.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6554
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.87 E-value=9.1e-05 Score=63.21 Aligned_cols=76 Identities=9% Similarity=0.059 Sum_probs=44.7
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcccCCC--C---cc--cHHHHHHHHHHHH-hCCCCCeEEEEEEEecCCeEE
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--D---PV--SQDHLYQEVRCMK-LVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~--~---~~--~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~ 93 (259)
-.+.++.|..+.+|++. .++..++||....... . .. ....+..|+..+. ......+++++.+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 35778999999999996 3567899995332110 1 11 1222333332222 22234566777665 45568
Q ss_pred EEEecc-CC
Q psy3663 94 LILELG-DG 101 (259)
Q Consensus 94 lv~e~~-~~ 101 (259)
+|||++ .+
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00056 Score=55.10 Aligned_cols=79 Identities=14% Similarity=0.061 Sum_probs=55.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCC---CeEEEEEEEecCCeEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP---NVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~l 94 (259)
....-++.+|.|..+.||++... +|+.+++|+..... ......+..|+..|+.+... .+++++.+. . .++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~l 87 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTL 87 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEE
T ss_pred CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceE
Confidence 35566888999999999999754 78899999865433 22345677899988888532 245555542 2 268
Q ss_pred EEeccCCCC
Q psy3663 95 ILELGDGGD 103 (259)
Q Consensus 95 v~e~~~~~s 103 (259)
+||++.+..
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 899997643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=8.7e-05 Score=62.43 Aligned_cols=139 Identities=14% Similarity=0.148 Sum_probs=81.6
Q ss_pred eeeecccccceEEEEEEee-------cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC-eEEEEEEEecCCeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVF-------TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN-VVRLYEVIDTNSKLYL 94 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~l 94 (259)
++.|..|-...+|++.... ++..+++|+.... ......+.+|..+++.+...+ .++++..+.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 4567778889999998532 3578999996332 123566678999888886333 2456666543 28
Q ss_pred EEeccCCCChHH--------------HHHh-cC------CCCC--HHHHHHHHHHHHH-------------------HHH
Q psy3663 95 ILELGDGGDLYD--------------YIMK-HD------AGLS--ETYAREYFAQIVR-------------------AIS 132 (259)
Q Consensus 95 v~e~~~~~sL~~--------------~~~~-~~------~~~~--~~~i~~~~~ql~~-------------------al~ 132 (259)
|++|++|.+|.. .+.+ +. .+.. ...+..++.++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999998754321 1111 01 1111 3455556554422 223
Q ss_pred HHH----H----CCcEeccCCCCCeEeeec---CCeEEEEecccccc
Q psy3663 133 FCH----K----LHVVHRDLKPENVVFFER---LGVVKLTDFGFSNR 168 (259)
Q Consensus 133 ~LH----~----~~i~H~dl~p~nIlv~~~---~~~i~l~df~~~~~ 168 (259)
.|. . ..++|+|+.+.||++..+ .+.+.++||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 2 248999999999999765 35799999998753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.72 E-value=9.1e-05 Score=60.67 Aligned_cols=140 Identities=16% Similarity=0.129 Sum_probs=75.5
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC--eEEEEEE------EecCCeEE
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN--VVRLYEV------IDTNSKLY 93 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~ 93 (259)
-.+.|+.|....+|++.. ++..+++|...... ....+..|..+++.+...+ +++++.. ....+..+
T Consensus 26 ~~~~i~~G~~n~~~~v~~--~~g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHT--TKDPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEECC---EEEEEEEE--SSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred EeeccCCCcccceEEEEe--CCccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 356677888899999874 34479999986521 2234556777776664222 2333321 11235678
Q ss_pred EEEeccCCCChH---------------HHHHhc-C--CC----CCHHHHHHH---------------HHHHHHHHHHHHH
Q psy3663 94 LILELGDGGDLY---------------DYIMKH-D--AG----LSETYAREY---------------FAQIVRAISFCHK 136 (259)
Q Consensus 94 lv~e~~~~~sL~---------------~~~~~~-~--~~----~~~~~i~~~---------------~~ql~~al~~LH~ 136 (259)
+++++++|.++. .+-... . .+ ......... -..+...+..+..
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 999999885431 111100 1 00 011100000 0113344555542
Q ss_pred -------CCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 137 -------LHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 137 -------~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.+++|||+++.||++.++ +.+.|+||+.+..
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~-~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 217 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred hCcccCCcccCCCCCCccCEEEeCC-ceEEEecchhccC
Confidence 368999999999999654 4447999997643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.64 E-value=8.4e-05 Score=63.66 Aligned_cols=73 Identities=18% Similarity=0.187 Sum_probs=48.9
Q ss_pred eeeecccccceEEEEEEee-------cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCe-EEEEEEEecCCeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVF-------TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV-VRLYEVIDTNSKLYL 94 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~l 94 (259)
.+.|+.|....+|++.... .+..+++|+..... ....+.+|..+++.+...++ +++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 5678889899999997542 25789999974321 12455578888888764333 456665532 28
Q ss_pred EEeccCCCC
Q psy3663 95 ILELGDGGD 103 (259)
Q Consensus 95 v~e~~~~~s 103 (259)
+++|++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 899998633
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00017 Score=59.50 Aligned_cols=140 Identities=15% Similarity=0.153 Sum_probs=71.1
Q ss_pred eeeecccccce-EEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC--CCeEEEEEEEecCCeEEEEEecc
Q psy3663 23 EETLGRGHFAV-VKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH--PNVVRLYEVIDTNSKLYLILELG 99 (259)
Q Consensus 23 ~~~i~~g~~~~-vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~ 99 (259)
.+.|+.|.... +|++.. .++..+++|...... ...+..|+.+++.+.. -.+++++.+..+++ +++||++
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~-----~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l 94 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE-----GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDL 94 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT-----TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC-----CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeC
Confidence 44566665554 556652 136778888654321 0223456666665542 23455666543433 6899999
Q ss_pred CCCChHHHHHhcC-------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHH
Q psy3663 100 DGGDLYDYIMKHD-------------------------AGLSETYAR-------EYF-------------AQIVRAISFC 134 (259)
Q Consensus 100 ~~~sL~~~~~~~~-------------------------~~~~~~~i~-------~~~-------------~ql~~al~~L 134 (259)
.+.++.+.+.... ..++..... .+. ..+..++..+
T Consensus 95 ~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l 174 (333)
T 3csv_A 95 GDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQI 174 (333)
T ss_dssp CSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHH
T ss_pred CCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 7766654432110 012221110 000 1111222333
Q ss_pred ------HHCCcEeccCCCCCeEeeec---CCeEEEEeccccccCC
Q psy3663 135 ------HKLHVVHRDLKPENVVFFER---LGVVKLTDFGFSNRFN 170 (259)
Q Consensus 135 ------H~~~i~H~dl~p~nIlv~~~---~~~i~l~df~~~~~~~ 170 (259)
+...++|||+++.||++..+ .+.+.|+||+.+....
T Consensus 175 ~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 175 LSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred HHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 13469999999999999653 1478999999876543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00054 Score=52.51 Aligned_cols=120 Identities=17% Similarity=0.137 Sum_probs=77.2
Q ss_pred CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcccccc
Q psy3663 101 GGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC 179 (259)
Q Consensus 101 ~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH-~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~ 179 (259)
..+|.+++...+.+++++++|.++.|.+.+|..+- .+.-...-+.|..|++..+ |.|-+.+-. +. .
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~d-G~V~f~~~~-s~-----------~ 98 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRD-GAVTLAPAA-DD-----------A 98 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETT-SCEEECCC----------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecC-Cceeccccc-cc-----------c
Confidence 35899999999999999999999999999987762 2222234455788888776 666665411 10 0
Q ss_pred CCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCC-CCCCCCChHHHHHhhhcc
Q psy3663 180 GSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQA-PFQEANDSETLTMIMDVS 235 (259)
Q Consensus 180 ~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~-pf~~~~~~~~~~~i~~~~ 235 (259)
....+.|||.... ..+.+.=|||||+++|..+--.. +=....-.+.++.++...
T Consensus 99 ~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 99 GEPPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHM 153 (229)
T ss_dssp --------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHH
T ss_pred cccCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHH
Confidence 1224668887642 22348899999999999997444 344455556666666444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00089 Score=54.85 Aligned_cols=75 Identities=11% Similarity=0.110 Sum_probs=47.4
Q ss_pred eeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC--eEEEEEE-----EecCCeEEEEE
Q psy3663 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN--VVRLYEV-----IDTNSKLYLIL 96 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~lv~ 96 (259)
..++ |....+|.+... +|+.+++|...... .....+..|..+++.+.... +++++.. ....+..++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4456 778899987632 46689999986432 23456677888777775222 3334432 12245668899
Q ss_pred eccCCCC
Q psy3663 97 ELGDGGD 103 (259)
Q Consensus 97 e~~~~~s 103 (259)
++++|.+
T Consensus 107 ~~i~G~~ 113 (328)
T 1zyl_A 107 PSVGGRQ 113 (328)
T ss_dssp ECCCCEE
T ss_pred EecCCCC
Confidence 9998743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0053 Score=52.90 Aligned_cols=75 Identities=15% Similarity=0.141 Sum_probs=47.7
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCe-EEEEEEEecCCeEEEEEeccCC
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV-VRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
.+.|+.|....+|++.....+..+++|+...... ..-...+|..+++.+...++ +++++.+. + ..+++|++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCC
Confidence 5678889999999998543347899998754221 11123578888888875554 45666653 2 259999987
Q ss_pred CCh
Q psy3663 102 GDL 104 (259)
Q Consensus 102 ~sL 104 (259)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 433
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0022 Score=53.49 Aligned_cols=74 Identities=14% Similarity=0.005 Sum_probs=43.8
Q ss_pred eeeecccccceEEEEEEeec--------CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC-eEEEEEEEecCCeEE
Q psy3663 23 EETLGRGHFAVVKLARHVFT--------GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN-VVRLYEVIDTNSKLY 93 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~--------~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~ 93 (259)
.+.++.|....+|++..... +..+++|+..... ........|..+++.+...+ +++++... .+ +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--G 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence 56778888999999975431 2689999875421 11112457777777775333 34565544 22 6
Q ss_pred EEEeccCCCC
Q psy3663 94 LILELGDGGD 103 (259)
Q Consensus 94 lv~e~~~~~s 103 (259)
++++|++|.+
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.94 E-value=0.015 Score=47.98 Aligned_cols=32 Identities=16% Similarity=0.189 Sum_probs=26.4
Q ss_pred CCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 137 ~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
..++|||+++.||++..+ +.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-ESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGG-GCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCC-CeEEEEECCCCeeC
Confidence 458999999999999765 57999999876543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0025 Score=54.28 Aligned_cols=74 Identities=12% Similarity=0.042 Sum_probs=47.6
Q ss_pred eeeecccccceEEEEEEeec-------CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC-eEEEEEEEecCCeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVFT-------GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN-VVRLYEVIDTNSKLYL 94 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~-------~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~l 94 (259)
++.+..|-...+|++..... +..+++|+..... .......+|..+++.+...+ .+++++.+ .+ +.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CE
Confidence 56677788999999985421 5789999964422 11223457888887775323 34555433 22 68
Q ss_pred EEeccCCCC
Q psy3663 95 ILELGDGGD 103 (259)
Q Consensus 95 v~e~~~~~s 103 (259)
|++|++|.+
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 899999855
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0046 Score=52.33 Aligned_cols=30 Identities=27% Similarity=0.476 Sum_probs=24.7
Q ss_pred cEeccCCCCCeEeee-----cCCeEEEEecccccc
Q psy3663 139 VVHRDLKPENVVFFE-----RLGVVKLTDFGFSNR 168 (259)
Q Consensus 139 i~H~dl~p~nIlv~~-----~~~~i~l~df~~~~~ 168 (259)
++|+|+.+.||++.. +.+.+.++||.++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999943 346799999998754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.09 E-value=1.3 Score=33.66 Aligned_cols=122 Identities=11% Similarity=0.172 Sum_probs=79.5
Q ss_pred HHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccC-CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCC
Q psy3663 67 EVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGD-GGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLK 145 (259)
Q Consensus 67 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~-~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~ 145 (259)
|+.+|.. .+|++++. .+-.+.+.+.+.++.-. +.+...+ . .++..+.++++.+|+....+ ...-+|--|+
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-k----~~~~~eKlr~l~ni~~l~~~--~~~r~tf~L~ 106 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-K----SFTKNEKLRYLLNIKNLEEV--NRTRYTFVLA 106 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-G----GSCHHHHHHHHHHGGGGGGG--GGSSEECCCS
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-H----hcCHHHHHHHHHHHHHHHHH--hcCceEEEEe
Confidence 3444432 58889876 56667777777776654 3334332 2 27899999999999987733 3445788999
Q ss_pred CCCeEeeecCCeEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy3663 146 PENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ 220 (259)
Q Consensus 146 p~nIlv~~~~~~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 220 (259)
|+||+++.+ +.+++.--|....+. |. .. ++..-+-..=+++..+++++..|.
T Consensus 107 P~NL~f~~~-~~p~i~~RGik~~l~----------------P~-----~~-~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 107 PDELFFTRD-GLPIAKTRGLQNVVD----------------PL-----PV-SEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGGEEECTT-SCEEESCCEETTTBS----------------CC-----CC-CHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cceEEEcCC-CCEEEEEccCccCCC----------------CC-----CC-CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999777 778887777543221 11 01 112333455678888888888883
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=87.37 E-value=2.5 Score=32.21 Aligned_cols=84 Identities=11% Similarity=0.073 Sum_probs=61.0
Q ss_pred CCCCeEEEEEEEecCCeEEEEEeccC-CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee
Q psy3663 75 QHPNVVRLYEVIDTNSKLYLILELGD-GGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE 153 (259)
Q Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~~-~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~ 153 (259)
.+|++ ...+-.+.+.+.+.++.-. +.+...+ .. ++..+.++++.+|+..... |...-+|--|+|+||+++.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-~~----~~~~eKlrll~nl~~L~~~-~~~~r~tf~l~P~NL~f~~ 119 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-RK----TTLLSRIRAAIHLVSKVKH-HSARRLIFIVCPENLMFNR 119 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-HT----SCHHHHHHHHHHHHHHHSS-CCSSSEECCCCGGGEEECT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-Hh----cCHHHHHHHHHHHHHHHHH-hhhCceeEEEeCceEEEeC
Confidence 48888 5556577888888877763 3344443 22 7899999999998886652 2355688899999999966
Q ss_pred cCCeEEEEeccccc
Q psy3663 154 RLGVVKLTDFGFSN 167 (259)
Q Consensus 154 ~~~~i~l~df~~~~ 167 (259)
+ +.+++.--|...
T Consensus 120 ~-~~p~i~hRGi~~ 132 (219)
T 4ano_A 120 A-LEPFFLHVGVKE 132 (219)
T ss_dssp T-CCEEESCCEETT
T ss_pred C-CcEEEEEcCCcc
Confidence 6 788888877543
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=85.22 E-value=5.3 Score=32.57 Aligned_cols=139 Identities=16% Similarity=0.103 Sum_probs=78.4
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEE-------------
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEV------------- 85 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------------- 85 (259)
..+.++....|..|..+.+. ++..++||... ....+.+-.++...-.+.-|.+.-+...
T Consensus 70 ~v~~I~~s~~Gstgvff~~t---d~~~~VVK~s~-----~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~ 141 (342)
T 1cja_A 70 QFKGIERSEKGTEGLFFVET---ESGVFIVKRST-----NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAA 141 (342)
T ss_dssp GEEEEEECCSTTSCEEEEEE---SSCEEEEECCT-----THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHH
T ss_pred CeeEEEeccCCCCCeEEEEe---CCCEEEEeCcH-----HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHH
Confidence 46677777777765544444 57789999541 2234444455555555666665433211
Q ss_pred Ee---------cCCeEEEEEeccCCCChHHHHHhc-CCCCCHHHHHHHHHHH--HHHHHHHHHCC-----cEeccCCCCC
Q psy3663 86 ID---------TNSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFAQI--VRAISFCHKLH-----VVHRDLKPEN 148 (259)
Q Consensus 86 ~~---------~~~~~~lv~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql--~~al~~LH~~~-----i~H~dl~p~n 148 (259)
.. ..+.++++|+|..|..|.+.-... ...+.... +.+| +-++..+..++ +.+..-+++|
T Consensus 142 ~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~----~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~N 217 (342)
T 1cja_A 142 IDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKST----MQQLGSLMALDVIVNNSDRLPIAWTNEGNLDN 217 (342)
T ss_dssp HCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHH----HHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGG
T ss_pred hhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHH----HHhhchhheehhhhcCCccCcccccCCCChhh
Confidence 00 123578999999876554321100 00022222 2332 23455665543 2223458999
Q ss_pred eEeeecCCeEEEEeccccccC
Q psy3663 149 VVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 149 Ilv~~~~~~i~l~df~~~~~~ 169 (259)
|++..+++.+.++|-+.+..-
T Consensus 218 IL~~~~n~~~~~IDhn~af~~ 238 (342)
T 1cja_A 218 IMLSERGATVVPIDSKIIPLD 238 (342)
T ss_dssp EEEESBTTCEEECSCCCCCCC
T ss_pred eEEeCCCCeEEEEcCCccccC
Confidence 999888667999999988643
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=81.91 E-value=5.6 Score=35.90 Aligned_cols=44 Identities=23% Similarity=0.338 Sum_probs=30.7
Q ss_pred HHHHHHHHHH--HHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 119 YAREYFAQIV--RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 119 ~i~~~~~ql~--~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.+..++++++ ..+.|+ .|| ||=+++||+++ ++|++.-+|||++.
T Consensus 530 ar~nF~~SlA~~Svv~YI--LGl--GDRH~~NILid-~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 530 VMDTYIKSCAGYCVITYL--LGV--GDRHLDNLLLT-TNGKLFHIDFGYIL 575 (696)
T ss_dssp HHHHHHHHHHHHHHHHHH--HTC--CCCCTTTEEEC-TTSCEEECCCCSCT
T ss_pred HHHHHHHHHHHHHHHHHH--ccC--CCCCCcceEEe-CCCCEEEEeehhhh
Confidence 3445555544 334444 344 79999999998 46999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 259 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-72 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-70 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-69 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-68 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-68 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-67 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-67 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-66 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-66 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-64 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-63 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-61 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-60 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-60 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-59 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-58 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-58 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-57 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-57 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-57 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-56 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-55 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-54 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-54 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-54 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-54 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-53 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-51 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-50 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-50 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-50 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-43 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-40 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-36 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-19 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 221 bits (565), Expect = 7e-72
Identities = 68/218 (31%), Positives = 120/218 (55%), Gaps = 4/218 (1%)
Query: 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ 75
+ YD+ E LG G F VV TG A K + ++ + +E++ M +++
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLR 81
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
HP +V L++ + ++++ +I E GG+L++ + +SE A EY Q+ + + H
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 136 KLHVVHRDLKPENVVF-FERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDS 194
+ + VH DLKPEN++F +R +KL DFG + +P Q ++ + G+ ++APE+ G
Sbjct: 142 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 201
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
D+WS+GV+ Y+L++G +PF ND ETL +
Sbjct: 202 VG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 6e-70
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 8/219 (3%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN 78
+++ LG G F V A++ T A KVID + + E+ + HPN
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPN 70
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V+L + + L++++E GG + +++ + L+E+ + Q + A+++ H
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDA 197
++HRDLK N++F G +KL DFG S + Q+ ++ G+ + APE+++ ++
Sbjct: 131 IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 198 ----PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
DVWSLG+ L + + P E N L I
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 228
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 216 bits (551), Expect = 1e-69
Identities = 65/221 (29%), Positives = 113/221 (51%), Gaps = 4/221 (1%)
Query: 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMK 72
+ YD+ E LG G F VV TG K I+ P+ + + E+ M
Sbjct: 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMN 81
Query: 73 LVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAIS 132
+ HP ++ L++ + ++ LILE GG+L+D I D +SE Y Q +
Sbjct: 82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 133 FCHKLHVVHRDLKPENVVF-FERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL 191
H+ +VH D+KPEN++ ++ VK+ DFG + + NP + ++ + + ++APEI+
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 201
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ D+W++GV+ Y+L++G +PF +D ETL +
Sbjct: 202 REPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-68
Identities = 75/216 (34%), Positives = 116/216 (53%), Gaps = 5/216 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPN 78
+++ LG+G F V LAR + +A+KV+ K +L + L +EV ++HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++RLY +++YLILE G +Y + K E Y ++ A+S+CH
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKR 126
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
V+HRD+KPEN++ G +K+ DFG+S P + T CG+L Y PE++ G +D
Sbjct: 127 VIHRDIKPENLLLGSA-GELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMHD-E 183
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
VD+WSLGV+ Y + G+ PF+ ET I V
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 2e-68
Identities = 76/216 (35%), Positives = 123/216 (56%), Gaps = 6/216 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+DL +TLG G + V+LA + T E VAVK++D K +++ +E+ K++ H NV
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINKMLNHENV 65
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V+ Y + YL LE GG+L+D I + D G+ E A+ +F Q++ + + H + +
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYD 196
HRD+KPEN++ ER +K++DFG + F + L CG+L Y APE+L +
Sbjct: 125 THRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
A VDVWS G++L ++AG+ P+ + +DS
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-67
Identities = 72/217 (33%), Positives = 112/217 (51%), Gaps = 7/217 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPN 78
+ + LG G F+ V LAR + T + A+K+++K + ++ +E M + HP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
V+LY + KLY L G+L YI K ET R Y A+IV A+ + H
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKG 128
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSY 195
++HRDLKPEN++ E +++TDFG + +P K + G+ Y +PE+L S
Sbjct: 129 IIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 196 DAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+ D+W+LG I+Y LVAG PF+ N+ I+
Sbjct: 188 C-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-67
Identities = 60/245 (24%), Positives = 110/245 (44%), Gaps = 11/245 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
++ LG G+ VV H +G +A K+I ++ P ++ + +E++ + P +
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL-EIKPAIRNQIIRELQVLHECNSPYI 66
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH-KLH 138
V Y ++ ++ + +E DGG L + K + E + +++ +++ K
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
++HRD+KP N++ R G +KL DFG S + G+ +Y +PE L G Y
Sbjct: 126 IMHRDVKPSNILVNSR-GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYS-V 182
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM-----DVSESSCTCWWRGRPRSRRRT 253
D+WS+G+ L + G+ P + E M D +E+ GRP S
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 254 TRKPS 258
+P
Sbjct: 243 DSRPP 247
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 208 bits (530), Expect = 5e-67
Identities = 80/219 (36%), Positives = 128/219 (58%), Gaps = 5/219 (2%)
Query: 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ 75
I +YD + LG G F+ V LA T + VA+K I K L+ + + E+ + ++
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIK 65
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
HPN+V L ++ ++ LYLI++L GG+L+D I++ +E A Q++ A+ + H
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH 124
Query: 136 KLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD 193
L +VHRDLKPEN++++ + + ++DFG S +PG L T+CG+ Y APE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
Y AVD WS+GVI Y+L+ G PF + ND++ I+
Sbjct: 185 PYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL 222
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-66
Identities = 70/225 (31%), Positives = 107/225 (47%), Gaps = 13/225 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y++ T+G G + + R G+ + K +D + + L EV ++ ++HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 80 VRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHDA---GLSETYAREYFAQIVRAISFC 134
VR Y+ I TN+ LY+++E +GGDL I K L E + Q+ A+ C
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 135 HKLH-----VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-CGSLAYSAPE 188
H+ V+HRDLKP NV + VKL DFG + N + G+ Y +PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE 184
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
+ SY+ D+WSLG +LY L A PF + E I +
Sbjct: 185 QMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 4e-66
Identities = 58/215 (26%), Positives = 106/215 (49%), Gaps = 5/215 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + E LGRG F +V + + K + D Q + +E+ + + +H N+
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNI 63
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
+ L+E ++ +L +I E G D+++ I L+E Y Q+ A+ F H ++
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 140 VHRDLKPENVVF-FERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
H D++PEN+++ R +K+ +FG + + PG + Y APE+ D
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS-T 182
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
A D+WSLG ++Y+L++G PF + + + IM+
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 6e-66
Identities = 65/228 (28%), Positives = 114/228 (50%), Gaps = 10/228 (4%)
Query: 6 SRSSDGHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLY 65
S S G P K Y E +G+G V A V TG++VA++ ++ + ++ +
Sbjct: 11 SIVSVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELII 65
Query: 66 QEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA 125
E+ M+ ++PN+V + +L++++E GG L D + + + E
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCR 123
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAY 184
+ ++A+ F H V+HRD+K +N++ G VKLTDFGF + K T G+ +
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 185 SAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
APE++ +Y P VD+WSLG++ ++ G+ P+ N L +I
Sbjct: 183 MAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 200 bits (510), Expect = 1e-64
Identities = 86/227 (37%), Positives = 128/227 (56%), Gaps = 15/227 (6%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD-------HLYQEVRCM- 71
Y+ +E LGRG +VV+ H T ++ AVK+ID T S + +EV +
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 72 KLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
K+ HPN+++L + +TN+ +L+ +L G+L+DY+ + LSE R+ ++ I
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVI 123
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL 191
HKL++VHRDLKPEN++ + +KLTDFGFS + +PG+KL CG+ +Y APEI+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182
Query: 192 GDSYDA-----PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
D VD+WS GVI+Y L+AG PF L MIM
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (511), Expect = 3e-64
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 8/217 (3%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHP 77
L+ +G G F V AR V E VA+K + + + +EVR ++ ++HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
N ++ +L++E G H L E ++ +++ H
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDA 197
+++HRD+K N++ E G+VKL DFG ++ P + G+ + APE++L
Sbjct: 135 NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQ 190
Query: 198 --PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
VDVWSLG+ L + P N L I
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 3e-63
Identities = 50/218 (22%), Positives = 99/218 (45%), Gaps = 10/218 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ + +G G F V + VAVK+++ T P EV ++ +H N+
Sbjct: 10 ITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
+ T +L ++ + +G LY ++ + + Q + + + H +
Sbjct: 67 LLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI 125
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFS---NRFNPGQKLETSCGSLAYSAPEILLGDSYD 196
+HRDLK N+ E VK+ DFG + +R++ + E GS+ + APE++ +
Sbjct: 126 IHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 197 A--PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
DV++ G++LY L+ GQ P+ N+ + + ++
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 7e-63
Identities = 81/226 (35%), Positives = 129/226 (57%), Gaps = 9/226 (3%)
Query: 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL----DPVSQDHLYQEVRCM 71
+ YD E LG G FAVVK R TG + A K I K + VS++ + +EV +
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 72 KLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
K +QHPNV+ L+EV + + + LILEL GG+L+D++ + + L+E A E+ QI+ +
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGV 126
Query: 132 SFCHKLHVVHRDLKPENVVFFER---LGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPE 188
+ H L + H DLKPEN++ +R +K+ DFG +++ + G + + G+ + APE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
I+ + D+WS+GVI Y+L++G +PF ETL + V
Sbjct: 187 IVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 8e-63
Identities = 54/219 (24%), Positives = 97/219 (44%), Gaps = 10/219 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ +GRG F V T +VA + KL + +E +K +QHPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 80 VRLYEVIDTNSK----LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
VR Y+ ++ K + L+ EL G L Y+ + + R + QI++ + F H
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLH 129
Query: 136 KLH--VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD 193
++HRDLK +N+ G VK+ D G + + G+ + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFMAPEMYEE- 187
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
YD +VDV++ G+ + + + P+ E ++ + +
Sbjct: 188 KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 225
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-61
Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 17/229 (7%)
Query: 13 PTKIAGLYD-LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM 71
I Y + LG G V + T EK A+K++ +EV
Sbjct: 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-------KARREVELH 58
Query: 72 -KLVQHPNVVRLYEVIDT----NSKLYLILELGDGGDLYDYIMKH-DAGLSETYAREYFA 125
+ Q P++VR+ +V + L +++E DGG+L+ I D +E A E
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK 118
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVF--FERLGVVKLTDFGFSNRFNPGQKLETSCGSLA 183
I AI + H +++ HRD+KPEN+++ ++KLTDFGF+ L T C +
Sbjct: 119 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 178
Query: 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
Y APE+L + YD + D+WSLGVI+Y+L+ G PF + +
Sbjct: 179 YVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 226
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 2e-60
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 7/215 (3%)
Query: 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL----DPVSQDHLYQEVRCM 71
+ Y + LG G F V V VA+K ++K ++ + + + EV +
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 72 KLVQ--HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVR 129
K V V+RL + + LILE + + L E AR +F Q++
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 130 AISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEI 189
A+ CH V+HRD+K EN++ G +KL DFG G+ YS PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEW 180
Query: 190 LLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND 224
+ Y + VWSLG++LY +V G PF+ +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 9e-60
Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 6/216 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTK-LDPVSQDHLYQEVRCMKLV-QHP 77
+ L + LG+G F V LA T + A+K + K L + E R + L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKL 137
+ ++ T L+ ++E +GGDL +I + A Y A+I+ + F H
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK 122
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS-CGSLAYSAPEILLGDSYD 196
+V+RDLK +N+ ++ G +K+ DFG G + CG+ Y APEILLG Y+
Sbjct: 123 GIVYRDLKLDNI-LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
+VD WS GV+LY ++ GQ+PF ++ E I
Sbjct: 182 -HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 216
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 187 bits (475), Expect = 3e-59
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 12/229 (5%)
Query: 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCM 71
P+ ++ Y+L E LG G + V LAR + VAVKV+ DP +E +
Sbjct: 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61
Query: 72 KLVQHPNVVRLYEVIDTNSK----LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQI 127
+ HP +V +Y+ + + Y+++E DG L D + ++ A E A
Sbjct: 62 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADA 120
Query: 128 VRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF----NPGQKLETSCGSLA 183
+A++F H+ ++HRD+KP N++ VK+ DFG + N + G+
Sbjct: 121 CQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 184 YSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
Y +PE GDS D DV+SLG +LY ++ G+ PF + +
Sbjct: 180 YLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-58
Identities = 62/240 (25%), Positives = 105/240 (43%), Gaps = 6/240 (2%)
Query: 24 ETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQD---HLYQEVRCMKLVQHPNVV 80
+ LG G FA V AR T + VA+K I +E++ ++ + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
L + S + L+ + + I + L+ ++ + Y ++ + + H+ ++
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET-SCGSLAYSAPEILLGDSYDAPA 199
HRDLKP N++ E GV+KL DFG + F + T + Y APE+L G
Sbjct: 123 HRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181
Query: 200 VDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSRRRTTRKPSP 259
VD+W++G IL L+ +D + LT I + + W T K P
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 4e-58
Identities = 62/241 (25%), Positives = 110/241 (45%), Gaps = 14/241 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + +G G F VV A+ +GE VA+K + + K +E++ M+ + H N+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNI 75
Query: 80 VRLYEVIDTNSK------LYLILELGDGGDLYD--YIMKHDAGLSETYAREYFAQIVRAI 131
VRL ++ + L L+L+ + + L Y + Y Q+ R++
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILL 191
++ H + HRD+KP+N++ V+KL DFG + + G+ + S Y APE++
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 192 GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSRR 251
G + ++DVWS G +L L+ GQ F + + L I+ V + R +
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255
Query: 252 R 252
Sbjct: 256 E 256
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 185 bits (470), Expect = 1e-57
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 7/216 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ----EVRCMKLVQ 75
+ + +GRG F V R TG+ A+K +DK ++ + L + +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
P +V + T KL IL+L +GGDL+ ++ +H SE R Y A+I+ + H
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEHMH 124
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSY 195
VV+RDLKP N + + G V+++D G + F+ +K S G+ Y APE+L
Sbjct: 125 NRFVVYRDLKPAN-ILLDEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVA 182
Query: 196 DAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMI 231
+ D +SLG +L+ L+ G +PF++ + +
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 2e-57
Identities = 77/239 (32%), Positives = 114/239 (47%), Gaps = 2/239 (0%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ E +G G + VV AR+ TGE VA+K I +E+ +K + HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V+L +VI T +KLYL+ E G+ + Y Q+++ ++FCH V
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGDSYDAP 198
+HRDLKP+N++ G +KL DFG + F P + +L Y APEILLG Y +
Sbjct: 124 LHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSRRRTTRKP 257
AVD+WSLG I +V +A F ++ + L I + W G P
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-57
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 13/217 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
L +T+G+G F V L + G KVAVK I + E M ++H N+
Sbjct: 9 LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNL 62
Query: 80 VRLYEV-IDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKL 137
V+L V ++ LY++ E G L DY+ L ++ + A+ +
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 138 HVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDA 197
+ VHRDL NV+ E V K++DFG + + Q +T + ++APE L +
Sbjct: 123 NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFS- 178
Query: 198 PAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
DVWS G++L+ + G+ P+ + + +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 182 bits (464), Expect = 4e-57
Identities = 63/215 (29%), Positives = 115/215 (53%), Gaps = 6/215 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPN 78
+ + TLG G F V L R G A+KV+ K + +H E + +V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
++R++ ++++I++ +GG+L+ + K A+ Y A++ A+ + H
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
+++RDLKPEN++ + G +K+TDFGF+ T CG+ Y APE++ Y+
Sbjct: 125 IIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVSTKPYN-K 180
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
++D WS G+++Y ++AG PF ++N +T I++
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 179 bits (454), Expect = 4e-56
Identities = 68/241 (28%), Positives = 115/241 (47%), Gaps = 4/241 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y E +G G + VV A++ GE A+K I K D +E+ +K ++H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V+LY+VI T +L L+ E D + GL A+ + Q++ I++CH V
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDAP 198
+HRDLKP+N++ G +K+ DFG + F P +K +L Y AP++L+G +
Sbjct: 122 LHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSRRRTTRKPS 258
+D+WS+G I +V G F ++++ L I + + + W +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 259 P 259
Sbjct: 241 Y 241
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-56
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 9/217 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ LG G F VVK + VA+K+I + +S+D +E + M + H +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKL 61
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V+LY V +++I E G L +Y+ + E + A+ +
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILLGDSYDA 197
+HRDL N + ++ GVVK++DFG S + + + +S PE+L+ +
Sbjct: 122 LHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS- 179
Query: 198 PAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
D+W+ GV+++ + G+ P++ +SET I
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 8e-56
Identities = 59/258 (22%), Positives = 108/258 (41%), Gaps = 14/258 (5%)
Query: 11 GHPTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRC 70
G + Y +G G + +V A +VA+K I + +E++
Sbjct: 1 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKI 59
Query: 71 MKLVQHPNVVRLYEVIDTNS-----KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFA 125
+ +H N++ + ++I + +YL+ L G DLY + LS + +
Sbjct: 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL-MGADLYKLLKTQ--HLSNDHICYFLY 116
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ----KLETSCGS 181
QI+R + + H +V+HRDLKP N++ +K+ DFG + +P L +
Sbjct: 117 QILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVAT 175
Query: 182 LAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTC 241
Y APEI+L ++D+WS+G IL +++ + F + + L I+ + S
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235
Query: 242 WWRGRPRSRRRTTRKPSP 259
+ R P
Sbjct: 236 DLNCIINLKARNYLLSLP 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-55
Identities = 69/215 (32%), Positives = 115/215 (53%), Gaps = 5/215 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPN 78
+D + LG+G F V L R TG A+K++ K + H E R ++ +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+ L T+ +L ++E +GG+L+ ++ + +E AR Y A+IV A+ + H
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD 125
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRF-NPGQKLETSCGSLAYSAPEILLGDSYDA 197
VV+RD+K EN++ + G +K+TDFG + G ++T CG+ Y APE+L + Y
Sbjct: 126 VVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG- 183
Query: 198 PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
AVD W LGV++Y ++ G+ PF + +I+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 178 bits (451), Expect = 5e-55
Identities = 58/231 (25%), Positives = 114/231 (49%), Gaps = 13/231 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMK-LVQHPN 78
Y L LGRG ++ V A ++ EKV VK++ K + + +E++ ++ L PN
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPN 91
Query: 79 VVRLYEVI--DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
++ L +++ + L+ E + D L++ R Y +I++A+ +CH
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS 147
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYD 196
+ ++HRD+KP NV+ ++L D+G + ++PGQ+ S + PE+L+
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDS-ETLTMIMDVSESSCTCWWRGR 246
++D+WSLG +L ++ + PF +D+ + L I V + + +
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-54
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 11/218 (5%)
Query: 23 EETLGRGHFAVVKLARHVF--TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVV 80
++ LG G+F VK + + VAVK++ DP +D L E M+ + +P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 81 RLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVV 140
R+ + + S L++E+ + G L Y+ ++ + + E Q+ + + + + V
Sbjct: 72 RMIGICEAES-WMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 141 HRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS----CGSLAYSAPEILLGDSYD 196
HRDL NV+ + K++DFG S + + + + APE + +
Sbjct: 130 HRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 197 APAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
DVWS GV+++ GQ P++ SE M+
Sbjct: 189 -SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-54
Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 15/228 (6%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y+ +G+G F V ARH TG+KVA+K + +E++ ++L++H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 80 VRLYEVIDT--------NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
V L E+ T +YL+ + + + + + ++ +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRVMQMLLNGL 130
Query: 132 SFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE-----TSCGSLAYSA 186
+ H+ ++HRD+K NV+ GV+KL DFG + F+ + + +L Y
Sbjct: 131 YYIHRNKILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 187 PEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDV 234
PE+LLG+ P +D+W G I+ + Q + L +I +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 3e-54
Identities = 71/249 (28%), Positives = 113/249 (45%), Gaps = 11/249 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFT-GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKL---VQ 75
Y+ +G G + V AR + G VA+K + + +EV ++ +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 76 HPNVVRLYEVI-----DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRA 130
HPNVVRL++V D +KL L+ E D + G+ ++ Q++R
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 128
Query: 131 ISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEIL 190
+ F H VVHRDLKP+N++ G +KL DFG + ++ L + +L Y APE+L
Sbjct: 129 LDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 187
Query: 191 LGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSR 250
L SY VD+WS+G I + + F+ ++D + L I+DV W
Sbjct: 188 LQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 251 RRTTRKPSP 259
R+ S
Sbjct: 247 RQAFHSKSA 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 6e-54
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 11/215 (5%)
Query: 26 LGRGHFAVVKLARHVFTGEK--VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLY 83
LG G+F V+ + ++ VA+KV+ + + + + +E + M + +P +VRL
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ-GTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRD 143
V L L++E+ GG L+ +++ + + E Q+ + + + + VHRD
Sbjct: 76 GVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 134
Query: 144 LKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS----CGSLAYSAPEILLGDSYDAPA 199
L NV+ R K++DFG S T+ L + APE + +
Sbjct: 135 LAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 192
Query: 200 VDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
DVWS GV ++ L GQ P+++ E + I
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 7e-54
Identities = 62/251 (24%), Positives = 117/251 (46%), Gaps = 12/251 (4%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
++ +Y + +G G + V A TG KVA+K + + + Y+E+R +K +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 75 QHPNVVRLYEV------IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIV 128
+H NV+ L +V +D + YL++ G +MKH+ L E + Q++
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPF--MGTDLGKLMKHE-KLGEDRIQFLVYQML 131
Query: 129 RAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPE 188
+ + + H ++HRDLKP N+ E +K+ DFG + ++ + Y APE
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLAR--QADSEMTGYVVTRWYRAPE 188
Query: 189 ILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPR 248
++L VD+WS+G I+ ++ G+ F+ ++ + L IM V+ + + +
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 249 SRRRTTRKPSP 259
+ K P
Sbjct: 249 DEAKNYMKGLP 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 9e-54
Identities = 52/217 (23%), Positives = 100/217 (46%), Gaps = 9/217 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
+ +G G F +V L + +KVA+K I + +S++ +E M + HP +
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKL 62
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
V+LY V + + L+ E + G L DY+ + + +++ + V
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC--GSLAYSAPEILLGDSYDA 197
+HRDL N + E V+K++DFG + Q ++ + +++PE+ Y
Sbjct: 123 IHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS- 180
Query: 198 PAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
DVWS GV+++ + G+ P++ ++SE + I
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-53
Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 11/218 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
L E LG G F V + + KVAVK + + +S D E MK +QH +
Sbjct: 15 LKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQRL 70
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKLH 138
VRLY V+ T +Y+I E + G L D++ L+ + AQI ++F + +
Sbjct: 71 VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--KLETSCGSLAYSAPEILLGDSYD 196
+HRDL+ N++ + K+ DFG + + E + + ++APE + ++
Sbjct: 130 YIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 197 APAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
DVWS G++L ++ G+ P+ + E + +
Sbjct: 189 -IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (433), Expect = 9e-53
Identities = 48/224 (21%), Positives = 93/224 (41%), Gaps = 13/224 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEK---VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
+E+ +G G F V G++ VA+K + + E M H
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFDH 86
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
PNV+ L V+ ++ + +I E + G L ++ ++D + I + +
Sbjct: 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS------CGSLAYSAPEIL 190
++ VHRDL N++ V K++DFG S T + ++APE +
Sbjct: 147 MNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 191 LGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ A DVWS G++++ ++ G+ P+ + + + + I
Sbjct: 206 QYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 9e-53
Identities = 77/214 (35%), Positives = 122/214 (57%), Gaps = 6/214 (2%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQ-DHLYQEVRCMKLVQHPN 78
+D +TLG G F V L +H +G A+K++DK K+ + Q +H E R ++ V P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 79 VVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH 138
+V+L NS LY+++E GG+++ ++ + SE +AR Y AQIV + H L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAP 198
+++RDLKPEN++ ++ G +++TDFGF+ R T CG+ APEI+L Y+
Sbjct: 162 LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILSKGYN-K 217
Query: 199 AVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
AVD W+LGV++Y + AG PF + I+
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (432), Expect = 9e-53
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 8/217 (3%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
++ LG G + V VAVK + + D + + +E MK ++HPN+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNL 75
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG-LSETYAREYFAQIVRAISFCHKLH 138
V+L V Y+I E G+L DY+ + + +S QI A+ + K +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS--CGSLAYSAPEILLGDSYD 196
+HRDL N + E +VK+ DFG S + + ++APE L + +
Sbjct: 136 FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 197 APAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
DVW+ GV+L+ + D + +++
Sbjct: 195 -IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-52
Identities = 65/222 (29%), Positives = 91/222 (40%), Gaps = 12/222 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEK---VAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQ 75
L E LG G F VV+ K VAVK + L P + D +EV M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
H N++RLY V+ T + ++ EL G L D + KH Y Q+ + +
Sbjct: 70 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS----CGSLAYSAPEILL 191
+HRDL N++ R +VK+ DFG A+ APE L
Sbjct: 129 SKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 192 GDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIM 232
++ A D W GV L+ M GQ P+ N S+ L I
Sbjct: 188 TRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 1e-51
Identities = 59/245 (24%), Positives = 106/245 (43%), Gaps = 10/245 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y +G G + V A TG +VAVK + + + Y+E+R +K ++H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 80 VRLYEVIDTNSKL-----YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
+ L +V L ++ G DL + + L++ + + QI+R + +
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYI 137
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDS 194
H ++HRDLKP N+ E +K+ DFG + + + Y APEI+L
Sbjct: 138 HSADIIHRDLKPSNLAVNED-CELKILDFGLARHTDDEMT--GYVATRWYRAPEIMLNWM 194
Query: 195 YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSRRRTT 254
+ VD+WS+G I+ L+ G+ F + + L +I+ + + + R
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 255 RKPSP 259
+
Sbjct: 255 IQSLT 259
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-51
Identities = 58/246 (23%), Positives = 92/246 (37%), Gaps = 35/246 (14%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGE-----KVAVKVIDKTKLDPVSQDHLYQEVRCM-KL 73
+ + LG G F V A + +VAVK++ + K D ++ L E++ M +L
Sbjct: 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALMSELKMMTQL 97
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETY-------------- 119
H N+V L + +YLI E GDL +Y+ SE
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 120 --------AREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171
+ Q+ + + F VHRDL NV+ VVK+ DFG +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMS 216
Query: 172 GQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSET 227
+ + + APE L Y DVWS G++L+ + G P+
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 228 LTMIMD 233
++
Sbjct: 276 FYKLIQ 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 3e-51
Identities = 59/221 (26%), Positives = 96/221 (43%), Gaps = 10/221 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKT---KLDPVSQDHLYQEVRCMKLVQH 76
+ + LG G F V + GEKV + V K P + + E M V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
P+V RL + T+ + LI +L G L DY+ +H + Y + QI + +++
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC---GSLAYSAPEILLGD 193
+VHRDL NV+ VK+TDFG + +K + + + A E +L
Sbjct: 130 RRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 194 SYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
Y DVWS GV ++ ++ G P+ SE +++
Sbjct: 189 IYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-51
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 10/220 (4%)
Query: 20 YDLEETLGRGHFAVVKLARHVFT---GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH 76
+L +G G F V ++ VA+K ++ QE M+ H
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDH 67
Query: 77 PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK 136
P++V+L VI T + +++I+EL G+L ++ L Y Q+ A+++
Sbjct: 68 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC--GSLAYSAPEILLGDS 194
VHRD+ NV+ VKL DFG S + S + + APE +
Sbjct: 127 KRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 195 YDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ A DVW GV ++ +L+ G PFQ +++ + I +
Sbjct: 186 FT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-51
Identities = 76/238 (31%), Positives = 130/238 (54%), Gaps = 14/238 (5%)
Query: 6 SRSSDGHPTKIAGL--YDLEETLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKL--DP 58
+ + GH K+ G+ ++L + LG G + V L R + TG+ A+KV+ K +
Sbjct: 11 TANLTGHAEKV-GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA 69
Query: 59 VSQDHLYQEVRCMKLVQH-PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSE 117
+ +H E + ++ ++ P +V L+ T +KL+LIL+ +GG+L+ ++ + + +E
Sbjct: 70 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTE 128
Query: 118 TYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP--GQKL 175
+ Y +IV A+ HKL +++RD+K EN++ G V LTDFG S F ++
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERA 187
Query: 176 ETSCGSLAYSAPEILLG-DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
CG++ Y AP+I+ G DS AVD WSLGV++Y L+ G +PF + + I
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 6e-51
Identities = 44/228 (19%), Positives = 85/228 (37%), Gaps = 15/228 (6%)
Query: 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
++ Y L +G G F + L + GE+VA+K+ L+ E + K++
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMM 59
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
Q + +++ G L D S Q++ I +
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 135 HKLHVVHRDLKPENVVFF--ERLGVVKLTDFGFSNRFNPGQ--------KLETSCGSLAY 184
H + +HRD+KP+N + ++ +V + DFG + ++ + + + G+ Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 185 SAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIM 232
++ LG D+ SLG +L G P+Q +
Sbjct: 180 ASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 5e-50
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 11/217 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
LE LG+G F V + +VA+K + + P + QE + MK ++H +
Sbjct: 19 LRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKL 74
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLS-ETYAREYFAQIVRAISFCHKLH 138
V+LY V+ + +Y++ E G L D++ + AQI +++ +++
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133
Query: 139 VVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--KLETSCGSLAYSAPEILLGDSYD 196
VHRDL+ N++ E V K+ DFG + + + + + ++APE L +
Sbjct: 134 YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192
Query: 197 APAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIM 232
DVWS G++L + G+ P+ + E L +
Sbjct: 193 -IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 7e-50
Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 4/242 (1%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y+ E +G G + V A++ T E VA+K + D +E+ +K ++H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 80 VRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHV 139
VRL++V+ ++ KL L+ E D + + + + Q+++ + FCH +V
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 140 VHRDLKPENVVFFERLGVVKLTDFGFSNRFN-PGQKLETSCGSLAYSAPEILLGDSYDAP 198
+HRDLKP+N++ G +KL +FG + F P + +L Y P++L G +
Sbjct: 123 LHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 199 AVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSRRRTTRKP 257
++D+WS G I + AG+ F + + L I + + W +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241
Query: 258 SP 259
P
Sbjct: 242 YP 243
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 163 bits (413), Expect = 9e-50
Identities = 43/234 (18%), Positives = 85/234 (36%), Gaps = 19/234 (8%)
Query: 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ 75
+ Y + +G G F V+ ++ ++VA+K + P L E R KL+
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP----QLRDEYRTYKLLA 58
Query: 76 H-PNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
+ +Y L+++L G L D + S Q++ +
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDL-LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 135 HKLHVVHRDLKPENVVFFERL----GVVKLTDFGFSNRFNPG--------QKLETSCGSL 182
H+ +V+RD+KP+N + ++ + DFG + ++ + G+
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236
Y + LG D+ +LG + + G P+Q + + E
Sbjct: 178 RYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 1e-49
Identities = 56/239 (23%), Positives = 97/239 (40%), Gaps = 12/239 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV 79
Y + +G G +V A VA+K + + + Y+E+ MK V H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 80 VRLYEVIDTNSK------LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISF 133
+ L V +YL++EL D M+ D Q++ I
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD----HERMSYLLYQMLCGIKH 134
Query: 134 CHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGD 193
H ++HRDLKP N+V +K+ DFG + + + Y APE++LG
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 194 SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPRSRRR 252
Y VD+WS+G I+ +V + F + + +++ + C + + + R
Sbjct: 194 GYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 7e-49
Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 20/232 (8%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVID-KTKLDPVSQDHLYQEVRCM-KLVQHP 77
++ +G G+F V AR G ++ + K E+ + KL HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 78 NVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHD---------------AGLSETYARE 122
N++ L + LYL +E G+L D++ K + LS
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSCGSL 182
+ A + R + + + +HRDL N++ E V K+ DFG S K +
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPV 190
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ A E L Y DVWS GV+L+ ++ G P+ +E +
Sbjct: 191 RWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 2e-48
Identities = 53/246 (21%), Positives = 87/246 (35%), Gaps = 35/246 (14%)
Query: 20 YDLEETLGRGHFAVVKLARH-----VFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
+ +G G F V AR VAVK++ + + Q +E M
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEF 73
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHD---------------------- 112
+PN+V+L V + L+ E GDL +++
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 113 -AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP 171
LS Q+ +++ + VHRDL N + E VVK+ DFG S
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYS 192
Query: 172 GQKLETS---CGSLAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSET 227
+ + + PE + + Y DVW+ GV+L+ + G P+ E
Sbjct: 193 ADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251
Query: 228 LTMIMD 233
+ + D
Sbjct: 252 IYYVRD 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-48
Identities = 48/259 (18%), Positives = 101/259 (38%), Gaps = 30/259 (11%)
Query: 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ 75
IA L+E++G+G F V + GE+VAVK+ + E+ +++
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER---SWFREAEIYQTVMLR 55
Query: 76 HPNVVRLYEVI----DTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAI 131
H N++ T ++L+L+ + + G L+DY+ ++ ++ + +
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGL 113
Query: 132 SFCH--------KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-----KLETS 178
+ H K + HRDLK +N++ + G + D G + R +
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 179 CGSLAYSAPEILLGDSYDA-----PAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233
G+ Y APE+L D++++G++ + + + D + +
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232
Query: 234 VSESSCTCWWRGRPRSRRR 252
S+ S + + R
Sbjct: 233 PSDPSVEEMRKVVCEQKLR 251
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-47
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 12/223 (5%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGEK----VAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ 75
++ +G G F V + K VA+K + + E M
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-GYTEKQRVDFLGEAGIMGQFS 67
Query: 76 HPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCH 135
H N++RL VI + +I E + G L ++ + D S I + +
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 136 KLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS----CGSLAYSAPEILL 191
++ VHRDL N++ V K++DFG S + + + ++APE +
Sbjct: 128 NMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 192 GDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ A DVWS G++++ ++ G+ P+ E ++ E + I D
Sbjct: 187 YRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 1e-45
Identities = 51/225 (22%), Positives = 87/225 (38%), Gaps = 13/225 (5%)
Query: 19 LYDLEETLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ 75
+ E +GRGHF V + AVK +++ D E MK
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFS 86
Query: 76 HPNVVRLYEV-IDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFC 134
HPNV+ L + + + ++L GDL ++I + + Q+ + + F
Sbjct: 87 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 135 HKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETSC-----GSLAYSAPEI 189
VHRDL N + E+ VK+ DFG + + + + A E
Sbjct: 147 ASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 190 LLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
L + DVWS GV+L+ ++ G P+ + N + ++
Sbjct: 206 LQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-45
Identities = 47/241 (19%), Positives = 85/241 (35%), Gaps = 30/241 (12%)
Query: 20 YDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCM-KL 73
+TLG G F V A VAVK++ + ++ L E++ + L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYL 83
Query: 74 VQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH-----------------DAGLS 116
H N+V L +I E GDL +++ + + L
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 117 ETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLE 176
+ Q+ + ++F + +HRDL N++ + K+ DFG +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYV 202
Query: 177 TS---CGSLAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIM 232
+ + APE + Y DVWS G+ L+ + G +P+ ++
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 233 D 233
Sbjct: 262 K 262
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-43
Identities = 55/240 (22%), Positives = 95/240 (39%), Gaps = 28/240 (11%)
Query: 20 YDLEETLGRGHFAVVKLARHVFTGE-------KVAVKVIDKTKLDPVSQDHLYQEVRCMK 72
L + LG G F V LA + + KVAVK++ + D + +
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 73 LVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKH---------------DAGLSE 117
+ +H N++ L + LY+I+E G+L +Y+ + LS
Sbjct: 75 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134
Query: 118 TYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLET 177
Q+ R + + +HRDL NV+ E V+K+ DFG + + +
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKK 193
Query: 178 S---CGSLAYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ + + APE L Y DVWS GV+L+ + G +P+ E ++ +
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 6e-43
Identities = 51/232 (21%), Positives = 89/232 (38%), Gaps = 21/232 (9%)
Query: 20 YDLEETLGRGHFAVVKLARH-----VFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
+ LG+G F +V +VA+K +++ + E MK
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEF 80
Query: 75 QHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAG---------LSETYAREYFA 125
+VVRL V+ +I+EL GDL Y+ S + +
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 126 QIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKLETS---CGSL 182
+I +++ + VHRDL N + E VK+ DFG + +
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 183 AYSAPEILLGDSYDAPAVDVWSLGVILY-MLVAGQAPFQEANDSETLTMIMD 233
+ +PE L + DVWS GV+L+ + + P+Q ++ + L +M+
Sbjct: 200 RWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 3e-40
Identities = 55/239 (23%), Positives = 89/239 (37%), Gaps = 27/239 (11%)
Query: 20 YDLEETLGRGHFAVVKLAR-----HVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV 74
L + LGRG F V A T VAVK++ + + + + + +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 75 QHPNVVRLYEVI-DTNSKLYLILELGDGGDLYDYIMKHD---------------AGLSET 118
H NVV L L +I+E G+L Y+ L+
Sbjct: 75 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134
Query: 119 YAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ---KL 175
+ Y Q+ + + F +HRDL N++ E+ VVK+ DFG + +
Sbjct: 135 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRK 193
Query: 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQA-PFQEANDSETLTMIMD 233
+ L + APE + Y DVWS GV+L+ + + A P+ E +
Sbjct: 194 GDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (325), Expect = 3e-36
Identities = 53/271 (19%), Positives = 104/271 (38%), Gaps = 38/271 (14%)
Query: 12 HPTKI-----AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQ 66
HP Y L LG GHF+ V LA+ + VA+K++ D V +
Sbjct: 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAED 58
Query: 67 EVRCMKLVQHPNVVRL---------------YEVIDTNSKLYLILELGDGGDLYDYIMKH 111
E++ ++ V + + + ++ E+ L
Sbjct: 59 EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE 118
Query: 112 DAGLSETYAREYFAQIVRAISFC-HKLHVVHRDLKPENVVF-----FERLGVVKLTDFGF 165
G+ Y ++ Q++ + + + ++H D+KPENV+ E L +K+ D G
Sbjct: 119 HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 178
Query: 166 SNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ----- 220
+ ++ S + Y +PE+LLG + D+WS +++ L+ G F+
Sbjct: 179 ACWYDEHYT--NSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGH 235
Query: 221 -EANDSETLTMIMDVSESSCTCWWRGRPRSR 250
D + + I+++ + R +R
Sbjct: 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTR 266
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.4 bits (195), Expect = 8e-19
Identities = 24/164 (14%), Positives = 47/164 (28%), Gaps = 31/164 (18%)
Query: 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQE----------- 67
+ + + +G G + V + VK
Sbjct: 1 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59
Query: 68 -----VRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYARE 122
R ++ +Q V ++Y +++EL K + E
Sbjct: 60 SARNEFRALQKLQGLAVPKVYAWEGN----AVLMEL--------IDAKELYRVRVENPDE 107
Query: 123 YFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFS 166
I+ ++ + +VH DL NV+ E + + DF S
Sbjct: 108 VLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 259 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.92 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.4 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.33 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.75 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.62 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.41 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-50 Score=330.02 Aligned_cols=229 Identities=35% Similarity=0.679 Sum_probs=184.3
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.++.++|++.+.||+|+||.||+|.+..+++.||||++....... ....+.+|+.+++.++||||+++++++.+++.++
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 457889999999999999999999999999999999997654322 3456778999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee--cCCeEEEEeccccccCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE--RLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~--~~~~i~l~df~~~~~~~~ 171 (259)
+||||++|++|.+++...+ .+++.++..++.||+.||.|||++||+|+||||+||++.. +++.++|+|||++.....
T Consensus 84 lvmE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EEECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 9999999999999997654 4999999999999999999999999999999999999953 347899999999987766
Q ss_pred CCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 172 GQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 172 ~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
........++..|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+....+++....++.+.|..
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTT
T ss_pred CCeeeeeeeCccccCcHHHcCCCCCc-HHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccC
Confidence 66666678999999999998887775 99999999999999999999999999999999998777666555443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=322.84 Aligned_cols=218 Identities=34% Similarity=0.605 Sum_probs=193.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+++++.++||||+++++++.+++..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999875432 223456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
|||+++++|.+++..... +++..+..++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++..... ...
T Consensus 85 mEy~~~g~L~~~l~~~~~-l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~~kl~DFG~a~~~~~-~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPS-SRR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEECCCCSCSCCCC-CCC
T ss_pred EeecCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCC-CCEeecccceeeecCC-Ccc
Confidence 999999999999987654 9999999999999999999999999999999999999776 7899999999976543 334
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
....++..|+|||++.+..++. ++|||||||++|+|++|+.||...+..+.+..+.+.....
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~-~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 223 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 223 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC
T ss_pred cccCCCCcccCHHHHcCCCCCc-hhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 4557899999999999887765 9999999999999999999999999999999888766544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.4e-50 Score=334.76 Aligned_cols=230 Identities=28% Similarity=0.508 Sum_probs=205.9
Q ss_pred CccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 14 TKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 14 ~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
+.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.++++++||||+++++++.+++.++
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456788999999999999999999999999999999987643 334567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee-cCCeEEEEeccccccCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE-RLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~-~~~~i~l~df~~~~~~~~~ 172 (259)
+||||++|++|.+.+.....++++.+++.++.||+.||.|||++||+|+||||+|||++. +.+.++|+|||++......
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999999999988777767999999999999999999999999999999999999963 4478999999999888776
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
.......++..|+|||++.+..++. ++|||||||++|+|++|++||.+.+..+.+..+.+...+++...|.+-
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 255 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGF-YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCH-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTS
T ss_pred CceeeccCcccccCHHHHcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 6667778999999999999888875 999999999999999999999999999999999988777666555443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.1e-50 Score=334.66 Aligned_cols=228 Identities=30% Similarity=0.581 Sum_probs=204.4
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
.+.++|++.+.||+|+||.||+|.+..+|..||||++.... ......+.+|++++++++||||+++++++.+.+.+++
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46789999999999999999999999999999999987543 3345778899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec-CCeEEEEeccccccCCCCC
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER-LGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~-~~~i~l~df~~~~~~~~~~ 173 (259)
||||++|++|.+++......+++..++.++.||+.||.|||++||+|+||||+||++..+ ++.++|+|||++.......
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999999999997666669999999999999999999999999999999999999643 4689999999998877766
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
......++..|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+.+..+......++...|.+
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~~~-~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 251 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPVGY-YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 251 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCBCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGG
T ss_pred ccceecCcccccCHHHHcCCCCCh-hHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 666778999999999999888775 99999999999999999999999999999999998777666555444
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=327.50 Aligned_cols=232 Identities=31% Similarity=0.520 Sum_probs=198.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.++|++.+.||+|+||.||+|.+..+++.||||++.+... .......+.+|++++++++||||+++++++.+++.+++|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999875431 233467789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC--
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-- 173 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-- 173 (259)
|||+++++|.+++...+. +++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++..+....
T Consensus 87 mEy~~gg~L~~~~~~~~~-l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp ECCCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhccCC-CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCC-ceEEecccccceecccCCcc
Confidence 999999999999877654 9999999999999999999999999999999999999776 789999999998764332
Q ss_pred -ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc-----------cc
Q psy3663 174 -KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC-----------TC 241 (259)
Q Consensus 174 -~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-----------~~ 241 (259)
......|+..|+|||++.+..++. ++|||||||++|+|++|+.||...+..+.+..+.+....++ ..
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred cccccccCCccccCceeeccCCCCc-ccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 223456899999999999888875 99999999999999999999999998899999887655443 33
Q ss_pred ccccCchhhh
Q psy3663 242 WWRGRPRSRR 251 (259)
Q Consensus 242 ~~~~~~~~~~ 251 (259)
+|..+|..|.
T Consensus 244 ~L~~dP~~R~ 253 (288)
T d1uu3a_ 244 LLVLDATKRL 253 (288)
T ss_dssp TSCSSGGGST
T ss_pred HccCCHhHCc
Confidence 5566666654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=327.46 Aligned_cols=212 Identities=35% Similarity=0.624 Sum_probs=181.7
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
+.++|++.+.||+|+||.||+|.+..+|+.||||++..... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 57899999999999999999999999999999999976542 22345688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC--
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-- 173 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-- 173 (259)
|||+++++|.+++.... .+++.+++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++.......
T Consensus 82 mEy~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~-~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCCTTCEECEETTEE
T ss_pred EeccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC-CCEEEccchhheeeccCCcc
Confidence 99999999999886544 49999999999999999999999999999999999999766 789999999997654332
Q ss_pred -ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy3663 174 -KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTM 230 (259)
Q Consensus 174 -~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (259)
......|++.|+|||++.+..+++.++|||||||++|+|++|++||...........
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~ 217 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 223456899999999998887765589999999999999999999987665544333
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=322.16 Aligned_cols=228 Identities=36% Similarity=0.639 Sum_probs=201.4
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC----cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD----PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.+.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 86 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 3678999999999999999999999999999999999765432 224678899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCC---eEEEEeccccc
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLG---VVKLTDFGFSN 167 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~---~i~l~df~~~~ 167 (259)
.+++||||+++++|.+++..... +++..++.++.||+.||.|||++||+|+||||+||++..+.. .++++|||++.
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~-l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCccccchhccccc-cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999999987654 999999999999999999999999999999999999976532 59999999998
Q ss_pred cCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccc
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
............++..|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+.+..+......++...+.
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCC-cccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 877666666677899999999998877765 9999999999999999999999999999999988876665544433
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=323.21 Aligned_cols=213 Identities=28% Similarity=0.509 Sum_probs=189.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 4689999999999999999999999999999999876542 24577899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Ccc
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~ 175 (259)
||+.+++|.+++... .+++.+++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++...... ...
T Consensus 97 Ey~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp ECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSTTCCB
T ss_pred EecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC-CcEeeccchhheeeccccccc
Confidence 999999999987664 49999999999999999999999999999999999999766 78999999999876543 334
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVS 235 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (259)
....++..|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~ 232 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred cccccCCCccChhhhcCCCCCc-hhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Confidence 5567899999999999887775 9999999999999999999999888888777776543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=324.04 Aligned_cols=215 Identities=28% Similarity=0.480 Sum_probs=189.1
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
+.|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 57999999999999999999999999999999987643 3456778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Cccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~~ 176 (259)
|+++++|.+++.+...++++..+..++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++...... ....
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~-~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECHHHHHHHT
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC-CCEEEEechhhhccCCCccccc
Confidence 999999999988777779999999999999999999999999999999999999776 78999999998654322 2233
Q ss_pred cccCCCccCCccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccc
Q psy3663 177 TSCGSLAYSAPEILL-----GDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 177 ~~~~~~~~~apE~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
...++..|+|||++. +..++ .++|||||||++|+|++|+.||.+.+..+.+..+.+...
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~-~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~ 232 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP 232 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTT-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC
T ss_pred ccccccccCCHHHHhhcccCCCCCC-hhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 457899999999984 23344 599999999999999999999999999999888887643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-49 Score=326.58 Aligned_cols=221 Identities=31% Similarity=0.534 Sum_probs=196.3
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.++|++.+.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 4689999999999999999999999999999999976432 233467788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCC-CCc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNP-GQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~-~~~ 174 (259)
|||+.|++|.+++..... +++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++..... ...
T Consensus 84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~-g~vkl~DFG~a~~~~~~~~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCSCCTTCC
T ss_pred eeccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCC-CCEEEeecccccccccCCcc
Confidence 999999999999887665 8999999999999999999999999999999999999776 8999999999986543 334
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT 240 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (259)
....+|++.|+|||++.+..++. ++|+|||||++|+|++|++||...+..+.+..+......++.
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~-~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~ 226 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred cccceeCHHHhhhhhccCCCCCh-hhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc
Confidence 45567899999999999988875 999999999999999999999999998888888876655443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=321.01 Aligned_cols=220 Identities=32% Similarity=0.506 Sum_probs=183.6
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCeEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT--NSKLYL 94 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 94 (259)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+......+...+.+.+|++++++++||||+++++++.+ .+.+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 478999999999999999999999999999999998877666667888999999999999999999999864 466899
Q ss_pred EEeccCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----cEeccCCCCCeEeeecCCeEEEEecccc
Q psy3663 95 ILELGDGGDLYDYIMKH---DAGLSETYAREYFAQIVRAISFCHKLH-----VVHRDLKPENVVFFERLGVVKLTDFGFS 166 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~---~~~~~~~~i~~~~~ql~~al~~LH~~~-----i~H~dl~p~nIlv~~~~~~i~l~df~~~ 166 (259)
||||+++++|.+++.+. ...+++..++.++.||+.||.|||+.+ |+|+||||+||+++.+ +.++|+|||++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~-~~vkl~DFG~a 161 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLA 161 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT-SCEEECCHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC-CcEEEeeccce
Confidence 99999999999998643 456999999999999999999999876 9999999999999776 78999999999
Q ss_pred ccCCCCCc-cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccc
Q psy3663 167 NRFNPGQK-LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 167 ~~~~~~~~-~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
........ .....+++.|+|||++.+..++. ++|||||||++|+|++|+.||...+..+....+.+.....
T Consensus 162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~ 233 (269)
T d2java1 162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNE-KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR 233 (269)
T ss_dssp HHC-----------CCCSCCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred eecccCCCccccCCCCcccCCHHHHcCCCCCh-HHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 87654332 34457899999999998887775 9999999999999999999999998888888888765543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=326.08 Aligned_cols=227 Identities=25% Similarity=0.475 Sum_probs=204.3
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
++.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+++++.++||||+++++++.+++.+++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999999999999999999997643 234567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec-CCeEEEEeccccccCCCCC
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER-LGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~-~~~i~l~df~~~~~~~~~~ 173 (259)
||||++|++|.+++...+..+++.+++.++.||+.||.|||++||+|+||||+||+++.+ ...++|+|||.+.......
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 999999999999998777679999999999999999999999999999999999999754 3579999999998877666
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
......++..|+|||.+.+..++. ++|||||||++|+|++|.+||...+..+.+..|.+....++.+.|.+
T Consensus 159 ~~~~~~~t~~y~ape~~~~~~~~~-~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred cccccccccccccchhccCCCCCc-hhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccC
Confidence 666677899999999998888775 99999999999999999999999999999999998887776665554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=312.30 Aligned_cols=214 Identities=25% Similarity=0.461 Sum_probs=183.4
Q ss_pred ccCe-eEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec----CCe
Q psy3663 17 AGLY-DLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT----NSK 91 (259)
Q Consensus 17 ~~~y-~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 91 (259)
.++| ++.+.||+|+||.||+|.+..++..|++|.+............+.+|++++++++||||+++++++.+ +..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 3455 78889999999999999999999999999998776666667788999999999999999999999864 456
Q ss_pred EEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 92 LYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLH--VVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~--i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
+++||||+++++|.+++.+... +++..++.++.||+.||.|||+++ |+|+||||+||+++++++.++|+|||++...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~-~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEeCCCCCcHHHHHhcccc-ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 8999999999999999977654 999999999999999999999998 9999999999999765588999999999754
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHH-HHHhhhc
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSET-LTMIMDV 234 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~i~~~ 234 (259)
. ........+++.|+|||++.+ .++ .++|||||||++|+|++|+.||.+...... ...+.+.
T Consensus 166 ~-~~~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~ 228 (270)
T d1t4ha_ 166 R-ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 228 (270)
T ss_dssp C-TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred c-CCccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC
Confidence 3 334455679999999999876 355 599999999999999999999987665554 4444443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.9e-48 Score=311.48 Aligned_cols=224 Identities=38% Similarity=0.612 Sum_probs=196.3
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCccc-------HHHHHHHHHHHHhCC-CCCeEEEEEEEe
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVS-------QDHLYQEVRCMKLVQ-HPNVVRLYEVID 87 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~-------~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 87 (259)
|.++|++.+.||+|+||.||+|.+..+++.||||++.+....... ...+.+|+.++++++ ||||+++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 468999999999999999999999999999999999876543222 245778999999997 999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
+++..++||||+++++|.+++...+. +++..++.++.||++||.|||++||+|+||+|+||+++.+ +.++|+|||++.
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~-l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~-~~~kl~DFG~a~ 158 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSC 158 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-CCEEECCCTTCE
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCC-CCeEEccchhee
Confidence 99999999999999999999987654 9999999999999999999999999999999999999666 789999999998
Q ss_pred cCCCCCccccccCCCccCCcccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccc
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLG-----DSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTC 241 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (259)
............++..|.|||.+.+ ....+.++||||+||++|+|++|++||.+.+..+....+.+....++.+
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 8776666666778999999998853 2223459999999999999999999999999999999888776554443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-48 Score=314.47 Aligned_cols=232 Identities=28% Similarity=0.470 Sum_probs=192.4
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS- 90 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 90 (259)
|..+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+++++.++||||+++++++...+
T Consensus 2 p~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred CcCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 67889999999999999999999999999999999999986543 2334567889999999999999999999986543
Q ss_pred ---eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 91 ---KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 91 ---~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.+|+||||++|++|.+++...+. +++.+++.++.||+.||.+||++||+|+||||+||+++.+ +.++++||+.+.
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~~~~-l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~-~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISAT-NAVKVMDFGIAR 159 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-SCEEECCCTTCE
T ss_pred CCceEEEEEECCCCCEehhhhcccCC-CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcc-ccceeehhhhhh
Confidence 48999999999999998876654 9999999999999999999999999999999999999777 789999999876
Q ss_pred cCCCCC----ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccc
Q psy3663 168 RFNPGQ----KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWW 243 (259)
Q Consensus 168 ~~~~~~----~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 243 (259)
...... ......++..|+|||++.+..++. ++|||||||++|+|++|++||...+..+.+..++.....++...+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCc-ceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence 543322 233446899999999998887775 999999999999999999999999888888888877666555544
Q ss_pred ccCc
Q psy3663 244 RGRP 247 (259)
Q Consensus 244 ~~~~ 247 (259)
.+-|
T Consensus 239 ~~~s 242 (277)
T d1o6ya_ 239 EGLS 242 (277)
T ss_dssp SSCC
T ss_pred cCCC
Confidence 4433
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-48 Score=318.84 Aligned_cols=218 Identities=29% Similarity=0.573 Sum_probs=193.2
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.++|++.+.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 3679999999999999999999999999999999975422 223467788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
|||+.|++|..++..... +++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++..... ..
T Consensus 83 mE~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~-g~vkL~DFG~a~~~~~--~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD--VT 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT-SCEEECCCSSCEECSS--CB
T ss_pred eeecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCC-CCEEEecCccceEecc--cc
Confidence 999999999998876654 8999999999999999999999999999999999999766 8999999999987643 33
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
....|+..|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+....++......+
T Consensus 159 ~~~~Gt~~Y~APE~l~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p 221 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP 221 (316)
T ss_dssp CCCCSCTTTCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC
T ss_pred ccccCcccccCHHHHcCCCCCc-hhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence 4567899999999998888875 99999999999999999999999999999988887655443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=320.84 Aligned_cols=206 Identities=25% Similarity=0.465 Sum_probs=181.5
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
..++|++.+.||+|+||.||+|.+..+|+.||+|+++... .......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3578999999999999999999999999999999997653 344567889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
|||+.+++|.+++.+.+. +++..++.++.||+.||.|||+ +||+|+||||+||+++++ +.++|+|||++..... ..
T Consensus 83 mEy~~gg~L~~~l~~~~~-l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~-~~vkl~DFGla~~~~~-~~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR-GEIKLCDFGVSGQLID-SM 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTT-CCEEECCCCCCHHHHH-HT
T ss_pred EEcCCCCcHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCC-CCEEEeeCCCccccCC-Cc
Confidence 999999999999987654 9999999999999999999997 599999999999999766 7899999999876532 22
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (259)
.....++..|+|||++.+..++. ++||||+||++|+|++|+.||...+..+
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~-~~DiWSlGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCT-THHHHHHHHHHHHHHHSSCCSSCCCTTH
T ss_pred cccccCCccccCchHHcCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 34557899999999999988875 9999999999999999999997765443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-48 Score=311.50 Aligned_cols=212 Identities=23% Similarity=0.422 Sum_probs=178.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|+||.||+|. .+..||||+++...........+.+|+.++++++||||+++++++.+ ..+++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~---~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEE---SSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEE---ECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 5789999999999999999997 34469999998776666677889999999999999999999998754 5678999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC---
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ--- 173 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~--- 173 (259)
||+++++|.+++.....++++..+..++.||++||.|||+++|+|+||||+||+++.+ +.++|+|||++.......
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~-~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT-SSEEECCCCCSCC--------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCC-CCEEEccccceeeccccCCcc
Confidence 9999999999998777779999999999999999999999999999999999999766 789999999987654322
Q ss_pred ccccccCCCccCCcccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 174 KLETSCGSLAYSAPEILLGDS--YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
......+++.|+|||++.+.. ..+.++|||||||++|||++|+.||.+.+....+..++.
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~ 223 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHh
Confidence 223456889999999986432 223499999999999999999999998887776665554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=313.91 Aligned_cols=227 Identities=34% Similarity=0.584 Sum_probs=194.4
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|+||.||+|.+..+|+.||||++......+.....+.+|++++++++||||+++++++.+.+.++++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999999999999999997765555556788899999999999999999999999999999999
Q ss_pred ccCCCChHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-Ccc
Q psy3663 98 LGDGGDLYDYI-MKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-QKL 175 (259)
Q Consensus 98 ~~~~~sL~~~~-~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~~~ 175 (259)
++.+ .+..++ ......+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||.+...... ...
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~-~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECSTTHHHHHCCCSBCT
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc-CcceeccCCcceeccCCcccc
Confidence 9977 555544 4445669999999999999999999999999999999999999766 78999999999766443 333
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
....++..|+|||.+....+.+.++|+|||||++|+|++|+.||...+..+.+..+.+..+.+....|..-
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 44578999999999888777666999999999999999999999999999999999888877777666543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-47 Score=320.37 Aligned_cols=218 Identities=35% Similarity=0.578 Sum_probs=193.7
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.++|++++.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+++++.++||||+++++++.+....+++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 4799999999999999999999999999999999875431 223456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
|+++.+++|..++..... +++..++.++.||+.||.|||++||+|+||||+|||++.+ +.++|+|||++...... .
T Consensus 120 ~e~~~~g~l~~~l~~~~~-l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~-g~ikL~DFG~a~~~~~~--~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCC-CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-SCEEECCCTTCEECSSC--B
T ss_pred cccccccchhhhHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCC-CCEEeeeceeeeecccc--c
Confidence 999999999999977654 9999999999999999999999999999999999999766 78999999999876533 3
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSC 239 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (259)
....++..|+|||++.+..++. ++|||||||++|+|++|+.||.+.+....+..+......++
T Consensus 196 ~~~~Gt~~Y~APE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p 258 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSKGYNK-AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP 258 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ccccCccccCCHHHHcCCCCCc-cccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC
Confidence 4457899999999999888775 99999999999999999999999988888888887665443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-47 Score=313.54 Aligned_cols=215 Identities=27% Similarity=0.422 Sum_probs=186.0
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
.+.|+..+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 35699999999999999999999999999999999765433 23356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 96 LELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
|||+.+++|..++... .++++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++..... .
T Consensus 94 ~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~-~~~Kl~DFG~a~~~~~---~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAP---A 168 (309)
T ss_dssp EECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT-TEEEECCCTTCBSSSS---B
T ss_pred EEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCC-CCEEEeecccccccCC---C
Confidence 9999998887665544 459999999999999999999999999999999999999766 8999999999976543 3
Q ss_pred ccccCCCccCCcccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccc
Q psy3663 176 ETSCGSLAYSAPEILLGD---SYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
....|++.|+|||++.+. .++ .++|||||||++|+|++|..||.+.+..+.+..+.....+
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~-~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~ 232 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC
T ss_pred CccccCccccCHHHHhccCCCCcC-chhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC
Confidence 445789999999998643 344 4999999999999999999999998888888877765443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-47 Score=313.60 Aligned_cols=232 Identities=21% Similarity=0.396 Sum_probs=185.4
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCc---eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGE---KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~---~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.++|++.+.||+|+||.||+|.+..+++ .|+||.+.... .......+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 4689999999999999999999876665 57888876543 3445567899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++|||+++++|.+++......+++.++..++.||+.||.|||+++|+|+||||+||+++.+ +.++|+|||++.......
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCC----------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCC-CcEEECCcccceEccCCC
Confidence 9999999999999988877779999999999999999999999999999999999999766 789999999997664432
Q ss_pred ccc------cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc-------
Q psy3663 174 KLE------TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC------- 239 (259)
Q Consensus 174 ~~~------~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~------- 239 (259)
... ...++..|+|||.+.+..++. ++|||||||++|||+| |++||.+.+..+.+..+.+....+.
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCc-ccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHH
Confidence 221 124578899999998887775 9999999999999998 8999999999888888876654332
Q ss_pred -----ccccccCchhhh
Q psy3663 240 -----TCWWRGRPRSRR 251 (259)
Q Consensus 240 -----~~~~~~~~~~~~ 251 (259)
..+|..+|..|.
T Consensus 262 l~~li~~cl~~~P~~RP 278 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRP 278 (299)
T ss_dssp HHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCHhHCc
Confidence 345666666553
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=312.48 Aligned_cols=232 Identities=31% Similarity=0.489 Sum_probs=196.1
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCC-CcccHHHHHHHHHHHH-hCCCCCeEEEEEEEecCCeEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DPVSQDHLYQEVRCMK-LVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~l 94 (259)
.++|++.+.||+|+||.||+|.+..+++.||||++.+... .......+..|..++. .++||||+++++++.+.+..++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 3689999999999999999999999999999999975421 1223455566666654 6899999999999999999999
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC-C
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG-Q 173 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~-~ 173 (259)
||||+.+++|.+++..... +++.+++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||.+...... .
T Consensus 81 vmEy~~~g~L~~~i~~~~~-~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~-~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSS-CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT-SCEEECCCTTCBCCCCTTC
T ss_pred EEeecCCCcHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC-Cceeccccchhhhcccccc
Confidence 9999999999999987654 8999999999999999999999999999999999999766 88999999999765433 3
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccc-----------cc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCT-----------CW 242 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~-----------~~ 242 (259)
......++..|+|||++.+..++. ++|||||||++|+|++|+.||.+.+..+.+..+.......+. .+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNH-SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCCc-hhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 334457899999999999988875 999999999999999999999999999988888766544332 25
Q ss_pred cccCchhhh
Q psy3663 243 WRGRPRSRR 251 (259)
Q Consensus 243 ~~~~~~~~~ 251 (259)
|..+|..|.
T Consensus 238 L~~dP~~R~ 246 (320)
T d1xjda_ 238 FVREPEKRL 246 (320)
T ss_dssp SCSSGGGSB
T ss_pred cccCCCCCc
Confidence 666666654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=305.08 Aligned_cols=228 Identities=25% Similarity=0.460 Sum_probs=185.7
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 47999999999999999999976 67789999987643 345678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc--
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL-- 175 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~-- 175 (259)
|+.+++|.+++......+++..++.++.||+.||.|||+++|+||||||+||+++.+ +.++|+|||++.........
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGG-GCEEECSCC-------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCC-CCeEecccchheeccCCCceee
Confidence 999999999998877779999999999999999999999999999999999999777 78999999998765433222
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc------------ccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC------------TCW 242 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~------------~~~ 242 (259)
....++..|+|||.+.+..++. ++||||||+++|||++ |.+||...+..+.+..+........ ..+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~-k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 238 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCH-HHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred cceecCcccCChHHhcCCCCCc-hhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHH
Confidence 2345788999999999888775 9999999999999999 6777887777778888876644332 235
Q ss_pred cccCchhhh
Q psy3663 243 WRGRPRSRR 251 (259)
Q Consensus 243 ~~~~~~~~~ 251 (259)
|..+|..|.
T Consensus 239 l~~~p~~Rp 247 (263)
T d1sm2a_ 239 WKERPEDRP 247 (263)
T ss_dssp TCSSGGGSC
T ss_pred ccCCHhHCc
Confidence 666666553
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-46 Score=306.19 Aligned_cols=213 Identities=24% Similarity=0.368 Sum_probs=181.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|+||.||+|.+..++..||||+++... ...+.+.+|++++++++||||+++++++.+.+.++++|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 468999999999999999999999999999999987543 34677899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc
Q psy3663 97 ELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~ 175 (259)
||+.+++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||++.+ +.++|+|||++.........
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~-~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCCTTTCCSSSSE
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCC-CcEEEccccceeecCCCCce
Confidence 999999999998764 4568999999999999999999999999999999999999777 78999999999766543322
Q ss_pred --ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCChHHHHHhhhc
Q psy3663 176 --ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPF-QEANDSETLTMIMDV 234 (259)
Q Consensus 176 --~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~i~~~ 234 (259)
....++..|+|||++.+..++. ++|||||||++|||++|..|| ...+.....+.+.+.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~-k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~ 232 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 232 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred eeccccccccccChHHHcCCCCCc-hhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC
Confidence 2234678899999998888775 999999999999999976665 444444444444443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=309.97 Aligned_cols=223 Identities=26% Similarity=0.427 Sum_probs=186.8
Q ss_pred EeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc---cHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEec
Q psy3663 22 LEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV---SQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILEL 98 (259)
Q Consensus 22 ~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (259)
..+.||+|+||.||+|.+..+|+.||||++........ ....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46789999999999999999999999999976543222 235688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-cccc
Q psy3663 99 GDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLET 177 (259)
Q Consensus 99 ~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~~~ 177 (259)
+.++++..+ ......+++..+..++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||.+....... ....
T Consensus 82 ~~~~~~~~~-~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~-~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVII-KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp CSEEHHHHH-TTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCCGGGSTTTSCCCCCCC
T ss_pred hcchHHhhh-hhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC-CccccccCccccccCCCcccccc
Confidence 988555544 4445569999999999999999999999999999999999999766 889999999997654432 3344
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
..++..|+|||++......+.++|||||||++|+|++|.+||...+..+++..|.+..+++..+-|...
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence 568899999999876655556999999999999999999999999999999999999888877666443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=302.98 Aligned_cols=214 Identities=26% Similarity=0.458 Sum_probs=188.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|+||.||+|... ++..||||.++.... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 57899999999999999999975 777899999986543 45678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc--c
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK--L 175 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~--~ 175 (259)
|+.+++|.+++......+++..++.++.||++||.|||++||+|+||+|+||+++.+ +.++|+|||++........ .
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTT-CCEEECCCSSCCBCSSSSCCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCC-CcEEECcchhheeccCCCceee
Confidence 999999999988777779999999999999999999999999999999999999766 7899999999976543322 2
Q ss_pred ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccc
Q psy3663 176 ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 176 ~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
....++..|+|||.+.+..++. ++||||||+++|||+| |+.||...+..+....+.+....
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~-ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~ 220 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL 220 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred cccCCCCCcCCcHHhcCCCCCc-ceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC
Confidence 2345788999999998888775 9999999999999998 89999999999988888876443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=308.01 Aligned_cols=228 Identities=30% Similarity=0.469 Sum_probs=194.4
Q ss_pred ccCeeEeeeecccccceEEEEEEeec-CceEEEEEcccCCCCcccHHHHHHHHHHHHhC---CCCCeEEEEEEEe-----
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFT-GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV---QHPNVVRLYEVID----- 87 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~-~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~----- 87 (259)
.++|++.+.||+|+||.||+|.+..+ ++.||||++............+.+|+.+++.+ +||||+++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47999999999999999999998755 56789999976554444445566777776665 7999999999984
Q ss_pred cCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 88 TNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.....+++||++.++.+..........+++..++.++.||+.||.|||++||+|+||||+|||++.+ +.++|+|||.+.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~-~~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCC-CCeeecchhhhh
Confidence 2357899999998866665555556669999999999999999999999999999999999999766 789999999988
Q ss_pred cCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 168 RFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
............++..|+|||++.+..++. ++||||+||++|+|++|++||...+..+++..+++..+.+....|...
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~-~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhcccccCCCcccChhhcCcchhcCCCCCh-hehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence 766666666778999999999999888876 999999999999999999999999999999999998888776666544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.7e-46 Score=312.24 Aligned_cols=210 Identities=30% Similarity=0.473 Sum_probs=177.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCC-cccHHHHH---HHHHHHHhCCCCCeEEEEEEEecCCeE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-PVSQDHLY---QEVRCMKLVQHPNVVRLYEVIDTNSKL 92 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~-~~~~~~~~---~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (259)
.++|++.+.||+|+||.||+|.+..+|+.||||++.+.... ......+. +++.+++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 36899999999999999999999999999999998653211 11122233 346777788899999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
++||||+.|++|.+++..... +++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++......
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~-~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~-g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV-FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH-GHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS-CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-SCEEECCCTTCEECSSS
T ss_pred EEEEEecCCCcHHHHHHhccc-ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCC-CcEEEeeeceeeecCCC
Confidence 999999999999999987654 8999999999999999999999999999999999999766 88999999999876543
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHH
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (259)
......++..|+|||++......+.++|||||||++|+|++|+.||...+..+...
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 216 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 216 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 34456799999999999765444459999999999999999999998776655444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-45 Score=301.41 Aligned_cols=226 Identities=30% Similarity=0.536 Sum_probs=193.9
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|+||.||+|.++ +|+.||||++............+.+|+.++++++||||+++++++.+.+..+++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 69999999999999999999986 78999999997765555557889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc-cc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK-LE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~-~~ 176 (259)
++.++ +...+......+++..++.++.||+.||++||+.||+|+||||+||+++.+ +.++++|||.+........ ..
T Consensus 81 ~~~~~-~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~-~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 81 HLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp CCSEE-HHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-SCEEECCTTHHHHHCC------
T ss_pred eehhh-hHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC-CCEEecccccceecccCccccc
Confidence 99874 444455555669999999999999999999999999999999999999776 7899999999977543322 33
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
...++..|+|||.+.+....+.++|+|||||++|+|++|++||...+..+++.++.+..+.+....|...
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence 4457889999999987766556999999999999999999999999999999999988888877777543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=300.35 Aligned_cols=229 Identities=24% Similarity=0.465 Sum_probs=191.4
Q ss_pred cCeeEeee-ecccccceEEEEEEeec--CceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEE
Q psy3663 18 GLYDLEET-LGRGHFAVVKLARHVFT--GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 18 ~~y~~~~~-i~~g~~~~vy~~~~~~~--~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (259)
++|.+.+. ||+|+||.||+|.+... +..||||++.... .......+.+|++++++++||||+++++++.++ ..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEE
Confidence 56888885 99999999999976543 4479999987543 344567789999999999999999999998764 5789
Q ss_pred EEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 95 ILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 95 v~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
||||+++++|.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++........
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEET-TEEEECCCTTCEECTTCSC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccC-Cceeeccchhhhccccccc
Confidence 999999999999987776679999999999999999999999999999999999999777 8999999999987654332
Q ss_pred c----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc----------
Q psy3663 175 L----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC---------- 239 (259)
Q Consensus 175 ~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~---------- 239 (259)
. ....++..|+|||.+....++. ++|||||||++|||+| |+.||.+.+..+....+.++..+..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCCCCCc-cchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 2 2234678899999998877775 9999999999999998 9999999999988888887654432
Q ss_pred --ccccccCchhh
Q psy3663 240 --TCWWRGRPRSR 250 (259)
Q Consensus 240 --~~~~~~~~~~~ 250 (259)
..+|..+|.+|
T Consensus 244 li~~cl~~~p~~R 256 (285)
T d1u59a_ 244 LMSDCWIYKWEDR 256 (285)
T ss_dssp HHHHTTCSSGGGS
T ss_pred HHHHHcCCCHhHC
Confidence 23566666666
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=308.63 Aligned_cols=211 Identities=32% Similarity=0.532 Sum_probs=180.2
Q ss_pred CCCccccCeeEee-eecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHh-CCCCCeEEEEEEEec-
Q psy3663 12 HPTKIAGLYDLEE-TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKL-VQHPNVVRLYEVIDT- 88 (259)
Q Consensus 12 ~~~~~~~~y~~~~-~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~- 88 (259)
....+.++|++.+ .||+|+||.||+|.+..+++.||||++.. ...+.+|+.++.+ .+||||++++++|.+
T Consensus 5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 3456788999875 59999999999999999999999999853 3457789988654 579999999999865
Q ss_pred ---CCeEEEEEeccCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeec--CCeEEEEe
Q psy3663 89 ---NSKLYLILELGDGGDLYDYIMKHD-AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFER--LGVVKLTD 162 (259)
Q Consensus 89 ---~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~--~~~i~l~d 162 (259)
...+++||||++|++|.+++...+ ..+++.+++.++.||+.||.|||++||+|+||||+||+++.+ .+.++|+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 467899999999999999998753 459999999999999999999999999999999999999763 35799999
Q ss_pred ccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHH
Q psy3663 163 FGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTM 230 (259)
Q Consensus 163 f~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 230 (259)
||++.............+++.|+|||++.+..++. ++|||||||++|+|++|++||.+.+..+....
T Consensus 158 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~-~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~ 224 (335)
T d2ozaa1 158 FGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224 (335)
T ss_dssp CTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSH-HHHHHHHHHHHHHHTTSSCSCEETTCC-----
T ss_pred cceeeeccCCCccccccCCcccCCcHHHcCCCCCH-HHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH
Confidence 99998877666667778999999999998887775 99999999999999999999987766554443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=304.80 Aligned_cols=215 Identities=26% Similarity=0.416 Sum_probs=179.6
Q ss_pred cCeeEeeeecccccceEEEEEEeecCc-----eEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGE-----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~-----~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 91 (259)
++|++.+.||+|+||.||+|.+...++ .|++|.+.... .......+.+|+.++.++ +||||+++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 689999999999999999999875544 68999886543 233456788999999988 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCe
Q psy3663 92 LYLILELGDGGDLYDYIMKHD----------------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENV 149 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~----------------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nI 149 (259)
.++||||+++++|.+++.... ..+++..++.++.||++||.|||+++|+|+||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 999999999999999997643 2378899999999999999999999999999999999
Q ss_pred EeeecCCeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCCh
Q psy3663 150 VFFERLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDS 225 (259)
Q Consensus 150 lv~~~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 225 (259)
+++.+ +.++|+|||++......... ....++..|+|||++.+..++. ++|||||||++|||++ |.+||.+.+..
T Consensus 196 ll~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 196 LVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI-KSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCc-ceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99766 89999999999765433322 2344688999999998888775 9999999999999997 89999988777
Q ss_pred HHHHHhhhcc
Q psy3663 226 ETLTMIMDVS 235 (259)
Q Consensus 226 ~~~~~i~~~~ 235 (259)
+.+..+++..
T Consensus 274 ~~~~~~~~~~ 283 (325)
T d1rjba_ 274 ANFYKLIQNG 283 (325)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHhcC
Confidence 7776666543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=299.19 Aligned_cols=211 Identities=25% Similarity=0.472 Sum_probs=176.7
Q ss_pred eeecccccceEEEEEEee--cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEeccCC
Q psy3663 24 ETLGRGHFAVVKLARHVF--TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILELGDG 101 (259)
Q Consensus 24 ~~i~~g~~~~vy~~~~~~--~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (259)
+.||+|+||.||+|.... .++.||||++.....++.....+.+|+.++++++||||+++++++.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 479999999999998653 456899999976655555567899999999999999999999999764 56899999999
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc----cc
Q psy3663 102 GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL----ET 177 (259)
Q Consensus 102 ~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~----~~ 177 (259)
++|.+++..... +++..++.++.||+.||.|||+++|+|+||||+||+++.+ +.++|+|||++......... ..
T Consensus 92 g~L~~~l~~~~~-l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~-~~~kl~DFGla~~~~~~~~~~~~~~~ 169 (277)
T d1xbba_ 92 GPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTH 169 (277)
T ss_dssp EEHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEECCTTCSEEEC---
T ss_pred CcHHHHHhhccC-CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccccc-Ccccccchhhhhhccccccccccccc
Confidence 999999876554 9999999999999999999999999999999999999777 89999999999766543322 22
Q ss_pred ccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc
Q psy3663 178 SCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 178 ~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
..++..|+|||.+.+..++. ++||||||+++|||++ |++||.+.+..+....+.++....
T Consensus 170 ~~gt~~y~APE~l~~~~~~~-~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~ 230 (277)
T d1xbba_ 170 GKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 230 (277)
T ss_dssp -CCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cCCCceecCchhhcCCCCCc-hhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 35778999999998877775 9999999999999998 899999998888888887755433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=306.56 Aligned_cols=226 Identities=26% Similarity=0.445 Sum_probs=192.6
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS---- 90 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 90 (259)
++.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 4789999999999999999999999999999999999876655566778899999999999999999999997654
Q ss_pred --eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 91 --KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 91 --~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.++++|||+ +.+|..+.... .+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++++|||.+..
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~-~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED-CELKILDFGLARQ 170 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEE
T ss_pred cceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccc-cccccccccceec
Confidence 579999999 55787776543 49999999999999999999999999999999999999776 7899999999987
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
... ......++..|+|||++.+....+.++||||+||++|+|++|++||.+.+..+.+..+.+..+.++.++|...
T Consensus 171 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 643 3445678899999999987666556999999999999999999999999999999999999888887766543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=299.21 Aligned_cols=230 Identities=25% Similarity=0.445 Sum_probs=193.5
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-------
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT------- 88 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 88 (259)
-.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|++++++++||||+++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 3799999999999999999999999999999999998766556667788899999999999999999998754
Q ss_pred -CCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 89 -NSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 89 -~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
++..+++||++.++ +..........+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++.
T Consensus 88 ~~~~~~iv~e~~~~~-~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~-~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD-GVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEE-HHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-SCEEECCCTTCE
T ss_pred cCceEEEEEeccCCC-ccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCC-CcEEeeecceee
Confidence 35689999999774 444444555569999999999999999999999999999999999999776 789999999997
Q ss_pred cCCCCC-----ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccc
Q psy3663 168 RFNPGQ-----KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCW 242 (259)
Q Consensus 168 ~~~~~~-----~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (259)
...... ......++..|+|||++.+....++++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++..+
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 654322 223345789999999998765444599999999999999999999999999999999999999988887
Q ss_pred cccCc
Q psy3663 243 WRGRP 247 (259)
Q Consensus 243 ~~~~~ 247 (259)
|.+..
T Consensus 246 ~~~~~ 250 (318)
T d3blha1 246 WPNVD 250 (318)
T ss_dssp STTCC
T ss_pred ccccc
Confidence 76654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=299.72 Aligned_cols=204 Identities=32% Similarity=0.538 Sum_probs=176.3
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcc----cHHHHHHHHHHHHhCC--CCCeEEEEEEEecC
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPV----SQDHLYQEVRCMKLVQ--HPNVVRLYEVIDTN 89 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~----~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~ 89 (259)
+.++|++.+.||+|+||.||+|.+..+|..||||++........ ....+.+|+.++++++ ||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 57899999999999999999999999999999999976543221 1233568999999987 89999999999999
Q ss_pred CeEEEEEeccCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 90 SKLYLILELGDG-GDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 90 ~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
+..++|||++.+ +++.+++.... .+++.+++.++.||+.||.|||++||+|+||||+||+++.+.+.++|+|||.+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CeEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 999999999975 57777776654 4999999999999999999999999999999999999987767999999999976
Q ss_pred CCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 169 FNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
... .......++..|+|||.+.+..+++.++|||||||++|+|++|+.||..
T Consensus 161 ~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 161 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 543 3444567899999999998777665579999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-45 Score=303.88 Aligned_cols=221 Identities=28% Similarity=0.412 Sum_probs=188.4
Q ss_pred CeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec------CCeE
Q psy3663 19 LYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT------NSKL 92 (259)
Q Consensus 19 ~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 92 (259)
+|+..+.||+|+||.||+|.+..+|+.||||++...... ..+|++++++++||||+++++++.. ..+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 799999999999999999999999999999999765321 2379999999999999999999843 3457
Q ss_pred EEEEeccCCCChHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 93 YLILELGDGGDLYDYIM--KHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~--~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
+++|||+.++.+..+.. .....+++..++.++.||+.||+|||++||+|+||||+||+++.+...++|+|||++....
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 89999998743333322 2355699999999999999999999999999999999999998775689999999998877
Q ss_pred CCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhcccccccccccc
Q psy3663 171 PGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRG 245 (259)
Q Consensus 171 ~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (259)
.........++..|+|||.+.+....+.++||||+||++|+|++|+.||...+..+++..+.+..+++..++|..
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 666666778899999999987765545699999999999999999999999999999999998888776665543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=293.00 Aligned_cols=218 Identities=24% Similarity=0.399 Sum_probs=177.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecC---ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTG---EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
.++|++.+.||+|+||.||+|.+..++ ..|+||.+.... .......+.+|+.++++++||||+++++++.+ +..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEE
Confidence 478999999999999999999876543 368888875433 34456778899999999999999999999864 6689
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+||||+.+++|.+++.....++++..++.++.||++||.|||+++|+|+||||+||+++.+ +.++|+|||++.......
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~-~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEET-TEEEECC-----------
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCC-CcEEEccchhheeccCCc
Confidence 9999999999999988877779999999999999999999999999999999999999777 799999999997654332
Q ss_pred c--cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc
Q psy3663 174 K--LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 174 ~--~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
. .....++..|+|||.+.+..++. ++|||||||++|||++ |.+||...+..+.+..+.+....+
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~-~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~ 229 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 229 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred ceeccceecCcccchhhHhccCCCCC-ccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 2 23345678999999998877775 9999999999999998 899999999999999988766543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-45 Score=293.29 Aligned_cols=216 Identities=27% Similarity=0.438 Sum_probs=181.6
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLI 95 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (259)
-.++|++.+.||+|+||.||+|.+. ++..||||.+.... ...+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 3579999999999999999999975 56789999987543 345678999999999999999999998755 557899
Q ss_pred EeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
|||+.+++|.+++... ..++++..++.++.||++||.|||+++|+||||||+||+++.+ +.++|+|||++........
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~-~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT-SCEEECCCTTCEECSSSCE
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecc-cceeeccccceEEccCCcc
Confidence 9999999999876543 3358999999999999999999999999999999999999766 7899999999987654332
Q ss_pred --cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccc
Q psy3663 175 --LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 175 --~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
.....++..|+|||++.+..++. ++|||||||++|||+| |.+||...+..+.+..+.+...+.
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~-~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~ 230 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTI-KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccccccCCcccccChHHHhCCCCCc-hhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 23345778999999998777765 9999999999999999 566777777777888877665443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=296.44 Aligned_cols=229 Identities=28% Similarity=0.433 Sum_probs=186.9
Q ss_pred cCeeEeeeecccccceEEEEEEeecCc----eEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGE----KVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~----~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
++|++.+.||+|+||.||+|.+..+|+ +|++|.+.... .......+.+|+.++++++||||+++++++.++. .+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-ee
Confidence 469999999999999999999887776 57888876433 3345678899999999999999999999998754 56
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++++++.+++|.+.+......+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++.......
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~-~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEET-TEEEECCCSHHHHTTTTC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCC-CCeEeeccccceeccccc
Confidence 7788888889999988887789999999999999999999999999999999999999777 799999999998765433
Q ss_pred cc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhcccccc----------
Q psy3663 174 KL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSC---------- 239 (259)
Q Consensus 174 ~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~---------- 239 (259)
.. ....++..|+|||.+.+..++. ++|||||||++|||+| |.+||.+.+..+....+.++...+.
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~-~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCCh-hhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 32 2235688999999998887775 9999999999999998 8999999888888888876654432
Q ss_pred --ccccccCchhh
Q psy3663 240 --TCWWRGRPRSR 250 (259)
Q Consensus 240 --~~~~~~~~~~~ 250 (259)
..+|..+|..|
T Consensus 245 li~~cl~~dP~~R 257 (317)
T d1xkka_ 245 IMVKCWMIDADSR 257 (317)
T ss_dssp HHHHHTCSSGGGS
T ss_pred HHHHhCCCChhhC
Confidence 24566666655
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-44 Score=292.38 Aligned_cols=218 Identities=22% Similarity=0.356 Sum_probs=177.1
Q ss_pred cCeeEeeeecccccceEEEEEEeecC----ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTG----EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~----~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
+.|++.+.||+|+||.||+|....++ ..||||.+.... .......+.+|++++++++||||+++++++.+....+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 46999999999999999999876554 369999986543 3344567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
++||++.++++.+++......+++.++..++.||+.|+.|||+++|+|+||||+|||++.+ +.++|+|||++.......
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC--------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCC-CeEEEcccchhhcccCCC
Confidence 9999999999999888877779999999999999999999999999999999999999776 789999999997654332
Q ss_pred c----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHhhhccccc
Q psy3663 174 K----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAG-QAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 174 ~----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
. .....++..|+|||.+.+..++. ++|||||||++|||+++ .+||...+..+.+..+.+...++
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~-~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~ 233 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 233 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC
T ss_pred ccceEeccCCCCccccCHHHHccCCCCC-cccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC
Confidence 2 12234678899999998888775 99999999999999995 55566666777777776654433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=300.83 Aligned_cols=225 Identities=24% Similarity=0.417 Sum_probs=185.9
Q ss_pred CCccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC--
Q psy3663 13 PTKIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS-- 90 (259)
Q Consensus 13 ~~~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 90 (259)
.-++..+|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CCCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred ccCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 3467789999999999999999999999999999999997543 3344667889999999999999999999986542
Q ss_pred ---eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 91 ---KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 91 ---~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
.++++++ +.+++|.+++... .+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++.
T Consensus 82 ~~~~~~l~~~-~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~-~~~kl~DfG~a~ 157 (345)
T d1pmea_ 82 QMKDVYLVTH-LMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT-CDLKICDFGLAR 157 (345)
T ss_dssp TCCCEEEEEE-CCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCE
T ss_pred ccceEEEEEe-ecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCC-CCEEEcccCcee
Confidence 3555554 5578999999764 48999999999999999999999999999999999999766 789999999987
Q ss_pred cCCCCCc----cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccc
Q psy3663 168 RFNPGQK----LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCW 242 (259)
Q Consensus 168 ~~~~~~~----~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (259)
....... .....++..|+|||++......+.++||||+||++|+|++|+.||...+..+....+......+....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 6543322 33446788999999986665555699999999999999999999999998888888887776665443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=290.25 Aligned_cols=225 Identities=26% Similarity=0.452 Sum_probs=182.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCeEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT-NSKLYLI 95 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 95 (259)
.++|++.+.||+|+||.||+|.. .|..||||+++... ..+.+.+|++++++++||||+++++++.+ ++.+++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 35799999999999999999985 57899999996543 45778899999999999999999998854 5668999
Q ss_pred EeccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCc
Q psy3663 96 LELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQK 174 (259)
Q Consensus 96 ~e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~ 174 (259)
|||+++++|.+++... ...+++..++.++.||+.|+.|||+++|+|+||+|+||+++.+ +.++++|||++......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~-~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED-NVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-SCEEECCCCC---------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCC-CCEeecccccceecCCC--
Confidence 9999999999998654 2348999999999999999999999999999999999999766 78999999998765432
Q ss_pred cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccccccc------------c
Q psy3663 175 LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSESSCT------------C 241 (259)
Q Consensus 175 ~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~------------~ 241 (259)
.....++..|+|||.+.+..++. ++||||||+++|||++ |++||......+....+.+...+..+ .
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~-~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 235 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred CccccccccCCChHHHhCCCCCh-HHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence 33345678999999998877765 9999999999999998 79999999999999998875554433 3
Q ss_pred ccccCchhhh
Q psy3663 242 WWRGRPRSRR 251 (259)
Q Consensus 242 ~~~~~~~~~~ 251 (259)
+|..+|.+|.
T Consensus 236 cl~~dP~~Rp 245 (262)
T d1byga_ 236 CWHLDAAMRP 245 (262)
T ss_dssp HTCSSGGGSC
T ss_pred HcccCHhHCc
Confidence 5677776663
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=289.97 Aligned_cols=225 Identities=26% Similarity=0.457 Sum_probs=194.1
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEEe
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLILE 97 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (259)
++|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 68999999999999999999999999999999998776556667889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC-ccc
Q psy3663 98 LGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-KLE 176 (259)
Q Consensus 98 ~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-~~~ 176 (259)
++.++++..++... ..+++..++.++.|++.||+|||++||+|+||||+||++..+ +.++|+|||.+....... ...
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~-~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT-CCEEECCCTTCEECCSCCSCCC
T ss_pred eccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC-CceeeeecchhhcccCCCccce
Confidence 99987777766544 458999999999999999999999999999999999999766 789999999998765433 233
Q ss_pred cccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCCChHHHHHhhhccccccccccc
Q psy3663 177 TSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPF-QEANDSETLTMIMDVSESSCTCWWR 244 (259)
Q Consensus 177 ~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (259)
...++..|.|||.+......+.++|||||||++|+|++|+.|| ...+..+.+..+....+++...+|.
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence 3456788999999887765556999999999999999999885 5666677788888777776666554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=290.85 Aligned_cols=216 Identities=31% Similarity=0.480 Sum_probs=175.2
Q ss_pred cCeeEeeeecccccceEEEEEEeec-C--ceEEEEEcccCCCC-cccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFT-G--EKVAVKVIDKTKLD-PVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~-~--~~~~lK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (259)
++|++.+.||+|+||.||+|..... + ..||||++...... ....+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 5799999999999999999976533 2 36899998765432 33456789999999999999999999999764 567
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ 173 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~ 173 (259)
+||||+.++++.+++.....++++..+..++.||+.||.|||++||+|+||||+||+++.+ +.++|+|||++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~-~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEET-TEEEECCCTTCEECCC-C
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccc-cceeeccchhhhhcccCC
Confidence 9999999999999888777779999999999999999999999999999999999999887 799999999998765443
Q ss_pred cc----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHHHhhhccc
Q psy3663 174 KL----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLTMIMDVSE 236 (259)
Q Consensus 174 ~~----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 236 (259)
.. ....++..|+|||.+.+..++. ++||||||+++|||++ |.+||.+.+..+.+..+.+...
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~ 232 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred CcceecCccccCcccCCHHHHhCCCCCc-chhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC
Confidence 32 1224567899999998877775 9999999999999998 8999999999999888876543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=302.16 Aligned_cols=227 Identities=25% Similarity=0.417 Sum_probs=187.3
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec------C
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT------N 89 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~ 89 (259)
+.++|++.+.||+|+||+||+|.+..+|..||||++............+.+|+.++++++||||+++++++.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4578999999999999999999999999999999998776666666778899999999999999999999853 4
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
..++++|||+.+ ++.+.+. ..+++..++.++.||+.||.+||++||+|+||||+||++..+ +.++++||+.+...
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~-~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD-CTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT-CCEEECCCCC----
T ss_pred ceeEEEEeccch-HHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccc-cceeeechhhhhcc
Confidence 689999999977 4444442 348999999999999999999999999999999999999776 78999999998877
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccCch
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGRPR 248 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (259)
..........++..|+|||++.+..++. ++||||+||++++|++|++||...+......++++..+++..++|..-..
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~l~~~~~~~-~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccccccccccccccccChhhhcCCCCCC-CcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 7666666677899999999998887775 99999999999999999999999999999999999999988887765433
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=289.64 Aligned_cols=215 Identities=26% Similarity=0.435 Sum_probs=176.8
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCeEEEEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (259)
.++|++.+.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.++++++||||+++++++.+ +..++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence 478999999999999999999976 446799999975542 45778999999999999999999999855 4578999
Q ss_pred eccCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCC--
Q psy3663 97 ELGDGGDLYDYIMKH-DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQ-- 173 (259)
Q Consensus 97 e~~~~~sL~~~~~~~-~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~-- 173 (259)
||+.+++|..++... ...+++.+++.++.||+.||.+||++||+|+||||+||+++.+ +.++|+|||++.......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~-~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCCTTC--------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCC-CcEEEcccchhhhccCCCce
Confidence 999999999887654 3458999999999999999999999999999999999999776 789999999997654332
Q ss_pred ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHhhhccccc
Q psy3663 174 KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAG-QAPFQEANDSETLTMIMDVSESS 238 (259)
Q Consensus 174 ~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~ 238 (259)
......++..|+|||.+....++. ++||||||+++|||++| .+||......+.+..+.+....+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~-ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred eeccccccccccChHHHhCCCCCc-HHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 223346788999999998888875 99999999999999995 55667777777888877655443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-43 Score=294.27 Aligned_cols=213 Identities=26% Similarity=0.513 Sum_probs=182.6
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEec--CCeE
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDT--NSKL 92 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~~ 92 (259)
-.++|++.+.||+|+||.||+|.+..+|+.||||++... ....+.+|+++++.++ ||||+++++++.. ....
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 346899999999999999999999999999999998643 3567889999999996 9999999999874 4568
Q ss_pred EEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCC
Q psy3663 93 YLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPG 172 (259)
Q Consensus 93 ~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~ 172 (259)
+++|||+.+++|..+. ..+++..++.++.||+.||.|||++||+|+||||+|||++.+++.++|+|||++......
T Consensus 108 ~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999998887653 349999999999999999999999999999999999999877678999999999887766
Q ss_pred CccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-hHHHHHhhhcccc
Q psy3663 173 QKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAND-SETLTMIMDVSES 237 (259)
Q Consensus 173 ~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~i~~~~~~ 237 (259)
.......++..|+|||.+.+....+.++|+||+||++++|++|+.||..... .++...+.+..++
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~ 249 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCH
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCC
Confidence 6666677899999999988766545599999999999999999999976553 4455555555443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-44 Score=297.99 Aligned_cols=227 Identities=25% Similarity=0.411 Sum_probs=191.0
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTN----- 89 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (259)
++.++|++.+.||+|+||.||+|.+..+|+.||||++.....+......+.+|+++++.++||||+++++++...
T Consensus 15 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EEETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred cCCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 346799999999999999999999999999999999987765556667888999999999999999999998532
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccC
Q psy3663 90 SKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRF 169 (259)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~ 169 (259)
...+++++++.+++|.+++... .+++.+++.++.||+.||.|||++||+|+||||+||+++.+ +.++++|||.+...
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~-~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED-CELKILDFGLARHT 171 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-CCEEECCC----CC
T ss_pred CceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccc-ccccccccchhccc
Confidence 2345556666788999988653 49999999999999999999999999999999999999776 88999999998654
Q ss_pred CCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhhccccccccccccC
Q psy3663 170 NPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMDVSESSCTCWWRGR 246 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (259)
. .......++..|+|||.+.+....+.++|||||||++|+|++|++||.+.+.......+.+..+.+..+.+...
T Consensus 172 ~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 172 D--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp T--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred C--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 3 33445567889999999888776666999999999999999999999999999999999988887766655443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-42 Score=284.26 Aligned_cols=206 Identities=20% Similarity=0.318 Sum_probs=177.5
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCC-CCeEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQH-PNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 93 (259)
.++++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|++.++.++| +|++.+++++.+....+
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 35789999999999999999999999999999999986543 23446788899999975 89999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee----cCCeEEEEeccccccC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE----RLGVVKLTDFGFSNRF 169 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~----~~~~i~l~df~~~~~~ 169 (259)
+|||++ +++|.+++......++...+..++.|++.+|++||++||+|+||||+||++.. ..+.++|+|||++...
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 999999 56999999887777999999999999999999999999999999999999964 2468999999999765
Q ss_pred CCCC--------ccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChH
Q psy3663 170 NPGQ--------KLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSE 226 (259)
Q Consensus 170 ~~~~--------~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 226 (259)
.... ......|++.|+|||.+.+..++. ++||||||+++|+|++|+.||.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~-~~DiwSlG~~l~elltg~~Pf~~~~~~~ 220 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGLKAAT 220 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCCh-HHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence 4321 122346899999999999887775 9999999999999999999998655443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-43 Score=287.61 Aligned_cols=218 Identities=24% Similarity=0.367 Sum_probs=182.5
Q ss_pred ccCeeEeeeecccccceEEEEEEeecCce--EEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCeEE
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTGEK--VAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~~~--~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (259)
.++|++.+.||+|+||.||+|.+..++.. |+||.+.... .......+.+|++++.++ +||||+++++++.+++..+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 36999999999999999999999888774 6677765433 233456789999999998 6999999999999999999
Q ss_pred EEEeccCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeE
Q psy3663 94 LILELGDGGDLYDYIMKH---------------DAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVV 158 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~---------------~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i 158 (259)
+||||+++++|.+++... ...+++..++.++.||+.|+.|||+++|+|+||||+|||++.+ +.+
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~-~~~ 166 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVA 166 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG-GCE
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC-Cce
Confidence 999999999999998653 3558999999999999999999999999999999999999777 789
Q ss_pred EEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHhhhcccc
Q psy3663 159 KLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAG-QAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 159 ~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
+|+|||++.............++..|+|||.+.+..++. ++||||||+++|||++| .+||...+..+....+.+....
T Consensus 167 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~ 245 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 245 (309)
T ss_dssp EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred EEccccccccccccccccceecCCcccchHHhccCCCCc-cceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Confidence 999999997665544444556788999999998888775 99999999999999996 5689988888888888765443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-43 Score=285.71 Aligned_cols=221 Identities=26% Similarity=0.443 Sum_probs=182.2
Q ss_pred ccCeeEeeeecccccceEEEEEEeecC-------ceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEec
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHVFTG-------EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDT 88 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~~~~-------~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (259)
.++|++.+.||+|+||.||+|.+...+ ..||||+++... .......+.+|...+.++ +||||+++++++.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 579999999999999999999876544 379999997644 334457777888888887 79999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee
Q psy3663 89 NSKLYLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE 153 (259)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~ 153 (259)
++..++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+||+++.
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence 999999999999999999997653 34899999999999999999999999999999999999976
Q ss_pred cCCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHH
Q psy3663 154 RLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLT 229 (259)
Q Consensus 154 ~~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (259)
+ +.++|+|||.+........ .....++..|+|||.+.+..++. ++||||||+++|+|++ |++||.+.+..+.+.
T Consensus 171 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~-k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 171 D-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp T-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred C-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCc-hhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 6 7899999999876543322 23345778999999998888775 9999999999999998 799999988888888
Q ss_pred Hhhhccccccc
Q psy3663 230 MIMDVSESSCT 240 (259)
Q Consensus 230 ~i~~~~~~~~~ 240 (259)
.+.+...+..+
T Consensus 249 ~i~~~~~~~~p 259 (299)
T d1fgka_ 249 LLKEGHRMDKP 259 (299)
T ss_dssp HHHTTCCCCCC
T ss_pred HHHcCCCCCCC
Confidence 88776555443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-42 Score=284.95 Aligned_cols=219 Identities=24% Similarity=0.344 Sum_probs=186.5
Q ss_pred ccCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCCe
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNSK 91 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (259)
.++|++.+.||+|+||.||+|... .++..||||.+.... .......+.+|+.++++++||||+++++++.+...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 468999999999999999999865 345789999987543 33446778999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCC
Q psy3663 92 LYLILELGDGGDLYDYIMKHD-----------------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPEN 148 (259)
Q Consensus 92 ~~lv~e~~~~~sL~~~~~~~~-----------------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~n 148 (259)
.+++||++.+++|.+++.... ..++...++.++.||+.||+|||+++++||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 999999999999999986532 237889999999999999999999999999999999
Q ss_pred eEeeecCCeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCC
Q psy3663 149 VVFFERLGVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQ-APFQEAND 224 (259)
Q Consensus 149 Ilv~~~~~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~ 224 (259)
|+++.+ +.++|+|||++........ .....++..|+|||.+.+..++. ++|||||||++|||+++. +||.+.+.
T Consensus 171 ILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~-ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 171 CLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred eEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh-hhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999776 7899999999875533222 22345678899999999888875 999999999999999985 78999999
Q ss_pred hHHHHHhhhccccc
Q psy3663 225 SETLTMIMDVSESS 238 (259)
Q Consensus 225 ~~~~~~i~~~~~~~ 238 (259)
.+....+.+...++
T Consensus 249 ~e~~~~v~~~~~~~ 262 (301)
T d1lufa_ 249 EEVIYYVRDGNILA 262 (301)
T ss_dssp HHHHHHHHTTCCCC
T ss_pred HHHHHHHHcCCCCC
Confidence 99999988776543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-43 Score=289.14 Aligned_cols=215 Identities=33% Similarity=0.569 Sum_probs=181.7
Q ss_pred ccCeeEeeeecccccceEEEEEEe---ecCceEEEEEcccCCC--CcccHHHHHHHHHHHHhCCC-CCeEEEEEEEecCC
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHV---FTGEKVAVKVIDKTKL--DPVSQDHLYQEVRCMKLVQH-PNVVRLYEVIDTNS 90 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~---~~~~~~~lK~~~~~~~--~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~ 90 (259)
.++|++.+.||+|+||.||+|.+. .+|+.||||++.+... .......+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 478999999999999999999874 3578999999876432 22345667899999999987 89999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFN 170 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~ 170 (259)
.++++||++.+++|.+++..... +++..++.++.||+.||.|+|+++|+|+||||+||+++.+ +.++|+|||++....
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~-~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT-SCEEESCSSEEEECC
T ss_pred ceeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCC-CCEEEeeccchhhhc
Confidence 99999999999999999987765 7899999999999999999999999999999999999776 889999999987654
Q ss_pred CCCc--cccccCCCccCCcccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHHHhhh
Q psy3663 171 PGQK--LETSCGSLAYSAPEILLGDS-YDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLTMIMD 233 (259)
Q Consensus 171 ~~~~--~~~~~~~~~~~apE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~i~~ 233 (259)
.... .....++..|++||.+.+.. ..+.++|||||||++|+|++|+.||...+..+....+.+
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~ 246 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 246 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3322 23456889999999997653 334599999999999999999999988776666655554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-42 Score=281.65 Aligned_cols=212 Identities=26% Similarity=0.403 Sum_probs=164.8
Q ss_pred cCeeEeeeecccccceEEEEEEeec-----CceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEec-CC
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFT-----GEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDT-NS 90 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~-----~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~ 90 (259)
++|++.+.||+|+||.||+|.+... ++.||||.+.... .......+.+|..++.++ +|+||+.+++++.. +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 6899999999999999999997643 3579999987543 233455666777777666 58999999998755 45
Q ss_pred eEEEEEeccCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecC
Q psy3663 91 KLYLILELGDGGDLYDYIMKHD---------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERL 155 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~ 155 (259)
.++++|||+++++|.+++.... ..+++.++..++.||+.||.|||+++|+|+||||+||+++.+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~- 170 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK- 170 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG-
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC-
Confidence 6899999999999999987542 348899999999999999999999999999999999999776
Q ss_pred CeEEEEeccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHh
Q psy3663 156 GVVKLTDFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAG-QAPFQEANDSETLTMI 231 (259)
Q Consensus 156 ~~i~l~df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~i 231 (259)
+.++|+|||++........ .....++..|+|||.+.+..++. ++|||||||++|||+++ .+||......+.+...
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~ 249 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCc-ccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 7899999999976543322 22346788999999998887775 99999999999999986 5689877655555444
Q ss_pred h
Q psy3663 232 M 232 (259)
Q Consensus 232 ~ 232 (259)
+
T Consensus 250 ~ 250 (299)
T d1ywna1 250 L 250 (299)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-42 Score=281.16 Aligned_cols=233 Identities=24% Similarity=0.360 Sum_probs=194.6
Q ss_pred cccCeeEeeeecccccceEEEEEEee-----cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEecCC
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVF-----TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDTNS 90 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~-----~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (259)
-.++|++.+.||+|+||.||+|.+.. .+..||||.++... .......+.+|++++++++||||+++++++....
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 34899999999999999999998753 35689999997543 3445567889999999999999999999999989
Q ss_pred eEEEEEeccCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEE
Q psy3663 91 KLYLILELGDGGDLYDYIMKHD---------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLT 161 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~---------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~ 161 (259)
..++||||+.+++|.+++.... ..++...+..++.|+++||.|||+++|+|+||||+|||++.+ +.++|+
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~-~~~Kl~ 175 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIG 175 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT-CCEEEC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCC-ceEEEe
Confidence 9999999999999999886532 336889999999999999999999999999999999999766 789999
Q ss_pred eccccccCCCCCc---cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCChHHHHHhhhcccc
Q psy3663 162 DFGFSNRFNPGQK---LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAG-QAPFQEANDSETLTMIMDVSES 237 (259)
Q Consensus 162 df~~~~~~~~~~~---~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~i~~~~~~ 237 (259)
|||++........ .....++..|+|||.+.+..++. ++|+||||+++|||++| .+||.+.+..+.+..+.+....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~-~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCc-ccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 9999876543322 22335788999999998888775 99999999999999997 6899999999999998876655
Q ss_pred ccc------------cccccCchhhh
Q psy3663 238 SCT------------CWWRGRPRSRR 251 (259)
Q Consensus 238 ~~~------------~~~~~~~~~~~ 251 (259)
+.+ .+|..+|..|+
T Consensus 255 ~~p~~~~~~l~~li~~cl~~~P~~RP 280 (308)
T d1p4oa_ 255 DKPDNCPDMLFELMRMCWQYNPKMRP 280 (308)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCcccchHHHHHHHHHHcCCChhHCc
Confidence 433 24666666553
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-42 Score=281.04 Aligned_cols=228 Identities=24% Similarity=0.340 Sum_probs=180.4
Q ss_pred eEeeeecccccceEEEEEEeecC---ceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCeEEEEE
Q psy3663 21 DLEETLGRGHFAVVKLARHVFTG---EKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNVVRLYEVIDT-NSKLYLIL 96 (259)
Q Consensus 21 ~~~~~i~~g~~~~vy~~~~~~~~---~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 96 (259)
.+.+.||+|+||.||+|.+..++ ..|+||.++.. ........+.+|++++.+++||||+++++++.+ +...++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 34678999999999999876543 36899998643 244456789999999999999999999999764 56899999
Q ss_pred eccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEeccccccCCCCCcc-
Q psy3663 97 ELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDFGFSNRFNPGQKL- 175 (259)
Q Consensus 97 e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~~~~~~~~- 175 (259)
||+.+++|.+++.......+...++.++.|++.||.|||+.+|+||||||+||+++.+ +.++|+|||++.........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~-~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT-CCEEECSSGGGCCTTTTTCCC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC-CCEEEecccchhhcccccccc
Confidence 9999999999998877778899999999999999999999999999999999999766 78999999999766433222
Q ss_pred ----ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC-CCCChHHHHHhhhccccccc----------
Q psy3663 176 ----ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQ-EANDSETLTMIMDVSESSCT---------- 240 (259)
Q Consensus 176 ----~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~i~~~~~~~~~---------- 240 (259)
....++..|+|||.+.+..++. ++||||||+++|||++|..||. ..+..+....+.++..+..+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~-ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCCC-hhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 2234678999999998877775 9999999999999999666664 44555566666665544332
Q ss_pred --cccccCchhhh
Q psy3663 241 --CWWRGRPRSRR 251 (259)
Q Consensus 241 --~~~~~~~~~~~ 251 (259)
.+|..+|..|+
T Consensus 267 i~~cl~~dP~~RP 279 (311)
T d1r0pa_ 267 MLKCWHPKAEMRP 279 (311)
T ss_dssp HHHHTCSSGGGSC
T ss_pred HHHHcCCCHhHCc
Confidence 45666776663
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-42 Score=279.86 Aligned_cols=209 Identities=22% Similarity=0.316 Sum_probs=172.6
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCC-eEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPN-VVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~ 93 (259)
.++++|++.+.||+|+||.||+|.+..+|+.||||++.... ....+..|+++++.++|++ |+.+..++.++..++
T Consensus 4 ~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 79 (299)
T ss_dssp EETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEE
T ss_pred eECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEE
Confidence 46689999999999999999999999999999999987643 2334778999999998665 556666678888999
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee--cCCeEEEEeccccccCCC
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE--RLGVVKLTDFGFSNRFNP 171 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~--~~~~i~l~df~~~~~~~~ 171 (259)
++||++.+ ++...+......+++..+..++.|++.||++||++||+|+||||+||++.. ....++|+|||++.....
T Consensus 80 ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 80 MVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp EEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99999955 888887777777999999999999999999999999999999999999754 335799999999987643
Q ss_pred CCc--------cccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCChHHHH
Q psy3663 172 GQK--------LETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEANDSETLT 229 (259)
Q Consensus 172 ~~~--------~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 229 (259)
... .....++..|+|||.+.+..++. ++|||||||++|+|++|+.||..........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~ 223 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCH-HHHHHHHHHHHHHHHHSSCTTCCCC------
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCC-hhhEEecCHHHHHHHhCCCcccccchHHHHH
Confidence 221 23346899999999999888775 9999999999999999999998766554433
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=282.48 Aligned_cols=215 Identities=22% Similarity=0.388 Sum_probs=182.2
Q ss_pred ccCeeEeeeecccccceEEEEEEe-----ecCceEEEEEcccCCCCcccHHHHHHHHHHHHhC-CCCCeEEEEEEEecCC
Q psy3663 17 AGLYDLEETLGRGHFAVVKLARHV-----FTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLV-QHPNVVRLYEVIDTNS 90 (259)
Q Consensus 17 ~~~y~~~~~i~~g~~~~vy~~~~~-----~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (259)
.++|++.+.||+|+||.||+|... .++..||||.++... .......+.+|+.++.++ +||||+++++++.+..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 479999999999999999999853 455689999997654 344566788999999999 6999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeee
Q psy3663 91 KLYLILELGDGGDLYDYIMKHD-----------------AGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFE 153 (259)
Q Consensus 91 ~~~lv~e~~~~~sL~~~~~~~~-----------------~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~ 153 (259)
..+++|||+.+++|.+++.... ..+++..+..++.||+.|+.|||+++++|+||||+||+++.
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~ 180 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence 9999999999999999987543 24899999999999999999999999999999999999976
Q ss_pred cCCeEEEEeccccccCCCCCcc---ccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCChHHHH
Q psy3663 154 RLGVVKLTDFGFSNRFNPGQKL---ETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVA-GQAPFQEANDSETLT 229 (259)
Q Consensus 154 ~~~~i~l~df~~~~~~~~~~~~---~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 229 (259)
+ +.++++|||.+......... ....++..|+|||.+.+..++. ++||||||+++|||++ |.+||...+..+.+.
T Consensus 181 ~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 181 G-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp T-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred c-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCC-cccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 6 79999999999766543222 2235688999999998877775 9999999999999998 777787877777766
Q ss_pred Hhhhc
Q psy3663 230 MIMDV 234 (259)
Q Consensus 230 ~i~~~ 234 (259)
.+++.
T Consensus 259 ~~i~~ 263 (311)
T d1t46a_ 259 KMIKE 263 (311)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 66543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-40 Score=268.46 Aligned_cols=196 Identities=21% Similarity=0.417 Sum_probs=159.9
Q ss_pred cccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHH--HHHHHHHhCCCCCeEEEEEEEecCC---
Q psy3663 16 IAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLY--QEVRCMKLVQHPNVVRLYEVIDTNS--- 90 (259)
Q Consensus 16 ~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~--~e~~~l~~l~~~~i~~~~~~~~~~~--- 90 (259)
+..+|.+.+.||+|+||.||+|. .+|+.||||++.... ..... .|+..+..++||||+++++++.+++
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~--~~g~~vAvK~~~~~~-----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEE--ETTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CCcEEEEEEEEeeCCCeEEEEEE--ECCEEEEEEEECccc-----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 45789999999999999999998 478899999986432 23333 3555556788999999999986543
Q ss_pred -eEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcEeccCCCCCeEeeecCCeEEEE
Q psy3663 91 -KLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK--------LHVVHRDLKPENVVFFERLGVVKLT 161 (259)
Q Consensus 91 -~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~--------~~i~H~dl~p~nIlv~~~~~~i~l~ 161 (259)
.+++||||+++++|.+++.+. ++++..++.++.|++.++.++|+ +||+|+||||+||+++.+ +.++|+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~-~~~Kl~ 150 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIA 150 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTT-SCEEEC
T ss_pred eEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCC-CCeEEE
Confidence 589999999999999999865 38999999999999999999996 599999999999999766 899999
Q ss_pred eccccccCCCCCc-----cccccCCCccCCcccccCCCC-----CCCchhHHHHHHHHHHHHhCCCCCCC
Q psy3663 162 DFGFSNRFNPGQK-----LETSCGSLAYSAPEILLGDSY-----DAPAVDVWSLGVILYMLVAGQAPFQE 221 (259)
Q Consensus 162 df~~~~~~~~~~~-----~~~~~~~~~~~apE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~ 221 (259)
|||++........ .....++..|+|||.+.+... .+.++|||||||++|||++|.+||..
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 9999876643322 234568999999999876432 12389999999999999999988743
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-36 Score=253.27 Aligned_cols=225 Identities=22% Similarity=0.428 Sum_probs=175.1
Q ss_pred cCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-----------CCCeEEEEEEE
Q psy3663 18 GLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-----------HPNVVRLYEVI 86 (259)
Q Consensus 18 ~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~~ 86 (259)
++|++++.||+|+||.||+|.+..+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 47999999999999999999999999999999987542 23456778888888775 47899999887
Q ss_pred ec--CCeEEEEEeccCCCChHHH--HHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCCCCeEeeecCC-----
Q psy3663 87 DT--NSKLYLILELGDGGDLYDY--IMKHDAGLSETYAREYFAQIVRAISFCHK-LHVVHRDLKPENVVFFERLG----- 156 (259)
Q Consensus 87 ~~--~~~~~lv~e~~~~~sL~~~--~~~~~~~~~~~~i~~~~~ql~~al~~LH~-~~i~H~dl~p~nIlv~~~~~----- 156 (259)
.. ....+.++.+......... .......+++..++.++.||+.|+.+||+ .||+|+||||+||+++.+..
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 54 3455566655544332222 22334558999999999999999999998 89999999999999976532
Q ss_pred eEEEEeccccccCCCCCccccccCCCccCCcccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------ChHHHHH
Q psy3663 157 VVKLTDFGFSNRFNPGQKLETSCGSLAYSAPEILLGDSYDAPAVDVWSLGVILYMLVAGQAPFQEAN------DSETLTM 230 (259)
Q Consensus 157 ~i~l~df~~~~~~~~~~~~~~~~~~~~~~apE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~------~~~~~~~ 230 (259)
.++++|||.+.... .......++..|+|||.+....++. ++|+||+||++++|++|+.||...+ ..+.+..
T Consensus 170 ~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 170 QIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGC-GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCT-HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeeEeecccccccc--cccccccccccccChhhccccCCCc-cccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 49999999987543 2334567889999999999888875 9999999999999999999997543 3456677
Q ss_pred hhhccccccccccccCch
Q psy3663 231 IMDVSESSCTCWWRGRPR 248 (259)
Q Consensus 231 i~~~~~~~~~~~~~~~~~ 248 (259)
+.+.+++++.+++.....
T Consensus 247 ~~~~lg~~~~~~~~~~~~ 264 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKY 264 (362)
T ss_dssp HHHHHCSCCHHHHHHCTT
T ss_pred HHHHhCCCCHHHhhcccc
Confidence 778888877777755443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3.1e-25 Score=169.12 Aligned_cols=136 Identities=20% Similarity=0.194 Sum_probs=106.1
Q ss_pred eeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCc----------------ccHHHHHHHHHHHHhCCCCCeEEEE
Q psy3663 20 YDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDP----------------VSQDHLYQEVRCMKLVQHPNVVRLY 83 (259)
Q Consensus 20 y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~~~~i~~~~ 83 (259)
+.+.+.||+|++|.||+|.+. +|+.||||+++...... ........|...+.++.+.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568999999999999999985 78899999876432110 0122344678889999999998887
Q ss_pred EEEecCCeEEEEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCCCCeEeeecCCeEEEEec
Q psy3663 84 EVIDTNSKLYLILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHKLHVVHRDLKPENVVFFERLGVVKLTDF 163 (259)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~~~i~H~dl~p~nIlv~~~~~~i~l~df 163 (259)
+... .+++||++++..+.+ ++......++.||+.++.+||++||+|+||||+||++++ +.++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~--~~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE--EGIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET--TEEEECCC
T ss_pred EecC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC--CCEEEEEC
Confidence 6632 268999998855433 445556788999999999999999999999999999964 46999999
Q ss_pred cccccCC
Q psy3663 164 GFSNRFN 170 (259)
Q Consensus 164 ~~~~~~~ 170 (259)
|.+....
T Consensus 147 G~a~~~~ 153 (191)
T d1zara2 147 PQSVEVG 153 (191)
T ss_dssp TTCEETT
T ss_pred CCcccCC
Confidence 9886654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.92 E-value=2.6e-09 Score=83.52 Aligned_cols=142 Identities=18% Similarity=0.120 Sum_probs=96.0
Q ss_pred ccccCeeEeeeecccccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCeEE
Q psy3663 15 KIAGLYDLEETLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQ-HPNVVRLYEVIDTNSKLY 93 (259)
Q Consensus 15 ~~~~~y~~~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 93 (259)
.+.+.|+.++..+.++.+.||++. .++..+++|....... .....+.+|...++.+. +-.+++++.+..+.+..+
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 456788888876666667899886 5677788898754422 12334667888877765 333667788888888899
Q ss_pred EEEeccCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q psy3663 94 LILELGDGGDLYDYIMKHDAGLSETYAREYFAQIVRAISFCHK------------------------------------- 136 (259)
Q Consensus 94 lv~e~~~~~sL~~~~~~~~~~~~~~~i~~~~~ql~~al~~LH~------------------------------------- 136 (259)
++|+++.|.++.+.... ......++.++...+..||+
T Consensus 87 lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 99999999777654321 11122334445555555553
Q ss_pred ----------------------CCcEeccCCCCCeEeeecCCeEEEEeccccc
Q psy3663 137 ----------------------LHVVHRDLKPENVVFFERLGVVKLTDFGFSN 167 (259)
Q Consensus 137 ----------------------~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~ 167 (259)
..++|||++|.||++.++ +.+-|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCC-ceEEEeechhcc
Confidence 126899999999999654 445699999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.40 E-value=2.9e-07 Score=71.20 Aligned_cols=78 Identities=19% Similarity=0.161 Sum_probs=52.5
Q ss_pred eeEeeeeccccc-ceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCC--CeEEEEEEEecCCeEEEEE
Q psy3663 20 YDLEETLGRGHF-AVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHP--NVVRLYEVIDTNSKLYLIL 96 (259)
Q Consensus 20 y~~~~~i~~g~~-~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~~~~lv~ 96 (259)
++.. .+..|.. +.||++... .+..+++|...... ...+..|...++.+... .+.+++.+..+.+..+++|
T Consensus 13 ~~~~-~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~ 85 (255)
T d1nd4a_ 13 YDWA-QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 85 (255)
T ss_dssp CEEE-ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CceE-EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEE
Confidence 4443 4444543 678988743 56678889864332 33466777877776532 3567788878888899999
Q ss_pred eccCCCCh
Q psy3663 97 ELGDGGDL 104 (259)
Q Consensus 97 e~~~~~sL 104 (259)
++++|.++
T Consensus 86 ~~i~G~~~ 93 (255)
T d1nd4a_ 86 GEVPGQDL 93 (255)
T ss_dssp ECCSSEET
T ss_pred Eeeecccc
Confidence 99987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.33 E-value=7.1e-07 Score=73.68 Aligned_cols=79 Identities=13% Similarity=0.006 Sum_probs=50.3
Q ss_pred eeeecccccceEEEEEEeecCceEEEEEcccC-----CCCcccHHHHHHHHHHHHhCC---CCCeEEEEEEEecCCeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVFTGEKVAVKVIDKT-----KLDPVSQDHLYQEVRCMKLVQ---HPNVVRLYEVIDTNSKLYL 94 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~~~~~~~lK~~~~~-----~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 94 (259)
.+.||.|....||++.+...++.+++|..... ...+........|...++.+. ...+++++.+. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 45789999999999998877889999965321 112233445667887777664 23456666553 344578
Q ss_pred EEeccCCCC
Q psy3663 95 ILELGDGGD 103 (259)
Q Consensus 95 v~e~~~~~s 103 (259)
+||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.75 E-value=3.8e-05 Score=63.04 Aligned_cols=73 Identities=18% Similarity=0.173 Sum_probs=50.4
Q ss_pred eeeecccccceEEEEEEee-------cCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCe-EEEEEEEecCCeEEE
Q psy3663 23 EETLGRGHFAVVKLARHVF-------TGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV-VRLYEVIDTNSKLYL 94 (259)
Q Consensus 23 ~~~i~~g~~~~vy~~~~~~-------~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~l 94 (259)
++.|+.|..-.+|++.... ..+.+++++.... .......+|..+++.+...++ +++++++.+ ..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 4678889999999998652 2457888886532 134456788898888864444 467776643 57
Q ss_pred EEeccCCCC
Q psy3663 95 ILELGDGGD 103 (259)
Q Consensus 95 v~e~~~~~s 103 (259)
|++|++|.+
T Consensus 119 I~efi~g~~ 127 (395)
T d1nw1a_ 119 LEEYIPSRP 127 (395)
T ss_dssp EECCCCEEE
T ss_pred EEEEecccc
Confidence 899998643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.62 E-value=3.9e-05 Score=61.23 Aligned_cols=69 Identities=10% Similarity=0.099 Sum_probs=45.8
Q ss_pred cccceEEEEEEeecCceEEEEEcccCCCCcccHHHHHHHHHHHHhCCCCCe--EEEEEE-----EecCCeEEEEEeccCC
Q psy3663 29 GHFAVVKLARHVFTGEKVAVKVIDKTKLDPVSQDHLYQEVRCMKLVQHPNV--VRLYEV-----IDTNSKLYLILELGDG 101 (259)
Q Consensus 29 g~~~~vy~~~~~~~~~~~~lK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~-----~~~~~~~~lv~e~~~~ 101 (259)
+.-..||++... +|.+|++|+..... .+..++..|...+..|....+ +.+... +......+.+++++.|
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~~---~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEcC-CCCEEEEEEeCCCC---CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 334689998754 78899999986543 356778888888888763322 222211 2335668889999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.41 E-value=0.00017 Score=56.99 Aligned_cols=31 Identities=35% Similarity=0.528 Sum_probs=25.4
Q ss_pred CCcEeccCCCCCeEeeecCCeEEEEecccccc
Q psy3663 137 LHVVHRDLKPENVVFFERLGVVKLTDFGFSNR 168 (259)
Q Consensus 137 ~~i~H~dl~p~nIlv~~~~~~i~l~df~~~~~ 168 (259)
.|++|||+.++||+++.+ +..-++||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~-~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGD-ELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETT-EEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccc-cceeEeccccccc
Confidence 569999999999999655 4557999997743
|